Completed,Country,ISO,Domain,Metric,Yes? (Indicators),Indicators,Total number of indicators
Y,France,FRA,Health,Level of availability of harm reduction services and harm reduction scale up,Yes,"National survey of low-threshold structures (CAARUDs) conducted every 2 years, measures the number of users seen in these structures, the characteristics of these users and their use patterns. [...] The questions asked are on use (frequency, age of experimentation, administration route, equipment-sharing), screening (HIV, HBV and HCV) and social situation (social coverage, housing, level of education, support from friends and family) {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.104} ~ Network of outpatient treatment facilities (total number of units): Total number of units offering treatment services, broken down into: specialized drug treatment centers, low-threshold agencies, general/mental health care, prisons (see table 1) {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.84} ~",2
Y,France,FRA,Health,Presence of needle and syringe programs,Yes,"number of syringes distributed {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.134} ~",1
Y,France,FRA,Health,Prevalence of substance use disorders,Yes,"Proportion of 17 year old’s who are considered problematic/high risk users, divided by sex {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.37} ~ proportion and number of problem users {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.50} ~ ",2
Y,France,FRA,Health,Prevalence of psychiatric comorbidities,No,n/a,0
Y,France,FRA,Health,Drug-related mortality,Yes,"Reduce deaths, suicides and attempted suicides linked to drug use {Plan gouvernemental de lutte contre les drogues et les conduites addictives. Plan d'actions 2013-2015, p.36} ~ Drug-related deaths {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015,p.124} ~ percent of fatal overdoses {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.124} ~ number of AIDS deaths occurred among IDU (injection drug use) {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.128} ~",4
Y,France,FRA,Health,Prevalence of drug-related infectious disease,Yes,"Reduce the prevalence and incidence of infectious diseases {Plan gouvernemental de lutte contre les drogues et les conduites addictives. Plan d'actions 2013-2015, p.23} ~ prevalence of HIV among drug-users {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.127} ~ prevalence of HCV among drug users {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.127} ~",3
Y,France,FRA,Health,Proportion of people who use drugs who engage in risky consumption,No,n/a,0
Y,France,FRA,Health,Proportion of people who use drugs who engage in safe consumption practices,No,n/a,0
Y,France,FRA,Health,"Coverage of services for the prevention, testing, and treatment of bloodborne diseases",No,n/a,0
Y,France,FRA,Health,Presence of specialised training for addiction care,No,n/a,0
Y,France,FRA,Health,Presence of health harms related to drug use,Yes,"Reduce the prevalence of pathologies and traumas caused by the consumption of psychoactive products (especially punctual alcoholism) and behavioral addictions {Plan gouvernemental de lutte contre les drogues et les conduites addictives. Plan d'actions 2013-2015, p.20} ~ ",1
Y,France,FRA,Health,Presence of other health metrics,No,n/a,0
Y,France,FRA,Peace and Security,"Prevalence of alcohol and drugs in accidents, and interventions to increase road safety",Yes,"Reduce the prevalence of alcohol and drugs in accidents, especially fatal ones {Plan gouvernemental de lutte contre les drogues et les conduites addictives. Plan d'actions 2013-2015, p.35} ~ percent of prosecutions related to driving under the influence of narcotics {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.158} ~",2
Y,France,FRA,Peace and Security,Annual number of public disorder and violent crime reports,No,n/a,0
Y,France,FRA,Peace and Security,Number of non-lethal drug market violent events reported,No,n/a,0
Y,France,FRA,Peace and Security,Number of drug market related homicides and disappearances,No,n/a,0
Y,France,FRA,Peace and Security,Presence of other peace and security metrics,No,n/a,0
Y,France,FRA,Development,Coverage of housing assistance for people who use drugs,No,n/a,0
Y,France,FRA,Development,Coverage of social assistance for people who use drugs (not including housing),No,n/a,0
Y,France,FRA,Development,Number of households enrolled in alternative development,No,n/a,0
Y,France,FRA,Development,Presence of other development metrics,No,n/a,0
Y,France,FRA,Human Rights,"Prevalence and incidence of infectious diseases in vulnerable populations (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"Decrease the prevalence and incidence of infectious diseases in prisons {Plan gouvernemental de lutte contre les drogues et les conduites addictives. Plan d'actions 2013-2015, p.22} ~ prevalence of HIV and HCV in prison populations {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.170 & 173} ~ ",2
Y,France,FRA,Human Rights,"Prevalence of vulnerable people who use drugs (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"the prevalence of injection drug use in prisons {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.173} ~ ",1
Y,France,FRA,Human Rights,Proportion of people who use drugs in prison that are receiving medication assisted treatment (MAT),Yes,"The proportion of inmates receiving OST {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.96} ~ ",1
Y,France,FRA,Human Rights,Distribution of sterile injecting equipment in prisons,No,n/a,0
Y,France,FRA,Human Rights,Presence of programs and services targeted towards women ,No,n/a,0
Y,France,FRA,Human Rights,Presence of programs and services targeted towards people of color,No,n/a,0
Y,France,FRA,Human Rights,Presence of challenges and/or harms experienced by people of color,No,n/a,0
Y,France,FRA,Human Rights,"Presence of programs and services targeted towards vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"The number of prisoners that receive treatment from CSAPA services {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.85} ~",1
Y,France,FRA,Human Rights,"Presence of challenges and/or harms experienced by vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,France,FRA,Human Rights,Presence of other human rights metrics,No,n/a,0
Y,France,FRA,Demand Reduction,Prevalence of drug use by age,Yes,"Reduce youth consumption {Plan gouvernemental de lutte contre les drogues et les conduites addictives. Plan d'actions 2013-2015, p.16} ~ Lifetime, past 12 month use of cannabis and stimulant use among 17-year old’s {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.34, p.37, p.44} ~ Poly drug use: proportion of poly drug use in adult population {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.32} ~ stimulant use in schools and other populations {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.44} ~ ",3
Y,France,FRA,Demand Reduction,Prevalence of drug use by sex,Yes,"Proportion of 17 year old’s who have used cannabis in the last year by sex {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.37} ~ Levels of drug use (cannabis, poly-drug use, stimulant use) in men vs women {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.32, p.33, p.44} ~",2
Y,France,FRA,Demand Reduction,Prevalence of drug use by type,Yes,"Poly drug use: proportion of poly drug use in adult population {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.32} ~ stimulant use in schools and other populations {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.44} ~ Proportion of how many people have tried cannabis and crack {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.31, p.43} ~ Proportion of population considered recent cannabis users {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.31} ~ Proportion of regular cannabis users (10 times/month) {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.31} ~ Proportion of people who are at high risk of problem cannabis use {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.31} ~ Lifetime and past year prevalence of cannabis, cocaine, MDMA/ecstasy, amphetamines, heroin and other opioids {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.33, p.43, p.47, p.50} ~ ",7
Y,France,FRA,Demand Reduction,Number of people who use drugs,No,n/a,0
Y,France,FRA,Demand Reduction,"Prevalence of drug use by mode of administration (oral, mucosa, inhalation, and injection)",Yes,"proportion of users who used injection as the route of administration {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.45, p.51} ~ proportion of people whose route of administration was  oral {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.51} ~ ",2
Y,France,FRA,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT)",Yes,"Number of clients in treatment: Total number of clients in treatment, Total all clients entering treatment (See table 5) {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.90} ~ Network of outpatient treatment facilities (total number of units): Total number of units offering treatment services, broken down into: specialized drug treatment centers, general/mental health care (see table 1) {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.84} ~ Proportion of cannabis users and opioid users visiting a specialized addiction treatment structure for the first time {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.81} ~ Number of individuals admitted in outpatient CSAPA for problem use of illegal drugs or misappropriated psychoactive medicines {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.85} ~ Trends in numbers of first-time clients entering treatment, by primary drug (Opioids, Cocaine, Amphetamine/Methamphetamine, Ecstasy, Other substances, Cannabis, Missing Data), 2006-2014 (See figure 2) {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.100} ~ Trends in numbers of all clients entering treatment, by primary drug, (Opioids, Cocaine, Amphetamine/Methamphetamine, Ecstasy, Other substances, Cannabis, Missing Data) 2005-2014 (See figure 3) {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.100} ~",6
Y,France,FRA,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT) by age",Yes,"Number of cannabis users admitted to Youth Addiction Outpatient Clinics (CJC) {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.35} ~",1
Y,France,FRA,Demand Reduction,Level of access to opioid substitution treatment and medication assisted treatment (OST/MAT),Yes,"Number of clients in treatment: Total number of clients in treatment, Total OST clients, Total all clients entering treatment {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.90} ~ Opioid substitution treatments: use of buprenorphine and methadone from 1995 to 2014 in terms of daily dose/1,000 inhabitants aged 20 to 39 years/day (See figure 5) {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.99} ~ Trends in numbers of clients in opioid substitution treatment, 2010-2014 (See figure 4) {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.101} ~ Monitoring of indicators for diversion (targeting individuals dispensed more than 32 mg buprenorphine per day, together with users having at least 5 prescribers or 5 pharmacies dispensing treatment) in the OSM reimbursement databases of the National Health Insurance Fund {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.102} ~ number of people reimbursed for OST {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.51} ~ percentage of physicians prescribing OST {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.94} ~ ENa-CAARUD surveys (OFDT): route of administration of buprenorphine by CAARUD clients {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015,p.103} ~ Oppidum survey (ANSM): route of administration of buprenorphine by CSAPA or CAARUD clients {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.103} ~",8
Y,France,FRA,Demand Reduction,Level of coverage of inpatient treatment,Yes,"Network of inpatient treatment facilities (total number of units): Hospital-based residential drug treatment, Residential drug treatment (nonhospital based), Therapeutic communities, Prisons, Other inpatient units (See table 3) {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.87} ~ Total inpatient treatment provision (number of clients): Hospital-based residential drug treatment, Residential drug treatment (nonhospital based), Therapeutic communities, Prisons, Other inpatient units (See table 4) {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.89} ~ percentage of hospitalizations due to psychological problems not related to withdrawal (psychiatric comorbidities) {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.129} ~",3
Y,France,FRA,Demand Reduction,Proportion of people who use drugs enrolled in voluntary treatment,Yes,"The percent of people who consult the services voluntarily (spontaneously) {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.74} ~ ",1
Y,France,FRA,Demand Reduction,Proportion of people who use drugs enrolled in coerced treatment,Yes,"The percent of people who have been referred to services by the judicial system, family, by schools (by school health professionals, school consultation points or by school authorities within the framework of a sanction) {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.74} ~ ",2
Y,France,FRA,Demand Reduction,Proportion of people who use drugs enrolled in compulsory treatment,No,n/a,0
Y,France,FRA,Demand Reduction,Presence of prevention programming in law enforcement,No,n/a,0
Y,France,FRA,Demand Reduction,Presence of prevention programming in the media,No,n/a,0
Y,France,FRA,Demand Reduction,Presence of prevention programming in schools,No,n/a,0
Y,France,FRA,Demand Reduction,Presence of prevention programming in the workplace,No,n/a,0
Y,France,FRA,Demand Reduction,Presence of prevention programming for youth and the community,Yes,"number of youth who have attended consultation points (mainland and overseas). {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.74} ~ ",1
Y,France,FRA,Demand Reduction,Presence of other demand reduction metrics,Yes,"proportion of users who do cannabis for ""the search for pleasure and conviviality"" vs proportion of users who do cannabis for self-therapeutic reasons {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.35} ~ Percentage of drug use prior to imprisonment {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.172} ~",2
Y,France,FRA,Supply Reduction,Size and value of the illegal drug market,Yes,"the number of proceedings related to drug trafficking {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.24} ~ Percent of drug-related offenses broken down as follows: commerce-transport, import-export, dealing and selling, aiding and abetting {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.158} ~",2
Y,France,FRA,Supply Reduction,Level of procedures related to crop eradication,No,n/a,0
Y,France,FRA,Supply Reduction,"Number of arrests, seizures, and offences",Yes,"Percent of drug-related offenses broken down as follows: illegal use, possession, acquisition {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.158} ~ number of arrests {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.19} ~ Percentage of seizures classified by type of drug (See figures on,p.156 & p.160) {Plan gouvernemental de lutte contre les drogues et les conduites addictives. Plan d'actions 2013-2015, p.27; National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.156 & p.160} ~ number of arrests for drug-related offenses {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.158} ~ Quantity of drugs seized in kg (See table on page 161) {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.161} ~ ",5
Y,France,FRA,Supply Reduction,Level of law enforcement activity and interdiction in the market,Yes,"number of proceedings {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.19} ~ number of proceedings for simple use {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.23} ~ Percentage of checks classified by type of drug (See figures on,p.156 & p.160) {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.156 & p.160; Plan gouvernemental de lutte contre les drogues et les conduites addictives. Plan d'actions 2013-2015, p.27} ~",3
Y,France,FRA,Supply Reduction,"Price, purity and potency of drugs, and related process indicators",Yes,"Qualitative monitoring via the TREND scheme (OFDT) in 7 cities which track the availability and prices of OSM on the black market together with patterns of use {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.103} ~ ",1
Y,France,FRA,Supply Reduction,Number of people engaged with the criminal justice system,Yes,"Percent of prison sentences without remission or partial sentence suspension related to convictions for drug-related offences {National Report (2014 data) to the EMCDDA by the Reitox National Focal Point, 2015, p.158} ~",1
Y,France,FRA,Supply Reduction,Presence of other supply reduction metrics,No,n/a,0
Y,France,FRA,International Cooperation,Level of engagement in international cooperation,No,n/a,0
Y,Belgium,BEL,Health,Level of availability of harm reduction services and harm reduction scale up,Yes,"""Drugs, taking less risks” is a harm reduction information project at festive places which is set up by peers as well as professionals coming from the psychological, medical and social sector: Total number of interventions {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.49} ~ Total number of [...] sterile spoons, plastic flasks of water, and alcohol pads distributed by: Stérifix” project {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.99} ~ Snowball operations – French community – harm reduction services: Number of people they have come into contact with, and proportion reporting to be a current drug user {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.62} ~ ",3
Y,Belgium,BEL,Health,Presence of needle and syringe programs,Yes,"Total number of syringes distributed by NEP, Stérifix, the Flemish (FL) and French Community (FR) {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.99, p.100} ~ Total number of syringes recuperated by NEP, the Flemish (FL) and French Community (FR) {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.100p.99, p.100, p.101} ~ The location of where IDUs receive information about syringe exchange programmes (low threshold drug treatment (%) and through acquaintances (%)) {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.101} ~ Proportion of new clients reached via NEP {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.102}~ Injecting drug users in contact with needles exchange programmes in the Flemish Community {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p. 60} ~ Proportion of participants indicated to know at least one injecting drug user not in contact with the syringe exchange programmes. {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.61} ~ Proportion of Responses to the Injecting Risk Questionnaire (IRQ) within the needle exchange programmes in the Flemish region in 2013 (see table 6.3) {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.85} ~ ",7
Y,Belgium,BEL,Health,Prevalence of substance use disorders,Yes,"Decrease the number of drug-dependent citizens {Note politique du Gouvernement fédéral relative à la problématique de la drogue, 2001, p.7} ~ monitoring the problematic and intensive use of heroin, cocaine, amphetamines and cannabis by different groups such as detainees, female workers, youth and the festive environment {Une politique globale et intégrée en matière de drogues pour la Belgique, 2010, p.75} ~ monitoring the problematic and intensive use of heroin, cocaine, amphetamines and cannabis by different groups such as detainees, female workers, youth and the festive environment {Une politique globale et intégrée en matière de drogues pour la Belgique, 2010, p.75} ~ ",3
Y,Belgium,BEL,Health,Prevalence of psychiatric comorbidities,Yes,"Prevalence of psychiatric comorbidity of clients entering treatment in the Flemish Community (De Sleutel) between 2006 and 2013 (see table 6.6) {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.89} ~",1
Y,Belgium,BEL,Health,Drug-related mortality,Yes,"Drug-related deaths in the general population and problematic consumers {Une politique globale et intégrée en matière de drogues pour la Belgique, 2010, p.75; Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.9} ~ Number of deaths per region: Brussels, Flemish, Walloon {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.90}~ Number of drug-induced deaths (15-64yrs) based on the General Mortality Register (Selection B) between 2004 and 2011 (see table 6.7) {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.91} ~",3
Y,Belgium,BEL,Health,Prevalence of drug-related infectious disease,Yes,"reduce infectious diseases related to injection drug use {Une politique globale et intégrée en matière de drogues pour la Belgique, 2010, p.75} ~ Proportion of persons newly diagnosed with HIV being probably attributable to injecting drug use (IDU) {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.80}~ Proportion of AIDS diagnoses related to IDU {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.80} ~ Proportion of new HIV seropositive registrations {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.80} ~ Prevalence rate (%) of HIV-seropositivity among ever-IDUs in treatment in the Flemish region between 2006 and 2012 (see table 6.1) {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.81} ~ HIV-prevalence rates among injecting drug users and 95% Wilson’s confidence intervals by year and source between 1995 and 2013 (see figure 6.1) {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.81}~ Prevalence rate of Hepatitis B among ever-IDUs at treatment and other diagnostic settings in the Flemish Community between 2006 and 2013 (see table 6.2) {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.82} ~ Prevalence rate of Hepatitis C among ever-IDUs at treatment and other diagnostic settings in the Flemish Community between 2006 and 2013 (see figure 6.2) {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.83} ~ Incidence rate of tuberculosis (rate/100,000) {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.84}~ ",9
Y,Belgium,BEL,Health,Proportion of people who use drugs who engage in risky consumption,Yes,"Proportion of patients who have shared their syringes, classified by geographic area and type of center {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.131, p.132} ~ Proportion of patients who have shared their syringes, classified by program type {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.133} ~ Proportion of patients who have shared their syringes, classified by sex {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.133} ~ Proportion of patients who have shared their syringes, classified by age group {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.134} ~ Proportion of patients who have shared their syringes, classified by major substance {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.134} ~ Proportion of patients who have shared their syringes, classified by history of treatment {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.134} ~ Proportion of IDUs indicated to engage in unsafe disposal of their injecting equipment, e.g. throwing uncapped needles into garbage bins or on the street {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.102} ~ Proportion of IDU who have reported sharing needles {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.86} ~ Proportion who have injected with needles/syringes found on the street during the last six months {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.86} ~ Proportion (%) of injecting risk behaviour among street-recruited injecting drug users in the French Community (Modus Vivendi) between 2006 and 2013 (see table 6.4) {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.87} ~",10
Y,Belgium,BEL,Health,Proportion of people who use drugs who engage in safe consumption practices,No,n/a,0
Y,Belgium,BEL,Health,"Coverage of services for the prevention, testing, and treatment of bloodborne diseases",Yes,"Proportion of clients tested for syphilis with positive result {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.83}~ Proportion of those reporting a known risk factor of intravenous drug use being associated with the TB diagnosis {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.84} ~",2
Y,Belgium,BEL,Health,Presence of specialised training for addiction care,No,n/a,0
Y,Belgium,BEL,Health,Presence of health harms related to drug use,Yes,"Non-fatal overdose in injecting drug users in contact with syringe exchange in the Flemish region: Percentage reporting 1 overdose in the past year and percentage reporting multiple overdoses in the past year {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.88} ~ Proportion who did not experience an injection abscess during the last year, proportion who reported more than one injection abscess {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.86} ~",2
Y,Belgium,BEL,Health,Presence of other health metrics,Yes,"Proportion of patients living alone, classified by age group {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.50, p.51, p.54} ~ Proportion of patients living alone, classified by geographic area and type of center {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.52} ~ Proportion of patients living alone, classified by type of program {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.53} ~ Proportion of patients living alone, classified by sex {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.53} ~ Proportion of patients living alone, classified by major substance {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.54} ~ Proportion of patients living alone, classified by history of treatment {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.54} ~ Proportion of participants reporting to be injected by someone else during first injection. {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.61} ~ ",7
Y,Belgium,BEL,Peace and Security,"Prevalence of alcohol and drugs in accidents, and interventions to increase road safety",Yes,"In 2010, the number of serious drug-related injuries will be 545 at most {Une politique globale et intégrée en matière de drogues pour la Belgique, 2010, p.33} ~ For 2008 at the latest, the amount of driving under the influence of drugs shall not exceed 1% and the extent of driving under the influence of alcohol combined with the taking of illicit drugs shall not exceed 0,5% {Une politique globale et intégrée en matière de drogues pour la Belgique, 2010, p.33} ~ 1 in 10 drivers must be checked annually for illegal drugs in the traffic. This corresponds to 625,000 checks per year {Une politique globale et intégrée en matière de drogues pour la Belgique, 2010, p.33} ~ The subjective risk of being caught must be such that at least 90% of the Belgian population in possession of a driving license believe that the risk of being taken under the influence of the driver Alcohol and / or illicit drugs is very high {Une politique globale et intégrée en matière de drogues pour la Belgique, 2010, p.33} ~ The aim is to increase the current number of drug checks and to ensure that controls are better targeted at the locations and times, as well as the themes and target groups whose drug use - according to analyses of road accidents - show that they contribute substantially to road fatalities (reduce road fatalities) {Une politique globale et intégrée en matière de drogues pour la Belgique, 2010, p.34} ~",5
Y,Belgium,BEL,Peace and Security,Annual number of public disorder and violent crime reports,No,n/a,0
Y,Belgium,BEL,Peace and Security,Number of non-lethal drug market violent events reported,No,n/a,0
Y,Belgium,BEL,Peace and Security,Number of drug market related homicides and disappearances,No,n/a,0
Y,Belgium,BEL,Peace and Security,Presence of other peace and security metrics,No,n/a,0
Y,Belgium,BEL,Development,Coverage of housing assistance for people who use drugs,Yes,"Proportion of patients with a housing problem, classified by main substance {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.55, p.58} ~ Proportion of patients with housing problems classified by geographical area and type of center {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.55, p.56} ~ Proportion of patients with housing problems, classified by type of program {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.57} ~ Proportion of patients with housing problems, classified per year of registration in participating treatment programs on a regular basis between 2012 and 2015 {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.57} ~ Proportion of patients with housing problems, classified by sex {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.57} ~ Proportion of patients with housing problems, classified by age group {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.58} ~ Proportion of patients with housing problems, classified by history of treatment {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.58} ~ Proportion of IDUs living in an unstable environment (homeless or living with others) {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.61} ~ percentage of patients living in an unstable accommodation {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.109} ~",9
Y,Belgium,BEL,Development,Coverage of social assistance for people who use drugs (not including housing),No,n/a,0
Y,Belgium,BEL,Development,Number of households enrolled in alternative development,No,n/a,0
Y,Belgium,BEL,Development,Presence of other development metrics,Yes,"Patients with a low income, and patients with a low level of education can be measured and classified by age group {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.62 & p.71} ~ Patients with a low income, and patients with a low level of education can be measured and classified by sex {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.70} ~ Proportion of Belgian population with no degree or a primary degree of education {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.107} ~ Evolution of the proportion of people with a lower educational level in the general population and the drug user population (15 years and older) between 2011 and 2013 (see figure 8.1) {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.108} ~ Proportion of people looking for a job in the general population, and the proportion of people looking for a job in the drug user population in treatment {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.108}~ Evolution of the unemployment rate in the general population and in the drug user population (15-64 years) between 2011 and 2013 (see figure 8.2) {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.109}~",6
Y,Belgium,BEL,Human Rights,"Prevalence and incidence of infectious diseases in vulnerable populations (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Belgium,BEL,Human Rights,"Prevalence of vulnerable people who use drugs (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"monitoring the problematic and intensive use of heroin, cocaine, amphetamines and cannabis by different groups such as detainees {Une politique globale et intégrée en matière de drogues pour la Belgique, 2010, p.75} ~ ",1
Y,Belgium,BEL,Human Rights,Proportion of people who use drugs in prison that are receiving medication assisted treatment (MAT),Yes,"Proportion of Belgian prison population receiving OST {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.131} ~ Proportion of methadone used and proportion of buprenorphine used in Belgian Prison Population {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.131} ~",2
Y,Belgium,BEL,Human Rights,Distribution of sterile injecting equipment in prisons,No,n/a,0
Y,Belgium,BEL,Human Rights,Presence of programs and services targeted towards women ,No,n/a,0
Y,Belgium,BEL,Human Rights,Presence of programs and services targeted towards people of color,No,n/a,0
Y,Belgium,BEL,Human Rights,Presence of programs and services targeted towards people of color,No,n/a,0
Y,Belgium,BEL,Human Rights,Presence of challenges and/or harms experienced by people of color,No,n/a,0
Y,Belgium,BEL,Human Rights,"Presence of programs and services targeted towards vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Belgium,BEL,Human Rights,"Presence of challenges and/or harms experienced by vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Belgium,BEL,Human Rights,Presence of other human rights metrics,No,n/a,0
Y,Belgium,BEL,Demand Reduction,Prevalence of drug use by age,Yes,"Age characteristics classified by main substance of use {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.36} ~ Average age during the first consumption classified by substance type and by region {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.122} ~ Average age during the first consumption classified by substance type and by type of centre {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.123} ~ Average age during the first consumption classified by substance type and by sex {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.123} ~ Average age during the first consumption classified by substance type and by age {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.124} ~ Average age during the first consumption classified by substance type and by treatment history {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.124} ~ Proportion of minors classified by major substance {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.44} ~ Proportion of 12-18-year-old students who have ever used illicit psychoactive substances and who has used them the last year. {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.20} ~ Proportion of youth being the lifetime, last year and last month use (cannabis, cocaine, amphetamines, ecstasy, LSD, heroin, methadone, and buprenorphine); frequency of last month cannabis use; the age of first time cannabis use. Also classified by gender {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.20, p.22} ~ Proportion/prevalence of youth who use cannabis regularly {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.20} ~ The mean age at which school students used cannabis for the first time {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.20} ~ Proportion (%) of youth aged 15-24 reporting the use of cannabis {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.26} ~ Proportion (%) of youth aged 15-24 reporting the use of NPS: in the last 30 days, in the last 12 months, or more than 12 months ago {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.26} ~ Proportion of youth who used NPS with their friends or at a party event {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.26} ~Proportion of students who have ever used cannabis and have used another illicit psychoactive substance {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.58} ~ Proportion of students who are regular users of cannabis and have used another illicit drug {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.58} ~ Proportion of students who used more cannabis or longer than intended {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.59} ~ Proportion of students who felt the need to stop or reduce their consumption of cannabis {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.59} ~ Distribution of the frequency of consumption classified by type of drug and by age {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.120} ~",19
Y,Belgium,BEL,Demand Reduction,Prevalence of drug use by sex,Yes,"Average age during the first consumption classified by substance type and by sex {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.123} ~ Proportion of youth being the lifetime, last year and last month cannabis use; frequency of last month cannabis use; the age of first time cannabis use. Also classified by gender {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.20} ~ Proportion of female and male students reporting no expressions of problematic cannabis use {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.59} ~ Distribution of the frequency of consumption classified by type of drug and by sex {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.119} ~ ",4
Y,Belgium,BEL,Demand Reduction,Prevalence of drug use by type,Yes,"Age characteristics classified by main substance of use {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.36} ~ Average age during the first consumption classified by substance type and by region {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.122} ~ Average age during the first consumption classified by substance type and by type of centre {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.123} ~ Average age during the first consumption classified by substance type and by sex {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.123} ~ Average age during the first consumption classified by substance type and by age {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.124} ~ Average age during the first consumption classified by substance type and by treatment history {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.124} ~ Proportion of minors classified by major substance {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.44} ~ Proportion of youth being the lifetime, last year and last month of drug use (cannabis, cocaine, amphetamines, ecstasy, LSD, heroin, methadone and buprenorphine); frequency of last month cannabis use; the age of first time cannabis use. Also classified by gender {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.19, p.20, p.22} ~ Proportion/prevalence of youth who use cannabis regularly {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.20} ~ The mean age at which school students used cannabis for the first time {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.20} ~ Proportion (%) of youth aged 15-24 reporting the use of cannabis {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.26} ~ Proportion (%) of youth aged 15-24 reporting the use of NPS: in the last 30 days, in the last 12 months, or more than 12 months ago {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.26} ~ Proportion of youth who used NPS with their friends or at a party event {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.26} ~ Proportion of students who have ever used cannabis and have used another illicit psychoactive substance {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.58} ~ Proportion of students who are regular users of cannabis and have used another illicit drug {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.58} ~ Proportion of students who used more cannabis or longer than intended {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.59} ~ Proportion of students who felt the need to stop or reduce their consumption of cannabis {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.59} ~ All other: prevalence data of daily substance use, polydrug use (patterns) {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.55}~ Prevalence (%) of polydrug use within nightlife settings in the French Community between 2006 and 2013 (see table 4.2) {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p. 60, p.62} ~ Proportion of frequently declared substances {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.49} ~ Flemish Community & French community: prevalence of injected drug of choice, classified by substance - opiates, cocaine, amphetamines, heroin and methadone {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.61, p.62, p.63} ~ Proportion of “current” drug users, reporting current use of more than two products and reported the current use of three products or more. {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.62} ~ Proportion of Illicit substances mentioned during telephone enquiries received by the Belgian National Poison Centre in 2013 (see table 6.5) {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.88} ~ Distribution of the frequency of consumption classified by type of drug and by region {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.116} ~ Distribution of the frequency of consumption classified by type of drug and by type of centre {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.118} ~ Distribution of the frequency of consumption classified by type of drug and by age {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.120} ~ Distribution of the frequency of consumption classified by type of drug and by treatment history {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.121} ~",27
Y,Belgium,BEL,Demand Reduction,Number of people who use drugs,Yes,"proportion of drug use in the general population {Une politique globale et intégrée en matière de drogues pour la Belgique, 2010, p.75} ~ Prevalence of illicit substance use {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.19} ~ ",2
Y,Belgium,BEL,Demand Reduction,"Prevalence of drug use by mode of administration (oral, mucosa, inhalation, and injection)",Yes,"Proportion of the mode of consumption classified by type of drug and by region {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.110} ~ Distribution of mode of consumption classified by type of drug and by type of centre {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.112} ~ Distribution of mode of consumption classified by type of drug and by sex {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.113} ~ Distribution of mode of consumption classified by type of drug and by age {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.114} ~ Distribution of mode of consumption classified by type of drug and by treatment history {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.115} ~ The proportion of patients having already injected drugs classified by year of registration in treatment programs participating on a regular basis between 2012 and 2015 {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.126} ~ The proportion of patients having already injected drugs classified by geographical area and type of centre {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.128} ~ The proportion of patients having already injected drugs classified by program type {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.129} ~ The proportion of patients having already injected drugs classified by year of registration in treatment programs participating on a regular basis between 2012 and 2015 {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.129} ~ The proportion of patients having already injected drugs classified by sex {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.129} ~ The proportion of patients having already injected drugs classified by age {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.130} ~ The proportion of patients having already injected drugs classified by main substance of use {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.130} ~ The proportion of patients having already injected drugs classified by treatment history {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.130} ~ National prevalence estimation of injecting drug use {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.55, p.57, p.58} ~ Proportion of participants reported to be initiated into IDU before the age of 15 and/or 21 years {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.61} ~ Snowball operations: Number of respondents reporting to be lifetime IDU {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.62} ~ Proportion of lifetime IDUs reporting to be current IDUs {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.62} ~ Prevalence (%) of injecting drug use within nightlife settings in the French Community between 2006 and 2013 (see table 4.2) {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p. 60, p.62} ~",18
Y,Belgium,BEL,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT)",Yes,"Peer support in recreational settings – Mobile Team: Proportion of ppl who have consumed at least one psychotropic substance {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.49} ~ Average number of substances mentioned by patients classified by geographical area and type of centre {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.107} ~ Average number of substances mentioned by patients classified by sex {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.108} ~ Number of reported substances by patients classified by program type {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.93} ~ Number of reported substances by patients classified by sex {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.94} ~ Number of reported substances by patients classified by treatment history {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.96} ~ Number of reported substances by patients classified by main substance of use {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.96} ~ Evolution of the proportion of main substances reported per year of registration in treatment programs participating on a regular basis between 2012 and 2015 {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.98} ~ Distribution of the main substance of use causing most harm to patients classified by geographical area and type of centre {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.99} ~ Distribution of the main substance of use causing most harm to patients classified by program type {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.103} ~ Distribution of the main substance of use causing most harm to patients classified by year of registration in programs participating on a regular basis between 2012 and 2015 {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.104} ~ Distribution of the main substance of use causing most harm to patients classified by sex {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.104} ~ Distribution of the main substance of use causing most harm to patients classified by treatment history {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.105} ~ Patients with a low income, and patients with a low level of education can be measured and classified by major substance {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.62, p.68 & p.72} ~ Average number of substances mentioned by patients classified by main substance of use {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.106, p.109} ~ Number and proportion of treatment episodes (the amount times someone went for treatment), classified by geographical area {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.27} ~ Number of treatment episodes per year of registration {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.26, p.27, p.28} ~ Number and proportion of treatment episodes by treatment program {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.28} ~ Number and proportion of treatment episodes by treatment history by 2015 {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.29} ~ Number of patients per maximum number of treatment episodes observed in the 2011 to 2015 database {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.136} ~ Proportion of patients entering treatment for the first time classified by type of program {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.73, p.75} ~ Proportion of patients entering treatment for the first time classified by geographical area and type of centre {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.74} ~ Proportion of patients entering treatment for the first time classified by year of registration in treatment programs participating on a regular basis between 2012 and 2015 {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.75} ~ Proportion of patients entering treatment for the first time classified by sex {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.75} ~ Proportion of patients entering treatment for the first time classified by main substance of use {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.76} ~ Trends in numbers of clients entering treatment for the first time, by primary drug in the centres with a convention with the National Institute for Health and Disability Insurance between 2011 and 2013 (see figure 5.2 & 5.3) {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.75} ~ Characteristics of patients entering treatment in 2013 by type of primary drug: % women, % ever injected, % daily users, % use of only one substance, % first time in treatment (see table 5.5) {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.71} ~ Proportion of patients with multiple episodes between 2011 and 2015 treated in different treatment programs {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.140} ~ Proportion of patients with multiple episodes between 2011 and 2015 treated in different regions {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.137} ~ Proportion of patients with multiple episodes between 2011 and 2015 treated in different provinces {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.138} ~ Network of outpatient treatment facilities (total number of units) (see table 5.1) {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.68} ~ Total outpatient treatment provision for illicit drug treatment demand (number of clients) in 2013 (see table 5.2) {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.68} ~  Proportion currently in treatment, proportion reported never to have been in treatment. {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.61} ~ Patients with a low income, and patients with a low level of education can be measured and classified by type of program {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.59, p.61 & p.70} ~ Patients with a low income, and patients with a low level of education can be measured and classified by treatment history {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.62 & p.73} ~ Percentage of population entering treatment for substance use with no degree/education {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.107 }~ The following indicators - Proportion of women, Patients aged 60 years and older, Patients with children - can be measured and classified by age group (p.31, 34, 63, 66,), by geographical area and type of center (p.32, 46, 64), by type of program (p.33, 45, 47, 65), per year of registration in treatment programs participating on a regular basis between 2012 and 2015 (p.33, 47), by major substance (p.34, 48, 66), per treatment history (p.34, 48, 66), by sex (p.48, 65) {L’enregistrement TDI en Belgique Rapport annuel, 2015} ~Average number of substances mentioned by patients classified by program type and treatment history {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.108, p.109} ~",38
Y,Belgium,BEL,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT) by age",Yes,"Age characteristics classified by geographical area and type of centre {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.37} ~ Age characteristics classified by program type {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.39} ~ Age characteristics classified by year of registration in treatment programs participating on a regular basis between 2012 and 2015 {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.39} ~ Age characteristics classified by sex {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.40} ~ age characteristics classified by main substance of use {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.40} ~ Age characteristics classified by treatment history {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.40} ~ Proportions of minors classified by geographical area and type of center {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.42} ~ Proportions of minors classified by type of program {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.41 & p.43} ~ Proportion of minors classified by year of registration in treatment programs participating on a regular basis between 2012 and 2015 {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.43} ~ Proportion of minors classified by treatment history {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.44} ~ Proportions of minors classified by sex {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.44} ~ Average number of substances mentioned by patients classified by age {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.109} ~ Number of reported substances by patients classified by age {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.95} ~ Distribution of the main substance of use classified by age {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.105} ~ Proportion of patients entering treatment for the first time classified by age {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.76} ~ Characteristics of patients entering treatment in 2013 % mean age, Mean age at time of first use (see table 5.5) {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.71} ~ ",16
Y,Belgium,BEL,Demand Reduction,Level of access to opioid substitution treatment and medication assisted treatment (OST/MAT),Yes,"Proportion of problematic heroin users who have already undergone substitution therapy, classified by geographical area and type of center {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.86, p.87} ~ Proportion of problematic heroin users who have already undergone substitution treatment classified by program type {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.88} ~ Proportion of problematic heroin users who have already undergone substitution treatment, classified by sex {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.88} ~ Proportion of problematic heroin users who have already received substitution treatment, classified by age group {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.89} ~ Proportion of problematic heroin users who have already undergone substitution treatment by main drug {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.89} ~ Characteristics of patients receiving methadone or buprenorphine in 2013 by type of substance: Total amount (N), % women, Mean age, Region (%): Flemish, Brussels-capital, Walloon (see table 5.6) {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.72} ~ Trends in number of clients receiving methadone or buprenorphine between 2009 and 2013 (see figure 5.4) {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.76} ~",7
Y,Belgium,BEL,Demand Reduction,Level of coverage of inpatient treatment,Yes,"Network of inpatient treatment facilities (total number of units) (see table 5.3) {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.69} ~ Total inpatient treatment provision for illicit drug treatment demand (number of clients) in 2013 (see table 5.4) {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.70} ~ Demographic characteristics and patterns of use of persons admitted to Crisis Intervention Center’s in 2013 by substance: Total number of admissions into the crisis intervention center, Number of admissions related to the use of illicit drugs, Average length of stay (see table 7.1) {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.95} ~",3
Y,Belgium,BEL,Demand Reduction,Proportion of people who use drugs enrolled in voluntary treatment,Yes,"Reason for seeking treatment (voluntary, judicial, family referral) classified by age {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.81, p.85} ~ Reason for seeking treatment (voluntary, judicial, family referral) classified by geographical area and type of centre {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.82} ~ Reason for seeking treatment (voluntary, judicial, family referral) classified by program type {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.84} ~ Reason for seeking treatment (voluntary, judicial, family referral) classified by sex {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.84} ~ Reason for seeking treatment (voluntary, judicial, family referral) classified by main substance of use {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.85} ~ Reason for seeking treatment (voluntary, judicial, family referral) classified by treatment history {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.85} ~ Proportion of reason for orientation – individual, red cross, through a friend or through a peer {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.49} ~",7
Y,Belgium,BEL,Demand Reduction,Proportion of people who use drugs enrolled in coerced treatment,Yes,"Reason for seeking treatment (voluntary, judicial, family referral) classified by age {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.81, p.85} ~ Reason for seeking treatment (voluntary, judicial, family referral) classified by geographical area and type of centre {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.82} ~ Reason for seeking treatment (voluntary, judicial, family referral) classified by program type {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.84} ~ Reason for seeking treatment (voluntary, judicial, family referral) classified by sex {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.84} ~ Reason for seeking treatment (voluntary, judicial, family referral) classified by main substance of use {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.85} ~ Reason for seeking treatment (voluntary, judicial, family referral) classified by treatment history {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.85} ~ Proportion of reason for orientation – individual, red cross, through a friend or through a peer {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.49} ~",7
Y,Belgium,BEL,Demand Reduction,Proportion of people who use drugs enrolled in compulsory treatment,Yes,"Reason for seeking treatment (voluntary, judicial, family referral) classified by age {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.81, p.85} ~ Reason for seeking treatment (voluntary, judicial, family referral) classified by geographical area and type of centre {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.82} ~ Reason for seeking treatment (voluntary, judicial, family referral) classified by program type {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.84} ~ Reason for seeking treatment (voluntary, judicial, family referral) classified by sex {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.84} ~ Reason for seeking treatment (voluntary, judicial, family referral) classified by main substance of use {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.85} ~ Reason for seeking treatment (voluntary, judicial, family referral) classified by treatment history {L’enregistrement TDI en Belgique Rapport annuel, 2015, p.85} ~  Number of new assignments at the houses of justice for drug-related crimes between 2006 and 2013: Alternatives to pre-conviction detention, autonomous work sentence, mediation in criminal matters, probation, electronic surveillance {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.126} ~  ",7
Y,Belgium,BEL,Demand Reduction,Presence of prevention programming in law enforcement,Yes,"Substances detected in blood samples after a positive oral fluid screening test between 2011 and 2013 (see table 9.1) {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.122} ~",1
Y,Belgium,BEL,Demand Reduction,Presence of prevention programming in the media,Yes,"Proportion of youth who received information about NPS from the media, the internet or not at all {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.26} ~ Proportion of youth (age 25 and younger) who use the online services from Infor-Drogue and DrugLijn {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.40} ~ DrugLijn and Infor-Drogues: Number (N) and prevalence (%) of calls by gender and substance in 2013, DrugLijn and Infor-drogues. Figures include telephone calls & enquiries by e-mail. Percentages for 'involved substances' are calculated on total number of persons that mention at least 1 drug (5,486 persons) (see table, 3.1) {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.40} ~ Proportion of callers categorized by age group: 26-35, 36-50, 18-25 {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.41} ~ Non-profit association NADJA (prevention service): proportion of symptoms mentioned in the calls, absenteeism and unhooking, degradation of the relation with the parents, isolation, withdrawal and small criminal behaviour (fights, dealing, harassment, verbal threats, and violence are mentioned by parents as a motivation for a request. {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.46} ~ Number of self-assessment tests and knowledge tests filled out on the website. Number of people registered for the online self-help programmes for cannabis and cocaine. The number of website visitors, and the total number of page views {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.51} ~ The centres for alcohol and drug problems (CAD) and Drug aid Kempen (Drughulp Kempen): total number of visitors on their website, and total number of persons registering for treatment {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.52} ~ Proportion of groups who call the helplines: users, relatives, and professionals (Professionals include health care professionals, the educational sector, professionals of the justice sector, journalists and public authorities). {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.41} ~ Proportion of women and men who use these services {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.49} ~ Telephone inquiries related to drug intoxications {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.87} ~",10
Y,Belgium,BEL,Demand Reduction,Presence of prevention programming in schools,Yes,"Proportion of youth who received information about NPS from schools {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.26} ~ ",1
Y,Belgium,BEL,Demand Reduction,Presence of prevention programming in the workplace,No,n/a,0
Y,Belgium,BEL,Demand Reduction,Presence of prevention programming for youth and the community,Yes,"Number of patients followed by the service “Parenthood” (proportion divided: women, men and children) {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.46} ~ Proportion of people who returned to the ""Parenthood"" services voluntarily {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.46} ~ Number of families being followed by parenthood addiction team {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.46} ~ Proportion of youth who received information about NPS from friends or family {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.26} ~",4
Y,Belgium,BEL,Demand Reduction,Presence of other demand reduction metrics,No,n/a,0
Y,Belgium,BEL,Supply Reduction,Size and value of the illegal drug market,Yes,"Proportion of youth who obtained NPS from a friend, drug dealer, specialised shop, or online {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.26} ~",1
Y,Belgium,BEL,Supply Reduction,Level of procedures related to crop eradication,No,n/a,0
Y,Belgium,BEL,Supply Reduction,"Number of arrests, seizures, and offences",Yes,"Number and proportion of drug-related offences {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.118} ~ Proportion of drug law offences (%): Possession, Trade, Import and export, production, other {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.119}~ Number of drug law offences by type of drug: Cannabis, (Meth) amphetamine, Ecstasy, Heroin, Cocaine/Crack, Other {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.120}~ Sentences and suspensions for narcotic drugs, sleeping pills and psychotropic substances between 2006 and 2012: Drug related suspensions, Drug-related sentences {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.129}~ Number of drug seizures by substance (Cannabis (resin, herbal, plants, total), heroin, cocaine, amphetamine, methamphetamine, Ecstasy-type, LSD, GHB, Khat, total) between 2007 and 2013 (see table 10.1) {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.141}~ Total quantities of seized drugs by substance between 2007 and 2013 (see table 10.2) {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.143}~ Amounts of precursors seized between 2011 and 2013 (see table 10.3) {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.144}~ Number of seized cannabis plantations between 2008 and 2013, by plantation size (see table 10.5) {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.147}~",8
Y,Belgium,BEL,Supply Reduction,Level of law enforcement activity and interdiction in the market,Yes,"Number and type of synthetic drug labs dismantled by Belgian police services between 2007 and 2013 (see table 10.4) {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.145}~",1
Y,Belgium,BEL,Supply Reduction,"Price, purity and potency of drugs, and related process indicators",Yes,"Cannabis, heroin, cocaine, amphetamine, ecstasy and LSD price at street level (euro) {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.149, p.150, p.151, p.152 }~ Mean THC concentration (%) in samples of cannabis (herbal and resin), 2002- 2013 (see figure 10.1) {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.154} ~ Mean MDMA content (mg) in ecstasy tablets between 2002 and 2013 (see figure 10.2) {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.155} ~ Mean purity (%) of cocaine, heroin and amphetamine between 2002 and 2013 (see figure 10.3) {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.156}~ Composition of illicit drug tablets between 2008 and 2013 (see figure 10.4) {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.157}~ Description of tablet category ‘miscellaneous’ between 2008 and 2013 (see figure 10.5) {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.158}~ Adulterants/cutting agents found in seized drug powders in 2013 (see table 10.11) {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.160}~",7
Y,Belgium,BEL,Supply Reduction,Number of people engaged with the criminal justice system,Yes,"Proportion of drug/doping related cases entering the youth prosecution system in 2013 {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.128} ~ Drug/doping related cases entering the prosecution system of first line court between 2006-2013 {Belgian National Report on drugs 2014 New Developments and Trends, 2014, p.127} ~",2
Y,Belgium,BEL,Supply Reduction,Presence of other supply reduction metrics,No,n/a,0
Y,Belgium,BEL,International Cooperation,Level of engagement in international cooperation,No,n/a,0
Y,Australia,AUS,Health,Level of availability of harm reduction services and harm reduction scale up,Yes,"National NSP occasion of service health education interventions in 2017 and 2018 (BBV & STI; Drug health; Other health; Other non-health; More than one) {Needle Syringe Program National Minimum Data Collection, 2018, p.19} ~ National NSP occasion of service referral destination in 2017 and 2018 (BBV & STI; Drug health; Other health; Other non-health; More than one) {Needle Syringe Program National Minimum Data Collection, 2018, p.20} ~",2
Y,Australia,AUS,Health,Presence of needle and syringe programs,Yes,"Number (percentage) of respondents source of needle acquisition (Needle Syringe Program; Chemist/Pharmacy; Personal Sources; Dispensing/Vending Machine; Other Sources) and survey year {Australian Needle and Syringe Program Survey: National Data Report, 2018, p.14} ~ National and jurisdictional NSP services (%) by outlet type in 2018 (syringe dispensing machines; primary; secondary; pharmacy) {Needle Syringe Program National Minimum Data Collection, 2018, p.6} ~ National NSPs (%) by outlet type (syringe dispensing machines; primary; secondary; pharmacy) and remoteness area in 2018 (major cities; inner regional; outer regional; remote; very remote) {Needle Syringe Program National Minimum Data Collection, 2018, p.8} ~ National number of NSPs by outlet type and SA3 in 2018 {Needle Syringe Program National Minimum Data Collection, 2018, p.9, p.10} ~ National NSPs (%) by outlet type (syringe dispensing machines; primary; secondary; pharmacy) and greater capital city statistical area in 2018 (Greater Capital City; Rest of State) {Needle Syringe Program National Minimum Data Collection, 2018, p.11} ~ National occasion of service in 2016, 2017 and 2018 {Needle Syringe Program National Minimum Data Collection, 2018, p.12} ~ National occasion of service (%) by age group in 2016, 2017 and 2018 (less than 20 years; 20-29 years; 30-39 years; 40-49 years; 50+ years) {Needle Syringe Program National Minimum Data Collection, 2018, p.13} ~ National needle and syringe distribution by public and pharmacy sector NSP, 2008/09-2017/18 {Needle Syringe Program National Minimum Data Collection, 2018, p.21} ~ National syringe distribution and per capita syringes distributed, 2008/09-2017/18 (Public; Pharmacy; Total) {Needle Syringe Program National Minimum Data Collection, 2018, p.22, p.23} ~ National syringe distribution per ‘regular’ PWID, 2008/09-2017/18 (Number of 'regular' PWID; Syringes distributed (millions); Syringes per regular PWID) {Needle Syringe Program National Minimum Data Collection, 2018, p.24} ~ National syringe coverage per ‘regular’ PWID, 2008/09-2017/18 {Needle Syringe Program National Minimum Data Collection, 2018, p.24} ~ Mid-point, upper and lower estimates of the proportion of injections covered by a sterile syringe among ‘regular’ PWID, 2008/09-2017/18 {Needle Syringe Program National Minimum Data Collection, 2018, p.25} ~ National occasion of service drug injected (%) by ABS Drugs of Concern Broad Groups in 2016, 2017 and 2018 (Analgesics; Stimulants and Hallucinogens; Anabolic Agents and Selected Hormones; Other/More than one; Not reported) {Needle Syringe Program National Minimum Data Collection, 2018, p.16} ~ National occasion of service drug injected by ABS Drugs of Concern Broad groups and Base groups in 2017 and 2018 (Group 1 - Analgesics: Heroin, Methadone, Morphine, Subutex, Other Opiates, Multiple Opiates; Group 2 - Stimulants and Hallucinogens: Amphetamine, Methamphetamine, Cocaine, Other Stimulants, Multiple Stimulants; Group 3 - Anabolic Agents and Selected Hormones: Steroids, Peptides, Growth Hormone, Other PIED, Multiple PIED) {Needle Syringe Program National Minimum Data Collection, 2018, p.17} ~ National occasion of service among young people (aged <25 years) and older people (aged 50+ years) by gender (male, female) and drug injected in 2018 (Analgesics; Stimulants and Hallucinogens; Anabolic Agents and Selected Hormones; Other/ more than one; Not reported) {Needle Syringe Program National Minimum Data Collection, 2018, p.18} ~",15
Y,Australia,AUS,Health,Prevalence of substance use disorders,No,n/a,0
Y,Australia,AUS,Health,Prevalence of psychiatric comorbidities,No,n/a,0
Y,Australia,AUS,Health,Drug-related mortality,Yes,"% of Reduction in the drug-related burden of disease, including mortality {National Drug Strategy, 2017-2026, p.2 & p.41} ~ Number (percentage) of respondents who overdosed in the last 12 months (Yes; No; Not reported) and survey year {Australian Needle and Syringe Program Survey: National Data Report, 2018, p.13} ~ National number of accidental deaths due to opioids among those aged 15-54 years, 2005-2013 {Needle Syringe Program National Minimum Data Collection, 2018, p.32} ~",3
Y,Australia,AUS,Health,Prevalence of drug-related infectious disease,Yes,"Hepatitis C virus (HCV) and HIV/AIDS incidence {National Drug Strategy, 2017-2026, p.42} ~ Number of new diagnoses of hepatitis C virus infection among people aged 15-24 years, 2005/06-2016/17 {Needle Syringe Program National Minimum Data Collection, 2018, p.32} ~ HIV/HCV/HCV RNA antibody prevalence by gender (male, female, total) and survey year {Australian Needle and Syringe Program Survey: National Data Report, 2018, p.17, p.25, p.32} ~ HIV/HCV/HCV RNA antibody prevalence by sexual identity, gender (Heterosexual, Bisexual, Homosexual) and survey year {Australian Needle and Syringe Program Survey: National Data Report, 2018, p.17, p.25, p.32} ~ HIV/HCV/HCV RNA antibody prevalence by age group (< 25 years; 25-34 years; 35-44 years; 45+ years), gender (male, female, total) and survey year {Australian Needle and Syringe Program Survey: National Data Report, 2018, p.18, p.26, p.33} ~ HIV/HCV/HCV RNA antibody prevalence by last drug injected (Heroin, Methamphetamine, Other opioids, PIEDs, Other drugs), gender (male, female, total) and survey year {Australian Needle and Syringe Program Survey: National Data Report, 2018, p.19, p.28, p.34} ~ HIV/HCV/HCV RNA antibody prevalence by years since first injection (< 3 years; 3-10 years; 11+ years), gender (male, female, total) and survey year {Australian Needle and Syringe Program Survey: National Data Report, 2018, p.20, p.27, p.33} ~ HIV/HCV/HCV RNA antibody prevalence by re-use of someone else's used needle and syringe last month (No receptive sharing; receptive sharing), gender (male, female, total) and survey year {Australian Needle and Syringe Program Survey: National Data Report, 2018, p.20, p.27, p.33} ~ HIV/HCV/HCV RNA antibody prevalence by frequency of drug injection last month (less than daily; daily or more; not last month), gender (male, female, total) and survey year {Australian Needle and Syringe Program Survey: National Data Report, 2018, p.21, p.29, p.34} ~ HIV antibody prevalence by condom use at last sex with regular partner (No condom use; condom use), gender (male, female, total) and survey year {Australian Needle and Syringe Program Survey: National Data Report, 2018, p.22} ~ HIV antibody prevalence by sex work last month (No sex work; Sex work), gender (male, female, total) and survey year {Australian Needle and Syringe Program Survey: National Data Report, 2018, p.22} ~ HIV/HCV/HCV RNA antibody prevalence by region/country of birth (Australia; Other Oceania; Asia; UK & Ireland; Other) , gender (male, female, total) and survey year {Australian Needle and Syringe Program Survey: National Data Report, 2018, p.24, p.31, p.35} ~ HIV/HCV/HCV RNA antibody prevalence by main language spoken at home by parents (English speaking; Non-English speaking), gender (male, female, total) and survey year {Australian Needle and Syringe Program Survey: National Data Report, 2018, p.23, p.30, p.35} ~ ",13
Y,Australia,AUS,Health,Proportion of people who use drugs who engage in risky consumption,Yes,"Number (percentage) of respondents who re-used someone else's used needle & syringe last month (None; Once; Twice; 3-5 times; >5 times; Not reported) and survey year {Australian Needle and Syringe Program Survey: National Data Report, 2018, p.14} ~ Number (percentage) of respondents whose needle and syringe was re-used after last month (None; One; Two; Three to five; More than five; Don't know; Not reported) and survey year {Australian Needle and Syringe Program Survey: National Data Report, 2018, p.14} ~ Number (percentage) of respondents relationship to people needle & syringe was used after last month (Regular Sex Partner; Casual Sex Partner; Close Friend; Acquaintance; Other) and survey year {Australian Needle and Syringe Program Survey: National Data Report, 2018, p.14} ~ Number (percentage) of respondents equipment used after someone else (Spoon; Water; Filter; Drug Mix; None) and survey year {Australian Needle and Syringe Program Survey: National Data Report, 2018, p.14} ~ ",4
Y,Australia,AUS,Health,Proportion of people who use drugs who engage in safe consumption practices,Yes,"Number (percentage) of respondents present when someone injected for the first time in the last 12 months (Yes; No; Not reported) and survey year {Australian Needle and Syringe Program Survey: National Data Report, 2018, p.13} ~ Number (percentage) of respondents use of new needles and sterile needles and syringes last month (All injections; Most of the time; Half of the time; Some of the time; Not last month; Not reported) and survey year {Australian Needle and Syringe Program Survey: National Data Report, 2018, p.14} ~ Number (percentage) of respondents injected by someone after that person injected themselves or others last month and survey year{Australian Needle and Syringe Program Survey: National Data Report, 2018, p.14} ~",3
Y,Australia,AUS,Health,"Coverage of services for the prevention, testing, and treatment of bloodborne diseases",Yes,"Number (percentage) of respondents reporting previous HIV test , HCV test (Yes, ever; Yes, last year; > 1 year ago; Never tested; Not reported) and survey year {Australian Needle and Syringe Program Survey: National Data Report, 2018, p.15} ~ Number (percentage) of respondents lifetime treatment for HCV (Antiviral treatment; No antiviral treatment; Not reported) and survey year {Australian Needle and Syringe Program Survey: National Data Report, 2018, p.15} ~ Number (percentage) of respondents treatment for HCV in the past 12 months (Antiviral treatment; No antiviral treatment; Not reported) and survey year {Australian Needle and Syringe Program Survey: National Data Report, 2018, p.15} ~",3
Y,Australia,AUS,Health,Presence of specialised training for addiction care,Yes,"Number of long-term filled positions in agencies providing specialist AOD prevention and treatment services {National Alcohol and other Drug Workforce Development Strategy, 2015-2018, p.16} ~ Level of available mentoring, clinical supervision and appraisal programs {National Alcohol and other Drug Workforce Development Strategy, 2015-2018, p.16} ~ Career paths defined and expanded for AOD workers. {National Alcohol and other Drug Workforce Development Strategy, 2015-2018, p. 16} ~ Level of articulation between different types and levels of competencies required to work in the AOD field. {National Alcohol and other Drug Workforce Development Strategy, 2015-2018, p. 17} ~ Availability of education and training programs and resources for the AOD specialist workforce on the practicalities and benefits of consumer participation in service provision, policy, planning and research. {National Alcohol and other Drug Workforce Development Strategy, 2015-2018, p. 22} ~",5
Y,Australia,AUS,Health,Presence of health harms related to drug use,Yes,"Estimated intensity of withdrawal periods {National Ice Action Strategy, 2015, p. 21} ~",1
Y,Australia,AUS,Health,Presence of other health metrics,Yes,"Percentage of cost to Australian society of alcohol and other drug use in 2004, including costs to the health and hospitals system {National Drug Strategy, 2017-2026, p.13} ~ Number (percentage) of respondents by sex with a regular partner last month (Yes; No; Not reported) and survey year {Australian Needle and Syringe Program Survey: National Data Report, 2018, p.16} ~ Number (percentage) of respondents by condom used with regular partner last month (Never; Sometimes; Every time; Not reported) and survey year {Australian Needle and Syringe Program Survey: National Data Report, 2018, p.16} ~ Number (percentage) of respondents by sex with other partner(s) last month (No; Yes; Not reported) and survey year {Australian Needle and Syringe Program Survey: National Data Report, 2018, p.16} ~ Number (percentage) of respondents by condom used with other partners last month (Never; Sometimes; Every time; Not reported) and survey year {Australian Needle and Syringe Program Survey: National Data Report, 2018, p.16} ~ Number (percentage) of respondents by sex work last month (Yes; No; Not reported) and survey year {Australian Needle and Syringe Program Survey: National Data Report, 2018, p.16} ~ Number (percentage) of respondents by condom used at last sex work (Yes) and survey year {Australian Needle and Syringe Program Survey: National Data Report, 2018, p.16} ~",7
Y,Australia,AUS,Peace and Security,"Prevalence of alcohol and drugs in accidents, and interventions to increase road safety",Yes,"victims of drug related incidents {National Drug Strategy, 2017-2026, p.2} ~ Victims of illicit drug-related incidents in the last 12 months {National Drug Strategy, 2017-2026, p.41} ~",2
Y,Australia,AUS,Peace and Security,Annual number of public disorder and violent crime reports,Yes,Number (percentage) of respondents by type of places injected last month (Public; Private; Not reported) and survey year {p.14} ~,1
Y,Australia,AUS,Peace and Security,Number of non-lethal drug market violent events reported,No,n/a,0
Y,Australia,AUS,Peace and Security,Number of drug market related homicides and disappearances,No,n/a,0
Y,Australia,AUS,Peace and Security,Presence of other peace and security metrics,Yes,"Percentage of cost to Australian society of alcohol and other drug use in 2004, including costs to road accidents and crime. {National Drug Strategy, 2017-2026, p.13} ~ Number of workforce programs to develop effective linkages between criminal justice and specialist AOD agencies. {National Alcohol and other Drug Workforce Development Strategy, 2015-2018, p.30} ~ Availability of workforce development resources and programs for criminal justice workers to enhance their capacity to reduce AOD harm {National Alcohol and other Drug Workforce Development Strategy, 2015-2018, p.30} ~",3
Y,Australia,AUS,Development,Coverage of housing assistance for people who use drugs,No,n/a,0
Y,Australia,AUS,Development,Coverage of social assistance for people who use drugs (not including housing),No,n/a,0
Y,Australia,AUS,Development,Number of households enrolled in alternative development,No,n/a,0
Y,Australia,AUS,Development,Presence of other development metrics,Yes,"Percentage of cost to Australian society of alcohol and other drug use in 2004, including costs to lost workplace productivity {National Drug Strategy, 2017-2026, p.13} ~",1
Y,Australia,AUS,Human Rights,"Prevalence and incidence of infectious diseases in vulnerable populations (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"Proportion of blood‐borne viral infections due to injecting drug use among Aboriginal and Torres Strait Islander peoples {National Aboriginal Torres Strait Islander Peoples Drug Strategy, 2014-2019, p.5, p.34} ~ HIV/HCV/HCV RNA antibody prevalence by imprisonment last year (no imprisonment; imprisonment), gender (male, female, total) and survey year {Australian Needle and Syringe Program Survey: National Data Report, 2018, p.21, p.29, p.34}~ HIV/HCV/HCV RNA antibody prevalence by Aboriginal and Torres Strait Islander origin status (Non Indigenous; Indigenous), gender (male, female, total) and survey year {Australian Needle and Syringe Program Survey: National Data Report, 2018, p.23, p.30, p.35} ~ ",3
Y,Australia,AUS,Human Rights,"Prevalence of vulnerable people who use drugs (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"% of prison entrants reported using an illicit drug in the 12 months prior to entering prison, and prevalence of prison entrants reported using methamphetamine {National Drug Strategy, 2017-2026, p. 28} ~ Detainees who tested positive for drug use based on urinalysis {National Drug Strategy, 2017-2026, p.41} ~ Levels of illicit and licit drug use among national Aboriginal Torres Strait Islander Peoples {National Aboriginal Torres Strait Islander Peoples Drug Strategy, 2014-2019, p.5, p.34} ~",3
Y,Australia,AUS,Human Rights,Proportion of people who use drugs in prison that are receiving medication assisted treatment (MAT),No,n/a,0
Y,Australia,AUS,Human Rights,Distribution of sterile injecting equipment in prisons,No,n/a,0
Y,Australia,AUS,Human Rights,Presence of programs and services targeted towards women ,Yes,"National occasion of service proportion female (%) by age group in 2016, 2017 and 2018 {Needle Syringe Program National Minimum Data Collection, 2018, p.14} ~ ",1
Y,Australia,AUS,Human Rights,Presence of programs and services targeted towards people of color,Yes,"Access to needle and syringe exchange programs (both in mainstream and community‐controlled services), targeted to Aboriginal and Torres Strait Islander peoples {National Aboriginal Torres Strait Islander Peoples Drug Strategy, 2014-2019, p.26, p.35} ~ Number of Aboriginal and Torres Strait Islander people on opioid replacement therapy and referred from harm reduction services to general and mental health services and other social and welfare support services. {National Aboriginal Torres Strait Islander Peoples Drug Strategy, 2014-2019, p.26, p.35} ~ Number of culturally and community‐focused diversionary programs available to Aboriginal and Torres Strait Islander people, and particularly young Aboriginal and Torres Strait Islander people. {National Aboriginal Torres Strait Islander Peoples Drug Strategy, 2014-2019, p.22, p. 26, p.31, p.34} ~ Inclusion of cultural competencies within the range of organisations that interact with AOD clients. {National Aboriginal Torres Strait Islander Peoples Drug Strategy, 2014-2019, p.26, p.31, p. 35} ~ Number of long term filled positions and staff turnover rates among Aboriginal and Torres Strait Islander AOD workers. {National Alcohol and other Drug Workforce Development Strategy, 2015-2018, p. 24} ~ Percentage of Aboriginal and Torres Strait Islander AOD workers receiving mentoring and support. {National Alcohol and other Drug Workforce Development Strategy, 2015-2018, p.24} ~ Number of Aboriginal and Torres Strait Islander individuals undergoing training as AOD workers, doctors, nurses, psychologists, social workers and addiction medicine doctors. {National Alcohol and other Drug Workforce Development Strategy, 2015-2018, p.24} ~ Number of trained Aboriginal and Torres Strait Islander workers in the AOD field. {National Aboriginal Torres Strait Islander Peoples Drug Strategy, 2014-2019, p.22, p.35} ~ Level of qualifications of Aboriginal and Torres Strait Islander workers, including doctors, nurses, and psychologists in the AOD field in collaboration with universities and other training institutions. {National Aboriginal Torres Strait Islander Peoples Drug Strategy, 2014-2019, p.22, p.35} ~ Capacity of the AOD workforce to manage mental health and suicide risk {National Aboriginal Torres Strait Islander Peoples Drug Strategy, 2014-2019, p.22, p. 34} ~ Number of services which train staff in suicide prevention and mental health first aid {National Aboriginal Torres Strait Islander Peoples Drug Strategy, 2014-2019, p.22, p.35} ~ Number of workforce development programs among the broader AOD workforce that address culturally safe services to Indigenous Australians and that enhance linkages between AOD and multicultural/ethno-specific agencies {National Alcohol and other Drug Workforce Development Strategy, 2015-2018, p.24, p. 25 } ~ Extent of involvement of Aboriginal and Torres Strait Islander peoples and of CALD individuals in service planning {National Alcohol and other Drug Workforce Development Strategy, 2015-2018, p.24, p. 25} ~ Career satisfaction, stress and burnout rates among Aboriginal and Torres Strait Islander staff and among bilingual and bicultural workers providing AOD services. {National Alcohol and other Drug Workforce Development Strategy, 2015-2018, p. 24, p. 25} ~ Number of bilingual and bicultural workers recruited. {National Alcohol and other Drug Workforce Development Strategy, 2015-2018, p. 25} ~ Provision of after care services for National Aboriginal Torres Strait Islander Peoples  {National Aboriginal Torres Strait Islander Peoples Drug Strategy, 2014-2019, p.26, p.35} ~ Proportion of AOD and Social and Emotional Wellbeing services delivered by community‐controlled organisations {National Aboriginal Torres Strait Islander Peoples Drug Strategy, 2014-2019, p.26, p.31, p.35} ~ Number of through‐care programs in correctional and juvenile detention centres. {National Aboriginal Torres Strait Islander Peoples Drug Strategy, 2014-2019, p.31 & p.35} ~ Engagement in different types of drug treatment and treatment completion {National Aboriginal Torres Strait Islander Peoples Drug Strategy, 2014-2019, p.33} ~ Client satisfaction with treatment {National Aboriginal Torres Strait Islander Peoples Drug Strategy, 2014-2019, p.33, p.35} ~ Access of Aboriginal and Torres Strait Islander people to AOD programs, measured by awareness, convenience, availability, affordability, cultural safety and respect  {National Aboriginal Torres Strait Islander Peoples Drug Strategy, 2014-2019, p.34} ~ Dispensing of free nicotine replacement treatments. {National Aboriginal Torres Strait Islander Peoples Drug Strategy, 2014-2019, p.26, p.35} ~ Access to pharmacotherapies {National Aboriginal Torres Strait Islander Peoples Drug Strategy, 2014-2019, p. 26, p.35} ~ Number of referrals of offenders whose offences are AOD‐related to treatment, for example counselling services or residential rehabilitation diversion programs and culturally appropriate AOD services within prisons {National Aboriginal Torres Strait Islander Peoples Drug Strategy, 2014-2019, p.26, p.31, p.35} ~ Number of community‐driven and community‐accountable prevention programs, for example alcohol management strategies. {National Aboriginal Torres Strait Islander Peoples Drug Strategy, 2014-2019, p.31, p.34} ~ Access to low aromatic fuel in regions at risk of petrol‐sniffing. {National Aboriginal Torres Strait Islander Peoples Drug Strategy, 2014-2019, p.26 & p.35} ~ National occasion of service (%) by Indigenous status in 2016, 2017 and 2018 {Needle Syringe Program National Minimum Data Collection, 2018, p.15} ~",27
Y,Australia,AUS,Human Rights,Presence of challenges and/or harms experienced by people of color,Yes,"AOD‐related offending and involvement in the criminal justice system. {National Aboriginal Torres Strait Islander Peoples Drug Strategy, 2014-2019, p.5, p.34} ~",1
Y,Australia,AUS,Human Rights,"Presence of programs and services targeted towards vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"Number of workforce development programs to enhance linkages between AOD and LGBTI specific agencies. {National Alcohol and other Drug Workforce Development Strategy, 2015-2018, p.26} ~ Number of LGBTI workers recruited. {National Alcohol and other Drug Workforce Development Strategy, 2015-2018, p.26} ~  Career satisfaction, stress and burnout rates among LGBTI staff providing AOD services {National Alcohol and other Drug Workforce Development Strategy, 2015-2018, p.26} ~  Extent of involvement of LGBTI individuals in service planning. {National Alcohol and other Drug Workforce Development Strategy, 2015-2018, p.26} ~",4
Y,Australia,AUS,Human Rights,"Presence of challenges and/or harms experienced by vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Australia,AUS,Human Rights,Presence of other human rights metrics,Yes,"Number of agencies with policies in place concerning consumer participation in AOD service provision, policy, planning and research. {National Alcohol and other Drug Workforce Development Strategy, 2015-2018, p.22} ~ Extent of consumer participation in service provision, policy, planning and research in the AOD field. {National Alcohol and other Drug Workforce Development Strategy, 2015-2018, p.22} ~",2
Y,Australia,AUS,Demand Reduction,Prevalence of drug use by age,Yes,"average age of uptake of drugs, by drug type {National Drug Strategy, 2017-2026, p.2} ~ average age of initiation into illicit drug use {National Drug Strategy, 2017-2026, p.8, p. 41} ~ Prevalence of Australians aged 14 years and over that had used methamphetamine or cannabis in the last 12 months {National Drug Strategy, 2017-2026, p.30, p. 33} ~",2
Y,Australia,AUS,Demand Reduction,Prevalence of drug use by sex,No,n/a,0
Y,Australia,AUS,Demand Reduction,Prevalence of drug use by type,Yes,"average age of uptake of drugs, by drug type {National Drug Strategy, 2017-2026, p.2} ~ Prevalence of Australians aged 14 years and over that had used methamphetamine or cannabis in the last 12 months {National Drug Strategy, 2017-2026, p.30, p. 33} ~ Prevalence of crystal-methamphetamine use {National Drug Strategy, 2017-2026, p.30} ~ percentage of users consuming methamphetamine daily or weekly {National Drug Strategy, 2017-2026, p.30} ~ Prevalence of Australians had used cannabis in their lifetime {National Drug Strategy, 2017-2026, p.33} ~ Prevalence of Heroin use ‘in the last 12 months’ {National Drug Strategy, 2017-2026, p.33} ~ estimates of Australians reporting that they used ice in 2013, compared to an estimates in 2007 {National Ice Action Strategy, 2015, p.8} ~ Number of people using ice at least weekly {National Ice Action Strategy, 2015, p.9} ~ Frequency of use by ice users {National Ice Action Strategy, 2015, p.9} ~ Australian populations with high rates of ice use {National Ice Action Strategy, 2015, p.9} ~ Reasons given for continued ice use by ice users {National Ice Action Strategy, 2015, p.21} ~",11
Y,Australia,AUS,Demand Reduction,Number of people who use drugs,Yes,"recent use of any drug (people living in households) {National Drug Strategy, 2017-2026, p.2} ~ Prevalence of the population that have used at least one illicit drug in the last year {National Drug Strategy, 2017-2026, p. 8, p.41} ~  arrestees’ illicit drug use in the month before committing an offence {National Drug Strategy, 2017-2026, p.2} ~ ",3
Y,Australia,AUS,Demand Reduction,"Prevalence of drug use by mode of administration (oral, mucosa, inhalation, and injection)",Yes,"Method of use by people receiving treatment for meth/amphetamines {National Ice Action Strategy, 2015, p.9} ~ Prevalence among those who use meth/amphetamine, the use of powder as the main form of the drug {National Drug Strategy, 2017-2026, p.30} ~ Number (percentage) of respondents by last drug injected (Cocaine; Methamphetamine; Heroin; Pharm. Opioids; Methadone; Buprenorphine; Burprenorphine/Naloxone; PIEDs; More than one; Other; Not reported) and survey year {Australian Needle and Syringe Program Survey: National Data Report, 2018, p.13} ~ Number (percentage) of respondents who have ever injected opioids (Yes; No; Not reported) and survey year {Australian Needle and Syringe Program Survey: National Data Report, 2018, p.13} ~ Number (percentage) of respondents by frequency of injection last month (Not last month; Less than weekly; Weekly not daily; Daily or more; Not reported) and survey year {Australian Needle and Syringe Program Survey: National Data Report, 2018, p.13} ~ National lifetime and recent (past 12 months) injection of illicit drugs (%) among people aged 14 years or older, 2001-2016 {Needle Syringe Program National Minimum Data Collection, 2018, p.31} ~ Trends in the estimated number of ‘regular’ PWID in Australia 2000/01-2017/18 {Needle Syringe Program National Minimum Data Collection, 2018, p.33} ~",7
Y,Australia,AUS,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT)",Yes,"Level of capability among generalist health, community, welfare and support services workers to prevent and reduce AOD harm. {National Alcohol and other Drug Workforce Development Strategy, 2015-2018, p.28} ~ number of specialist drug treatments provided for meth/amphetamines {National Ice Action Strategy, 2015, p.8} ~ Drug treatment episodes {National Drug Strategy, 2017-2026, p. 42} ~ Number of formally accredited AOD services. {National Aboriginal Torres Strait Islander Peoples Drug Strategy, 2014-2019, p.33 & p.35} ~ Alcohol and other drug attributable hospital admissions and ambulance attendances {National Drug Strategy, 2017-2026, p.42} ~ Number (percentage) of respondents who participated ever in any treatment/therapy for drug use (No; Yes; Not reported) and survey year {Australian Needle and Syringe Program Survey: National Data Report, 2018, p.15} ~ Number of principal opioid-related hospital admissions/separations per million persons aged 15-54 years, 2005/06-2014/15 {Needle Syringe Program National Minimum Data Collection, 2018, p.32} ~",7
Y,Australia,AUS,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT) by age",No,n/a,0
Y,Australia,AUS,Demand Reduction,Level of access to opioid substitution treatment and medication assisted treatment (OST/MAT),Yes,"Opioid pharmacotherapy clients {National Drug Strategy, 2017-2026, p.42} ~ Number (percentage) of respondents who have a history of methadone maintenance treatment/buprenorphine (Subutex) treatment/burprenorphine-naloxone treatment (Suboxone) and survey year {Australian Needle and Syringe Program Survey: National Data Report, 2018, p.15} ~ ",2
Y,Australia,AUS,Demand Reduction,Level of coverage of inpatient treatment,Yes,"The number of hospitalisations related to methamphetamine between 2009–10 and 2013–14 {National Ice Action Strategy, 2015, p.8} ~ ",1
Y,Australia,AUS,Demand Reduction,Proportion of people who use drugs enrolled in voluntary treatment,No,n/a,0
Y,Australia,AUS,Demand Reduction,Proportion of people who use drugs enrolled in coerced treatment,No,n/a,0
Y,Australia,AUS,Demand Reduction,Proportion of people who use drugs enrolled in compulsory treatment,Yes,"number of diversions for cannabis-related offences {National Drug Strategy, 2017-2026, p.4} ~",1
Y,Australia,AUS,Demand Reduction,Presence of prevention programming in law enforcement,No,n/a,0
Y,Australia,AUS,Demand Reduction,Presence of prevention programming in the media,No,n/a,0
Y,Australia,AUS,Demand Reduction,Presence of prevention programming in schools,Yes,"Availability of workforce development resources and programs for the education sector enabling them to enhance their capacity to prevent and reduce AOD harms among students. {National Alcohol and other Drug Workforce Development Strategy, 2015-2018, p.31} ~ Number of workforce programs to develop effective linkages between the education sector (primary, secondary, VET, tertiary) and specialist AOD sector (service providers, registered training organisations and research agencies) {National Alcohol and other Drug Workforce Development Strategy, 2015-2018, p.31} ~",2
Y,Australia,AUS,Demand Reduction,Presence of prevention programming in the workplace,Yes,"Availability of workforce development resources and programs for generalist workers to increase their capacity to prevent and reduce AOD harm. {National Alcohol and other Drug Workforce Development Strategy, 2015-2018, p.28} ~ Availability of specialist AOD professionals to act as consultants to generalist staff {National Alcohol and other Drug Workforce Development Strategy, 2015-2018, p.28} ~ Percentage of specialist AOD prevention and treatment staff receiving mentoring and support. {National Alcohol and other Drug Workforce Development Strategy, 2015-2018, p.16} ~ Career satisfaction enhanced and stress and burnout rates minimised among specialist AOD prevention and treatment staff {National Alcohol and other Drug Workforce Development Strategy, 2015-2018, p.16} ~",4
Y,Australia,AUS,Demand Reduction,Presence of prevention programming for youth and the community,Yes,"Prevalence of Australians identified methamphetamine as the illicit drug of most concern to the community {National Drug Strategy, 2017-2026, p. 31} ~ Percentage of AOD roles that have child and family sensitive practice defined as a key workforce capability {National Alcohol and other Drug Workforce Development Strategy, 2015-2018, p.20} ~ Proportion of AOD agencies which have implemented organisational policies, guidelines, practices and workforce development measures to support child and family sensitive practice. {National Alcohol and other Drug Workforce Development Strategy, 2015-2018, p.20} ~ Availability of workforce development resources and programs for the AOD sector focused on enhancing child and family sensitive practice. {National Alcohol and other Drug Workforce Development Strategy, 2015-2018, p.20} ~ Number of AOD agencies that have developed links with child wellbeing/welfare/ family violence services. {National Alcohol and other Drug Workforce Development Strategy, 2015-2018, p.20} ~",5
Y,Australia,AUS,Demand Reduction,Presence of other demand reduction metrics,Yes,"Nationally consistent terminology to describe the roles of the specialist AOD prevention and treatment workforce {National Alcohol and other Drug Workforce Development Strategy, 2015-2018, p.14} ~ Comprehensive knowledge of the extent and nature of the specialist AOD prevention and treatment workforce {National Alcohol and other Drug Workforce Development Strategy, 2015-2018, p.14} ~ Percentage of agencies providing specialist AOD prevention and treatment services that report they are able to attract and retain requisite staff {National Alcohol and other Drug Workforce Development Strategy, 2015-2018, p.16} ~ Appropriate turnover rates in specialist AOD prevention and treatment services {National Alcohol and other Drug Workforce Development Strategy, 2015-2018, p.16} ~ Number of methamphetamine related hospital separations {National Ice Action Strategy, 2015, p.9} ~ Australian spending on alcohol and other drug treatment, funder and source 2012–13 {National Ice Action Strategy, 2015, p.13} ~",6
Y,Australia,AUS,Supply Reduction,Size and value of the illegal drug market,Yes,"Australian injecting drug users reporting that it is easy or very easy to access ice {National Ice Action Strategy, 2015, p.19} ~ the availability and purity of methamphetamine (as indicated by more domestic seizures, border detections and arrests) {National Drug Strategy, 2017-2026, p.12} ~ the number of prescriptions for opioid prescriptions subsidised by the Pharmaceutical Benefits Scheme {National Drug Strategy, 2017-2026, p.33} ~ The availability of illegal drugs, as perceived by people who use illegal drugs {National Drug Strategy, 2017-2026, p.42} ~ ",4
Y,Australia,AUS,Supply Reduction,Level of procedures related to crop eradication,No,n/a,0
Y,Australia,AUS,Supply Reduction,"Number of arrests, seizures, and offences",Yes,"Kilograms of ice seized at the Australian border {National Ice Action Strategy, 2015, p.9} ~ Arrests for amphetamine-type stimulant drug offences {National Ice Action Strategy, 2015, p.18} ~ Illicit drugs and precursors seized {National Drug Strategy, 2017-2026, p.42} ~ Domestically and at the border, the number in tons of drugs seized and its estimated price (2013-2014) {National Ice Action Strategy, 2015, p.18} ~ % of adult detainees interviewed as part of the Drug Use Monitoring in Australia program reported that their alcohol and other drug use contributed to their current detention by police {National Drug Strategy, 2017-2026, p. 28} ~  National number of illicit drug arrests, 2005/06-2016/17 {Needle Syringe Program National Minimum Data Collection, 2018, p.31} ~ National number of illicit drug seizures, 2005/06-2016/17 {National Drug Strategy, 2017-2026, p.4; Needle Syringe Program National Minimum Data Collection, 2018, p.31} ~",7
Y,Australia,AUS,Supply Reduction,Level of law enforcement activity and interdiction in the market,Yes,"Diversion of licit drugs e.g. pharmaceuticals {National Drug Strategy, 2017-2026, p.42} ~",1
Y,Australia,AUS,Supply Reduction,"Price, purity and potency of drugs, and related process indicators",Yes,"National annual median street price for one gram of ice {National Ice Action Strategy, 2015, p.19} ~ National annual median purity of domestically seized methamphetamine {National Ice Action Strategy, 2015, p.19} ~ availability and purity of methamphetamine (as indicated by more domestic seizures, border detections and arrests) {National Drug Strategy, 2017-2026, p.12} ~ The purity of illegal drugs {National Drug Strategy, 2017-2026, p.42} ~ Domestically and at the border, the number in tons of drugs seized and its estimated price (2013-2014) {National Ice Action Strategy, 2015, p.18} ~",5
Y,Australia,AUS,Supply Reduction,Number of people engaged with the criminal justice system,No,n/a,0
Y,Australia,AUS,Supply Reduction,Presence of other supply reduction metrics,No,n/a,0
Y,Australia,AUS,International Cooperation,Level of engagement in international cooperation,No,n/a,0
Y,Tunisia,TUN,Health,Level of availability of harm reduction services and harm reduction scale up,Yes,"Chems for young people: Number of sterile gauze pads distributed. Number of condoms distributed. Number of educational brochures distributed {Tunisia: Drug Situation and Policy, 2014, p.25}~ Results produced - 2018: At least 80% of IDUs welcomed by associations, have access to risk reduction measures {Plan Stratégique National de la riposte au VIH/sida et aux IST en Tunisie, 2015-2018, p.78}~",2
Y,Tunisia,TUN,Health,Presence of needle and syringe programs,Yes,"Chems for young people: Needle exchange programme: number of needles distributed and/or exchanged {Tunisia: Drug Situation and Policy, 2014, p.25}~ ",1
Y,Tunisia,TUN,Health,Prevalence of substance use disorders,No,n/a,0
Y,Tunisia,TUN,Health,Prevalence of psychiatric comorbidities,No,n/a,0
Y,Tunisia,TUN,Health,Drug-related mortality,No,n/a,0
Y,Tunisia,TUN,Health,Prevalence of drug-related infectious disease,Yes,"Evolution of the distribution of the mode of transmission of new cases of HIV/AIDS, Tunisia 1986-2013 (IDU) {Plan Stratégique National de la riposte au VIH/sida et aux IST en Tunisie, 2015-2018, p.32}~ Changes in the pattern of transmission of new HIV / AIDS cases by sex (males and females) Tunisia (IDU) {Plan Stratégique National de la riposte au VIH/sida et aux IST en Tunisie, 2015-2018, p.32, p.33}~ Distribution of modes of transmission of new HIV/AIDS cases by gender, Tunisia in 2012 and 2013 (IDU) {Plan Stratégique National de la riposte au VIH/sida et aux IST en Tunisie, 2015-2018, p.33}~ Prevalence (%) of HIV infection in IDU, Sero-Behavioral Surveys 2009 - 2011 - 2014 {Plan Stratégique National de la riposte au VIH/sida et aux IST en Tunisie, 2015-2018, p.34, p.36}~",4
Y,Tunisia,TUN,Health,Proportion of people who use drugs who engage in risky consumption,No,n/a,0
Y,Tunisia,TUN,Health,Proportion of people who use drugs who engage in safe consumption practices,Yes,"Prevalence of each key population (IDU), affected by the programs adopt a lower risk behavior by 2018 (PS, MSM, IDU) {Plan Stratégique National de la riposte au VIH/sida et aux IST en Tunisie, 2015-2018, p.78}~",1
Y,Tunisia,TUN,Health,"Coverage of services for the prevention, testing, and treatment of bloodborne diseases",Yes,"ATUPRET: Number of persons screened for HIV/AIDS from 2010 to 2012, The number of men and women screened, and the number who tested HIV positive {Tunisia: Drug Situation and Policy, 2014, p.21}~ The percent of IDUs who are screened and follow up on their test results. {Tunisia: Drug Situation and Policy, 2014, p.26}~ Outcome 2012:  Prevalence of HIV screening in key populations (MSM, HCWs, IDUs) {Plan Stratégique National de la riposte au VIH/sida et aux IST en Tunisie, 2015-2018, p.74}~ Outcome in 2012: Prevalence of sensitization activities for key populations (TS, inmates, IDUs, MSM) {Plan Stratégique National de la riposte au VIH/sida et aux IST en Tunisie, 2015-2018, p.74}~",4
Y,Tunisia,TUN,Health,Presence of specialised training for addiction care,No,n/a,0
Y,Tunisia,TUN,Health,Presence of health harms related to drug use,No,n/a,0
Y,Tunisia,TUN,Health,Presence of other health metrics,No,n/a,0
Y,Tunisia,TUN,Peace and Security,"Prevalence of alcohol and drugs in accidents, and interventions to increase road safety",No,n/a,0
Y,Tunisia,TUN,Peace and Security,Annual number of public disorder and violent crime reports,No,n/a,0
Y,Tunisia,TUN,Peace and Security,Number of non-lethal drug market violent events reported,No,n/a,0
Y,Tunisia,TUN,Peace and Security,Number of drug market related homicides and disappearances,No,n/a,0
Y,Tunisia,TUN,Peace and Security,Presence of other peace and security metrics,No,n/a,0
Y,Tunisia,TUN,Development,Coverage of housing assistance for people who use drugs,No,n/a,0
Y,Tunisia,TUN,Development,Coverage of social assistance for people who use drugs (not including housing),No,n/a,0
Y,Tunisia,TUN,Development,Number of households enrolled in alternative development,No,n/a,0
Y,Tunisia,TUN,Development,Presence of other development metrics,No,n/a,0
Y,Tunisia,TUN,Human Rights,"Prevalence and incidence of infectious diseases in vulnerable populations (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"the number of prisoners who were tested HIV-positive {Tunisia: Drug Situation and Policy, 2014, p.21}~",1
Y,Tunisia,TUN,Human Rights,"Prevalence of vulnerable people who use drugs (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Tunisia,TUN,Human Rights,Proportion of people who use drugs in prison that are receiving medication assisted treatment (MAT),No,n/a,0
Y,Tunisia,TUN,Human Rights,Distribution of sterile injecting equipment in prisons,No,n/a,0
Y,Tunisia,TUN,Human Rights,Presence of programs and services targeted towards women ,No,n/a,0
Y,Tunisia,TUN,Human Rights,Presence of programs and services targeted towards people of color,No,n/a,0
Y,Tunisia,TUN,Human Rights,Presence of challenges and/or harms experienced by people of color,No,n/a,
Y,Tunisia,TUN,Human Rights,"Presence of programs and services targeted towards vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"Awareness raising and screening of prisoners across all Tunisian prisons: Number of prisoners who benefitted from the awareness raising campaigns, the number of prisoners who were screened for HIV/AIDS {Tunisia: Drug Situation and Policy, 2014, p.21}~ Prevalence of sensitization activities for key populations (inmates) {Plan Stratégique National de la riposte au VIH/sida et aux IST en Tunisie, 2015-2018, p.74}~ ",2
Y,Tunisia,TUN,Human Rights,"Presence of challenges and/or harms experienced by vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,
Y,Tunisia,TUN,Human Rights,Presence of other human rights metrics,No,n/a,0
Y,Tunisia,TUN,Demand Reduction,Prevalence of drug use by age,Yes,"Cannabis (zatla) use amongst high school students (ages 15 to 17) according to gender: at least once in their lifetime, in the past year, in the past month {Tunisia: Drug Situation and Policy, 2014, p.15}~ Use of psychotropic drugs amongst high school students (ages 15 to 17) according to their knowledge of the fictitious drug “zarga”: Have heard of zarga, never heard of zarga, and total (at least once in their lifetime, in the past year, in the past month) {Tunisia: Drug Situation and Policy, 2014, p.15}~",2
Y,Tunisia,TUN,Demand Reduction,Prevalence of drug use by sex,Yes,"Cannabis (zatla) use amongst high school students (ages 15 to 17) according to gender: at least once in their lifetime, in the past year, in the past month {Tunisia: Drug Situation and Policy, 2014, p.15}~ ",1
Y,Tunisia,TUN,Demand Reduction,Prevalence of drug use by type,Yes,"Cannabis (zatla) use amongst high school students (ages 15 to 17) according to gender: at least once in their lifetime, in the past year, in the past month {Tunisia: Drug Situation and Policy, 2014, p.15}~ Use of psychotropic drugs amongst high school students (ages 15 to 17) according to their knowledge of the fictitious drug “zarga”: Have heard of zarga, never heard of zarga, and total (at least once in their lifetime, in the past year, in the past month) {Tunisia: Drug Situation and Policy, 2014, p.15}~",2
Y,Tunisia,TUN,Demand Reduction,Number of people who use drugs,No,n/a,0
Y,Tunisia,TUN,Demand Reduction,"Prevalence of drug use by mode of administration (oral, mucosa, inhalation, and injection)",No,n/a,0
Y,Tunisia,TUN,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT)",Yes,"The number of counselling sessions the Chems centre provided in 2012 for HIV-positive persons and drug users {Tunisia: Drug Situation and Policy, 2014, p.21}~ Chems for young people - Counselling IDUs: Number of IDUs counselled, number of IDUs dropped by the centre, or rate per month. Number of IDUs who benefited from a drug rehabilitation programme (total, and number of women). {Tunisia: Drug Situation and Policy, 2014, p.25}~ An assessment of the CAMU’s rehabilitation protocols in cases of addiction to Subutex or opioid dependency - assessing the programme’s effectiveness, particularly in the long-term: % of the success rate 1 year after treatment, % of the success rate 2 years after treatment, the % of the success rate 5 years after treatment {Tunisia: Drug Situation and Policy, 2014, p.27, p.28} ~ The representation of key populations receiving treatment (% IDU) {Plan Stratégique National de la riposte au VIH/sida et aux IST en Tunisie, 2015-2018, p.43}~",4
Y,Tunisia,TUN,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT) by age",No,n/a,0
Y,Tunisia,TUN,Demand Reduction,Level of access to opioid substitution treatment and medication assisted treatment (OST/MAT),No,n/a,0
Y,Tunisia,TUN,Demand Reduction,Level of coverage of inpatient treatment,No,n/a,0
Y,Tunisia,TUN,Demand Reduction,Proportion of people who use drugs enrolled in voluntary treatment,No,n/a,0
Y,Tunisia,TUN,Demand Reduction,Proportion of people who use drugs enrolled in coerced treatment,No,n/a,0
Y,Tunisia,TUN,Demand Reduction,Proportion of people who use drugs enrolled in compulsory treatment,No,n/a,0
Y,Tunisia,TUN,Demand Reduction,Presence of prevention programming in law enforcement,No,n/a,0
Y,Tunisia,TUN,Demand Reduction,Presence of prevention programming in the media,No,n/a,0
Y,Tunisia,TUN,Demand Reduction,Presence of prevention programming in schools,No,n/a,0
Y,Tunisia,TUN,Demand Reduction,Presence of prevention programming in the workplace,No,n/a,0
Y,Tunisia,TUN,Demand Reduction,Presence of prevention programming for youth and the community,No,n/a,0
Y,Tunisia,TUN,Demand Reduction,Presence of other demand reduction metrics,No,n/a,0
Y,Tunisia,TUN,Supply Reduction,Size and value of the illegal drug market,Yes,"Value of seized contraband (goods and vehicles) in dinars {Activité des unités de la garde nationale en matière de sécurité publique et de lutte contre la contrebande et le passage illicite des frontières durant le mois de janvier 2015, np}~",1
Y,Tunisia,TUN,Supply Reduction,Level of procedures related to crop eradication,No,n/a,0
Y,Tunisia,TUN,Supply Reduction,"Number of arrests, seizures, and offences",Yes,"Drugs Seized in Tunisia: Quantity, Unit, Year (Psychotropic Pills, Cannabis resin, Cannabis, Cocaine, Heroin, Hashish) {Tunisia: Drug Situation and Policy, 2014, p.16}~ number of public security arrests {Activité des unités de la garde nationale en matière de sécurité publique et de lutte contre la contrebande et le passage illicite des frontières durant le mois de janvier 2015, np}~ number of vehicles that were searched and seized {Activité des unités de la garde nationale en matière de sécurité publique et de lutte contre la contrebande et le passage illicite des frontières durant le mois de janvier 2015, np}~ the number of clandestine migrants that were arrested (land and sea) {Activité des unités de la garde nationale en matière de sécurité publique et de lutte contre la contrebande et le passage illicite des frontières durant le mois de janvier 2015, np}~",4
Y,Tunisia,TUN,Supply Reduction,Level of law enforcement activity and interdiction in the market,Yes,"number of failed contraband operations {Activité des unités de la garde nationale en matière de sécurité publique et de lutte contre la contrebande et le passage illicite des frontières durant le mois de janvier 2015, np}~ number of failed attempts to cross the border illegally (land and sea) {Activité des unités de la garde nationale en matière de sécurité publique et de lutte contre la contrebande et le passage illicite des frontières durant le mois de janvier 2015, np}~ Number of drug-related (abuse and sale) cases and sentences according to the judicial year: number of cases related to consumption, number of cases related to selling, number of sentences related to consumption, number of sentences related to selling {Tunisia: Drug Situation and Policy, 2014, p.16}~ ",3
Y,Tunisia,TUN,Supply Reduction,"Price, purity and potency of drugs, and related process indicators",No,n/a,0
Y,Tunisia,TUN,Supply Reduction,Number of people engaged with the criminal justice system,No,n/a,0
Y,Tunisia,TUN,Supply Reduction,Presence of other supply reduction metrics,No,n/a,0
Y,Tunisia,TUN,International Cooperation,Level of engagement in international cooperation,No,n/a,0
Y,Algeria,DZA,Health,Level of availability of harm reduction services and harm reduction scale up,No,n/a,0
Y,Algeria,DZA,Health,Presence of needle and syringe programs,No,n/a,0
Y,Algeria,DZA,Health,Prevalence of substance use disorders,Yes,"The only data available in respect of drug-dependent users come from a survey conducted at the Frantz Fanon detoxification centre in Blida, the oldest and largest centre in Algeria. The number of people who have multiple drug addictions, the number of people dependent on cannabis, the number of people dependent on psychotropic substances, the number of people dependent on alcohol, the number of people dependent on opiates, and the number of people dependent on solvents. (for the years 2008-2012) {Drug Situation and Policy, 2014, p.29}~",1
Y,Algeria,DZA,Health,Prevalence of psychiatric comorbidities,No,n/a,0
Y,Algeria,DZA,Health,Drug-related mortality,No,n/a,0
Y,Algeria,DZA,Health,Prevalence of drug-related infectious disease,Yes,"The number of cases of people confirmed to be seropositive [...] between 1985 and at the end of the year 2012, the number of cases of AIDS, and the number of new cases diagnosed {Drug Situation and Policy, 2014, p.33}~  HIV prevalence among IDUs: Expected results - 2008, 2009, 2010, 2011, 2012 {Plan National Stratégique de lutte contre les IST/VIH/Sida, 2008-2012, p.62, p.64}~ Distribution of AIDS cases by mode of transmission (IDU): Period 1985-2008, 2008 {Plan National Stratégique de lutte contre les IST/VIH/Sida, 2008-2012, p.20}~ Distribution of HIV seropositivity cases by mode of transmission (IDU): Period 1985-2008, 2008 {Plan National Stratégique de lutte contre les IST/VIH/Sida, 2008-2012, p.22}~",4
Y,Algeria,DZA,Health,Proportion of people who use drugs who engage in risky consumption,No,n/a,0
Y,Algeria,DZA,Health,Proportion of people who use drugs who engage in safe consumption practices,Yes,"% IDU reporting that they used sterile injection equipment the last time they injected the drug {Plan National Stratégique de lutte contre les IST/VIH/Sida, 2008-2012, p.63}~",1
Y,Algeria,DZA,Health,"Coverage of services for the prevention, testing, and treatment of bloodborne diseases",Yes,"The number of persons who were found to be seropositive in 2012, and the total number of people tested in 2012 {Drug Situation and Policy, 2014, p.34} ~ Injecting drug users: In Algiers,% of people interviewed who have access to HIV testing say they are infected with HIV [it is not possible to estimate an HIV prevalence rate at the national level in this population group. ] {Plan National Stratégique de lutte contre les IST/VIH/Sida, 2008-2012, p.16}~ Number of facilities able to provide care for HIV infection, including prescribing ARV treatment {Plan National Stratégique de lutte contre les IST/VIH/Sida, 2008-2012, p.63}~ % of persons living with HIV (eligible adults and children) receiving antiretroviral therapy according to national consensus {Plan National Stratégique de lutte contre les IST/VIH/Sida, 2008-2012, p.63}~ % of people 15-24 years of age among the most exposed populations, and % of vulnerable groups (IDU) with accurate knowledge of how to prevent the risk of sexual transmission of HIV and who reject major misconceptions about the transmission of the virus {Plan National Stratégique de lutte contre les IST/VIH/Sida, 2008-2012, p.62, p.65}~ ",5
Y,Algeria,DZA,Health,Presence of specialised training for addiction care,No,n/a,0
Y,Algeria,DZA,Health,Presence of health harms related to drug use,No,n/a,0
Y,Algeria,DZA,Health,Presence of other health metrics,Yes,"% of IDU reporting that they used a condom the last time they had sex in the last 12 months {Plan National Stratégique de lutte contre les IST/VIH/Sida, 2008-2012, p.63, p.65}~ ",1
Y,Algeria,DZA,Peace and Security,"Prevalence of alcohol and drugs in accidents, and interventions to increase road safety",No,n/a,0
Y,Algeria,DZA,Peace and Security,Annual number of public disorder and violent crime reports,No,n/a,0
Y,Algeria,DZA,Peace and Security,Number of non-lethal drug market violent events reported,No,n/a,0
Y,Algeria,DZA,Peace and Security,Number of drug market related homicides and disappearances,No,n/a,0
Y,Algeria,DZA,Peace and Security,Presence of other peace and security metrics,No,n/a,0
Y,Algeria,DZA,Development,Coverage of housing assistance for people who use drugs,No,n/a,0
Y,Algeria,DZA,Development,Coverage of social assistance for people who use drugs (not including housing),No,n/a,0
Y,Algeria,DZA,Development,Number of households enrolled in alternative development,No,n/a,0
Y,Algeria,DZA,Development,Presence of other development metrics,No,n/a,0
Y,Algeria,DZA,Human Rights,"Prevalence and incidence of infectious diseases in vulnerable populations (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"%  inmates [...] who are infected with HIV {Plan National Stratégique de lutte contre les IST/VIH/Sida, 2008-2012, p.62}~ ",1
Y,Algeria,DZA,Human Rights,"Prevalence of vulnerable people who use drugs (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Algeria,DZA,Human Rights,Proportion of people who use drugs in prison that are receiving medication assisted treatment (MAT),No,n/a,0
Y,Algeria,DZA,Human Rights,Distribution of sterile injecting equipment in prisons,No,n/a,0
Y,Algeria,DZA,Human Rights,Presence of programs and services targeted towards women ,No,n/a,0
Y,Algeria,DZA,Human Rights,Presence of programs and services targeted towards people of color,No,n/a,0
Y,Algeria,DZA,Human Rights,Presence of challenges and/or harms experienced by people of color,No,n/a,
Y,Algeria,DZA,Human Rights,"Presence of programs and services targeted towards vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"Number and percentage of prisoners who entered examinations in 2013 {Drug Situation and Policy, 2014, p.25}~ The number of detainees who obtained the upper secondary qualification, the number of detainees who obtained the lower secondary qualification, the number of detainees who obtained a vocational training in 2012 {Drug Situation and Policy, 2014, p.25}~ ",2
Y,Algeria,DZA,Human Rights,"Presence of challenges and/or harms experienced by vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,
Y,Algeria,DZA,Human Rights,Presence of other human rights metrics,No,n/a,0
Y,Algeria,DZA,Demand Reduction,Prevalence of drug use by age,Yes,"Percentage of population 12 and over who uses some kind of drug: cannabis, opium, heroin, cocaine, psychoactive substances {Drug Situation and Policy, 2014, p.28}~ Determine the age and geographical distribution of the different population groups concerned {Plan Directeur National de Prévention et de Lutte Contre la Drogue et la Toxicomanie, 2004-2008, p.17}~ % of youth who consume drugs daily in a school environment. {Plan National Stratégique de lutte contre les IST/VIH/Sida, 2008-2012, p.16}",3
Y,Algeria,DZA,Demand Reduction,Prevalence of drug use by sex,No,n/a,0
Y,Algeria,DZA,Demand Reduction,Prevalence of drug use by type,Yes,"Percentage of population 12 and over who uses some kind of drug: cannabis, opium, heroin, cocaine, psychoactive substances {Drug Situation and Policy, 2014, p.28}~ Report on the state of drug addicts (number and percentage): number and percentage of drug addicts, family situation (married, single, or other), sexe (male or female), age (less than 15 years, 16-25 years, 26-35 years, 35 years and older), personal situation (student, employed, unemployed), consumed substances (cannabis, psychotropic substances, poly drug use/drug addiction, other), Terms and conditions of charge (External consultation, voluntary hospitalisation, therapeutic injunction) {Activités de lutte contre la drogue et la toxicomanie - Bilan statistique des onze premiers mois, 2016, p.14}~ Number of people involved in the use of psychotropic substances, cocaine, and heroin {Activités de lutte contre la drogue et la toxicomanie - Bilan statistique des onze premiers mois, 2016, p.6}~ ",3
Y,Algeria,DZA,Demand Reduction,Number of people who use drugs,Yes,"Number of people involved in the use of psychotropic substances {Activités de lutte contre la drogue et la toxicomanie - Bilan statistique des onze premiers mois, 2016, p.6}~ ",1
Y,Algeria,DZA,Demand Reduction,"Prevalence of drug use by mode of administration (oral, mucosa, inhalation, and injection)",No,n/a,0
Y,Algeria,DZA,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT)",Yes,"The numbers of medical consultations [...] at treatment centres and CISTs nationwide over the past three years (2011-2013) {Drug Situation and Policy, 2014, p.28}~ ",1
Y,Algeria,DZA,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT) by age",No,n/a,0
Y,Algeria,DZA,Demand Reduction,Level of access to opioid substitution treatment and medication assisted treatment (OST/MAT),No,n/a,0
Y,Algeria,DZA,Demand Reduction,Level of coverage of inpatient treatment,Yes,"The numbers of [...] hospitalisations at treatment centres and CISTs nationwide over the past three years (2011-2013) {Drug Situation and Policy, 2014, p.28}~ ",1
Y,Algeria,DZA,Demand Reduction,Proportion of people who use drugs enrolled in voluntary treatment,Yes,"Report on the state of drug addicts (number and percentage): number and percentage of drug addicts, family situation (married, single, or other), sexe (male or female), age (less than 15 years, 16-25 years, 26-35 years, 35 years and older), personal situation (student, employed, unemployed), consumed substances (cannabis, psychotropic substances, poly drug use/drug addiction, other), Terms and conditions of charge (External consultation, voluntary hospitalisation, therapeutic injunction) {Activités de lutte contre la drogue et la toxicomanie - Bilan statistique des onze premiers mois, 2016, p.14}~",1
Y,Algeria,DZA,Demand Reduction,Proportion of people who use drugs enrolled in coerced treatment,No,n/a,0
Y,Algeria,DZA,Demand Reduction,Proportion of people who use drugs enrolled in compulsory treatment,Yes,"The number of people ordered to do community service, as an alternative to imprisonment in 2009, 2010 and 2011 {Drug Situation and Policy, 2014, p.25}~",1
Y,Algeria,DZA,Demand Reduction,Presence of prevention programming in law enforcement,No,n/a,0
Y,Algeria,DZA,Demand Reduction,Presence of prevention programming in the media,No,n/a,0
Y,Algeria,DZA,Demand Reduction,Presence of prevention programming in schools,No,n/a,0
Y,Algeria,DZA,Demand Reduction,Presence of prevention programming in the workplace,No,n/a,0
Y,Algeria,DZA,Demand Reduction,Presence of prevention programming for youth and the community,No,n/a,0
Y,Algeria,DZA,Demand Reduction,Presence of other demand reduction metrics,No,n/a,0
Y,Algeria,DZA,Supply Reduction,Size and value of the illegal drug market,Yes,"Number of people involved in the trafficking, use and cultivation of cannabis, psychotropic substances, cocaine, heroin, and crack {Activités de lutte contre la drogue et la toxicomanie - Bilan statistique des onze premiers mois, 2016, p.6}~ Cases handled by control services in 2016: number of cases related to the illicit trafficking of drugs, number of cases related to the commercialisation of cannabis, number of cases related to the international trafficking of cannabis resin, number of cases related to the traffic and commercialisation of cocaine, number of cases related to the international trafficking of cocaine, number of cases related to the traffic and commercialisation of crack, number of cases related to the traffic and commercialisation of heroin, number of cases related to the commercialisation of psychotropic substances, and number of cases related to the international trafficking of psychotropic substances {Activités de lutte contre la drogue et la toxicomanie - Bilan statistique des onze premiers mois, 2016, p.6}~ Number of people involved who were foreigners {Activités de lutte contre la drogue et la toxicomanie - Bilan statistique des onze premiers mois, 2016, p.6}~ Cannabis and Resins/Crack/Cocaine/Heroin/Opium/Psychotropic Substances: Number of cases related to traffic and commercialisation inside the country, number of cases related to traffic and commercialisation at the border, the number of cases related to the detention and use, and finally the number of cases related to the cultivation, and the final total {Activités de lutte contre la drogue et la toxicomanie - Bilan statistique des onze premiers mois, 2016, p.7, p.8,p.9}~ Percentage of seized quantities by the services concerned in recent years, and the percentage that is intended to be marketed in other countries in Europe, Africa and the Middle East (% in 2000 and % in 2001, and a % estimation for 2002) {Plan Directeur National de Prévention et de Lutte Contre la Drogue et la Toxicomanie, 2004-2008, p.7}~ Persons involved in illegal trafficking of drugs, categorized by professions: S/Profession, workers and laborers, officials and equivalent employees, liberal Professions, students, other categories, foreigners, totals {Plan Directeur National de Prévention et de Lutte Contre la Drogue et la Toxicomanie, 2004-2008, p.26}~ Percentage of seized quantities by the services concerned in recent years, and the percentage that is intended to be marketed in other countries in Europe, Africa and the Middle East (% in 2000 and % in 2001, and a % estimation for 2002) {Plan Directeur National de Prévention et de Lutte Contre la Drogue et la Toxicomanie, 2004-2008, p.7}~ ",7
Y,Algeria,DZA,Supply Reduction,Level of procedures related to crop eradication,Yes,"Number of people involved in the trafficking, use and cultivation of cannabis and opium {Activités de lutte contre la drogue et la toxicomanie - Bilan statistique des onze premiers mois, 2016, p.6}~ The number of discovered and eradicated cannabis crops and opium crops {Activités de lutte contre la drogue et la toxicomanie - Bilan statistique des onze premiers mois, 2016, p.3}~ Cases handled by control services in 2016: number of cases related to the cultivation of cannabis, number of cases related to the cultivation of opium {Activités de lutte contre la drogue et la toxicomanie - Bilan statistique des onze premiers mois, 2016, p.6}~ ",3
Y,Algeria,DZA,Supply Reduction,"Number of arrests, seizures, and offences",Yes,"Cases handled by control services in 2016: number of cases related to the detention and use of drugs, number of cases related to the detention and use of cannabis resin, number of cases related to the detention and use of cocaine, number of cases related to the detention and use of heroin, and number of cases related to the detention and use of other psychotropic substances {Activités de lutte contre la drogue et la toxicomanie - Bilan statistique des onze premiers mois, 2016, p.6}~ Amount of cannabis, cannabis seeds, cocaine, crack, heroin, opium, and opium seeds seized in kg and gr {Activités de lutte contre la drogue et la toxicomanie - Bilan statistique des onze premiers mois, 2016, p.3} ~ The number of different psychotropic substances in the form of tablets that have been seized, the number of vials containing psychotropic substances that have been seized, and the number of capsules that have been seized {Activités de lutte contre la drogue et la toxicomanie - Bilan statistique des onze premiers mois, 2016, p.3}~ Quantities seized during the first 11 months of 2015: Cannabis and Resins (Cannabis resin, cannabis herb, cannabis seeds, cannabis plants), Cocaine, Crack, Heroin, Opium (Opium poppy, opium seeds, opium plants), other psychotropic substances (tablets and vials) {Activités de lutte contre la drogue et la toxicomanie - Bilan statistique des onze premiers mois, 2016, p.3, p.4}~ Cannabis and Resins in kg/Cocaine in grams/Crack in grams/Heroin in grams/Opium in grams/ Psychotropic Substances in the form of tablets, vials and capsules: traffic and trade inside the country, traffic and trade at the border - quantity seized in the first 11 months of 2015, quantity seized in the first 11 months of 2016, variation between 2015 and 2016, and % of variation between 2015 and 2016; Detention and use - quantity seized in the first 11 months of 2015, quantity seized in the first 11 months of 2016, variation between 2015 and 2016, and % of variation between 2015 and 2016; Total quantity seized in the first 11 months of 2015, quantity seized in the first 11 months of 2016, variation between 2015 and 2016, and % of variation between 2015 and 2016 {Activités de lutte contre la drogue et la toxicomanie - Bilan statistique des onze premiers mois, 2016, p.4, p.5}~ Cases handled by control services in 2016: number of cases related to the detention and use of drugs, number of cases related to the detention and use of cannabis resin, number of cases related to the detention and use of cocaine, number of cases related to the detention and use of heroin, and number of cases related to the detention and use of other psychotropic substances {Activités de lutte contre la drogue et la toxicomanie - Bilan statistique des onze premiers mois, 2016, p.6}~ The variation in quantities of seized cannabis and resins/psychotropic substances during the first 11 months of 2016 {Activités de lutte contre la drogue et la toxicomanie - Bilan statistique des onze premiers mois, 2016, p.13}~ The number of cannabis (kg) and psychotropic substance (tablets) seizures according to the 4 regions of the country: West, South, East and Central {Activités de lutte contre la drogue et la toxicomanie - Bilan statistique des onze premiers mois, 2016, p.14}~ Quantities of drugs seized annually by the law-enforcement agencies 2004-2013: Type of drug (Cannabis (resin, and plants), cocaine, heroin, opium, psychotropic substances) {Drug Situation and Policy, 2014, p.22}~ the quantity of cannabis seizures (in tons) and the arrest of those involved in trafficking, the majority being foreign trafficking {Plan Directeur National de Prévention et de Lutte Contre la Drogue et la Toxicomanie, 2004-2008, p.6}~ quantity of cannabis resin, heroin, cocaine and psychotropic substance seizures (in tons) and the number of arrests made throughout the year {Plan Directeur National de Prévention et de Lutte Contre la Drogue et la Toxicomanie, 2004-2008, p.6}~ The control services also report a number of cocaine and heroin seizures introduced into Algeria by postal parcels from Europe, by sea or air freight {Plan Directeur National de Prévention et de Lutte Contre la Drogue et la Toxicomanie, 2004-2008, p.7}~ The cases dealt with by nature of the infringement: type of drugs (cannabis, cocaine, crack, heroine, opium, psychotropic substances), traffic and commercialisation (number of cases, number of people arrested (natives and foreigners)), Detention and Use (number of cases, number of people arrested (natives and foreigners)), Cultivation (number of cases, number of people arrested (natives and foreigners)), Total {Activités de lutte contre la drogue et la toxicomanie - Bilan statistique des onze premiers mois, 2016, p.9}~ ",13
Y,Algeria,DZA,Supply Reduction,Level of law enforcement activity and interdiction in the market,Yes,"Total number of cases handled: number of cases handled in the first 11 months of 2016, The number of people involved in the first 11 months of 2016 (foreigners, natives, total, on the run) – Cannabis and Resins (Cannabis Resins, Cannabis herbs, Cannabis seeds, Cannabis Plants), Cocaine, Crack, Heroin, Opium, Psychotropic Substances {Activités de lutte contre la drogue et la toxicomanie - Bilan statistique des onze premiers mois, 2016, p.7}~ The cases dealt with by nature of the infringement: type of drugs (cannabis, cocaine, crack, heroine, opium, psychotropic substances), traffic and commercialisation (number of cases, number of people arrested (natives and foreigners)), Detention and Use (number of cases, number of people arrested (natives and foreigners)), Cultivation (number of cases, number of people arrested (natives and foreigners)), Total {Activités de lutte contre la drogue et la toxicomanie - Bilan statistique des onze premiers mois, 2016, p.9}~ Drug cases dealt with by the courts, 2006-2012 {Drug Situation and Policy, 2014, p.21}~",3
Y,Algeria,DZA,Supply Reduction,"Price, purity and potency of drugs, and related process indicators",No,n/a,0
Y,Algeria,DZA,Supply Reduction,Number of people engaged with the criminal justice system,Yes,"Number, percentage, and total - Age of convicted persons: - 18 years, 19-25 years, 36-45 years, 46-55 years, + 55 years {Plan Directeur National de Prévention et de Lutte Contre la Drogue et la Toxicomanie, 2004-2008, p.27}~ Statistics relating to drug cases dealt with by the courts and the number of individuals tried during the period 2006 – 2012: the number of cases, and the number of individuals {Drug Situation and Policy, 2014, p.21}~ Total number of cases handled: number of cases handled in the first 11 months of 2016, The number of people involved in the first 11 months of 2016 (foreigners, natives, total, on the run) – Cannabis and Resins (Cannabis Resins, Cannabis herbs, Cannabis seeds, Cannabis Plants), Cocaine, Crack, Heroin, Opium, Psychotropic Substances {Activités de lutte contre la drogue et la toxicomanie - Bilan statistique des onze premiers mois, 2016, p.7}~ Number of individuals tried by the courts in drug cases {Drug Situation and Policy, 2014, p.21}~ ",4
Y,Algeria,DZA,Supply Reduction,Presence of other supply reduction metrics,Yes,"% of variation between 2015 and 2016: Cannabis and Resins (Cannabis resin, cannabis herb, cannabis seeds, cannabis plants), Cocaine, Crack, Heroin, Opium (Opium poppy, opium seeds, opium plants), other psychotropic substances (tablets, vials, and capsules) {Activités de lutte contre la drogue et la toxicomanie - Bilan statistique des onze premiers mois, 2016, p.4} ~",1
Y,Algeria,DZA,International Cooperation,Level of engagement in international cooperation,No,n/a,0
Y,Brazil,BRA,Health,Level of availability of harm reduction services and harm reduction scale up,Yes,"Distribution of mapped institutions with harm reduction program, by region. {Relatório Brasileiro sobre Drogas, 2010, p.322} ~ Distribution of mapped institutions with harm reduction programs, according to all the activities carried out. Brazil, Regions and Federative Units {Relatório Brasileiro sobre Drogas, 2010, p.323} ~ ",2
Y,Brazil,BRA,Health,Presence of needle and syringe programs,No,n/a,0
Y,Brazil,BRA,Health,Prevalence of substance use disorders,No,n/a,0
Y,Brazil,BRA,Health,Prevalence of psychiatric comorbidities,No,n/a,0
Y,Brazil,BRA,Health,Drug-related mortality,Yes,"Number of deaths associated with mental and behavioral disorders due to drug use. Brazil, 2001 to 2007 {Relatório Brasileiro sobre Drogas, 2010, p.183} ~ Number of deaths associated with drug use. Brazil, Regions and Federative Units/ Capitals of residence, 2001 to 2007 {Relatório Brasileiro sobre Drogas, 2010, p.184, p.193} ~ Percentage of deaths associated with drug use in relation to the total number of deaths. Brazil, Regions and Federative Units/ Capitals of residence, 2001 to 2007 {Relatório Brasileiro sobre Drogas, 2010, p.186, p.194} ~ Number of deaths associated with drug use per 100,000 inhabitants. Brazil, Regions and Federative Units/ Capitals of residence, 2001 to 2007 {Relatório Brasileiro sobre Drogas, 2010, p.188, p.196} ~ Evolution of the number of deaths associated with drug use per 100,000 inhabitants. Brazil, Regions and Federative Units/ Capitals of residence, 2001 to 2007 {Relatório Brasileiro sobre Drogas, 2010, p.189, p.197} ~ Evolution of the number of deaths associated with drug use per 100,000 inhabitants. States of the North Region/ States of the Northeast Region/ States of the Southeast Region/ States of the Southern Region/ States of the Central-West Region/ Capitals of the North Region/ Capitals of the Northeast Region/ Capitals of the Southern Region/ Capitals of the Central-West Region 2001 to 2007. {Relatório Brasileiro sobre Drogas, 2010, p.189, p.190, p.191, p.197, p.198, p.199} ~ Number of deaths associated with drug use by age group. Brazil, 2001 to 2007 {Relatório Brasileiro sobre Drogas, 2010, p.200} ~ Number of deaths associated with drug use, by gender. Brazil, 2001 to 2007 {Relatório Brasileiro sobre Drogas, 2010, p.200} ~",8
Y,Brazil,BRA,Health,Prevalence of drug-related infectious disease,Yes,"New cases of AIDS associated with injecting drug use per hundred thousand inhabitants [2007] {Relatório Brasileiro sobre Drogas, 2010, p.111} ~ New cases of AIDS in individuals in the IDU exposure category. Brazil, Regions and Federative Units/ Capitals of residence, 2001 to 2007 {Relatório Brasileiro sobre Drogas, 2010, p.113, p.123} ~ Cases of AIDS in individuals in the IDU exposure category. Brazil, Regions and Federative Units/ Capitals of residence, 2001 to 2007 {Relatório Brasileiro sobre Drogas, 2010, p.117, p.125} ~  Percentage of AIDS cases in individuals in the IDU exposure category in relation to the total number of AIDS cases. Brazil, Regions and Federative Units/ Capitals of residence, 2001 to 2007 {Relatório Brasileiro sobre Drogas, 2010, p.115, p.124} ~ Evolution of AIDS cases per 100,000 inhabitants in individuals in the IDU exposure category. Regions and Federative Units/ States of the North Region/ States of the Northeast Region/ States of the Southeast/ States of the South Region/ States of the Central-West Region/ Capitals of the North Region/ Capitals of the Northeast Region/ Capitals of the Southeast Region/ Capitals of the South Region/ Capitals of the Central-West Region, Brazil, 2001 to 2007 {Relatório Brasileiro sobre Drogas, 2010, p.118, p.119, p.120, p.121, p.126, p.127, p.128} ~ AIDS cases by age group, in individuals in the IDU exposure category. Brazil, 2001 to 2007 {Relatório Brasileiro sobre Drogas, 2010, p.129} ~ Cases of AIDS by gender, in individuals of the IDU exposure category. Brazil, 2001 to 2007 {Relatório Brasileiro sobre Drogas, 2010, p.129} ~ Percentage of hepatitis B cases with drug use as a likely source of infection in relation to the total number of hepatitis B cases. Brazil, Regions and Federative Units/ Resident capital, 2001 to 2007 {Relatório Brasileiro sobre Drogas, 2010, p.135, p.149} ~ Percentage of cases of hepatitis C with drug use as a probable source of infection in relation to the total number of cases of hepatitis C. Brazil, Regions and Federative Units/ Resident capital, 2001 to 2007 {Relatório Brasileiro sobre Drogas, 2010, p.136, p.150} ~ Cases of hepatitis B with drug use as likely source of infection per 100,000 inhabitants. Brazil, Regions and Federative Units/ Capitals of residence, 2001 - 2007 {Relatório Brasileiro sobre Drogas, 2010, p.133, p.138, p.147, p.151} ~ Evolution of cases of hepatitis B with drug use as a probable source of infection per 100,000 inhabitants. Regions and Federative Units/ States of the North Region/ States of the Northeast Region/ States of the Southeast Region/ States of the South Region/ States of the Central-West Region/ Capitals of the North Region/ Northeast Region/ Capitals of the Southeast Region/ Capitals of the Southern Region/ Capitals of the Central-West Region, Brazil, 2001 to 2007 {Relatório Brasileiro sobre Drogas, 2010, p.139, p.140, p.141, p.152, p.153, p.154} ~ Cases of hepatitis C with drug use as likely source of infection per 100,000 inhabitants. Brazil, Regions and Federative Units/ Capitals of residence, 2001 to 2007 {Relatório Brasileiro sobre Drogas, 2010, p.134, p.142, p.148, p.155} ~ Evolution of cases of hepatitis C with use of drugs as a probable source of infection per 100,000 inhabitants. Regions and Federative Units/ States of the North Region/ States of the Northeast Region/ States of the Southeast Region / States of the Southern Region/ States of the Central-Eastern Region/ Capitals of the North Region/ Capitals of the Northeast Region/Capitals of the Southeast Region/ Capitals of the South Region/ Capitals of the Central-West Region, Brazil, 2001 to 2007 {Relatório Brasileiro sobre Drogas, 2010, p.143, p.144, p.145, p.156, p.157, p.158} ~ Cases of hepatitis B with drug use as likely source of infection by age group. Brazil, 2001 to 2007 {Relatório Brasileiro sobre Drogas, 2010, p.159} ~ Cases of hepatitis B with drug use as likely source of genital infection. Brazil, 2001 to 2007 {Relatório Brasileiro sobre Drogas, 2010, p.160} ~ Cases of hepatitis C with drug use as likely source of genital infection. Brazil, 2001 to 2007 {Relatório Brasileiro sobre Drogas, 2010, p.160} ~ Some sociodemographic and behavioral characteristics of crack users and / or similar according to HIV serological status, by group of municipalities Brazil, 2012 {Pesquisa Nacional Sobre O Uso de Crack, 2014, p.77, p.78} ~ Some sociodemographic and behavioral characteristics of users of crack and / or similar according to serological status for HCV, by group of municipalities, Brazil, 2012 {Pesquisa Nacional Sobre O Uso de Crack, 2014, p.77, p.78, p.79} ~ Report of suggestive symptomatology, contact and history of tuberculosis of crack users and / or similar, by group of municipalities, Brazil 2012 {Pesquisa Nacional Sobre O Uso de Crack, 2014, p.80} ~ ",19
Y,Brazil,BRA,Health,Proportion of people who use drugs who engage in risky consumption,Yes,"Sharing of paraphernalia for use of crack and / or similar, by group of municipalities Brazil, 2012 {Pesquisa Nacional Sobre O Uso de Crack, 2014, p.63}~ Risk behaviors of users of crack and / or similar, by group of municipalities, Brazil, 2012 (See table) {Pesquisa Nacional Sobre O Uso de Crack, 2014, p.73, p.74} ~ ",2
Y,Brazil,BRA,Health,Proportion of people who use drugs who engage in safe consumption practices,No,n/a,0
Y,Brazil,BRA,Health,"Coverage of services for the prevention, testing, and treatment of bloodborne diseases",No,n/a,0
Y,Brazil,BRA,Health,Presence of specialised training for addiction care,Yes,"Training and capacity building: 350 thousand nursing assistants and community health agents; 11 thousand professionals; 100 thousand undergraduate students in health; 15 thousand managers and professionals of the Therapeutic Communities; 82% increase in new places of medical residency in psychiatry; 304 new vacancies in mental health for Multiprofessional Residency; 1,659 CAPS-AD professionals as teleconsultores {19 Crack, É Possivel Vencer, 2014, p.134} ~ Offer of 34,200 vacancies in 2012 of refresher courses, 39,000 jobs per year from 2013 onwards {19 Crack, É Possivel Vencer, 2014, p.136} ~ Therapeutic Communities: Number of jobs to meet demand {19 Crack, É Possivel Vencer, 2014, p.134} ~ ",3
Y,Brazil,BRA,Health,Presence of health harms related to drug use,Yes,"Overdose in crack users and / or similar, by group of municipalities, 2012 {Pesquisa Nacional Sobre O Uso de Crack, 2014, p.65} ~ Number and percentage of withdrawals per drug, Regions and Federative Units, Brazil 2001-2006 {Relatório Brasileiro sobre Drogas, 2010, p.204, p.221} ~ Number of withdrawals due to the consumption of psychoactive substances. Brazil, Regions and Federative Units/ Capitals of residence, 2001 to 2007 {Relatório Brasileiro sobre Drogas, 2010, p.205, p.207, p.212, p.214, p.222, p.229} ~ Percentage of withdrawals due to the consumption of psychoactive substances in relation to the total number of withdrawals. Brazil, Regions and Federative Units/ Capitals of residence, 2001 to 2007 {Relatório Brasileiro sobre Drogas, 2010, p.206, p.213} ~ Evolution of the number of withdrawals due to the consumption of psychoactive substances per 100,000 inhabitants. Regions and Federative Units/ States of the North Region/ States of the Northeast Region/ States of the Southeast Region/ States of the South Region/States of the Central-West Region/ Capitals of the North Region/ Capitals of the Northeast Region/ Capitals of Southeast Region/Capitals of the Southern Region/ Capitals of the Central-West Region, Brazil, 2001 to 2007 {Relatório Brasileiro sobre Drogas, 2010, p.208, p.209, p.210, p.211, p.215, p.216, p.217} ~ Number of withdrawals due to the consumption of psychoactive substances by age group. Brazil, 2001 to 2007. {Relatório Brasileiro sobre Drogas, 2010, p.218, p.235} ~ Number of withdrawals due to the consumption of psychoactive substances by gender. Brazil, 2001 to 2007. {Relatório Brasileiro sobre Drogas, 2010, p.218, p.235} ~ Number of withdrawals from cocaine intoxication by age, 2001 to 2006 {Relatório Brasileiro sobre Drogas, 2010, p.220, p.237} ~ Number of withdrawals from cocaine intoxication by gender, 2001 to 2006 {Relatório Brasileiro sobre Drogas, 2010, p.220, p.237} ~ Percentage of withdrawals due to the consumption of psychoactive substances in relation to the total number of pensions. Brazil, Regions and Federative Units/ Capitals of residence, 2001 to 2007. {Relatório Brasileiro sobre Drogas, 2010, p.223, p.230} ~ Number of withdrawals due to the consumption of psychoactive substances per 100,000 inhabitants. Brazil, Regions and Federative Units/ Capitals of residence, 2001 to 2007. {Relatório Brasileiro sobre Drogas, 2010, p.224, p.231} ~ Evolution of the number of withdrawal due to the consumption of psychoactive substances per 100,000 inhabitants. Brazil, Regions and Federative Units/ States of the North Region/ States of the Northeast Region/States of the Southeast Region/States of the South Region/ States of the Central-West Region/Capitals of the North Region/Capitals of the Northeast Region/Capitals of Southeast Region/Capitals of the South Region/Capitals of the Central-West Region ,2001 to 2007. {Relatório Brasileiro sobre Drogas, 2010, p.225, p.226, p.227, p.228, p.232, p.233, p.234} ~",12
Y,Brazil,BRA,Health,Presence of other health metrics,Yes,"Type of sexual partner, number of partners and condom use, reported by crack users and / or similar, related to 30 days prior to the survey, by sex, Brazil, 2012 {Pesquisa Nacional Sobre O Uso de Crack, 2014, p.112} ~ Sexual behavior reported by users of crack and / or similar sex, Brazil, 2012 {Pesquisa Nacional Sobre O Uso de Crack, 2014, p.94} ~ Sexual behavior reported by women users of crack and / or similar, by group of municipalities, 2012 {Pesquisa Nacional Sobre O Uso de Crack, 2014, p.95} ~ Reproductive history of women using crack and / or similar, by group of municipalities, 2012 {Pesquisa Nacional Sobre O Uso de Crack, 2014, p.96} ~ Type of sexual relationship reported by users of crack and / or similar, related to 30 days prior to the survey, by group of municipalities, Brazil, 2012 {Pesquisa Nacional Sobre O Uso de Crack, 2014, p.110} ~ Type of sexual relationship reported by crack and / or female users, related to 30 days prior to the survey, by group of municipalities, 2012 {Pesquisa Nacional Sobre O Uso de Crack, 2014, p.110} ~ STI Symptomatology related to the 30 days prior to the survey, reported by crack users and / or similar, by group of municipalities, 2012 {Pesquisa Nacional Sobre O Uso de Crack, 2014, p.113, p.114} ~ Crack and / or similar users who reported STD and TB compatible symptomatology for access to some health service, Brazil, 2012 {Pesquisa Nacional Sobre O Uso de Crack, 2014, p.114} ~ State of health self-reported by users of crack and / or similar, related to 30 days prior to research, Brazil, 2012 {Pesquisa Nacional Sobre O Uso de Crack, 2014, p.115} ~ Self-reported health status by users of crack and / or similar, related to 30 days prior to the survey, by group of municipalities, 2012 {Pesquisa Nacional Sobre O Uso de Crack, 2014, p.115} ~",10
Y,Brazil,BRA,Peace and Security,"Prevalence of alcohol and drugs in accidents, and interventions to increase road safety",No,n/a,0
Y,Brazil,BRA,Peace and Security,Annual number of public disorder and violent crime reports,No,n/a,0
Y,Brazil,BRA,Peace and Security,Number of non-lethal drug market violent events reported,No,n/a,0
Y,Brazil,BRA,Peace and Security,Number of drug market related homicides and disappearances,No,n/a,0
Y,Brazil,BRA,Peace and Security,Presence of other peace and security metrics,No,n/a,0
Y,Brazil,BRA,Development,Coverage of housing assistance for people who use drugs,No,n/a,0
Y,Brazil,BRA,Development,Coverage of social assistance for people who use drugs (not including housing),Yes,"Use of social assistance by crack users and / or similar, by group of municipalities, Brazil, 2012 {Pesquisa Nacional Sobre O Uso de Crack, 2014, p.105} ~ ",1
Y,Brazil,BRA,Development,Number of households enrolled in alternative development,No,n/a,0
Y,Brazil,BRA,Development,Presence of other development metrics,No,n/a,0
Y,Brazil,BRA,Human Rights,"Prevalence and incidence of infectious diseases in vulnerable populations (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Brazil,BRA,Human Rights,"Prevalence of vulnerable people who use drugs (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Brazil,BRA,Human Rights,Proportion of people who use drugs in prison that are receiving medication assisted treatment (MAT),No,n/a,0
Y,Brazil,BRA,Human Rights,Distribution of sterile injecting equipment in prisons,No,n/a,0
Y,Brazil,BRA,Human Rights,Presence of programs and services targeted towards women ,No,n/a,0
Y,Brazil,BRA,Human Rights,Presence of programs and services targeted towards people of color,No,n/a,0
Y,Brazil,BRA,Human Rights,Presence of challenges and/or harms experienced by people of color,No,n/a,0
Y,Brazil,BRA,Human Rights,"Presence of programs and services targeted towards vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"Important aspects in a care service for people who use drugs from the point of view of crack users and / or similar, by group of municipalities, 2012 {Pesquisa Nacional Sobre O Uso de Crack, 2014, p.108, p.109} ~ Increase in the number of street clinics (308 to 2014), composed of Health professionals {19 Crack, É Possivel Vencer, 2014, p.133} ~ number of people per year attending, focused on the homeless population {19 Crack, É Possivel Vencer, 2014, p.133} ~ Attendance and referral to other health and social care units (CRAS and CREAS) {19 Crack, É Possivel Vencer, 2014, p.133} ~ Follow-up by teams of social approach in the street {19 Crack, É Possivel Vencer, 2014, p.133} ~ Network of attention to the user and family with increase of the number of CAPS 24h to 175 until the end of 2014. {19 Crack, É Possivel Vencer, 2014, p.133} ~ Average attendance of people per month {19 Crack, É Possivel Vencer, 2014, p.133} ~ Increase of specialized wards, and the number of new beds {19 Crack, É Possivel Vencer, 2014, p.133} ~ Number of existing beds that are suitable for crack and other drugs {19 Crack, É Possivel Vencer, 2014, p.133} ~ ",9
Y,Brazil,BRA,Human Rights,"Presence of challenges and/or harms experienced by vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Brazil,BRA,Human Rights,Presence of challenges and/or harms experienced by people of vulnerable,No,n/a,0
Y,Brazil,BRA,Human Rights,Presence of other human rights metrics,No,n/a,0
Y,Brazil,BRA,Demand Reduction,Prevalence of drug use by age,Yes,"Age range of crack users and / or similar, by group of municipalities, 2012 {Pesquisa Nacional Sobre O Uso de Crack, 2014, p.48, p.49} ~ Estimates (in percentage & absolute numbers) of the regular use in the last 6 months of ""crack and / or similar"" in the capitals of Brazil, by age group, 2012 {Pesquisa Nacional Sobre O Uso de Crack, 2014, p.138, p.139} ~ Estimates (in percentage & absolute numbers) of the regular use in the last 6 months of crack and / or similar in the capitals of Brazil, by age group, according to macro-region, 2012 {Pesquisa Nacional Sobre O Uso de Crack, 2014, p.139, p.140} ~",3
Y,Brazil,BRA,Demand Reduction,Prevalence of drug use by sex,Yes,"Age range of crack users and / or similar by sex (estimated ratios and 95% confidence intervals), Brazil, 2012 {Pesquisa Nacional Sobre O Uso de Crack, 2014, p.88} ~ Age range of women using crack and / or similar (estimated ratios and 95% confidence intervals), Brazil, 2012 {Pesquisa Nacional Sobre O Uso de Crack, 2014, p.89} ~ Report of use of other drugs in the 30 days prior to the survey by women users of crack and / or similar, by group of municipalities, 2012 {Pesquisa Nacional Sobre O Uso de Crack, 2014, p.93} ~ Sex of crack users and / or similar, by group of municipalities, 2012 {Pesquisa Nacional Sobre O Uso de Crack, 2014, p.49, p.50} ~ ",4
Y,Brazil,BRA,Demand Reduction,Prevalence of drug use by type,Yes,"Age range of crack users and / or similar, by group of municipalities, 2012 {Pesquisa Nacional Sobre O Uso de Crack, 2014, p.48, p.49} ~ Report of use of other drugs in the 30 days prior to the search by users of crack and / or similar sex, Brazil, 2012 {Pesquisa Nacional Sobre O Uso de Crack, 2014, p.93} ~ Estimates (in percentage & absolute numbers) of the regular use in the last 6 months of illicit drugs (except marijuana) and crack and / or similar drugs in the capitals of Brazil, 2012, by macroregion {Pesquisa Nacional Sobre O Uso de Crack, 2014, p.135, p.136, p.137, p.138} ~ Estimates (in percentage & absolute numbers) of the regular use in the last 6 months of ""crack and / or similar"" in the capitals of Brazil, by age group, 2012 {Pesquisa Nacional Sobre O Uso de Crack, 2014, p.138, p.139} ~ Estimates (in percentage & absolute numbers) of the regular use in the last 6 months of crack and / or similar in the capitals of Brazil, by age group, according to macro-region, 2012 {Pesquisa Nacional Sobre O Uso de Crack, 2014, p.139, p.140} ~ Number of stones / crack and / or similar portions that users consume per day, per group of municipalities, 2012 {Pesquisa Nacional Sobre O Uso de Crack, 2014, p.61} ~ Frequency of use of crack and / or similar by users, by group of municipalities, 2012 {Pesquisa Nacional Sobre O Uso de Crack, 2014, p.61} ~ History of crack use and / or similar users, by group of municipalities, 2012 {Pesquisa Nacional Sobre O Uso de Crack, 2014, p.62} ~ Forms of crack and / or similar consumption by users, by group of municipalities, 2012 {Pesquisa Nacional Sobre O Uso de Crack, 2014, p.64} ~ Estimates (in percentage & absolute numbers) of the regular use in the last 6 months of ""crack and / or similar"" and ""crack"" in the capitals of Brazil, 2012 {Pesquisa Nacional Sobre O Uso de Crack, 2014, p.134, p.135} ~ Estimates (in percentage & absolute numbers) of the regular use in the last 6 months of crack and / or similar in the capitals of Brazil, by macroregion, 2012 {Pesquisa Nacional Sobre O Uso de Crack, 2014, p.136, p.137} ~ Estimates of the percentage of users of ""crack and / or similar"" who consume on a regular basis in the last 6 months in public / visible places, in the capitals of Brazil, according to macro-region and Brazil, 2012 {Pesquisa Nacional Sobre O Uso de Crack, 2014, p.141} ~ Comparison of estimates (as a percentage  & absolute numbers) of regular use in the last 6 months of ""crack and / or similar"" generated through the Scale-up (indirect) and Traditional (direct) methods in the capitals of Brazil, 2012 {Pesquisa Nacional Sobre O Uso de Crack, 2014, p.142} ~ Comparison of estimates (in percentage & absolute numbers) of the regular use in the last 6 months of ""crack and / or similar"" generated through Scale-up (indirect) and Traditional (direct) methods in Brazilian capitals, by macroregion, 2012 {Pesquisa Nacional Sobre O Uso de Crack, 2014, p.143} ~ ",14
Y,Brazil,BRA,Demand Reduction,Number of people who use drugs,No,n/a,0
Y,Brazil,BRA,Demand Reduction,"Prevalence of drug use by mode of administration (oral, mucosa, inhalation, and injection)",Yes,"Injecting drug use in the lives of users of crack and / or similar, by group of municipalities, 2012 {Pesquisa Nacional Sobre O Uso de Crack, 2014, p.64} ~ ",1
Y,Brazil,BRA,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT)",Yes,"Use of health services by crack users and / or similar, by group of municipalities, Brazil, 2012 {Pesquisa Nacional Sobre O Uso de Crack, 2014, p.105} ~ Number of Regional Reference Centers consolidated and implemented - CRR, total number of centers throughout the national territory {19 Crack, É Possivel Vencer, 2014, p.136} ~ Distribution of self-help institutions mapped according to the program developed. Brazil, Regions and Federative Units. {Relatório Brasileiro sobre Drogas, 2010, p.317} ~ Distribution of Mapped Institutions Providing Treatment by Region {Relatório Brasileiro sobre Drogas, 2010, p.320} ~ Distribution of the mapped institutions that provide treatment, according to all the activities developed. Brazil, Regions and Federative Units. {Relatório Brasileiro sobre Drogas, 2010, p.321} ~ Number of Psychosocial Care Centers (CAPS) and CAPS indicator / 100,000 inhabitants. Brazil, Regions and Federative Units, June 2009. {Relatório Brasileiro sobre Drogas, 2010, p.331} ~ Number of psychiatric beds SUS according to the hospital profile. Brazil, 2002 and 2007. {Relatório Brasileiro sobre Drogas, 2010, p.333} ~ Number of hospitals and psychiatric beds SUS and number of beds per 1,000 inhabitants. Brazil, Regions and Federative Units, October 2008. {Relatório Brasileiro sobre Drogas, 2010, p.334} ~ Number of psychiatric beds SUS in general hospitals. Capitals, July 2008. {Relatório Brasileiro sobre Drogas, 2010, p.335} ~ Self-reported physical and mental health status and access to health services reported by crack users and / or similar sex, Brazil, 2012 {Pesquisa Nacional Sobre O Uso de Crack, 2014, p.97} ~ Self-reported physical and mental health status and access to health services reported by women users of crack and / or similar, by group of municipalities, 2012 {Pesquisa Nacional Sobre O Uso de Crack, 2014, p.98} ~ ",11
Y,Brazil,BRA,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT) by age",Yes,"number of units with the same purpose as the previous one that will serve young people between 10 and 18 years {19 Crack, É Possivel Vencer, 2014, p.134} ~ ",1
Y,Brazil,BRA,Demand Reduction,Level of access to opioid substitution treatment and medication assisted treatment (OST/MAT),No,n/a,0
Y,Brazil,BRA,Demand Reduction,Level of coverage of inpatient treatment,Yes,"Hospital treatment for abstinence cases; and Short-term hospitalization until the clinical stability of the patient {19 Crack, É Possivel Vencer, 2014, p.133} ~ Number of hospitalizations associated with mental and behavioral disorders by drug use. Brazil, 2007 {Relatório Brasileiro sobre Drogas, 2010, p.164} ~ Number of hospitalizations due to drug use. Brazil, Regions and Federative Units/Capitals of residence, 2001 to 2007. {Relatório Brasileiro sobre Drogas, 2010, p.165, p.173} ~ Percentage of hospitalizations due to drug use in relation to the total number of hospitalizations. Brazil, Regions and Federative Units/Capitals of residence, 2001 to 2007 {Relatório Brasileiro sobre Drogas, 2010, p.166, p.174} ~ Number of hospitalizations due to drug use per 100,000 inhabitants. Brazil, Regions and Federative Units/Capitals of residence, 2001 to 2007. {Relatório Brasileiro sobre Drogas, 2010, p.167, p.175} ~ Evolution of the number of hospitalizations due to the use of drugs per 100,000 inhabitants. Brazil Regions and Federative Units/ States of the North Region/ States of the Northeast Region/ States of the Southeast Region/States of the South Region/ States of the Central-West Region/Capitals of the North Region/ Capitals of the Northeast Region/ Capitals of the Southeast Region/. Capitals of the South Region/ Capitals of the Central-West Region, 2001 to 2007. {Relatório Brasileiro sobre Drogas, 2010, p.168, p.169, p.170, p.171, p.176, p.177, p.178} ~ Number of hospitalizations due to drug use by gender. Brazil, 2001 to 2007. {Relatório Brasileiro sobre Drogas, 2010, p.179} ~ Number of hospitalizations due to drug use by age group. Brazil, 2001 to 2007. {Relatório Brasileiro sobre Drogas, 2010, p.179} ~",8
Y,Brazil,BRA,Demand Reduction,Proportion of people who use drugs enrolled in voluntary treatment,Yes,"Crack users and / or the like who would use treatment services, people who use drugs if there was this service close to where they live (punctual estimates and 95% confidence intervals), by municipality group Brazil, 2012 {Pesquisa Nacional Sobre O Uso de Crack, 2014, p.106} ~ Crack and / or similar users who expressed willingness to perform treatment for drug use at the time of the research (point estimates and 95% confidence intervals), by group of municipalities, 2012 {Pesquisa Nacional Sobre O Uso de Crack, 2014, p.107, p.108} ~",2
Y,Brazil,BRA,Demand Reduction,Proportion of people who use drugs enrolled in coerced treatment,Yes,"Orienting users to reception and treatment services {19 Crack, É Possivel Vencer, 2014, p.135} ~",1
Y,Brazil,BRA,Demand Reduction,Proportion of people who use drugs enrolled in compulsory treatment,No,n/a,0
Y,Brazil,BRA,Demand Reduction,Presence of prevention programming in law enforcement,Yes,"Number of educators and military police educators trained for the Program Education for Drug Resistance and Violence – PROERD {19 Crack, É Possivel Vencer, 2014, p.136} ~ Reference Centers in Distance Education: number of operators of the Law (judges, promoters and professionals of the psychosocial area who special criminal courts, sticks of childhood and youth, and public ministry. - partnership with USP {19 Crack, É Possivel Vencer, 2014, p.136} ~",2
Y,Brazil,BRA,Demand Reduction,Presence of prevention programming in the media,No,n/a,0
Y,Brazil,BRA,Demand Reduction,Presence of prevention programming in schools,Yes,"Number of educators and military police educators trained for the Program Education for Drug Resistance and Violence – PROERD {19 Crack, É Possivel Vencer, 2014, p.136} ~ Reference Centers in Distance Education: number of operators of the Law (judges, promoters and professionals of the psychosocial area who special criminal courts, sticks of childhood and youth, and public ministry. - partnership with USP {19 Crack, É Possivel Vencer, 2014, p.136} ~ Number of schools who participated, and number of students reached {19 Crack, É Possivel Vencer, 2014, p.136} ~ Reference Centers in Distance Education: number of health and social assistance professionals {19 Crack, É Possivel Vencer, 2014, p.136} ~",4
Y,Brazil,BRA,Demand Reduction,Presence of prevention programming in the workplace,No,n/a,0
Y,Brazil,BRA,Demand Reduction,Presence of prevention programming for youth and the community,Yes,"Distribution of mapped institutions that carry out prevention activities, by region. {Relatório Brasileiro sobre Drogas, 2010, p.318} ~ Distribution of institutions mapped with prevention programs, according to all the activities developed. Brazil, Regions and Federative Units {Relatório Brasileiro sobre Drogas, 2010, p.319} ~",2
Y,Brazil,BRA,Demand Reduction,Presence of other demand reduction metrics,Yes,"The number of units in partnership with entities and non-profit institutions {19 Crack, É Possivel Vencer, 2014, p.134} ~ Distribution of mapped institutions that carry out teaching and / or research activities, by region. {Relatório Brasileiro sobre Drogas, 2010, p.324} ~ Distribution of mapped entities with teaching and / or research activities, according to all activities developed. Brazil, Regions and Federative Units. {Relatório Brasileiro sobre Drogas, 2010, p.325} ~ Color / race of users of crack and / or similar, by group of municipalities, 2012 {Pesquisa Nacional Sobre O Uso de Crack, 2014, p.50, p.51} ~ Marital situation of users of crack and / or similar by group of municipalities, 2012 {Pesquisa Nacional Sobre O Uso de Crack, 2014, p.51, p.52} ~ Socio-demographic characteristics of users of crack and / or similar by sex, Brazil, 2012 {Pesquisa Nacional Sobre O Uso de Crack, 2014, p.90} ~ Sociodemographic characteristics of women using crack and / or similar by group of municipalities, 2012 {Pesquisa Nacional Sobre O Uso de Crack, 2014, p.91} ~",7
Y,Brazil,BRA,Supply Reduction,Size and value of the illegal drug market,Yes,"the number of police reports for drug trafficking offenses. Federative Units, 2004 to 2007 {Relatório Brasileiro sobre Drogas, 2010, p.254} ~ The roads and routes of greatest drug seizure {19 Crack, É Possivel Vencer, 2014, p.135} ~ Evolution of drug trafficking crimes per 100,000 inhabitants. States of the North Region/ States of the Northeast Region/ States of the Southeast Region/ States of the South Region/ States of the Central-West Region/ Capitals of the North/ Capitals of the Northeast Region/ Capitals of the Southeast Region/ Capitals of the Southern Region/ Capitals of the Central-West Region, 2004 to 2007. {Relatório Brasileiro sobre Drogas, 2010, p.263, p.264, p.265, p.276, p.277, p.278} ~ Percentage of drug trafficking offenses in relation to total number of crimes. Federative Units,Capitals, 2004 to 2007 {Relatório Brasileiro sobre Drogas, 2010, p.256, p.270} ~ number of police reports of drug trafficking crimes per 100,000 inhabitants. Federative Units, Capitals, 2004 to 2007 {Relatório Brasileiro sobre Drogas, 2010, p.262, p.275} ~ number of police reports of crimes for possession of illegal drugs. Federative Units, Capitals, 2004 to 2007 {Relatório Brasileiro sobre Drogas, 2010, p.253, p.267} ~ Percentage of possession crimes for use of illegal drugs in relation to the total number of crimes. Federative Units, Capitals, 2004 to 2007 {Relatório Brasileiro sobre Drogas, 2010, p.255, p.269} ~ Number of Police reports of possession crimes for use of illegal drugs per 100,000 inhabitants. Federative Units, Capitals, 2004 to 2007 {Relatório Brasileiro sobre Drogas, 2010, p.258, p.271} ~ Evolution of possession crimes for use of illegal drugs per 100,000 inhabitants. States of the North Region / States of the Northeast Region / States of the Southeast Region / States of the South Region / States of the Central-West Region / Capitals of the North Region Brazil/ Capitals of the Northeast Region/ Capitals of the Southeast Region/ Capitals of the Southern Region/ Capitals of the Central-West Region, 2004 to 2007. {Relatório Brasileiro sobre Drogas, 2010, p.259, p.260, p.261, p.272, p.273, p.274} ~ number of police reports of drug trafficking offenses. Capitals, 2004 to 2007 {Relatório Brasileiro sobre Drogas, 2010, p.268} ~ ",10
Y,Brazil,BRA,Supply Reduction,Level of procedures related to crop eradication,No,n/a,0
Y,Brazil,BRA,Supply Reduction,"Number of arrests, seizures, and offences",Yes,"Cocaine seizures (kg); Crack seizures (kg); Pasta base seizures (kg); Marijuana seizures (kg); Hashish seizures (kg); Ecstasy seizures (tablets); GHB seizures; Morphine seizures; Heroin seizures. Brazil, Regions and Federative Units, 2001 to 2007 {Relatório Brasileiro sobre Drogas, 2010, p.285, p.289, p.292, p.293, p.297, p.299, p.300} ~ Evolution of cocaine seizures (kg); Evolution of merla seizures (kg); Evolution of Pasta base seizures (kg); Evolution of marijuana seizures (kg); Evolution of LSD seizures (tablets); Evolution of ecstasy seizures (tablets); Evolution of heroin seizures (kg); Evolution of lanca-perfume seizures (units), (States of the North Region, States of the Northeast Region, States of the Southeast Region, States of the South Region, States of the Central-West Region) Brazil, 2001 to 2007. {Relatório Brasileiro sobre Drogas, 2010, p.286, p.287, p.288, p.290, p.291, p.294, p.295, p.296, p.297, p.298, p.300, p.301, p.302} ~ Prevalence of crack users and/or similar who have been to prison, at least once in their life, by group of municipalities, 2012 {Pesquisa Nacional Sobre O Uso de Crack, 2014, p.65} ~ Detention in the last year among users of crack and / or similar, by group of municipalities, 2012 {Pesquisa Nacional Sobre O Uso de Crack, 2014, p.66} ~",4
Y,Brazil,BRA,Supply Reduction,Level of law enforcement activity and interdiction in the market,Yes,"Number of investigations instituted Brazil, 2001 to 2007. {Relatório Brasileiro sobre Drogas, 2010, p.278} ~ ",1
Y,Brazil,BRA,Supply Reduction,"Price, purity and potency of drugs, and related process indicators",No,n/a,0
Y,Brazil,BRA,Supply Reduction,Number of people engaged with the criminal justice system,Yes,"Number of persons indicted by the Federal Police. Brazil, 2001 to 2007. {Relatório Brasileiro sobre Drogas, 2010, p.278} ~ Percentage of those indicted by the Federal Police by gender. Brazil, 2001 to 2007. {Relatório Brasileiro sobre Drogas, 2010, p.279} ~ Percentage of those indicted by the Federal Police by age group. Brazil, 2001 to 2007 {Relatório Brasileiro sobre Drogas, 2010, p.279} ~",3
Y,Brazil,BRA,Supply Reduction,Presence of other supply reduction metrics,No,n/a,0
Y,Brazil,BRA,International Cooperation,Level of engagement in international cooperation,No,n/a,0
Y,Argentina,ARG,Health,Level of availability of harm reduction services and harm reduction scale up,No,n/a,0
Y,Argentina,ARG,Health,Presence of needle and syringe programs,No,n/a,0
Y,Argentina,ARG,Health,Prevalence of substance use disorders,Yes,"% of cocaine and marijuana users presenting dependence/problematic use in the general population {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.22, p.28} ~ Dependence of marijuana and cocaine in population who has consumed drugs in the last year. Percentage according to sex. {Resumen de los Resultados del Estudio 2017 de Consumo de Sustancias Psicoactivas, 2017, p.9} ~ Prevalence of marijuana users aged 16-65 who exhibit signs and symptoms of compulsive use, tolerance, withdrawal symptoms, and is a possible treatment/rehabilitation applicant for marijuana and cocaine {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.30} ~",3
Y,Argentina,ARG,Health,Prevalence of psychiatric comorbidities,No,n/a,0
Y,Argentina,ARG,Health,Drug-related mortality,No,n/a,0
Y,Argentina,ARG,Health,Prevalence of drug-related infectious disease,No,n/a,0
Y,Argentina,ARG,Health,Proportion of people who use drugs who engage in risky consumption,No,n/a,0
Y,Argentina,ARG,Health,Proportion of people who use drugs who engage in safe consumption practices,No,n/a,0
Y,Argentina,ARG,Health,"Coverage of services for the prevention, testing, and treatment of bloodborne diseases",No,n/a,0
Y,Argentina,ARG,Health,Presence of specialised training for addiction care,No,n/a,0
Y,Argentina,ARG,Health,Presence of health harms related to drug use,No,n/a,0
Y,Argentina,ARG,Health,Presence of other health metrics,No,n/a,0
Y,Argentina,ARG,Peace and Security,"Prevalence of alcohol and drugs in accidents, and interventions to increase road safety",Yes,"The prevalence of people who tested positive for marijuanna, anxiolytics, sedatives & tranquilizers, and cocaine after an injury or car accident {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.30} ~ Prevalence of traffic accidents related to substance use {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.30} ~ Prevalence of individuals admitted to a hospital due to violent situations after substance use {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.30} ~ ",3
Y,Argentina,ARG,Peace and Security,Annual number of public disorder and violent crime reports,Yes,"prevalence of those who committed a crime while under the influence of drugs: just one time, rarely, many times, always, never, n/a {Infracción a la ley de drogas y problemáticas asociadas: Análisis de estadísticas carcelarias en Argentina, 2015, p.24} ~ prevalence of those who committed a crime in order to buy drugs: just one time, rarely, many times, always, never, n/a {Infracción a la ley de drogas y problemáticas asociadas: Análisis de estadísticas carcelarias en Argentina, 2015, p.24} ~ prevalence of those under the influence of drugs with intent to commit a crime: just one time, rarely, many tines, always, never, n/a {Infracción a la ley de drogas y problemáticas asociadas: Análisis de estadísticas carcelarias en Argentina, 2015, p.24} ~ How did you get the money to use drugs?: Job; Stole; Ask for money; Robbery; Various; Sell your things; Sell drugs; Prostitution {Infracción a la ley de drogas y problemáticas asociadas: Análisis de estadísticas carcelarias en Argentina, 2015, p.23} ~ ",4
Y,Argentina,ARG,Peace and Security,Number of non-lethal drug market violent events reported,No,n/a,0
Y,Argentina,ARG,Peace and Security,Number of drug market related homicides and disappearances,No,n/a,0
Y,Argentina,ARG,Peace and Security,Presence of other peace and security metrics,No,n/a,0
Y,Argentina,ARG,Development,Coverage of housing assistance for people who use drugs,No,n/a,0
Y,Argentina,ARG,Development,Coverage of social assistance for people who use drugs (not including housing),No,n/a,0
Y,Argentina,ARG,Development,Number of households enrolled in alternative development,No,n/a,0
Y,Argentina,ARG,Development,Presence of other development metrics,Yes,"Labor inclusion at the time of arrest: Full time worker, Part-time worker, Not busy {Infracción a la ley de drogas y problemáticas asociadas: Análisis de estadísticas carcelarias en Argentina, 2015 ,p.12} ~",1
Y,Argentina,ARG,Human Rights,"Prevalence and incidence of infectious diseases in vulnerable populations (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,"Prevalence of drug use (marijuana, cocaine) among prosecuted adolescents {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.31} ~ ",1
Y,Argentina,ARG,Human Rights,"Prevalence of vulnerable people who use drugs (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"Prevalence of drug use (psychoactive substance, marijuana, cocaine) among inmates {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.31} ~ ",1
Y,Argentina,ARG,Human Rights,Proportion of people who use drugs in prison that are receiving medication assisted treatment (MAT),No,n/a,0
Y,Argentina,ARG,Human Rights,Distribution of sterile injecting equipment in prisons,No,n/a,0
Y,Argentina,ARG,Human Rights,Presence of programs and services targeted towards women ,No,n/a,0
Y,Argentina,ARG,Human Rights,Presence of programs and services targeted towards people of color,No,n/a,0
Y,Argentina,ARG,Human Rights,Presence of challenges and/or harms experienced by people of color,No,n/a,0
Y,Argentina,ARG,Human Rights,"Presence of programs and services targeted towards vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"Prevalence of inmates who received treatment {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.31} ~ Prevalence of drug users in prison who received treatment through either therapy, self-help groups, or community therapy {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.31} ~ Prevalence of prosecuted adolescents receiving treatment for any kind of consumption {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.31} ~",3
Y,Argentina,ARG,Human Rights,"Presence of challenges and/or harms experienced by vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"Prevalence of inmates who display symptoms of drug dependence (marijuana, cocaine) {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.31} ~ ",1
Y,Argentina,ARG,Human Rights,Presence of other human rights metrics,No,n/a,0
Y,Argentina,ARG,Demand Reduction,Prevalence of drug use by age,Yes,"Disaggregating consumption by age groups {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.24} ~ Prevalence of the consumption of psychotropic drugs with a prescription among users aged 18-24, and % of the consumption of psychotropic drugs with a prescription among older users {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.28} ~ Prevalence of non-prescription stimulants, non-prescription tranquilizers, and Paco (made from residue of coca leaves) use in the population aged 16-65 years {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.28, p.29, p.30} ~ Friends who get drunk or consume drugs among the population of 12 to 17 years old, expressed as a percentage: Two or more Friends or family members who get drunk; Two or more Friends or family members use drugs {Resumen de los Resultados del Estudio 2017 de Consumo de Sustancias Psicoactivas, 2017, p.10} ~ Prevalence of occasional marijuana use among the population aged 25-34 years {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.28} ~ Prevalence of frequent marijuana use among the population aged 25-34 years {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.28} ~ Prevalence of students who have ever used drugs at age 17 (marijuana, ecstasy) {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.26, p.27} ~ % of students reporting having ever used drugs (non-prescription psychotropics, non-prescription tranquillizers, non-prescription stimulants, {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.26} ~ Prevalence of students aged 15-16 years old having consumed ecstasy {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.27} ~ prevalence of psychotropic substances without a prescription used among women and men aged 25-34 {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.28} ~ The prevalence of men and women between the ages of 18-34 who have used marijuana {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.28} ~ Highest prevalence of cocaine use for men and women aged 18-24 years {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.28} ~ Prevalence of males and females aged 25-34 who use cocaine occasionally {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.28} ~ prevalence of the population aged 12 to 65 years who have consumed an illicit drug in the last year {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.21} ~ % of the population between age 12-65 having consumed drugs in the last year (marijuana, cocaine) {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.22} ~ % of students having used marijuana in the last year {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.25} ~ % of students who reported having tried drugs (marijuana, cocaine, ecstasy) at least once in the last year {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.25, p.26, p.27, p.28} ~ % of students reporting having used drugs (marijuana, non-prescription psychotropics) at least once before the age of 15 {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.26} ~ prevalence of psychotropic substance use for students at least once in their life before age 17 {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.26} ~ Tendency in the ""once in a lifetime"" use of illicit substances. Population from 12 to 17 years old, expressed as a percentage: cocaine, ecstasy, other illicit drugs {Resumen de los Resultados del Estudio 2017 de Consumo de Sustancias Psicoactivas, 2017, p.5} ~ % of adolescents who use marijuana experimentally {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.22, p.28} ~ The average age at which students report having tried cocaine for the first time {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.26} ~ Consumption sometime in the last month - Population of 12 to 17 years, expressed as a percentage: Tobacco, Alcohol, Marijuana, other illicit drugs {Resumen de los Resultados del Estudio 2017 de Consumo de Sustancias Psicoactivas, 2017, p.4} ~ Marijuana use in the last month in a population between 12 and 65 years old {Resumen de los Resultados del Estudio 2017 de Consumo de Sustancias Psicoactivas, 2017, p.9} ~",24
Y,Argentina,ARG,Demand Reduction,Prevalence of drug use by sex,Yes,"prevalence of psychotropic substances without a prescription used among women and men aged 25-34 {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.28} ~ The prevalence of men and women between the ages of 18-34 who have used marijuana {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.28} ~ Highest prevalence of cocaine use for men and women aged 18-24 years {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.28} ~ Prevalence of males and females aged 25-34 who use cocaine occasionally {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.28} ~ prevalence of men and women who use cocaine {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.22, p.28} ~ % of males, % of females who have tried marijuana at least once in their lifetime {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.25, p.26} ~ % of males, % of females who have used marijuana at least once in the past year {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.25, p.26} ~ ",7
Y,Argentina,ARG,Demand Reduction,Prevalence of drug use by type,Yes,"Prevalence of the consumption of psychotropic drugs with a prescription among users aged 18-24, and % of the consumption of psychotropic drugs with a prescription among older users {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.28} ~ Prevalence of non-prescription stimulants, non-prescription tranquilizers, and Paco (made from residue of coca leaves) use in the population aged 16-65 years {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.28, p.29, p.30} ~ prevalence of drug use (marijuana, tranquillizer use without a prescription, cocaine, solvents and inhalants, ecstasy, pasta base/paco, stimulants without a prescription {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.21, p.22, p.27} ~ % of casual cocaine use {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.22} ~ Prevalence of occasional marijuana use among the population aged 25-34 years {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.28} ~ Prevalence of occasional drug use (marijuana, cocaine) {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.22, p.28} ~ Prevalence of frequent marijuana use among the population aged 25-34 years {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.28} ~ % of the frequent drug use (marijuana, cocaine) {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.22, p.28} ~ Prevalence of students who have ever used drugs at age 17 (marijuana, ecstasy) {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.26, p.27} ~ % of students reporting having ever used drugs (non-prescription psychotropics, non-prescription tranquillizers, non-prescription stimulants, {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.26} ~ Prevalence of students aged 15-16 years old having consumed ecstasy {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.27} ~ prevalence of psychotropic substances without a prescription used among women and men aged 25-34 {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.28} ~ The prevalence of men and women between the ages of 18-34 who have used marijuana {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.28} ~ Highest prevalence of cocaine use for men and women aged 18-24 years {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.28} ~ Prevalence of males and females aged 25-34 who use cocaine occasionally {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.28} ~ prevalence of men and women who use cocaine {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.22, p.28} ~ % of males, % of females who have tried marijuana at least once in their lifetime {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.25, p.26} ~ % of males, % of females who have used marijuana at least once in the past year {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.25, p.26} ~ % of the population between age 12-65 having consumed drugs in the last year (marijuana, cocaine) {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.22} ~ % of students having used marijuana in the last year {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.25} ~ % of students who reported having tried drugs (marijuana, cocaine, ecstasy) at least once in the last year {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.25, p.26, p.27, p.28} ~ % of students reporting having used drugs (marijuana, non-prescription psychotropics) at least once before the age of 15 {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.26} ~ prevalence of psychotropic substance use for students at least once in their life before age 17 {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.26} ~ the prevalence of ecstasy consumption at least once in the last month {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.27} ~ Tendency in the ""once in a lifetime"" use of illicit substances. Population from 12 to 17 years old, expressed as a percentage: cocaine, ecstasy, other illicit drugs {Resumen de los Resultados del Estudio 2017 de Consumo de Sustancias Psicoactivas, 2017, p.5} ~ % of adolescents who use marijuana experimentally {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.22, p.28} ~ The average age at which students report having tried cocaine for the first time {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.26} ~ Consumption sometime in the last month - Population of 12 to 17 years, expressed as a percentage: Tobacco, Alcohol, Marijuana, other illicit drugs {Resumen de los Resultados del Estudio 2017 de Consumo de Sustancias Psicoactivas, 2017, p.4} ~ Marijuana use in the last month in a population between 12 and 65 years old {Resumen de los Resultados del Estudio 2017 de Consumo de Sustancias Psicoactivas, 2017, p.9} ~",29
Y,Argentina,ARG,Demand Reduction,Number of people who use drugs,No,n/a,0
Y,Argentina,ARG,Demand Reduction,"Prevalence of drug use by mode of administration (oral, mucosa, inhalation, and injection)",No,n/a,0
Y,Argentina,ARG,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT)",Yes,"Search for treatment in the last year, by sex, according to the results of the search, expressed as a percentage. {Resumen de los Resultados del Estudio 2017 de Consumo de Sustancias Psicoactivas, 2017, p.11} ~",1
Y,Argentina,ARG,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT) by age",No,n/a,0
Y,Argentina,ARG,Demand Reduction,Level of access to opioid substitution treatment and medication assisted treatment (OST/MAT),No,n/a,0
Y,Argentina,ARG,Demand Reduction,Level of coverage of inpatient treatment,No,n/a,0
Y,Argentina,ARG,Demand Reduction,Proportion of people who use drugs enrolled in voluntary treatment,No,n/a,0
Y,Argentina,ARG,Demand Reduction,Proportion of people who use drugs enrolled in coerced treatment,No,n/a,0
Y,Argentina,ARG,Demand Reduction,Proportion of people who use drugs enrolled in compulsory treatment,No,n/a,0
Y,Argentina,ARG,Demand Reduction,Presence of prevention programming in law enforcement,No,n/a,0
Y,Argentina,ARG,Demand Reduction,Presence of prevention programming in the media,No,n/a,0
Y,Argentina,ARG,Demand Reduction,Presence of prevention programming in schools,No,n/a,0
Y,Argentina,ARG,Demand Reduction,Presence of prevention programming in the workplace,No,n/a,0
Y,Argentina,ARG,Demand Reduction,Presence of prevention programming for youth and the community,Yes,"percentage of children and adolescents that consider it not risky to smoke marijuanna in 2010 compared to 2017 {Resumen de los Resultados del Estudio 2017 de Consumo de Sustancias Psicoactivas, 2017, p.5} ~ ",1
Y,Argentina,ARG,Demand Reduction,Presence of other demand reduction metrics,Yes,"Indicators of the propensity to consume drugs according to sex and age groups (disagregated by age and sex): I am curious to try drugs; I would try a drug if I had the occassion {Resumen de los Resultados del Estudio 2017 de Consumo de Sustancias Psicoactivas, 2017, p.6} ~ Prevalence of the population that reports a propensity to consume an illicit drug due to curiosity {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.29} ~ ",2
Y,Argentina,ARG,Supply Reduction,Size and value of the illegal drug market,Yes,"Prevalence (%) of perceived ease of access to drugs (marijuana, cocaine, ecstasy) {Plan Nacional de Reducción de la Demanda de Drogas, 2016-2020, p.29} ~ Perceived ease of access to obtain marijuana in a term of 24 hours according to age groups: It would be easy for me; It would be difficult for me; I could not get it; I do not know if it is easy or difficult; n/a {Resumen de los Resultados del Estudio 2017 de Consumo de Sustancias Psicoactivas, 2017, p.6} ~ ",2
Y,Argentina,ARG,Supply Reduction,Level of procedures related to crop eradication,No,n/a,0
Y,Argentina,ARG,Supply Reduction,"Number of arrests, seizures, and offences",Yes,"Persons detained by law N ° 23.737 (drug law) expressed in percentage by sex (2005-2015) {Infracción a la ley de drogas y problemáticas asociadas: Análisis de estadísticas carcelarias en Argentina, 2015, p.6} ~ Provincial rate of detainees for infringement 23737 - SNEEP; Offense Law 23.737. Year 2015 Quantity of drug seizures (kg)  (Cocaine, Marijuana) (kg) SSLN 2015 * (Provincial Force) {Infracción a la ley de drogas y problemáticas asociadas: Análisis de estadísticas carcelarias en Argentina, 2015, p.16} ~ Proportion of individuals who committed some offense outside of their home: proportion of total population; population up to 25 years; population up to 18 years {Infracción a la ley de drogas y problemáticas asociadas: Análisis de estadísticas carcelarias en Argentina, 2015, p.22} ~",3
Y,Argentina,ARG,Supply Reduction,Level of law enforcement activity and interdiction in the market,Yes,"The jurisdictional variations that were presented in the period 2005-2015, expressing a marked transfer of cases from the Federal Court to the Provincial Jurisdictions: National Jurisdiction; Provincial Jurisdiction; Federal Jurisdiction {Infracción a la ley de drogas y problemáticas asociadas: Análisis de estadísticas carcelarias en Argentina, 2015, p.17} ~ ",1
Y,Argentina,ARG,Supply Reduction,"Price, purity and potency of drugs, and related process indicators",No,n/a,0
Y,Argentina,ARG,Supply Reduction,Number of people engaged with the criminal justice system,Yes,"map of the last place of residence of the population who infringed the law 23.737 - 2015 Rate c / 100,000 inhabitants {Infracción a la ley de drogas y problemáticas asociadas: Análisis de estadísticas carcelarias en Argentina, 2015, p.13} ~ Last province of residence of those who infringed the drug law - 2005 rate c / 100,000; 2015 rate c / 100,000 {Infracción a la ley de drogas y problemáticas asociadas: Análisis de estadísticas carcelarias en Argentina, 2015, p.14} ~ General prison population procedural situation: Condemned, Indicted {Infracción a la ley de drogas y problemáticas asociadas: Análisis de estadísticas carcelarias en Argentina, 2015, p.19} ~ Population detained by law N ° 23.737 Procedural Situation: Condemned; Indicted {Infracción a la ley de drogas y problemáticas asociadas: Análisis de estadísticas carcelarias en Argentina, 2015, p.20} ~ % of prison population 2005; % of prison population 2010; % of prison population 2015 (disaggregated by sex) {Infracción a la ley de drogas y problemáticas asociadas: Análisis de estadísticas carcelarias en Argentina, 2015, p.7} ~ Age of the detainees for infringing law 23.737 - 2005-2015 {Infracción a la ley de drogas y problemáticas asociadas: Análisis de estadísticas carcelarias en Argentina, 2015, p.9} ~",6
Y,Argentina,ARG,Supply Reduction,Presence of other supply reduction metrics,No,n/a,0
Y,Argentina,ARG,International Cooperation,Level of engagement in international cooperation,No,n/a,0
Y,Haiti,HTI,Health,Level of availability of harm reduction services and harm reduction scale up,No,n/a,0
Y,Haiti,HTI,Health,Presence of needle and syringe programs,No,n/a,0
Y,Haiti,HTI,Health,Prevalence of substance use disorders,No,n/a,0
Y,Haiti,HTI,Health,Prevalence of psychiatric comorbidities,No,n/a,0
Y,Haiti,HTI,Health,Drug-related mortality,No,n/a,0
Y,Haiti,HTI,Health,Prevalence of drug-related infectious disease,No,n/a,0
Y,Haiti,HTI,Health,Proportion of people who use drugs who engage in risky consumption,No,n/a,0
Y,Haiti,HTI,Health,Proportion of people who use drugs who engage in safe consumption practices,No,n/a,0
Y,Haiti,HTI,Health,"Coverage of services for the prevention, testing, and treatment of bloodborne diseases",No,n/a,0
Y,Haiti,HTI,Health,Presence of specialised training for addiction care,No,n/a,0
Y,Haiti,HTI,Health,Presence of health harms related to drug use,No,n/a,0
Y,Haiti,HTI,Health,Presence of other health metrics,No,n/a,0
Y,Haiti,HTI,Peace and Security,"Prevalence of alcohol and drugs in accidents, and interventions to increase road safety",No,n/a,0
Y,Haiti,HTI,Peace and Security,Annual number of public disorder and violent crime reports,No,n/a,0
Y,Haiti,HTI,Peace and Security,Number of non-lethal drug market violent events reported,No,n/a,0
Y,Haiti,HTI,Peace and Security,Number of drug market related homicides and disappearances,No,n/a,0
Y,Haiti,HTI,Peace and Security,Presence of other peace and security metrics,No,n/a,0
Y,Haiti,HTI,Development,Coverage of housing assistance for people who use drugs,No,n/a,0
Y,Haiti,HTI,Development,Coverage of social assistance for people who use drugs (not including housing),No,n/a,0
Y,Haiti,HTI,Development,Number of households enrolled in alternative development,No,n/a,0
Y,Haiti,HTI,Development,Presence of other development metrics,No,n/a,0
Y,Haiti,HTI,Human Rights,"Prevalence and incidence of infectious diseases in vulnerable populations (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Haiti,HTI,Human Rights,"Prevalence of vulnerable people who use drugs (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Haiti,HTI,Human Rights,Proportion of people who use drugs in prison that are receiving medication assisted treatment (MAT),No,n/a,0
Y,Haiti,HTI,Human Rights,Distribution of sterile injecting equipment in prisons,No,n/a,0
Y,Haiti,HTI,Human Rights,Presence of programs and services targeted towards women ,No,n/a,0
Y,Haiti,HTI,Human Rights,Presence of programs and services targeted towards people of color,No,n/a,0
Y,Haiti,HTI,Human Rights,Presence of challenges and/or harms experienced by people of color,No,n/a,0
Y,Haiti,HTI,Human Rights,"Presence of programs and services targeted towards vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Haiti,HTI,Human Rights,"Presence of challenges and/or harms experienced by vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Haiti,HTI,Human Rights,Presence of other human rights metrics,No,n/a,0
Y,Haiti,HTI,Demand Reduction,Prevalence of drug use by age,No,n/a,0
Y,Haiti,HTI,Demand Reduction,Prevalence of drug use by sex,No,n/a,0
Y,Haiti,HTI,Demand Reduction,Prevalence of drug use by type,Yes,"Prevalence of substances used and a comparative analysis between 2009 and 2014 for the following substances: Cigarettes, Alcohol, Tranquilizers, Stimulants, Inhalants, Marijuana, Cocaine HCL, Crack, Any illegal drug {Situation de la drogue en Haiti aperçu par l’Observatoire Haitien, 2011-2015, np} ~",1
Y,Haiti,HTI,Demand Reduction,Number of people who use drugs,No,n/a,0
Y,Haiti,HTI,Demand Reduction,"Prevalence of drug use by mode of administration (oral, mucosa, inhalation, and injection)",No,n/a,0
Y,Haiti,HTI,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT)",No,n/a,0
Y,Haiti,HTI,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT) by age",No,n/a,0
Y,Haiti,HTI,Demand Reduction,Level of access to opioid substitution treatment and medication assisted treatment (OST/MAT),No,n/a,0
Y,Haiti,HTI,Demand Reduction,Level of coverage of inpatient treatment,No,n/a,0
Y,Haiti,HTI,Demand Reduction,Proportion of people who use drugs enrolled in voluntary treatment,No,n/a,0
Y,Haiti,HTI,Demand Reduction,Proportion of people who use drugs enrolled in coerced treatment,No,n/a,0
Y,Haiti,HTI,Demand Reduction,Proportion of people who use drugs enrolled in compulsory treatment,No,n/a,0
Y,Haiti,HTI,Demand Reduction,Presence of prevention programming in law enforcement,No,n/a,0
Y,Haiti,HTI,Demand Reduction,Presence of prevention programming in the media,No,n/a,0
Y,Haiti,HTI,Demand Reduction,Presence of prevention programming in schools,No,n/a,0
Y,Haiti,HTI,Demand Reduction,Presence of prevention programming in the workplace,No,n/a,0
Y,Haiti,HTI,Demand Reduction,Presence of prevention programming for youth and the community,No,n/a,0
Y,Haiti,HTI,Demand Reduction,Presence of other demand reduction metrics,No,n/a,0
Y,Haiti,HTI,Supply Reduction,Size and value of the illegal drug market,No,n/a,0
Y,Haiti,HTI,Supply Reduction,Level of procedures related to crop eradication,No,n/a,0
Y,Haiti,HTI,Supply Reduction,"Number of arrests, seizures, and offences",Yes,"Number of marijuana, cocaine, crack, amphetamine, heroin and LSD seizures per year {Situation de la drogue en Haiti aperçu par l’Observatoire Haitien, 2011-2015, np} ~ Amount of money seized in US dollars and “Gourdes” {Situation de la drogue en Haiti aperçu par l’Observatoire Haitien, 2011-2015, np} ~ Number of firearms seized {Situation de la drogue en Haiti aperçu par l’Observatoire Haitien, 2011-2015, np} ~ Number of arrests per year {Situation de la drogue en Haiti aperçu par l’Observatoire Haitien, 2011-2015, np} ~ Number of arrests per year classified by sex (men and women) {Situation de la drogue en Haiti aperçu par l’Observatoire Haitien, 2011-2015, np} ~",5
Y,Haiti,HTI,Supply Reduction,Level of law enforcement activity and interdiction in the market,No,n/a,0
Y,Haiti,HTI,Supply Reduction,"Price, purity and potency of drugs, and related process indicators",No,n/a,0
Y,Haiti,HTI,Supply Reduction,Number of people engaged with the criminal justice system,Yes,"Number of convictions, and number of conviction classified by gender (men and women) {Situation de la drogue en Haiti aperçu par l’Observatoire Haitien, 2011-2015, np} ~ Ratio of men who are convicted/arrested vs women {Situation de la drogue en Haiti aperçu par l’Observatoire Haitien, 2011-2015, np} ~ Nationality of those who are convicted (%) {Situation de la drogue en Haiti aperçu par l’Observatoire Haitien, 2011-2015, np}~",3
Y,Haiti,HTI,Supply Reduction,Presence of other supply reduction metrics,No,n/a,0
Y,Haiti,HTI,International Cooperation,Level of engagement in international cooperation,No,n/a,0
Y,The Democratic Republic of Congo,COD,Health,Level of availability of harm reduction services and harm reduction scale up,Yes,"Quantity of equipment granted by ZS {Plan quinquennal de couverture du programme national de lutte contre les toxicomanies et des substances toxiques, 2016-2020, p. 7}~ ",1
Y,The Democratic Republic of Congo,COD,Health,Presence of needle and syringe programs,No,n/a,0
Y,The Democratic Republic of Congo,COD,Health,Prevalence of substance use disorders,Yes,"Percentage of Congolese children aged 10 to 19 years who are poly addicts and percentage displaying violent behavior {Plan quinquennal de couverture du programme national de lutte contre les toxicomanies et des substances toxiques, 2016-2020, p.2} ~ Prevalence of drug addiction: % of young people aged 10 to 19 who are addicted to drugs {Programme national de lutte contre les toxicomanies et les substances toxiques (PNLCT), 2016-2020, p.3} ~",2
Y,The Democratic Republic of Congo,COD,Health,Prevalence of psychiatric comorbidities,No,n/a,0
Y,The Democratic Republic of Congo,COD,Health,Drug-related mortality,No,n/a,0
Y,The Democratic Republic of Congo,COD,Health,Prevalence of drug-related infectious disease,Yes,"HIV Seroprevalence in Drug Addicts {Plan quinquennal de couverture du programme national de lutte contre les toxicomanies et des substances toxiques, 2016-2020, p.2, p. 25} ~ Number of drug users with HIV / AIDS (Seropositive) by province: Number of cases (%) {Programme national de lutte contre les toxicomanies et les substances toxiques (PNLCT), 2016-2020, p. 4} ~ HIV prevalence among injecting drug users (%) {Plan Stratégique National de lutte contre le VIH et le Sida, 2014-2017, p.75} ~",3
Y,The Democratic Republic of Congo,COD,Health,Proportion of people who use drugs who engage in risky consumption,No,n/a,0
Y,The Democratic Republic of Congo,COD,Health,Proportion of people who use drugs who engage in safe consumption practices,No,n/a,0
Y,The Democratic Republic of Congo,COD,Health,"Coverage of services for the prevention, testing, and treatment of bloodborne diseases",Yes,"Percentage of key populations (HSH, IDU, SW et clients) that are reached by HIV prevention programs {Plan Stratégique National de lutte contre le VIH et le Sida, 2014-2017, p. 26} ~  ",1
Y,The Democratic Republic of Congo,COD,Health,Presence of specialised training for addiction care,Yes,"Number of managers trained {Plan quinquennal de couverture du programme national de lutte contre les toxicomanies et des substances toxiques, 2016-2020, p. 6} ~ Number of RECOs formed, and number of educator pairs formed {Plan quinquennal de couverture du programme national de lutte contre les toxicomanies et des substances toxiques, 2016-2020, p. 7} ~ Number of people trained by ZS {Plan quinquennal de couverture du programme national de lutte contre les toxicomanies et des substances toxiques, 2016-2020, p. 7}~",3
Y,The Democratic Republic of Congo,COD,Health,Presence of health harms related to drug use,No,n/a,0
Y,The Democratic Republic of Congo,COD,Health,Presence of other health metrics,Yes,"Percentage of individuals who did not use condoms during their last occasional sexual intercourse {Plan quinquennal de couverture du programme national de lutte contre les toxicomanies et des substances toxiques, 2016-2020, p. 2} ~ Percentage of individuals who have had at-risk intercourse in the last 3 months {Plan quinquennal de couverture du programme national de lutte contre les toxicomanies et des substances toxiques, 2016-2020, p. 2} ~ Percentage of drug users who practice unprotected sex {Plan quinquennal de couverture du programme national de lutte contre les toxicomanies et des substances toxiques, 2016-2020, p. 2} ~ ",3
Y,The Democratic Republic of Congo,COD,Peace and Security,"Prevalence of alcohol and drugs in accidents, and interventions to increase road safety",Yes,"Number of car accidents, number of car accidents including death, number of car accidents with serious material damage, and percentage of accidents due to intoxication {Plan quinquennal de couverture du programme national de lutte contre les toxicomanies et des substances toxiques, 2016-2020, p.2}~",1
Y,The Democratic Republic of Congo,COD,Peace and Security,Annual number of public disorder and violent crime reports,Yes,"Number of cases of sexual violence due to alcohol and drug abuse {Plan quinquennal de couverture du programme national de lutte contre les toxicomanies et des substances toxiques, 2016-2020, p. 2} ~ The average age of sexual violence victims {Plan quinquennal de couverture du programme national de lutte contre les toxicomanies et des substances toxiques, 2016-2020, p. 2} ~ ",2
Y,The Democratic Republic of Congo,COD,Peace and Security,Number of non-lethal drug market violent events reported,No,n/a,0
Y,The Democratic Republic of Congo,COD,Peace and Security,Number of drug market related homicides and disappearances,No,n/a,0
Y,The Democratic Republic of Congo,COD,Peace and Security,Presence of other peace and security metrics,No,n/a,0
Y,The Democratic Republic of Congo,COD,Development,Coverage of housing assistance for people who use drugs,No,n/a,0
Y,The Democratic Republic of Congo,COD,Development,Coverage of social assistance for people who use drugs (not including housing),No,n/a,0
Y,The Democratic Republic of Congo,COD,Development,Number of households enrolled in alternative development,No,n/a,0
Y,The Democratic Republic of Congo,COD,Development,Presence of other development metrics,No,n/a,0
Y,The Democratic Republic of Congo,COD,Human Rights,"Prevalence and incidence of infectious diseases in vulnerable populations (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,The Democratic Republic of Congo,COD,Human Rights,"Prevalence of vulnerable people who use drugs (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"Percentage of street children who consume drugs {Plan quinquennal de couverture du programme national de lutte contre les toxicomanies et des substances toxiques, 2016-2020, p. 2} ~ ",1
Y,The Democratic Republic of Congo,COD,Human Rights,Proportion of people who use drugs in prison that are receiving medication assisted treatment (MAT),No,n/a,0
Y,The Democratic Republic of Congo,COD,Human Rights,Distribution of sterile injecting equipment in prisons,No,n/a,0
Y,The Democratic Republic of Congo,COD,Human Rights,Presence of programs and services targeted towards women ,No,n/a,0
Y,The Democratic Republic of Congo,COD,Human Rights,Presence of programs and services targeted towards people of color,No,n/a,0
Y,The Democratic Republic of Congo,COD,Human Rights,Presence of challenges and/or harms experienced by people of color,No,n/a,0
Y,The Democratic Republic of Congo,COD,Human Rights,"Presence of programs and services targeted towards vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"Percentage of key populations (HSH, SW) that are reached by HIV prevention programs {Plan Stratégique National de lutte contre le VIH et le Sida, 2014-2017, p. 26} ~ ",2
Y,The Democratic Republic of Congo,COD,Human Rights,"Presence of challenges and/or harms experienced by vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,The Democratic Republic of Congo,COD,Human Rights,Presence of other human rights metrics,No,n/a,0
Y,The Democratic Republic of Congo,COD,Demand Reduction,Prevalence of drug use by age,No,n/a,0
Y,The Democratic Republic of Congo,COD,Demand Reduction,Prevalence of drug use by sex,No,n/a,0
Y,The Democratic Republic of Congo,COD,Demand Reduction,Prevalence of drug use by type,Yes,"Drug use data - The most consumed substances: percentages of alcohol, tabacco, cannabis, valium/diazepam, other psychoactive substances (amphetamines, roche 4, metaqualone, hallucinogens (LSD), caffeine), new psychoactive substances substances: gunpowder (child soldiers) Datura stramonium or ""36 birds (plant), 33 Towers, Paspalome root or lawn, Bamboo leaves, Peanut Leaves, Leaves of Fir, Mushrooms, Banknotes {Programme national de lutte contre les toxicomanies et les substances toxiques (PNLCT), 2016-2020, p.3} ~ Consumption rates by substance: cannabis (%), cocaine / heroin (%), other substances (%) {Programme national de lutte contre les toxicomanies et les substances toxiques (PNLCT), 2016-2020, p.3}~ ",2
Y,The Democratic Republic of Congo,COD,Demand Reduction,Number of people who use drugs,Yes,"Number of consumers and rate of consumption {Programme national de lutte contre les toxicomanies et les substances toxiques (PNLCT), 2016-2020, p. 3} ~",1
Y,The Democratic Republic of Congo,COD,Demand Reduction,"Prevalence of drug use by mode of administration (oral, mucosa, inhalation, and injection)",Yes,"Prevalence (%) and number of intravenous drug users {Plan Stratégique National de lutte contre le VIH et le Sida, 2014-2017, p.16, p.39} ~ ",1
Y,The Democratic Republic of Congo,COD,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT)",Yes,"Percentage of individuals who need psychosocial care {Plan quinquennal de couverture du programme national de lutte contre les toxicomanies et des substances toxiques, 2016-2020, p. 2} ~ ",1
Y,The Democratic Republic of Congo,COD,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT) by age",No,"Percentage of young people who need medical care {Plan quinquennal de couverture du programme national de lutte contre les toxicomanies et des substances toxiques, 2016-2020, p. 2} ~ ",1
Y,The Democratic Republic of Congo,COD,Demand Reduction,Level of access to opioid substitution treatment and medication assisted treatment (OST/MAT),No,n/a,0
Y,The Democratic Republic of Congo,COD,Demand Reduction,Level of coverage of inpatient treatment,No,n/a,0
Y,The Democratic Republic of Congo,COD,Demand Reduction,Proportion of people who use drugs enrolled in voluntary treatment,No,n/a,0
Y,The Democratic Republic of Congo,COD,Demand Reduction,Proportion of people who use drugs enrolled in coerced treatment,No,n/a,0
Y,The Democratic Republic of Congo,COD,Demand Reduction,Proportion of people who use drugs enrolled in compulsory treatment,No,n/a,0
Y,The Democratic Republic of Congo,COD,Demand Reduction,Presence of prevention programming in law enforcement,No,n/a,0
Y,The Democratic Republic of Congo,COD,Demand Reduction,Presence of prevention programming in the media,No,n/a,0
Y,The Democratic Republic of Congo,COD,Demand Reduction,Presence of prevention programming in schools,Yes,"Number of modules and guidelines developed in ZS (module for training of trainers, training of providers, training of RECOs, Training of educational pairs) {Plan quinquennal de couverture du programme national de lutte contre les toxicomanies et des substances toxiques, 2016-2020, p. 6} ~ ",1
Y,The Democratic Republic of Congo,COD,Demand Reduction,Presence of prevention programming in the workplace,No,n/a,0
Y,The Democratic Republic of Congo,COD,Demand Reduction,Presence of prevention programming for youth and the community,No,n/a,0
Y,The Democratic Republic of Congo,COD,Demand Reduction,Presence of other demand reduction metrics,Yes,"percentage of young people who claim to lose control of their partner after taking the drug {Plan quinquennal de couverture du programme national de lutte contre les toxicomanies et des substances toxiques, 2016-2020, p. 2} ~ percentage of people who claim they want to give up their drug addiction {Plan quinquennal de couverture du programme national de lutte contre les toxicomanies et des substances toxiques, 2016-2020, p. 2} ~ Rate of site attendance: men in uniform (%), adolescents (%), average drug use rate (%) {Programme national de lutte contre les toxicomanies et les substances toxiques (PNLCT), 2016-2020, p.3} ~ Percentage of individuals who acknowledge that alcohol and drugs excite their sexual desire {Plan quinquennal de couverture du programme national de lutte contre les toxicomanies et des substances toxiques, 2016-2020, p.2}~",4
Y,The Democratic Republic of Congo,COD,Supply Reduction,Size and value of the illegal drug market,Yes,"Number of sales and rate of sales {Programme national de lutte contre les toxicomanies et les substances toxiques (PNLCT), 2016-2020, p.3} ~ Site of sale: consumption census: number {Programme national de lutte contre les toxicomanies et les substances toxiques (PNLCT), 2016-2020, p. 3} ~",2
Y,The Democratic Republic of Congo,COD,Supply Reduction,Level of procedures related to crop eradication,No,n/a,0
Y,The Democratic Republic of Congo,COD,Supply Reduction,"Number of arrests, seizures, and offences",No,n/a,0
Y,The Democratic Republic of Congo,COD,Supply Reduction,Level of law enforcement activity and interdiction in the market,No,n/a,0
Y,The Democratic Republic of Congo,COD,Supply Reduction,"Price, purity and potency of drugs, and related process indicators",No,n/a,0
Y,The Democratic Republic of Congo,COD,Supply Reduction,Number of people engaged with the criminal justice system,No,n/a,0
Y,The Democratic Republic of Congo,COD,Supply Reduction,Presence of other supply reduction metrics,No,n/a,0
Y,The Democratic Republic of Congo,COD,International Cooperation,Level of engagement in international cooperation,No,n/a,0
Y,Canada,CAN,Health,Level of availability of harm reduction services and harm reduction scale up,Yes,"number of people who access prevention, harm reduction and treatment services, to reduce the rates of infectious diseases {Canadian drugs and substances strategy: Evidence, 2017, np} ~",1
Y,Canada,CAN,Health,Presence of needle and syringe programs,No,n/a,0
Y,Canada,CAN,Health,Prevalence of substance use disorders,Yes,"Lifetime cannabis use disorders by sex {Cannabis Stats Hub, 2018, np} ~ Past year prevalence of cannabis use disorders by sex {Cannabis Stats Hub, 2018, np} ~ ",2
Y,Canada,CAN,Health,Prevalence of psychiatric comorbidities,No,n/a,0
Y,Canada,CAN,Health,Drug-related mortality,Yes,"Number and rate (per 100,000 population) of apparent opioid-related deaths by province or territory, 2017. {Canadian drugs and substances strategy: Evidence, 2017, np; National report: Apparent opioid-related deaths in Canada, 2018, np; Infographic: Opioid-related harms in Canada, np} ~ Summary of apparent opioid-related deaths, 2016 and 2017 (Percent male; Percent by age group; Percent involving fentanyl or fentanyl analogues; Percent involving non-opioid substances) {National report: Apparent opioid-related deaths in Canada, 2018, np; Infographic: Opioid-related harms in Canada, np} ~ Number and rate (per 100,000 population) of accidental apparent opioid-related deaths by province or territory, and by quarter and province or territory, 2016 and 2017. {National report: Apparent opioid-related deaths in Canada, 2018, np} ~ Summary of accidental apparent opioid-related deaths by province or territory (Percent by sex; Percent by age group; Percent involving fentanyl or fentanyl analogues; Percent involving fentanyl or fentanyl analogues by quarter) 2017. {National report: Apparent opioid-related deaths in Canada, 2018, np} ~ Apparent opioid-related deaths classified as, or believed to be suicide, in Canada, 2016 and 2017 (number and rate per 100,000) {National report: Apparent opioid-related deaths in Canada, 2018, np} ~ Summary of apparent opioid-related deaths classified as, or believed to be suicide, in Canada, 2016 and 2017 (Percent male; Percent by age group; Percent involving fentanyl or fentanyl analogues; Percent involving non-opioid substances) {National report: Apparent opioid-related deaths in Canada, 2018, np} ~ ",6
Y,Canada,CAN,Health,Prevalence of drug-related infectious disease,No,n/a,0
Y,Canada,CAN,Health,Proportion of people who use drugs who engage in risky consumption,No,n/a,0
Y,Canada,CAN,Health,Proportion of people who use drugs who engage in safe consumption practices,No,n/a,0
Y,Canada,CAN,Health,"Coverage of services for the prevention, testing, and treatment of bloodborne diseases",No,n/a,0
Y,Canada,CAN,Health,Presence of specialised training for addiction care,No,n/a,0
Y,Canada,CAN,Health,Presence of health harms related to drug use,Yes,"The prevalence of Canadians aged 15 years and older reported experiencing at least one harm in the past year due to their illicit drug use by sex {Canadian Tobacco Alcohol and Drugs (CTADS): summary, 2015, np} ~ The prevalence of Canadians aged 15 years and older reported experiencing at least one harm in the past year due to their illicit drug use by age group (15-19, 20-24, 24+) {Canadian Tobacco Alcohol and Drugs (CTADS): summary, 2015, np} ~",2
Y,Canada,CAN,Health,Presence of other health metrics,Yes,"The prevalence of past-year cannabis use for medical purposes {Canadian Tobacco Alcohol and Drugs (CTADS): summary, 2015, np} ~ ",1
Y,Canada,CAN,Peace and Security,"Prevalence of alcohol and drugs in accidents, and interventions to increase road safety",Yes,"Prevalence of Canadians who used cannabis in the past three months within two hours of driving. {National Cannabis Survey, first quarter, 2018, p.4} ~ Number and rate of total drug impaired driving {Cannabis Stats Hub, 2018, np} ~ Number and rate of impaired operation causing death {Cannabis Stats Hub, 2018, np} ~ Number and rate of impaired operation causing bodily harm {Cannabis Stats Hub, 2018, np} ~ Number and rate of impaired operation vehicle, vessel, aircraft {Cannabis Stats Hub, 2018, np} ~ Number and rate of failure to comply or refusal {Cannabis Stats Hub, 2018, np} ~ Number and rate of failure to provide blood sample {Cannabis Stats Hub, 2018, np} ~",6
Y,Canada,CAN,Peace and Security,Annual number of public disorder and violent crime reports,Yes,"police-reported crime (rate per 100,000 population) {Drug-related offences in Canada, 2013, np} ~ Police-reported violations associated with drug violations (physical assault, weapons violations, breaking and entering, fraud, possession of stolen property, uttering threats, other violent violation, other criminal code violation, other property violation, other federal statute violation) {Drug-related offences in Canada, 2013, np} ~",2
Y,Canada,CAN,Peace and Security,Number of non-lethal drug market violent events reported,No,n/a,0
Y,Canada,CAN,Peace and Security,Number of drug market related homicides and disappearances,No,n/a,0
Y,Canada,CAN,Peace and Security,Presence of other peace and security metrics,No,n/a,0
Y,Canada,CAN,Development,Coverage of housing assistance for people who use drugs,No,n/a,0
Y,Canada,CAN,Development,Coverage of social assistance for people who use drugs (not including housing),No,n/a,0
Y,Canada,CAN,Development,Number of households enrolled in alternative development,No,n/a,0
Y,Canada,CAN,Development,Presence of other development metrics,No,n/a,0
Y,Canada,CAN,Human Rights,"Prevalence and incidence of infectious diseases in vulnerable populations (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Canada,CAN,Human Rights,"Prevalence of vulnerable people who use drugs (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Canada,CAN,Human Rights,Proportion of people who use drugs in prison that are receiving medication assisted treatment (MAT),No,n/a,0
Y,Canada,CAN,Human Rights,Distribution of sterile injecting equipment in prisons,No,n/a,0
Y,Canada,CAN,Human Rights,Presence of programs and services targeted towards women ,No,n/a,0
Y,Canada,CAN,Human Rights,Presence of programs and services targeted towards people of color,No,n/a,0
Y,Canada,CAN,Human Rights,Presence of challenges and/or harms experienced by people of color,No,n/a,0
Y,Canada,CAN,Human Rights,"Presence of programs and services targeted towards vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Canada,CAN,Human Rights,"Presence of challenges and/or harms experienced by vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Canada,CAN,Human Rights,Presence of other human rights metrics,No,n/a,0
Y,Canada,CAN,Demand Reduction,Prevalence of drug use by age,Yes,"Use of at least one of these six illicit drugs (cannabis, cocaine or crack, ecstasy, speed or methamphetamines, hallucinogens or heroin) among youth (15-19), young adults (20-24) and adults (25 and above) {Canadian Tobacco Alcohol and Drugs (CTADS): summary, 2015, np; Cannabis Stats Hub, 2018, np} ~ The median age of initiating use of cannabis {Canadian Tobacco Alcohol and Drugs (CTADS): summary, 2015, np} ~ The reported rate of abuse for psychoactive pharmaceuticals among past year users by age (youth: 15-19; young adults: 20-24: adults: 24+) {Canadian Tobacco Alcohol and Drugs (CTADS): summary, 2015, np} ~ The rate of stimulant abuse among users for young adults aged 20 to 24 {Canadian Tobacco Alcohol and Drugs (CTADS): summary, 2015, np} ~ Cannabis users in the past three months, by age group {National Cannabis Survey, first quarter, 2018, p.2} ~ ",5
Y,Canada,CAN,Demand Reduction,Prevalence of drug use by sex,Yes,"the prevalence of past-year illicit drug use by sex (cannabis, cocaine or crack, ecstasy, speed or methamphetamines, hallucinogens or heroin) {Canadian Tobacco Alcohol and Drugs (CTADS): summary, 2015, np; Cannabis Stats Hub, 2018, np} ~ The prevalence of past-year abuse of psychoactive pharmaceuticals by sex (i.e., used it for the experience, the feeling it caused, to get high or for “other” reasons) {Canadian Tobacco Alcohol and Drugs (CTADS): summary, 2015, np} ~ Lifetime cannabis use by sex {Cannabis Stats Hub, 2018, np} ~",2
Y,Canada,CAN,Demand Reduction,Prevalence of drug use by type,Yes,"The prevalence of past-year use of at least one of six illicit drugs (cannabis, cocaine or crack, ecstasy, speed or methamphetamines, hallucinogens or heroin) {Canadian Tobacco Alcohol and Drugs (CTADS): summary, 2015, np; Cannabis Stats Hub, 2018, np} ~ The median age of initiating use of cannabis {Canadian Tobacco Alcohol and Drugs (CTADS): summary, 2015, np} ~ The prevalence of past-year cannabis users reported using cannabis in the past 3 months, and by province {Canadian Tobacco Alcohol and Drugs (CTADS): summary, 2015, np; National Cannabis Survey, first quarter, 2018, p.1} ~ The prevalence of cannabis users reported consuming cannabis on a daily or almost daily basis {Canadian Tobacco Alcohol and Drugs (CTADS): summary, 2015, np} ~ Provincial prevalence of past-year cannabis use {Canadian Tobacco Alcohol and Drugs (CTADS): summary, 2015, np} ~ The prevalence of past-year abuse of (psychoactive pharmaceuticals, opioid pain relievers, stimulants, sedatives) (i.e., used it for the experience, the feeling it caused, to get high or for “other” reasons) {Canadian Tobacco Alcohol and Drugs (CTADS): summary, 2015, np} ~ The reported rate of abuse for psychoactive pharmaceuticals among past year users by age (youth: 15-19; young adults: 20-24: adults: 24+) {Canadian Tobacco Alcohol and Drugs (CTADS): summary, 2015, np} ~ The rate of stimulant abuse among users for young adults aged 20 to 24 {Canadian Tobacco Alcohol and Drugs (CTADS): summary, 2015, np} ~ Types of products used by cannabis consumers in the past three months (Dried flower, Edibles, Hashish, Oil cartridges or vape pens, Liquid concentrate, Solid concentrate, Other, Liquids) {National Cannabis Survey, first quarter, 2018, p.3} ~ Consuming population 2017 (number of persons) By frequency - Total, all frequencies, Once, Less than once a month, One to three times a month, At least once a week, daily {Cannabis Stats Hub, 2018, np} ~ Consuming population 2017 (number of persons) By year: 1961 to 2017 {Cannabis Stats Hub, 2018, np} ~",11
Y,Canada,CAN,Demand Reduction,Number of people who use drugs,No,n/a,0
Y,Canada,CAN,Demand Reduction,"Prevalence of drug use by mode of administration (oral, mucosa, inhalation, and injection)",Yes,"The prevalence of cannabis users reported using a vaporizer to consume cannabis. {Canadian Tobacco Alcohol and Drugs (CTADS): summary, 2015, np} ~ ",1
Y,Canada,CAN,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT)",No,n/a,0
Y,Canada,CAN,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT) by age",No,n/a,0
Y,Canada,CAN,Demand Reduction,Level of access to opioid substitution treatment and medication assisted treatment (OST/MAT),No,n/a,0
Y,Canada,CAN,Demand Reduction,Level of coverage of inpatient treatment,Yes,"The average number of people that were hospitalized due to opioid poisoning in Canada each day in 2017 {Infographic: Opioid-related harms in Canada, 2018, np} ~ Number and crude rate per 100,000 population of opioid poisoning hospitalizations by diagnosis type, Canada, 2007–2008 to 2014–2015 {Hospitalizations and Emergency Department Visits Due to Opioid Poisoning in Canada, 2016, np} ~ Average total length of stay, and total days of care for significant opioid poisoning hospitalizations by age group, Canada, 2007–2008 to 2014–2015 {Hospitalizations and Emergency Department Visits Due to Opioid Poisoning in Canada, 2016, np} ~ Number and crude rate of significant opioid poisoning hospitalizations by facility province/territory, Canada, 2007–2008 to 2014–2015 {Hospitalizations and Emergency Department Visits Due to Opioid Poisoning in Canada, 2016, np} ~ Age-adjusted rate per 100,000 population of significant opioid poisoning hospitalizations by facility province/territory, Canada, 2007–2008 to 2014–2015 {Hospitalizations and Emergency Department Visits Due to Opioid Poisoning in Canada, 2016, np} ~ Age–sex-adjusted rate per 100,000 population of significant opioid poisoning hospitalizations by facility province/territory, Canada, 2007–2008 to 2014–2015 {Hospitalizations and Emergency Department Visits Due to Opioid Poisoning in Canada, 2016, np} ~ Number and crude rate of significant opioid poisoning hospitalizations by opioid type, Canada, 2007–2008 to 2014–2015 {Hospitalizations and Emergency Department Visits Due to Opioid Poisoning in Canada, 2016, np} ~ Number and crude rate of significant opioid poisoning hospitalizations by gender, Canada, 2007–2008 to 2014–2015 {Hospitalizations and Emergency Department Visits Due to Opioid Poisoning in Canada, 2016, np} ~ Number and crude rate of significant opioid poisoning hospitalizations by age group, Canada, 2007–2008 to 2014–2015 {Hospitalizations and Emergency Department Visits Due to Opioid Poisoning in Canada, 2016, np} ~ Number of significant opioid poisoning hospitalizations by documented reason, Canada, 2007–2008 to 2014–2015 {Hospitalizations and Emergency Department Visits Due to Opioid Poisoning in Canada, 2016, np} ~ Number of significant opioid poisoning hospitalizations by documented reason and gender, Canada, 2007–2008 to 2014–2015 {Hospitalizations and Emergency Department Visits Due to Opioid Poisoning in Canada, 2016, np} ~ Number of significant opioid poisoning hospitalizations by documented reason and age group, Canada, 2007–2008 to 2014–2015 {Hospitalizations and Emergency Department Visits Due to Opioid Poisoning in Canada, 2016, np} ~ Number of significant opioid poisoning hospitalizations by common co-poisonings and reason, Canada, 2007–2008 to 2014–2015 {Hospitalizations and Emergency Department Visits Due to Opioid Poisoning in Canada, 2016, np} ~",13
Y,Canada,CAN,Demand Reduction,Proportion of people who use drugs enrolled in voluntary treatment,No,n/a,0
Y,Canada,CAN,Demand Reduction,Proportion of people who use drugs enrolled in coerced treatment,Yes,"Percentage of Drug Treatment Court participants retained in the program for six months {National Anti-Drug Strategy, 2007, np} ~",1
Y,Canada,CAN,Demand Reduction,Proportion of people who use drugs enrolled in compulsory treatment,No,n/a,0
Y,Canada,CAN,Demand Reduction,Presence of prevention programming in law enforcement,Yes,"Percentage of total clean Urine Drug Test results {National Anti-Drug Strategy, 2007, np} ~ Awareness (RCMP): 1) Number and nature of awareness products. 2) Number and category (targeted audiences) of Canadians reached. 3) Percentage of participants from targeted audiences who demonstrate an increase in awareness of substance misuse. {National Anti-Drug Strategy, 2007, np} ~ PBC: The percentage of individuals (i.e., general public and victims) who are satisfied with the quality of the service. {National Anti-Drug Strategy, 2007, np} ~ PBC: The percentage of those who access the PBC’s Internet site that finds the information useful. {National Anti-Drug Strategy, 2007, np} ~ PBC: The percentage of requests for information through the Decision Registry that are responded to in a timely manner. {National Anti-Drug Strategy, 2007, np} ~ ",5
Y,Canada,CAN,Demand Reduction,Presence of prevention programming in the media,No,n/a,0
Y,Canada,CAN,Demand Reduction,Presence of prevention programming in schools,No,n/a,0
Y,Canada,CAN,Demand Reduction,Presence of prevention programming in the workplace,No,n/a,0
Y,Canada,CAN,Demand Reduction,Presence of prevention programming for youth and the community,Yes,"identify Canadians' level of knowledge about various substances with addictive properties {Canadian drugs and substances strategy: Evidence, 2017, np} ~ evaluate and measure public education campaigns {Canadian drugs and substances strategy: Evidence, 2017, np} ~",2
Y,Canada,CAN,Demand Reduction,Presence of other demand reduction metrics,No,n/a,0
Y,Canada,CAN,Supply Reduction,Size and value of the illegal drug market,Yes,"CBSA: Average dollar value of goods, shipments and conveyances seized attributed to Intelligence {National Anti-Drug Strategy, 2007, np} ~ Sources of cannabis reported in the past three months (Family/friend, Shared amongst a group, Acquaintance, Dispensary/storefront, Dealer, Online licensed producer, Authorized retailer, Grown (by them/someone else), Other) {National Cannabis Survey, first quarter, 2018, p.4} ~ Household consumption expenditure 2017 by: Expenditure; Quantity; Price per gram {Cannabis Stats Hub, 2018, np} ~ Household consumption expenditure 2017 by: Total - 15 years and over; 15 to 24 years, 25 to 64 years, 45 to 64 years, 65 years and over {Cannabis Stats Hub, 2018, np} ~ Domestic production (basic prices) ($ millions) by year, and by province {Cannabis Stats Hub, 2018, np} ~ Own-use ($ millions) by year, and by province {Cannabis Stats Hub, 2018, np} ~ Market output ($ millions) by year, and by province {Cannabis Stats Hub, 2018, np} ~ Intermediate consumption ($ millions) by year and by province {Cannabis Stats Hub, 2018, np} ~ Gross value added ($ millions) by year and by province {Cannabis Stats Hub, 2018, np} ~ Supply (purchaser prices) ($ millions) by year and by province {Cannabis Stats Hub, 2018, np} ~ Total margins ($ millions) by year and by province {Cannabis Stats Hub, 2018, np} ~ Illegal purchases from abroad ($ millions) by year and by province {Cannabis Stats Hub, 2018, np} ~ Purchases from other provinces ($ millions) by year and by province {Cannabis Stats Hub, 2018, np} ~ Household expenditure ($ millions) by year and by province {Cannabis Stats Hub, 2018, np} ~ Illegal sales abroad ($ millions) by year and by province {Cannabis Stats Hub, 2018, np} ~ Sales to other provinces ($ millions) by year and by province {Cannabis Stats Hub, 2018, np} ~ ",16
Y,Canada,CAN,Supply Reduction,Level of procedures related to crop eradication,No,n/a,0
Y,Canada,CAN,Supply Reduction,"Number of arrests, seizures, and offences",Yes,"Investigations (RCMP): Number/type/nature of seizures made by clandestine laboratory teams related to investigations on illicit drug production and/or distribution. {National Anti-Drug Strategy, 2007,np} ~ Police-reported drug offences (rate per 100,000 population) {Drug-related offences in Canada, 2013, np} ~ Police-reported drug offences by type of substance (cannabis, cocaine, other CDSA) {Drug-related offences in Canada, 2013, np; Cannabis Stats Hub, 2018, np} ~ Police-reported drug offences by type of drug (cannabis, cocaine, other controlled drugs and substances) and by type of offence (total, possession, supply) {Drug-related offences in Canada, 2013, np; Cannabis Stats Hub, 2018, np} ~ Police-reported drug-offences by province and territory {Drug-related offences in Canada, 2013, np; Cannabis Stats Hub, 2018, np} ~ Police-reported drug offences by census metropolitan area {Drug-related offences in Canada, 2013, np} ~ The prevalence of police-reported drug-related offences that were cleared, or solved, by police. {Drug-related offences in Canada, 2013, np} ~ Completed cases in adult criminal court sentenced to custody, by length of custody, type of offence, and type of drug {Drug-related offences in Canada, 2013, np} ~ Completed drug-related cases in adult criminal and youth courts, by number of charges and type of drug, Canada, 2008/2009 to 2011/2012 {Drug-related offences in Canada, 2013, np} ~ Completed cases in adult criminal and youth courts, where at least one charge is drug-related, by province or territory, 2008/2009 to 2011/2012 {Drug-related offences in Canada, 2013, np} ~ Completed drug-related cases in adult criminal court and youth court, by decision, type of offence, and type of drug, Canada, 2008/2009 to 2011/2012 {Drug-related offences in Canada, 2013, np} ~ Completed drug-related cases with a decision of guilt in adult criminal court and youth court, by selected type of sentence, type of offence, and type of drug, Canada, 2008/2009 to 2011/2012 {np} ~",12
Y,Canada,CAN,Supply Reduction,Level of law enforcement activity and interdiction in the market,Yes,"Investigations (RCMP): Number and nature of collaboration and coordination efforts related to enforcement with local partners. {National Anti-Drug Strategy, 2007, np} ~ Investigations (RCMP): Number of investigations initiated regarding illicit drug production and/or distribution. {National Anti-Drug Strategy, 2007, np} ~ PPSC: Number of litigation files related to the prosecution of drug offences under the Controlled Drugs and Substances Act referred to the PPSC during the fiscal year. {National Anti-Drug Strategy, 2007, np} ~ PPSC: Number of litigation files related to the prosecution of serious drug offences under the CDSA referred to the PPSC during the fiscal year to which mandatory minimum penalties are applicable. {National Anti-Drug Strategy, 2007, np} ~ The number of active NADS files (projects) worked on related to determining whether the assets of a suspect were derived from criminal activities {National Anti-Drug Strategy, 2007, np} ~ Number of reports produced. This is further measured by classifying stage or status of each report (for example; still in legal process, settled, gone to trial, or dropped). {National Anti-Drug Strategy, 2007, np} ~ Total number of FINTRAC disclosures of actionable financial intelligence made to regime partners, and the number of unique disclosures of actionable financial intelligence that relate to at least one drug-related offence. {National Anti-Drug Strategy, 2007, np} ~",7
Y,Canada,CAN,Supply Reduction,"Price, purity and potency of drugs, and related process indicators",Yes,"Spending by cannabis consumers, past three months (Nothing, Between $1 and $50, Between $51 and $100, Between $101 and $250, Over $250) {National Cannabis Survey, first quarter, 2018,p.5} ~ Cannabis consumer prices (Dollars per gram or Price index) by region: Total - Canada; by each province {Cannabis Stats Hub, 2018, np} ~ Cannabis consumer prices (Dollars per gram or Price index) By Characteristics: Medical purposes and Non-medical purposes {Cannabis Stats Hub, 2018, np} ~ Cannabis consumer prices (Dollars per gram or Price index) by year: 2010 to 2017 {Cannabis Stats Hub, 2018, np} ~",4
Y,Canada,CAN,Supply Reduction,Number of people engaged with the criminal justice system,Yes,"Total number of provincial offenders convicted of a drug offence (Schedule II) supervised by CSC. {National Anti-Drug Strategy, 2007, np} ~ Total number of provincial offenders convicted of a drug offence (Schedule II) with a residency requirement. {National Anti-Drug Strategy, 2007, np} ~ Total number of case preparation reports (pre- and post-release) completed for all provincial offenders. {National Anti-Drug Strategy, 2007, np} ~ The percentage of offenders on parole who are not convicted of a violent offence during their supervision period. {National Anti-Drug Strategy, 2007, np} ~ The percentage of offenders who completed their sentences on full parole and who are not re-admitted after release because of a violent conviction (five years post-warrant expiry). {National Anti-Drug Strategy, 2007, np} ~ Police-reported rate of drug offences and Criminal code offences, by age of accused persons {Drug-related offences in Canada, 2013, np} ~ Police-reported rate of drug offences, by age group of accused persons and violation {Drug-related offences in Canada, 2013, np} ~ Completed drug-related cases involving possession in adult criminal and youth court, by age group and sex of accused persons {Drug-related offences in Canada, 2013, np} ~",8
Y,Canada,CAN,Supply Reduction,Presence of other supply reduction metrics,Yes,"The percentage of decisions that are affirmed by the Appeal Division. {National Anti-Drug Strategy, 2007, np} ~ PPSC: Number of files for which legal advice was provided by PPSC counsel. {National Anti-Drug Strategy, 2007, np} ~ PPSC: Number of files for which legal advice was provided by PPSC counsel where mandatory minimum penalties are applicable. {National Anti-Drug Strategy, 2007, np} ~ PPSC: Percentage of overall NADS-related expenditures for corporate support to in-house legal staff. {National Anti-Drug Strategy, 2007, np} ~ Change rate: 80% or more of audits resulting in (re) assessments {National Anti-Drug Strategy, 2007, np} ~ Number of licensed facilities to produce cannabis by year and by province {Cannabis Stats Hub, 2018, np} ~ Number of Client registrations {Cannabis Stats Hub, 2018, np} ~ Released for sale (Kilograms Cannabis, dried; kilograms Cannabis oil) {Cannabis Stats Hub, 2018, np} ~ Client registrations sales (Kilograms Cannabis, dried; Kilograms Cannabis oil) {Cannabis Stats Hub, 2018, np} ~ ",9
Y,Canada,CAN,International Cooperation,Level of engagement in international cooperation,Yes,"Investigations (RCMP): Number and nature of collaboration and coordination efforts related to enforcement with international partners. {National Anti-Drug Strategy, 2007, np} ~",1
Y,South Africa,ZAF,Health,Level of availability of harm reduction services and harm reduction scale up,No,n/a,0
Y,South Africa,ZAF,Health,Presence of needle and syringe programs,No,n/a,0
Y,South Africa,ZAF,Health,Prevalence of substance use disorders,No,n/a,0
Y,South Africa,ZAF,Health,Prevalence of psychiatric comorbidities,No,n/a,0
Y,South Africa,ZAF,Health,Drug-related mortality,No,n/a,0
Y,South Africa,ZAF,Health,Prevalence of drug-related infectious disease,Yes,"The prevalence of HIV among people who inject drugs {South Africa's National Strategic Plan for HIV, TB and STIs, 2017-2022, p.7, p.87} ~",1
Y,South Africa,ZAF,Health,Proportion of people who use drugs who engage in risky consumption,No,n/a,0
Y,South Africa,ZAF,Health,Proportion of people who use drugs who engage in safe consumption practices,No,n/a,0
Y,South Africa,ZAF,Health,"Coverage of services for the prevention, testing, and treatment of bloodborne diseases",Yes,"Number of IDU receiving oral PrEP for the first time during the reporting period {South Africa's National Strategic Plan for HIV, TB and STIs, 2017-2022, p.81} ~ Percentage of specific key populations who correctly identify risks of HIV, STI and TB transmission and how to prevent them and reject major misconceptions about HIV {South Africa's National Strategic Plan for HIV, TB and STIs, 2017-2022, p.87} ~ Percentage of specific key and vulnerable populations living with HIV who know their HIV status (1st 90) {South Africa's National Strategic Plan for HIV, TB and STIs, 2017-2022, p.88} ~ Percentage of specific key and vulnerable populations living with HIV receiving ART (2nd 90) {South Africa's National Strategic Plan for HIV, TB and STIs, 2017-2022, p.89} ~ Percentage of specific key and vulnerable populations living with HIV who have suppressed viral loads (3rd 90) {South Africa's National Strategic Plan for HIV, TB and STIs, 2017-2022, p.89} ~ Percentage of specific key and vulnerable populations with access to core package of HIV,TB and STI services {South Africa's National Strategic Plan for HIV, TB and STIs, 2017-2022, p.89} ~ Scale-up will aim to ensure that, by 2022, at least 90% of all key and vulnerable people have access to comprehensive, integrated services, including targeted social and behaviour change communication. {South Africa's National Strategic Plan for HIV, TB and STIs, 2017-2022, p.23} ~",7
Y,South Africa,ZAF,Health,Presence of specialised training for addiction care,Yes,"Percentage increase in persons employed in the substance abuse field {National Drug Master Plan, 2013-2017, p.85 & p.107} ~ ",1
Y,South Africa,ZAF,Health,Presence of health harms related to drug use,No,n/a,0
Y,South Africa,ZAF,Health,Presence of other health metrics,Yes,"Percentage of specific key and vulnerable populations reporting using a condom {South Africa's National Strategic Plan for HIV, TB and STIs, 2017-2022, p.88} ~ Percentage reduction of the bio-psychosocial and economic impact of substance abuse on South Africa's public service by province, region and district {National Drug Master Plan, 2013-2017, p.83, p.89} ",2
Y,South Africa,ZAF,Peace and Security,"Prevalence of alcohol and drugs in accidents, and interventions to increase road safety",Yes,"The number of crime involving driving under the influence of alcohol or drugs {Crime Statistics, 2014, np} ~ ",1
Y,South Africa,ZAF,Peace and Security,Annual number of public disorder and violent crime reports,Yes,"Detection rate for serious crimes (contact crime, contact related crime, property related crime, other serious crime) % {Outcome Sub-Outcome Key Actions Indicators Baseline Target - Programme of Action (POA), 2018, p.9} ~ The number of drug related crime {Crime Statistics, 2014, np} ~",2
Y,South Africa,ZAF,Peace and Security,Number of non-lethal drug market violent events reported,No,n/a,0
Y,South Africa,ZAF,Peace and Security,Number of drug market related homicides and disappearances,No,n/a,0
Y,South Africa,ZAF,Peace and Security,Presence of other peace and security metrics,No,n/a,0
Y,South Africa,ZAF,Development,Coverage of housing assistance for people who use drugs,No,n/a,0
Y,South Africa,ZAF,Development,Coverage of social assistance for people who use drugs (not including housing),No,n/a,0
Y,South Africa,ZAF,Development,Number of households enrolled in alternative development,No,n/a,0
Y,South Africa,ZAF,Development,Presence of other development metrics,No,n/a,0
Y,South Africa,ZAF,Human Rights,"Prevalence and incidence of infectious diseases in vulnerable populations (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"The prevalence of HIV among inmates {South Africa's National Strategic Plan for HIV, TB and STIs, 2017-2022, p.7} ~ ",1
Y,South Africa,ZAF,Human Rights,"Prevalence of vulnerable people who use drugs (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,South Africa,ZAF,Human Rights,Proportion of people who use drugs in prison that are receiving medication assisted treatment (MAT),No,n/a,0
Y,South Africa,ZAF,Human Rights,Distribution of sterile injecting equipment in prisons,No,n/a,0
Y,South Africa,ZAF,Human Rights,Presence of programs and services targeted towards women ,No,n/a,0
Y,South Africa,ZAF,Human Rights,Presence of programs and services targeted towards people of color,No,n/a,0
Y,South Africa,ZAF,Human Rights,Presence of challenges and/or harms experienced by people of color,No,n/a,0
Y,South Africa,ZAF,Human Rights,"Presence of programs and services targeted towards vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"Number of key population surveillance activities conducted {South Africa's National Strategic Plan for HIV, TB and STIs, 2017-2022, p.87} ~",1
Y,South Africa,ZAF,Human Rights,"Presence of challenges and/or harms experienced by vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,South Africa,ZAF,Human Rights,Presence of other human rights metrics,No,n/a,0
Y,South Africa,ZAF,Demand Reduction,Prevalence of drug use by age,Yes,"Prevalence of students through grades 8-11 that admitted lifetime use (used the substance at some time in their life) of drugs (cannabis, mandrax, cocaine, heroin, crystal methamphetamine, over-the-counter/prescription medications, inhalants) in 2002 as well as in 2008 {National Drug Master Plan, 2013-2017, p.41} ~ ",1
Y,South Africa,ZAF,Demand Reduction,Prevalence of drug use by sex,No,n/a,0
Y,South Africa,ZAF,Demand Reduction,Prevalence of drug use by type,Yes,"Prevalence of students through grades 8-11 that admitted lifetime use (used the substance at some time in their life) of drugs (cannabis, mandrax, cocaine, heroin, crystal methamphetamine, over-the-counter/prescription medications, inhalants) in 2002 as well as in 2008 {National Drug Master Plan, 2013-2017, p.41} ~ Trends in consumption of specified drugs {National Drug Master Plan, 2013-2017, p.65} ~ ",2
Y,South Africa,ZAF,Demand Reduction,Number of people who use drugs,Yes,"Frequency of use and consumption by defined populations (e.g. under-aged persons, drivers, public servants) {National Drug Master Plan, 2013-2017, p.91} ~ ",1
Y,South Africa,ZAF,Demand Reduction,"Prevalence of drug use by mode of administration (oral, mucosa, inhalation, and injection)",Yes,"During the period January to June 2011, the proportion of patients who were in treatment centres in the Western Cape, Gauteng and in the Mpumalanga-Limpopo region for primarily heroin use reported that they injected this drug {National Drug Master Plan, 2013-2017, p.40} ~ ",1
Y,South Africa,ZAF,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT)",Yes,"During the period January to June 2011, the proportion of patients who were in treatment centres in the Western Cape, Gauteng and in the Mpumalanga-Limpopo region for primarily heroin use reported that they injected this drug {National Drug Master Plan, 2013-2017, p.40} ~ Prevalence (%) of patients by region that reported their primary drug of abuse (cannabis, cocaine, heroin, amphetamine-type stimualnts (ATS), OTC and prescription medication,) {National Drug Master Plan, 2013-2017, p.40} ~ The total number of persons treated for drugs other than alcohol from 2008-2010 in the Western Cape, KwaZulu-Natal, Eastern Cape, Gauteng, Mpumalanga and Limpopo, Free State, North West and Northern Cape {National Drug Master Plan, 2013-2017, p.43} ~ Number of vulnerable people frequenting outlets for dependence-forming substances {National Drug Master Plan, 2013-2017, p.83, p.90} ~ Percentage of prevention, treatment and aftercare policies, practices and protocols that apply an integrated approach to substance dependence treatment {National Drug Master Plan, 2013-2017, p.84, p.98} ~ Number of facilities created and percentage used by vulnerable populations {National Drug Master Plan, 2013-2017, p.90} ~ Increase in the percentage of multi-disciplinary and multi-modal protocols and practices for integrated diagnosis, treatment and funding of cooccurring disorders for adults, youths and children in place and applied in treatment facilities {National Drug Master Plan, 2013-2017, p.99} ~ Increase in the percentage of aftercare facilities, and facilities applying policies, practices, protocols and an integrated approach to substance dependence treatment, and an increase in the treatment offered to and accepted by patients, and the success rate of treatment and aftercare {National Drug Master Plan, 2013-2017, p.100} ~",8
Y,South Africa,ZAF,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT) by age",No,n/a,0
Y,South Africa,ZAF,Demand Reduction,Level of access to opioid substitution treatment and medication assisted treatment (OST/MAT),Yes,"Percentage of people who inject drugs receiving opioid substitution therapy (OST) {South Africa's National Strategic Plan for HIV, TB and STIs, 2017-2022, p.90} ~ ",1
Y,South Africa,ZAF,Demand Reduction,Level of coverage of inpatient treatment,No,n/a,0
Y,South Africa,ZAF,Demand Reduction,Proportion of people who use drugs enrolled in voluntary treatment,No,n/a,0
Y,South Africa,ZAF,Demand Reduction,Proportion of people who use drugs enrolled in coerced treatment,No,n/a,0
Y,South Africa,ZAF,Demand Reduction,Proportion of people who use drugs enrolled in compulsory treatment,No,n/a,0
Y,South Africa,ZAF,Demand Reduction,Presence of prevention programming in law enforcement,Yes,"Enhance communication in order to improve perception (GCIS) {Outcome Sub-Outcome Key Actions Indicators Baseline Target - Programme of Action (POA), 2018, p.21} ~",1
Y,South Africa,ZAF,Demand Reduction,Presence of prevention programming in the media,No,n/a,0
Y,South Africa,ZAF,Demand Reduction,Presence of prevention programming in schools,No,n/a,0
Y,South Africa,ZAF,Demand Reduction,Presence of prevention programming in the workplace,No,n/a,0
Y,South Africa,ZAF,Demand Reduction,Presence of prevention programming for youth and the community,Yes,"percent of respondents that indicated that they were aware of the problem (substance abuse problem and related issues) {National Drug Master Plan, 2013-2017, p.44} ~ percent of respondents that reported that they had a substance user/abuser in their home {National Drug Master Plan, 2013-2017, p.44} ~ the percent of respondents that reported they were aware of the support services available to substance users and abusers {National Drug Master Plan, 2013-2017, p.44} ~ Trends in the growth and success of community interventions to counter drug use {National Drug Master Plan, 2013-2017, p.65} ~ Trends in the effectiveness of social policies developed to combat drug use {National Drug Master Plan, 2013-2017, p.65} ~ Trends in the effectiveness of the application of social policy to combat drug use. {National Drug Master Plan, 2013-2017, p.65} ~ Percentage increase in members of communities able to apply parenting skills, knowledge of substance abuse and life skills to influence a reduction in problems resulting from substance abuse {National Drug Master Plan, 2013-2017, p.83} ~ Awareness campaigns: number of people reached, results of random testing of dealing with problems of substance abuse {National Drug Master Plan, 2013-2017, p.87} ~ Number of Anti-Substance Abuse awareness campaigns drug action committees {Outcome Sub-Outcome Key Actions Indicators Baseline Target - Programme of Action (POA), 2018, p.10} ~ Number of provinces targeted for capacity building on community based services {Outcome Sub-Outcome Key Actions Indicators Baseline Target - Programme of Action (POA), 2018, p.10} ~ Number of people reached through substance abuse prevention programmes {South Africa's National Strategic Plan for HIV, TB and STIs, 2017-2022, p.92} ~ Resistance of defined population groups to starting to take specified drugs {National Drug Master Plan, 2013-2017, p.65} ~",12
Y,South Africa,ZAF,Demand Reduction,Presence of other demand reduction metrics,Yes,"the known direct cost of illicit drug use in 2005 {National Drug Master Plan, 2013-2017, p.43} ~ ",1
Y,South Africa,ZAF,Supply Reduction,Size and value of the illegal drug market,Yes,"Reduction in the number of sources of alcoholic beverages and other dependence forming substances {National Drug Master Plan, 2013-2017, p.91} ~ The number of methamphetamine laboratories still functioning {National Drug Master Plan, 2013-2017, p.42} ~ Trends in the world drug market and the South African market for specified illicit drugs, licit and illicit alcohol and selected other drugs {National Drug Master Plan, 2013-2017, p.67} ~ Production and sources of specified illicit drugs, licit and illicit alcohol and selected other drugs in the same markets {National Drug Master Plan, 2013-2017, p.67} ~ Consumption of the specified illicit drugs, licit and illicit alcohol and selected other drugs in the same markets, with emphasis on the South African market per province and region {National Drug Master Plan, 2013-2017, p.67} ~ Trafficking in the specified illicit drugs and selected other drugs, with emphasis on the South African market per province and region {National Drug Master Plan, 2013-2017, p.67} ~ Control of the distribution and sale of and access to the specified illicit drugs, licit and illicit alcohol, selected other drugs and precursor materials, with emphasis on the South African market per province and region {National Drug Master Plan, 2013-2017, p.67} ~ Percentage drop in transgressions per year {National Drug Master Plan, 2013-2017, p.102} ~ Number of crimes for unlawful possession of and dealing in drugs reported {Outcome Sub-Outcome Key Actions Indicators Baseline Target - Programme of Action (POA), 2018, p.9} ~ ",9
Y,South Africa,ZAF,Supply Reduction,Level of procedures related to crop eradication,Yes,"number in metric tons of cannabis produced in South Africa, and the proportion of which this represents of the total production in Africa and the world {National Drug Master Plan, 2013-2017, p.42} ~ ",1
Y,South Africa,ZAF,Supply Reduction,"Number of arrests, seizures, and offences",Yes,"Seizures of specified illicit drugs, licit and illicit alcohol, selected other drugs, precursor materials and production or manufacturing facilities in the same markets {National Drug Master Plan, 2013-2017,p.67} ~ the number in kilograms of drugs confiscated (cannabis, cocaine, crystal meth, heroin, mandrax tablets) {Outcome Sub-Outcome Key Actions Indicators Baseline Target - Programme of Action (POA), 2018, p.9} ~ ",2
Y,South Africa,ZAF,Supply Reduction,Level of law enforcement activity and interdiction in the market,Yes,"Legal action taken to curb production, consumption and distribution of the specified illicit drugs, licit and illicit alcohol, selected other drugs and precursor materials, with emphasis on the South African market per province and region. {National Drug Master Plan, 2013-2017, p.67} ~ Number of Clandestine Drug Laboratories dismantled nationally {Outcome Sub-Outcome Key Actions Indicators Baseline Target - Programme of Action (POA), 2018, p.10; National Drug Master Plan, 2013-2017, p.42} ~",2
Y,South Africa,ZAF,Supply Reduction,"Price, purity and potency of drugs, and related process indicators",Yes,"Prices of the specified illicit drugs, licit and illicit alcohol, selected other drugs and precursor materials in the same markets {National Drug Master Plan, 2013-2017, p.67} ~ Purity data on the specified illicit drugs, licit and illicit alcohol and selected other drugs in the same markets {National Drug Master Plan, 2013-2017, p.67} ~ ",2
Y,South Africa,ZAF,Supply Reduction,Number of people engaged with the criminal justice system,Yes,"Number of individuals held legally liable for transgression of the law {National Drug Master Plan, 2013-2017, p.102} ~ ",1
Y,South Africa,ZAF,Supply Reduction,Presence of other supply reduction metrics,No,n/a,0
Y,South Africa,ZAF,International Cooperation,Level of engagement in international cooperation,No,n/a,0
Y,Portugal,PRT,Health,Level of availability of harm reduction services and harm reduction scale up,Yes,"number of users without social-familiar framework on Risk and Harm Reduction (RRMD) structures {Plano Nacional para a Redução dos Comportamentos Aditivos e das dependências, 2013-2020, p. 32}~ Number of projects under development in the area of Risk Reduction and Damage Minimization {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências, 2013-2016, p. 43} ~ Number of RRDM socio-sanitary Structures and Programs certified by region {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências, 2013-2016, p. 48} ~ Number of individuals covered by RRDM projects, by region {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências, 2013-2016, p. 51} ~ Number of actions and individuals covered in the field of prevention and risk reduction and harm minimization, associated with sexual risk behaviors, under the influence of psychoactive substances {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências 2013-2016 p. 62} ~",5
Y,Portugal,PRT,Health,Presence of needle and syringe programs,Yes,"Number of syringes dispensed/exchanged in the participating Syringe Exchange Program structures, by participating entity {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências, 2013-2016, p 65} ~ Total syringe kits distributed/collected by region/district by 2015 {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências, 2013-2016, p. 65} ~",2
Y,Portugal,PRT,Health,Prevalence of substance use disorders,Yes,"Number of young people with problems related to addictive behavior and dependencies monitored in 2015 by the Social Security Institute {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências 2013-2016 p. 29} ~  number of adult individuals with addiction related problems and specific problems related to alcohol accompanied by the Institute of Social Security in 2015 {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências 2013-2016 p. 31} ~ cannabis addiction evaluation through CAST {Plano Estratégico 2017-2019,p. 27}~ ",3
Y,Portugal,PRT,Health,Prevalence of psychiatric comorbidities,Yes,"most frequently diagnosed psychiatric comorbiditiy {Plano Nacional para a Redução dos Comportamentos Aditivos e das dependências, 2013-2020, p. 33} ~ Number of patients with a diagnosis of psychiatric comorbidities {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências, 2013-2016, p. 66} ~",2
Y,Portugal,PRT,Health,Drug-related mortality,Yes,"Fatal overdose due to the consumption of illicit drugs {Plano Nacional para a Redução dos Comportamentos Aditivos e das dependências, 2013-2020, p. 27}~ Notification of deaths on HIV cases, in the last 3 years, associated with drug addiction {Plano Nacional para a Redução dos Comportamentos Aditivos e das dependências, 2013-2020, p. 27}~ Death rates associated with illicit substance consumption {Plano Nacional para a Redução dos Comportamentos Aditivos e das dependências, 2013-2020, p. 33; Plano Estratégico, 2017-2019, p. 29}~ ",3
Y,Portugal,PRT,Health,Prevalence of drug-related infectious disease,Yes,"notifications of diagnosed cases of HIV/AIDS, in the last 3 years, associated with drug addiction {Plano Nacional para a Redução dos Comportamentos Aditivos e das dependências, 2013-2020, p. 27} ~ positivity values on screenings for various infectious diseases (HIV, hepatitis C, hepatitis B and tuberculosis) {Plano Nacional para a Redução dos Comportamentos Aditivos e das dependências, 2013-2020, p. 33} ~ HIV/AIDS, 01/01/2006- 31/12/2015: notifications of diagnosed cases of HIV/SIDA associated with drug addiction {Plano Estratégico, 2017-2019, p. 29} ~",3
Y,Portugal,PRT,Health,Proportion of people who use drugs who engage in risky consumption,No,n/a,0
Y,Portugal,PRT,Health,Proportion of people who use drugs who engage in safe consumption practices,No,n/a,0
Y,Portugal,PRT,Health,"Coverage of services for the prevention, testing, and treatment of bloodborne diseases",Yes,"Number of users that carried out HIV screening by Regional Health Administration {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências 2013-2016 p. 43} ~ Screening for Infectious Diseases in Treatment Units in 2015 {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências 2013-2016 p. 52} ~ Screening, among active users, for Hepatitis B (HB), Hepatitis C (HC), Syphilis (VDRL) and Tuberculosis (TB) {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências 2013-2016 P. 64} ~ Number of technically and financially supported projects for the screening of HIV infection, Viral Hepatitis and Sexually Transmitted Infections, targeting vulnerable populations {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências 2013-2016 p. 35} ~",4
Y,Portugal,PRT,Health,Presence of specialised training for addiction care,Yes,number of training actions carried out by the Unit for Intensive Treatment of Drug Addiction and Alcoholism within the scope of the Armed Forces {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências 2013-2016 p. 32} ~,1
Y,Portugal,PRT,Health,Presence of health harms related to drug use,Yes,Number of psychological emergencies {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências 2013-2016 p. 43} ~,1
Y,Portugal,PRT,Health,Presence of other health metrics,No,n/a,0
Y,Portugal,PRT,Peace and Security,"Prevalence of alcohol and drugs in accidents, and interventions to increase road safety",Yes,"road accidents mortality associated with drugs and alcohol consumption {Plano Nacional para a Redução dos Comportamentos Aditivos e das dependências 2013-2020, p. 35}~",1
Y,Portugal,PRT,Peace and Security,Annual number of public disorder and violent crime reports,No,n/a,0
Y,Portugal,PRT,Peace and Security,Number of non-lethal drug market violent events reported,No,n/a,0
Y,Portugal,PRT,Peace and Security,Number of drug market related homicides and disappearances,No,n/a,0
Y,Portugal,PRT,Peace and Security,Presence of other peace and security metrics,No,n/a,0
Y,Portugal,PRT,Development,Coverage of housing assistance for people who use drugs,Yes,Number of people with housing needs and number of people answered {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências 2013-2016 p. 56} ~,1
Y,Portugal,PRT,Development,Coverage of social assistance for people who use drugs (not including housing),Yes,"Number of people with employment needs and number of people answered {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências, 2013-2016 p. 55} ~ Number of people with education needs and number of people answered {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências, 2013-2016 p. 56} ~ Number of people with occupational needs and number of people answered {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências, 2013-2016 p. 57} ~ Number of people covered by Social Skills Training Groups and other therapeutic groups {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências, 2013-2016 p. 57} ~ Number of people with social protection needs and number of respondents {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências, 2013-2016, p. 56} ~ Number of individuals covered by reintegration projects (final target population and strategic target population) {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências 2013-2016 p. 52} ~ Types of interventions developed and number of people covered in reintegration projects {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências 2013-2016 p. 53} ~",7
Y,Portugal,PRT,Development,Number of households enrolled in alternative development,No,n/a,0
Y,Portugal,PRT,Development,Presence of other development metrics,No,n/a,0
Y,Portugal,PRT,Human Rights,"Prevalence and incidence of infectious diseases in vulnerable populations (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Portugal,PRT,Human Rights,"Prevalence of vulnerable people who use drugs (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"National survey on addictive behaviour in the prison environment, 2014: frequency of lifelong drug-taking and current imprisonment {Plano Estratégio 2017-2019,p. 28}~ survey on addictive behaviour among young people detained in Educative Centres, 2015 (14-20 years): frequency of lifelong drug-taking and in the last 12 months before detention {Plano Estratégio 2017-2019,p. 29}~",2
Y,Portugal,PRT,Human Rights,Proportion of people who use drugs in prison that are receiving medication assisted treatment (MAT),Yes,"Number of inmates that initiated pharmacological programmes and were inserted in Drug Free Unities {Plano Nacional para a Redução dos Comportamentos Aditivos e das dependências 2013-2020, p. 32}~",1
Y,Portugal,PRT,Human Rights,Distribution of sterile injecting equipment in prisons,No,n/a,0
Y,Portugal,PRT,Human Rights,Presence of programs and services targeted towards women ,Yes,"specific interventions targeting pregnant women, most of which are Individual Consultations {Relatório Anual 2015 - Descritivo de Respostas e Intervenções no âmbito das Ações do Plano de Ação para a Redução dos Comportamentos Aditivos e Dependências, 2013-2016, p. 61} ~",1
Y,Portugal,PRT,Human Rights,Presence of programs and services targeted towards people of color,No,n/a,0
Y,Portugal,PRT,Human Rights,Presence of challenges and/or harms experienced by people of color,No,n/a,0
Y,Portugal,PRT,Human Rights,"Presence of programs and services targeted towards vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"Number of people with access to the basic conditions for the exercise of citizenship needs and number of people answered {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências, 2013-2016 p. 56} ~ Number of individuals in situations of social exclusion supported by the Social Security Institute in their Social Reintegration Apartments {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências 2013-2016, p. 36} ~ Number of actions taken with dependent inmates, by Regional Health Administration {Relatório Anual 2015 - Descritivo de Respostas e Intervenções no âmbito das Ações do Plano de Ação para a Redução dos Comportamentos Aditivos e Dependências, 2013-2016, p. 35} ~ Number of open contests for project funding to be developed by non-profit organizations, targeting specific groups, including sex workers, men who have sex with men, injecting drug users, migrants and persons living without shelter {Relatório Anual 2015 - Descritivo de Respostas e Intervenções no âmbito das Ações do Plano de Ação para a Redução dos Comportamentos Aditivos e Dependências, 2013-2016,p. 35} ~",4
Y,Portugal,PRT,Human Rights,"Presence of challenges and/or harms experienced by vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Portugal,PRT,Human Rights,Presence of other human rights metrics,No,n/a,0
Y,Portugal,PRT,Demand Reduction,Prevalence of drug use by age,Yes,"beginning of consumption at 13 years or less {Plano Nacional para a Redução dos Comportamentos Aditivos e das dependências, 2013-2020 p. 25}~ Survey on young people: frequency of lifelong drug-taking and in the last 12 months (alcohol, tobacco, drugs and other addictive behaviors and addiction {Plano Estratégico, 2017-2019, p. 28}~ National survey on the psychoactive substance consumption in the overall population, 2012 (15-74 years): frequency of lifelong drug-taking and in the last 12 months (any illicit substance) and cannabis addiction evaluation through CAST {Plano Estratégico 2017-2019,p. 27}~ frequency of psychoactive substance consumption disaggregated by age and gender {Plano Nacional para a Redução dos Comportamentos Aditivos e das dependências, 2013-2020 p. 69}~ average age of first use {Plano Nacional para a Redução dos Comportamentos Aditivos e das dependências, 2013-2020, p. 25}~ ",5
Y,Portugal,PRT,Demand Reduction,Prevalence of drug use by sex,Yes,"frequency of psychoactive substance consumption disaggregated by age and sex {Plano Nacional para a Redução dos Comportamentos Aditivos e das dependências, 2013-2020 p. 69}~ ",1
Y,Portugal,PRT,Demand Reduction,Prevalence of drug use by type,Yes,"Survey on young people: frequency of lifelong drug-taking and in the last 12 months (alcohol, tobacco, drugs and other addictive behaviors and addiction {Plano Estratégico, 2017-2019, p. 28}~ National survey on the psychoactive substance consumption in the overall population, 2012 (15-74 years): frequency of lifelong drug-taking and in the last 12 months (any illicit substance) and cannabis addiction evaluation through CAST {Plano Estratégico 2017-2019,p. 27}~ frequency of psychoactive substance consumption disaggregated by age and gender {Plano Nacional para a Redução dos Comportamentos Aditivos e das dependências, 2013-2020 p. 69}~ ",3
Y,Portugal,PRT,Demand Reduction,Number of people who use drugs,Yes,frequency of risky drug-taking and addiction (last 12 months) {Plano Nacional para a Redução dos Comportamentos Aditivos e das dependências 2013-2020 p. 26} ~ recent frequency of drug-taking (last 12 months) {Plano Nacional para a Redução dos Comportamentos Aditivos e das dependências 2013-2020 p. 26}~,2
Y,Portugal,PRT,Demand Reduction,"Prevalence of drug use by mode of administration (oral, mucosa, inhalation, and injection)",No,n/a,0
Y,Portugal,PRT,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT)",Yes,"Number of active outpatients in the Integrated Response Centers and in the Alcoholics Unit in the Regional Health Administration of Lisbon and Vale do Tejo {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências 2013-2016 p. 43} ~ Number of active users on an outpatient basis by Regional Health Administration {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências 2013-2016 p. 43} ~ Number of new users admitted on an outpatient basis by Regional Health Administration {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências 2013-2016 p. 43} ~ Number of consultations/outpatient visits by Regional Health Administration {p. 43} ~ Number of individuals with addiction covered by region and focus of intervention {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências 2013-2016 p. 50} ~ Number of medical, psychiatric, psychological or other medical appointments {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências 2013-2016 p. 51} ~ users in treatment and users that begun treatment in 2015 (ambulatory and public health network) {Plano Estratégico 2017-2019, p. 29} ~ number of admission in therapeutic communities (CT), Rehabilitation Unities (UD) and Alcohology Unities (UA) {Plano Nacional para a Redução dos Comportamentos Aditivos e das dependências 2013-2020, p. 32} ~ Number of admissions in Therapeutic Communities by Regional Health Administration {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências 2013-2016 p. 44} ~ number of users integrated in the public treatment network for illicit substances and alcohol {Plano Nacional para a Redução dos Comportamentos Aditivos e das dependências 2013-2020, p. 32}~ number of days of interventions carried out by health structures linked to addictive behaviour an addictions developed by regions of the country, number of young people covered, number of technicians and hours of work {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências 2013-2016 p. 31} ~ Number of Integrated Response Centers and interventions carried out by Regional Health Administration {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências 2013-2016 p. 42} ~ Number of counseling email requests received {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências 2013-2016 p. 58} ~ Funding amount allocated by region and focus of intervention (prevention, RRDM, treatment and reintegration) {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências 2013-2016 p. 49} ~",14
Y,Portugal,PRT,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT) by age",Yes,"number of signalizations to the National Commission for the Promotion of Rights and Protection of Children and Young People in situations of danger of children and young people by exposure or practice of addictive behaviors and/or dependencies {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências, 2013-2016 p. 27} ~ Number of children referenced in response to the early emergence of addictive behaviors with or without substances, by age, by reference structure and by Regional Health Administration {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências, 2013-2016 p. 34} ~ Number of occurrences related to the consumption of alcohol and drugs by children and young people and number of signalizations, of children or young people up to the age of 14, to the Commissions for the Protection of Children and Young People at Risk because they are in a situation of danger or risk {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências, 2013-2016, p. 37} ~ Number of children and young people treated by the Regional Health Administration {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências, 2013-2016, p. 38} ~",4
Y,Portugal,PRT,Demand Reduction,Level of access to opioid substitution treatment and medication assisted treatment (OST/MAT),Yes,"Number of users under treatment and in Opioid Agonist Treatment Programs (methadone and buprenorphine) {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências, 2013-2016, p. 51} ~ Number of users in Opiate Replacement Program by Regional Health Administration {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências, 2013-2016, p. 43} ~",2
Y,Portugal,PRT,Demand Reduction,Level of coverage of inpatient treatment,Yes,"Rate of inpatients in the Rehabilitation Unit and in the Alcohol Unit in the Regional Health Administration of Lisbon and Vale do Tejo {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências 2013-2016 p. 43} ~ Number of hospitalizations, occupancy rate and retention rate in the Rehabilitation Unit by Regional Health Administration {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências 2013-2016 p. 43} ~",2
Y,Portugal,PRT,Demand Reduction,Proportion of people who use drugs enrolled in voluntary treatment,No,n/a,0
Y,Portugal,PRT,Demand Reduction,Proportion of people who use drugs enrolled in coerced treatment,No,n/a,0
Y,Portugal,PRT,Demand Reduction,Proportion of people who use drugs enrolled in compulsory treatment,Yes,"Number of minors hospitalized in Therapeutic Communities by court order in the Center Regional Health Administration {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências, 2013-2016, p. 37} ~",1
Y,Portugal,PRT,Demand Reduction,Presence of prevention programming in law enforcement,Yes,"Number of awareness-raising actions carried out by the Security Forces, which focused on several issues, including ""Alcohol and Drugs"" {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências 2013-2016 p. 39} ~ Number of screenings, in the military population, for substance use detection, conducted in 2015 by branch of the Armed Forces {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências 2013-2016, p.45} ~ ",2
Y,Portugal,PRT,Demand Reduction,Presence of prevention programming in the media,Yes,"Communication campaigns and addiction awareness actions {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências 2013-2016 p. 110} ~ Number of calls received under the SICAD advisory, information and telephone referral service {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências 2013-2016 p. 57} ~ Categorization of individuals that called the ""Life Line - SOS Drugs 1414"" {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências 2013-2016 p. 57} ~",3
Y,Portugal,PRT,Demand Reduction,Presence of prevention programming in schools,Yes,"Number of prevention projects developed under the intervention of the Directorate General for Education {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências 2013-2016 p. 26} ~ number of intervention programs developed in schools, by teaching cycles and pupils covered, in the 2014/15 school year {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências 2013-2016 p. 26} ~ Number of persons covered in different prevention programs, by civil society entities, (disaggregated by categories: number of institutions/schools) {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências 2013-2016 p. 24} ~",3
Y,Portugal,PRT,Demand Reduction,Presence of prevention programming in the workplace,Yes,"number of actions/interventions, by Regional Health Administration, in the scope of the additive behaviors and dependencies performed for adults in the work environment {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências 2013-2016 p. 32} ~ ",1
Y,Portugal,PRT,Demand Reduction,Presence of prevention programming for youth and the community,Yes,"Number of awareness actions carried out under the Support 65 - Elderly Program {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências, 2013-2016, p. 39} ~ Number of persons covered in different prevention programs, by civil society entities, (disaggregated by categories: trained professionals, parents, children/young people) {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências 2013-2016 p. 24} ~ Number of children/young people covered by universal and selective prevention programs, by region {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências, 2013-2016 p. 23} ~ Number of preventive interventions, projects and programs of information/sensitization with children and young people, inside and outside the school context, by regional health administration {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências, 2013-2016, p. 25 } ~ action measures of the Portuguese Institute of Sports and Youth disaggregated by context, life cycle and number of projects and people covered {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências, 2013-2016, p. 30} ~ Number of institutions with universal and selective prevention programs, by region {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências 2013-2016 p. 23} ~ Universal and Selective Prevention Programs developed by national NGOs {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências 2013-2016 p. 24} ~ Number of projects implemented in 2015, by region and focus of intervention (prevention, RRDM, treatment and reintegration) {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências 2013-2016 p. 46} ~ health high risk perception {Plano Nacional para a Redução dos Comportamentos Aditivos e das dependências 2013-2020 p. 25} ~ hurt (physical or others) high risk perception {Plano Nacional para a Redução dos Comportamentos Aditivos e das dependências 2013-2020 p. 25} ~ Number of registered situations of minors and families at risk {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências 2013-2016 p. 38} ~",11
Y,Portugal,PRT,Demand Reduction,Presence of other demand reduction metrics,No,n/a,0
Y,Portugal,PRT,Supply Reduction,Size and value of the illegal drug market,Yes,"perceived ease of access (disaggregated by age and type of drug) {Plano Nacional para a Redução dos Comportamentos Aditivos e das dependências 2013-2020, p. 24}~ Number of actors involved in narcotic drugs trafficking, whether or not detained {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências 2013-2016 p. 75} ~ Actors related to traffic and consumer-traffic (disaggregated by detained or not detained, gender, age, nationality and type of drug) {Combate ao tráfico de Estupefacientes em Portugal: Relatório Anual 2016 p. 32}~",3
Y,Portugal,PRT,Supply Reduction,Level of procedures related to crop eradication,No,n/a,0
Y,Portugal,PRT,Supply Reduction,"Number of arrests, seizures, and offences",Yes,"Number of seizures, amount of illicit drugs seized, means of transportation, price, detainees (disaggregated by age, gender, traffic association and nationality), for each type of drug {Combate ao tráfico de Estupefacientes em Portugal: Relatório Anual 2016 p. 6}~ number of arrests directly or indirectly associated with drug use {Plano Nacional para a Redução dos Comportamentos Aditivos e das dependências 2013-2020 p. 43}~ Seizure of goods and assets {Combate ao tráfico de Estupefacientes em Portugal: Relatório Anual 2016 p. 36} ~ ",3
Y,Portugal,PRT,Supply Reduction,Level of law enforcement activity and interdiction in the market,Yes,"Number of controlled deliveries {Combate ao tráfico de Estupefacientes em Portugal: Relatório Anual 2016 p. 39} ~ Number of actions of patrolling, surveillance and inspection, in preventive and repressive activities, which resulted in the seizure of drug in quantities with some expression made by the Coastal Control Unit {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências 2013-2016 p. 73} ~ Actions and projects specific to collect information on the activities of criminal groups {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências 2013-2016 p. 77} ~ number of containerized controlled cargoes in ports {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências 2013-2016 p. 77} ~ Number of cases where information was provided on the collection of wealth and income, required for investigations involving the crime of money laundering, on the basis of drug trafficking {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências 2013-2016 p. 80} ~ number of legal procedures initiated associated with drug use {Plano Nacional para a Redução dos Comportamentos Aditivos e das dependências 2013-2020 p. 43} ~ number of legal procedures associated with the national drug law {Plano Nacional para a Redução dos Comportamentos Aditivos e das dependências 2013-2020 p. 43} ~ administrative violation procedures related to drug consumption, 2015 {Plano Estratégio, 2017-2019,p. 29} ~",8
Y,Portugal,PRT,Supply Reduction,"Price, purity and potency of drugs, and related process indicators",No,n/a,0
Y,Portugal,PRT,Supply Reduction,Number of people engaged with the criminal justice system,Yes,"Number of administrative violations of non-drug abusers between the ages of 15 and 19, between 20 and 24 and between 20 and 65 years {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências 2013-2016 p. 40} ~ number of incident reports sent to the CDT for people between the ages of 15 and 19 and 20 and 24 years {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências 2013-2016 p. 40} ~ number of presumed offenders (dealers and consumer-dealers) {Plano Nacional para a Redução dos Comportamentos Aditivos e das dependências 2013-2020 p. 43}~",3
Y,Portugal,PRT,Supply Reduction,Presence of other supply reduction metrics,No,n/a,0
Y,Portugal,PRT,International Cooperation,Level of engagement in international cooperation,Yes,"Number of participations, in international meetings and conferences, dealing with the phenomenon of narcotic drugs and psychotropic substances and their precursors trafficking {Relatório Anual 2015: descritivo de respostas e intervenções no âmbito das ações do plano de ação para redução dos comportamentos aditivos e dependências 2013-2016 p. 78} ~",1
Y,Cambodia,KHM,Health,Level of availability of harm reduction services and harm reduction scale up,Yes,"The NACD Secretariat has been facilitated with relevant institutions conducting activities of Harm Reduction course by the abuse of drugs in order to prevent the increase of vulnerable drugs HIV/AIDS {The 5-Year National Plan on Drug Control, 2011-2015, p.39} ~ The NACD Secretariat has asked guideline from the government to adopt an issue of good practices of foreign countries on harm reduction {The 5-Year National Plan on Drug Control, 2011-2015, p.40} ~ ",2
Y,Cambodia,KHM,Health,Presence of needle and syringe programs,Yes,"prevalence of people who inject drugs who were reached by NSPs in Southeast Asia {Sub-Regional Action Plan On Drug Control, 2011-2013, p.6; Mekong MOU on Drug Control Sub-Regional Action Plan On Drug Control Draft Version, 2014-2016, p.10} ~ NSP services continue at the MMT Program {The 5-Year National Plan on Drug Control, 2011-2015, p.47} ~ Quarterly reports are produced for MoH and donors as appropriate (for needle and syringe prorgams) {The 5-Year National Plan on Drug Control, 2011-2015, p.47} ~ ",3
Y,Cambodia,KHM,Health,Prevalence of substance use disorders,No,n/a,0
Y,Cambodia,KHM,Health,Prevalence of psychiatric comorbidities,No,n/a,0
Y,Cambodia,KHM,Health,Drug-related mortality,No,n/a,0
Y,Cambodia,KHM,Health,Prevalence of drug-related infectious disease,Yes,"HIV rate among drug users {The 5-Year National Plan on Drug Control, 2011-2015, p.12; Sub-Regional Action Plan On Drug Control, 2011-2013, p.6} ~ HIV among injecting drug users {The 5-Year National Plan on Drug Control, 2011-2015, p.12; Mekong MOU on Drug Control Sub-Regional Action Plan On Drug Control Draft Version, 2014-2016, p.10} ~ ",2
Y,Cambodia,KHM,Health,Proportion of people who use drugs who engage in risky consumption,No,n/a,0
Y,Cambodia,KHM,Health,Proportion of people who use drugs who engage in safe consumption practices,No,n/a,0
Y,Cambodia,KHM,Health,"Coverage of services for the prevention, testing, and treatment of bloodborne diseases",Yes,"Level of understanding on the harmful drugs and its transmition of HIV/AIDS by the abuse of drugs has increased among youths {The 5-Year National Plan on Drug Control, 2011-2015, p.39} ~ Number of drugs vulnerable HIV/AIDS has decreased {The 5-Year National Plan on Drug Control, 2011-2015, p.39} ~  vulnerable drugs HIV/AIDS has been prevented and reduced {The 5-Year National Plan on Drug Control, 2011-2015, p.40} ~ Facilitated with (MoEYS), (NAA), to integrate of illicit drugs and HIV/AIDS education in to all levels of education both formal and non-formal systems {The 5-Year National Plan on Drug Control, 2011-2015, p.42} ~ Problems and reasons lead to [...] vulnerable HIV/AIDS has been identified. The instrument tools to effectively address the issues of solving problems has been adopted as a strategy {The 5-Year National Plan on Drug Control, 2011-2015, p.43} ~ Cooperated with relevant partners, conducted survey and monitoring of drug abuses situation trends in order to improve quality of the program on [...] vulnerable HIV/AIDS {The 5-Year National Plan on Drug Control, 2011-2015, p.43} ~ ",6
Y,Cambodia,KHM,Health,Presence of specialised training for addiction care,Yes,"Conducted the training to the training of trainers (ToT) for drug addict treatment {The 5-Year National Plan on Drug Control, 2011-2015, p.17} ~ number of staff and nurses at health centers and target referral hospitals trained regarding the community based on drug care treatment {The 5-Year National Plan on Drug Control, 2011-2015, p.17} ~ Staffs who working in government and temporary drugs treatment centers have been receiving more skills on areas of treatment and rehabilitation drugs addict {The 5-Year National Plan on Drug Control, 2011-2015, p.45} ~ Capacity and skills of staff working in drug treatment and rehabilitation centers has been upgraded according to international standards {The 5-Year National Plan on Drug Control, 2011-2015, p.46} ~ Level of knowledge and capacity of staff that working in national and regional drugs treatment and rehabilitation centers were most similar {The 5-Year National Plan on Drug Control, 2011-2015, p.46} ~ Staff who working on area of community-based treatment has been trained on specific skills {The 5-Year National Plan on Drug Control, 2011-2015, p.47} ~",6
Y,Cambodia,KHM,Health,Presence of health harms related to drug use,No,n/a,0
Y,Cambodia,KHM,Health,Presence of other health metrics,Yes,"% of Health Center with stock-out of essential drug {National Strategic Development Plan, 2014-2018, p.190} ~",1
Y,Cambodia,KHM,Peace and Security,"Prevalence of alcohol and drugs in accidents, and interventions to increase road safety",No,n/a,0
Y,Cambodia,KHM,Peace and Security,Annual number of public disorder and violent crime reports,No,n/a,0
Y,Cambodia,KHM,Peace and Security,Number of non-lethal drug market violent events reported,No,n/a,0
Y,Cambodia,KHM,Peace and Security,Number of drug market related homicides and disappearances,No,n/a,0
Y,Cambodia,KHM,Peace and Security,Presence of other peace and security metrics,No,n/a,0
Y,Cambodia,KHM,Development,Coverage of housing assistance for people who use drugs,No,n/a,0
Y,Cambodia,KHM,Development,Coverage of social assistance for people who use drugs (not including housing),No,n/a,0
Y,Cambodia,KHM,Development,Number of households enrolled in alternative development,Yes,"The development partners participated with the NACD on the implementation of alternative development program to replace the destruction of Mreas Prov trees to extract Safrol oil {The 5-Year National Plan on Drug Control, 2011-2015, p.49} ~ A working group on alternative development plant has been set up in collaboration with the NACD, ministries and institutions. A working group has studied on the possibility including documentation on alternative development plant {The 5-Year National Plan on Drug Control, 2011-2015, p.54} ~ The working group has developed a plan to replace illegal cannabis cultivation in Cambodia {The 5-Year National Plan on Drug Control, 2011-2015, p.54} ~ Skill full staff from the relevant ministries has been selected in the working group in other to assist communities on the program of alternative development {The 5-Year National Plan on Drug Control, 2011-2015, p.54} ~ Alternative development program has been announced to the families and communities {The 5-Year National Plan on Drug Control, 2011-2015, p.54} ~ The (MoC) has found markets for the crops and products produced by those families and communities {The 5-Year National Plan on Drug Control, 2011-2015, p.54} ~ Information and experiences on the implementation of alternative development program has been developed and distributed to those families and communities {The 5-Year National Plan on Drug Control, 2011-2015, p.55} ~ ",7
Y,Cambodia,KHM,Development,Presence of other development metrics,No,n/a,0
Y,Cambodia,KHM,Human Rights,"Prevalence and incidence of infectious diseases in vulnerable populations (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Cambodia,KHM,Human Rights,"Prevalence of vulnerable people who use drugs (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Cambodia,KHM,Human Rights,Proportion of people who use drugs in prison that are receiving medication assisted treatment (MAT),No,n/a,0
Y,Cambodia,KHM,Human Rights,Distribution of sterile injecting equipment in prisons,No,n/a,0
Y,Cambodia,KHM,Human Rights,Presence of programs and services targeted towards women ,No,n/a,0
Y,Cambodia,KHM,Human Rights,Presence of programs and services targeted towards people of color,No,n/a,0
Y,Cambodia,KHM,Human Rights,Presence of challenges and/or harms experienced by people of color,No,n/a,0
Y,Cambodia,KHM,Human Rights,"Presence of programs and services targeted towards vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Cambodia,KHM,Human Rights,"Presence of challenges and/or harms experienced by vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Cambodia,KHM,Human Rights,Presence of other human rights metrics,No,n/a,0
Y,Cambodia,KHM,Demand Reduction,Prevalence of drug use by age,Yes,"The proportion of illicit drug users in the 18-25 age bracket and the 26-45 age bracket {The 5-Year National Plan on Drug Control, 2011-2015, p.12} ~ Proportion of illicit drug use among youth under the age of 26 {The 5-Year National Plan on Drug Control, 2011-2015, p.12} ~ ",2
Y,Cambodia,KHM,Demand Reduction,Prevalence of drug use by sex,No,n/a,0
Y,Cambodia,KHM,Demand Reduction,Prevalence of drug use by type,Yes,"Production and use of amphetamine-type stimulants (ATS) {Mekong MOU on Drug Control Sub-Regional Action Plan On Drug Control Draft Version, 2014-2016, p.7} ~ The most widely consumed drug: Methamphetamine followed by Crystal Methamphetamine {The 5-Year National Plan on Drug Control, 2011-2015, p.12} ~",2
Y,Cambodia,KHM,Demand Reduction,Number of people who use drugs,Yes,"Estimates of the number of drug users in Cambodia {The 5-Year National Plan on Drug Control, 2011-2015, p.12} ~ Prevalence of drug use by region: Pailin, Stung Treng, Sihanouk Ville, Koh Kong, Ratanakiri, Phnom Penh, Banteay Meanchey, Battambang, Siem Reap, Kampong Speu, and Kandal {The 5-Year National Plan on Drug Control, 2011-2015, p.12} ~ Research and assessment activities on drugs abuses in Cambodia has been made {The 5-Year National Plan on Drug Control, 2011-2015, p.42} ~ ",3
Y,Cambodia,KHM,Demand Reduction,"Prevalence of drug use by mode of administration (oral, mucosa, inhalation, and injection)",No,n/a,0
Y,Cambodia,KHM,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT)",Yes,"A draft of policy guideline on treatment, rehabilitation, and reintegration drugs addicts have been drafted and submitted to the government for adoption. {The 5-Year National Plan on Drug Control, 2011-2015, p.45} ~ The official government drugs treatment, rehabilitation of drugs addicts has been established {The 5-Year National Plan on Drug Control, 2011-2015, p.44} ~ The important regulations relating to the organization and function of a treatment and rehabilitation center has been arranged {The 5-Year National Plan on Drug Control, 2011-2015, p.44} ~ The infrastructure of suitable for the services of treatment rehabilitation drugs addicts in Phnom Penh municipality and priority provinces has been established {The 5-Year National Plan on Drug Control, 2011-2015, p.45} ~ A working on technical treatment and detoxification has been organized in order to implement their work {The 5-Year National Plan on Drug Control, 2011-2015, p.45} ~ The communities counselling team has been established in order to explain drugs abusers to receive treatment services at referral hospitals/temporally centers. {The 5-Year National Plan on Drug Control, 2011-2015, p.47} ~ Program on community-based treatment has been encouraged to families, former drugs users and other development partners to participate with the program {The 5-Year National Plan on Drug Control, 2011-2015, p.46} ~ The community based treatment program has been implemented in some provinces {The 5-Year National Plan on Drug Control, 2011-2015, p.46} ~ Drug addicts will be easier to receive services in their respective locations {The 5-Year National Plan on Drug Control, 2011-2015, p.46} ~",9
Y,Cambodia,KHM,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT) by age",No,n/a,0
Y,Cambodia,KHM,Demand Reduction,Level of access to opioid substitution treatment and medication assisted treatment (OST/MAT),Yes,"prevalence of people who inject opiates in Southeast Asia that were reached with OST {Sub-Regional Action Plan On Drug Control, 2011-2013, p.7; Mekong MOU on Drug Control Sub-Regional Action Plan On Drug Control Draft Version, 2014-2016, p.11} ~ The MMT program has been expanded in Phnom Penh city to other high opioid drug use areas {The 5-Year National Plan on Drug Control, 2011-2015, p.47} ~ MMT has been scaled up to other provinces with high rate/number of opioid dependent persons {The 5-Year National Plan on Drug Control, 2011-2015, p.47} ~ There is an increase in the number of people using MMT services - Quarterly reports are produced for MoH and donors as appropriate {The 5-Year National Plan on Drug Control, 2011-2015, p.47} ~ Through M&E, areas for capacity building have been identified (MMT programs) {The 5-Year National Plan on Drug Control, 2011-2015, p.47} ~ Interventions have been instituted for improvement (MMT programs) {The 5-Year National Plan on Drug Control, 2011-2015, p.47} ~",6
Y,Cambodia,KHM,Demand Reduction,Level of coverage of inpatient treatment,No,n/a,0
Y,Cambodia,KHM,Demand Reduction,Proportion of people who use drugs enrolled in voluntary treatment,No,n/a,0
Y,Cambodia,KHM,Demand Reduction,Proportion of people who use drugs enrolled in coerced treatment,No,n/a,0
Y,Cambodia,KHM,Demand Reduction,Proportion of people who use drugs enrolled in compulsory treatment,Yes,"The number of people who use drugs who are located in Compulsory Centres for Drug Users (CCDU) in Southeast Asia {Sub-Regional Action Plan On Drug Control, 2011-2013, p.7; Mekong MOU on Drug Control Sub-Regional Action Plan On Drug Control Draft Version, 2014-2016, p.11} ~",1
Y,Cambodia,KHM,Demand Reduction,Presence of prevention programming in law enforcement,Yes,"The preventive measure on drugs related offences has been implemented effectively based on the existing law on the control of drugs and other laws in Cambodia {The 5-Year National Plan on Drug Control, 2011-2015, p.58} ~ Consultation seminars with the participation of private sectors and the chemicals users have been developed precursor chemicals controlling plan in order to prevent the diversion of legal trades of precursor chemicals to illicit drugs production {The 5-Year National Plan on Drug Control, 2011-2015, p.48} ~ The awareness program of the law on the control of drugs has been organized {The 5-Year National Plan on Drug Control, 2011-2015, p.57} ~ The NACD Secretariat and relevant authorities has cooperated and encourages the participation of the public regarding the discloser of information related to illicit drugs trafficking, production, storing illegal consumption {The 5-Year National Plan on Drug Control, 2011-2015, p.50} ~ one curriculum on HR integrated into five regional police academic curricula {The 5-Year National Plan on Drug Control, 2011-2015, p.56} ~",5
Y,Cambodia,KHM,Demand Reduction,Presence of prevention programming in the media,Yes,"The dissemination by putting messages in CD or Karaoke: The number of titles that had written drug education message on cinema and video products {The 5-Year National Plan on Drug Control, 2011-2015, p.16} ~ Medias belong to the government and private (TV, Radios, Telecommunication companies) have been support on the awareness program in order to promote the understanding of the dangerous drugs and the prevention of drugs abuses {The 5-Year National Plan on Drug Control, 2011-2015, p.41} ~ The mobile reduction team conducted activities on the awareness at the important places regularly {The 5-Year National Plan on Drug Control, 2011-2015, p.41} ~ Cooperated with relevant institutions, NGOs and private sectors organized illicit awareness concerts, Question and Answer (Q&A) quizzes about illicit drugs, free telephone hotline among population, especially youth on drug issues and its dangerous {The 5-Year National Plan on Drug Control, 2011-2015, p.41} ~ ",4
Y,Cambodia,KHM,Demand Reduction,Presence of prevention programming in schools,Yes,"number of priority provinces that received Training of trainer (ToT) in the educational system {The 5-Year National Plan on Drug Control, 2011-2015, p.15} ~ ",1
Y,Cambodia,KHM,Demand Reduction,Presence of prevention programming in the workplace,No,n/a,0
Y,Cambodia,KHM,Demand Reduction,Presence of prevention programming for youth and the community,Yes,"Number of places, participants, and females who participated in drug education and prevention programs to youth in the community {The 5-Year National Plan on Drug Control, 2011-2015, p.15} ~ Illiteracy level accounted a number places, number of participants, and number of females, that were carried out every two months with collaboration with district/provincial department of education, youth and sport, as well as the local authorities {The 5-Year National Plan on Drug Control, 2011-2015, p.15} ~ Organized rewards and attractive gifts event for participants {The 5-Year National Plan on Drug Control, 2011-2015, p.42} ~ Other events were organized in order to attract people and youth to participate at the above mentioned program {The 5-Year National Plan on Drug Control, 2011-2015, p.42} ~ The program has provided student behavior change and self-confident in solving their problem {The 5-Year National Plan on Drug Control, 2011-2015, p.42} ~ Level of understanding on the harmful drugs {The 5-Year National Plan on Drug Control, 2011-2015, p.39} ~ Had been facilitated and cooperated with relevant NGOs in the various locations in order to promote activities of drugs demand reduction at such important places such as; cinemas, clubs, schools, factories, markets, and important down town {The 5-Year National Plan on Drug Control, 2011-2015, p.39} ~ The abuse of drugs [...] has been prevented and reduced {The 5-Year National Plan on Drug Control, 2011-2015, p.40} ~ The NACD Secretariat has evaluated an implementation of prevention activities regarding the transmition through IDU in order to improve the program of implementation {The 5-Year National Plan on Drug Control, 2011-2015, p.40} ~ Evaluated of the activities of public awareness on the dangerous drugs {The 5-Year National Plan on Drug Control, 2011-2015, p.40} ~ Experiences gain from these evaluation will use as reviewing tools of future implementation of drugs awareness {The 5-Year National Plan on Drug Control, 2011-2015, p.40} ~ The NACD Secretariat has collaborated and cooperated with NGOs, and development partners to set up strategic plan and guideline on the arrangement of the awareness campaign activities and its documentation {The 5-Year National Plan on Drug Control, 2011-2015, p.40} ~ Relevant NGOs, civil society and former drug users have been participated in the awareness program on drugs issues {The 5-Year National Plan on Drug Control, 2011-2015, p.41} ~ The arrangement of administrative mechanism through the organization of specialized committees and department has been arranged in order to monitor and evaluation of the prevention on drugs abuses {The 5-Year National Plan on Drug Control, 2011-2015, p.42} ~ Cooperated with relevant partners, conducted survey and monitoring of drug abuses situation trends in order to improve quality of the program on drugs prevention {The 5-Year National Plan on Drug Control, 2011-2015, p.43} ~ The NACD drugs information center has created and composed new documents regarding the effectiveness of public education awareness {The 5-Year National Plan on Drug Control, 2011-2015, p.43} ~ Mechanism of monitoring evaluation the activities of the abuses of drugs prevention has been arranged {The 5-Year National Plan on Drug Control, 2011-2015, p.43} ~ Information on the statistics of drug users has been improved {The 5-Year National Plan on Drug Control, 2011-2015, p.47} ~ ",18
Y,Cambodia,KHM,Demand Reduction,Presence of other demand reduction metrics,Yes,"Problems and reasons lead to the abuse of drugs [...] has been identified. The instrument tools to effectively address the issues of solving problems has been adopted as a strategy {The 5-Year National Plan on Drug Control, 2011-2015, p.43} ~",1
Y,Cambodia,KHM,Supply Reduction,Size and value of the illegal drug market,Yes,"Drug trafficking and related forms of criminal activity and the threat to security and the rule of law in the region {Mekong MOU on Drug Control Sub-Regional Action Plan On Drug Control Draft Version, 2014-2016, p.7} ~ Trafficking routes of methamphetamines, heroin & ATS {The 5-Year National Plan on Drug Control, 2011-2015, p.10, p.11; Mekong MOU on Drug Control Sub-Regional Action Plan On Drug Control Draft Version, 2014-2016, p.7, p.8} ~ Production and use of amphetamine-type stimulants (ATS) {Mekong MOU on Drug Control Sub-Regional Action Plan On Drug Control Draft Version, 2014-2016, p.7} ~ Production (in tons) of Safrole rich oils in 2006 once it was made illegal {The 5-Year National Plan on Drug Control, 2011-2015, p.12} ~ number of small-scale tableting operations {The 5-Year National Plan on Drug Control, 2011-2015, p.11} ~ Location of where Ephedra was stored for illegal extraction of Ephedrine {The 5-Year National Plan on Drug Control, 2011-2015, p.10} ~ Sources of packaging of heroin transportation into Cambodia: concealment in equipment, and swallowing into stomach {The 5-Year National Plan on Drug Control, 2011-2015, p.11} ~ ",7
Y,Cambodia,KHM,Supply Reduction,Level of procedures related to crop eradication,Yes,"The number of opium poppy hectares in 2009 {The 5-Year National Plan on Drug Control, 2011-2015, p.9; Sub-Regional Action Plan On Drug Control, 2011-2013, p.8} ~ The quantity of cannabis cultivation throughout the country {The 5-Year National Plan on Drug Control, 2011-2015, p.10} ~ Trends of cannabis cropping {The 5-Year National Plan on Drug Control, 2011-2015, p.10} ~ The number in square meters of cannabis illegal cultivation that was destroyed {The 5-Year National Plan on Drug Control, 2011-2015, p.18} ~ The effectiveness of prevention and suppression of illicit drug cultivation has been guaranty {The 5-Year National Plan on Drug Control, 2011-2015, p.49} ~ Illegal drugs cultivation has been decreased and lead to the completely eradication {The 5-Year National Plan on Drug Control, 2011-2015, p.55} ~ Principle of monitoring and evaluation mechanism has been developed in order to follow-up the illicit drugs cultivation {The 5-Year National Plan on Drug Control, 2011-2015, p.55} ~ Study tour for concern officials from ministries and institutions has been organized in order to learn experiences and lesson learnt in this regards from other countries in the region {The 5-Year National Plan on Drug Control, 2011-2015, p.55} ~",8
Y,Cambodia,KHM,Supply Reduction,"Number of arrests, seizures, and offences",Yes,"Number of drugs and precursors seized (methamphetamine, ephedra plants, chemicals used to extract ephedrine, Safrole oils) {The 5-Year National Plan on Drug Control, 2011-2015, p.11, p.12} ~ number of suppressed offences {The 5-Year National Plan on Drug Control, 2011-2015, p.18} ~ number of arrested offenders {The 5-Year National Plan on Drug Control, 2011-2015, p.18} ~ The NACD drugs information center enables data and information on the arrested, custodies and releases on drugs related offences {The 5-Year National Plan on Drug Control, 2011-2015, p.50} ~",4
Y,Cambodia,KHM,Supply Reduction,Level of law enforcement activity and interdiction in the market,Yes,"Number of border liaisons (BLOs) that have been established along the border of the country and the Mekong river to control and curb drug trafficking and precursor chemicals across the border {The 5-Year National Plan on Drug Control, 2011-2015, p.18} ~ The NACD secretariat has regularly received documents on imports and exports of precursor chemicals from (MoH), (CDC) and ministry of Industry Mine and Energy {The 5-Year National Plan on Drug Control, 2011-2015, p.48} ~ The NACD Secretariat as collaborated with competent authorities to supervise the importations of precursor chemicals across the border and to control of the illegal diversion of those chemicals to produce drugs {The 5-Year National Plan on Drug Control, 2011-2015, p.48} ~ A concrete plan on the supervision and control of illicit productions and trafficking of natural oil which consisting of rich Safrol has been developed {The 5-Year National Plan on Drug Control, 2011-2015, p.49} ~ Strengthening and expansion with neighbouring countries in order to prevent drugs related (TOC) across the border {The 5-Year National Plan on Drug Control, 2011-2015, p.51} ~ The situation supervision and drugs control along the border zones has significant achieved {The 5-Year National Plan on Drug Control, 2011-2015, p.51} ~ Throughout the early warning system and the effectiveness operation on controlled delivery {The 5-Year National Plan on Drug Control, 2011-2015, p.51} ~ Drug trafficking and cross-border security in the region {Mekong MOU on Drug Control Sub-Regional Action Plan On Drug Control Draft Version, 2014-2016, p.8} ~ The number of law enforcement officers who are working in Border Liaison Offices (BLO) throughout the country that have received training on drug control of the CBT training {The 5-Year National Plan on Drug Control, 2011-2015, p.18} ~ number of law enforcement officers trained on drug control skills through a Computer Based Training (CBT) program {The 5-Year National Plan on Drug Control, 2011-2015, p.18} ~ Number of law enforcement officers who participated in training along the border on the drug control skills, drug offences investigation, drug analysis, and drug control law {The 5-Year National Plan on Drug Control, 2011-2015, p.18} ~ Number of Cambodian law enforcement officials that were trained abroad on drug offences investigation skills and drug analysis {The 5-Year National Plan on Drug Control, 2011-2015, p.18} ~ The capacity of law enforcement officials who working on the control of precursor chemicals has been improved {The 5-Year National Plan on Drug Control, 2011-2015, p.48} ~ Seminar and training programs for law enforcement officials related to local legislations, and law on the control of drugs in line with precursor chemicals and psychotropic substances control has been organized {The 5-Year National Plan on Drug Control, 2011-2015, p.49} ~ Drugs law enforcement has significantly suppressed of drugs related crimes successfully through public information {The 5-Year National Plan on Drug Control, 2011-2015, p.50} ~ The NACD Secretariat has cooperated with MoJ, and relevant ministries provided capacity building for law enforcement (judges, prosecutors, and police, MP, and customs officers) enables them to use the law on the control of drugs properly and effectively {The 5-Year National Plan on Drug Control, 2011-2015, p.51} ~ Other Border Liaison Office (BLO) has been established at priority locations {The 5-Year National Plan on Drug Control, 2011-2015, p.51} ~ The staff NACD narcotics laboratory has received both in country and oversea training {The 5-Year National Plan on Drug Control, 2011-2015, p.52} ~ Law enforcement officials and competent authorities have received training on drugs related crimes trough the Computer Based Training (CBT). The program will contribute to the significant arrests and seizures of drugs criminals {The 5-Year National Plan on Drug Control, 2011-2015, p.53} ~ The training program excluded the (CBT) has been provided to law enforcement officials in order to promote their knowledge and skills {The 5-Year National Plan on Drug Control, 2011-2015, p.53} ~ The assessment of the effectiveness of the CBT has been identified and improved in the future in order to contribute of drugs control activities {The 5-Year National Plan on Drug Control, 2011-2015, p.53} ~ 90 police from four IDU hotspots in Phnom Penh trained on the SOP {The 5-Year National Plan on Drug Control, 2011-2015, p.56} ~ At least three hotspots have community policing in place {The 5-Year National Plan on Drug Control, 2011-2015, p.57} ~ The NACD lawyer's team has been function in order to promote the effectiveness follow up all drugs prosecution cases {The 5-Year National Plan on Drug Control, 2011-2015, p.57} ~ Research on the effectiveness involvement of other Cambodian laws and law on the control of drugs to prosecute drugs related criminals would be carried out {The 5-Year National Plan on Drug Control, 2011-2015, p.58} ~ Number of drugs in grams that were destroyed and confiscated (cannabis, methamphetamine tablets, methamphetamine powder, heroin, cocaine, ecstasy tablets, bottles of ketamine, codeine tablets, precursor chemicals, Safrol rich oils, pseudo ephedrine tablets) {The 5-Year National Plan on Drug Control, 2011-2015, p.18} ~ The number of drug production areas that were suppressed and destructed as well as precursor chemicals and equipment confiscated that were destroyed and confiscated {The 5-Year National Plan on Drug Control, 2011-2015, p.18} ~ The NACD's drugs information center has received information and experiences on drugs control activities done by institutions and NGOs {The 5-Year National Plan on Drug Control, 2011-2015, p.43} ~ Draft specific legislations on the control of precursor chemicals and psychotropic substances has been developed {The 5-Year National Plan on Drug Control, 2011-2015, p.48} ~ Regular meeting with law enforcement and Municipal/Provincial authorities has been organized {The 5-Year National Plan on Drug Control, 2011-2015, p.50} ~ Law enforcement and Municipal/Provincial authorities provided timely reports to the NACD drugs information center for analysis, reporting and dissemination {The 5-Year National Plan on Drug Control, 2011-2015, p.50} ~ The international communities provided equipment support for the effectiveness of drugs law enforcement {The 5-Year National Plan on Drug Control, 2011-2015, p.50} ~ Need assessment on the important needed of law enforcement agencies have been carried out in order to respond of consequences {The 5-Year National Plan on Drug Control, 2011-2015, p.53} ~ The draft of the law on the control of drugs has been ratified the national assembly and the senate {The 5-Year National Plan on Drug Control, 2011-2015, p.57} ~ The support on the arrangement of meetings, seminars of the law on the control of drugs has been received from development partners {The 5-Year National Plan on Drug Control, 2011-2015, p.57} ~",35
Y,Cambodia,KHM,Supply Reduction,"Price, purity and potency of drugs, and related process indicators",Yes,"Purity of methamphetamine and caffeine trafficked into Cambodia {The 5-Year National Plan on Drug Control, 2011-2015, p.11} ~ The number of installed drug analysis machines to be operated in the NACD's laboratory {The 5-Year National Plan on Drug Control, 2011-2015, p.18} ~ The NACD narcotics laboratory has already been equipped and well function of its drugs analysis report to the courts as stipulated by law on the control of drugs {The 5-Year National Plan on Drug Control, 2011-2015, p.52} ~ The NACD narcotics laboratory will assure of its quantitative and qualitative drugs analysis {The 5-Year National Plan on Drug Control, 2011-2015, p.52} ~ Drugs law enforcement has received enough the preliminary drugs testing kits and precursor chemicals {The 5-Year National Plan on Drug Control, 2011-2015, p.52} ~ The NACD narcotics mini lab has been set up and facilitate more effectively of sending and receiving drugs analysis report {The 5-Year National Plan on Drug Control, 2011-2015, p.53} ~",6
Y,Cambodia,KHM,Supply Reduction,Number of people engaged with the criminal justice system,No,n/a,0
Y,Cambodia,KHM,Supply Reduction,Presence of other supply reduction metrics,Yes,"Production (in tons) of Safrole rich oils in 2002-2003 and 2004-2005 when it was legal {The 5-Year National Plan on Drug Control, 2011-2015, p.12} ~ Monitoring checklists developed and in use for quality improvement {The 5-Year National Plan on Drug Control, 2011-2015, p.56} ~ One SOP for LE on Support of HR completed {The 5-Year National Plan on Drug Control, 2011-2015, p.56} ~ SOP disseminated to all appropriate police posts {The 5-Year National Plan on Drug Control, 2011-2015, p.56} ~ Meetings are taking place at least one time a quarter {The 5-Year National Plan on Drug Control, 2011-2015, p.56} ~ One baseline survey will be carried out in Phnom Penh {The 5-Year National Plan on Drug Control, 2011-2015, p.57} ~ One survey report will be produced and disseminated as appropriate {The 5-Year National Plan on Drug Control, 2011-2015, p.57} ~ Most of the government staff and people fully award of the law on the control of drugs {The 5-Year National Plan on Drug Control, 2011-2015, p.57} ~ Regulations relating to the draft of the sub-decree and the Prakas are drafted {The 5-Year National Plan on Drug Control, 2011-2015, p.58} ~",9
Y,Cambodia,KHM,International Cooperation,Level of engagement in international cooperation,Yes,"Number of UN conventions signed {The 5-Year National Plan on Drug Control, 2011-2015, p.14} ~ The implementation of the 3 international conventions and the convention against (TOC) has been promoted {The 5-Year National Plan on Drug Control, 2011-2015, p.58} ~ The progress report on the implementation of the 3 international conventions has timely reported to the government of Cambodia and the INCB {The 5-Year National Plan on Drug Control, 2011-2015, p.58} ~ Draft guideline for green drugs free villages and communes has been developed {The 5-Year National Plan on Drug Control, 2011-2015, p.59} ~ Priority villages and communes for implement of green drugs free along the borders are selected {The 5-Year National Plan on Drug Control, 2011-2015, p.59} ~ The working group on green drugs free villages and communes along the border was performed {The 5-Year National Plan on Drug Control, 2011-2015, p.59} ~ The effectiveness drugs control cooperation in the form of bilateral and trilateral with neighboring countries has been strengthened {The 5-Year National Plan on Drug Control, 2011-2015, p.59} ~ More achievement has been made through regular meetings of Border Liaison Office (BLO) {The 5-Year National Plan on Drug Control, 2011-2015, p.60} ~ The capacity building among officials of Border Liaison Office (BLO) has been improved {The 5-Year National Plan on Drug Control, 2011-2015, p.60} ~ The mechanism on cooperation in fighting against drugs among neighboring countries in the forms of bilateral and trilateral parties has been improved {The 5-Year National Plan on Drug Control, 2011-2015, p.60} ~ Meetings, training programs seminars on the binding obligation stipulated in the agreements and the three international drugs control conventions, 1961, 1971, 1988 has been organized {The 5-Year National Plan on Drug Control, 2011-2015, p.60} ~ Donor's countries and development partners participated and supported of the activities on drugs control in Cambodia {The 5-Year National Plan on Drug Control, 2011-2015, p.60} ~ The supported from international on drugs control activities in Cambodia in all forms, bilateral, trilateral and internationally has been improved {The 5-Year National Plan on Drug Control, 2011-2015, p.61} ~ The NACD has received the support and assistances from the UNODC and donors communities {The 5-Year National Plan on Drug Control, 2011-2015, p.61} ~ The trafficking of drugs across Cambodia to countries in the region has been prevented {The 5-Year National Plan on Drug Control, 2011-2015, p.61} ~ The action plans on drugs control between Cambodia and the ASEAN has been effectiveness strengthened and expanded {The 5-Year National Plan on Drug Control, 2011-2015, p.61} ~ Other mechanisms on drugs control cooperation among the Greater Mekong Sub-Region and the UNODC has been improved {The 5-Year National Plan on Drug Control, 2011-2015, p.62} ~ The cooperation on drugs control with other countries in the world has been strengthened {The 5-Year National Plan on Drug Control, 2011-2015, p.62} ~ The cooperation on drugs control among local, regional and international NGOs has been improved {The 5-Year National Plan on Drug Control, 2011-2015, p.62} ~",19
Y,China,CHN,Health,Level of availability of harm reduction services and harm reduction scale up,No,n/a,0
Y,China,CHN,Health,Presence of needle and syringe programs,Yes,"prevalence of people who inject drugs who were reached by NSPs in Southeast Asia {Sub-Regional Action Plan On Drug Control, 2011-2013, p.6; Mekong MOU on Drug Control Sub-Regional Action Plan On Drug Control Draft Version, 2014-2016, p.10} ~ ",1
Y,China,CHN,Health,Prevalence of substance use disorders,No,n/a,0
Y,China,CHN,Health,Prevalence of psychiatric comorbidities,No,n/a,0
Y,China,CHN,Health,Drug-related mortality,No,n/a,0
Y,China,CHN,Health,Prevalence of drug-related infectious disease,Yes,"HIV prevalence among people who use drugs {Sub-Regional Action Plan On Drug Control, 2011-2013, p.6} ~ HIV prevalence among people who inject drugs (PWID) {Mekong MOU on Drug Control Sub-Regional Action Plan On Drug Control Draft Version, 2014-2016, p.10} ~",2
Y,China,CHN,Health,Proportion of people who use drugs who engage in risky consumption,No,n/a,0
Y,China,CHN,Health,Proportion of people who use drugs who engage in safe consumption practices,No,n/a,0
Y,China,CHN,Health,"Coverage of services for the prevention, testing, and treatment of bloodborne diseases",No,n/a,0
Y,China,CHN,Health,Presence of specialised training for addiction care,Yes,"The number of training courses held for maintenance treatment {Annual Report on Drug Control in China, 2017, p.26} ~ the number of outpatient service staff members and frontline policmen trained in maintenance treatment {Annual Report on Drug Control in China, 2017, p.26} ~ ",2
Y,China,CHN,Health,Presence of health harms related to drug use,No,n/a,0
Y,China,CHN,Health,Presence of other health metrics,No,n/a,0
Y,China,CHN,Peace and Security,"Prevalence of alcohol and drugs in accidents, and interventions to increase road safety",Yes,"The number of revoked driving licenses of drugged drivers {Annual Report on Drug Control in China, 2017, p.24} ~ ",1
Y,China,CHN,Peace and Security,Annual number of public disorder and violent crime reports,No,n/a,0
Y,China,CHN,Peace and Security,Number of non-lethal drug market violent events reported,Yes,"The number of gun-related drug cases in 29 provinces {Annual Report on Drug Control in China, 2017, p.60} ~ ",1
Y,China,CHN,Peace and Security,Number of drug market related homicides and disappearances,No,n/a,0
Y,China,CHN,Peace and Security,Presence of other peace and security metrics,No,n/a,0
Y,China,CHN,Development,Coverage of housing assistance for people who use drugs,No,n/a,0
Y,China,CHN,Development,Coverage of social assistance for people who use drugs (not including housing),Yes,"number of job placement sites established for people successfully withdrawing from drugs {Annual Report on Drug Control in China, 2017, p.25} ~ ",1
Y,China,CHN,Development,Number of households enrolled in alternative development,No,n/a,0
Y,China,CHN,Development,Presence of other development metrics,No,n/a,0
Y,China,CHN,Human Rights,"Prevalence and incidence of infectious diseases in vulnerable populations (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,China,CHN,Human Rights,"Prevalence of vulnerable people who use drugs (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,China,CHN,Human Rights,Proportion of people who use drugs in prison that are receiving medication assisted treatment (MAT),No,n/a,0
Y,China,CHN,Human Rights,Distribution of sterile injecting equipment in prisons,No,n/a,0
Y,China,CHN,Human Rights,Presence of programs and services targeted towards women ,No,n/a,0
Y,China,CHN,Human Rights,Presence of programs and services targeted towards people of color,No,n/a,0
Y,China,CHN,Human Rights,Presence of challenges and/or harms experienced by people of color,No,n/a,0
Y,China,CHN,Human Rights,"Presence of programs and services targeted towards vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,China,CHN,Human Rights,"Presence of challenges and/or harms experienced by vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,China,CHN,Human Rights,Presence of other human rights metrics,No,n/a,0
Y,China,CHN,Demand Reduction,Prevalence of drug use by age,Yes,"Prevalence of drug users disaggregated by age {Annual Report on Drug Control in China, 2017, p.56} ~",1
Y,China,CHN,Demand Reduction,Prevalence of drug use by sex,No,n/a,0
Y,China,CHN,Demand Reduction,Prevalence of drug use by type,Yes,"The number of drug users registered in China: Synthetic drug users, opiate users, cannabis, cocaine, amphetamine-type stimulants (ATS) and other {Annual Report on Drug Control in China, 2017, p.54; Mekong MOU on Drug Control Sub-Regional Action Plan On Drug Control Draft Version, 2014-2016, p.7} ~",1
Y,China,CHN,Demand Reduction,Number of people who use drugs,Yes,"The number of drug users identified {Annual Report on Drug Control in China, 2017, p.23} ~ The number of new drug users identified in China in 2016 {Annual Report on Drug Control in China, 2017, p.23, p.55} ~ ",2
Y,China,CHN,Demand Reduction,"Prevalence of drug use by mode of administration (oral, mucosa, inhalation, and injection)",No,n/a,0
Y,China,CHN,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT)",Yes,"The number of community drug treatments that were ordered {Annual Report on Drug Control in China, 2017, p.23} ~ The number of people undergoing drug treatment and rehabilitation in communities {Annual Report on Drug Control in China, 2017, p.25} ~ number of full-time social workers dedicated to drug control {Annual Report on Drug Control in China, 2017, p.25} ~ The number of patients the medical institutions for detoxification receive a year {Annual Report on Drug Control in China, 2017, p.26} ~ ",4
Y,China,CHN,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT) by age",No,n/a,0
Y,China,CHN,Demand Reduction,Level of access to opioid substitution treatment and medication assisted treatment (OST/MAT),Yes,"Prevalence of people who inject opiates in Southeast Asia that were reached with OST {Sub-Regional Action Plan On Drug Control, 2011-2013, p.7; Mekong MOU on Drug Control Sub-Regional Action Plan On Drug Control Draft Version, 2014-2016, p.11} ~ number of people who access methadone maintenance treatment on a daily basis in China {Mekong MOU on Drug Control Sub-Regional Action Plan On Drug Control Draft Version, 2014-2016, p.11} ~ the number of outpatient services for maintenance treatment {Annual Report on Drug Control in China, 2017, p.26} ~ The number of mobile medication cars set up {Annual Report on Drug Control in China, 2017, p.26} ~ the number of medication points set up {Annual Report on Drug Control in China, 2017, p.26} ~ The number of people under maintenance treatment {Annual Report on Drug Control in China, 2017, p.26} ~",6
Y,China,CHN,Demand Reduction,Level of coverage of inpatient treatment,No,n/a,0
Y,China,CHN,Demand Reduction,Proportion of people who use drugs enrolled in voluntary treatment,Yes,"The number of medical institutions for voluntary detoxification and treatment across the country {Annual Report on Drug Control in China, 2017, p.26} ~ The number of beds in the medical institutions for voluntary detoxification treatment across the country {Annual Report on Drug Control in China, 2017, p.26} ~ ",2
Y,China,CHN,Demand Reduction,Proportion of people who use drugs enrolled in coerced treatment,No,n/a,0
Y,China,CHN,Demand Reduction,Proportion of people who use drugs enrolled in compulsory treatment,Yes,"The number of people who use drugs who are located in Compulsory Centres for Drug Users (CCDU) in Southeast Asia {Sub-Regional Action Plan On Drug Control, 2011-2013, p.7} ~",1
Y,China,CHN,Demand Reduction,Presence of prevention programming in law enforcement,No,n/a,0
Y,China,CHN,Demand Reduction,Presence of prevention programming in the media,Yes,"the number of users in the media who received publicity activities that push ""Say No to Drugs"" {Annual Report on Drug Control in China, 2017, p.16} ~ The number of news items the mobile phone newspaper for drug control sends per week {Annual Report on Drug Control in China, 2017, p.17} ~ ",2
Y,China,CHN,Demand Reduction,Presence of prevention programming in schools,Yes,"prevalence of schools across the country that carried out drug prevention education campaigns {Annual Report on Drug Control in China, 2017, p.14} ~ number of students who received the education on drug prevention {Annual Report on Drug Control in China, 2017, p.14} ~ The number of students and schools that participated in the National Juvenile Knowledge Competition for Drug Control {Annual Report on Drug Control in China, 2017, p.14} ~ ",3
Y,China,CHN,Demand Reduction,Presence of prevention programming in the workplace,No,n/a,0
Y,China,CHN,Demand Reduction,Presence of prevention programming for youth and the community,No,n/a,0
Y,China,CHN,Demand Reduction,Presence of other demand reduction metrics,Yes,"The number of former users who had not relapsed in three years {Annual Report on Drug Control in China, 2017, p.23} ~ The number of relapsed drug users in China in 2016 {Annual Report on Drug Control in China, 2017, p.55} ~",2
Y,China,CHN,Supply Reduction,Size and value of the illegal drug market,Yes,"Origin of ATS trafficked in the GMS {Mekong MOU on Drug Control Sub-Regional Action Plan On Drug Control, 2014-2016, p.7} ~ Drug trafficking and related forms of criminal activity and the threat to security and the rule of law in the region {Mekong MOU on Drug Control Sub-Regional Action Plan On Drug Control Draft Version, 2014-2016, p.7} ~ tracking and tracing transportation routes {Mekong MOU on Drug Control Sub-Regional Action Plan On Drug Control Draft Version, 2014-2016, p.8} ~ The number of drug trafficking cases involving a minimum of 1 kilogram of drugs per case. {Annual Report on Drug Control in China, 2017, p.60; Sub-Regional Action Plan On Drug Control, 2011-2013, p.14} ~ Production of amphetamine-type stimulants (ATS) {Mekong MOU on Drug Control Sub-Regional Action Plan On Drug Control Draft Version, 2014-2016, p.7} ~ ",5
Y,China,CHN,Supply Reduction,Level of procedures related to crop eradication,Yes,"prevalence of poppy cultivation (%) and in hectares in Southeast Asia {Sub-Regional Action Plan On Drug Control, 2011-2013, p.8} ~ ",1
Y,China,CHN,Supply Reduction,"Number of arrests, seizures, and offences",Yes,"the number in tons of drugs seized (heroin, crystal ice, ice tablets, ketamine, precursor chemicals, ATS) {Annual Report on Drug Control in China, 2017, p.28, p.34, p.61; Sub-Regional Action Plan On Drug Control, 2011-2013, p.8, p.9; Mekong MOU on Drug Control Sub-Regional Action Plan On Drug Control Draft Version, 2014-2016, p.8} ~ The number of drugs and precursors in tons seized by type of operation/project (5-14 drug source blocking and interdiction mechanism; Border Hunting; Iron Eagle; Skynet; Green Arrow; 4-14 mechanism; project 11-25; {Annual Report on Drug Control in China, 2017, p.28, p.29, p.30} ~ The number in tons of drugs and precursor chemicals seized (online enforcement actions, customs, national intelligence platform) {Annual Report on Drug Control in China, 2017, p.29, p.31, p.38} ~ The number in tons of drugs and precursor chemicals seized as a result of solving cases {Annual Report on Drug Control in China, 2017, p.32, p.58} ~ number of drug related suspects who were arrested by type of operation/project (5-14 drug source blocking and interdiction mechanism; Border Hunting; Iron Eagle; Skynet; Green Arrow; project 4-14; project 11-25 {Annual Report on Drug Control in China, 2017, p.28, p.29, p.30} ~ The number of suspects arrested by agency (customs, online enforcement actions, national intelligence analysis platform) {Annual Report on Drug Control in China, 2017, p.29, p.31, p.38} ~ The number of drugs suspects arrested as a result of solving target cases {Annual Report on Drug Control in China, 2017, p.32} ~ The number of arrested special drug suspects (Pregnant and lactating women, patients of acute infectious diseases, seriously ill and disabled people who cannot take care of themselves, and HIV carriers engage in drug trafficking) of Chinese nationality and the number of special drug suspects of foreign nationalities that were arrested {Annual Report on Drug Control in China, 2017, p.60} ~ Number of arrested Drug Suspects (2005-2016) {Annual Report on Drug Control in China, 2017, p.61} ~",9
Y,China,CHN,Supply Reduction,Level of law enforcement activity and interdiction in the market,Yes,"The number of rejected applications for driving licenses due to history of drug use {Annual Report on Drug Control in China, 2017, p.24} ~ total number of drug related criminal cases uncovered (customs, national intelligence platform) {Annual Report on Drug Control in China, 2017, p.28, p.29, p.38, p.58} ~ The number of drug related criminal cases cracked (manufacture) (4-14 mechanism; online enforcement actions) {Annual Report on Drug Control in China, 2017, p.30, p.31, p.61} ~ The number of drug related criminal cases solved (drug precursor cases, manufacture cases, drug target cases, drug trafficking cases) {p.32, p.34, p.58, p.60}  ~ The total number of cases cracked by type of operation/project (5-14 drug source blocking and interdiction mechanism; Border Hunting; Iron Eagle; Skynet; Green Arrow)  {Annual Report on Drug Control in China, 2017, p.28, p.29} ~ The number of drug clan labs destroyed by type of project (4-14 mechanism; project 11-25) {Annual Report on Drug Control in China, 2017, p.30} ~ The number of methamphetamine and ketamine clan labs destroyed {Annual Report on Drug Control in China, 2017, p.59} ~ The number of violations investigated by postal management agencies {Annual Report on Drug Control in China, 2017, p.29} ~ The number of law enforcement officers dispatched by postal management agencies {Annual Report on Drug Control in China, 2017, p.29} ~ The number of units inspected by postal management agencies {p.29} ~ The number of administrative penalties given by postal management agencies {Annual Report on Drug Control in China, 2017, p.29} ~ The number of online enforcement actions completed (deleted entries of illegal drug-related information; shut down drug-related websites; shut down drug-related communication accounts) {Annual Report on Drug Control in China, 2017, p.31} ~  The number of enterprises and key people screened for precursor chemicals {Annual Report on Drug Control in China, 2017, p.34} ~ The number of drug trafficking groups wiped out in China {Annual Report on Drug Control in China, 2017, p.60} ~ The number of frontline police that attended training by the national intelligence analysis platform {Annual Report on Drug Control in China, 2017, p.38} ~ The number of training classes relating to drug analysis technology, drug abuse testing, and drug profiling held. {Annual Report on Drug Control in China, 2017, p.50} ~",16
Y,China,CHN,Supply Reduction,"Price, purity and potency of drugs, and related process indicators",Yes,"The number of suspicious samples from various areas were collected and analyzed, and the number of uncontrolled NPS identified {Annual Report on Drug Control in China, 2017, p.50} ~ The number of samples for inspection that the lab analyzed {Annual Report on Drug Control in China, 2017, p.51} ~ The number of uncovered kinds of substances beyond the scheduling list. {Annual Report on Drug Control in China, 2017, p.58} ~",3
Y,China,CHN,Supply Reduction,Number of people engaged with the criminal justice system,No,n/a,0
Y,China,CHN,Supply Reduction,Presence of other supply reduction metrics,Yes,"Number in tons of finished drug product and semi-finished drug product {Annual Report on Drug Control in China, 2017, p.30} ~ ",1
Y,China,CHN,International Cooperation,Level of engagement in international cooperation,Yes,"The number of issued pre-export notifications of precursor chemicals {Annual Report on Drug Control in China, 2017, p.36} ~The number in tons of suspended precursor chemicals that were being exported, and the number of shipments that were suspended as a result {Annual Report on Drug Control in China, 2017, p.36} ~ The number of pieces of intelligence requested by foreign counterparts on drug precursors and NPS that were verified {Annual Report on Drug Control in China, 2017, p.36} ~ The number of pieces of NPS intelligence or case leadings provided to more than 20 countries and regions {Annual Report on Drug Control in China, 2017, p.36} ~ The number of countries that China exchanged information with drug enforcement agencies {Annual Report on Drug Control in China, 2017, p.41} ~ The number of international and cross-border drug target cases cracked (Third Joint Drug Interdiction Operation on the Sino-Vietnamese Border) {Annual Report on Drug Control in China, 2017, p.43, p.44} ~ number of international and cross-border suspects arrested, and by operation (Safe Mekong; Third Joint Drug Interdiction Operation on the Sino-Vietnamese Border; Operation Blaze with Australia) {Annual Report on Drug Control in China, 2017, p.43, p.44} ~ The number in tons of drugs seized at international and cross-border (Golden Triangle in Yunnan and Guangxi), and by type of operation (Safe Mekong; Third Joint Drug Interdiction Operation on the Sino-Vietnamese Border; Operation Blaze with Australia)  {Annual Report on Drug Control in China, 2017, p.43, p.44, p.58} ~ The number of uncovered cases (Safe Mekong” Joint Operation (Phase II); Operation Blaze with Australia) {Annual Report on Drug Control in China, 2017, p.44} ~ The number of uncovered cases by region (“Golden Crescent”; South America) {Annual Report on Drug Control in China, 2017, p.58} ~ The number of coordinated bilateral and multilateral training programs for foreign counterparts {Annual Report on Drug Control in China, 2017, p.45} ~ The number of foreign police officers who took part in the training {Annual Report on Drug Control in China, 2017, p.44} ~ Opium poppy cultivation in northern Myanmar and Laos from 2004 to 2016 (main source of drugs) {Annual Report on Drug Control in China, 2017, p.57} ~",13
Y,Lao PDR,LAO,Health,Level of availability of harm reduction services and harm reduction scale up,Yes,"Prevalence of estimated numbers of IDU are reached through harm reduction interventions {National Strategic and Action Plan on HIV/AIDS/STI Control and Prevention, 2011-2015, p.ix} ~",1
Y,Lao PDR,LAO,Health,Presence of needle and syringe programs,Yes,"prevalence of people who inject drugs who were reached by NSPs in Southeast Asia {Sub-Regional Action Plan On Drug Control, 2011-2013, p.6; Mekong MOU on Drug Control Sub-Regional Action Plan On Drug Controlt Version Draf, 2014-2016, p.10} ~ ",1
Y,Lao PDR,LAO,Health,Prevalence of substance use disorders,Yes,"The number of opium addicts in Laos {National Drug Control Master Plan, 2009-2013, p.5} ~",1
Y,Lao PDR,LAO,Health,Prevalence of psychiatric comorbidities,No,n/a,0
Y,Lao PDR,LAO,Health,Drug-related mortality,No,n/a,0
Y,Lao PDR,LAO,Health,Prevalence of drug-related infectious disease,Yes,"HIV prevalence among drug users {National Strategic and Action Plan on HIV/AIDS/STI Control and Prevention, 2011-2015, p.ix & p.42} ~ Annual estimated new HIV infection by risk groups {National Strategic and Action Plan on HIV/AIDS/STI Control and Prevention, 2011-2015, p.4} ~ HIV prevalence among most-at-risk populations {National Strategic and Action Plan on HIV/AIDS/STI Control and Prevention, 2011-2015, p.5} ~ Population size estimates for most-at-risk populations {National Strategic and Action Plan on HIV/AIDS/STI Control and Prevention, 2011-2015, p.6} ~",4
Y,Lao PDR,LAO,Health,Proportion of people who use drugs who engage in risky consumption,No,n/a,0
Y,Lao PDR,LAO,Health,Proportion of people who use drugs who engage in safe consumption practices,Yes,"prevalence of IDU reporting safe use of injecting equipment {National Strategic and Action Plan on HIV/AIDS/STI Control and Prevention, 2011-2015, p.ix} ~ Percentage injecting drug users who reported using sterile injecting equipment the last time they injected {National Strategic and Action Plan on HIV/AIDS/STI Control and Prevention, 2011-2015, p.42} ~ ",2
Y,Lao PDR,LAO,Health,"Coverage of services for the prevention, testing, and treatment of bloodborne diseases",Yes,"Percentage drug users who both correctly identify ways of preventing the sexual transmission of HIV and who reject major misconceptions about HIV transmission {National Strategic and Action Plan on HIV/AIDS/STI Control and Prevention, 2011-2015, p.42} ~ Number of drug users reached by prevention programmes {National Strategic and Action Plan on HIV/AIDS/STI Control and Prevention, 2011-2015, p.43} ~",2
Y,Lao PDR,LAO,Health,Presence of specialised training for addiction care,No,n/a,0
Y,Lao PDR,LAO,Health,Presence of health harms related to drug use,No,n/a,0
Y,Lao PDR,LAO,Health,Presence of other health metrics,Yes,"Prevalence % of IDU report consistent condom use {National Strategic and Action Plan on HIV/AIDS/STI Control and Prevention, 2011-2015, p.x} ~ Percentage drug users who reported the use of a condom at last sexual intercourse {National Strategic and Action Plan on HIV/AIDS/STI Control and Prevention, 2011-2015, p.42} ~",2
Y,Lao PDR,LAO,Peace and Security,"Prevalence of alcohol and drugs in accidents, and interventions to increase road safety",No,n/a,0
Y,Lao PDR,LAO,Peace and Security,Annual number of public disorder and violent crime reports,Yes,"Prevalence of drug related crime {National Drug Control Master Plan, 2009-2013, p.8} ~",1
Y,Lao PDR,LAO,Peace and Security,Number of non-lethal drug market violent events reported,No,n/a,0
Y,Lao PDR,LAO,Peace and Security,Number of drug market related homicides and disappearances,No,n/a,0
Y,Lao PDR,LAO,Peace and Security,Presence of other peace and security metrics,No,n/a,0
Y,Lao PDR,LAO,Development,Coverage of housing assistance for people who use drugs,No,n/a,0
Y,Lao PDR,LAO,Development,Coverage of social assistance for people who use drugs (not including housing),No,n/a,0
Y,Lao PDR,LAO,Development,Number of households enrolled in alternative development,Yes,"AD work linked with the MDG s and national economic growth programmes for implementation with development partners from national and international agencies. {National Drug Control Master Plan, 2009-2013, p.13} ~ Alternative Development Programme Modules and ensuing sub-projects: On-going projects; On-going requiring extension; Future priority target areas {National Drug Control Master Plan, 2009-2013, p.13} ~ Priority Former Opium Producing Districts {National Drug Control Master Plan, 2009-2013, p.14} ~ Prevalence of former opium poppy farmers could revert back for lack of alternatives and other opportunities. {National Drug Control Master Plan, 2009-2013, p.6} ~",4
Y,Lao PDR,LAO,Development,Presence of other development metrics,Yes,"Vulnerability to poverty in the Lao PDR (map that highlights the areas of poverty in Lao): Better off; Medium; Vulnerable; Very vulnerable {National Drug Control Master Plan, 2009-2013, p.6} ~ ",1
Y,Lao PDR,LAO,Human Rights,"Prevalence and incidence of infectious diseases in vulnerable populations (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Lao PDR,LAO,Human Rights,"Prevalence of vulnerable people who use drugs (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Lao PDR,LAO,Human Rights,Proportion of people who use drugs in prison that are receiving medication assisted treatment (MAT),No,n/a,0
Y,Lao PDR,LAO,Human Rights,Distribution of sterile injecting equipment in prisons,No,n/a,0
Y,Lao PDR,LAO,Human Rights,Presence of programs and services targeted towards women ,No,n/a,0
Y,Lao PDR,LAO,Human Rights,Presence of programs and services targeted towards people of color,No,n/a,0
Y,Lao PDR,LAO,Human Rights,Presence of challenges and/or harms experienced by people of color,No,n/a,0
Y,Lao PDR,LAO,Human Rights,"Presence of programs and services targeted towards vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Lao PDR,LAO,Human Rights,"Presence of challenges and/or harms experienced by vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Lao PDR,LAO,Human Rights,Presence of other human rights metrics,No,n/a,0
Y,Lao PDR,LAO,Demand Reduction,Prevalence of drug use by age,Yes,"Prevalence of high-risk students in urban areas had tried ATS {National Drug Control Master Plan, 2009-2013, p.8} ~ ",1
Y,Lao PDR,LAO,Demand Reduction,Prevalence of drug use by sex,No,n/a,0
Y,Lao PDR,LAO,Demand Reduction,Prevalence of drug use by type,Yes,"Prevalence of highland villages that have used heroin {National Drug Control Master Plan, 2009-2013, p.8} ~ Estimates of the number of people who have used Amphetamine Type Stimulants (ATS) {National Drug Control Master Plan, 2009-2013, p.7; Mekong MOU on Drug Control Sub-Regional Action Plan On Drug Control Draft Version, 2014-2016, p.7} ~ Prevalence of high-risk students in urban areas had tried ATS {National Drug Control Master Plan, 2009-2013, p.8} ~ ",3
Y,Lao PDR,LAO,Demand Reduction,Number of people who use drugs,No,n/a,0
Y,Lao PDR,LAO,Demand Reduction,"Prevalence of drug use by mode of administration (oral, mucosa, inhalation, and injection)",Yes,"Prevalence of highland villages that have used heroin, and the prevalence of those injecting {National Drug Control Master Plan, 2009-2013, p.8} ~ ",1
Y,Lao PDR,LAO,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT)",Yes,"The number of drug users treated for relapse {National Drug Control Master Plan, 2009-2013, p.5} ~ Treatment approaches designed for specific populations and substances being implemented. {National Drug Control Master Plan, 2009-2013, p.15} ~ ",2
Y,Lao PDR,LAO,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT) by age",No,n/a,0
Y,Lao PDR,LAO,Demand Reduction,Level of access to opioid substitution treatment and medication assisted treatment (OST/MAT),Yes,"estimates of people who are dependent on opiates in the six MOU countries in East Asia are currently reached with OST. {Mekong MOU on Drug Control Sub-Regional Action Plan On Drug Control Draft Version, 2014-2016, p.11; Sub-Regional Action Plan On Drug Control, 2011-2013, p.7} ~ ",1
Y,Lao PDR,LAO,Demand Reduction,Level of coverage of inpatient treatment,No,n/a,0
Y,Lao PDR,LAO,Demand Reduction,Proportion of people who use drugs enrolled in voluntary treatment,No,n/a,0
Y,Lao PDR,LAO,Demand Reduction,Proportion of people who use drugs enrolled in coerced treatment,No,n/a,0
Y,Lao PDR,LAO,Demand Reduction,Proportion of people who use drugs enrolled in compulsory treatment,Yes,"The number of people who use drugs who are located in Compulsory Centres for Drug Users (CCDU) in Southeast Asia {Sub-Regional Action Plan On Drug Control, 2011-2013, p.7} ~",1
Y,Lao PDR,LAO,Demand Reduction,Presence of prevention programming in law enforcement,No,n/a,0
Y,Lao PDR,LAO,Demand Reduction,Presence of prevention programming in the media,No,n/a,0
Y,Lao PDR,LAO,Demand Reduction,Presence of prevention programming in schools,Yes,"Number of urine tests performed on conducted on # students, in # of schools, in # of provinces {National Drug Control Master Plan, 2009-2013, p.8} ~ ",1
Y,Lao PDR,LAO,Demand Reduction,Presence of prevention programming in the workplace,No,n/a,0
Y,Lao PDR,LAO,Demand Reduction,Presence of prevention programming for youth and the community,Yes,"Increased activities for high-risk populations as alternatives to drug use being implemented. {National Drug Control Master Plan, 2009-2013, p.16} ~",1
Y,Lao PDR,LAO,Demand Reduction,Presence of other demand reduction metrics,No,n/a,0
Y,Lao PDR,LAO,Supply Reduction,Size and value of the illegal drug market,Yes,"The annual cash income of opium poppy growers {National Drug Control Master Plan, 2009-2013, p.6} ~ Origin of ATS trafficked in the GMS {Mekong MOU on Drug Control Sub-Regional Action Plan On Drug Control Draft Version, 2014-2016, p.7} ~ tracking and tracing transportation routes {Mekong MOU on Drug Control Sub-Regional Action Plan On Drug Control Draft Version, 2014-2016, p.7, p.8; Sub-Regional Action Plan On Drug Control, 2011-2013, p.14} ~",3
Y,Lao PDR,LAO,Supply Reduction,Level of procedures related to crop eradication,Yes,"the number in hectares of opium poppy crops that the Governments of Lao, PDR, Myanmar and Thailand have collectively eradicated {Mekong MOU on Drug Control Sub-Regional Action Plan On Drug Control Draft Version, 2014-2016, p.12} ~ Output 4 – Annual opium crop monitoring and assessments conducted, verified and reported. {Sub-Regional Action Plan On Drug Control, 2011-2013, p.13} ~ Prevalence of opium cultivation in Laos {National Drug Control Master Plan, 2009-2013, p.4; Mekong MOU on Drug Control Sub-Regional Action Plan On Drug Control Draft Version, 2014-2016, p.12; Sub-Regional Action Plan On Drug Control, 2011-2013, p.8} ~ Number of villages engaged in poppy cultivation on the number of hectares {National Drug Control Master Plan, 2009-2013, p.5} ~",4
Y,Lao PDR,LAO,Supply Reduction,"Number of arrests, seizures, and offences",Yes,"prevalence of amphetamine type stimulants (ATS) seizures {Sub-Regional Action Plan On Drug Control, 2011-2013, p.8} ~ Increased number and amount of seizures made {National Drug Control Master Plan, 2009-2013, p.17} ~",2
Y,Lao PDR,LAO,Supply Reduction,Level of law enforcement activity and interdiction in the market,Yes,"Increased capacity to control shipments of precursors and other illicit substances {National Drug Control Master Plan, 2009-2013, p.17} ~ Increased capacity to detect money laundering in the Lao PDR {National Drug Control Master Plan, 2009-2013, p.17} ~ More trained provincial and district drug enforcement personnel {National Drug Control Master Plan, 2009-2013, p.17} ~ Improved knowledge of judges, prosecutors, law enforcement officers, and other relevant officials about drugs, after courses provided and manuals prepared. {National Drug Control Master Plan, 2009-2013, p.18} ~ Training courses on relevant fields completed with trained staff operating in drug control sectors. {National Drug Control Master Plan, 2009-2013, p.20} ~ Integrated data collection on all aspects of drug use and related criminal activities being conducted. {National Drug Control Master Plan, 2009-2013, p.12} ~ ",6
Y,Lao PDR,LAO,Supply Reduction,"Price, purity and potency of drugs, and related process indicators",Yes,"Price of opium per kilogram {National Drug Control Master Plan, 2009-2013, p.5} ~ Increased number of substances analyzed. {National Drug Control Master Plan, 2009-2013, p.19} ~ ",2
Y,Lao PDR,LAO,Supply Reduction,Number of people engaged with the criminal justice system,Yes,"Increased number of cases made against drug traffickers {National Drug Control Master Plan, 2009-2013, p.17} ~ ",1
Y,Lao PDR,LAO,Supply Reduction,Presence of other supply reduction metrics,No,n/a,0
Y,Lao PDR,LAO,International Cooperation,Level of engagement in international cooperation,Yes,"Joint international activities carried out in drug enforcement AD, and other sectors with neighboring countries. {National Drug Control Master Plan, 2009-2013, p.19} ~",1
Y,Angola,AGO,Health,Level of availability of harm reduction services and harm reduction scale up,No,n/a,0
Y,Angola,AGO,Health,Presence of needle and syringe programs,No,n/a,0
Y,Angola,AGO,Health,Prevalence of substance use disorders,No,n/a,0
Y,Angola,AGO,Health,Prevalence of psychiatric comorbidities,Yes,"Number of cases and percentage of consumers with behavioral disorder due to use of drugs (cannabis sativa, alcohol and drug use) by treatment center (Emergency Bank of the Psychiatric Hospital of Luanda; External Psychological Consultations of the Psychiatric Hospital of Luanda) (2014, 2015, 2016) {Revista Anual do Instituto Nacional de Luta Anti-Drogas, p. 39, p.40, p.42, p.43} ~ Number of cases and percentage of consumers with mental disorder due to use of drugs (cannabis sativa, alcohol and drug use, stimulants, opiates) by treatment center (Emergency Bank of the Psychiatric Hospital of Luanda; External Psychological Consultations of the Psychiatric Hospital of Luanda) (2014, 2015, 2016) {Revista Anual do Instituto Nacional de Luta Anti-Drogas, p.40, p.43} ~ ",2
Y,Angola,AGO,Health,Drug-related mortality,No,n/a,0
Y,Angola,AGO,Health,Prevalence of drug-related infectious disease,No,n/a,0
Y,Angola,AGO,Health,Proportion of people who use drugs who engage in risky consumption,No,n/a,0
Y,Angola,AGO,Health,Proportion of people who use drugs who engage in safe consumption practices,No,n/a,0
Y,Angola,AGO,Health,"Coverage of services for the prevention, testing, and treatment of bloodborne diseases",No,n/a,0
Y,Angola,AGO,Health,Presence of specialised training for addiction care,No,n/a,0
Y,Angola,AGO,Health,Presence of health harms related to drug use,No,n/a,0
Y,Angola,AGO,Health,Presence of other health metrics,No,n/a,0
Y,Angola,AGO,Peace and Security,"Prevalence of alcohol and drugs in accidents, and interventions to increase road safety",No,n/a,0
Y,Angola,AGO,Peace and Security,Annual number of public disorder and violent crime reports,No,n/a,0
Y,Angola,AGO,Peace and Security,Number of non-lethal drug market violent events reported,No,n/a,0
Y,Angola,AGO,Peace and Security,Number of drug market related homicides and disappearances,No,n/a,0
Y,Angola,AGO,Peace and Security,Presence of other peace and security metrics,No,n/a,0
Y,Angola,AGO,Development,Coverage of housing assistance for people who use drugs,No,n/a,0
Y,Angola,AGO,Development,Coverage of social assistance for people who use drugs (not including housing),No,n/a,0
Y,Angola,AGO,Development,Number of households enrolled in alternative development,No,n/a,0
Y,Angola,AGO,Development,Presence of other development metrics,No,n/a,0
Y,Angola,AGO,Human Rights,"Prevalence and incidence of infectious diseases in vulnerable populations (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Angola,AGO,Human Rights,"Prevalence of vulnerable people who use drugs (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Angola,AGO,Human Rights,Proportion of people who use drugs in prison that are receiving medication assisted treatment (MAT),No,n/a,0
Y,Angola,AGO,Human Rights,Distribution of sterile injecting equipment in prisons,No,n/a,0
Y,Angola,AGO,Human Rights,Presence of programs and services targeted towards women ,No,n/a,0
Y,Angola,AGO,Human Rights,Presence of programs and services targeted towards people of color,No,n/a,0
Y,Angola,AGO,Human Rights,Presence of challenges and/or harms experienced by people of color,No,n/a,0
Y,Angola,AGO,Human Rights,"Presence of programs and services targeted towards vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Angola,AGO,Human Rights,"Presence of challenges and/or harms experienced by vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Angola,AGO,Human Rights,Presence of other human rights metrics,No,n/a,0
Y,Angola,AGO,Demand Reduction,Prevalence of drug use by age,Yes,"Number of drug consumers accompanied in 2015 & 2016, in the province of Luanda, disaggregated by drug type, municipality, gender, age group, marital status, educational level and whether they are workers or students {Revista Anual do Instituto Nacional de Luta Anti-Drogas, p. 36} ~ ",1
Y,Angola,AGO,Demand Reduction,Prevalence of drug use by sex,Yes,"Number of drug consumers accompanied in 2015 & 2016, in the province of Luanda, disaggregated by drug type, municipality, gender, age group, marital status, educational level and whether they are workers or students {Revista Anual do Instituto Nacional de Luta Anti-Drogas, p. 36} ~ ",1
Y,Angola,AGO,Demand Reduction,Prevalence of drug use by type,Yes,"Number of drug consumers accompanied in 2015 & 2016, in the province of Luanda, disaggregated by drug type, municipality, gender, age group, marital status, educational level and whether they are workers or students {Revista Anual do Instituto Nacional de Luta Anti-Drogas, p. 36} ~ types of most consumed drugs {I Conferência Internacional sobre o Consumo de Álcool e Drogas, p. 348} ~",2
Y,Angola,AGO,Demand Reduction,Number of people who use drugs,Yes,"Number of consumption cases distributed between 2014 and May 2016, by area of origin {Revista Anual do Instituto Nacional de Luta Anti-Drogas, 2015-2016, p. 49} ~",1
Y,Angola,AGO,Demand Reduction,"Prevalence of drug use by mode of administration (oral, mucosa, inhalation, and injection)",No,n/a,0
Y,Angola,AGO,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT)",Yes,"Type of drugs consumed from 2013 to 2016 in cases attended by the Center for Research on Medicines and Toxicology (CIMETOX) {Revista Anual do Instituto Nacional de Luta Anti-Drogas, p. 45} ~ Number of consultations, per type of drugs consumed, from 2013 to May 2016, at the Center for Research on Medicines and Toxicology (CIMETOX) {Revista Anual do Instituto Nacional de Luta Anti-Drogas, p. 48} ~ Number of cases of drug consumers, attended at the Center for Research on Medicines and Toxicology (CIMETOX), from 2013 to 2016, by gender {Revista Anual do Instituto Nacional de Luta Anti-Drogas, p. 45} ~ Number of drug addicts attended at the Center for Research on Medicines and Toxicology (CIMETOX), from 2014 to 2016, by area of origin {Revista Anual do Instituto Nacional de Luta Anti-Drogas, p. 46} ~ Number of psychiatric consultations on the emergency room and external consultation, in the Psychiatric Hospital of Luanda, due to alcohol and drug consumption (2012-2014) (disaggregated by province) {I Conferência Internacional sobre o Consumo de Álcool e Drogas, p. 90} ~ ",5
Y,Angola,AGO,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT) by age",Yes,"Number of drug consumers who attended the Center for Research on Medicines and Toxicology (CIMETOX), by age group, from 2013 to 2016 {Revista Anual do Instituto Nacional de Luta Anti-Drogas, p. 46} ~ Number of consultations due to drugs, from 2013 to May 2016, by age group and gender, at the Center for Research on Medicines and Toxicology (CIMETOX) {Revista Anual do Instituto Nacional de Luta Anti-Drogas, p. 47} ~ Number of people treated for alcohol and drug use disorders in the years 2014 and 2015, by age group, per Hospital {Revista Anual do Instituto Nacional de Luta Anti-Drogas, p. 39} ~ Number of people treated for alcohol and drug use disorders in the first quarter of 2016, by age group and gender, in each Hospital {Revista Anual do Instituto Nacional de Luta Anti-Drogas, p. 42} ~ ",4
Y,Angola,AGO,Demand Reduction,Level of access to opioid substitution treatment and medication assisted treatment (OST/MAT),No,n/a,0
Y,Angola,AGO,Demand Reduction,Level of coverage of inpatient treatment,No,n/a,0
Y,Angola,AGO,Demand Reduction,Proportion of people who use drugs enrolled in voluntary treatment,No,n/a,0
Y,Angola,AGO,Demand Reduction,Proportion of people who use drugs enrolled in coerced treatment,No,n/a,0
Y,Angola,AGO,Demand Reduction,Proportion of people who use drugs enrolled in compulsory treatment,No,n/a,0
Y,Angola,AGO,Demand Reduction,Presence of prevention programming in law enforcement,No,n/a,0
Y,Angola,AGO,Demand Reduction,Presence of prevention programming in the media,No,n/a,0
Y,Angola,AGO,Demand Reduction,Presence of prevention programming in schools,No,n/a,0
Y,Angola,AGO,Demand Reduction,Presence of prevention programming in the workplace,No,n/a,0
Y,Angola,AGO,Demand Reduction,Presence of prevention programming for youth and the community,Yes,"Number and type of community intervention activities {Revista Anual do Instituto Nacional de Luta Anti-Drogas, p. 31} ~ Number of people covered by type of intervention activities in the community {Revista Anual do Instituto Nacional de Luta Anti-Drogas, p. 31} ~",2
Y,Angola,AGO,Demand Reduction,Presence of other demand reduction metrics,Yes,"Number of drug addicts reinserted to society by the Psychiatric Hospital of Luanda, by area of origin and gender, in 2014, 2015, and 2016 {Revista Anual do Instituto Nacional de Luta Anti-Drogas, p. 41, p.44} ~ ",1
Y,Angola,AGO,Supply Reduction,Size and value of the illegal drug market,Yes,"number of cases recorded in each quarter of 2015, 2016 {Revista Anual do Instituto Nacional de Luta Anti-Drogas, p. 21, p.22} ~ Main international, regional and national routes of drug trafficking {I Conferência Internacional sobre o Consumo de Álcool e Drogas, p. 352} ~",2
Y,Angola,AGO,Supply Reduction,Level of procedures related to crop eradication,Yes,"provinces that produce the most cannabis {I Conferência Internacional sobre o Consumo de Álcool e Drogas, p. 347} ~ ",1
Y,Angola,AGO,Supply Reduction,"Number of arrests, seizures, and offences",Yes,"number of detainees and amount of illicit drugs seized (2013-2014), disaggregated by gender and type of drug {I Conferência Internacional sobre o Consumo de Álcool e Drogas, p. 385} ~ number of detainees, in each quarter of 2015 & 2016, men and women, national and foreign {Revista Anual do Instituto Nacional de Luta Anti-Drogas, p. 21, p.22} ~ quantity of drugs seized, by type (plants, cannabis, cocaine and crack) in each quarter of 2015 & 2016 {Revista Anual do Instituto Nacional de Luta Anti-Drogas, p. 21, p.22} ~ number of drugs seizures registered by the General Tax Administration, disaggregated by type of drug seized (cocaine and cannabis), quantities in grams, nationality of offenders, measure of age of offenders and origin of drugs {Revista Anual do Instituto Nacional de Luta Anti-Drogas, p. 23} ~",4
Y,Angola,AGO,Supply Reduction,Level of law enforcement activity and interdiction in the market,No,n/a,0
Y,Angola,AGO,Supply Reduction,"Price, purity and potency of drugs, and related process indicators",No,n/a,0
Y,Angola,AGO,Supply Reduction,Number of people engaged with the criminal justice system,No,n/a,0
Y,Angola,AGO,Supply Reduction,Presence of other supply reduction metrics,No,n/a,0
Y,Angola,AGO,International Cooperation,Level of engagement in international cooperation,No,n/a,0
Y,Germany,DEU,Health,Level of availability of harm reduction services and harm reduction scale up,Yes,"Availability of selected harm reduction responses: Take-home naloxone programs {Germany Country Drug Report, 2017, p.11} ~ Availability of selected harm reduction responses: drug consumption rooms {Germany Country Drug Report, 2017, p.11} ~ Availability of selected harm reduction responses: heroin assisted treatment {Germany Country Drug Report, 2017, p.11} ~ Number of low-threshold agencies: Low-threshold facilities (emergency overnight accommodation, consumption room, street work, etc.) {Treatment: Prevention: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.10} ~ Total number of drug consumption rooms in six German Laender {Harms and Harm Reduction: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.38} ~ Number of incidences of use in drug consumption rooms {Harms and Harm Reduction: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.39} ~ Trend in the issuing of consumption apparatus in Munich, 2012 to 2016: Cannulas (different lengths), Alcohol sponges, NaCl solution, Sterile filters {Harms and Harm Reduction: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.45} ~",7
Y,Germany,DEU,Health,Presence of needle and syringe programs,Yes,"Availability of selected harm reduction responses: Needle and Syringe programs {Germany Country Drug Report, 2017, p.11} ~ Number of Syringes distributed through specialised programmes {Germany Country Drug Report, 2017, p.19} ~ The number of syringes that were issued in facilities {Harms and Harm Reduction: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.41} ~ the locations of syringe vending machines {Harms and Harm Reduction: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.41} ~ The number of syringes were issued from vending machines {Harms and Harm Reduction: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.41} ~ Trend in syringes issued in projects in NRW, 2010 - 2016 {Harms and Harm Reduction: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.43} ~ Trend in syringes issued by vending machines in NRW, 2010 to 2016 {Harms and Harm Reduction: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.44} ~ Trend in the dispensing of different syringe sizes in Munich, 2012 to 2016: 1ml, 2ml, 5ml, 10ml {Harms and Harm Reduction: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.46} ~ Trend in the issuing of consumption apparatus in Munich, 2012 to 2016: Syringes {Harms and Harm Reduction: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.45} ~",9
Y,Germany,DEU,Health,Prevalence of substance use disorders,Yes,"number of people addicted to prescription drugs {National Strategy on Drug and Addiction Policy, 2012, p.36} ~ the proportion of 18- to 59-year-olds with a cannabis addiction {National Strategy on Drug and Addiction Policy, 2012, p.47} ~ Prevalence of individuals with a primary opioid diagnosis that were also diagnosed with a clinically relevant alcohol or cocaine related disorder {Drugs: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.39} ~",3
Y,Germany,DEU,Health,Prevalence of psychiatric comorbidities,Yes,"Comorbid somatic and mental disorders amongst drug users in Hamburg {Harms and Harm Reduction: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.33} ~ ",1
Y,Germany,DEU,Health,Drug-related mortality,Yes,"number of deaths due to drugs every year {National Strategy on Drug and Addiction Policy, 2012, p.46; Germany Country Drug Report, 2017, p.9; Harms and Harm Reduction: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.10, p.13} ~ Number of overdose deaths {Germany Country Drug Report, 2017, p.1} ~ The prevalence of drug induced deaths disaggregated by gender {Germany Country Drug Report, 2017, p.9} ~ Prevalence of opioid related deaths {Germany Country Drug Report, 2017, p.9; Drugs: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.38; Harms and Harm Reduction: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.10, p.15, p.16} ~ Age distribution of deaths in 2015 {Germany Country Drug Report, 2017, p.9, p.19; Harms and Harm Reduction: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.13} ~ % of Total & Number Drug-related deaths from substances other than opioids/opiates: Cocaine/Crack; Amphetamine/Methamphetamine of which: Amphetamine, Methamphetamine, Amphetamine derivatives; New Psychoactive Substances (NPS); Other (w.e.o. psychoactive medicinal drugs); not specified/unknown poisonings {Harms and Harm Reduction: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.10, p.16; Prevention: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.11} ~ % of Total & Number Drug-related deaths 2016 by substance for Suicides; Suicide by way of intoxication (already included in the causes mentioned above); Suicide through means other than intoxication {Harms and Harm Reduction: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.10} ~ % of Total & Number Drug-related deaths 2016 by substance for Long-term harms of which: Long-term harms in combination with intoxication consequences {Harms and Harm Reduction: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.10} ~ Mortality of opioid users treated on an outpatient basis, 2007 - 2016: Proportion of deaths among persons ending treatment (%) {Harms and Harm Reduction: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.12} ~ Trend in the DeStatis coding of the causes of drug-related deaths 2006 to 2015: F-codes, X41 accident/medicine, X42/X44 accident/drugs, X61 suicide/medicine, X62/X64 suicide/drugs, Y11 unknown intention/medicine, Y12/Y14 unknown intention/drugs {Harms and Harm Reduction: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.14} ~ The number of deaths in drug consumption rooms {Harms and Harm Reduction: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.39} ~",12
Y,Germany,DEU,Health,Prevalence of drug-related infectious disease,Yes,"Number of HIV diagnoses attributed to Injecting {Germany Country Drug Report, 2017, p.1} ~ Newly diagnosed HIV cases attributed to injecting drug use {Germany Country Drug Report, 2017, p.8, p.19} ~ Prevalence of HIV and HCV antibodies among people who inject drugs in Germany {Germany Country Drug Report, 2017, p.8} ~ HIV prevalence among PWID* (%) {Germany Country Drug Report, 2017, p.19} ~ HCV prevalence among PWID* (%) {Germany Country Drug Report, 2017, p.19} ~ New HIV diagnoses due to injecting drug use by age group 2008 to 2016 {Harms and Harm Reduction: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.24} ~ Prevalence of hepatitis B infectious {Harms and Harm Reduction: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.24} ~ Number of reported cases of newly diagnosed HCV with indication of injecting drug use by gender, Germany, 2011 to 2016 {Harms and Harm Reduction: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.27} ~",8
Y,Germany,DEU,Health,Proportion of people who use drugs who engage in risky consumption,No,n/a,0
Y,Germany,DEU,Health,Proportion of people who use drugs who engage in safe consumption practices,No,n/a,0
Y,Germany,DEU,Health,"Coverage of services for the prevention, testing, and treatment of bloodborne diseases",No,n/a,0
Y,Germany,DEU,Health,Presence of specialised training for addiction care,No,n/a,0
Y,Germany,DEU,Health,Presence of health harms related to drug use,Yes,"Number of overdoses in drug consumption rooms {Harms and Harm Reduction: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.39} ~ Prevalence of NPS users reporting having experienced unwanted side effects in the last 6 months {Drugs: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.45} ~ Number of acute intoxication and poisoning cases {Harms and Harm Reduction: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.18} ~ ",3
Y,Germany,DEU,Health,Presence of other health metrics,Yes,"Outpatient Treatment & Inpatient treatment: Prevalence of drug users living alone by primary drug: Opioids, Cannabinoids, Cocaine, Stimulants {Treatment: Prevention: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.19, p.20} ~ The prevalence of opioid prescriptions covered by statutory health insurance {Treatment: Prevention: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.42} ~ Sexual dysfunction among substituting patients {Harms and Harm Reduction: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.34} ~ Clinical use of drugs (amphetamines, methamphetamines, cocaine, cannabis, narcotics) in the last 12 months by age group (18-64) and by sex (males and females) {Drugs: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.9, p.21, p.33} ~",4
Y,Germany,DEU,Peace and Security,"Prevalence of alcohol and drugs in accidents, and interventions to increase road safety",Yes,"% of Total & Number Drug-related deaths 2016 by means of accidents {Harms and Harm Reduction: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.10} ~ number of police-registered accidents on German roads with injury to persons, and number of car drivers involved. Proportion of cases where the accident was self-inflicted {Drug Market and Crime: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.17} ~ The number of people involved in the accidents that were under the influence of alcohol and under the influence of ""other intoxicating substances"" {Drug Market and Crime: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.17} ~ Drug use and road traffic accidents, human causes (2003-2016): Accidents with injuries to persons, Incorrect driving behaviour, Drivers under the influence of alcohol, Drivers under the influence of other intoxicating substances {Drug Market and Crime: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.38} ~ ",4
Y,Germany,DEU,Peace and Security,Annual number of public disorder and violent crime reports,Yes,"number of drug crimes registered {National Strategy on Drug and Addiction Policy, 2012, p.54} ~ Prevalence of male and female drug users who have been victims of physical violence and sexual violence, also disaggregated by drug type (Cannabis, Opioids, Cocaine) {Drug Market and Crime: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.18} ~ Prevalence of Violence perpetrated by the client themselves (males and females) {Drug Market and Crime: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.18} ~ Number of cases of direct economic compulsive crimes {Drug Market and Crime: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.14} ~ Trend in economic compulsive crime 2010-2016: Counterfeiting for acquisition of narcotics, Theft of prescription documents for aquisition of narcotics, Theft of narcotics from manufacturers and wholesalers, Theft of narcotics from hospitals, Theft of narcotics from medical practices, Theft of narcotics from pharmacies, Robbery for acquisition of narcotics {Drug Market and Crime: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.31} ~",5
Y,Germany,DEU,Peace and Security,Number of non-lethal drug market violent events reported,No,n/a,0
Y,Germany,DEU,Peace and Security,Number of drug market related homicides and disappearances,No,n/a,0
Y,Germany,DEU,Peace and Security,Presence of other peace and security metrics,No,n/a,0
Y,Germany,DEU,Development,Coverage of housing assistance for people who use drugs,Yes,"Outpatient Treatment/Inpatient Treatment: Prevalence of drug users who are homeless by primary drug: Opioids, Cannabinoids, Cocaine, Stimulants {Treatment: Prevention: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.19, p.20} ~ ",1
Y,Germany,DEU,Development,Coverage of social assistance for people who use drugs (not including housing),No,n/a,0
Y,Germany,DEU,Development,Number of households enrolled in alternative development,No,n/a,0
Y,Germany,DEU,Development,Presence of other development metrics,Yes,"Outpatient Treatment/Inpatient Treatment: Prevalence of drug users who are unemployed by primary drug: Opioids, Cannabinoids, Cocaine, Stimulants {Treatment: Prevention: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.19, p.20} ~ ",1
Y,Germany,DEU,Human Rights,"Prevalence and incidence of infectious diseases in vulnerable populations (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Germany,DEU,Human Rights,"Prevalence of vulnerable people who use drugs (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Germany,DEU,Human Rights,Proportion of people who use drugs in prison that are receiving medication assisted treatment (MAT),No,n/a,0
Y,Germany,DEU,Human Rights,Distribution of sterile injecting equipment in prisons,Yes,"The number of syringe vending machine available in German prisons {Harms and Harm Reduction: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.41} ~",1
Y,Germany,DEU,Human Rights,Presence of programs and services targeted towards women ,No,n/a,0
Y,Germany,DEU,Human Rights,Presence of programs and services targeted towards people of color,No,n/a,0
Y,Germany,DEU,Human Rights,Presence of challenges and/or harms experienced by people of color,No,n/a,0
Y,Germany,DEU,Human Rights,"Presence of programs and services targeted towards vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"Prisons (in-reach or transferred): Number of External services for counselling/treatment in prison {Treatment: Prevention: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.10} ~ Number of secure psychiatric units in prison {Treatment: Prevention: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.12} ~ Outpatient treatment of drug problems in prisons: Number, %, Persons Treated for the First Time (Males, Females and Total) by primary diagnosis: Opioids, Cocaine, Stimulants, Hypnotics/Sedatives, Hallucinogens, Cannabinoids, Multiple Other Substances, Total {Prison: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.12} ~ Number of institutions and capacity as at 30 November 2003-2016: Number of institutions (Total & Open Prison) Total capacity, Population, Population1 {Prison: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.6} ~ ",4
Y,Germany,DEU,Human Rights,"Presence of challenges and/or harms experienced by vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"Proportion of rehabilitation patients in addiction treatment who have been released from prison with no health insurance in place at the beginning of the treatment {Prison: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.9} ~ The number of children who live in addiction affected families {Prevention: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.27} ~ ",2
Y,Germany,DEU,Human Rights,Presence of other human rights metrics,No,n/a,0
Y,Germany,DEU,Demand Reduction,Prevalence of drug use by age,Yes,"Prevalence of 15-24-year olds in Germany that have already have experience with illicit drugs {National Strategy on Drug and Addiction Policy, 2012, p.46} ~ Prevalence of doping substances among the adult population {National Strategy on Drug and Addiction Policy, 2012, p.37} ~ the lifetime prevalence of the consumption of illegal drugs by age group (12-17, 18-64) {National Strategy on Drug and Addiction Policy, 2012, p.46; Drugs: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.7} ~ Lifetime prevalence of use (cannabis, cocaine, amphetamines, MDMA) — schools (% , Source: ESPAD) {Germany Country Drug Report, 2017, p.18, p.19} ~ Lifetime prevalence of drug use (cannabis, amphetamines, methamphetamine, ecstasy, cocaine/crack, NPS) in Germany by age (12-17, 18-64) {Drugs: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.15, p.26, p.43} ~ Estimates of last-year drug use (cannabis, cocaine,  MDMA, amphetamines) among adults in Germany - disaggregated by age: 18-24, 25-34, 35-44, 45-54, 55-64 { Germany Country Drug Report, 2017, p.1, p.18, p.19; Germany Country Drug Report, 2017, p.5; National Strategy on Drug and Addiction Policy, 2012, p.47} ~ 12-month prevalence of the use of any illicit drug by age group (12-17, 18-64) {Drugs: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.7, p.8, p.12, p.13} ~ 30-day prevalence of the use of any illicit drug by age group (12-17, 18-64) {Drugs: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.7} ~ 30-day prevalence of drug use (cannabis, amphetamine, methamphetamine, ecstasy, cocaine/crack, NPS, speed) by age group (12-17, 18-64) {Drugs: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.15, p.26, p.32, p.43} ~ 12-month prevalence of drug use (cannabis, amphetamine, methamphetamine, ecstasy, cocaine/crack, NPS, speed) by age group (12-17, 18-64) {Drugs: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.8, p.15, p.16, p.17, p.20, p.26, p.27, p.28, p.32, p.43} ~ Mean age of first drug use (cannabis, cannabinoids, cocaine, opioids, stimulants, amphetamines, ecstasy, cocaine/crack) {Germany Country Drug Report, 2017, p.7; Drugs: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.20, p.31; Treatment: Prevention: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.19, p.20} ~ Prevalence of drug use (stimulant) by region (Bavaria, Hamburg, Saxony, North Rhine, Frankfurt) and by sex (males and females) among pupils (13-19, 14-17, 15-18) {Drugs: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.30} ~ 12-month prevalence for males and females (18-64) of any illicit drug use by Land: Bavaria, Hamburg, Hesse, North Westphalia, Saxony, Thuringia {Drugs: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.10} ~ Prevalence of illicit drug use in 2015/16 among pupils by age: 13-19, 14-17, 15-18 {Drugs: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.11} ~  Prevalence of illicit drug use in 2015/16 among pupils by time reference: Lifetime, 12-month {Drugs: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.11} ~ Prevalence of drug use (cannabis) in 2015/16 among pupils by age: 13-19, 14-17, 15-18 {Drugs: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.19} ~  Prevalence of drug use (cannabis) in 2015/16 among pupils by time reference: Lifetime, 12-month, 30-day {Drugs: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.19} ~ Prevalence of drug use (NPS, herbal smoke blend, stimulants) by region (Bavaria, Hamburg, Saxony, North Rhine, Frankfurt) among pupils (13-19, 14-17, 15-18) {Drugs: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.22, p.30} ~ Prevalence of NPS use in schools {Drugs: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.44} ~ Prevalence of high-risk drug use (opioids, heroin) by age group (15-64) {Drugs: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.37, p.38; Germany Country Drug Report, 2017, p.1, p.19} ~",20
Y,Germany,DEU,Demand Reduction,Prevalence of drug use by sex,Yes,"12-month prevalence of drug use by sex (males, females), by age group (12-17, 18-64) for any illicit drug - 2015 {Drugs: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.8} ~ Lifetime Prevalence of drug use (cannabis, amphetamines, methamphetamine, ecstasy, cocaine/crack, NPS) by sex (males and females) and age group (12-17, 18-64) of in Germany {Drugs: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.15, p.26, p.43} ~ 12-month Prevalence of drug use (cannabis, amphetamines, methamphetamine, ecstasy, cocaine/crack, NPS) by sex (Male and Female) by age group (12-17, 18-64) {Drugs: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.8, p.15, p.26, p.43} ~ 30-day Prevalence of drug use (cannabis, amphetamine, methamphetamine, ecstasy cocaine/crack, NPS) by sex (males and females) and age group (12-17, 18-64, p.43) in Germany {Drugs: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.15, p.26} ~ Prevalence of use of cannabis in 2015/16 among pupils disaggregated by gender (male and female) {Drugs: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.19} ~ Prevalence of drug use (stimulant) by region (Bavaria, Hamburg, Saxony, North Rhine, Frankfurt) and by sex (males and females) among pupils (13-19, 14-17, 15-18) {Drugs: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.30} ~ 12-month prevalence for males and females (18-64) of any illicit drug use by Land: Bavaria, Hamburg, Hesse, North Westphalia, Saxony, Thuringia {Drugs: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.10} ~ the prevalence of women and men who excessively consume the cocaine derivative, and the prevalence of men and women who engage in daily crack use of three to eight consumption units {Drugs: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.33} ~",8
Y,Germany,DEU,Demand Reduction,Prevalence of drug use by type,Yes,"Prevalence of doping substances among the adult population {National Strategy on Drug and Addiction Policy, 2012, p.37} ~ Lifetime prevalence of use (cannabis, cocaine, amphetamines, MDMA) — schools (% , Source: ESPAD) {Germany Country Drug Report, 2017, p.18, p.19} ~ Lifetime prevalence of drug use (cannabis, amphetamines, methamphetamine, ecstasy, cocaine/crack, NPS) in Germany by age (12-17, 18-64) {Drugs: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.15, p.26, p.43} ~ Estimates of last-year drug use (cannabis, cocaine,  MDMA, amphetamines) among adults in Germany - disaggregated by age: 18-24, 25-34, 35-44, 45-54, 55-64 {Germany Country Drug Report, 2017, p.1, p.18, p.19; Germany Country Drug Report, 2017, p.5; National Strategy on Drug and Addiction Policy, 2012, p.47} ~ 12-month prevalence of drug use (cannabis, amphetamine, methamphetamine, ecstasy, cocaine/crack, NPS, speed) by age group (12-17, 18-64) {Drugs: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.8, p.15, p.16, p.17, p.20, p.26, p.27, p.28, p.32, p.43} ~ Prevalence of people who used prescription drugs without a medical indication within the previous twelve months {National Strategy on Drug and Addiction Policy, 2012, p.37} ~ 30-day prevalence of drug use (cannabis, amphetamine, methamphetamine, ecstasy, cocaine/crack, NPS, speed) by age group (12-17, 18-64) {Drugs: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.15, p.26, p.32, p.43} ~ Mean age of first drug use (cannabis, cannabinoids, cocaine, opioids, stimulants, amphetamines, ecstasy, cocaine/crack) {Germany Country Drug Report, 2017, p.7; Drugs: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.20, p.31; Treatment: Prevention: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.19, p.20} ~ Prevalence of drug use (stimulant) by region (Bavaria, Hamburg, Saxony, North Rhine, Frankfurt) and by sex (males and females) among pupils (13-19, 14-17, 15-18) {Drugs: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.30} ~ the prevalence of women and men who excessively consume the cocaine derivative, and the prevalence of men and women who engage in daily crack use of three to eight consumption units {Drugs: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.33} ~ Prevalence of drug use (cannabis) in 2015/16 among pupils by age: 13-19, 14-17, 15-18 {Drugs: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.19} ~  Prevalence of drug use (cannabis) in 2015/16 among pupils by time reference: Lifetime, 12-month, 30-day {Drugs: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.19} ~ Prevalence of drug use (NPS, herbal smoke blend, stimulants) by region (Bavaria, Hamburg, Saxony, North Rhine, Frankfurt) among pupils (13-19, 14-17, 15-18) {Drugs: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.22, p.30} ~ Prevalence of NPS use in schools {Drugs: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.44} ~ party goers reported having taken a new psychoactive substance before. {Drugs: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.44} ~ Prevalence of high-risk drug use (opioids, heroin) by age group (15-64) {Drugs: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.37, p.38; Germany Country Drug Report, 2017, p.1, p.19} ~ Prevalence of drug use (cannabis, NPS) by land: Hamburg, Thuringia, other Laender, North Rhine-Westphalia {Drugs: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.17, p.44} ~ Prevalence of users reporting intensive use of heroin - daily or nearly daily use {Drugs: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.40} ~",18
Y,Germany,DEU,Demand Reduction,Number of people who use drugs,No,n/a,0
Y,Germany,DEU,Demand Reduction,"Prevalence of drug use by mode of administration (oral, mucosa, inhalation, and injection)",Yes,"Prevalence of users who reported using crack by mode of administration (smoking, injecting, inhaling) crack {Drugs: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.33} ~ Prevalence of users who reported using heroin by mode of administration (injection, nasal use, smoking, inhaling) {Drugs: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.40} ~ Injecting drug use (cases rate/1 000 population) {Germany Country Drug Report, 2017, p.19} ~ Route of drug administration of patients by substance in outpatient treatment in 2016 in the DSHS: Injection, Smoking, Oral, Inhalation, Other, Total All clients entering treatment {Harms and Harm Reduction: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.32} ~",4
Y,Germany,DEU,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT)",Yes,"Mortality of opioid users treated on an outpatient basis, 2007 - 2016: Treatment duration (days) {Harms and Harm Reduction: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.12} ~ Proportion and number of treatment demands by primary drug (outpatient): Opioids, Cannabinoids, Sedatives/Hypnotics, Cocaine, Stimulants, Amphetamines, MDMA, Hallucinogens, Volatile substances, Multiple/other substances {Treatment: Prevention: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.17; Germany Country Drug Report, 2017, p.1, p.7, p.13, p.18, p.19} ~ Proportion and number of first-time treatment demands by primary drug (outpatient): Opioids, Cannabinoids, Sedatives/Hypnotics, Cocaine, Stimulants, incl. caffeine, Hallucinogens, Volatile substances, amphetamines, MDMA, Multiple/other substances {Treatment: Prevention: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.18; Germany Country Drug Report, 2017, p.7, p.18, p.19} ~ Proportion of men and women entering treatment for drug use (cannabis, opioids, stimulants other than cocaine, cocaine) {Germany Country Drug Report, 2017, p.7} ~ The prevalence of drug users (cannabis) needing treatment (daily or almost daily use) who receive it it {Drugs: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.21} ~ Prevalence of people who began therapy due to drug-related problems by type of drug (opioids) {Drugs: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.40} ~ Number of specialized drug treatment centers (counselling and treatment facilities, psychiatric outpatient institutes, whole day outpatient rehabilitation, outpatient assisted living, employment projects/qualification measures, self-help groups, specialized psychiatric hospitals, transition facilities, social therapy day care facilities) {Treatment: Prevention: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.10, p.12} ~ Number of clients at specialized drug treatment centers, and total number of clients in outpatient treatment (counselling and treatment facilities, psychiatric outpatient institutes, whole day outpatient rehabilitation, outpatient assisted living, employment projects/qualification measures, self-help groups, specialized psychiatric hospitals) {Treatment: Prevention: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.10, p.12, p.16, p.24} ~ Primary diagnosis in outpatient therapy by substance (Opioids, Cannabinoids, Sedatives/Hypnotics, Cocaine, Stimulants, Hallucinogens, Volatile Substances, Multiple/Other Substances) for all patients treated (%) disaggregated by males, females, and all clients entering treatment {Treatment: Prevention: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.14} ~  Primary diagnosis in outpatient therapy by substance (Opioids, Cannabinoids, Sedatives/Hypnotics, Cocaine, Stimulants, Hallucinogens, Volatile Substances, Multiple/Other Substances) for persons treated for the first time (%) disaggregated by males, females, and all clients entering treatment {Treatment: Prevention: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.14} ~ The proportion of outpatient clients that finish their care as planned {Treatment: Prevention: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.25} ~ The prevalence of drug users (opioids, stimulants, cocaine, cannabis) that end their treatment prematurely in outpatient units {Treatment: Prevention: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.25} ~ The number of medical rehabilitation treatments for 2016 {Treatment: Prevention: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.24} ~ The number of addiction rehabilitation services provided for drug addicts {Treatment: Prevention: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.26} ~ Number of patients discharged from treatment {Treatment: Prevention: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.26} ~ The proportion of women with primary diagnosis ""methamphetamine"" {Treatment: Prevention: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.27} ~ Changes in admissions to outpatient addiction counselling for various primary diagnoses (2007-2016): Opioids, Cannabis, Cocaine, and Stimulants {Treatment: Prevention: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.34} ~ Changes in outpatient rehabilitation treatments (2003-2016): Total addiction (outpatient & inpatient), Total addiction (outpatient), Drugs/multiple use (outpatient) {Treatment: Prevention: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.36} ~ The number of psychotherapists and specialist doctors involved in the outpatient care of children, adolescents and adults with psychological disorders. {Treatment: Prevention: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.23} ~ The number of medical psychotherapists and psychological psychotherapists {Treatment: Prevention: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.23} ~ Prevalence of NPS use in outpatient populations {Drugs: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.44} ~ Outpatient Treatment & Inpatient treatment: Drug use by primary drug - Gender (ratio males): Opioids, Cannabinoids, Cocaine, Stimulants {Treatment: Prevention: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.19, p.20} ~ ",21
Y,Germany,DEU,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT) by age",Yes,"The number of treatments for drug use (stimulants) by age group (14-17, 22-35) {Drugs: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.32} ~ Mean age at first treatment entrant for drug use (cannabis, cannabinoids, cocaine, opioids, stimulants other than cocaine) {Germany Country Drug Report, 2017, p.7} ~ Age when starting treatment (outpatient, inpatient) in years by primary drug (opioids, cannabinoids, cocaine, stimulants) {Treatment: Prevention: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.19, p.20} ~",3
Y,Germany,DEU,Demand Reduction,Level of access to opioid substitution treatment and medication assisted treatment (OST/MAT),Yes,"The number of people in substitution programmes {National Strategy on Drug and Addiction Policy, 2012, p.53; Germany Country Drug Report, 2017, p.19; Treatment: Prevention: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.33} ~ the number of doctors offering substitution-based treatment {National Strategy on Drug and Addiction Policy, 2012, p.53; Treatment: Prevention: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.10, p.28} ~ Number of opioid substitution treatment clients {Germany Country Drug Report, 2017, p.1; Treatment: Prevention: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.10, p.16} ~ Opioid substitution treatment in Germany: proportions of clients in OST by medication and trends of the total number of clients {Germany Country Drug Report, 2017, p.13} ~ The nationwide average number of reported substitution patients per substitution doctor {Treatment: Prevention: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.28} ~ Type and proportion (%) of substances reported to the substitution register (2005-2016) by substitution drug: Methadone, Levomethadone, Buprenorphine, Dihydrocodeine, Codeine, Diamorphine {Treatment: Prevention: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.29} ~ The availability of substitution treatment in an inpatient setting {Treatment: Prevention: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.30} ~ ",7
Y,Germany,DEU,Demand Reduction,Level of coverage of inpatient treatment,Yes,"Number of inpatient treatment facilities (rehabilitation facilities, social therapy inpatient facilities hospitals) {Treatment: Prevention: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.12, p.38} ~ Number of persons treated in inpatient rehabilitation facilities {Treatment: Prevention: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.12, p.16} ~ Inpatients broken down by addiction diagnosis: Opioids, Cannabinoids, Sedatives or Hypnotics, Cocaine, Stimulants incl. caffeine, Hallucinogens, Volatile substances, Multiple Substance Use & Use of Other Substances, and Total {Treatment: Prevention: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.16} ~ Proportion of treatment demands by primary drug (inpatient): Opioids, Cannabinoids, Sedatives/Hypnotics, Cocaine, Stimulants, incl. caffeine, Hallucinogens, Volatile substances, Multiple/other substances {Treatment: Prevention: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.18} ~ The proportion of inpatient clients that finish their care as planned {Treatment: Prevention: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.25} ~ The prevalence of drug users (opioid, stimulant, cocaine, cannabis) that end their treatment prematurely in inpatient units {Treatment: Prevention: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.25} ~ Changes in admissions to inpatient addiction treatment for various primary diagnoses (2006-2014): Opioids, Cannabinoids, Sedatives or Hypnotics, Cocaine, Stimulants incl. Caffeine, Hallucinogens, Volatile substances, Other & multiple substance use {Treatment: Prevention: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.35} ~ Changes in inpatient rehabilitation treatments (2003-2016): Total addiction (outpatient & inpatient), Total addiction (inpatient), Drugs/multiple use (inpatient), {Treatment: Prevention: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.36} ~ Trend in acute drug-related (opium, heroin, other opioids, methadone, other synthetic narcotics, cocaine, other/unspecified narcotics, cannabinoids, LSD, other hallucinogens) emergencies admitted to inpatient treatment 2006 - 2015: all admissions, cases of intoxication, cases of poisoning {Harms and Harm Reduction: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.20, p.21} ~ Trend in non-fatal drug-related emergencies admitted to inpatient treatment: acute intoxications (F1x.0-Codes): opioids, cannabinoids, sedatives/hypnotics, cocaine, stimulants, hallucinogens, volatile solvents, multiple drug use {Harms and Harm Reduction: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.22} ~",10
Y,Germany,DEU,Demand Reduction,Proportion of people who use drugs enrolled in voluntary treatment,No,n/a,0
Y,Germany,DEU,Demand Reduction,Proportion of people who use drugs enrolled in coerced treatment,No,n/a,0
Y,Germany,DEU,Demand Reduction,Proportion of people who use drugs enrolled in compulsory treatment,No,n/a,0
Y,Germany,DEU,Demand Reduction,Presence of prevention programming in law enforcement,Yes,"Setting of the prevention measures from 2011 to 2016 (multiple responses): Police/Penal System, Municipality/Town Council, {Prevention: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.37} ~",1
Y,Germany,DEU,Demand Reduction,Presence of prevention programming in the media,No,n/a,0
Y,Germany,DEU,Demand Reduction,Presence of prevention programming in schools,Yes,"Setting of the prevention measures from 2011 to 2016 (multiple responses): Driving School, School/College, Nursery/Kindergarten, University/Academy, Adult/Family Education {Prevention: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.37} ~ Provision of interventions in schools in Germany (expert ratings): 0- No information available;1 - No provision; 2- rare provision; 3 - limited provision; 4 - extensive provision; 5 - full provision {Germany Country Drug Report, 2017, p.10} ~ ",2
Y,Germany,DEU,Demand Reduction,Presence of prevention programming in the workplace,Yes,"Setting of the prevention measures from 2011 to 2016 (multiple responses): Business, Municipality/Town Council, Church, Youth Welfare/Streetwork, University/Academy {Prevention: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.37} ~ Course of target levels recorded in Dot.sys between 2008 and 2016: Multipliers, Target Groups, Public Relations {Prevention: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.36} ~ ",2
Y,Germany,DEU,Demand Reduction,Presence of prevention programming for youth and the community,Yes,"Setting of the prevention measures from 2011 to 2016 (multiple responses): Business, Leisure, Family, Police/Penal System, Sports, Municipality/Town Council, Driving School, School/College, Church, Nursery/Kindergarten, Youth Welfare/Streetwork, University/Academy, Adult/Family Education, Adult/Family Education, Addiction Aid, Health Care {Prevention: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.37} ~ The number of addiction prevention measures, projects and programmes were documented in the online documentation system Dot.sys {Germany Country Drug Report, 2017, p.10} ~ Number of prevention activities recorded in Dot.sys from 2006 to 2016 {Prevention: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.35} ~ Proportion of prevention activities documented in Dot.Sys with connection to a substance from 2011 to 2016, categorized by substance (multiple responses): Alcohol, Cannabis, Tobacco, Amphetamine/Speed, Methamphetamine, Ecstasy, Pharmaceuticals, Opioids, Cocaine, Hallucinogens, Biogenic Drugs, Solvents {Prevention: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.39} ~",4
Y,Germany,DEU,Demand Reduction,Presence of other demand reduction metrics,Yes,"The prevalence of patients who are reported to have relapsed {Treatment: Prevention: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.26} ~ Change to the encryption of DRV treatment data (2012-2016) {See table 9, Treatment: Prevention: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.37} ~ ",2
Y,Germany,DEU,Supply Reduction,Size and value of the illegal drug market,Yes,"Prevalence of adolescents who reported that it was easy or very easy for them to obtain cannabis {Drugs: 2017 Report of the national REITOX Focal Point to the EMCDDA, 2016-2017, p.20} ~ Routes of drug trafficking by type of drug (Hashish, Marijuana, Heroin, Opium, Cocaine, Amphetamines, Ecstasy, Crystal Meth, {Drug Market and Crime: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.7, p.8} ~ number of cases of importing ""non-minor amounts"" as per Sec. 30 BtMG acases of importing ""non-minor amounts"" as per Sec. 30 BtMG {Drug Market and Crime: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.13} ~ Dealing/trafficking offences by drug type: cannabis, (meth)amphetamine, cocaine (including crack), ecstasy, heroin {Drug Market and Crime: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.13, p.14} ~ Trend in dealing/trafficking and smuggling offences (2006-2016), proportions and absolute numbers: Other, Ecstasy, Amphetamine, LSD, Cannabis, Cocaine, Heroin {Drug Market and Crime: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.32} ~ ",5
Y,Germany,DEU,Supply Reduction,Level of procedures related to crop eradication,No,n/a,0
Y,Germany,DEU,Supply Reduction,"Number of arrests, seizures, and offences",Yes,"the number of people incarcerated because of drug-related offences, and the proportion of men and women incarcerated as a result {National Strategy on Drug and Addiction Policy, 2012, p.57} ~ Number and percent of drug law offences: (use/possession, supply, narcotic, consumption, general violation of the BtMG, Dealing/trafficking & smuggling, Import in 'non-negligible' quantities, Other violation of the BtMG) {Germany Country Drug Report, 2017, p.1, p.4, p.19; Drug Market and Crime: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.13, p.30, p.33, p.34} ~ Number of seizures: Methamphetamine, MDMA, Heroin, Herbal Cannabis, Cocaine, Cannabis resin, Cannabis plants, Amphetamines, cannabis plantations {Germany Country Drug Report, 2017, p.1, p.16, p.18, p.19; Drug Market and Crime: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.6, p.21, p.22, p.23} ~ Quantities of drugs seized: Herbal cannabis (kg), cocaine/crack (kg), cannabis resin (kg), amphetamine (kg), methamphetamine (kg), heroin (kg), MDMA (tablets), marijuana, LSD, Khat, Mushrooms {Germany Country Drug Report, 2017, p.16, p.18, p.19; Drug Market and Crime: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.20} ~",4
Y,Germany,DEU,Supply Reduction,Level of law enforcement activity and interdiction in the market,Yes,"the number of legal penalties applied by region: For any minor drug possession; Not for minor cannabis possession, but possible for other drug possession; Not for minor drug possession {Germany Country Drug Report, 2017, p.4} ~ The number of illegal narcotics laboratories for manufacturing synthetic drugs were seized in Germany {Drug Market and Crime: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.7, p.23} ~ Number of judgments that issued under general (adult) criminal law {Drug Market and Crime: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.15} ~ ",3
Y,Germany,DEU,Supply Reduction,"Price, purity and potency of drugs, and related process indicators",Yes,"Potency — herbal & resin cannabis (% THC) (minimum and maximum values registered) {Germany Country Drug Report, 2017, p.18; Drug Market and Crime: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.28} ~ Price per gram/tablet — herbal & resin cannabis, cocaine, crack, LSD/Trip, methamphetamine, raw opium, amphetamine, MDMA, heroin) (EUR) (minimum and maximum values registered) {Germany Country Drug Report, 2017, p.18, p.19; Drug Market and Crime: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.9} ~ Purity (%) (minimum and maximum values registered) by drug (cocaine, amphetamine, MDMA/ecstasy, heroin, cannabis, {Germany Country Drug Report, 2017, p.18, p.19; Drug Market and Crime: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.10, p.11, p.12, p.27, p.29} ~ Street-level prices of various drugs (€), 2016: Heroin, Cocaine, Amphetamine, Ecstasy/tablets, Cannabis resin, Herbal cannabis, Crack, LSD/trip, Crystal meth {Drug Market and Crime: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.10} ~ Purity of Amphetamine {Drug Market and Crime: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p. 10, p.25} ~ Trend in wholesale average drug prices (0.5 to <1.5kg or 500 to <1,500 CU) 2010-2016 by drug type: Heroin, Cocaine, Crack, Ecstasy, Amphetamine, Marijuana, Cannabis resin, LSD, Crystal meth {Drug Market and Crime: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.26} ~ ",6
Y,Germany,DEU,Supply Reduction,Number of people engaged with the criminal justice system,Yes,"Number of judgements issued under criminal law relating to young offenders {Drug Market and Crime: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.15} ~ Number of Users of hard drugs who have come to the attention of law enforcement for the first time (EKhD), and trends by type of drug {Drug Market and Crime: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.14, p.35} ~ Proportion of convictions for narcotics among different groups of offenders: Male, Female, Youths, Adolescents, BtMG {Drug Market and Crime: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.16} ~ Trend in the number of convictions by type of sentence since 2005: Prison sentence, not suspended; Suspended prison sentence; Fine; Total {Drug Market and Crime: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.36} ~ Convictions under the BtMG (number of persons convicted): Total, Other Sec. 29 (1), Illegal import Sec. 29a (1) No. 2, Illegal import Sec. 30 (1) No. 4 {Drug Market and Crime: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.15, p.37} ~ Number of persons serving time in prison institutions as a result of violations against the BtMG. {Prison: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.7} ~ Prevalence of imprisoned women and imprisoned adolescents serving sentences due to crimes in violation of the BtMG {Prison: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.7, p.57} ~ Imprisoned persons and narcotics offences (2007- 2016): Total, Prisoners and persons in preventive custody (Male & Female), Custodial sentences for adults (Male & Female), Juvenile punishments (Male & Female), Preventive custody (Male & Female) {Prison: 2017 Report of the national REITOX Focal Point to the EMCDDA (Data year 2016 / 2017), 2016-2017, p.7} ~",8
Y,Germany,DEU,Supply Reduction,Presence of other supply reduction metrics,No,n/a,0
Y,Germany,DEU,International Cooperation,Level of engagement in international cooperation,No,n/a,0
Y,Russia,RUS,Health,Level of availability of harm reduction services and harm reduction scale up,No,n/a,0
Y,Russia,RUS,Health,Presence of needle and syringe programs,No,n/a,0
Y,Russia,RUS,Health,Prevalence of substance use disorders,Yes,"2002-2005: Drug Dependants Registered (opiates and other drugs) {Illicit Drug Trends in the Russian Federation, 2008, p.10} ~ ",1
Y,Russia,RUS,Health,Prevalence of psychiatric comorbidities,No,n/a,0
Y,Russia,RUS,Health,Drug-related mortality,No,n/a,0
Y,Russia,RUS,Health,Prevalence of drug-related infectious disease,Yes,"Prevalence of HIV among young people {Illicit Drug Trends in the Russian Federation, 2008, p.6} ~ 2002-2006: Drug Related Crime, Drug Abuse and HIV Trends {Illicit Drug Trends in the Russian Federation, 2008, p.12} ~ 1996-2006: New and Total HIV cases {Illicit Drug Trends in the Russian Federation, 2008, p.21} ~ % of registered HIV cases among young people aged 15-24 years {Illicit Drug Trends in the Russian Federation, 2008, p.21} ~",4
Y,Russia,RUS,Health,Proportion of people who use drugs who engage in risky consumption,No,n/a,0
Y,Russia,RUS,Health,Proportion of people who use drugs who engage in safe consumption practices,No,n/a,0
Y,Russia,RUS,Health,"Coverage of services for the prevention, testing, and treatment of bloodborne diseases",Yes,"Development and implementation of inter-agency HIV prevention programs for injecting drug users {STATE STRATEGY to Combat the Spread of HIV in Russia through 2020 and beyond, 2020, p.12} ~",1
Y,Russia,RUS,Health,Presence of specialised training for addiction care,No,n/a,0
Y,Russia,RUS,Health,Presence of health harms related to drug use,No,n/a,0
Y,Russia,RUS,Health,Presence of other health metrics,No,n/a,0
Y,Russia,RUS,Peace and Security,"Prevalence of alcohol and drugs in accidents, and interventions to increase road safety",No,n/a,0
Y,Russia,RUS,Peace and Security,Annual number of public disorder and violent crime reports,Yes,"Number of crimes the Russian police registered which had been committed by offenders whilst they were suffering drug intoxication. {Illicit Drug Trends in the Russian Federation, 2008, p.11} ~ Drug Related Crime, Drug Abuse and HIV Trends {Illicit Drug Trends in the Russian Federation, 2008, p.12} ~",2
Y,Russia,RUS,Peace and Security,Number of non-lethal drug market violent events reported,No,n/a,0
Y,Russia,RUS,Peace and Security,Number of drug market related homicides and disappearances,No,n/a,0
Y,Russia,RUS,Peace and Security,Presence of other peace and security metrics,No,n/a,0
Y,Russia,RUS,Development,Coverage of housing assistance for people who use drugs,No,n/a,0
Y,Russia,RUS,Development,Coverage of social assistance for people who use drugs (not including housing),No,n/a,0
Y,Russia,RUS,Development,Number of households enrolled in alternative development,No,n/a,0
Y,Russia,RUS,Development,Presence of other development metrics,No,n/a,0
Y,Russia,RUS,Human Rights,"Prevalence and incidence of infectious diseases in vulnerable populations (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Russia,RUS,Human Rights,"Prevalence of vulnerable people who use drugs (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Russia,RUS,Human Rights,Proportion of people who use drugs in prison that are receiving medication assisted treatment (MAT),No,n/a,0
Y,Russia,RUS,Human Rights,Distribution of sterile injecting equipment in prisons,No,n/a,0
Y,Russia,RUS,Human Rights,Presence of programs and services targeted towards women ,No,n/a,0
Y,Russia,RUS,Human Rights,Presence of programs and services targeted towards people of color,No,n/a,0
Y,Russia,RUS,Human Rights,Presence of challenges and/or harms experienced by people of color,No,n/a,0
Y,Russia,RUS,Human Rights,"Presence of programs and services targeted towards vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Russia,RUS,Human Rights,"Presence of challenges and/or harms experienced by vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Russia,RUS,Human Rights,Presence of other human rights metrics,No,n/a,0
Y,Russia,RUS,Demand Reduction,Prevalence of drug use by age,No,n/a,0
Y,Russia,RUS,Demand Reduction,Prevalence of drug use by sex,No,n/a,0
Y,Russia,RUS,Demand Reduction,Prevalence of drug use by type,Yes,"Drug Users Registered ( by Drug Type) {Illicit Drug Trends in the Russian Federation, 2008, p.10} ~",1
Y,Russia,RUS,Demand Reduction,Number of people who use drugs,Yes,"Estimates of illicit drug use {Illicit Drug Trends in the Russian Federation, 2008, p.10} ~",1
Y,Russia,RUS,Demand Reduction,"Prevalence of drug use by mode of administration (oral, mucosa, inhalation, and injection)",No,n/a,0
Y,Russia,RUS,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT)",No,n/a,0
Y,Russia,RUS,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT) by age",No,n/a,0
Y,Russia,RUS,Demand Reduction,Level of access to opioid substitution treatment and medication assisted treatment (OST/MAT),No,n/a,0
Y,Russia,RUS,Demand Reduction,Level of coverage of inpatient treatment,No,n/a,0
Y,Russia,RUS,Demand Reduction,Proportion of people who use drugs enrolled in voluntary treatment,No,n/a,0
Y,Russia,RUS,Demand Reduction,Proportion of people who use drugs enrolled in coerced treatment,No,n/a,0
Y,Russia,RUS,Demand Reduction,Proportion of people who use drugs enrolled in compulsory treatment,No,n/a,0
Y,Russia,RUS,Demand Reduction,Presence of prevention programming in law enforcement,No,n/a,0
Y,Russia,RUS,Demand Reduction,Presence of prevention programming in the media,No,n/a,0
Y,Russia,RUS,Demand Reduction,Presence of prevention programming in schools,No,n/a,0
Y,Russia,RUS,Demand Reduction,Presence of prevention programming in the workplace,No,n/a,0
Y,Russia,RUS,Demand Reduction,Presence of prevention programming for youth and the community,No,n/a,0
Y,Russia,RUS,Demand Reduction,Presence of other demand reduction metrics,Yes,"major reduction in drug supply and demand {State Antidrug Policy Strategy: STRATEGY for the Implementation of the National Anti-Drug Policy of the Russian Federation in the Period Until 2020, p.9} ~",1
Y,Russia,RUS,Supply Reduction,Size and value of the illegal drug market,Yes,"number of cases involved in the distribution of drugs {Illicit Drug Trends in the Russian Federation, 2008, p.11} ~ registered cases of illicit production of drugs in clandestine labs, 2006 {Illicit Drug Trends in the Russian Federation, 2008, p.14} ~ the number drug crimes (acquisition, sale, manufacture etc.) registered by the Russian law enforcement agencies in 2006 {Illicit Drug Trends in the Russian Federation, 2008, p.19} ~ Map: Number of registered crimes related to illicit drugs in Russian Federation, 2006 {Illicit Drug Trends in the Russian Federation, 2008, p.19} ~ Number of drug trafficking cases {Illicit Drug Trends in the Russian Federation, 2008, p.19} ~",5
Y,Russia,RUS,Supply Reduction,Level of procedures related to crop eradication,Yes,"Russian authorities estimate the production of wild cannabis (hectares) {Illicit Drug Trends in the Russian Federation, 2008, p.13} ~",1
Y,Russia,RUS,Supply Reduction,"Number of arrests, seizures, and offences",Yes,"1992-2006: Opiates (heroin and opium) and Cannabis Seizures  in the Russian Federation (kg) {Illicit Drug Trends in the Russian Federation, 2008, p. 9, p. 13} ~  Number of arrests of foreign nationals {Illicit Drug Trends in the Russian Federation, 2008, p.6} ~",2
Y,Russia,RUS,Supply Reduction,Level of law enforcement activity and interdiction in the market,No,n/a,0
Y,Russia,RUS,Supply Reduction,"Price, purity and potency of drugs, and related process indicators",Yes,"average price for 1 gram of heroin sold in the streets of Moscow (USD) {Illicit Drug Trends in the Russian Federation, 2008, p.6} ~",1
Y,Russia,RUS,Supply Reduction,Number of people engaged with the criminal justice system,Yes,"The number of women and young people prosecuted for drug crimes {Illicit Drug Trends in the Russian Federation, 2008, p.6} ~ Number of adolescents who committed drug related crimes (2006) {Illicit Drug Trends in the Russian Federation, 2008, p.11} ~ 2002-2006: Number of Convicted for Drug Related Crimes {Illicit Drug Trends in the Russian Federation, 2008, p.20} ~",3
Y,Russia,RUS,Supply Reduction,Presence of other supply reduction metrics,Yes,"major reduction in drug supply and demand {State Antidrug Policy Strategy: STRATEGY for the Implementation of the National Anti-Drug Policy of the Russian Federation in the Period Until 2020, p.9} ~",1
Y,Russia,RUS,International Cooperation,Level of engagement in international cooperation,Yes,"Map: Drug Trafficking Routes from Central Asia to the Russian Federation: Air Routes, Rail Roads and Automobile Roads {Illicit Drug Trends in the Russian Federation, 2008, p.17, p. 18} ~",1
Y,Jordan,JOR,Health,Level of availability of harm reduction services and harm reduction scale up,No,n/a,0
Y,Jordan,JOR,Health,Presence of needle and syringe programs,Yes,"total number of syringes that have been distributed in 2013 per person who injects drugs per year by needle and syringe programs {Country Progress Report: Hashemite Kingdom of Jordan, 2012-2013, p.13} ~ number of syringes the outreach workers were able to reach to the IDUs with {Country Progress Report: Hashemite Kingdom of Jordan, 2012-2013, p.30} ~ ",2
Y,Jordan,JOR,Health,Prevalence of substance use disorders,Yes,"Reduce heroin addictions in particular by 15%, by studying the reasons for people to relapse into drug use and by developing addiction rehabilitation programs, both resulting a performance indicator value {The National Strategy to Fight Drugs, 2009, p. 11} ~",1
Y,Jordan,JOR,Health,Prevalence of psychiatric comorbidities,No,n/a,0
Y,Jordan,JOR,Health,Drug-related mortality,Yes,"Death of individuals from 2004-2008 {The National Strategy to fight Drugs, 2009, p. 5} ~",1
Y,Jordan,JOR,Health,Prevalence of drug-related infectious disease,Yes,"Percentage of people who inject drugs who are living with HIV {Country Progress Report: Hashemite Kingdom of Jordan, 2012-2013, p.13} ~Total number of HIV and AIDS registered in 2012 and 2013 {Country Progress Report: Hashemite Kingdom of Jordan, 2012-2013, p.13} ~ % of Injecting drug use that contributes to HIV and AIDS cases registered in 2012 and 2013 among Jordanians {Country Progress Report: Hashemite Kingdom of Jordan, 2012-2013,p.22} ~ ",3
Y,Jordan,JOR,Health,Proportion of people who use drugs who engage in risky consumption,No,n/a,0
Y,Jordan,JOR,Health,Proportion of people who use drugs who engage in safe consumption practices,No,n/a,0
Y,Jordan,JOR,Health,"Coverage of services for the prevention, testing, and treatment of bloodborne diseases",Yes,"all those admitted into both rehabilitation centers were tested for transmissible diseases: HBV, HCV and HIV. The total number of tests carried out in both years with test results for HBV,HCV and HIV { Country Progress Report: Hashemite Kingdom of Jordan, 2012-2013, p.13, p. 28} ~ the total number of IDUs (including small number of non-Jordanians: Iraqi and to a lesser extent Syrian refugees) who were reached with various HIV prevention interventions in the past two years {Country Progress Report: Hashemite Kingdom of Jordan, 2012-2013, p. 30} ~ total number of IDUs (new and repetitive) they were able to reach with awareness raising messages on HIV {Country Progress Report: Hashemite Kingdom of Jordan, 2012-2013, p. 30} ~ Until the end of 2013, total number of patients that were enrolled in ARV treatment- regular adherence patients- with a male to female ratio {Country Progress Report: Hashemite Kingdom of Jordan, 2012-2013, p. 31} ~ % increase showed in the level of knowledge of participants when the training pre and post tests were performed utilizing UNAIDS newly developed training tools on “Monitoring and Evaluation for HIV/AIDS programmes"" in concentrated and low level epidemics {Country Progress Report: Hashemite Kingdom of Jordan, 2012-2013, p. 34} ~",5
Y,Jordan,JOR,Health,Presence of specialised training for addiction care,Yes,"total number of outreach workers that were trained specifically to reach IDUs with various HIV prevention interventions {Country Progress Report: Hashemite Kingdom of Jordan, 2012-2013, p.30} ~  ",1
Y,Jordan,JOR,Health,Presence of health harms related to drug use,No,n/a,0
Y,Jordan,JOR,Health,Presence of other health metrics,No,n/a,0
Y,Jordan,JOR,Peace and Security,"Prevalence of alcohol and drugs in accidents, and interventions to increase road safety",No,n/a,0
Y,Jordan,JOR,Peace and Security,Annual number of public disorder and violent crime reports,No,n/a,0
Y,Jordan,JOR,Peace and Security,Number of non-lethal drug market violent events reported,No,n/a,0
Y,Jordan,JOR,Peace and Security,Number of drug market related homicides and disappearances,No,n/a,0
Y,Jordan,JOR,Peace and Security,Presence of other peace and security metrics,No,n/a,0
Y,Jordan,JOR,Development,Coverage of housing assistance for people who use drugs,No,n/a,0
Y,Jordan,JOR,Development,Coverage of social assistance for people who use drugs (not including housing),No,n/a,0
Y,Jordan,JOR,Development,Number of households enrolled in alternative development,No,n/a,0
Y,Jordan,JOR,Development,Presence of other development metrics,No,n/a,0
Y,Jordan,JOR,Human Rights,"Prevalence and incidence of infectious diseases in vulnerable populations (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Jordan,JOR,Human Rights,"Prevalence of vulnerable people who use drugs (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Jordan,JOR,Human Rights,Proportion of people who use drugs in prison that are receiving medication assisted treatment (MAT),No,n/a,0
Y,Jordan,JOR,Human Rights,Distribution of sterile injecting equipment in prisons,No,n/a,0
Y,Jordan,JOR,Human Rights,Presence of programs and services targeted towards women ,No,n/a,0
Y,Jordan,JOR,Human Rights,Presence of programs and services targeted towards people of color,No,n/a,0
Y,Jordan,JOR,Human Rights,Presence of challenges and/or harms experienced by people of color,No,n/a,0
Y,Jordan,JOR,Human Rights,"Presence of programs and services targeted towards vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Jordan,JOR,Human Rights,"Presence of challenges and/or harms experienced by vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Jordan,JOR,Human Rights,Presence of other human rights metrics,No,n/a,0
Y,Jordan,JOR,Demand Reduction,Prevalence of drug use by age,Yes,"% of the respondents (Aman, Irbid) who were Jordanian and from other nationalities within the age group 18-35 years: % of the participants reported having tried alcohol, followed by Hashish and heroin. {Country Progress Report: Hashemite Kingdom of Jordan, 2012-2013, p.9, p.22, p.25} ~ ",1
Y,Jordan,JOR,Demand Reduction,Prevalence of drug use by sex,No,n/a,0
Y,Jordan,JOR,Demand Reduction,Prevalence of drug use by type,Yes,"% of the respondents (Aman, Irbid) who were Jordanian and from other nationalities within the age group 18-35 years: % of the participants reported having tried alcohol, followed by Hashish and heroin. {Country Progress Report: Hashemite Kingdom of Jordan, 2012-2013, p.9, p.22, p.25} ~ ",1
Y,Jordan,JOR,Demand Reduction,Number of people who use drugs,No,n/a,0
Y,Jordan,JOR,Demand Reduction,"Prevalence of drug use by mode of administration (oral, mucosa, inhalation, and injection)",Yes,"Percentage of respondents reported having injected any of the drugs mentioned in the last twelve months (Hashish, alcohol, heroin) {Country Progress Report: Hashemite Kingdom of Jordan, 2012-2013, p.22} ~ In 2012 and 2013, % of Heroin Addiction that comprises admissions to both National Centre for Rehabilitation of Addicts (MoH) & Substance Abuse Treatment Centre (PSD): % of addiction by injection and addiction by inhalation among all cases of heroin addiction admitted {Country Progress Report: Hashemite Kingdom of Jordan, 2012-2013, p.28} ~",2
Y,Jordan,JOR,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT)",Yes,"Number of Individuals who went to Management of fight against drug center and number of  individuals to National center for addict’s rehabilitation for treatment {The National Strategy to Fight Drugs, 2009, p. 5} ~ ",1
Y,Jordan,JOR,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT) by age",No,n/a,0
Y,Jordan,JOR,Demand Reduction,Level of access to opioid substitution treatment and medication assisted treatment (OST/MAT),No,n/a,0
Y,Jordan,JOR,Demand Reduction,Level of coverage of inpatient treatment,No,n/a,0
Y,Jordan,JOR,Demand Reduction,Proportion of people who use drugs enrolled in voluntary treatment,No,n/a,0
Y,Jordan,JOR,Demand Reduction,Proportion of people who use drugs enrolled in coerced treatment,No,n/a,0
Y,Jordan,JOR,Demand Reduction,Proportion of people who use drugs enrolled in compulsory treatment,No,n/a,0
Y,Jordan,JOR,Demand Reduction,Presence of prevention programming in law enforcement,Yes,"reduce the number of hashish (cannabis) users from the targeted age bracket by 15% especially new user of the same age bracket in 2008 and by 2010 via awareness of military personnel. Peformance Indicator(PI) value included for each {The National Strategy to Fight Drugs, 2009, p.10} ~ ",1
Y,Jordan,JOR,Demand Reduction,Presence of prevention programming in the media,Yes,"issue a special instruction to show the negative impacts of drug on society by focusing on the harm and dangers to human as a result of using tranquilizers and psychotropic substances through media, with a PI value indicated {The National Strategy to Fight Drugs, 2009, p.11} ~",1
Y,Jordan,JOR,Demand Reduction,Presence of prevention programming in schools,Yes,"reduce the number of hashish (cannabis) users from the targeted age bracket by 15% especially new user of the same age bracket in 2008 and by 2010 via University student awareness (both public and private), teachers training and awareness in public, private and UNRWA. Peformance Indicator(PI) value included for each {The National Strategy to Fight Drugs, 2009, p.10} ~ ",1
Y,Jordan,JOR,Demand Reduction,Presence of prevention programming in the workplace,Yes,"reduce the number of hashish (cannabis) users from the targeted age bracket by 15% especially new user of the same age bracket in 2008 and by 2010 via Ministry of  Islamic affairs training and awareness and mosques clergy, Employees of the largest (10) corporation training and awareness, targeting Two industrial cities employees and (3) craft area resulting, targeting Employees of (10) sport clubs and targeting employees of café, trade complexes, hotel. Peformance Indicator(PI) value included for each {The National Strategy to Fight Drugs, 2009, p.10} ~ ",1
Y,Jordan,JOR,Demand Reduction,Presence of prevention programming for youth and the community,Yes,"reduce the number of hashish (cannabis) users from the targeted age bracket by 15% especially new user of the same age bracket in 2008 and by 2010 via social workers, social development workers, targeting youth centers, sport clubs and cultural centers. Peformance Indicator(PI) value included for each {The National Strategy to Fight Drugs, 2009, p.10} ~ ",1
Y,Jordan,JOR,Demand Reduction,Presence of other demand reduction metrics,No,n/a,0
Y,Jordan,JOR,Supply Reduction,Size and value of the illegal drug market,Yes,"strict monitoring of pharmacies and modifying programs to follow up on pharmacies so that they don't sell tranquilizers and psychiatric medications without prescriptions; performance indicator value indicated {The National Strategy to Fight Drugs, 2009, p.11} ~                 ",1
Y,Jordan,JOR,Supply Reduction,Level of procedures related to crop eradication,No,n/a,0
Y,Jordan,JOR,Supply Reduction,"Number of arrests, seizures, and offences",Yes,"The total number of arrested individuals: out of which a certain number are drug users and a number of them are Jordanians {The National Strategy to Fight Drugs, 2009, p.4} ~ Total number of females arrested: number of Jordanians and Non- Jordanians {The National Strategy to Fight Drugs, 2009, p. 5} ~ number of  students arrested for drug supply: number of Jordanians and Non-Jordanians {The National Strategy to Fight Drugs, 2009, p. 5} ~ ",3
Y,Jordan,JOR,Supply Reduction,Level of law enforcement activity and interdiction in the market,Yes,"amending relevant legislation about punishing abuser and traffickers of tranquilizers and psychiatric medication; performance indicator value indicated {The National Strategy to Fight Drugs, 2009, p.11} ~                                       ",1
Y,Jordan,JOR,Supply Reduction,"Price, purity and potency of drugs, and related process indicators",No,n/a,0
Y,Jordan,JOR,Supply Reduction,Number of people engaged with the criminal justice system,No,n/a,0
Y,Jordan,JOR,Supply Reduction,Presence of other supply reduction metrics,No,n/a,0
Y,Jordan,JOR,International Cooperation,Level of engagement in international cooperation,No,n/a,0
Y,Cape Verde,CPV,Health,Level of availability of harm reduction services and harm reduction scale up,No,n/a,0
Y,Cape Verde,CPV,Health,Presence of needle and syringe programs,No,n/a,0
Y,Cape Verde,CPV,Health,Prevalence of substance use disorders,No,n/a,0
Y,Cape Verde,CPV,Health,Prevalence of psychiatric comorbidities,No,n/a,0
Y,Cape Verde,CPV,Health,Drug-related mortality,No,n/a,0
Y,Cape Verde,CPV,Health,Prevalence of drug-related infectious disease,No,"Prevalence rate of HIV/AIDS infection among injecting drug users in 2001 {Plano Nacional Integrado de Luta contra a Droga e o Crime, p. 55} ~ percentage of HIV/AIDS patients who were drug users in 2006 {Plano Nacional Integrado de Luta contra a Droga e o Crime, p. 55} ~ HIV/AIDS prevalence rate among drug users in 2011 {Plano Nacional Integrado de Luta contra a Droga e o Crime, p. 55} ~ Prevalence of HIV in the Therapeutical Community according to DU/IDU, per age group {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 65} ~",4
Y,Cape Verde,CPV,Health,Proportion of people who use drugs who engage in risky consumption,Yes,"Distribution of DUs according to frequency of syringe sharing {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 50} ~ Distribution of IDUs according to frequency of sharing of consumption materials {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 50} ~ ",2
Y,Cape Verde,CPV,Health,Proportion of people who use drugs who engage in safe consumption practices,Yes,"Distribution of IDUs according to needle cleaning {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 50} ~ ",1
Y,Cape Verde,CPV,Health,"Coverage of services for the prevention, testing, and treatment of bloodborne diseases",Yes,"Distribution of the number of people who inquired and adhered to HIV test, according to sex {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 14} ~ Distribution of the number of people who inquired and adhered to HIV test according to use or no use of injecting drugs {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 14} ~ Distribution of DUs who have ever done the HIV test according to statement of test results {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 58} ~  Distribution of DUs by sex (male, female) who have ever done the HIV/AIDS test  {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 58} ~ Distribution of DUs according to statement of knowledge about the means of HIV transmission and contamination and per sex partner {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 56} ~ Distribution of DUs who heard about HIV/AIDS, according to opinion on the existence of ways to prevent contamination to a partner {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 57} ~ Distribution of DUs according to opinion on protection means against HIV/AIDS and per sex partner {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 57} ~ Distribution of DUs who have heard of HIV/AIDS from a partner {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 56} ~ percentage of drug addicts, treated in health services for HIV/AIDS {Plano Nacional Integrado de Luta contra a Droga e o Crime, p. 54} ~",9
Y,Cape Verde,CPV,Health,Presence of specialised training for addiction care,No,n/a,0
Y,Cape Verde,CPV,Health,Presence of health harms related to drug use,Yes,"Distribution of IDUs according to problems due to drug injection and per sex  {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 49} ~",1
Y,Cape Verde,CPV,Health,Presence of other health metrics,Yes,"Distribution of DUs who had sexual intercourse in the last 3 months according to frequency of use of condoms {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 54} ~ Distribution of DUs who used condoms in the last 3 months according to regularity of his/her partner {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 55} ~ Distribution of DUs who used condoms with sex professionals in the last 3 months partner {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 55} ~ Distribution of DUs who had sexual intercourse in the last 3 months according to regularity of his/her partner {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 54} ~",4
Y,Cape Verde,CPV,Peace and Security,"Prevalence of alcohol and drugs in accidents, and interventions to increase road safety",No,n/a,0
Y,Cape Verde,CPV,Peace and Security,Annual number of public disorder and violent crime reports,No,n/a,0
Y,Cape Verde,CPV,Peace and Security,Number of non-lethal drug market violent events reported,No,n/a,0
Y,Cape Verde,CPV,Peace and Security,Number of drug market related homicides and disappearances,No,n/a,0
Y,Cape Verde,CPV,Peace and Security,Presence of other peace and security metrics,No,n/a,0
Y,Cape Verde,CPV,Development,Coverage of housing assistance for people who use drugs,No,n/a,0
Y,Cape Verde,CPV,Development,Coverage of social assistance for people who use drugs (not including housing),No,n/a,0
Y,Cape Verde,CPV,Development,Number of households enrolled in alternative development,No,n/a,0
Y,Cape Verde,CPV,Development,Presence of other development metrics,No,n/a,0
Y,Cape Verde,CPV,Human Rights,"Prevalence and incidence of infectious diseases in vulnerable populations (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"HIV/AIDS prevalence rate among the inmate population {Plano Nacional Integrado de Luta contra a Droga e o Crime, p. 55} ~ Inmates who did the HIV test according to declaration on test result {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 40} ~ Distribution of HIV positive DU inquired, detainees in prisons and treatment centers, according to age group {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 63, p.64} ~ Distribution of HIV positive DU inquired, detainees in prisons and treatment centers, according to institution {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 64} ~ Distribution of HIV positive DU inquired, detainees in prisons and treatment centers, according to the type of virus {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 65} ~ Distribution of HIV positive DU, detainees in prisons and treatment centers, inquired according to sex {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 63} ~",6
Y,Cape Verde,CPV,Human Rights,"Prevalence of vulnerable people who use drugs (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"percentage of detainees who reported experiencing drugs at least once {Plano Nacional Integrado de Luta contra a Droga e o Crime, p. 55} ~ Distribution of DU inmates according to substance consumed and detention situation {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 29} ~ Distribution of DU inmates according to drug acquisition form and per penal institution {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 29} ~ Distribution of DU inmates according to form of consumption {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 30} ~ Prevalence of injecting drug users according to some selected characteristics (related to incarceration and use of drugs in prison {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 30} ~ Prevalence of drug abuse in prisons according to detention time {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 28} ~ Distribution of DU inquired, detainees in prisons and treatment centers, according to the institution they are located {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 62} ~ Distribution of DU inquired, detainees in prisons and treatment centers, according to age group {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 63} ~ who shared materials for the last time and who injected in prison {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 31} ~ IDU according to frequency of use in the last month before detention {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 31} ~ percentage of sex workers who reported having used drugs {Plano Nacional Integrado de Luta contra a Droga e o Crime, p. 55} ~ percentage of sex workers reporting drug use in the four weeks prior to the survey {Plano Nacional Integrado de Luta contra a Droga e o Crime, p. 55} ~ ",12
Y,Cape Verde,CPV,Human Rights,Proportion of people who use drugs in prison that are receiving medication assisted treatment (MAT),No,n/a,0
Y,Cape Verde,CPV,Human Rights,Distribution of sterile injecting equipment in prisons,No,n/a,0
Y,Cape Verde,CPV,Human Rights,Presence of programs and services targeted towards women ,No,n/a,0
Y,Cape Verde,CPV,Human Rights,Presence of programs and services targeted towards people of color,No,n/a,0
Y,Cape Verde,CPV,Human Rights,Presence of challenges and/or harms experienced by people of color,No,n/a,0
Y,Cape Verde,CPV,Human Rights,"Presence of programs and services targeted towards vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"Inmates who did the HIV test, per penal institution {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 40} ~ DU inmates who had regular assistance before arrest {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 32} ~ inmates who tried drugs and inmates who sought treatment before arrest, according to assistance personnel {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 32} ~ Inmates who tried drugs and received treatment in the last 12 months per treatment institution {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 34} ~ Inmates who received some kind of treatment before detention {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 33} ~",5
Y,Cape Verde,CPV,Human Rights,"Presence of challenges and/or harms experienced by vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"IDUs inmates according to sharing of injection materials {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 31} ~ DU inmates according to reason for relapse {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 34} ~ Inmates who declared to have been victims of violence related to drugs in prison {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 35} ~ Inmates who declared to have been victims of violence according to form of violence {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 35} ~ Inmates who ever could not pay a debt due to drug abuse {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 36} ~ Inmates who declared have had some kind of problem with someone else per penal institution {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 36} ~ ",6
Y,Cape Verde,CPV,Human Rights,Presence of other human rights metrics,Yes,"Distribution of Prison Population in Cape Verde, by region and sex (Dec.2006) {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 11} ~ Distribution of inmates who have heard about HIV/AIDS {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 39} ~ Inmates according to knowledge on ways of transmitting HIV/AIDS {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 40} ~ Inmates according to opinion on forms of protection against HIV/AIDS {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 40} ~ percentage of drug users who reported having sex in exchange for money {Plano Nacional Integrado de Luta contra a Droga e o Crime, p. 55} ~ ",5
Y,Cape Verde,CPV,Demand Reduction,Prevalence of drug use by age,Yes,"age range of drug users {Plano Nacional Integrado de Luta contra a Droga e o Crime, p. 55} ~ Distribution of DUs interviewees according to age group {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 45} ~ ",2
Y,Cape Verde,CPV,Demand Reduction,Prevalence of drug use by sex,Yes,"Distribution of DUs according to sex and municipality {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 12, p. 44} ~ Distribution of DUs according to drug used and per sex {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 46} ~",2
Y,Cape Verde,CPV,Demand Reduction,Prevalence of drug use by type,Yes,"Distribution of DUs according to drug consumed for the first time {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 45} ~ Distribution of DUs according to drug used and per sex {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 46} ~ Distribution of DUs according to drug most consumed in the last 12 months prior to the survey {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 47} ~ percentage of drug users who used cocaine, heroin {Plano Nacional Integrado de Luta contra a Droga e o Crime, p. 54} ~ types of drugs most used and used in the country {Plano Nacional Integrado de Luta contra a Droga e o Crime, p. 54} ~",5
Y,Cape Verde,CPV,Demand Reduction,Number of people who use drugs,Yes,"number of drug users {Plano Nacional Integrado de Luta contra a Droga e o Crime, p. 54} ~ Distribution of DUs according to municipality {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 43} ~ Distribution of DUs interviewees according to nationality {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 45} ~ DU according to use of drugs in the last 12 months prior to the survey  {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 46} ~ Distribution of DUs according to frequency of drug abuse in the last 12 months prior to the survey {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 47} ~ Distribution of interviewed who have ever tried drugs {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 28} ~",6
Y,Cape Verde,CPV,Demand Reduction,"Prevalence of drug use by mode of administration (oral, mucosa, inhalation, and injection)",Yes,"percentage of forms of drug use (smoking, inhalation, ingestion, and injection) {Plano Nacional Integrado de Luta contra a Droga e o Crime, p. 55} ~ Distribution of DUs according to use of injecting drugs and per municipality {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 49} ~",2
Y,Cape Verde,CPV,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT)",Yes,"Distribution of DUs interviewed according to sex and per treatment institution {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 12, p.44} ~ Distribution of DUs who have ever received treatment, per sex {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 50} ~ Distribution of DUs according to the institution where they received treatment in the last 12 months {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p.52, p. 53} ~ Distribution of DUs who received treatment according to reason for relapsing {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 53} ~ Distribution of DUs who have ever received treatment, according to the initiative of the treatment centre {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 52} ~ Distribution of DUs according to reasons why they never received any treatment {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 51} ~",6
Y,Cape Verde,CPV,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT) by age",No,n/a,0
Y,Cape Verde,CPV,Demand Reduction,Level of access to opioid substitution treatment and medication assisted treatment (OST/MAT),No,n/a,0
Y,Cape Verde,CPV,Demand Reduction,Level of coverage of inpatient treatment,No,n/a,0
Y,Cape Verde,CPV,Demand Reduction,Proportion of people who use drugs enrolled in voluntary treatment,Yes,"Distribution of DUs according to their opinion on potential family support to try some treatment {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 51} ~",1
Y,Cape Verde,CPV,Demand Reduction,Proportion of people who use drugs enrolled in coerced treatment,Yes,"Distribution of DUs who received treatment according to opinion of possible family support to try some treatment {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 52} ~ ",1
Y,Cape Verde,CPV,Demand Reduction,Proportion of people who use drugs enrolled in compulsory treatment,No,n/a,0
Y,Cape Verde,CPV,Demand Reduction,Presence of prevention programming in law enforcement,No,n/a,0
Y,Cape Verde,CPV,Demand Reduction,Presence of prevention programming in the media,No,n/a,0
Y,Cape Verde,CPV,Demand Reduction,Presence of prevention programming in schools,No,n/a,0
Y,Cape Verde,CPV,Demand Reduction,Presence of prevention programming in the workplace,No,n/a,0
Y,Cape Verde,CPV,Demand Reduction,Presence of prevention programming for youth and the community,No,n/a,0
Y,Cape Verde,CPV,Demand Reduction,Presence of other demand reduction metrics,Yes,"percentage of the main reasons cited for legitimizing and justifying consumption {Plano Nacional Integrado de Luta contra a Droga e o Crime, p. 55} ~ Distribution of DUs according to reason for consumption and per sex {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 47} ~ ",2
Y,Cape Verde,CPV,Supply Reduction,Size and value of the illegal drug market,No,n/a,0
Y,Cape Verde,CPV,Supply Reduction,Level of procedures related to crop eradication,No,n/a,0
Y,Cape Verde,CPV,Supply Reduction,"Number of arrests, seizures, and offences",Yes,"Distribution of DUs who have been arrested due to crimes resulting from drug abuse in the last 12 months {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 59} ~ types and quantity (in grams) of seized drugs, from 2007 to 2011 {Plano Nacional Integrado de Luta contra a Droga e o Crime, p. 50} ~ ",2
Y,Cape Verde,CPV,Supply Reduction,Level of law enforcement activity and interdiction in the market,No,n/a,0
Y,Cape Verde,CPV,Supply Reduction,"Price, purity and potency of drugs, and related process indicators",No,n/a,0
Y,Cape Verde,CPV,Supply Reduction,Number of people engaged with the criminal justice system,Yes,"Distribution of DUs who were convicted due to crimes resulting from the drug abuse in the last 12 months {Study on the Situation of Drug Abuse and Drug Related HIV AIDS, p. 60} ~",1
Y,Cape Verde,CPV,Supply Reduction,Presence of other supply reduction metrics,No,n/a,0
Y,Cape Verde,CPV,International Cooperation,Level of engagement in international cooperation,No,n/a,0
Y,Sweden,SWE,Health,Level of availability of harm reduction services and harm reduction scale up,Yes,"Number of individuals treated in low-threshold agencies {Sweden Country Drug Report, 2017, p.12} ~ ",1
Y,Sweden,SWE,Health,Presence of needle and syringe programs,Yes,"Availability of needle and syringe programmes {Sweden Country Drug Report, 2017, p.11} ~  Syringes distributed through specialised programmes {Sweden Country Drug Report, 2017,p.1, p.19} ~ ",2
Y,Sweden,SWE,Health,Prevalence of substance use disorders,Yes,"Narcotic dependence: Women & Men, 17-84 years (%) {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~",1
Y,Sweden,SWE,Health,Prevalence of psychiatric comorbidities,No,n/a,0
Y,Sweden,SWE,Health,Drug-related mortality,Yes,"Drug-related mortality {En samlad strategi för alkohol-, narkotika-, dopnings- och tobakspolitiken, 2016-2020, p.54} ~ the number of deaths by type of drugs (methadone, buprenorphine, heroin) {En samlad strategi för alkohol-, narkotika-, dopnings- och tobakspolitiken, 2016-2020, p.54; Sweden Country Drug Report, 2017, p.9} ~ the prevalence of persons who died during the period 2006-2012 who have been in or have recently been released from LARO treatment at the time of the death. {En samlad strategi för alkohol-, narkotika-, dopnings- och tobakspolitiken, 2016-2020, p.54} ~ Mortality due to poisoning by drugs and narcotics: Women & Men, 16-84 years (number per 100.000 inhabitants aged 15 and above) & (%) {Indikatorlabbet - Monitoring System for ANDT, 2016, np; Sweden Country Drug Report, 2017, p.9, p.19} ~ Treated and deceased, alcohol and/or narcotics diagnosis: Women & Men, 16-84 years (%) {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~ number of overdose deaths {Sweden Country Drug Report, 2017, p.1} ~ Characteristics of and trends in drug-induced deaths in Sweden: Age distribution of deaths in 2015 {Sweden Country Drug Report, 2017, p.9} ~ ",7
Y,Sweden,SWE,Health,Prevalence of drug-related infectious disease,Yes,"Proportion of women and men injecting drugs infected by Hepatitis C {En samlad strategi för alkohol-, narkotika-, dopnings- och tobakspolitiken, 2016-2020, p.51; Sweden Country Drug Report, 2017, p.19} ~ The number of hepatitis C infected within the drug injecting group {En samlad strategi för alkohol-, narkotika-, dopnings- och tobakspolitiken, 2016-2020, p.51} ~ Newly diagnosed HIV cases attributed to injecting drug use {Sweden Country Drug Report, 2017, p.8, p.19} ~ HIV prevalence among PWID* (%) {Sweden Country Drug Report, 2017, p.1, p.19} ~",4
Y,Sweden,SWE,Health,Proportion of people who use drugs who engage in risky consumption,No,n/a,0
Y,Sweden,SWE,Health,Proportion of people who use drugs who engage in safe consumption practices,No,n/a,0
Y,Sweden,SWE,Health,"Coverage of services for the prevention, testing, and treatment of bloodborne diseases",No,n/a,0
Y,Sweden,SWE,Health,Presence of specialised training for addiction care,No,n/a,0
Y,Sweden,SWE,Health,Presence of health harms related to drug use,No,n/a,0
Y,Sweden,SWE,Health,Presence of other health metrics,No,n/a,0
Y,Sweden,SWE,Peace and Security,"Prevalence of alcohol and drugs in accidents, and interventions to increase road safety",Yes,"The proportion of sober traffic {En samlad strategi för alkohol-, narkotika-, dopnings- och tobakspolitiken, p.55} ~ prevalence of people killed in an alcohol and / or drug-related road accident {En samlad strategi för alkohol-, narkotika-, dopnings- och tobakspolitiken, p.55} ~ the number of drink driving offenses and number of those driving under the influence of drugs, known as drug driving. {En samlad strategi för alkohol-, narkotika-, dopnings- och tobakspolitiken, p.55} ~ Single-vehicle accidents at night: Drivers injured and driver fatalities, Women & Men (number per 100.000 inhabitants aged 15 and above) {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~",4
Y,Sweden,SWE,Peace and Security,Annual number of public disorder and violent crime reports,Yes,"Number of drug related crimes {En samlad strategi för alkohol-, narkotika-, dopnings- och tobakspolitiken, 2016-2020, p.43} ~ Treated in hospital, assault by another person: Inpatient Care, Women and Men, aged 18-64 (number per 100.000 inhabitants aged 15 and above) {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~ Self-reported cases of assault, influence offender: Women and Men (number per 100.000 inhabitants aged 16-79) {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~ Self-reported cases of assault, unknown influence offender at night: Women and Men (number per 100.000 inhabitants aged 16-79) {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~",4
Y,Sweden,SWE,Peace and Security,Number of non-lethal drug market violent events reported,No,n/a,0
Y,Sweden,SWE,Peace and Security,Number of drug market related homicides and disappearances,No,n/a,0
Y,Sweden,SWE,Peace and Security,Presence of other peace and security metrics,No,n/a,0
Y,Sweden,SWE,Development,Coverage of housing assistance for people who use drugs,No,n/a,0
Y,Sweden,SWE,Development,Coverage of social assistance for people who use drugs (not including housing),Yes,"number of visitors who are registered in needle syringe programs that are in contact with social services {En samlad strategi för alkohol-, narkotika-, dopnings- och tobakspolitiken, 2016-2020, p.51} ~",1
Y,Sweden,SWE,Development,Number of households enrolled in alternative development,No,n/a,0
Y,Sweden,SWE,Development,Presence of other development metrics,No,n/a,0
Y,Sweden,SWE,Human Rights,"Prevalence and incidence of infectious diseases in vulnerable populations (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Sweden,SWE,Human Rights,"Prevalence of vulnerable people who use drugs (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Sweden,SWE,Human Rights,Proportion of people who use drugs in prison that are receiving medication assisted treatment (MAT),No,n/a,0
Y,Sweden,SWE,Human Rights,Distribution of sterile injecting equipment in prisons,No,n/a,0
Y,Sweden,SWE,Human Rights,Presence of programs and services targeted towards women ,No,n/a,0
Y,Sweden,SWE,Human Rights,Presence of programs and services targeted towards people of color,No,n/a,0
Y,Sweden,SWE,Human Rights,Presence of challenges and/or harms experienced by people of color,No,n/a,0
Y,Sweden,SWE,Human Rights,"Presence of programs and services targeted towards vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"Number of individuals treated in prison (outpatient & inpatient) {Sweden Country Drug Report, 2017, p.12} ~",1
Y,Sweden,SWE,Human Rights,"Presence of challenges and/or harms experienced by vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"The number of unaccompanied children who are in asylum in Sweden {En samlad strategi för alkohol-, narkotika-, dopnings- och tobakspolitiken, 2016-2020 p.36} ~",1
Y,Sweden,SWE,Human Rights,Presence of other human rights metrics,No,n/a,0
Y,Sweden,SWE,Demand Reduction,Prevalence of drug use by age,Yes,"Lifetime prevalence of drug use (NPS, cannabis, cocaine, amphetamines, MDMA) by age (pupils, schools, young adults {En samlad strategi för alkohol-, narkotika-, dopnings- och tobakspolitiken, 2016-2020, p.40, p.47; Sweden Country Drug Report, 2017, p.6, p.18, p.19} ~ Past 12-month prevalence (%) of drugs (narcotics, cannabis, cocaine, amphetamines, MDMA) by age (pupils, schools, young adults) and sex {Indikatorlabbet - Monitoring System for ANDT, 2016, np; Sweden Country Drug Report, 2017, p.1, p.5, p.18} ~ Used anabolic-androgenic steroids (school pupils): At some point, Girls & Boys, Last year in compulsory school (%) {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~ Past 30 day prevalence of drug use by age (15-16 years) {Sweden Country Drug Report, 2017, p.6} ~ Use of cannabis (1 & 4 year mean values): The past 30 days, Women & Men, 16-84 years (%) {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~ Use of drugs (narcotics), over the past 12 months: Women & Men, 17-84 years (%) {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~ Use of narcotics, over the past 30 days: Women & Men, 17-84 years (%) {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~ Used anabolic-androgenic steroids at some point: Women & Men, 17-84 years (%) {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~ Last year prevalence of drug use (cannabis, cocaine, amphetamines, MDMA) — all adults {Sweden Country Drug Report, 2017, p.6, p.18, p.19} ~ Narcotic abuse: Women & Men, 17-84 years (%) {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~ ",10
Y,Sweden,SWE,Demand Reduction,Prevalence of drug use by sex,Yes,"Past 12-month prevalence (%) of drugs (narcotics) by age (pupils, schools, young adults) and sex {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~ Used anabolic-androgenic steroids (school pupils): At some point, Girls & Boys, Last year in compulsory school (%) {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~ Use of cannabis (1 & 4 year mean values): The past 30 days, Women & Men, 16-84 years (%) {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~ Use of drugs (narcotics), over the past 12 months: Women & Men, 17-84 years (%) {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~ Use of narcotics, over the past 30 days: Women & Men, 17-84 years (%) {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~ Used anabolic-androgenic steroids at some point: Women & Men, 17-84 years (%) {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~ number of men reporting that they have doped in the last 12 months {En samlad strategi för alkohol-, narkotika-, dopnings- och tobakspolitiken, 2016-2020, p.49} ~ Narcotic abuse: Women & Men, 17-84 years (%) {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~ ",8
Y,Sweden,SWE,Demand Reduction,Prevalence of drug use by type,Yes,"Lifetime prevalence of drug use (NPS, cannabis, cocaine, amphetamines, MDMA) by age (pupils, schools, young adults {En samlad strategi för alkohol-, narkotika-, dopnings- och tobakspolitiken, 2016-2020, p.40, p.47; Sweden Country Drug Report, 2017, p.6, p.18, p.19} ~ Past 12-month prevalence (%) of drugs (narcotics, cannabis, cocaine, amphetamines, MDMA) by age (pupils, schools, young adults) and sex {Indikatorlabbet - Monitoring System for ANDT, 2016, np; Sweden Country Drug Report, 2017, p.1, p.5, p.18} ~ Used anabolic-androgenic steroids (school pupils): At some point, Girls & Boys, Last year in compulsory school (%) {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~ Use of cannabis (1 & 4 year mean values): The past 30 days, Women & Men, 16-84 years (%) {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~ Use of drugs (narcotics), over the past 12 months: Women & Men, 17-84 years (%) {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~ Use of narcotics, over the past 30 days: Women & Men, 17-84 years (%) {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~ Used anabolic-androgenic steroids at some point: Women & Men, 17-84 years (%) {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~ Last year prevalence of drug use (cannabis, cocaine, amphetamines, MDMA) — all adults {Sweden Country Drug Report, 2017, p.6, p.18, p.19} ~ use of doping preparations, drugs and supplements in training facilities in 2014. {En samlad strategi för alkohol-, narkotika-, dopnings- och tobakspolitiken, 2016-2020, p.48} ~ prevalence of doping {En samlad strategi för alkohol-, narkotika-, dopnings- och tobakspolitiken, 2016-2020, p.48} ~ Narcotic abuse: Women & Men, 17-84 years (%) {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~ ",11
Y,Sweden,SWE,Demand Reduction,Number of people who use drugs,No,n/a,0
Y,Sweden,SWE,Demand Reduction,"Prevalence of drug use by mode of administration (oral, mucosa, inhalation, and injection)",Yes,"Injecting drug use (cases rate/1 000 population) {Sweden Country Drug Report, 2017, p.19} ~ ",1
Y,Sweden,SWE,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT)",Yes,"Treatment entrants: by primary drug (cannabis, cocaine, opioids, stimulants other than cocaine, amphetamines, MDMA) {Sweden Country Drug Report, 2017, p.1, p.7, p.13, p.18, p.19} ~ Number of first-time treatment entrants by type of drug (cannabis, cocaine, opioids, stimulants other than cocaine, amphetamines, MDMA) {Sweden Country Drug Report, 2017, p.7, p., p.19} ~ Prevalence of males and females entering treatment by type of drug (cannabis, cocaine, opioids, stimulants other than cocaine, {Sweden Country Drug Report, 2017, p.7} ~ Number of individuals treated in specialised treatment centres {Sweden Country Drug Report, 2017, p.12} ~ Treatment: All clients {Sweden Country Drug Report, 2017, p.19} ~ Treatment: First-time clients {Sweden Country Drug Report, 2017, p.19} ~",6
Y,Sweden,SWE,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT) by age",Yes,"Treated and deceased, alcohol and/or narcotics diagnosis: Women & Men, 16-84 years (%) {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~ Treated, re-admittance narcotics diagnoses: Women & Men, 16-84 years (%) {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~ ",2
Y,Sweden,SWE,Demand Reduction,Level of access to opioid substitution treatment and medication assisted treatment (OST/MAT),Yes,"type of drugs used in drug assisted treatment for opiate addiction {En samlad strategi för alkohol-, narkotika-, dopnings- och tobakspolitiken, 2016-2020, p.54} ~ number of opioid substitution treatment clients {Sweden Country Drug Report, 2017, p.1 & p.19} ~ Opioid substitution treatment in Sweden: proportions of clients in OST by medication (methadone and burprenorphine) and trends of the total number of client {Sweden Country Drug Report, 2017, p.13} ~ ",3
Y,Sweden,SWE,Demand Reduction,Level of coverage of inpatient treatment,Yes,"Treated in hospital, assault by another person: Inpatient Care, Women and Men, aged 18-64 (number per 100.000 inhabitants aged 15 and above) {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~ Treated, narcotics index: Inpatient care, Women & Men, 16-84 years (number per 100.000 inhabitants aged 15 and above) {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~ Number of individuals treated by type of program (hospital-based residential drug treatment, residential drug treatment) {Sweden Country Drug Report, 2017, p.12} ~ ",3
Y,Sweden,SWE,Demand Reduction,Proportion of people who use drugs enrolled in voluntary treatment,No,n/a,0
Y,Sweden,SWE,Demand Reduction,Proportion of people who use drugs enrolled in coerced treatment,No,n/a,0
Y,Sweden,SWE,Demand Reduction,Proportion of people who use drugs enrolled in compulsory treatment,No,n/a,0
Y,Sweden,SWE,Demand Reduction,Presence of prevention programming in law enforcement,Yes,"ANDT prevention work, collaboration for crime prevention, actors: number of police authority {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~ ANDT prevention work, cooperation agencies, narcotics: number of police authority {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~ ANDT prevention work, crime prevention, written agreement, actors: number of police authority {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~ ANDT prevention work, part of Krogar mot knark (Pubs against drugs): number of collaboration municipality, the Police and sector {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~",4
Y,Sweden,SWE,Demand Reduction,Presence of prevention programming in the media,No,n/a,0
Y,Sweden,SWE,Demand Reduction,Presence of prevention programming in schools,Yes,"Since 2010, there is also a statutory obligation for the principals to offer the persons who need intervention from both principals a coordinated individual plan (Chapter 2, Section 7, SoL and Section 3 of the HSL). [...] In open comparisons in 2014, prevalence of municipalities reported that they have procedures to inform the individual about the right to get such a plan. {En samlad strategi för alkohol-, narkotika-, dopnings- och tobakspolitiken, 2016-2020, p.50} ~ ANDT prevention work, cooperation trade and industry, narcotics: number of independent schools/preschools {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~ number of prevention of ANDT use among university students {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~ Provision of interventions in schools in Sweden (expert ratings): (No information available, No provision, Rare provision, Limited provision, Extensive provision, Full provision {Sweden Country Drug Report, 2017, p.10} ~ ",4
Y,Sweden,SWE,Demand Reduction,Presence of prevention programming in the workplace,Yes,"Prevalence of coaches who agree fully or partially with the statement ""It's important that the gym I work on actively works to counter doping."" {En samlad strategi för alkohol-, narkotika-, dopnings- och tobakspolitiken, 2016-2020, p.49} ~ Prevalence of trainers who stated that they had noted the 100 percent pure hard training logo. {En samlad strategi för alkohol-, narkotika-, dopnings- och tobakspolitiken, 2016-2020, p.49} ~ ANDT prevention work, cooperation ideology-driven organisations, doping/narcotics: number of sports associations {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~ ANDT prevention work, cooperation trade and industry, doping: number of gym/training facilities {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~ ANDT prevention work, methods: number of 100% pure hard training or similar {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~ ANDT prevention work, part of 100% pure hard training: number of training {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~ ",6
Y,Sweden,SWE,Demand Reduction,Presence of prevention programming for youth and the community,Yes,"ANDT prevention work, initiatives schools, early detected use: number of parental programme school year 1-5 {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~ ANDT prevention work, initiatives, early detected use: number of group activities children to abusers {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~ ANDT-prevention, universal action: number of active leisure for children and young people {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~ number of Parents program for alcohol and drugs, year P-5 {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~ number of Group activity for children {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~ ANDT prevention work, influence on attitudes: number of drug free activities {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~ ANDT prevention work, integrated in regular structure: number integrated {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~ ANDT prevention work, other measures: number of alcohol or drug use surveys {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~ ANDT prevention work, steering group: number exists {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~ number of prevention of the use of doping substances {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~ ANDT prevention work, cooperation agencies, doping: number of county administrative board {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~ ANDT prevention work, coordination, allocated hours: number of full-time equivalent employees {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~ ANDT prevention work, location coordinator: number of municipal executive board {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~ ANDT prevention work, monitored: number completely {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~ ANDT prevention work, written agreement, actors: number of agencies {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~ Comprehensive policy, ANDT prevention work, adopted: number of alcohol and/or drug policy {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~ Comprehensive political programme, includes ANDT prevention work, adopted in: number after 2011 {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~ Comprehensive political programme, includes ANDT prevention work, content: number of monitoring plan {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~ number of Evaluation of the ANDT-preventive work {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~ ",19
Y,Sweden,SWE,Demand Reduction,Presence of other demand reduction metrics,Yes,"Impacted negatively by narcotics use of others, known: Women & Men, 17-84 years (%) {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~ ",1
Y,Sweden,SWE,Supply Reduction,Size and value of the illegal drug market,Yes,"Trends of NPS trades, and sales of drug based preparations {En samlad strategi för alkohol-, narkotika-, dopnings- och tobakspolitiken, 2016-2020, p.40} ~ number of drug traffickers {En samlad strategi för alkohol-, narkotika-, dopnings- och tobakspolitiken, 2016-2020, p.55} ~ Drug dispensing, narcotics: Women & Men, 16-84 years (%) {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~",3
Y,Sweden,SWE,Supply Reduction,Level of procedures related to crop eradication,No,n/a,0
Y,Sweden,SWE,Supply Reduction,"Number of arrests, seizures, and offences",Yes,"Prevalence and number of reported drug law offences in Sweden: Use/Possession, Supply {Sweden Country Drug Report, 2017, p.1, p.4, p.19} ~ trends in number of seizures {Sweden Country Drug Report, 2017, p.1, p.16} ~ Quantity of drugs seized by type of drug: Cannabis resin (kg), Herbal Cannabis (kg), Amphetamine (kg), Cocaine (kg), MDMA (kg), Methamphetamine (kg), Heroin (kg), MDMA (tablets) {Sweden Country Drug Report, 2017, p.16, p.18, p.19} ~ Number of drug seizures by type of drug (herbal cannabis, cannabis resin, cocaine, amphetamine, heroin) {Sweden Country Drug Report, 2017, p.18, p.19} ~ ",4
Y,Sweden,SWE,Supply Reduction,Level of law enforcement activity and interdiction in the market,Yes,"The reported abuse crimes outdoors, unknown offender (21 police authorities): Women and Men (number per 100.000 inhabitants aged 15 and above) {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~",1
Y,Sweden,SWE,Supply Reduction,"Price, purity and potency of drugs, and related process indicators",Yes,"Price by type of drug (cannabis resin, herbal cannabis, heroin, cocaine, amphetamine, MDMA) { Indikatorlabbet - Monitoring System for ANDT, 2016, np; Sweden Country Drug Report, 2017, p.17, p.18, p.19} ~ Potency by type of drug (cannabis resin, herbal cannabis) {Sweden Country Drug Report, 2017, p.17, p.18} ~ Purity by type of drug (heroin, cocaine, amphetamine, MDMA) {Sweden Country Drug Report, 2017, p.17, p.18, p.19} ~",3
Y,Sweden,SWE,Supply Reduction,Number of people engaged with the criminal justice system,Yes,"Reported abuse crimes outdoors, unknown offender (7 police regions): Women and Men (number per 100.000 inhabitants aged 15 and above) {Indikatorlabbet - Monitoring System for ANDT, 2016, np} ~ ",1
Y,Sweden,SWE,Supply Reduction,Presence of other supply reduction metrics,No,n/a,0
Y,Sweden,SWE,International Cooperation,Level of engagement in international cooperation,No,n/a,0
Y,Afghanistan,AFG,Health,Level of availability of harm reduction services and harm reduction scale up,Yes,"number of harm reduction centers {National Drug Demand Reduction Policy, 2012-2016, p.10; Afghanistan Drug Report, 2015, p.74} ~ Harm reduction services by province {Afghanistan Drug Report, 2015, p.69} ~ Number of PWIDs received counselling by harm reduction centres, 2011 - 2014 {Afghanistan Drug Report, 2015, p.69} ~ Number and type of drug treatment services by region 2015 (Harm reduction) {Afghanistan Drug Report, 2015, p.75} ~",4
Y,Afghanistan,AFG,Health,Presence of needle and syringe programs,Yes,"Number of clean needles and syringes distributed to PWIDs and collected back and incinerated, 2011-2014 {Afghanistan Drug Report, 2015, p.70} ~ ",1
Y,Afghanistan,AFG,Health,Prevalence of substance use disorders,Yes,"number of drug addicts {Anti-drug Trafficking Policy, 2012-2017, p.35} ~ number of problem drug users {National Alternative Livelihood Policy, 2012, p.11} ~ Estimated number of problem drug users in Kabul city by type of drug: Hashish, Pharmaceutical drugs, Opium, Heroin, and Alcohol {Harm Reduction Strategy for IDU (Injecting Drug Use) and HIV/AIDS Prevention in Afghanistan, 2005, p.7} ~ ",3
Y,Afghanistan,AFG,Health,Prevalence of psychiatric comorbidities,No,n/a,0
Y,Afghanistan,AFG,Health,Drug-related mortality,No,n/a,0
Y,Afghanistan,AFG,Health,Prevalence of drug-related infectious disease,Yes,"prevalence of hepatitis and HIV/AIDS {National Drug Demand Reduction Policy, 2012-2016, p.5} ~ Total of HIV positive registered cases in Afghanistan, 2008 – 2014 {Afghanistan Drug Report, 2015, p.63} ~ Number (new cases and cumulative) of people living with HIV in Afghanistan, 2003 - 2014 {Afghanistan Drug Report, 2015, p.64} ~ Percentage of newly detected HIV cases in 2014 by gender {Afghanistan Drug Report, 2015, p.64} ~ Percentage of newly detected HIV cases in 2014 by age group {Afghanistan Drug Report, 2015, p.64} ~ Number of HBS, HCV and syphilis positive cases identified among test PWIDs, 2011-2014 {Afghanistan Drug Report, 2015, p.71} ~",6
Y,Afghanistan,AFG,Health,Proportion of people who use drugs who engage in risky consumption,No,n/a,0
Y,Afghanistan,AFG,Health,Proportion of people who use drugs who engage in safe consumption practices,No,n/a,0
Y,Afghanistan,AFG,Health,"Coverage of services for the prevention, testing, and treatment of bloodborne diseases",Yes,"Number of HIV tests conducted for PWIDs by harm reduction centres, and positive results, 2011-2014 {Afghanistan Drug Report, 2015, p.69} ~ Number of HBS, HCV and syphilis tests conducted for PWIDs by harm reduction centres, 2011-2014 {Afghanistan Drug Report, 2015, p.70} ~ ",2
Y,Afghanistan,AFG,Health,Presence of specialised training for addiction care,Yes,"Person hours of drug prevention and treatment training provided to addictions workers {Afghan National Drug Action Plan, 2015-2019, p.19} ~",1
Y,Afghanistan,AFG,Health,Presence of health harms related to drug use,No,n/a,0
Y,Afghanistan,AFG,Health,Presence of other health metrics,No,n/a,0
Y,Afghanistan,AFG,Peace and Security,"Prevalence of alcohol and drugs in accidents, and interventions to increase road safety",No,n/a,0
Y,Afghanistan,AFG,Peace and Security,Annual number of public disorder and violent crime reports,No,n/a,0
Y,Afghanistan,AFG,Peace and Security,Number of non-lethal drug market violent events reported,Yes,"Total casualities (wounded) of Afghan counter narcotics agency enforcement personnel, March 2011 – March 2015 {Afghanistan Drug Report, 2015, p.85} ~",1
Y,Afghanistan,AFG,Peace and Security,Number of drug market related homicides and disappearances,Yes,"Total casualities (killed) of Afghan counter narcotics agency enforcement personnel, March 2011 – March 2015 {Afghanistan Drug Report, 2015, p.85} ~",1
Y,Afghanistan,AFG,Peace and Security,Presence of other peace and security metrics,No,n/a,0
Y,Afghanistan,AFG,Development,Coverage of housing assistance for people who use drugs,Yes,"number of shelters for homeless drug addicts {National Drug Demand Reduction Policy, 2012-2016, p.10} ~",1
Y,Afghanistan,AFG,Development,Coverage of social assistance for people who use drugs (not including housing),No,n/a,0
Y,Afghanistan,AFG,Development,Number of households enrolled in alternative development,Yes,"Budget and number of MRRD projects in selected provinces of Afghanistan {Afghanistan Drug Report, 2015, p.39} ~ Implementation of development projects by province and district (MRRD) (Number of projects, Direct Beneficiaries, total budget spent - USD) {Afghanistan Drug Report, 2015, p.40} ~ Number of MAIL interventions in selected provinces of Afghanistan {Afghanistan Drug Report, 2015, p.41} ~ Number of MAIL projects by province and district {Afghanistan Drug Report, 2015, p.41} ~ MAIL alternative livelihood interventions by province and district (Baghlan, Badakhshan, Kandahar, Helmand, Kabul, Farah) {Afghanistan Drug Report, 2015, p.52, p.53, p.54} ~ ",5
Y,Afghanistan,AFG,Development,Presence of other development metrics,Yes,"prevalence of the Afghan population live below the poverty line, with per capita incomes of 45 cents per day or less {National Alternative Livelihood Policy, 2012, p.25} ~ prevalence of the population (5.7 million) that are only just above the poverty line and spend the majority of their income on food, indicating a high vulnerability to shocks {National Alternative Livelihood Policy, 2012, p.25} ~ number of communities mobilised {National Alternative Livelihood Policy, 2012, p.41} ~ number of registered CDCs {National Alternative Livelihood Policy, 2012, p.41} ~ Percent of agriculture that makes up Afghanistan‟s legal GDP {National Alternative Livelihood Policy, 2012, p.36} ~ Net income from wheat and opium in USD/Hectare (AOPS-2009-2014) {Afghanistan Drug Report, 2015, p.24} ~ Projects and budget of MoEW activities in selected provinces of Afghanistan {Afghanistan Drug Report, 2015, p.46} ~ Province wise budgets allocated by GPI in Afghanistan {Afghanistan Drug Report, 2015, p.42} ~ ",8
Y,Afghanistan,AFG,Human Rights,"Prevalence and incidence of infectious diseases in vulnerable populations (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Afghanistan,AFG,Human Rights,"Prevalence of vulnerable people who use drugs (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Afghanistan,AFG,Human Rights,Proportion of people who use drugs in prison that are receiving medication assisted treatment (MAT),No,n/a,0
Y,Afghanistan,AFG,Human Rights,Distribution of sterile injecting equipment in prisons,No,n/a,0
Y,Afghanistan,AFG,Human Rights,Presence of programs and services targeted towards women ,No,n/a,0
Y,Afghanistan,AFG,Human Rights,Presence of programs and services targeted towards people of color,No,n/a,0
Y,Afghanistan,AFG,Human Rights,Presence of challenges and/or harms experienced by people of color,No,n/a,0
Y,Afghanistan,AFG,Human Rights,"Presence of programs and services targeted towards vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Afghanistan,AFG,Human Rights,"Presence of challenges and/or harms experienced by vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Afghanistan,AFG,Human Rights,Presence of other human rights metrics,No,n/a,0
Y,Afghanistan,AFG,Demand Reduction,Prevalence of drug use by age,Yes,"Drug positive and drug use rate (for any type of drug) among total population, among adults, and children {Afghanistan Drug Report, 2015, p.59, p.60} ~ National drug use rate in general population and adult drug users by type of drug (Opioids, Cannabis, Benzodiazepines, Barbiturates, Alcohol, ATS) {Afghanistan Drug Report, 2015, p.61} ~ number of people who use drugs that are between the ages of 15-19 {Anti-drug Trafficking Policy, 2012-2017, p.35} ~ prevalence of Afghan children overall in the survey that tested positive for one or more drugs {Afghan National Drug Action Plan, 2015-2019, p.18} ~ Percentage of giving (administration) opium to children by parents/adults, 2009 – 2015 {Afghanistan Drug Report, 2015, p.62} ~ Percentage of drug use and exposure to drug use among children in Afghanistan (urban, rural and national level) {Afghanistan Drug Report, 2015, p.63} ~ Estimated number of adult drug users in Afghanistan, 2005 to 2015 {Afghanistan Drug Report, 2015, p.58} ~ ",7
Y,Afghanistan,AFG,Demand Reduction,Prevalence of drug use by sex,No,n/a,0
Y,Afghanistan,AFG,Demand Reduction,Prevalence of drug use by type,Yes,"National drug use rate in general population and adult drug users by type of drug (Opioids, Cannabis, Benzodiazepines, Barbiturates, Alcohol, ATS) {Afghanistan Drug Report, 2015, p.61} ~ Percentage of giving (administration) opium to children by parents/adults, 2009 – 2015 {Afghanistan Drug Report, 2015, p.62} ~ number of heroin and opium users {National Drug Demand Reduction Policy, 2012-2016, p.5} ~ National opioid use rate {Afghan National Drug Action Plan, 2015-2019, p.18} ~ ",4
Y,Afghanistan,AFG,Demand Reduction,Number of people who use drugs,Yes,"prevalence of Afghan population (rural and urban) testing positive for drug use {Afghan National Drug Action Plan, 2015-2019, p.18} ~ Prevalence of the population that use drugs {Afghan National Drug Action Plan, 2015-2019, p.5} ~ Percent of target population that have not used drugs after treatment {Afghan National Drug Action Plan, 2015-2019, p.19} ~ ",3
Y,Afghanistan,AFG,Demand Reduction,"Prevalence of drug use by mode of administration (oral, mucosa, inhalation, and injection)",No,n/a,0
Y,Afghanistan,AFG,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT)",Yes,"Number of drug treatment centres in Afghanistan by type of treatment service provided (Inpatient, Outreach & Aftercare; Inpatient, Outpatient, Outreach & Aftercare; Inpatient; Outpatient, Outreach & Aftercare; Outpatient & Aftercare; Community base, Outpatient, Outreach & Aftercare; Shelters; Outreach, Community base & Aftercare) {Afghanistan Drug Report, 2015, p.74; National Drug Demand Reduction Policy, 2012-2016, p.5} ~ number and percent of drug users receiving drug treatment services from the drug treatment centers, and by type of drug (heroin and opium) {National Drug Demand Reduction Policy, 2012-2016, p.5} ~ treatment capacity needs to be increased from 20 to 30% in the coming five years {National Drug Demand Reduction Policy, 2012-2016, p.23} ~ Number of non-government operated treatment programs transitioned to Ministry of Public Health {Afghan National Drug Action Plan, 2015-2019, p.19} ~ Number of villages receiving village-based treatment programs {Afghan National Drug Action Plan, 2015-2019, p.19} ~ Number of permanent mobile pharmacies established {Afghan National Drug Action Plan, 2015-2019, p.19} ~ Patients of health facilities and active health shuras in selected provinces of Afghanistan {Afghanistan Drug Report, 2015, p.44} ~ Street level drug users’ registration for drug treatment {Afghanistan Drug Report, 2015, p.71} ~ Number and capacity of drug treatment centres in country by donor {Afghanistan Drug Report, 2015, p.72} ~ Number and type of drug treatment services by region 2015 (Inpatient; Inpatient, Outpatient, Outreach & Aftercare; Inpatient, Outreach & Aftercare; Community-based, Outpatient, Outreach & Aftercare; Outpatient, Outreach & Aftercare; Outpatient & Aftercare; Outreach, Community-based & Aftercare) {Afghanistan Drug Report, 2015, p.72, p.74, p.75} ~ Total annual treatment capacity and number of clinical staff by region {Afghanistan Drug Report, 2015, p.76} ~ Distribution of drug treatment centres by age and gender on regional level {Afghanistan Drug Report, 2015, p.77} ~ Location of drug treatment centres in by gender, 2015 {Afghanistan Drug Report, 2015, p.77} ~",13
Y,Afghanistan,AFG,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT) by age",No,n/a,0
Y,Afghanistan,AFG,Demand Reduction,Level of access to opioid substitution treatment and medication assisted treatment (OST/MAT),No,n/a,0
Y,Afghanistan,AFG,Demand Reduction,Level of coverage of inpatient treatment,No,n/a,0
Y,Afghanistan,AFG,Demand Reduction,Proportion of people who use drugs enrolled in voluntary treatment,No,n/a,0
Y,Afghanistan,AFG,Demand Reduction,Proportion of people who use drugs enrolled in coerced treatment,No,n/a,0
Y,Afghanistan,AFG,Demand Reduction,Proportion of people who use drugs enrolled in compulsory treatment,No,n/a,0
Y,Afghanistan,AFG,Demand Reduction,Presence of prevention programming in law enforcement,Yes,"Number of poppy-cycle timed campaigns implemented {Afghan National Drug Action Plan, 2015-2019, p.21} ~ Classification of public awareness campaigns based on poppy cultivation level in provinces {Afghanistan Drug Report, 2015, p.68} ~ ",2
Y,Afghanistan,AFG,Demand Reduction,Presence of prevention programming in the media,No,n/a,0
Y,Afghanistan,AFG,Demand Reduction,Presence of prevention programming in schools,Yes,"Number of provinces implementing PDE {Afghan National Drug Action Plan, 2015-2019, p.20} ~ Number of ministries trained in UPC {Afghan National Drug Action Plan, 2015-2019, p.20} ~",2
Y,Afghanistan,AFG,Demand Reduction,Presence of prevention programming in the workplace,No,n/a,0
Y,Afghanistan,AFG,Demand Reduction,Presence of prevention programming for youth and the community,Yes,"Number of participants in the Youth Congress, 2010 – 2013 {Afghanistan Drug Report, 2015, p.66} ~ Target level and aim of public awareness campaigns {Afghanistan Drug Report, 2015, p.67} ~",2
Y,Afghanistan,AFG,Demand Reduction,Presence of other demand reduction metrics,Yes,"Detail of main donor agencies for Drug Demand Reduction/Harm Reduction Afghanistan (Donor, Number of DTCs/HR) {Afghanistan Drug Report, 2015, p.78} ~ Details of drug treatment centres transferred to MoPH during 2015 (Province, Implementing Agency, Target Population, Number of Beds) {Afghanistan Drug Report, 2015, p.80} ~",2
Y,Afghanistan,AFG,Supply Reduction,Size and value of the illegal drug market,Yes,"Distribution of income for opium growing farmers, farmers who have ceased to grow opium and farmers who never have grown opium in 2011, 2014 (Opium, Wheat, Wheat Straw, Other Crops, Livestock, Remittances, Daily/monthly wage, other, renting) {Afghanistan Drug Report, 2015, p.25, p.26} ~ Estimates (in USD) of proceeds from the illegal drug trade falling in the hands of the insurgents and warlords {National Alternative Livelihood Policy, 2012, p.11} ~ 30% reduction in drug trafficking in the first three years of this policy’s implementation {Anti-drug Trafficking Policy, 2012-2017, p.14} ~ number of major traffickers throughout Afghanistan {Anti-drug Trafficking Policy, 2012-2017,p.19} ~ the number in dollars that Criminals launder every day out of Afghanistan to other countries {Anti-drug Trafficking Policy, 2012-2017, p.27} ~ Value of narco-assets seized, forfeited or shared {Afghan National Drug Action Plan, 2015-2019, p.15} ~ Total amount of liquid and solid precursors across the country during March 2011 – March 2015. {Afghanistan Drug Report, 2015, p.89} ~ Illicit substance thresholds in Afghanistan (Substance & Amount) {Afghanistan Drug Report, 2015, p.94} ~ ",8
Y,Afghanistan,AFG,Supply Reduction,Level of procedures related to crop eradication,Yes,"% decrease in opium cultivation {National Alternative Livelihood Policy, 2012, p.9; Anti-drug Trafficking Policy, 2012-2017, p.49; Afghan National Drug Action Plan, 2015-2019, p.10} ~ the cultivation of opium poppy in 2011 (in hectares) {National Alternative Livelihood Policy, 2012, p.11; Regional and International Cooperation Policy, 2014, p.7; Afghan National Drug Action Plan, 2015-2019, p.10; Afghanistan Drug Report, 2015, p.20} ~ % of of global illicit opiates that Afghanistan produces {Regional and International Cooperation Policy, 2014, p.3; Afghan National Drug Action Plan, 2015-2019, p.7} ~ % of Afghan opium is converted into heroin and morphine {Regional and International Cooperation Policy, 2014, p.3} ~ % and number of people (general population, farmers, families) engaged in opium cultivation. {Regional and International Cooperation Policy, 2014, p.3; Anti-drug Trafficking Policy, 2012-2017, p.51} ~ Cultivation levels of opium by province and region (Area in hectares) {Afghanistan Drug Report, 2015, p.21, p.22; Anti-drug Trafficking Policy, 2012-2017, p.41} ~ number of provinces declared as clear/free of opium poppy {Regional and International Cooperation Policy, 2014, p.7; Afghan National Drug Action Plan, 2015-2019, p.10; Afghanistan Drug Report, 2015, p.23} ~ Number of hectares eradicated {Afghan National Drug Action Plan, 2015-2019, p.11; Afghanistan Drug Report, 2015, p.28, p.29, p.93} ~ Opium production in tons and farm gate opium price per kg in USD (1997 to 2015) {Afghanistan Drug Report, 2015, p.22; National Alternative Livelihood Policy, 2012, p.11} ~ Farmers’ motivations for stopping poppy cultivation (Govt Ban, Elders and Shura decision, Lack of water and unsuitable climatic conditions, other, against Islam, fear of government and eradication, not enough yield and high costs of input) {Afghanistan Drug Report, 2015, p.27} ~ Poppy crops and existence boys and girls school 2014 (Access, no access) {Afghanistan Drug Report, 2015, p.27} ~ ",11
Y,Afghanistan,AFG,Supply Reduction,"Number of arrests, seizures, and offences",Yes,"Total amount of drugs seized (metric tons, kilograms, grams), (Hashish, Dry Opium, Morphine, Heroin, precursors, opium, heroin, crystal methamphetamine) {Afghanistan Drug Report, 2015, p.86, p.91; Anti-drug Trafficking Policy, 2012-2017, p.14, p.36; Afghan National Drug Action Plan, 2015-2019, p.13;} ~ Kilograms of seizures in Afghanistan by region and type of drug {Afghanistan Drug Report, 2015, p.88} ~ Total number of drug traffickers arrested {Afghanistan Drug Report, 2015, p.91, p.92; Anti-drug Trafficking Policy, 2012-2017, p.14} ~ Number of seizures and arrests {Afghanistan Drug Report, 2015, p.93} ~ Narcotics-related incarcerations in Afghan prisons by region, March 2010 - March 2015 {Afghanistan Drug Report, 2015, p.96} ~ Juveniles incarcerated for narcotics-related crimes, March 2010 – March 2015 {Afghanistan Drug Report, 2015, p.97} ~",6
Y,Afghanistan,AFG,Supply Reduction,Level of law enforcement activity and interdiction in the market,Yes,"Primary, appellate and final prosecution of seizure cases, March 2010 – March 2013 (Primary Prosecution, Appellate Prosecution, Final Prosecution (Supreme)) {Afghanistan Drug Report, 2015, p.95} ~ percent of illicit drugs that are intercepted by law enforcement authorities while the unimpeded movement of the drugs, precursor chemicals, money, explosives, weapons and insurgents across the Durand Line and the international borders destabilize the country {National Alternative Livelihood Policy, 2012, p.11} ~ number of professional staff dedicated on Counter Narcotics (border police, ministry of interior) {Anti-drug Trafficking Policy, 2012-2017, p.60, p.61} ~ Number of narcotics trafficking organizations disrupted or dismantled {Afghan National Drug Action Plan, 2015-2019, p.13} ~ Percentage of shipments correctly profiled by each JPCU {Afghan National Drug Action Plan, 2015-2019, p.13} ~ Number of case referral packages to CNPA and ANP from FinTRACA {Afghan National Drug Action Plan, 2015-2019, p.15} ~ Total counter narcotics operations, March 2011 – March 2015 {Afghanistan Drug Report, 2015, p.84} ~ Drug and precursor lab destruction, March 2011 - March 2015 {Afghanistan Drug Report, 2015, p.93} ~ Narcotics-related crimes investigated and prosecuted, by CJTF and by nationality  (Afghan Officials, Afghan Nationals, Foreigners) March 2011 - March 2015 {Afghanistan Drug Report, 2015, p.95} ~ ",9
Y,Afghanistan,AFG,Supply Reduction,"Price, purity and potency of drugs, and related process indicators",Yes,"Total farm gate value of opium produced in Afghanistan (1994-2014) {Afghanistan Drug Report, 2015, p.22, p.23} ~ ",1
Y,Afghanistan,AFG,Supply Reduction,Number of people engaged with the criminal justice system,Yes,"Number of major narcotics traffickers convicted {Afghan National Drug Action Plan, 2015-2019, p.13} ~ Narcotics traffickers prosecuted at CNJC {Afghan National Drug Action Plan, 2015-2019, p.13} ~ Number of convictions for AML/CFT by AGO {Afghan National Drug Action Plan, 2015-2019, p.15} ~ ",3
Y,Afghanistan,AFG,Supply Reduction,Presence of other supply reduction metrics,Yes,"Total National GDP versus potential export value of opiates {Afghanistan Drug Report, 2015, p.24} ~",1
Y,Afghanistan,AFG,International Cooperation,Level of engagement in international cooperation,Yes,"Number of projects on border control, precursor chemical smuggling, interdiction operations, controlled deliveries, and container control, among other areas, implemented with international partners {Afghan National Drug Action Plan, 2015-2019, p.17} ~ Number of investments and budget of AISA activities in selected provinces of Afghanistan {Afghanistan Drug Report, 2015, p.45} ~",2
Y,Kenya,KEN,Health,Level of availability of harm reduction services and harm reduction scale up,No,n/a,0
Y,Kenya,KEN,Health,Presence of needle and syringe programs,No,n/a,0
Y,Kenya,KEN,Health,Prevalence of substance use disorders,Yes,"Levels of use in the general population (15 -65 years) (Proportion of dependent persons) {Rapid Situation Assessment of the Status of Drug and Substance Abuse in Kenya, 2012 p.52} ~ Health impact of drug and substance abuse (Do you have a family member who has a mental disorder because of taking drugs, in the last 12 months, prior to the survey?) {Rapid Situation Assessment of the Status of Drug and Substance Abuse in Kenya, 2012 p.49} ~ Levels of drug/substance usage by age category and area of residence (Proportion of dependent persons) {Rapid Situation Assessment of the Status of Drug and Substance Abuse in Kenya, 2012 p.52} ~",3
Y,Kenya,KEN,Health,Prevalence of psychiatric comorbidities,No,n/a,0
Y,Kenya,KEN,Health,Drug-related mortality,No,n/a,0
Y,Kenya,KEN,Health,Prevalence of drug-related infectious disease,Yes,"HIV prevalence among general and key populations (Injection Drug Users) {Kenya Aids Strategic Framework, 2015-2019, p.8} ~ proportion of new HIV diagnoses among people who inject drugs {Kenya Aids Strategic Framework, 2015-2019, p.14} ~",2
Y,Kenya,KEN,Health,Proportion of people who use drugs who engage in risky consumption,No,n/a,0
Y,Kenya,KEN,Health,Proportion of people who use drugs who engage in safe consumption practices,No,n/a,0
Y,Kenya,KEN,Health,"Coverage of services for the prevention, testing, and treatment of bloodborne diseases",No,n/a,0
Y,Kenya,KEN,Health,Presence of specialised training for addiction care,No,n/a,0
Y,Kenya,KEN,Health,Presence of health harms related to drug use,No,n/a,0
Y,Kenya,KEN,Health,Presence of other health metrics,No,n/a,0
Y,Kenya,KEN,Peace and Security,"Prevalence of alcohol and drugs in accidents, and interventions to increase road safety",No,n/a,0
Y,Kenya,KEN,Peace and Security,Annual number of public disorder and violent crime reports,Yes,"Percentage of respondent’s (aged 10 – 14 years) by context of first sexual encounter (Was not willing to have sex then; Given incentives; Self had taken drugs; Partner had taken any drug; Was threatened (rape); was given drug by partner) {Rapid Situation Assessment of the Status of Drug and Substance Abuse in Kenya, 2012, p.49} ~ proportion of persons who inject drugs that were arrested or beaten up by police or city “askaris” in the last six months. {Kenya Aids Strategic Framework, 2015-2019, p.30} ~ Reduced levels of sexual and gender-based violence for PLHIV, key populations, women, men, boys and girls by 50% {Kenya Aids Strategic Framework, 2015-2019, p.29} ~",3
Y,Kenya,KEN,Peace and Security,Number of non-lethal drug market violent events reported,No,n/a,0
Y,Kenya,KEN,Peace and Security,Number of drug market related homicides and disappearances,No,n/a,0
Y,Kenya,KEN,Peace and Security,Presence of other peace and security metrics,No,n/a,0
Y,Kenya,KEN,Development,Coverage of housing assistance for people who use drugs,No,n/a,0
Y,Kenya,KEN,Development,Coverage of social assistance for people who use drugs (not including housing),No,n/a,0
Y,Kenya,KEN,Development,Number of households enrolled in alternative development,No,n/a,0
Y,Kenya,KEN,Development,Presence of other development metrics,No,n/a,0
Y,Kenya,KEN,Human Rights,"Prevalence and incidence of infectious diseases in vulnerable populations (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"proportion of new HIV diagnoses among people in prison {Kenya Aids Strategic Framework, 2015-2019, p.14} ~",1
Y,Kenya,KEN,Human Rights,"Prevalence of vulnerable people who use drugs (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Kenya,KEN,Human Rights,Proportion of people who use drugs in prison that are receiving medication assisted treatment (MAT),No,n/a,0
Y,Kenya,KEN,Human Rights,Distribution of sterile injecting equipment in prisons,No,n/a,0
Y,Kenya,KEN,Human Rights,Presence of programs and services targeted towards women ,No,n/a,0
Y,Kenya,KEN,Human Rights,Presence of programs and services targeted towards people of color,No,n/a,0
Y,Kenya,KEN,Human Rights,Presence of challenges and/or harms experienced by people of color,No,n/a,0
Y,Kenya,KEN,Human Rights,"Presence of programs and services targeted towards vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Kenya,KEN,Human Rights,"Presence of challenges and/or harms experienced by vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"Reduced social exclusion for PLHIV, key populations, women, men, boys and girls by 50% {Kenya Aids Strategic Framework, 2015-2019, p.29} ~ ",1
Y,Kenya,KEN,Human Rights,Presence of other human rights metrics,No,n/a,0
Y,Kenya,KEN,Demand Reduction,Prevalence of drug use by age,Yes,"Ever use of drugs (miraa, narcotics: bhang, hashish, cocaine, heroin, inhalants and prescription drugs) by age group (10-14, 15-65) {Rapid Situation Assessment of the Status of Drug and Substance Abuse in Kenya, 2012, p.32, p.33, p.34, p.35} ~ Never used any drug by age group (10-14, 15-65) {Rapid Situation Assessment of the Status of Drug and Substance Abuse in Kenya, 2012, p.36} ~ Current use of drugs (khat, narcotics, inhalants, prescription, synthetic and other drugs, miraa) by age group (15-65) {Rapid Situation Assessment of the Status of Drug and Substance Abuse in Kenya, 2012, p.42, p.43, p.44} ~ Levels of use in the general population (15 -65 years) (Proportion of moderate users, Proportion of abusers, General annual prevalence) {Rapid Situation Assessment of the Status of Drug and Substance Abuse in Kenya, 2012, p.52} ~ Levels of drug/substance usage by age category and area of residence (Proportion of moderate users, Proportion of abusers, General annual prevalence) {Rapid Situation Assessment of the Status of Drug and Substance Abuse in Kenya, 2012, p.52} ~",5
Y,Kenya,KEN,Demand Reduction,Prevalence of drug use by sex,No,n/a,0
Y,Kenya,KEN,Demand Reduction,Prevalence of drug use by type,Yes,"Ever use of drugs (miraa, narcotics: bhang, hashish, cocaine, heroin, inhalants and prescription drugs) by age group (10-14, 15-65) {Rapid Situation Assessment of the Status of Drug and Substance Abuse in Kenya, 2012, p.32, p.33, p.34, p.35} ~ Current use of drugs (khat, narcotics, inhalants, prescription, synthetic and other drugs, miraa) by age group (15-65) {Rapid Situation Assessment of the Status of Drug and Substance Abuse in Kenya, 2012, p.42, p.43, p.44} ~ ",2
Y,Kenya,KEN,Demand Reduction,Number of people who use drugs,Yes,"Ever use of at least one substance of abuse (%) {Rapid Situation Assessment of the Status of Drug and Substance Abuse in Kenya, 2012, p.46} ~ Current use of at least one substance of abuse (%) {Rapid Situation Assessment of the Status of Drug and Substance Abuse in Kenya, 2012, p.46} ~",2
Y,Kenya,KEN,Demand Reduction,"Prevalence of drug use by mode of administration (oral, mucosa, inhalation, and injection)",No,n/a,0
Y,Kenya,KEN,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT)",Yes,"Users of various drugs who have ever sought treatment due to drug use (%) {Rapid Situation Assessment of the Status of Drug and Substance Abuse in Kenya, 2012, p.48} ~",1
Y,Kenya,KEN,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT) by age",No,n/a,0
Y,Kenya,KEN,Demand Reduction,Level of access to opioid substitution treatment and medication assisted treatment (OST/MAT),No,n/a,0
Y,Kenya,KEN,Demand Reduction,Level of coverage of inpatient treatment,No,n/a,0
Y,Kenya,KEN,Demand Reduction,Proportion of people who use drugs enrolled in voluntary treatment,No,n/a,0
Y,Kenya,KEN,Demand Reduction,Proportion of people who use drugs enrolled in coerced treatment,No,n/a,0
Y,Kenya,KEN,Demand Reduction,Proportion of people who use drugs enrolled in compulsory treatment,No,n/a,0
Y,Kenya,KEN,Demand Reduction,Presence of prevention programming in law enforcement,No,n/a,0
Y,Kenya,KEN,Demand Reduction,Presence of prevention programming in the media,No,n/a,0
Y,Kenya,KEN,Demand Reduction,Presence of prevention programming in schools,No,n/a,0
Y,Kenya,KEN,Demand Reduction,Presence of prevention programming in the workplace,No,n/a,0
Y,Kenya,KEN,Demand Reduction,Presence of prevention programming for youth and the community,Yes,"Spontaneous recall (%) of drugs by age group (10-14, 15-65) (knowledge of drugs and other substances of abuse: Khat: miraa; Khat: muguka; cocaine, heroin, hashish, bhang) {Rapid Situation Assessment of the Status of Drug and Substance Abuse in Kenya, 2012, p.15, p.25} ~ Total awareness (%) of drugs (narcotics, bhang, khat, inhalants, prescription and synthetic drugs) by age group (10-14, 15-65) by sample characteristics and region (knowledge of drugs and other substances of abuse:Hashish, Bhang, Cocaine, Heroin) {Rapid Situation Assessment of the Status of Drug and Substance Abuse in Kenya, 2012, p.19, p.21, p.23, p.24} ~ ",2
Y,Kenya,KEN,Demand Reduction,Presence of other demand reduction metrics,Yes,"Percentage distribution of respondents by measures taken to end addiction (No action, Keeping oneself busy, Reducing amount taken gradually, Avoiding places where substance is sold, Thinking to stop, Cutting down on amount taken per day, Avoiding peer influence, Seekging divine intervention, Forgetting about it, Not spending money on drugs, Using alternatives when cravings strikes, Medical assistance, Counselling sessions, Others) {Rapid Situation Assessment of the Status of Drug and Substance Abuse in Kenya, 2012, p.53} ~ Reasons for using alcohol & drugs {Rapid Situation Assessment of the Status of Drug and Substance Abuse in Kenya, 2012, p.57} ~",2
Y,Kenya,KEN,Supply Reduction,Size and value of the illegal drug market,Yes,"Access to drugs (Kuber, Khat, narcotics, synthetic and prescription drugs) by region (%) (Very difficult; Fairly difficult; Fairly easy; Very easy; Do not know) {Rapid Situation Assessment of the Status of Drug and Substance Abuse in Kenya, 2012, p.27, p.28} ~ ",1
Y,Kenya,KEN,Supply Reduction,Level of procedures related to crop eradication,No,n/a,0
Y,Kenya,KEN,Supply Reduction,"Number of arrests, seizures, and offences",Yes,"proportion of persons who inject drugs that were arrested or beaten up by police or city “askaris” in the last six months. {Kenya Aids Strategic Framework, 2015-2019, p.30} ~ number of locals and foreigners arrested for being in possession/drug trafficking {Annual Crime Report, 2016, p.10} ~ The number of drug seizures in kilograms and tablets 2015-2016 (Heroin, Cocaine, Methamphetamine, Cannabis Herbal, Psychotropic Substances, Rohypnol) {Annual Crime Report, 2016, p.10} ~ Locations in which drug traffickers were arrested {Annual Crime Report, 2016, p.10} ~",4
Y,Kenya,KEN,Supply Reduction,Level of law enforcement activity and interdiction in the market,Yes,"number and proportion of cases related to dangerous drugs {Annual Crime Report, 2016, p.3 & p.10} ~",1
Y,Kenya,KEN,Supply Reduction,"Price, purity and potency of drugs, and related process indicators",No,n/a,0
Y,Kenya,KEN,Supply Reduction,Number of people engaged with the criminal justice system,No,n/a,0
Y,Kenya,KEN,Supply Reduction,Presence of other supply reduction metrics,No,n/a,0
Y,Kenya,KEN,International Cooperation,Level of engagement in international cooperation,No,n/a,0
Y,Vietnam,VNM,Health,Level of availability of harm reduction services and harm reduction scale up,No,n/a,0
Y,Vietnam,VNM,Health,Presence of needle and syringe programs,Yes,"prevalence of people who inject drugs who were reached by NSPs in Southeast Asia {Sub-Regional Action Plan On Drug Control, 2011-2013, p.6; Mekong MOU on Drug Control Sub-Regional Action Plan On Drug Control Draft Version, 2014-2016, p.10} ~ Number of syringes distributed per person who injects drugs per year by needle and syringe programmes {Vietnam AIDS RESPONSE PROGRESS Report, 2012, p.12 & p.166} ~ The number of free needles and syringes distributed in 2011 {Vietnam AIDS RESPONSE PROGRESS Report, 2012, p.41} ~",3
Y,Vietnam,VNM,Health,Prevalence of substance use disorders,Yes,"number of drug addicts {The National Strategy for Drug Prevention, Combat and Control in Vietnam through 2020 and orientations towards 2030, 2020-2030, p.2} ~ Number of documented drug addicts by cities/provinces {Drug addiction treatment figures, 2009, np} ~ rate of drug re-addiction {The National Strategy for Drug Prevention, Combat and Control in Vietnam through 2020 and orientations towards 2030, 2020-2030, p.4} ~",3
Y,Vietnam,VNM,Health,Prevalence of psychiatric comorbidities,No,n/a,0
Y,Vietnam,VNM,Health,Drug-related mortality,No,n/a,0
Y,Vietnam,VNM,Health,Prevalence of drug-related infectious disease,Yes,"HIV prevalence among people who use drugs {Sub-Regional Action Plan On Drug Control, 2011-2013, p.6} ~ Addicts detoxified at Rehabilitation Centers: The remaining number at the end of the term - HIV-infected - by cities/provinces {Drug addiction treatment figures, 2009, np} ~ Comparison of HIV prevalence among MWID - IBBS 2006 and 2009 {Vietnam AIDS RESPONSE PROGRESS Report, 2012, p.17} ~ HIV prevalence among men who inject drugs 1994-2011 {Vietnam AIDS RESPONSE PROGRESS Report, 2012, p.17} ~ HIV transmission among people who inject drugs (PWID) {Vietnam AIDS RESPONSE PROGRESS Report, 2012, p.38} ~ Percentage of people who inject drugs who are living with HIV {Vietnam AIDS RESPONSE PROGRESS Report, 2012, p.12, p.170; Mekong MOU on Drug Control Sub-Regional Action Plan On Drug Control Draft Version, 2014-2016, p.10} ~ ",6
Y,Vietnam,VNM,Health,Proportion of people who use drugs who engage in risky consumption,Yes,"Proportion of MWID reporting needle and syringe sharing – IBBS 2009 {Vietnam AIDS RESPONSE PROGRESS Report, 2012, p.18} ~",1
Y,Vietnam,VNM,Health,Proportion of people who use drugs who engage in safe consumption practices,Yes,"Percentage of people who inject drugs who reported using sterile injecting equipment the last time they injected {Vietnam AIDS RESPONSE PROGRESS Report, 2012, p.12 & p.168} ~",1
Y,Vietnam,VNM,Health,"Coverage of services for the prevention, testing, and treatment of bloodborne diseases",Yes,"Percentage of people who inject drugs who have received an HIV test in the past 12 months and know their results {Vietnam AIDS RESPONSE PROGRESS Report, 2012, p.12 & p.169} ~ The number of peer educators in 2011 (former and current drug users) participating in the HIV prevention programme {Vietnam AIDS RESPONSE PROGRESS Report, 2012, p.39} ~ The number of district collaborators (mostly health-service staff) participating in the HIV prevention programme {Vietnam AIDS RESPONSE PROGRESS Report, 2012, p.39} ~",3
Y,Vietnam,VNM,Health,Presence of specialised training for addiction care,No,n/a,0
Y,Vietnam,VNM,Health,Presence of health harms related to drug use,No,n/a,0
Y,Vietnam,VNM,Health,Presence of other health metrics,Yes,"Percentage of people who inject drugs reporting the use of a condom at last sexual intercourse {Vietnam AIDS RESPONSE PROGRESS Report, 2012, p.12 & p.167} ~ Proportion of MWID who reported consistent condom use by type of partner in the past 12 months – IBBS 2009 {Vietnam AIDS RESPONSE PROGRESS Report, 2012, p.18} ~",2
Y,Vietnam,VNM,Peace and Security,"Prevalence of alcohol and drugs in accidents, and interventions to increase road safety",No,n/a,0
Y,Vietnam,VNM,Peace and Security,Annual number of public disorder and violent crime reports,Yes,"the percentage of reported drug users involved in crime {Vietnam AIDS RESPONSE PROGRESS Report, 2012, p.41} ~",1
Y,Vietnam,VNM,Peace and Security,Number of non-lethal drug market violent events reported,No,n/a,0
Y,Vietnam,VNM,Peace and Security,Number of drug market related homicides and disappearances,No,n/a,0
Y,Vietnam,VNM,Peace and Security,Presence of other peace and security metrics,No,n/a,0
Y,Vietnam,VNM,Development,Coverage of housing assistance for people who use drugs,No,n/a,0
Y,Vietnam,VNM,Development,Coverage of social assistance for people who use drugs (not including housing),Yes,"number of addicts given educational courses by cities/provinces {Drug addiction treatment figures, 2009, np} ~ Addicts undergoing job training (trained at the rehabilitation services, participated in community-based training, and total), by cities/provinces {Drug addiction treatment figures, 2009, np} ~",2
Y,Vietnam,VNM,Development,Number of households enrolled in alternative development,No,n/a,0
Y,Vietnam,VNM,Development,Presence of other development metrics,No,n/a,0
Y,Vietnam,VNM,Human Rights,"Prevalence and incidence of infectious diseases in vulnerable populations (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Vietnam,VNM,Human Rights,"Prevalence of vulnerable people who use drugs (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Vietnam,VNM,Human Rights,Proportion of people who use drugs in prison that are receiving medication assisted treatment (MAT),No,n/a,0
Y,Vietnam,VNM,Human Rights,Distribution of sterile injecting equipment in prisons,No,n/a,0
Y,Vietnam,VNM,Human Rights,Presence of programs and services targeted towards women ,No,n/a,0
Y,Vietnam,VNM,Human Rights,Presence of programs and services targeted towards people of color,No,n/a,0
Y,Vietnam,VNM,Human Rights,Presence of challenges and/or harms experienced by people of color,No,n/a,0
Y,Vietnam,VNM,Human Rights,"Presence of programs and services targeted towards vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Vietnam,VNM,Human Rights,"Presence of challenges and/or harms experienced by vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Vietnam,VNM,Human Rights,Presence of other human rights metrics,No,n/a,0
Y,Vietnam,VNM,Demand Reduction,Prevalence of drug use by age,No,n/a,0
Y,Vietnam,VNM,Demand Reduction,Prevalence of drug use by sex,No,n/a,0
Y,Vietnam,VNM,Demand Reduction,Prevalence of drug use by type,Yes,"Production and use of amphetamine-type stimulants (ATS) {Mekong MOU on Drug Control Sub-Regional Action Plan On Drug Control Draft Version, 2014-2016, p.7} ~ The prevalence of people nationwide whom inject opiates {Vietnam AIDS RESPONSE PROGRESS Report, 2012, p.38} ~",2
Y,Vietnam,VNM,Demand Reduction,Number of people who use drugs,Yes,"Reduce at least 30%-40% of the current number of drug addicts; strive to keep 70% of communes, wards and residential areas and 90% of State agencies, organizations, army units, businesses, and schools free from drugs menace. {The National Strategy for Drug Prevention, Combat and Control in Vietnam through 2020 and orientations towards 2030, 2020-2030, p.3} ~ FSW who have ever used drugs – IBBS 2009 {Vietnam AIDS RESPONSE PROGRESS Report, 2012, p.24} ~ The number of people nationwide using drugs {Vietnam AIDS RESPONSE PROGRESS Report, 2012, p.38} ~",3
Y,Vietnam,VNM,Demand Reduction,"Prevalence of drug use by mode of administration (oral, mucosa, inhalation, and injection)",Yes,"number of addicts who engage in drug injection {The National Strategy for Drug Prevention, Combat and Control in Vietnam through 2020 and orientations towards 2030, 2020-2030, p.2} ~ The prevalence of people nationwide whom inject opiates {Vietnam AIDS RESPONSE PROGRESS Report, 2012, p.38} ~",1
Y,Vietnam,VNM,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT)",Yes,"% of addicts that are detected and managed {The National Strategy for Drug Prevention, Combat and Control in Vietnam through 2020 and orientations towards 2030, 2020-2030, p.4} ~ % of addicts that are treated, detoxified and provided with vocational training {The National Strategy for Drug Prevention, Combat and Control in Vietnam through 2020 and orientations towards 2030, 2020-2030, p.4} ~ % of addicts in detention, education and rehabilitation centers that are detoxified {The National Strategy for Drug Prevention, Combat and Control in Vietnam through 2020 and orientations towards 2030, 2020-2030, p.4} ~ Total number of drug addicts treated by cities/provinces {Drug addiction treatment figures, 2009, np} ~ Addicts detoxified at Rehabilitation Centers: number at the beginning of the term, new entrants during the term, remaining number at the end of the term, by cities/provinces {Drug addiction treatment figures, 2009, np} ~ Number of individuals who participated in community-based detoxification by cities/provinces {Drug addiction treatment figures, 2009, np} ~ ",6
Y,Vietnam,VNM,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT) by age",No,n/a,0
Y,Vietnam,VNM,Demand Reduction,Level of access to opioid substitution treatment and medication assisted treatment (OST/MAT),Yes,"prevalence of people who inject opiates in Southeast Asia that were reached with OST {Sub-Regional Action Plan On Drug Control, 2011-2013, p.7; Mekong MOU on Drug Control Sub-Regional Action Plan On Drug Control Draft Version, 2014-2016, p.11} ~ The number of provinces the Methadone Maintenance Therapy (MMT) programme has been expanded to {Vietnam AIDS RESPONSE PROGRESS Report, 2012, p.39} ~ The number of people treated who participate in MMT {Vietnam AIDS RESPONSE PROGRESS Report, 2012, p.39} ~ Prevalence of adherence rate for MMT programme {Vietnam AIDS RESPONSE PROGRESS Report, 2012, p.39} ~ The number of MMT programs implemented {Vietnam AIDS RESPONSE PROGRESS Report, 2012, p.41} ~ The number of people receiving services from MMT {Vietnam AIDS RESPONSE PROGRESS Report, 2012, p.41 & p.53} ~ Total number of MMT clinics {Vietnam AIDS RESPONSE PROGRESS Report, 2012, p.54} ~",7
Y,Vietnam,VNM,Demand Reduction,Level of coverage of inpatient treatment,No,n/a,0
Y,Vietnam,VNM,Demand Reduction,Proportion of people who use drugs enrolled in voluntary treatment,Yes,Addicts detoxified at Rehabilitation Centers: New entrants during the term - Voluntary Entrants - by cities/provinces {np} ~,1
Y,Vietnam,VNM,Demand Reduction,Proportion of people who use drugs enrolled in coerced treatment,No,n/a,0
Y,Vietnam,VNM,Demand Reduction,Proportion of people who use drugs enrolled in compulsory treatment,Yes,"number of people who use drugs who are located in Compulsory Centres for Drug Users (CCDU) in Southeast Asia {Sub-Regional Action Plan On Drug Control, 2011-2013, p.7} ~ Addicts detoxified at Rehabilitation Centers: New entrants during the term - Compulsory Entrants - by cities/provinces {Drug addiction treatment figures, 2009, np} ~",2
Y,Vietnam,VNM,Demand Reduction,Presence of prevention programming in law enforcement,No,n/a,0
Y,Vietnam,VNM,Demand Reduction,Presence of prevention programming in the media,No,n/a,0
Y,Vietnam,VNM,Demand Reduction,Presence of prevention programming in schools,No,n/a,0
Y,Vietnam,VNM,Demand Reduction,Presence of prevention programming in the workplace,No,n/a,0
Y,Vietnam,VNM,Demand Reduction,Presence of prevention programming for youth and the community,No,n/a,0
Y,Vietnam,VNM,Demand Reduction,Presence of other demand reduction metrics,Yes,"Prevalence of users who achieved detoxification {The National Strategy for Drug Prevention, Combat and Control in Vietnam through 2020 and orientations towards 2030, 2020-2030, p.2} ~ ",1
Y,Vietnam,VNM,Supply Reduction,Size and value of the illegal drug market,Yes,"Production and use of amphetamine-type stimulants (ATS) {Mekong MOU on Drug Control Sub-Regional Action Plan On Drug Control Draft Version, 2014-2016, p.7} ~ Origin of ATS trafficked in the GMS {Mekong MOU on Drug Control Sub-Regional Action Plan On Drug Control Draft Version, 2014-2016, p.7} ~ Drug trafficking and related forms of criminal activity and the threat to security and the rule of law in the region {Mekong MOU on Drug Control Sub-Regional Action Plan On Drug Control Draft Version, 2014-2016, p.7} ~ Drug trafficking and cross-border security in the region {Mekong MOU on Drug Control Sub-Regional Action Plan On Drug Control Draft Version, 2014-2016, p.8} ~ tracking and tracing transportation routes {Mekong MOU on Drug Control Sub-Regional Action Plan On Drug Control Draft Version, 2014-2016, p.8} ~ illegal trafficking of drugs from foreign countries {The National Strategy for Drug Prevention, Combat and Control in Vietnam through 2020 and orientations towards 2030, 2020-2030, p. 2} ~ ",6
Y,Vietnam,VNM,Supply Reduction,Level of procedures related to crop eradication,Yes,"prevalence of poppy cultivation (%) and in hectares in Southeast Asia {Sub-Regional Action Plan On Drug Control, 2011-2013, p.8} ~",1
Y,Vietnam,VNM,Supply Reduction,"Number of arrests, seizures, and offences",Yes,"prevalence of heroin seizures {Sub-Regional Action Plan On Drug Control, 2011-2013, p.9} ~ Levels of opiate seizures at significant levels in 2011 and 2012 {Mekong MOU on Drug Control Sub-Regional Action Plan On Drug Control Draft Version, 2014-2016, p.8} ~ Raise the rate of drug detection and seizure in the border area to over 30% of the total drugs seized nationwide {The National Strategy for Drug Prevention, Combat and Control in Vietnam through 2020 and orientations towards 2030, 2020-2030, p.4} ~",3
Y,Vietnam,VNM,Supply Reduction,Level of law enforcement activity and interdiction in the market,No,n/a,0
Y,Vietnam,VNM,Supply Reduction,"Price, purity and potency of drugs, and related process indicators",No,n/a,0
Y,Vietnam,VNM,Supply Reduction,Number of people engaged with the criminal justice system,No,n/a,0
Y,Vietnam,VNM,Supply Reduction,Presence of other supply reduction metrics,No,n/a,0
Y,Vietnam,VNM,International Cooperation,Level of engagement in international cooperation,No,n/a,0
Y,Switzerland,CHE,Health,Level of availability of harm reduction services and harm reduction scale up,No,n/a,0
Y,Switzerland,CHE,Health,Presence of needle and syringe programs,Yes,"Number of syringes distributed within the framework of needle and syringe exchange programs in low-threshold facilities, per injecting drug (estimate) {Indicateurs système de monitorage addictions, 2017–2024, p.10} ~ ",1
Y,Switzerland,CHE,Health,Prevalence of substance use disorders,Yes,"Number of dependence syndrome: Alcohol, Derivatives of cannabis, Opiates, Other drugs, Use of multiple substances, All diagnoses combined {Stratégie nationale addictions, 2017–2024, p.35} ~ ",1
Y,Switzerland,CHE,Health,Prevalence of psychiatric comorbidities,Yes,"Number of psychotic disorders: Alcohol, Derivatives of cannabis, Opiates, Other drugs, Use of multiple substances, All diagnoses combined {Stratégie nationale addictions, 2017–2024, p.35} ~ Percentage of persons with risky (consumption) behavior, according to self-assessment, with moderate or severe psychological distress compared to persons with low-risk (consumer) behavior {Indicateurs système de monitorage addictions, 2017–2024, p.12}~ ",2
Y,Switzerland,CHE,Health,Drug-related mortality,Yes,"Number of drug related deaths {Stratégie nationale addictions, 2017–2024, p. 36, p. 79} ~ number of fatal overdoses {Stratégie nationale addictions, 2017–2024, p.36} ~ Suicide related to drugs {Stratégie nationale addictions, 2017–2024, p.36} ~ Number of deaths resulting from poisoning and/or overdose per year {Indicateurs système de monitorage addictions, 2017–2024, p.5 & p.12} ~",4
Y,Switzerland,CHE,Health,Prevalence of drug-related infectious disease,Yes,"Prevalence of HIV, hepatitis C and hepatitis B (a) in people who have injected drugs in their lifetime (b) who have injected drugs during the last 12 months {Indicateurs système de monitorage addictions, 2017–2024, p.18}~",1
Y,Switzerland,CHE,Health,Proportion of people who use drugs who engage in risky consumption,Yes,"Percentage of persons with risky (consumption) behavior, which according to self-assessment with moderate or severe psychological distress compared to persons with low-risk (consumer) behavior {Indicateurs système de monitorage addictions, 2017–2024, p.12}~ Percentage of subjects with risky (consumption) behavior and with NCD-related disease compared to persons with low risk (consumer) behavior {Indicateurs système de monitorage addictions, 2017–2024, p.12}~",2
Y,Switzerland,CHE,Health,Proportion of people who use drugs who engage in safe consumption practices,No,n/a,0
Y,Switzerland,CHE,Health,"Coverage of services for the prevention, testing, and treatment of bloodborne diseases",No,n/a,0
Y,Switzerland,CHE,Health,Presence of specialised training for addiction care,No,n/a,0
Y,Switzerland,CHE,Health,Presence of health harms related to drug use,Yes,"Percentage of subjects with risky (consumption) behavior and with NCD-related disease compared to persons with low risk (consumer) behavior {Indicateurs système de monitorage addictions, 2017–2024, p.12} ~ Number of intoxications: Alcohol, Derivatives of cannabis, Opiates, Other drugs, Use of multiple substances, All diagnoses combined {Stratégie nationale addictions, 2017–2024, p.35}~ Number of harmful uses for health: Alcohol, Derivatives of cannabis, Opiates, Other drugs, Use of multiple substances, All diagnoses combined {Stratégie nationale addictions, 2017–2024, p.35}~ Number of weaning syndrome: Alcohol, Derivatives of cannabis, Opiates, Other drugs, Use of multiple substances, All diagnoses combined {Stratégie nationale addictions, 2017–2024, p.35} ~",4
Y,Switzerland,CHE,Health,Presence of other health metrics,No,n/a,0
Y,Switzerland,CHE,Peace and Security,"Prevalence of alcohol and drugs in accidents, and interventions to increase road safety",Yes,"Proportion of driving license suspensions for driving under the influence of alcohol, drugs and drugs, (a) per 100'000 inhabitants, (b) as a percentage of driving license suspensions, (c)% of controls carried out, by substance {Indicateurs système de monitorage addictions, 2017–2024, p.12}~ Number of accidents, number of serious injuries, and number of deaths due to driving under the influence of a substance (a) per 1,000 inhabitants, (B) per 1,000 persons with risk behaviors, after using a substance (alcohol, drugs, medication) {Indicateurs système de monitorage addictions, 2017–2024, p.13}~ Number of injuries, number of injured persons,and number of traffic loads due to driving under the influence of substances (a) per 1000 inhabitants, (b) per 1000 persons with risk-taking behaviour, by substance type (alcohol, drugs) { Indicateurs système de monitorage addictions, 2017–2024, p.13}~",3
Y,Switzerland,CHE,Peace and Security,Annual number of public disorder and violent crime reports,Yes,"drug related deaths due to accidents or violence {Stratégie nationale addictions, 2017–2024, p.36}~ Number of incidents of domestic violence per 100,000 related to substance use {Indicateurs système de monitorage addictions, 2017–2024, p.12}~ Number of incidents of domestic violence per 100,000 inhabitants and proportion of incidents with substance inflow {Indicateurs système de monitorage addictions, 2017–2024, p.12}~",3
Y,Switzerland,CHE,Peace and Security,Number of non-lethal drug market violent events reported,No,n/a,0
Y,Switzerland,CHE,Peace and Security,Number of drug market related homicides and disappearances,No,n/a,0
Y,Switzerland,CHE,Peace and Security,Presence of other peace and security metrics,No,n/a,0
Y,Switzerland,CHE,Development,Coverage of housing assistance for people who use drugs,Yes,"percentage of those with a stable lodgement situation: Alcohol, Opiates, Cocaine, Cannabis {Stratégie nationale addictions, 2017–2024, p.39}~ Percentage of people in addiction treatment with stable housing {Indicateurs système de monitorage addictions, 2017–2024, p.12}~ Rate of employment and the proportion of persons who engage in risky behaviours (SGB), and persons in addiction treatment (Act-info) with a stable residential situation compared to reference population. (A) Acquisition rate of persons with risky (consumer) behavior compared to persons with low-risk (consumer) behavior (SGB) (B) Acquisition rate of persons in addiction treatment, according to main problem (act-info) (C) proportion of persons in addiction treatment with a stable living situation, according to main problem (actinfo) {Indicateurs système de monitorage addictions, 2017–2024, p.12}~",3
Y,Switzerland,CHE,Development,Coverage of social assistance for people who use drugs (not including housing),Yes,"proportions of social assistance recipients {Stratégie nationale addictions, 2017–2024, p.38} ~ percentage of those receiving income; receiving annuity or private income; receiving social assistance from activities; or in the course of training: Alcohol, Opiates, Cocaine, Cannabis {Stratégie nationale addictions, 2017–2024, p.39}~ ",2
Y,Switzerland,CHE,Development,Number of households enrolled in alternative development,No,n/a,0
Y,Switzerland,CHE,Development,Presence of other development metrics,Yes,"percentage of those absent from the labor market, for reasons related to drugs: Alcohol, Opiates, Cocaine, Cannabis {Stratégie nationale addictions, 2017–2024, p.39}~ Proportion of opiate users without employment {Stratégie nationale addictions, 2017–2024, p.38}~ Employment rate and proportion of individuals who are considered to be at risk with stable housing compared to the general population {Indicateurs système de monitorage addictions, 2017–2024, p.12}~ rate of employment for persons at risk compared to persons with low-risk {Indicateurs système de monitorage addictions, 2017–2024, p.12}~",4
Y,Switzerland,CHE,Human Rights,"Prevalence and incidence of infectious diseases in vulnerable populations (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Switzerland,CHE,Human Rights,"Prevalence of vulnerable people who use drugs (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Switzerland,CHE,Human Rights,Proportion of people who use drugs in prison that are receiving medication assisted treatment (MAT),Yes,"proportion of prisons that provide access to (a) Substitution treatments, (b) needle exchange programs and (c) condoms {Indicateurs système de monitorage addictions, 2017–2024, p.10}~",1
Y,Switzerland,CHE,Human Rights,Distribution of sterile injecting equipment in prisons,Yes,"proportion of prisons that provide access to (a) Substitution treatments, (b) needle exchange programs and (c) condoms {Indicateurs système de monitorage addictions, 2017–2024, p.10}~",1
Y,Switzerland,CHE,Human Rights,Presence of programs and services targeted towards women ,No,n/a,0
Y,Switzerland,CHE,Human Rights,Presence of programs and services targeted towards people of color,No,n/a,0
Y,Switzerland,CHE,Human Rights,Presence of challenges and/or harms experienced by people of color,No,n/a,0
Y,Switzerland,CHE,Human Rights,"Presence of programs and services targeted towards vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Switzerland,CHE,Human Rights,"Presence of challenges and/or harms experienced by vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"Number and proportion of children living in a household with persons: (a) alcohol-dependent, (b) nicotine addictive or (c) drug-dependent {Indicateurs système de monitorage addictions, 2017–2024, p.12}~",1
Y,Switzerland,CHE,Human Rights,Presence of other human rights metrics,No,n/a,0
Y,Switzerland,CHE,Demand Reduction,Prevalence of drug use by age,Yes,"Percentage of persons between 15 and 64 years of age who have (a) consumed illegal substances (excluding cannabis) during their last 30 days, (b) in the last 12 months, (c) have already used illegal substances in their lives {Indicateurs système de monitorage addictions, 2017–2024, p.4, p.8} ~ Percentage of persons between 15 and 64 years, who (a) currently consume cannabis (B) have consumed cannabis in the last 12 months, (C) have ever used cannabis in their lives {Indicateurs système de monitorage addictions, 2017–2024, p.4, p.8} ~ Percentage of persons aged 15 years and older with risk behavior in relation to 1, 2, 3 and more substances / behaviors (tobacco, alcohol, cannabis, money play) {Indicateurs système de monitorage addictions, 2017–2024, p.9} ~ Percentage of 14-15-year-olds with risk-related effects on 1, 2, 3 and more substances (alcohol, tobacco, cannabis, other psychoactive substances) {Indicateurs système de monitorage addictions, 2017–2024, p.9} ~ Percentage of persons aged 15 years and above with good or very good subjective health and risk (consumer behavior) compared to the proportion of persons aged 15 years or over with good or very good subjective health, but without risky (consumer) behavior {Indicateurs système de monitorage addictions, 2017–2024, p.11} ~ Percentage of people aged 15 years with high-risk substance use / behavior, differentiated on the substance or behavior: Cannabis, Use of Illicit Substances, Chronic Drug Use {Indicateurs système de monitorage addictions, 2017–2024, p.7}~ Percentage of persons aged 15 years or over who have used painkillers or (soaps - sleeping pills maybe?) / tranquilizers during the last 12 months for at least 3 months, by type of preparation and by reference source {Indicateurs système de monitorage addictions, 2017–2024, p.5, p.8}~ Proportion of 14-15 year olds who (a) currently use cannabis or (b) have already used cannabis in their lives {Indicateurs système de monitorage addictions, 2017–2024, p.8} ~ Percentage of people aged 15 years or over who have used medicines for at least 3 months (almost) daily in the last 12 months without medical prescription to increase attention, performance or wakefulness {Indicateurs système de monitorage addictions, 2017–2024,p.8} ~ ",9
Y,Switzerland,CHE,Demand Reduction,Prevalence of drug use by sex,Yes,"proportion of women and men (gender sensitive indicator) who use medications: Painkillers, sleeping pills or tranquilizers {Indicateurs système de monitorage addictions, 2017–2024,p.35}~",1
Y,Switzerland,CHE,Demand Reduction,Prevalence of drug use by type,Yes,"Drug consumption/prevalence of illegal drug use: cannabis, heroin and cocaine, LSD, speed and other amphetamines, ecstasy and ketamine {Stratégie nationale addictions, 2017–2024, p.33}~ Percentage of persons between 15 and 64 years, who (a) currently consume cannabis (B) have consumed cannabis in the last 12 months, (C) have ever used cannabis in their lives {Indicateurs système de monitorage addictions, 2017–2024, p.4, p.8} ~ Percentage of persons aged 15 years or over who have used painkillers or (soaps - sleeping pills maybe?) / tranquilizers during the last 12 months for at least 3 months, by type of preparation and by reference source {Indicateurs système de monitorage addictions, 2017–2024, p.5, p.8}~ Proportion of 14-15 year olds who (a) currently use cannabis or (b) have already used cannabis in their lives {Indicateurs système de monitorage addictions, 2017–2024, p.8} ~ Percentage of people aged 15 years or over who have used medicines for at least 3 months (almost) daily in the last 12 months without medical prescription to increase attention, performance or wakefulness {Indicateurs système de monitorage addictions, 2017–2024,p.8} ~ proportion of women and men (gender sensitive indicator) who use medications: Painkillers, sleeping pills or tranquilizers {Indicateurs système de monitorage addictions, 2017–2024,p.35} ~ Percentage of persons aged 15 years and older with risk behavior in relation to 1, 2, 3 and more substances / behaviors (tobacco, alcohol, cannabis, money play) {Indicateurs système de monitorage addictions, 2017–2024, p.9} ~ Percentage of 14-15-year-olds with risk-related effects on 1, 2, 3 and more substances (alcohol, tobacco, cannabis, other psychoactive substances) {Indicateurs système de monitorage addictions, 2017–2024, p.9} ~",8
Y,Switzerland,CHE,Demand Reduction,Number of people who use drugs,No,n/a,0
Y,Switzerland,CHE,Demand Reduction,"Prevalence of drug use by mode of administration (oral, mucosa, inhalation, and injection)",Yes,"Percentage of people in drug addiction who have injected illegal substances over the past 12 months, according to main problem substance {Indicateurs système de monitorage addictions, 2017–2024, p.8}~  ",1
Y,Switzerland,CHE,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT)",Yes,"number of people entering treatment {Stratégie nationale addictions, 2017–2024, p. 79}~ Number of entries into outpatient addiction treatment, by main problem and type of institution (medico-psychiatric vs. psychosocial), per 1,000 inhabitants {Indicateurs système de monitorage addictions, 2017–2024, p.5}~ Number of treatment cases (entries) due to a substance-related disturbance in somatic or psychiatric hospitals, by substance, per 1000 inhabitants {Indicateurs système de monitorage addictions, 2017–2024, p.5, p. 11}~ Number of clients in outpatient treatment and number of clients in inpatient treatment and addiction treatment in inpatient psychosocial institutions, differentiated by substance/main problem {Indicateurs système de monitorage addictions, 2017–2024, p.10}~ Number of outpatient counseling/treatment institutions per 100,000 inhabitants {p.10, p. 11}~ Number of clients in outpatient addiction treatment per 1'000 persons with risky substance consumption, differentiated according to substances/main problem {Indicateurs système de monitorage addictions, 2017–2024, p.11}~ Number of admissions to outpatient addiction treatment, main problem and institution type (medico-psychiatric vs. psychosocial), per 1,000 inhabitants {Indicateurs système de monitorage addictions, 2017–2024, p.11}~ ",7
Y,Switzerland,CHE,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT) by age",No,n/a,0
Y,Switzerland,CHE,Demand Reduction,Level of access to opioid substitution treatment and medication assisted treatment (OST/MAT),Yes,"Number of persons in a methadone- or heroin-assisted substitution treatment, per calendar year, by type of substitute preparation and place of delivery {Indicateurs système de monitorage addictions, 2017–2024, p.11} ~ ",1
Y,Switzerland,CHE,Demand Reduction,Level of coverage of inpatient treatment,Yes,"Number of admissions to inpatient addiction treatment in psychosocial institutions, according to the main problem, per year, per 100'000 inhabitants {Indicateurs système de monitorage addictions, 2017–2024, p.5, p.11} ~ Number of clients in outpatient treatment and number of clients in inpatient treatment and addiction treatment in inpatient psychosocial institutions, differentiated by substance /main problem {Indicateurs système de monitorage addictions, 2017–2024, p.10} ~  Number of inpatient stays with a main diagnosis or a secondary diagnoses, per 1000 inhabitants {Indicateurs système de monitorage addictions, 2017–2024, p.13} ~",3
Y,Switzerland,CHE,Demand Reduction,Proportion of people who use drugs enrolled in voluntary treatment,No,n/a,0
Y,Switzerland,CHE,Demand Reduction,Proportion of people who use drugs enrolled in coerced treatment,No,n/a,0
Y,Switzerland,CHE,Demand Reduction,Proportion of people who use drugs enrolled in compulsory treatment,No,n/a,0
Y,Switzerland,CHE,Demand Reduction,Presence of prevention programming in law enforcement,No,n/a,0
Y,Switzerland,CHE,Demand Reduction,Presence of prevention programming in the media,No,n/a,0
Y,Switzerland,CHE,Demand Reduction,Presence of prevention programming in schools,No,n/a,0
Y,Switzerland,CHE,Demand Reduction,Presence of prevention programming in the workplace,No,n/a,0
Y,Switzerland,CHE,Demand Reduction,Presence of prevention programming for youth and the community,Yes,"Percentage of persons aged 15 or over who agree to certain preventive measures {Indicateurs système de monitorage addictions, 2017–2024, p.9}~ ",1
Y,Switzerland,CHE,Demand Reduction,Presence of other demand reduction metrics,Yes,"Proportion of population who have used medications to improve mood {Stratégie nationale addictions, 2017–2024, p.34}~  Calculation / estimation of the direct, indirect and intangible costs of the Alcohol, tobacco and drug use in Switzerland, (a) absolute, (b) per inhabitant (C) as a percentage of GDP {Indicateurs système de monitorage addictions, 2017–2024, p.5, p.13}~ Cost of treating addictions and secondary diseases due to drug use {Indicateurs système de monitorage addictions, 2017–2024, p.13}~ Costs of treatment for people with diseases and follow-up disorders in inpatient facilities {Indicateurs système de monitorage addictions, 2017–2024, p.13}~ Costs of treatment for people with a disease and of secondary diseases in inpatient facilities, (A) absolute, (b) per 1,000 inhabitants, (C) as a percentage of the total cost of stationary treatments {Indicateurs système de monitorage addictions, 2017–2024, p.13} ~ Economic costs of addiction behavior, differentiated by main problem / substance {Indicateurs système de monitorage addictions, 2017–2024, p.13}~",5
Y,Switzerland,CHE,Supply Reduction,Size and value of the illegal drug market,No,n/a,0
Y,Switzerland,CHE,Supply Reduction,Level of procedures related to crop eradication,No,n/a,0
Y,Switzerland,CHE,Supply Reduction,"Number of arrests, seizures, and offences",Yes,"Number of crime reports due to offense against the Narcotics Act  (BetmG) for possession, cultivation and consumption, per 1000 Inhabitants, by substance {Indicateurs système de monitorage addictions, 2017–2024, p.12}~ Number of crime reports due to offense against the Narcotics Act concerning production and trade, (a) per 1000 inhabitants / (b) per 1000 persons with risky behavior, by substance {Indicateurs système de monitorage addictions, 2017–2024, p.13}~",2
Y,Switzerland,CHE,Supply Reduction,Level of law enforcement activity and interdiction in the market,No,n/a,0
Y,Switzerland,CHE,Supply Reduction,"Price, purity and potency of drugs, and related process indicators",No,n/a,0
Y,Switzerland,CHE,Supply Reduction,Number of people engaged with the criminal justice system,No,n/a,0
Y,Switzerland,CHE,Supply Reduction,Presence of other supply reduction metrics,No,n/a,0
Y,Switzerland,CHE,International Cooperation,Level of engagement in international cooperation,No,n/a,0
Y,Spain,ESP,Health,Level of availability of harm reduction services and harm reduction scale up,Yes,"Number of facilities for supervised drug consumption available in the autonomous communities of Catalonia and the Basque Country {Spain Drug Report 2018, p. 14} ~ Harm reduction programs in the CCAA: No. of CCAA that have Overdose Prevention, Syringe Exchange, HM in marginal contexts, HIV and HCV, Prevention in HM leisure contexts, Health Education, or HM in prisons {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 64, p.65; Spain Drug Report 2018, p. 14} ~ Territorial coverage of harm reduction programs {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 64} ~ No. of Harm Reduction resources (Social Emergency Centers, HM Mobile Units, Supervised Consumption Devices, Other Resources of HM, Assistance Network Center) {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 65} ~ Population served: No. Injecting Drug Users in the last year. Average value among the population aged 15-64 years {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 66} ~ Evaluation and quality in harm reduction in the CCAA {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 66} ~ Number of overdose prevention activities provided in the autonomous communities and cities {Spain Drug Report 2018, p. 14} ~ Coordination Profiles CCAA - Public bodies and civil societies in the areas of harm reduction {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 19, p.20} ~ ",8
Y,Spain,ESP,Health,Presence of needle and syringe programs,Yes,"Number of syringes dispensed in harm reduction programs according to type of program {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 66; Spain Drug Report 2018, p.14, p. 22} ~",1
Y,Spain,ESP,Health,Prevalence of substance use disorders,Yes,"Prevalence of people who engage in problematic use of drugs (cannabis, cocaine) by age (15-64) in the last 30 days {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p. 75, p.111; Informe 2017 Alcohol, tabaco y drogas ilegales en España - Consumo Problemático de Drogas, p. 16, p.17; Encuesta sobre Uso de Drogas en Enseñanzas Secundarias en España, p. 70, p.82} ~ Prevalence of people who engage in problematic use of drugs by type of drug and by age (15-64) in the last 12 months {Estrategia Nacional sobre Adicciones 2017-2019, p. 10, p.12, p.80; Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 47} ~ Prevalence of problematic use of drugs (cannabis, heroin, hypnosedatives) by age and sex (15-64) {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p. 78; Encuesta sobre Uso de Drogas en Enseñanzas Secundarias en España, p. 68; Informe 2017 Alcohol, tabaco y drogas ilegales en España - Consumo Problemático de Drogas, p.06, p. 20, p.23} ~ Categorization of Secondary Education students of 14-18 years who have used cannabis in the last 12 months according to their classification in the CAST scale, by sex and age (%). Spain, 2016 {Encuesta sobre Uso de Drogas en Enseñanzas Secundarias en España, p. 69} ~ Percentage of adolescents with problematic use (Drunkenness, Binge Drinking, Cannabis) {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 47; Informe 2017 Alcohol, tabaco y drogas ilegales en España - Consumo Problemático de Drogas, p. 11} ~ Estimation of the percentage of problem consumers in relation to the number of occasional consumers last year {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 47} ~",6
Y,Spain,ESP,Health,Prevalence of psychiatric comorbidities,No,n/a,0
Y,Spain,ESP,Health,Drug-related mortality,Yes,"Number and percentage of people who died of overdose in Spain in 2015, by type of drug (psychoactive substances, only opioids, opioids and non-cocaine, opioids and cocaine) {Estrategia Nacional sobre Adicciones 2017-2019, p. 15; Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p. 180, p.182, p.183; Spain Drug Report 2018, p. 11; Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 51} ~ Number of deaths from psychoactive substances use according to different sources of information. Spain, 1983-2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p. 180} ~ Characteristics of the deceased by overdoses after the consumption of psychoactive substances. Spain, 2003-2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p. 181} ~ Evolution of the percentage of deaths by type of drug (methadone, methadone only, and methadone and no other opioid - although there are other substances, cocaine, cocaine and non-opioids, cocaine and alcohol opioids,). Spain, 2005-2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p. 183, p.184, p.185, p.186} ~ Evolution of the number of deaths by consumption of psychoactive substances, by sex. Spain, 1999-2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p. 187; Spain Drug Report 2018, p. 11} ~ Evolution of the number of deaths due to the use of psychoactive substances, according to age (18-30, 15-64). Spain, 1999-2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p. 187; Spain Drug Report 2018, p. 11, p.22} ~ Number of deaths related to drugs according to cause (overdoses, traffic accidents (alcohol), traffic accidents (drugs except alcohol), violent death and occupational accident) {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 50} ~",7
Y,Spain,ESP,Health,Prevalence of drug-related infectious disease,Yes,"Percentage of new HIV/AIDS diagnoses according to category of transmission (PID (People who inject drugs), MSM (Men who have sex with men), Hetero (heterosexual Relations of risk)). Spain, 2009-2015 {Informe 2017 Alcohol, tabaco y drogas ilegales en España - Infecciones en Consumidores, p. 05, p.06} ~ Prevalence of HIV infection among those admitted to treatment for abuse or dependence on psychoactive substances (total, admitted with previous treatment, admitted without prior treatment) (%). Spain, 2005-2015 {Informe 2017 Alcohol, tabaco y drogas ilegales en España - Infecciones en Consumidores, p. 07} ~ Newly diagnosed HIV cases attributed to injecting drug use (Cases per million population) {Spain Drug Report 2018, p. 10, p.22; Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 66} ~ Percentage of HIV prevalence among people who inject drugs (country data and EU range) {Spain Drug Report 2018, p. 22} ~ Percentage of HCV prevalence among people who inject drugs (country data and EU range) {Spain Drug Report 2018, p. 22} ~ Prevalence of HIV and HCV antibodies among people who inject drugs in Spain (%) {Spain Drug Report 2018, p. 09} ~ ",6
Y,Spain,ESP,Health,Proportion of people who use drugs who engage in risky consumption,No,n/a,0
Y,Spain,ESP,Health,Proportion of people who use drugs who engage in safe consumption practices,No,n/a,0
Y,Spain,ESP,Health,"Coverage of services for the prevention, testing, and treatment of bloodborne diseases",Yes,"Prevalence (%) of HIV infection among those admitted to treatment for psychoactive drugs abuse or dependence that have used the injection route in the last year and that knew its serological status, according to sex. Spain, 1996-2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p. 157; Informe 2017 Alcohol, tabaco y drogas ilegales en España - Infecciones en Consumidores, p. 10} ~ Prevalence (%) of HIV infection among those admitted to treatment for psychoactive drugs abuse or dependence that have used the injection route in the last year and that knew its serological status, according to age. Spain, 1996-2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p. 158; Informe 2017 Alcohol, tabaco y drogas ilegales en España - Infecciones en Consumidores, p. 09, p.10, p.11} ~ Prevalence and knowledge of HIV status/serological status, hepatitis B (HBV) and hepatitis C (HCV) among injectors (once in life and last year) admitted to treatment for abuse or dependence on psychoactive drugs (absolute numbers and%). Spain, 2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p. 174, p.175; Informe 2017 Alcohol, tabaco y drogas ilegales en España - Infecciones en Consumidores, p. 12; Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 52; Spain Drug Report 2018, p. 09} ~ Percentage of injection and serological status for HIV, HBV and HCV for the total of those admitted to treatment, depending on the previous treatment and whether or not they were an injector (absolute numbers and %). Spain, 2015 {Informe 2017 Alcohol, tabaco y drogas ilegales en España - Infecciones en Consumidores, p. 07} ~ Percentage of injection and serological status for HIV, HBV and HCV depending on the substance that generates the admission to treatment (absolute numbers and%). Spain, 2015 {Informe 2017 Alcohol, tabaco y drogas ilegales en España - Infecciones en Consumidores, p. 08} ~ ",5
Y,Spain,ESP,Health,Presence of specialised training for addiction care,Yes,"Number of CCAA who carry out training activities, according to the type of professional groups to which the training is directed {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 101} ~ Number of Professionals trained by the PAD {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 102} ~ No. of CCAA that have Master and Postgraduate Courses {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 102} ~ ",3
Y,Spain,ESP,Health,Presence of health harms related to drug use,No,n/a,0
Y,Spain,ESP,Health,Presence of other health metrics,Yes,"Perception of the health status of the population aged 15-64 according to sex and age (percentages). Spain, 2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p. 133, p.134} ~ Perception of health status among the population aged 15-64, according to psychoactive substances consumption in the last 30 days or not (row percentages). Spain, 2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p. 135} ~ ",2
Y,Spain,ESP,Peace and Security,"Prevalence of alcohol and drugs in accidents, and interventions to increase road safety",Yes,"percentage of deceased drivers and pedestrians, due to traffic accidents, who presented some psychoactive substance in their blood {Estrategia Nacional sobre Adicciones 2017-2019, p. 15} ~ percentage of population who drives private cars that has consumed some illegal drug and/or alcohol, before driving {Estrategia Nacional sobre Adicciones 2017-2019, p. 10} ~ Infractions against road safety due to drug use (Infractions against road safety (alcohol), Infractions against road safety (drugs except alcohol)) {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 53} ~ most consumed drugs among drivers {Estrategia Nacional sobre Adicciones 2017-2019, p. 10} ~  Driving a motor vehicle under the effects of psychoactive substances and traveling as a passenger of a motor vehicle driven by someone under the effects of psychoactive substances in the last 12 months among Secondary Education students of 14-18 years, according to age and sex (%) Spain, 2016 {Encuesta sobre Uso de Drogas en Enseñanzas Secundarias en España, p. 142} ~ ",5
Y,Spain,ESP,Peace and Security,Annual number of public disorder and violent crime reports,Yes,"Drug-related offenses (Crimes against road safety (alcohol), Crimes against road safety (other drugs), Cases of suspected chemical submission of a sexual nature or for other crimes) {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 53} ~",1
Y,Spain,ESP,Peace and Security,Number of non-lethal drug market violent events reported,No,n/a,0
Y,Spain,ESP,Peace and Security,Number of drug market related homicides and disappearances,No,n/a,0
Y,Spain,ESP,Peace and Security,Presence of other peace and security metrics,Yes,"Undesirable situations (fighting or aggression, sexual relations and repentance, sexual relations without condoms, not remembering, having a hangover, family discussion, suffering, bullying) that students of Secondary Education of 14-18 years have experienced in the last 12 months, according with the consumption or not of different psychoactive substances. Spain, 2016 {Encuesta sobre Uso de Drogas en Enseñanzas Secundarias en España, p. 143} ~",1
Y,Spain,ESP,Development,Coverage of housing assistance for people who use drugs,Yes,"Percentage of cases of people who are in treatment that reside in precarious or unstable accommodation {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 73} ~",1
Y,Spain,ESP,Development,Coverage of social assistance for people who use drugs (not including housing),Yes,"Typology, coverage and distribution of welfare programs in the CCAA {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p.56, p. 57} ~ Profiles of welfare programs in the CCAA according to region {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 58} ~ Typology and Coverage of programs of Social Incorporation in the CCAA (social relation and leisure, formation, residential support and labor incorporation) {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 70} ~ Profile of the programs of Social Incorporation in the CCAA (according to the region) {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 71} ~  No. of cases in Incorporation programs {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 72} ~ Percentage of cases in Social Incorporation related to Admissions to Treatment {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 72} ~ Average degree of coverage, accreditation and coordination of Social Incorporation Programs {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 73} ~ Quality of care of welfare programs in the CCAA (degree of accreditation of programs and number of PADs that have catalogs or portfolios of services) {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p.62, p. 63} ~ Care assessment in the CCAA (No. of PADs that have carried out studies and reports of satisfaction of the users of the welfare network or of evaluation of care programs and services and No. of PAD that perform Needs, Results or Processes Evaluation) {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 63} ~ Quality of Social Incorporation programs in the CCAA {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 74} ~ Evaluation in Social Incorporation programs in the CCAA {p. 74} ~ Nº of CCAA that promote social participation {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 113} ~ ",12
Y,Spain,ESP,Development,Number of households enrolled in alternative development,No,n/a,0
Y,Spain,ESP,Development,Presence of other development metrics,Yes,"estimated drug-related public expenditure in percentage of gross domestic product {Spain Drug Report, 2018, p. 03} ~ Percentage of cases with employment between admissions to treatment {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 73} ~ ",2
Y,Spain,ESP,Human Rights,"Prevalence and incidence of infectious diseases in vulnerable populations (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"Prevalence, in the total prison population, of HIV, HBV and HCV infection {Spanish survey on health and drug use among prisoners, p. 10} ~ Prevalence, in the total prison population who have ever injected, of HIV, HBV and HCV infection {Spanish survey on health and drug use among prisoners, p. 10; Spain Drug Report 2018, p. 18} ~ Percentage of people with health problems related to drugs in prisons and population in treatment (HIV positive in admitted to treatment, HIV positive in inmate population, HCV positive in admitted to treatment, positive HCV in prison population) {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 52} ~ ",3
Y,Spain,ESP,Human Rights,"Prevalence of vulnerable people who use drugs (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"Percentage of inmates that have used some illegal drug (cannabis, opiates, methadone without prescription, cocaine, amphetamines, ecstasy, hallucinogens, inhalants) in prison in the last 30 days {Spanish survey on health and drug use among prisoners, p. 09, p.13, p.14, p.15; Spain Drug Report 2018, p. 18} ~ Age of onset drug use in prison population, per type of drug {Spanish survey on health and drug use among prisoners, p. 11} ~ Percentage of use of illegal drugs in the prison population, at some point in life, in the last 12 months in freedom, in the last month in freedom, in the last month in prison {Spanish survey on health and drug use among prisoners, p.11, p. 12} ~ Percentage of those who initiate drug use in freedom or in prison, among those who have ever used each substance {Spanish survey on health and drug use among prisoners, p. 13} ~ Percentage and characteristics drug users in prison (last 30 days), by sex and age and drug type (cannabis, cocaine powder, heroin, amphetamines, ecstasy, hallucinogens, inhalants) {Spanish survey on health and drug use among prisoners, p.16, p. 18} ~ Percentage of inmates who declare having injected drugs (freedom and in prison), in lifetime and last month {Spanish survey on health and drug use among prisoners, p. 20} ~ Prevalence of drug use in prison population, by time reference and place of use {Spanish survey on health and drug use among prisoners, p. 26} ~ Prevalence of drug use in prison (last 30 days) by age, sex, nationality and procedural situation {Spanish survey on health and drug use among prisoners, p. 27} ~ Evolution of drug use in prison population. Spain 2006, 2011 and 2016 {Spanish survey on health and drug use among prisoners, p. 28} ~ Frequency of drug use in the prison population in freedom and in prison. Spain 2016 {Spanish survey on health and drug use among prisoners, p.14, p. 29} ~ Main route of drug administration in the prison population being in freedom and in prison, and route of administration by drug (cocaine, heroin). Spain 2016 {Spanish survey on health and drug use among prisoners, p.20, p. 30} ~",11
Y,Spain,ESP,Human Rights,Proportion of people who use drugs in prison that are receiving medication assisted treatment (MAT),Yes,"Number of prisons where opioid substitution treatment (OST) is available {Spain Drug Report 2018, p. 16} ~ Number of inmates that  received Methadone Maintenance Treatment (MMT) in 2016 {Spain Drug Report 2018, p. 18} ~",2
Y,Spain,ESP,Human Rights,Distribution of sterile injecting equipment in prisons,Yes,"Number of prisons were needle and syringe exchange programme are available  {Spain Drug Report, 2018, p. 18} ~ Number of syringes distributed in 20 prisons {Spain Drug Report, 2018,p. 18} ~",2
Y,Spain,ESP,Human Rights,Presence of programs and services targeted towards women ,No,n/a,0
Y,Spain,ESP,Human Rights,Presence of programs and services targeted towards people of color,No,n/a,0
Y,Spain,ESP,Human Rights,Presence of challenges and/or harms experienced by people of color,No,n/a,0
Y,Spain,ESP,Human Rights,"Presence of programs and services targeted towards vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"Extension of measures to improve the accessibility of programs and services in the CCAA {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 113} ~ Number of CCAA with measures to counteract the access difficulties of certain groups, such as people with disabilities, minors, those over 65, people who practice prostitution and other marginal or more vulnerable groups {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 114} ~ Percentage of inmates that have been tested for HIV, HBV and HCV detection {Spanish survey on health and drug use among prisoners, p. 10} ~ Percentage of inmates who have ever injected that have been tested for HIV, HBV and HCV detection {Spanish survey on health and drug use among prisoners, p. 10} ~ Percentage of inmates that are currently in treatment with psychiatric medication or a attending a mental health programme in prison {Spanish survey on health and drug use among prisoners, p. 09} ~ % of inmates that have received treatment at some point in life while in freedom to control/stop drug use {Spanish survey on health and drug use among prisoners, p. 23} ~ % of inmates in drug treatment while in freedom, that continued their treatment after entering prison {Spanish survey on health and drug use among prisoners, p. 23} ~ % of inmates in drug treatment while in freedom, that did not continued their treatment after entering prison, according to the reason (was not offered to continue, did not want to continue and other reasons) {Spanish survey on health and drug use among prisoners, p. 23} ~ % of inmates that have received treatment at some point in life while in prison to control/stop drug use {Spanish survey on health and drug use among prisoners, p. 23} ~ Characteristics of current treatments to control/stop drug use in prison (accordingly to the type of drug, type of treatment, type of personnel, assessment of care, and reasons to end treatment) {Spanish survey on health and drug use among prisoners, p. 23} ~ Percentage of inmates that have used some illegal drug in prison in the last 30 days and who are currently in treatment with psychiatric medication {Spanish survey on health and drug use among prisoners, p. 09} ~ ",11
Y,Spain,ESP,Human Rights,"Presence of challenges and/or harms experienced by vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"Percentage of inmates that have been diagnosed with a mental disorder at some point in their life {Spanish survey on health and drug use among prisoners, p. 09} ~ Percentage of inmates that have tried to take their life at some point {Spanish survey on health and drug use among prisoners, p. 09} ~ Non-fatal overdoses in prison population (freedom and in prison) in lifetime and in the last 3 years or less {Spanish survey on health and drug use among prisoners, p. 19} ~ Non-fatal overdoses in prison population, accordingly to how long ago it happened {Spanish survey on health and drug use among prisoners, p. 19} ~ Non-fatal overdoses in prison population, accordingly to where it happened {Spanish survey on health and drug use among prisoners, p. 19} ~ Drugs attributed to non-fatal overdoses by inmates (freedom and in prison) {Spanish survey on health and drug use among prisoners, p. 19} ~",6
Y,Spain,ESP,Human Rights,Presence of other human rights metrics,Yes,"Use of condoms in prison population {Spanish survey on health and drug use among prisoners, p. 21} ~ Use of condoms in prison population (% among those who know that they are infected with (HIV, HBV, HCV) {Spanish survey on health and drug use among prisoners, p. 21} ~ Perception of disinfection of tattooing equipment in prison {Spanish survey on health and drug use among prisoners, p. 21} ~ Knowledge about transmission of infectious diseases (HIV and HCV) in prison population. % of inmates who answer correctly/incorrectly or do not know about each transmission mechanism {Spanish survey on health and drug use among prisoners, p. 22} ~ Health status self-perception among prison population {Spanish survey on health and drug use among prisoners, p. 08} ~ ",5
Y,Spain,ESP,Demand Reduction,Prevalence of drug use by age,Yes,"Evolution of the prevalence of drug use (cannabis, cocaine powder, cocaine base, ecstasy, amphetamine, hallucinogens, heroin, volatile inhalants, NPS, hypnosedatives, hallucinogens, GHB, methamphetamine, anabolic steroids) and average age of first consumption in the population aged 15-64 (percentages per year), Spain, 1995-2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p.26, p.27, p. 71, p.82, p.83, p.89, p.92, p.96, p.100, p.102, p.116. Encuesta sobre Uso de Drogas en Enseñanzas Secundarias en España, p.14, p.20, p. 56, p.57, p.71, p.75, p.78, p.81, p.83, p.84, p.85, p.86. Estrategia Nacional sobre Adicciones 2017-2019, p. 9, p.38} ~ Lifetime prevalence of drug use (hypnosedatives, cannabis, spice (K2), heroin, volatile inhalants, NPS, amphetamines, MDMA) in the population by age (schools, young adults, adults) and gender (percentages), Spain, 2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p.11, p.24, p.27, p.30, p.33, p. 71, p.77, p.101, p.102, p.103, p.114, p.115, p.116, p.117, p.119. Spain Drug Report 2018, p. 05, p.07, p.21. Encuesta sobre Uso de Drogas en Enseñanzas Secundarias en España, p.12, p.16, p. 57. Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 44} ~  Past 12-month prevalence of drug use (hypnosedatives, cannabis, cocaine (powder and base), ecstasy, amphetamine, methamphetamine, hallucinogens, mushrooms, NPS, MDMA) in the population by age (schools, young adults, adults) and gender (percentages). Spain, 2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p.11, p.24, p.28, p.31, p.35, p.40, p.42, p.54, p. 72, p.84, p.85, p.88, p.89, p.90, p.93, p.95, p.96, p.97, p.98, p.99, p.104, p.105, p.107, p.114, p.115, p.117, p.120, p.121. Spain Drug Report 2018, p.06, p. 21. Encuesta sobre Uso de Drogas en Enseñanzas Secundarias en España, p.12, p.15, p.16, p.19, p. 42, p.61, p.62, p.74, p.93, p.98, p.133, p.134, p.135, p.136. Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p.9, p. 38} ~ Evolution of the prevalence of drug use (cannabis, cocaine (powder), ecstasy, NPS) in the last 12 months of the population (schools, young adults, adults) and sex Spain, 1997-2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p. 73, p.85, p.86, p.91. Encuesta sobre Uso de Drogas en Enseñanzas Secundarias en España, p. 60, p.90} ~ Past 30-day prevalence of drug use (cannabis, cannabis & tobacco, methamphetamine, mushrooms) in the population (schools, young adults, adults) and gender (percentages). Spain, 2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p.25, p.29, p.32, p.37, p.41, p.47, p. 72, p.77, p.95, p.99, p.104, p.106, p.109. Spain Drug Report 2018, p. 07. Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 44. Encuesta sobre Uso de Drogas en Enseñanzas Secundarias en España, p.12, p.16, p.99} ~ Number and prevalence of drug use (cannabis, cocaine powder, cocaine base, ecstasy, amphetamine, hallucinogen, NPS, hypnosedatives, hallucinogens, mushrooms) in the population (schools, young adults, adults) and sex (percentages). Spain, 2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p.26, p.39, p. 73, p.75, p.84, p.87, p.90, p.94, p.97, p.107, p.108, p.109. Spain Drug Report 2018, p. 05. Encuesta sobre Uso de Drogas en Enseñanzas Secundarias en España, p. 26, p.56, p.58, p. 60, p.72, p.76, p.79, p.81, p.83, p.94, p.95, p.96. Estrategia Nacional sobre Adicciones 2017-2019, p. 9, p.46} ~ Characteristics of drug users use in the population by age (14-18, 15-64) and sex by drug (cannabis, hypnosedatives, cocaine powder, cocaine base, ecstasy, amphetamines, hallucinogens) (percentages). Spain, 2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p. 74. Encuesta sobre Uso de Drogas en Enseñanzas Secundarias en España, p. 58, p.61, p.62, p.64, p.73, p.77, p.80, p.82. Informe 2017 Alcohol, tabaco y drogas ilegales en España - Consumo Problemático de Drogas, p. 14} ~ Prevalence of daily drug use in the population aged 15-64 years, Spain, 1997-2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p. 25} ~ Prevalence of daily drug use in the last 30 days among the population aged 15-64 (percentages by type of drug), Spain, 2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p. 42} ~ Prevalence of consumption of five or more psychoactive substances ever among the population from 15 to 64 years as they have been consumed on some occasion new substances, ketamine, GHB, spice (K2) or sage (percentages). Spain, 2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p. 120} ~ Percentage of the general population and adolescents that do not use drugs {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 45} ~ Number of people (adolescents and adults) who began to consume drugs (by type) in the last year {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 46} ~ Number and percentage of frequent cannabis users (have used cannabis 20 days or more in the last month) in the population aged 15 to 64 years. Spain, 2011, 2013 and 2015 {Informe 2017 Alcohol, tabaco y drogas ilegales en España - Consumo Problemático de Drogas, p. 14} ~ Prevalence of drug use (cocaine and cannabis) among students of Secondary Education of 14-18 years based on the perception that all or only a few of their peers consume that same substance (last 30 days) (%). Spain, 2016 {Encuesta sobre Uso de Drogas en Enseñanzas Secundarias en España, p. 117, p.118} ~ General profile of the population of Secondary Education students of 14-18 years of age and of specific consumers, according to family relationships and norms (Parent Permission, Parental Relations, Rules at home and/or away from home (%). Spain, 2016 {Encuesta sobre Uso de Drogas en Enseñanzas Secundarias en España, p 119} ~ Distribution by gender, marital status, level of education, employment status, frequency of consumption of cannabis in the last 30 days, prevalence of binge drinking in the last 30 days and prevalence of other illegal drugs in the last 12 months among the population aged 15-64 of age who answered CAST, according to the score obtained, and among the general population (percentages). Spain, 2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p. 81} ~ Marital status, level of education and perception of health status among the population aged 15-64, according to the number of psychoactive substances consumed in the last 12 months (percentages). Spain, 2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p. 112} ~ Incidence of consumption in the general population by sex {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 46} ~ ",19
Y,Spain,ESP,Demand Reduction,Prevalence of drug use by sex,Yes,"Lifetime prevalence of drug use (hypnosedatives, cannabis, spice (K2), heroin, volatile inhalants, NPS, amphetamines, MDMA) in the population by age (schools, young adults, adults) and gender (percentages), Spain, 2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p.11, p.24, p.27, p.30, p.33, p. 71, p.77, p.101, p.102, p.103, p.114, p.115, p.116, p.117, p.119. Spain Drug Report 2018, p. 05, p.07, p.21. Encuesta sobre Uso de Drogas en Enseñanzas Secundarias en España, p.12, p.16, p. 57. Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 44} ~ Past 12-month prevalence of drug use (hypnosedatives, cannabis, cocaine (powder and base), ecstasy, amphetamine, methamphetamine, hallucinogens, mushrooms, NPS, MDMA) in the population by age (schools, young adults, adults) and gender (percentages). Spain, 2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p.11, p.24, p.28, p.31, p.35, p.40, p.42, p.54, p. 72, p.84, p.85, p.88, p.89, p.90, p.93, p.95, p.96, p.97, p.98, p.99, p.104, p.105, p.107, p.114, p.115, p.117, p.120, p.121. Spain Drug Report 2018, p.06, p. 21. Encuesta sobre Uso de Drogas en Enseñanzas Secundarias en España, p.12, p.15, p.16, p.19, p. 42, p.61, p.62, p.74, p.93, p.98, p.133, p.134, p.135, p.136. Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p.9, p. 38} ~ Evolution of the prevalence of drug use (cannabis, cocaine (powder), ecstasy, NPS) in the last 12 months of the population (schools, young adults, adults) and sex Spain, 1997-2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p. 73, p.85, p.86, p.91. Encuesta sobre Uso de Drogas en Enseñanzas Secundarias en España, p. 60, p.90} ~ Past 30-day prevalence of drug use (cannabis, cannabis & tobacco, methamphetamine, mushrooms) in the population (schools, young adults, adults) and gender (percentages). Spain, 2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p.25, p.29, p.32, p.37, p.41, p.47, p. 72, p.77, p.95, p.99, p.104, p.106, p.109. Spain Drug Report 2018, p. 07. Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 44. Encuesta sobre Uso de Drogas en Enseñanzas Secundarias en España, p.12, p.16, p.99} ~ Number and prevalence of drug use (cannabis, cocaine powder, cocaine base, ecstasy, amphetamine, hallucinogen, NPS, hypnosedatives, hallucinogens, mushrooms) in the population (schools, young adults, adults) and sex (percentages). Spain, 2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p.26, p.39, p. 73, p.75, p.84, p.87, p.90, p.94, p.97, p.107, p.108, p.109. Spain Drug Report 2018, p. 05. Encuesta sobre Uso de Drogas en Enseñanzas Secundarias en España, p. 26, p.56, p.58, p. 60, p.72, p.76, p.79, p.81, p.83, p.94, p.95, p.96. Estrategia Nacional sobre Adicciones 2017-2019, p. 9, p.46} ~ Characteristics of drug users use in the population by age (14-18, 15-64) and sex by drug (cannabis, hypnosedatives, cocaine powder, cocaine base, ecstasy, amphetamines, hallucinogens) (percentages). Spain, 2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p. 74. Encuesta sobre Uso de Drogas en Enseñanzas Secundarias en España, p. 58, p.61, p.62, p.64, p.73, p.77, p.80, p.82. Informe 2017 Alcohol, tabaco y drogas ilegales en España - Consumo Problemático de Drogas, p. 14} ~ Distribution by gender, marital status, level of education, employment status, frequency of consumption of cannabis in the last 30 days, prevalence of binge drinking in the last 30 days and prevalence of other illegal drugs in the last 12 months among the population aged 15-64 of age who answered CAST, according to the score obtained, and among the general population (percentages). Spain, 2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p. 81} ~ ",8
Y,Spain,ESP,Demand Reduction,Prevalence of drug use by type,Yes,"Evolution of the prevalence of drug use (cannabis, cocaine powder, cocaine base, ecstasy, amphetamine, hallucinogens, heroin, volatile inhalants, NPS, hypnosedatives, hallucinogens, GHB, methamphetamine, anabolic steroids) and average age of first consumption in the population aged 15-64 (percentages per year), Spain, 1995-2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p.26, p.27, p. 71, p.82, p.83, p.89, p.92, p.96, p.100, p.102, p.116. Encuesta sobre Uso de Drogas en Enseñanzas Secundarias en España, p.14, p.20, p. 56, p.57, p.71, p.75, p.78, p.81, p.83, p.84, p.85, p.86. Estrategia Nacional sobre Adicciones 2017-2019, p. 9, p.38} ~ Lifetime prevalence of drug use (hypnosedatives, cannabis, spice (K2), heroin, volatile inhalants, NPS, amphetamines, MDMA) in the population by age (schools, young adults, adults) and gender (percentages), Spain, 2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p.11, p.24, p.27, p.30, p.33, p. 71, p.77, p.101, p.102, p.103, p.114, p.115, p.116, p.117, p.119. Spain Drug Report 2018, p. 05, p.07, p.21. Encuesta sobre Uso de Drogas en Enseñanzas Secundarias en España, p.12, p.16, p. 57. Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 44} ~  Past 12-month prevalence of drug use (hypnosedatives, cannabis, cocaine (powder and base), ecstasy, amphetamine, methamphetamine, hallucinogens, mushrooms, NPS, MDMA) in the population by age (schools, young adults, adults) and gender (percentages). Spain, 2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p.11, p.24, p.28, p.31, p.35, p.40, p.42, p.54, p. 72, p.84, p.85, p.88, p.89, p.90, p.93, p.95, p.96, p.97, p.98, p.99, p.104, p.105, p.107, p.114, p.115, p.117, p.120, p.121. Spain Drug Report 2018, p.06, p. 21. Encuesta sobre Uso de Drogas en Enseñanzas Secundarias en España, p.12, p.15, p.16, p.19, p. 42, p.61, p.62, p.74, p.93, p.98, p.133, p.134, p.135, p.136. Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p.9, p. 38} ~ Evolution of the prevalence of drug use (cannabis, cocaine (powder), ecstasy, NPS) in the last 12 months of the population (schools, young adults, adults) and sex Spain, 1997-2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p. 73, p.85, p.86, p.91. Encuesta sobre Uso de Drogas en Enseñanzas Secundarias en España, p. 60, p.90} ~ Past 30-day prevalence of drug use (cannabis, cannabis & tobacco, methamphetamine, mushrooms) in the population (schools, young adults, adults) and gender (percentages). Spain, 2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p.25, p.29, p.32, p.37, p.41, p.47, p. 72, p.77, p.95, p.99, p.104, p.106, p.109. Spain Drug Report 2018, p. 07. Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 44. Encuesta sobre Uso de Drogas en Enseñanzas Secundarias en España, p.12, p.16, p.99} ~ Number and prevalence of drug use (cannabis, cocaine powder, cocaine base, ecstasy, amphetamine, hallucinogen, NPS, hypnosedatives, hallucinogens, mushrooms) in the population (schools, young adults, adults) and sex (percentages). Spain, 2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p.26, p.39, p. 73, p.75, p.84, p.87, p.90, p.94, p.97, p.107, p.108, p.109. Spain Drug Report 2018, p. 05. Encuesta sobre Uso de Drogas en Enseñanzas Secundarias en España, p. 26, p.56, p.58, p. 60, p.72, p.76, p.79, p.81, p.83, p.94, p.95, p.96. Estrategia Nacional sobre Adicciones 2017-2019, p. 9, p.46} ~ Characteristics of drug users use in the population by age (14-18, 15-64) and sex by drug (cannabis, hypnosedatives, cocaine powder, cocaine base, ecstasy, amphetamines, hallucinogens) (percentages). Spain, 2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p. 74. Encuesta sobre Uso de Drogas en Enseñanzas Secundarias en España, p. 58, p.61, p.62, p.64, p.73, p.77, p.80, p.82. Informe 2017 Alcohol, tabaco y drogas ilegales en España - Consumo Problemático de Drogas, p. 14} ~ Number of high-risk drug users (heroin, cocaine, cannabis, hypnosedatives) {Spain Drug Report 2018, p. 07, p.08, p.21. Informe 2017 Alcohol, tabaco y drogas ilegales en España - Consumo Problemático de Drogas, p. 10, p.12, p.13, p.20, p.24} ~ Prevalence of daily drug use in the last 30 days among the population aged 15-64 (percentages by type of drug), Spain, 2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p. 42} ~ Prevalence of consumption of five or more psychoactive substances ever among the population from 15 to 64 years as they have been consumed on some occasion new substances, ketamine, GHB, spice (K2) or sage (percentages). Spain, 2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p. 120} ~ Number of people (adolescents and adults) who began to consume drugs (by type) in the last year {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 46} ~ Number and percentage of frequent cannabis users (have used cannabis 20 days or more in the last month) in the population aged 15 to 64 years. Spain, 2011, 2013 and 2015 {Informe 2017 Alcohol, tabaco y drogas ilegales en España - Consumo Problemático de Drogas, p. 14} ~ Prevalence of drug use (cocaine and cannabis) among students of Secondary Education of 14-18 years based on the perception that all or only a few of their peers consume that same substance (last 30 days) (%). Spain, 2016 {Encuesta sobre Uso de Drogas en Enseñanzas Secundarias en España, p. 117, p.118} ~ Distribution by gender, marital status, level of education, employment status, frequency of consumption of cannabis in the last 30 days, prevalence of binge drinking in the last 30 days and prevalence of other illegal drugs in the last 12 months among the population aged 15-64 of age who answered CAST, according to the score obtained, and among the general population (percentages). Spain, 2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p. 81} ~ ",15
Y,Spain,ESP,Demand Reduction,Number of people who use drugs,No,n/a,0
Y,Spain,ESP,Demand Reduction,"Prevalence of drug use by mode of administration (oral, mucosa, inhalation, and injection)",Yes,"Route of administration for drug-related to hospital emergencies (%). Spain, 2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p. 179} ~ Number of admissions to treatment (first time) for abuse or dependence on heroin, according to the main route of administration of this drug. Spain, 1991-2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p. 151} ~ Injecting drug use - aged 15-64 (cases rate/1 000 population) (country data and EU range) {p. 22} ~ Number of recent injectors of heroin. Average value (minimum and maximum value) {Informe 2017 Alcohol, tabaco y drogas ilegales en España - Consumo Problemático de Drogas, p. 22}~",4
Y,Spain,ESP,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT)",Yes,"Number of admissions to treatment for the abuse/dependence of drugs (psychoactive substances, illegal drugs, heroin, cocaine, cannabis, hypnosedatives, amphetamines, ecstasy/MDMA, hallucinogens, ketamine, opioids), 1987-2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p. 138, p.139, p.140, p.141, p.142, p.143, p.144, p.156, p.159, p.160, p.161; Spain Drug Report 2018, p. 17, p.21, p.22; Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 61} ~ Number of people who inject drugs admitted to treatment for drug abuse or dependence (total admitted) by type of drug (psychoactive substances). Spain, 1996-2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p. 145} ~ Number of injectors admitted to treatment for psychoactive substance abuse or dependence (admitted for the first time). Spain, 1996-2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p. 146} ~ Number of admissions to treatment (first time) for abuse or dependence by type of drug (heroin, cocaine, cannabis, amphetamines, MDMA, opioids), according to the main route of administration of this drug. Spain, 1991-2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p. 151, p.152, p.153, p.154, p.155; Spain Drug Report 2018, p. 21, p.22} ~ Number and rate (per 100,000 population) of admissions to treatment for substance use psychoactive, according to Community/Autonomous City. Spain, 2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p. 162} ~ Sociodemographic characteristics of those admitted to treatment for psychoactive drugs abuse or dependence, according to whether or not previous treatment and according to sex. Spain, 2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p. 163} ~ Characteristics of those admitted to treatment for abuse or dependence of psychoactive substances, {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p. 168; Spain Drug Report 2018, p. 09} ~ Evolution of the number of injectors (once in life and last year) admitted to treatment for psychoactive drugs abuse or dependence (absolute numbers and%). Spain, 2005-2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p. 175} ~ percentage of increase in the number of cases attended in the network of attention to drug problems {Estrategia Nacional sobre Adicciones 2017-2019, p. 22} ~ Number of drug users that received drug treatment in 2015, the majority of whom were treated in outpatient settings {Spain Drug Report 2018, p. 16} ~ number of clients entering treatment each year {Spain Drug Report 2018, p. 16} ~ Number of healthcare resources in the CCAA (ambulatory care centers, day centers, detoxification hospital units, therapeutic communities, treatment support floors) {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 59; Spain Drug Report 2018, p. 17} ~ Number of cases attended in healthcare centers {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 60} ~ Number of cases attended in specific programs (Courts, Commissariats, Dual pathology, Women, Games, pathological, Minor offenders, Minors) {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 60} ~ Number of years elapsed between the start of the consumption and the treatment (by type of drug) {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 61} ~ Estimation of the percentage of people in treatment in relation to the number of problematic consumers {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 62} ~ Percentage of NGOs that believe that the END is sufficiently accessible {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 119} ~ Total number of hospital emergency episodes related to drug use. Spain, 1996-2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p.11, p. 76, p.176, p.177} ~ Characteristics of hospital emergency episodes related to drug use (total, sex and drug). Spain, 2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p.11, p. 178} ~ Percentage of hospital emergency related to the consumption of some illegal drugs, by sex. Spain, 2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p. 179} ~ Percentage of episodes of hospital emergencies related to illegal drugs according to the drug detected {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 51} ~",21
Y,Spain,ESP,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT) by age",Yes,"Average age of admission to treatment for abuse or dependence by type of drug (heroin, cocaine, opioids) (total of treated). Spain, 1987-2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p. 147, p.148, p.149, p.150; Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 52} ~ ",1
Y,Spain,ESP,Demand Reduction,Level of access to opioid substitution treatment and medication assisted treatment (OST/MAT),Yes,"Number of specialised outpatient centres, other health, and mental health centres, at inpatient facilities and in prisons where opioid substitution treatment (OST) is available {Spain Drug Report 2018, p. 16} ~ Number of people that were prescribed OST in Spain {Spain Drug Report 2018, p. 16} ~ Opioid substitution treatment in Spain: proportions of clients in OST by medication Methadone and Buprenorphine) and trends of the total number of clients {Spain Drug Report 2018, p. 18} ~ Clients in substitution treatment (country data and EU range) {Spain Drug Report 2018, p. 22} ~ ",4
Y,Spain,ESP,Demand Reduction,Level of coverage of inpatient treatment,Yes,"Number of healthcare resources in the CCAA (ambulatory care centers, day centers, detoxification hospital units, therapeutic communities, treatment support floors) {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 59; Spain Drug Report 2018, p. 17} ~ ",1
Y,Spain,ESP,Demand Reduction,Proportion of people who use drugs enrolled in voluntary treatment,No,n/a,0
Y,Spain,ESP,Demand Reduction,Proportion of people who use drugs enrolled in coerced treatment,No,n/a,0
Y,Spain,ESP,Demand Reduction,Proportion of people who use drugs enrolled in compulsory treatment,No,n/a,0
Y,Spain,ESP,Demand Reduction,Presence of prevention programming in law enforcement,No,n/a,0
Y,Spain,ESP,Demand Reduction,Presence of prevention programming in the media,No,n/a,0
Y,Spain,ESP,Demand Reduction,Presence of prevention programming in schools,Yes,"Information sources. School Population (%) {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 26} ~ Degree of Teacher Concern (%) {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 27} ~ percentage of school population covered by preventive programs {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p.14, p. 32} ~ School prevention. 1: School centers with prevention programs. 2. Teachers who applies programs. 3. Teachers trained in prevention. 2009-2015 {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 32} ~ Number of teachers trained in prevention by the PAD {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 102} ~ Percentage of ESO teachers trained in drugs {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 103} ~ Percentage of Secondary Education students aged 14-18 who are unaware of the health problems that can occur due to the consumption of any of the following new psychoactive substances, according to whether they consume or do not consume the substance (%). Spain, 2016 {Encuesta sobre Uso de Drogas en Enseñanzas Secundarias en España, p. 90} ~ Percentage of Secondary Education students aged 14-18 who have received training in their school or in their family about drug use and associated problems, according to age and sex. (%) Spain, 2016 {Encuesta sobre Uso de Drogas en Enseñanzas Secundarias en España, p. 112, p.113} ~ Frequency of leisure activities among students of Secondary Education of 14-18 years according to the consumption of psychoactive substances (%). Spain, 2016 {Encuesta sobre Uso de Drogas en Enseñanzas Secundarias en España, p. 130} ~ Trend of increase or decrease of prevention programmes (school-based) {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 12} ~ ",10
Y,Spain,ESP,Demand Reduction,Presence of prevention programming in the workplace,Yes,"Perception of the importance of the drug problem in the general population and in the workplace (%) {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 27} ~",1
Y,Spain,ESP,Demand Reduction,Presence of prevention programming for youth and the community,Yes,"Perception of Normality of Consumption:% of students aged 14-18 who believe that most of their friends have used drugs in the last 30 days (by type of drug) {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 39} ~ Perceived risk of consumption of drugs (GHB, ketamine, hallucinogens, cannabis, cocaine, ecstasy, amphetamines, mushrooms, heroin, psychoactive substances, NPS) once per month or less (percentage of population aged 15-64, 14-18, who thinks that each use can produce many or enough problems), according to age and sex. Spain, 2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p.73, p.80, p.86, p.91, p.92, p.95, p.98, p.100, p.101, p.113, p. 118, p.124, p.126, p.127, p.128; Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p.10, p.27; Encuesta sobre Uso de Drogas en Enseñanzas Secundarias en España, p. 91, p.105} ~ Evolution of the perceived risk to different behaviors of consumption of psychoactive substances (percentage of the population aged 15-64 who thinks that each consumption behavior can produce many or enough problems). Spain, 1997-2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p. 123, p.125; Encuesta sobre Uso de Drogas en Enseñanzas Secundarias en España, p. 100} ~ Risk perceived by Secondary Education students of 14-18 years in the habitual consumption of psychoactive substances (percentage of students who think that habitual consumption, once a week or more frequently, can cause enough or many problems), according to age and sex (%) Spain, 2016 {Encuesta sobre Uso de Drogas en Enseñanzas Secundarias en España, p. 101, p.103} ~ Assessment of various actions as ""very important"" to solve the drug problem among the population aged 15-64, according to whether they have used any new psychoactive substances time in life or not (percentages). Spain, 2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p. 122, p.131; Encuesta sobre Uso de Drogas en Enseñanzas Secundarias en España, p. 114} ~ Evolution of the importance given by the population aged 15-64 to the illegal drugs problem in the place where they live (percentages). Spain, 1997-2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p. 129} ~ Measures to solve the drug problem in the general population and adolescents (Education, Legalization of cannabis, Legalization of drugs) (%) {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 27} ~ Information on drugs among adolescents: Percentage of adolescents who feel sufficiently informed (OEDA) {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 26; Encuesta sobre Uso de Drogas en Enseñanzas Secundarias en España, p. 111} ~ If the consumption of hashish or marijuana is legal, it would be tried by Secondary Education students of 14-18 years, according to age and sex (%). Spain, 2016 {Encuesta sobre Uso de Drogas en Enseñanzas Secundarias en España, p. 65} ~ Trend of increase or decrease of prevention programmes (family-based, community-based) {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 12} ~ No. of PADs that carry out awareness raising activities, by type of activity {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 24} ~ Territorial coverage of awareness raising programs, by type of activity {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 24} ~ information and awareness raising programs profile, per region {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 25} ~ Information sources. General population (%) {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 26} ~ Programs of Prevention of the CCAA according to the number of PAD that implement them and the territorial coverage of the programs {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 30} ~ Distribution of CCAA prevention programs per PAD and type of program {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 31} ~ Participants in prevention programs in Spain 2009-16 {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 31} ~ Main recipients of prevention programs in Spain 2009-2015 (Students, Mothers and Fathers, Participants in Alternative Leisure Program, Minors vulnerable) {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 32} ~ Degree of accreditation of the CCAA prevention programs according to the territory {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 33, p.110} ~ CCAA Prevention Programs Profile according to the territory {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 34} ~ Degree of accreditation of prevention programs in the CCAA {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 110} ~ Coordination Profiles CCAA - Public bodies and civil societies in the areas of prevention, incorporation, assistance {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 19, p.20} ~ Perception of parental tolerance for cannabis among students of Secondary Education of 14-18 years according to cannabis use that students have (%). Spain, 2016 {Encuesta sobre Uso de Drogas en Enseñanzas Secundarias en España, p. 124} ~ Percentage of people who have never heard of new psychoactive substances in the population aged 15-64, according to age and sex. Spain, 2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p. 117} ~  Percentage of people who have never heard of new psychoactive substances in the population aged 15-64, according to age and sex. Spain, 2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p. 117} ~ ",25
Y,Spain,ESP,Demand Reduction,Presence of other demand reduction metrics,Yes,"Percentage of public expenditure by agency (autonomous communities and cities; central government) and program (treatment, prevention, research and institutional cooperation) {p. 03} ~ number of inmates that had used drugs during the 30 days prior to imprisonment {Spain Drug Report 2018, p. 18} ~ Visibility of drug use: % of the population that frequently sees the following behaviors (Cannabis use by the general population, Consumption of alcohol doing “botellón” for the general population, Consumption of alcohol and drugs by the working population, Cannabis use in the surroundings of the school) {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 39} ~ No. of drug research projects 2006-2015 {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 94} ~ No. of CCAA that introduce the gender perspective {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 115} ~ Money available (euros) per week for personal expenses among students of Secondary Education of 14-18 years depending on the consumption of psychoactive substances. Spain, 2016 {Encuesta sobre Uso de Drogas en Enseñanzas Secundarias en España, p. 139} ~ Circumstances related to the school environment among students of Secondary Education of 14-18 years according to the consumption of psychoactive substances. Spain, 2016 {Encuesta sobre Uso de Drogas en Enseñanzas Secundarias en España, p. 140} ~",7
Y,Spain,ESP,Supply Reduction,Size and value of the illegal drug market,Yes,"Perceived availability of psychoactive substances (NPS, GHB, ketamine, cocaine, ecstasy, hallucinogen, heroin, cannabis) (obtaining them in 24 hours is relatively easy/very easy), among the population by age (14-18, 15-64 years) according to age and sex (percentages). Spain, 2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p.73, p.80, p.86, p.91, p.99, p.102, p. 119, p.129; Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 39; Encuesta sobre Uso de Drogas en Enseñanzas Secundarias en España, p. 92, p.106, p.109, p.110} ~ Routes of obtaining new psychoactive substances in the last 12 months among the population of 15-64 years who have consumed new substances in the last 12 months (percentages). Spain, 2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p. 119} ~ Evolution of visibility in the near environment of some situations related to the use of illegal drugs (percentage of the population aged 15-64 who are often near those situation where they live). Spain, 1995-2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p. 130} ~ Ways to get new psychoactive substances for 14-18 years secondary education students who have used new substances in the last 12 months (%). Spain, 2014-2016 {Encuesta sobre Uso de Drogas en Enseñanzas Secundarias en España, p. 89} ~ ",4
Y,Spain,ESP,Supply Reduction,Level of procedures related to crop eradication,No,n/a,0
Y,Spain,ESP,Supply Reduction,"Number of arrests, seizures, and offences",Yes,"Percentage of drug seizures by type (MDMA, cocaine), by organizations (State Security Forces, Spanish Airports) {Estrategia Nacional sobre Adicciones 2017-2019, p. 16, p.17} ~ quantities of drugs seized (herbal cannabis, cannabis resin, hashish, cocaine, amphetamine, MDMA, heroin) and % variation, per year and type of drug {Estrategia Nacional sobre Adicciones 2017-2019, p. 17; Spain Drug Report 2018, p. 20, p.21; Informe 2017 Alcohol, tabaco y drogas ilegales en España - oferta de drogas y medidas de control, p. 09, p.10, p.11, p.12} ~ Prevalence and number of drug seizures by type (cocaine, hashish, marijuana, cannabis plants, MDMA, herbal cannabis, cannabis resin, amphetamine, heroin) {Estrategia Nacional sobre Adicciones 2017-2019, p. 17, p.18, p.19; Spain Drug Report 2018, p. 21} ~ percentage of heroin seizures with human couriers {Estrategia Nacional sobre Adicciones 2017-2019, p. 18} ~ percent of arrests for drug trafficking between 2015 and 2016 {Estrategia Nacional sobre Adicciones 2017-2019, p. 19} ~ number of arrests disaggregated by drug families {Estrategia Nacional sobre Adicciones 2017-2019, p. 19; Informe 2017 Alcohol, tabaco y drogas ilegales en España - oferta de drogas y medidas de control, p. 18} ~ Actions to prevent retail traffic in school and leisure zones (Number of arrests, complaints, seizures, deactivated points of sale and type of drug apprehended) according to the year {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 79} ~ Number of reported drug law offences in Spain categorized in supply or use/possession {Spain Drug Report 2018, p. 05, p.22} ~ Detentions, complaints, seizures and deactivated points of sale in leisure areas (Number of arrests, complaints, seizures, deactivated points of sale and type of drug seized) according to the year {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 81; Estrategia Nacional sobre Adicciones 2017-2019, p. 19} ~ Detentions for drug trafficking (absolute numbers). Spain, 2002-2016 {Informe 2017 Alcohol, tabaco y drogas ilegales en España - oferta de drogas y medidas de control, p. 16} ~ Distribution of detentions by type of substances (percentage). Spain, 2016 {Informe 2017 Alcohol, tabaco y drogas ilegales en España - oferta de drogas y medidas de control, p. 17} ~ ",11
Y,Spain,ESP,Supply Reduction,Level of law enforcement activity and interdiction in the market,Yes,"Infringements of operators of substances susceptible to diversion to illicit channels {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 84} ~ Inspections of operators of substances, susceptible to diversion to illicit channels, per year {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 83} ~ Number of professionals trained by the General Secretariat of Penitentiary Institutions {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 103} ~ ",3
Y,Spain,ESP,Supply Reduction,"Price, purity and potency of drugs, and related process indicators",Yes,"Potency (%) by type of drug (herbal cannabis, cannabis resin) {Spain Drug Report 2018, p. 21} ~ Purity (%) by type of drug (cocaine, amphetamine, MDMA (mg/tablet), heroin) {Spain Drug Report 2018, p. 21, p.22. Informe 2017 Alcohol, tabaco y drogas ilegales en España - oferta de drogas y medidas de control, p. 15} ~ Price (EUR) per gram by type of drug (herbal cannabis, cannabis resin, cocaine, amphetamine, MDMA, heroin) {Spain Drug Report 2018, p. 21, p.22; Informe 2017 Alcohol, tabaco y drogas ilegales en España - oferta de drogas y medidas de control, p. 14} ~ Ratios of purity of heroin and cocaine seizures (ratios of purity kg/dose purity, kg/gram purity and gram/dose purity). Spain, 2000-2016 {Informe 2017 Alcohol, tabaco y drogas ilegales en España - oferta de drogas y medidas de control, p. 15} ~",5
Y,Spain,ESP,Supply Reduction,Number of people engaged with the criminal justice system,Yes,"Number of reported drug law offenders in Spain categorized in supply or use/possession {Spain Drug Report 2018, p. 05, p.22} ~ percentage of people between 19 and 25 years prosecuted {Estrategia Nacional sobre Adicciones 2017-2019, p. 19} ~ percentage of men between 19 and 25 years prosecuted {Estrategia Nacional sobre Adicciones 2017-2019, p. 19} ~",3
Y,Spain,ESP,Supply Reduction,Presence of other supply reduction metrics,Yes,"Complaints based on the Organic Law 1/1992 for possession and consumption of drugs in a public place (absolute numbers). Spain, 2002-2016 {Informe 2017 Alcohol, tabaco y drogas ilegales en España - oferta de drogas y medidas de control, p. 17} ~ Distribution and evolution of complaints by family of drugs (% of the total). Spain, 2006-2016 {Informe 2017 Alcohol, tabaco y drogas ilegales en España - oferta de drogas y medidas de control, p. 18} ~ Denunciations to the Organic Law of Public Safety {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 82} ~ Percentage of people by age group (14-18, 15-64) who rate as ""nothing, something or very important"" the legalization of cannabis to solve the problem of drugs, whether they have consumed it or not in the last 12 months (percentages). Spain, 2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p. 132; Encuesta sobre Uso de Drogas en Enseñanzas Secundarias en España, p. 116} ~ Percentage of people by age group (14-18, 15-64) who value as ""very important"" cannabis legalization and the legalization of all drugs to solve the drug problem, according to age and sex (percentages). Spain, 2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p. 132; Estrategia Nacional sobre Adicciones 2017-2019, p. 10; Encuesta sobre Uso de Drogas en Enseñanzas Secundarias en España, p. 115} ~  Percentage of people aged 15-64 who rate as ""nothing, something or very important"" the legalization of all drugs to solve the drug problem, whether they have consumed or not some illegal drugs in the last 12 months (percentages). Spain, 2015 {Estadísticas 2017 Alcohol, tabaco y drogas ilegales en España, p. 133} ~ levels of illicit drugs and their metabolites found in wastewater samples from four Spanish cities (Barcelona, Castellón, Santiago and Valencia) {Spain Drug Report 2018, p. 05} ~ ",7
Y,Spain,ESP,International Cooperation,Level of engagement in international cooperation,Yes,"Exchange of information from Spain with other ORAs Individuals and legal entities investigated {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 87} ~ Degree of International Coordination of DGPNSD {Estrategia Nacional sobre Drogas 2009-2016 Informe de la Evaluación final, p. 107} ~",2
Y,Mexico,MEX,Health,Level of availability of harm reduction services and harm reduction scale up,No,n/a,0
Y,Mexico,MEX,Health,Presence of needle and syringe programs,No,n/a,0
Y,Mexico,MEX,Health,Prevalence of substance use disorders,Yes,"Prevalence of drug dependence – 2008, and 2011 disaggregated by gender {Programa Contra La Pharmacodependencia, 2015-2018, p.26; Programa De Acción Específico – Prevención Y Atención Integral De Las Adicciones, 2013-2018, p.45} ~ The number of people who meet criteria for drug dependence in 2008, and 2011 {Programa De Acción Específico – Prevención Y Atención Integral De Las Adicciones, 2013-2018, p.45} ~ ",2
Y,Mexico,MEX,Health,Prevalence of psychiatric comorbidities,No,n/a,0
Y,Mexico,MEX,Health,Drug-related mortality,Yes,"total number of deaths in 2012 in forensic medical services, that were found to be corroborated by alcohol (%) and cocaine (%) {Programa De Acción Específico – Prevención Y Atención Integral De Las Adicciones, 2013-2018, p.45} ~ In 2012, in all people whose cause of death was accident, homicide, suicide, or non-violent death, clinical or toxicological data showed consumption of alcohol (%), marijuana and tranquilizers {Programa De Acción Específico – Prevención Y Atención Integral De Las Adicciones, 2013-2018, p.46}~",2
Y,Mexico,MEX,Health,Prevalence of drug-related infectious disease,No,n/a,0
Y,Mexico,MEX,Health,Proportion of people who use drugs who engage in risky consumption,No,n/a,0
Y,Mexico,MEX,Health,Proportion of people who use drugs who engage in safe consumption practices,No,n/a,0
Y,Mexico,MEX,Health,"Coverage of services for the prevention, testing, and treatment of bloodborne diseases",No,n/a,0
Y,Mexico,MEX,Health,Presence of specialised training for addiction care,Yes,"Percentage of people who received training in prevention and addiction care in the programmed demand: (Number of people trained annually/Number of persons scheduled to be trained annually) X 100 {Programa Contra La Pharmacodependencia, 2015-2018, p.41} ~ number of volunteers and health promoters involved in the care of addictions. {Programa De Acción Específico – Prevención Y Atención Integral De Las Adicciones, 2013-2018, p.77} ~ Number of volunteers  and person trained annually/Number of people scheduled to be trained annually x 100 {Programa De Acción Específico – Prevención Y Atención Integral De Las Adicciones, 2013-2018, p.85} ~ people who were trained in prevention and attention of addictions. {Programa De Acción Específico – Prevención Y Atención Integral De Las Adicciones, 2013-2018, p.77}~ Number of persons trained annually/ number of persons scheduled to be trained each year) X 100 {Programa De Acción Específico – Prevención Y Atención Integral De Las Adicciones, 2013-2018, p.84}~",5
Y,Mexico,MEX,Health,Presence of health harms related to drug use,Yes,"Mean age of cases with evidence of intoxication by psychoactive substances that were treated in hospital emergency departments in 2012 {Programa De Acción Específico – Prevención Y Atención Integral De Las Adicciones, 2013-2018, p.45} ~ Proportion of 15-19 year olds with evidence of intoxication by psychoactive substances that were treated in hospital emergency departments {Programa De Acción Específico – Prevención Y Atención Integral De Las Adicciones, 2013-2018, p.45}~  ",2
Y,Mexico,MEX,Health,Presence of other health metrics,No,n/a,0
Y,Mexico,MEX,Peace and Security,"Prevalence of alcohol and drugs in accidents, and interventions to increase road safety",No,n/a,0
Y,Mexico,MEX,Peace and Security,Annual number of public disorder and violent crime reports,Yes,"juvenile offenses: type of crime (Theft, Violent Acts, Possession of fire arm, crime against health, sexual offence, weapon carrying stab, Other) and Type of drug involved in the crime (tobacco, alcohol, marijuana, inhalants, illicit drugs, medical drugs) {Programa De Acción Específico – Prevención Y Atención Integral De Las Adicciones, 2013-2018, p.46} ~ Prevalence (%) crimes committed by minor offenders in 2012: robbery, crimes against health, and other offenses {Programa De Acción Específico – Prevención Y Atención Integral De Las Adicciones, 2013-2018, p.46} ~",2
Y,Mexico,MEX,Peace and Security,Number of non-lethal drug market violent events reported,No,n/a,0
Y,Mexico,MEX,Peace and Security,Number of drug market related homicides and disappearances,Yes,"In 2012, in all people whose cause of death was accident, homicide, suicide, or non-violent death, clinical or toxicological data showed consumption of alcohol (%), marijuana and tranquilizers {Programa De Acción Específico – Prevención Y Atención Integral De Las Adicciones, 2013-2018, p.46} ~",1
Y,Mexico,MEX,Peace and Security,Presence of other peace and security metrics,No,n/a,0
Y,Mexico,MEX,Development,Coverage of housing assistance for people who use drugs,No,n/a,0
Y,Mexico,MEX,Development,Coverage of social assistance for people who use drugs (not including housing),No,n/a,0
Y,Mexico,MEX,Development,Number of households enrolled in alternative development,No,n/a,0
Y,Mexico,MEX,Development,Presence of other development metrics,No,n/a,0
Y,Mexico,MEX,Human Rights,"Prevalence and incidence of infectious diseases in vulnerable populations (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Mexico,MEX,Human Rights,"Prevalence of vulnerable people who use drugs (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Mexico,MEX,Human Rights,Proportion of people who use drugs in prison that are receiving medication assisted treatment (MAT),No,n/a,0
Y,Mexico,MEX,Human Rights,Distribution of sterile injecting equipment in prisons,No,n/a,0
Y,Mexico,MEX,Human Rights,Presence of programs and services targeted towards women ,No,n/a,0
Y,Mexico,MEX,Human Rights,Presence of programs and services targeted towards people of color,No,n/a,0
Y,Mexico,MEX,Human Rights,Presence of challenges and/or harms experienced by people of color,No,n/a,0
Y,Mexico,MEX,Human Rights,"Presence of programs and services targeted towards vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Mexico,MEX,Human Rights,"Presence of challenges and/or harms experienced by vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Mexico,MEX,Human Rights,Presence of other human rights metrics,No,n/a,0
Y,Mexico,MEX,Demand Reduction,Prevalence of drug use by age,Yes,"Average age of onset of substance use for youth – 2012 {Programa De Acción Específico – Prevención Y Atención Integral De Las Adicciones, 2013-2018, p.46} ~  Average age of onset of drug use – 2002 and 2011 {Programa Contra La Pharmacodependencia, 2015-2018, p.8, p. 20} ~ % of students that have used drugs in the past year or at least once in their life time – 2014 {Programa Contra La Pharmacodependencia, 2015-2018, p.8} ~ Proportion of 5th and 6th grade students who have used drugs at any point in their lifetime, 2014, disaggregated by gender) {Programa Contra La Pharmacodependencia, 2015-2018, p. 8 p. 24} ~ Prevalence (%) of illegal drug use by age and type of drug: 26-34 years, 12-25 years, 35-65 years (marijuana, cocaine, crack, inhalable, type stimulants amphetamine, hallucinogens, heroin, total of illegal drug use - 2011 {Programa Contra La Pharmacodependencia, 2015-2018, p.22} ~ Prevalence (%) of medical drug use by age and type of drug: 12-25 years, 26-34 years, 35-65 years (tranquilizers, amphetamines, opiates, sedatives) {Programa Contra La Pharmacodependencia, 2015-2018, p.23} ~ Prevalence of drug use in middle and high school students: use drugs at least once in their life time (disaggregated by gender), use drugs in the past year (disaggregated by gender) - 2014 {Programa Contra La Pharmacodependencia, 2015-2018, p.24} ~ Prevalence of drug use at any time, in the last year, and in the last month, classified by level of schooling (elementary school, high school, baccalaureate) - 2014 {Programa Contra La Pharmacodependencia, 2015-2018, p.24} ~ % of students that have used drugs in the past year or at least once in their life time disaggregated by gender– 2014 {Programa Contra La Pharmacodependencia, 2015-2018, p.8} ~  prevalence of marijuana, cocaine and inhalables among 12-17 year olds – 2011 {Programa De Acción Específico – Prevención Y Atención Integral De Las Adicciones, 2013-2018, p.42} ~ Main drug of onset in young offenders disaggregated by age group and type of drug: 10-14 years, 15-18 years (%tobacco and % inhalents) {Programa De Acción Específico – Prevención Y Atención Integral De Las Adicciones, 2013-2018, p.46} ~ % of children who consume drugs in 2012 {Programa De Acción Específico – Prevención Y Atención Integral De Las Adicciones, 2013-2018, p.46} ~ Prevalence of drug use in urban and rural populations, between the ages of 12 and 65 who live in households - 2012 {Programa Contra La Pharmacodependencia, 2015-2018, p.19} ~ Ratio of drug consumption between men and women, and the average age of onset disaggregated by gender {Programa De Acción Específico – Prevención Y Atención Integral De Las Adicciones, 2013-2018, p.42} ~ ",14
Y,Mexico,MEX,Demand Reduction,Prevalence of drug use by sex,Yes,"Prevalence of drug use in middle and high school students: use drugs at least once in their life time (disaggregated by gender), use drugs in the past year (disaggregated by gender) - 2014 {Programa Contra La Pharmacodependencia, 2015-2018, p.24} ~ % of students that have used drugs in the past year or at least once in their life time disaggregated by gender– 2014 {Programa Contra La Pharmacodependencia, 2015-2018, p.8} ~ Proportion of 5th and 6th grade students who have used drugs at any point in their lifetime, 2014, disaggregated by gender) {Programa Contra La Pharmacodependencia, 2015-2018, p. 8 p. 24} ~ Ratio of drug consumption between men and women, and the average age of onset disaggregated by gender {Programa De Acción Específico – Prevención Y Atención Integral De Las Adicciones, 2013-2018, p.42} ~ % of alcohol and inhalant consumption – disaggregated by gender – 2012 {Programa De Acción Específico – Prevención Y Atención Integral De Las Adicciones, 2013-2018, p.46} ~ Number of people who consumed drugs in 2008 and 2011 - Disaggregated by gender & Disaggregated by gender – for the past year {Programa Contra La Pharmacodependencia, 2015-2018, p.22, Programa De Acción Específico – Prevención Y Atención Integral De Las Adicciones, 2013-2018, p.42} ~ Trends 2002-2011 of use of any illegal drug in the last year, by sex {Programa De Acción Específico – Prevención Y Atención Integral De Las Adicciones, 2013-2018, p.42} ~",7
Y,Mexico,MEX,Demand Reduction,Prevalence of drug use by type,Yes,"Prevalence (%) of illegal drug use by age and type of drug: 26-34 years, 12-25 years, 35-65 years (marijuana, cocaine, crack, inhalable, type stimulants amphetamine, hallucinogens, heroin, total of illegal drug use - 2011 {Programa Contra La Pharmacodependencia, 2015-2018, p.22} ~ Prevalence (%) of medical drug use by age and type of drug: 12-25 years, 26-34 years, 35-65 years (tranquilizers, amphetamines, opiates, sedatives) {Programa Contra La Pharmacodependencia, 2015-2018, p.23} ~ The prevalence of marijuana, cocaine and inhalables among 12-17 year olds – 2011 {Programa De Acción Específico – Prevención Y Atención Integral De Las Adicciones, 2013-2018, p.42} ~ Main drug of onset in young offenders disaggregated by age group and type of drug: 10-14 years, 15-18 years (%tobacco and % inhalents) {Programa De Acción Específico – Prevención Y Atención Integral De Las Adicciones, 2013-2018, p.46} ~ Prevalence of marijuana, cocaine, and crack use {Programa Contra La Pharmacodependencia, 2015-2018, p.20} ~ Prevalence (%) of the most widely consumed drugs: marijuana, inhalants, and cocaine – 2013 {Programa Contra La Pharmacodependencia, 2015-2018, p. 26} ~ Prevalence of marijuana use (%), cocaine use (%), and other illegal drugs (%) in 2011 {Programa De Acción Específico – Prevención Y Atención Integral De Las Adicciones, 2013-2018, p.42} ~ % of alcohol and inhalant consumption – disaggregated by gender – 2012 {Programa De Acción Específico – Prevención Y Atención Integral De Las Adicciones, 2013-2018, p.46} ~",8
Y,Mexico,MEX,Demand Reduction,Number of people who use drugs,Yes,"Prevalence (%) of drug use – 2008 and 2011 {Programa Contra La Pharmacodependencia, 2015-2018, p.8, p.22} ~ ",1
Y,Mexico,MEX,Demand Reduction,"Prevalence of drug use by mode of administration (oral, mucosa, inhalation, and injection)",Yes,"Frequency (%) of injecting drug use in 2012, total and disaggregated by gender {Programa De Acción Específico – Prevención Y Atención Integral De Las Adicciones, 2013-2018, p.47}~ ",1
Y,Mexico,MEX,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT)",Yes,"Ratio of dependent drug users who have sought treatment in the past year total and disaggregated by gender – 2011 {Programa Contra La Pharmacodependencia, 2015-2018, p.26} ~ Percentage of monitoring and supervision visits made to establishments specialized in addictions {Programa Contra La Pharmacodependencia, 2015-2018, p.43} ~ Number of cases with evidence of intoxication by psychoactive substances that were treated in hospital emergency departments, total, due to alcohol, and due to marijuana in 2012 {Programa De Acción Específico – Prevención Y Atención Integral De Las Adicciones, 2013-2018, p.45} ~ % of people who received brief interventions {Programa De Acción Específico – Prevención Y Atención Integral De Las Adicciones, 2013-2018, p.45} ~ number of people who attended treatment for addiction in 2012 total and disaggregated by gender {Programa De Acción Específico – Prevención Y Atención Integral De Las Adicciones, 2013-2018, p.47} ~ Reason for treatment based on drug type in 2012: % alcohol, % tobacco, and % for marijuana {Programa De Acción Específico – Prevención Y Atención Integral De Las Adicciones, 2013-2018, p.47} ~ first time consultations granted in public centers of attention to addictions {Programa De Acción Específico – Prevención Y Atención Integral De Las Adicciones, 2013-2018, p.76} ~ Number of queries from first time granted in primary care in addictions / number of queries from first time scheduled in primary care in addictions X 100 {Programa De Acción Específico – Prevención Y Atención Integral De Las Adicciones, 2013-2018, p.82} ~ treatments in addictions in residential mode granted through grant {Programa De Acción Específico – Prevención Y Atención Integral De Las Adicciones, 2013-2018, p.76, p.83} ~ Number of visits of follow-up and monitoring establishments specializing in addictions {Programa De Acción Específico – Prevención Y Atención Integral De Las Adicciones, 2013-2018, p.77, p.84} ~ In 2012, in the northern regions of the country, cocaine (%) and crystal (%) were the top reasons for seeking treatment {Programa De Acción Específico – Prevención Y Atención Integral De Las Adicciones, 2013-2018, p.47}~",11
Y,Mexico,MEX,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT) by age",Yes,"Average age of people who attended treatment for addiction in 2012 { Programa De Acción Específico – Prevención Y Atención Integral De Las Adicciones, 2013-2018, p.47} ~ Adolescents from 12 to 17 years who started treatment in public centers of attention to addictions. {Programa De Acción Específico – Prevención Y Atención Integral De Las Adicciones, 2013-2018, p.76, p.83} ~  ",2
Y,Mexico,MEX,Demand Reduction,Level of access to opioid substitution treatment and medication assisted treatment (OST/MAT),No,n/a,0
Y,Mexico,MEX,Demand Reduction,Level of coverage of inpatient treatment,No,n/a,0
Y,Mexico,MEX,Demand Reduction,Proportion of people who use drugs enrolled in voluntary treatment,No,n/a,0
Y,Mexico,MEX,Demand Reduction,Proportion of people who use drugs enrolled in coerced treatment,No,n/a,0
Y,Mexico,MEX,Demand Reduction,Proportion of people who use drugs enrolled in compulsory treatment,No,n/a,0
Y,Mexico,MEX,Demand Reduction,Presence of prevention programming in law enforcement,No,n/a,0
Y,Mexico,MEX,Demand Reduction,Presence of prevention programming in the media,Yes,"communication campaigns implemented for the prevention and treatment of tobacco, alcohol and other drug use. {Programa De Acción Específico – Prevención Y Atención Integral De Las Adicciones, 2013-2018, p.74}~ (Number of implemented prevention communication campaigns / number of scheduled preventive communication campaigns)X 100 {Programa De Acción Específico – Prevención Y Atención Integral De Las Adicciones, 2013-2018, p.80}~",2
Y,Mexico,MEX,Demand Reduction,Presence of prevention programming in schools,Yes,"Exposure to prevention and drug consumption in the last year, for the population aged 12-17 years: % of students who did drugs and received the intervention vs the % of students who did drugs and did not receive the intervention – 2011 {Programa Contra La Pharmacodependencia, 2015-2018, p.27}~ The number of screening instruments applied in primary education school populations, and with high school students between 2008 and 2012 {Programa De Acción Específico – Prevención Y Atención Integral De Las Adicciones, 2013-2018, p.49}~",2
Y,Mexico,MEX,Demand Reduction,Presence of prevention programming in the workplace,No,n/a,0
Y,Mexico,MEX,Demand Reduction,Presence of prevention programming for youth and the community,Yes,"percentage of people aged 18 to 34 years receiving prevention actions regarding addictions: Number of people aged 18 to 34 who receive addiction prevention actions/Number of people 18 to 34 years scheduled for prevention actions addictions X100 {Programa Contra La Pharmacodependencia, 2015-2018, p.41, p. 75} ~ number of adolescents 12 to 17 years involved in addiction prevention activities. {Programa De Acción Específico – Prevención Y Atención Integral De Las Adicciones, 2013-2018, p. 75, p.80} ~ screening instruments applied in adolescent population {Programa De Acción Específico – Prevención Y Atención Integral De Las Adicciones, 2013-2018, p.75, p.82} ~  Number of health units of first level in State health services which perform actions to the attention of addictions in priority municipalities / number of health units of first level in State health services which perform actions to the attention of addictions X 100 {Programa De Acción Específico – Prevención Y Atención Integral De Las Adicciones, 2013-2018, p.81} ~ % of people who do not consume drugs, % health promotion, % who are exposed to drugs but have not consumed drugs, […] {Programa De Acción Específico – Prevención Y Atención Integral De Las Adicciones, 2013-2018, p.45}~ Percentage of Municipal Committees Against Addictions (COMCA) operating in priority municipalities: (Number of COMCA operating / Number of COMCA installed) X 100 {Programa Contra La Pharmacodependencia, 2015-2018, p.42}~",6
Y,Mexico,MEX,Demand Reduction,Presence of other demand reduction metrics,No,n/a,0
Y,Mexico,MEX,Supply Reduction,Size and value of the illegal drug market,No,n/a,0
Y,Mexico,MEX,Supply Reduction,Level of procedures related to crop eradication,No,n/a,0
Y,Mexico,MEX,Supply Reduction,"Number of arrests, seizures, and offences",No,n/a,0
Y,Mexico,MEX,Supply Reduction,Level of law enforcement activity and interdiction in the market,No,n/a,0
Y,Mexico,MEX,Supply Reduction,"Price, purity and potency of drugs, and related process indicators",No,n/a,0
Y,Mexico,MEX,Supply Reduction,Number of people engaged with the criminal justice system,Yes,"total number of minor offenders, disaggregated by age -2012 {Programa De Acción Específico – Prevención Y Atención Integral De Las Adicciones, 2013-2018, p.46} ~ total number of minor offenders – disaggregated by gender - 2012 {Programa De Acción Específico – Prevención Y Atención Integral De Las Adicciones, 2013-2018, p.46}~",2
Y,Mexico,MEX,Supply Reduction,Presence of other supply reduction metrics,No,n/a,0
Y,Mexico,MEX,International Cooperation,Level of engagement in international cooperation,Yes,"compliance with requests for participation and information by the international agencies that address aspects of prevention and comprehensive care of addictions {Programa De Acción Específico – Prevención Y Atención Integral De Las Adicciones, 2013-2018, p.79} ~ Number of requests for participation and information catered) / (number of requests for participation and information received) X 100 {Programa De Acción Específico – Prevención Y Atención Integral De Las Adicciones, 2013-2018, p.87}~",2
Y,Morocco,MAR,Health,Level of availability of harm reduction services and harm reduction scale up,Yes,"Number of specific structures (i. Reception, referral, and prevention, ii. Risk Reduction/Low Threshold units/Mobile units, iii. Care systems, iv. Rehabilitation) {Programme national de lutte contre la toxicomania, 2009, p.2} ~ Number of IDUs who benefited from the risk reduction program 2009. The target for 2016 is 8,000 for risk reduction program {Plan Stratégique Nationale de Lutte Contre le Sida, 2012-2016, p.85, p.92} ~ Targets for combined prevention coverage of injecting drug users and current “active” injectors: 1) Number of IDUs (heroin and/or cocaine/crack), all routes of administration combined, benefiting under the DDR programme. (Base value in 2011, 2012, 2013, 2014, 2015, 2016) 2) Number of active injectors benefiting under the DDR programme (Base value in 2011, 2012, 2013, 2014, 2015, 2016) {Annual Report of the National Observatory of Drugs and Addiction 2014, p.35}~",3
Y,Morocco,MAR,Health,Presence of needle and syringe programs,Yes,"Number of syringes distributed to IDUs at intervention sites of risk reduction programs {Plan Stratégique Nationale de Lutte Contre le Sida, 2012-2016, p.92}~",1
Y,Morocco,MAR,Health,Prevalence of substance use disorders,Yes,"Prevalence of major problems in adults aged 15 years and over. (National General Population Prevalence Survey, 2003-2006): Alcohol Abuse, Alcohol Dependence, Substance Abuse, Substance Dependence {Programme national de lutte contre la toxicomania, 2009, p.1}~  % of people with substance dependence, and the prevalence in the general population {Stratégie Sectorielle de Santé, 2012-2016, p.71}~ the prevalence of substance dependence of those over 15 in 2006 {Drug Situation and Policy, 2014, p.10}~  The prevalence of substance abuse in 2003, and substance dependence in 2003 (for all substances and routes of administration combined) {Annual Report of the National Observatory of Drugs and Addiction 2014, p.42}~ % of those who reported abusing or dependence on these substances in 2003 {Annual Report of the National Observatory of Drugs and Addiction 2014, p.55}~ prevalence of drug abuse amongst 15 year olds in 2006 {Drug Situation and Policy, 2014, p.10}~",5
Y,Morocco,MAR,Health,Prevalence of psychiatric comorbidities,No,n/a,0
Y,Morocco,MAR,Health,Drug-related mortality,Yes,"Number of people living with HIV/AIDS in 2009, and the number who died from AIDS {Drug Situation and Policy, 2014, p.24}~",1
Y,Morocco,MAR,Health,Prevalence of drug-related infectious disease,Yes,"prevalence of new HIV infections among injecting drug users {Annual Report of the National Observatory of Drugs and Addiction 2014, p.34}~ % of new cases of HIV infections due to IDU {Plan Stratégique Nationale de Lutte Contre le Sida, 2012-2016, p.17} ~ Prevalence (%) HIV among IDUs in 2010, and the target for 2016 <5% {Plan Stratégique Nationale de Lutte Contre le Sida, 2012-2016, p.84} ~  HIV prevalence among key populations at higher risk of HIV infection (PS, MSM, IDU) {Plan Stratégique Nationale de Lutte Contre le Sida, 2012-2016, p.92}~ Number of people living with HIV/AIDS in 2009, and the number who died from AIDS {Drug Situation and Policy, 2014, p.24}~ Prevalence of HIV amongst IDUs and that of Hepatitis C {Drug Situation and Policy, 2014, p.25} ~  HIV seropositivity rate (%) among the drug users tested in Nador - 2005 {Annual Report of the National Observatory of Drugs and Addiction, 2014, p.57}~ HCV seropositivity rates (%) among the drug users tested in Nador and Al Hoceima {Annual Report of the National Observatory of Drugs and Addiction, 2014, p.57}~  Prevalence (%) of HIV among injecting drug users in 2014 {Annual Report of the National Observatory of Drugs and Addiction, 2014, p.73}~ % of new HIV infections attributable to injection drug users and their partners in 2014 {Annual Report of the National Observatory of Drugs and Addiction, 2014, p.73} ~ HIV prevalence in Al Hoceima, Tangier, Nador {Annual Report of the National Observatory of Drugs and Addiction, 2014, p.73}~",11
Y,Morocco,MAR,Health,Proportion of people who use drugs who engage in risky consumption,Yes,"Percentage of IDUs who have shared syringes in the past month - 2005 {Plan Stratégique Nationale de Lutte Contre le Sida, 2012-2016, p.19}~ Sharing rate of needles in the previous month (%), sharing rate for water used for preparation (%), sharing rate of spoons (%), and the sharing rate of cotton filters (%), in Tangier and Nador in 2010-2011 {Annual Report of the National Observatory of Drugs and Addiction, 2014, p.75}~ % of people who have reused their needle in the past month, % of people who had used already used needles the last time they injected drugs in Tangier and Nador, 2010-2011 {Annual Report of the National Observatory of Drugs and Addiction, 2014, p.75}~",3
Y,Morocco,MAR,Health,Proportion of people who use drugs who engage in safe consumption practices,Yes,"% of IDUs reported using sterile injection equipment (Core values - year 2012, 2013, 2014, 2015, 2016) {Plan Stratégique Nationale de Lutte Contre le Sida, 2012-2016, p.42} ~  Percentage of IDU reporting using sterile injection equipment at last injection {Plan Stratégique Nationale de Lutte Contre le Sida, 2012-2016, p. 84, p.92}~",2
Y,Morocco,MAR,Health,"Coverage of services for the prevention, testing, and treatment of bloodborne diseases",Yes,"Targets for combined prevention coverage of key populations at higher risk of infection: IDU (Core Values in 2010, 2012, 2013, 2014, 2015, 2016, Coverage Estimated in 2016%) IDU- Methadone (Core values in 2010, 2012, 2013, 2014, 2015, 2016, coverage estimated in 2016%) {Plan Stratégique Nationale de Lutte Contre le Sida, 2012-2016, p.42}~ Percentage of key individuals at risk of HIV infection (PS, MSM, IDU) who have had an HIV test in the last 12 months and who are aware of the outcome {Plan Stratégique Nationale de Lutte Contre le Sida, 2012-2016, p.93}~ Percentage of IDUs who were screened for HIV {Plan Stratégique Nationale de Lutte Contre le Sida, 2012-2016, p.19}~  % of IDUs who get screened for HIV and follow up with their test results – 2012 {Drug Situation and Policy, 2014, p.26}~ % of Moroccans who had access to antiretroviral therapy in 2010 {Drug Situation and Policy, 2014, p.26}~ Coverage of prevention, care and support activities (number of persons): IDU (2012, 2013, 2014, 2015, 2016) {Plan Stratégique Nationale de Lutte Contre le Sida, 2012-2016, p.71}~ Number of people (new and old) among key populations at higher risk of infection or vulnerable (PS, MSM, IDU, working people, detainees, migrants, road workers, etc.) who benefited from prevention programs in 2010 Level of priority regions {Plan Stratégique Nationale de Lutte Contre le Sida, 2012-2016, p.22}~ Percentage of key people at higher risk of HIV infection (PS, MSM, IDU) affected by HIV prevention programs {Plan Stratégique Nationale de Lutte Contre le Sida, 2012-2016, p.92} ~",8
Y,Morocco,MAR,Health,Presence of specialised training for addiction care,Yes,"Number of professionals and stakeholders trained in drug addiction {Programme national de lutte contre la toxicomania, 2009, p.2} ~ Strengthen the basic and continuing training of health professionals: 1) Increase the number of trained child psychiatrists and addictologists. 2) Strengthen the training of specialized nurses (100/year versus 80/year currently) {Stratégie Sectorielle de Santé, 2012-2016, p.72}~ Number of people have been trained since the creation of this diploma {Drug Situation and Policy, 2014, p.29}~ ",3
Y,Morocco,MAR,Health,Presence of health harms related to drug use,No,n/a,0
Y,Morocco,MAR,Health,Presence of other health metrics,No,n/a,0
Y,Morocco,MAR,Peace and Security,"Prevalence of alcohol and drugs in accidents, and interventions to increase road safety",No,n/a,0
Y,Morocco,MAR,Peace and Security,Annual number of public disorder and violent crime reports,Yes,"Trends in the number of drug-related crimes from 2002 to 2013 (number of cases): Kif, Cannabis Resin, Cannabis Oil, Cocaine, Opiates, Heroin, Morphine, Synthetic Drugs, Psychotropic Drugs, Psychostimulants, Solvents, Hallucinogenic gases, Maajoun, Tobacco, Total {Annual Report of the National Observatory of Drugs and Addiction, 2014, p.90}~ ",1
Y,Morocco,MAR,Peace and Security,Number of non-lethal drug market violent events reported,No,n/a,0
Y,Morocco,MAR,Peace and Security,Number of drug market related homicides and disappearances,No,n/a,0
Y,Morocco,MAR,Peace and Security,Presence of other peace and security metrics,No,n/a,0
Y,Morocco,MAR,Development,Coverage of housing assistance for people who use drugs,No,n/a,0
Y,Morocco,MAR,Development,Coverage of social assistance for people who use drugs (not including housing),No,n/a,0
Y,Morocco,MAR,Development,Number of households enrolled in alternative development,No,n/a,0
Y,Morocco,MAR,Development,Presence of other development metrics,No,n/a,0
Y,Morocco,MAR,Human Rights,"Prevalence and incidence of infectious diseases in vulnerable populations (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"Prevalence of HIV among prison populations {Plan Stratégique Nationale de Lutte Contre le Sida, 2012-2016, p.19}~  HIV prevalence among key populations at higher risk of HIV infection (PS, MSM, IDU) {Plan Stratégique Nationale de Lutte Contre le Sida, 2012-2016, p.92}~",2
Y,Morocco,MAR,Human Rights,"Prevalence of vulnerable people who use drugs (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"% of drug users in prison {Annual Report of the National Observatory of Drugs and Addiction, 2014, p.70}~",1
Y,Morocco,MAR,Human Rights,Proportion of people who use drugs in prison that are receiving medication assisted treatment (MAT),Yes,"Phasing of admission to the prison methadone programme: 2012 – 0; 2013 – 75; 2014 – 100; 2015- 150; 2016 – 200 {Annual Report of the National Observatory of Drugs and Addiction 2014, p.70}~ The coverage target is 10% of beneficiaries of the OST programme (200 in 2016) in Moroccan prisons. {Annual Report of the National Observatory of Drugs and Addiction 2014, p.84}~",2
Y,Morocco,MAR,Human Rights,Distribution of sterile injecting equipment in prisons,No,n/a,0
Y,Morocco,MAR,Human Rights,Presence of programs and services targeted towards women ,No,n/a,0
Y,Morocco,MAR,Human Rights,Presence of programs and services targeted towards people of color,No,n/a,0
Y,Morocco,MAR,Human Rights,Presence of challenges and/or harms experienced by people of color,No,n/a,0
Y,Morocco,MAR,Human Rights,"Presence of programs and services targeted towards vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"Percentage of key people at higher risk of HIV infection (PS, MSM, IDU) affected by HIV prevention programs {Plan Stratégique Nationale de Lutte Contre le Sida, 2012-2016, p.92} ~ Percentage of key individuals at risk of HIV infection (PS, MSM, IDU) who have had an HIV test in the last 12 months and who are aware of the outcome {Plan Stratégique Nationale de Lutte Contre le Sida, 2012-2016, p.93}~ Number of people (new and old) among key populations at higher risk of infection or vulnerable (PS, MSM, IDU, working people, detainees, migrants, road workers, etc.) who benefited from prevention programs in 2010 Level of priority regions {Plan Stratégique Nationale de Lutte Contre le Sida, 2012-2016, p.22}~ Number of detainees, migrants, road workers and workers who benefited from HIV prevention programs in 2010, and the target for 2016 is 135,000 {Plan Stratégique Nationale de Lutte Contre le Sida, 2012-2016, p.85}~ ",4
Y,Morocco,MAR,Human Rights,"Presence of challenges and/or harms experienced by vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"Proportion of drug users that have been subjected to violence by the police in 2011. […]. When asked to specify the kind of ill-treatment they had suffered, % that mentioned harassment and the % that mentioned illegal practices {Annual Report of the National Observatory of Drugs and Addiction, 2014, p.20}~ ",1
Y,Morocco,MAR,Human Rights,Presence of other human rights metrics,No,n/a,0
Y,Morocco,MAR,Demand Reduction,Prevalence of drug use by age,Yes,"prevalence, demand and drug use at school {Annual Report of the National Observatory of Drugs and Addiction 2014, p.38}~ Prevalence (%) of cannabis and psychotropic substance use by gender in the 15-17 age group {Annual Report of the National Observatory of Drugs and Addiction 2014, p.47}~",2
Y,Morocco,MAR,Demand Reduction,Prevalence of drug use by sex,Yes,"Prevalence (%) of cannabis and psychotropic substance use by gender in the 15-17 age group {Annual Report of the National Observatory of Drugs and Addiction 2014, p.47}~",1
Y,Morocco,MAR,Demand Reduction,Prevalence of drug use by type,Yes,"Number of IDUs injecting heroin in 2013 {Drug Situation and Policy, 2014, p.24} ~ Prevalence of cannabis, sedative, cocaine, solvents, and opioid use in the general population in 2003 {Annual Report of the National Observatory of Drugs and Addiction 2014, p.42} ~ Prevalence (%) of cannabis and psychotropic substance use by gender in the 15-17 age group {Annual Report of the National Observatory of Drugs and Addiction 2014, p.47}~ Most used substance – Heroin- %, and regions where use is seen (%). Percentage that have used the injection method at least once in their lifetime, and the frequency range in Nador and Fes  - 2005 {p.56}~",4
Y,Morocco,MAR,Demand Reduction,Number of people who use drugs,Yes," % of those who reported psychoactive substance use in the previous 12 months in 2003 {Annual Report of the National Observatory of Drugs and Addiction, 2014, p.55}~ Lifetime prevalence of psychoactive substance use in 2003 {Annual Report of the National Observatory of Drugs and Addiction 2014, p.42}~",2
Y,Morocco,MAR,Demand Reduction,"Prevalence of drug use by mode of administration (oral, mucosa, inhalation, and injection)",Yes,"Number of Injecting Drug Users (IDU) in Morocco in 2013 {Drug Situation and Policy, 2014, p.24}~ Number of IDUs injecting heroin in 2013 {Drug Situation and Policy, 2014, p.24} ~ Ratio of people who have injected drugs (3/4) – 2005 {Annual Report of the National Observatory of Drugs and Addiction, 2014, p.55}~  Most used substance – Heroin- %, and regions where use is seen (%). Percentage that have used the injection method at least once in their lifetime, and the frequency range in Nador and Fes  - 2005 {p.56}~  Percentage of people more likely to be affected by IDU in 2010, and the target for 2016: 40% {Plan Stratégique Nationale de Lutte Contre le Sida, 2012-2016, p.84} ~",5
Y,Morocco,MAR,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT)",Yes,"Number of specific structures (i. Reception, referral, and prevention, ii. Risk Reduction/Low Threshold units/Mobile units, iii. Care systems, iv. Rehabilitation) {Programme national de lutte contre la toxicomania, 2009, p.2}~ Number of users that have access to the different facilities/structures for drug users {Programme national de lutte contre la toxicomania, 2009, p.2}~ Treating and rehabilitating drug users (2008 priority): Creation of 16 detoxification units for drug users in psychiatric facilities {Annual Report of the National Observatory of Drugs and Addiction 2014, p.25} ~",3
Y,Morocco,MAR,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT) by age",No,n/a,0
Y,Morocco,MAR,Demand Reduction,Level of access to opioid substitution treatment and medication assisted treatment (OST/MAT),Yes,"Number of injecting drug users enrolled in a methadone maintenance program {Programme national de lutte contre la toxicomania, 2009, p.2} ~ Targets for combined prevention coverage of key populations at higher risk of infection: IDU (Core Values in 2010, 2012, 2013, 2014, 2015, 2016, Coverage Estimated in 2016%) IDU- Methadone (Core values in 2010, 2012, 2013, 2014, 2015, 2016, coverage estimated in 2016%) {Plan Stratégique Nationale de Lutte Contre le Sida, 2012-2016, p.42} ~ Number of IDUs receiving methadone substitution treatment {Plan Stratégique Nationale de Lutte Contre le Sida, 2012-2016, p. 85, p. 92}~  ",3
Y,Morocco,MAR,Demand Reduction,Level of coverage of inpatient treatment,No,n/a,0
Y,Morocco,MAR,Demand Reduction,Proportion of people who use drugs enrolled in voluntary treatment,No,n/a,0
Y,Morocco,MAR,Demand Reduction,Proportion of people who use drugs enrolled in coerced treatment,No,n/a,0
Y,Morocco,MAR,Demand Reduction,Proportion of people who use drugs enrolled in compulsory treatment,No,n/a,0
Y,Morocco,MAR,Demand Reduction,Presence of prevention programming in law enforcement,No,n/a,0
Y,Morocco,MAR,Demand Reduction,Presence of prevention programming in the media,No,n/a,0
Y,Morocco,MAR,Demand Reduction,Presence of prevention programming in schools,No,n/a,0
Y,Morocco,MAR,Demand Reduction,Presence of prevention programming in the workplace,No,n/a,0
Y,Morocco,MAR,Demand Reduction,Presence of prevention programming for youth and the community,No,n/a,0
Y,Morocco,MAR,Demand Reduction,Presence of other demand reduction metrics,No,n/a,0
Y,Morocco,MAR,Supply Reduction,Size and value of the illegal drug market,No,n/a,0
Y,Morocco,MAR,Supply Reduction,Level of procedures related to crop eradication,Yes,"Number of people involved in the production of cannabis {Drug Situation and Policy, 2014, p.8} ~ Number of hectares of cannabis crops {Drug Situation and Policy, 2014, p.9}~ Number of hectares of illegal cannabis crops destroyed in 2010 {Drug Situation and Policy, 2014, p.12}~ Total surface area of cannabis crops in 2010 {Drug Situation and Policy, 2014, p.12}~ reduce the areas on which cannabis is grown by 65%. The number of hectares in 2003, and 2010. The number of hectares eradicated in 2010 {Annual Report of the National Observatory of Drugs and Addiction, 2014, p.37 & p.86}~",5
Y,Morocco,MAR,Supply Reduction,"Number of arrests, seizures, and offences",Yes,"Number (in tons) of kif seized - 2011 {Drug Situation and Policy, 2014, p.16}~ Number (in tons) of cannabis resin seizures – 2011 {Drug Situation and Policy, 2014, p.16}~ % of prisoners incarcerated for drug-related offenses, and the number of prisoners incarcerated for drug-related offenses {Drug Situation and Policy, 2014, p.17}~ % of those imprisoned for drug trafficking purposes {Annual Report of the National Observatory of Drugs and Addiction, 2014, p.91}~ Quantities of drugs seized in 2012 and 2013 (tonnes, kg, gr, units): Cannabis Resin, Cannabis Leaf, Cocaine, Heroin, Psychotropic Substances {Annual Report of the National Observatory of Drugs and Addiction, 2014, p.92}~ Number of cases related to illicit trafficking in drugs, and the number resulting in the arrest – in 2013 {Annual Report of the National Observatory of Drugs and Addiction, 2014, p.93}~ Quantities of drugs seized in the fight against drug abuse (kg, gr, units): Cannabis Resin, Cannabis Leaf (Kif), Cocaine, Heroin, Psychotropic Substances {Annual Report of the National Observatory of Drugs and Addiction, 2014, p.93}~ Quantities of drugs seized in 2013 in areas around schools (kg, gr): Cannabis Resin, Cannabis Leaf (Kif), Maajoun, Cocaine {Annual Report of the National Observatory of Drugs and Addiction, 2014, p.94}~ Total quantities of narcotics seized at the border {Drug Situation and Policy, 2014, p.11}~ ",9
Y,Morocco,MAR,Supply Reduction,Level of law enforcement activity and interdiction in the market,Yes,"Fight Against Drug Abuse: number of law enforcement cases, number of arresting users, number of minors {Annual Report of the National Observatory of Drugs and Addiction, 2014, p.93}~ Number of requests for financial intelligence, number of agencies demanding the requests, number of foreign intelligence units, number of issued requisitions - between 2009 – 2012 {Drug Situation and Policy, 2014, p.14, Annual Report of the National Observatory of Drugs and Addiction, 2014, p.22} ~",2
Y,Morocco,MAR,Supply Reduction,"Price, purity and potency of drugs, and related process indicators",Yes,"data on drug use in prisons: purity and price of drugs and on the proportion of prison sentences related to drug use or trafficking {Annual Report of the National Observatory of Drugs and Addiction, 2014, p.38}~",1
Y,Morocco,MAR,Supply Reduction,Number of people engaged with the criminal justice system,Yes,"Percentage of prison population sentenced for drug-related crimes, ranging from mere personal use to trafficking committed by an organized group in 2010 and 2011 {Drug Situation and Policy, 2014, p.16, Annual Report of the National Observatory of Drugs and Addiction, 2014, p.20, p.89, Annual Report of the National Observatory of Drugs and Addiction, 2014, p.38}~ Trends in the number of persons prosecuted for drug-related crimes from 2002 to 2013 (number of persons prosecuted for drug-related crimes from 2002 to 2013): Kif, Cannabis Resin, Cannabis Oil, Cocaine, Opiates, Heroin, Morphine, Synthetic Drugs, Psychotropic Drugs, Psychostimulants, Solvents, Hallucinogenic gases, Maajoun, Tobacco, Total {Annual Report of the National Observatory of Drugs and Addiction, 2014, p.90}~ ",2
Y,Morocco,MAR,Supply Reduction,Presence of other supply reduction metrics,No,n/a,0
Y,Morocco,MAR,International Cooperation,Level of engagement in international cooperation,No,n/a,0
Y,Jamaica,JAM,Health,Level of availability of harm reduction services and harm reduction scale up,No,n/a,0
Y,Jamaica,JAM,Health,Presence of needle and syringe programs,No,n/a,0
Y,Jamaica,JAM,Health,Prevalence of substance use disorders,No,n/a,0
Y,Jamaica,JAM,Health,Prevalence of psychiatric comorbidities,No,n/a,0
Y,Jamaica,JAM,Health,Drug-related mortality,No,n/a,0
Y,Jamaica,JAM,Health,Prevalence of drug-related infectious disease,No,n/a,0
Y,Jamaica,JAM,Health,Proportion of people who use drugs who engage in risky consumption,Yes,"Annual Reported risk behaviours among adults with HIV (1982 – Dec 2015 cumulative): Crack, Cocaine use; IV drug use and the number of persons involved {HIV Epidemiological Profile 2015,facts and figures, 2015, p.9, p.25} ~ ",1
Y,Jamaica,JAM,Health,Proportion of people who use drugs who engage in safe consumption practices,No,n/a,0
Y,Jamaica,JAM,Health,"Coverage of services for the prevention, testing, and treatment of bloodborne diseases",No,n/a,0
Y,Jamaica,JAM,Health,Presence of specialised training for addiction care,No,n/a,0
Y,Jamaica,JAM,Health,Presence of health harms related to drug use,No,n/a,0
Y,Jamaica,JAM,Health,Presence of other health metrics,No,n/a,0
Y,Jamaica,JAM,Peace and Security,"Prevalence of alcohol and drugs in accidents, and interventions to increase road safety",No,n/a,0
Y,Jamaica,JAM,Peace and Security,Annual number of public disorder and violent crime reports,No,n/a,0
Y,Jamaica,JAM,Peace and Security,Number of non-lethal drug market violent events reported,No,n/a,0
Y,Jamaica,JAM,Peace and Security,Number of drug market related homicides and disappearances,No,n/a,0
Y,Jamaica,JAM,Peace and Security,Presence of other peace and security metrics,No,n/a,0
Y,Jamaica,JAM,Development,Coverage of housing assistance for people who use drugs,No,n/a,0
Y,Jamaica,JAM,Development,Coverage of social assistance for people who use drugs (not including housing),No,n/a,0
Y,Jamaica,JAM,Development,Number of households enrolled in alternative development,No,n/a,0
Y,Jamaica,JAM,Development,Presence of other development metrics,No,n/a,0
Y,Jamaica,JAM,Human Rights,"Prevalence and incidence of infectious diseases in vulnerable populations (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"The prevalence of inmates who are HIV positive {HIV Epidemiological Profile 2015,facts and figures, 2015, p.11; Highlights of Key Initiatives: Annual Report 2016-2017, 2017, p.92} ~ The prevalence of homeless drug users who are HIV positive {HIV Epidemiological Profile 2015,facts and figures, 2015, p.11} ~",2
Y,Jamaica,JAM,Human Rights,"Prevalence of vulnerable people who use drugs (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Jamaica,JAM,Human Rights,Proportion of people who use drugs in prison that are receiving medication assisted treatment (MAT),No,n/a,0
Y,Jamaica,JAM,Human Rights,Distribution of sterile injecting equipment in prisons,No,n/a,0
Y,Jamaica,JAM,Human Rights,Presence of programs and services targeted towards women ,No,n/a,0
Y,Jamaica,JAM,Human Rights,Presence of programs and services targeted towards people of color,No,n/a,0
Y,Jamaica,JAM,Human Rights,Presence of challenges and/or harms experienced by people of color,No,n/a,0
Y,Jamaica,JAM,Human Rights,"Presence of programs and services targeted towards vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Jamaica,JAM,Human Rights,"Presence of challenges and/or harms experienced by vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Jamaica,JAM,Human Rights,Presence of other human rights metrics,No,n/a,0
Y,Jamaica,JAM,Demand Reduction,Prevalence of drug use by age,Yes,"prevalence of marijuana use by sex and age (% included) {Highlights of Key Initiatives: Annual Report 2016-2017, 2017, p.76} ~ prevalence of marijuana use among students age 15-16 {National Secondary School Survey 2013 FACT SHEET, 2014, p.1; Student Ganja Use: Jamaica Secondary school survey, 2013, p.1, p.2} ~ Average age of first use of marijuana {Student Ganja Use: Jamaica Secondary school survey, 2013, p.2; National Secondary School Survey 2013 FACT SHEET, 2014, p.1} ~ Proportion of students who are current marijuana user that are at higher risk for marijuana misuse {National Secondary School Survey 2013 FACT SHEET, 2014, p.1; Student Ganja Use: Jamaica Secondary school survey, 2013, p.2} ~ ",4
Y,Jamaica,JAM,Demand Reduction,Prevalence of drug use by sex,Yes,"prevalence of marijuana use by sex and age (% included) {Highlights of Key Initiatives: Annual Report 2016-2017, 2017, p.76} ~ ",1
Y,Jamaica,JAM,Demand Reduction,Prevalence of drug use by type,Yes,"prevalence of marijuana use by sex and age (% included) {Highlights of Key Initiatives: Annual Report 2016-2017, 2017, p.76} ~ prevalence of marijuana use among students age 15-16 {National Secondary School Survey 2013 FACT SHEET, 2014, p.1; Student Ganja Use: Jamaica Secondary school survey, 2013, p.1, p.2} ~ Average age of first use of marijuana {Student Ganja Use: Jamaica Secondary school survey, 2013, p.2; National Secondary School Survey 2013 FACT SHEET, 2014, p.1} ~ Prevalence Use of Main Substances (%): Marijuana, Inhalants; over lifetime, past month and past year {National Secondary School Survey 2013 FACT SHEET, 2014, p.1; Highlights of Key Initiatives: Annual Report 2016-2017, 2017, p.76} ~ Proportion of students who are current marijuana user that are at higher risk for marijuana misuse {National Secondary School Survey 2013 FACT SHEET, 2014, p.1; Student Ganja Use: Jamaica Secondary school survey, 2013, p.1, p.2} ~ % of the participants who reported that they smoked marijuana at some point in their lifetime, past year, and past month {Student Ganja Use: Jamaica Secondary school survey, 2013, p.2} ~ % who reported that some of their friends smoke marijuana on a frequent basis {Student Ganja Use: Jamaica Secondary school survey, 2013, p.2} ~ ",7
Y,Jamaica,JAM,Demand Reduction,Number of people who use drugs,Yes,"% that reported that their father/guardian smoked regularly, mothers/guardian (%) and both parents {National Secondary School Survey 2013 FACT SHEET, 2014, p.2} ~ ",1
Y,Jamaica,JAM,Demand Reduction,"Prevalence of drug use by mode of administration (oral, mucosa, inhalation, and injection)",Yes,"The number of cases of IV Drug use reported since 1982, % that were reported in the period 2008 – 2015 {HIV Epidemiological Profile 2015,facts and figures, 2015, p.10} ~",1
Y,Jamaica,JAM,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT)",No,n/a,0
Y,Jamaica,JAM,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT) by age",Yes,"the number of children seeking assistance at public medical facilities for ganja-related illnesses since decriminalized in 2015 {Highlights of Key Initiatives: Annual Report 2016-2017, 2017, p.78} ~ ",1
Y,Jamaica,JAM,Demand Reduction,Level of access to opioid substitution treatment and medication assisted treatment (OST/MAT),No,n/a,0
Y,Jamaica,JAM,Demand Reduction,Level of coverage of inpatient treatment,No,n/a,0
Y,Jamaica,JAM,Demand Reduction,Proportion of people who use drugs enrolled in voluntary treatment,No,n/a,0
Y,Jamaica,JAM,Demand Reduction,Proportion of people who use drugs enrolled in coerced treatment,Yes,"% of the adolescents seen in the NCDA’s drug treatment program that are referred due to problems associated with marijuana use {Highlights of Key Initiatives: Annual Report 2016-2017, 2017, p.76} ~ ",1
Y,Jamaica,JAM,Demand Reduction,Proportion of people who use drugs enrolled in compulsory treatment,No,n/a,0
Y,Jamaica,JAM,Demand Reduction,Presence of prevention programming in law enforcement,No,n/a,0
Y,Jamaica,JAM,Demand Reduction,Presence of prevention programming in the media,No,n/a,0
Y,Jamaica,JAM,Demand Reduction,Presence of prevention programming in schools,No,n/a,0
Y,Jamaica,JAM,Demand Reduction,Presence of prevention programming in the workplace,No,n/a,0
Y,Jamaica,JAM,Demand Reduction,Presence of prevention programming for youth and the community,Yes,"According to the treatment reports, the % increase in students enrolled in a ganja prevention programme called “STEP-UP” since the decriminalization of possession of 2 ounces or less of ganja {Highlights of Key Initiatives: Annual Report 2016-2017, 2017, p.76} ~ % who felt that “smoking marijuana sometimes” was very harmful to health {Student Ganja Use: Jamaica Secondary school survey, 2013, p.2} ~ % who reported that all of their friends would disapprove of them smoking marijuana while % who said none would disapprove {Student Ganja Use: Jamaica Secondary school survey, 2013, p.2} ~ % who reported that all of their friends would convince them to stop smoking marijuana while % who said none of their friends would convince them to stop {Student Ganja Use: Jamaica Secondary school survey, 2013, p.2} ~",4
Y,Jamaica,JAM,Demand Reduction,Presence of other demand reduction metrics,Yes,"% of participants who reported that they were curious to try marijuana while % who reported that they would try an illicit drug if given the chance {Student Ganja Use: Jamaica Secondary school survey, 2013, p.2} ~ ",1
Y,Jamaica,JAM,Supply Reduction,Size and value of the illegal drug market,Yes,"% who reported drugs were available in and around school compounds {Highlights of Key Initiatives: Annual Report 2016-2017, 2017, p.77; National Secondary School Survey 2013 FACT SHEET, 2014, p.2; Student Ganja Use: Jamaica Secondary school survey, 2013, p.1} ~ % that felt drugs (marijuana, cocaine, ecstasy) was easy to access {National Secondary School Survey 2013 FACT SHEET, 2014, p.2} ~ % of people by sex (males and females) who reported that drugs were easily accessible (marijuana, cocaine, crack, ecstasy, LSD, heroin) {National Secondary School Survey 2013 FACT SHEET, 2014, p.2} ~ Significantly more students from 4th form (grade 10) reported easy accessibility to illicit drugs than all other grade levels {National Secondary School Survey 2013 FACT SHEET, 2014, p.2} ~ % of students who had been offered marijuana {Student Ganja Use: Jamaica Secondary school survey, 2013, p.2} ~",5
Y,Jamaica,JAM,Supply Reduction,Level of procedures related to crop eradication,No,n/a,0
Y,Jamaica,JAM,Supply Reduction,"Number of arrests, seizures, and offences",No,n/a,0
Y,Jamaica,JAM,Supply Reduction,Level of law enforcement activity and interdiction in the market,No,n/a,0
Y,Jamaica,JAM,Supply Reduction,"Price, purity and potency of drugs, and related process indicators",No,n/a,0
Y,Jamaica,JAM,Supply Reduction,Number of people engaged with the criminal justice system,No,n/a,0
Y,Jamaica,JAM,Supply Reduction,Presence of other supply reduction metrics,No,n/a,0
Y,Jamaica,JAM,International Cooperation,Level of engagement in international cooperation,No,n/a,0
Y,Guyana,GUY,Health,Level of availability of harm reduction services and harm reduction scale up,No,n/a,0
Y,Guyana,GUY,Health,Presence of needle and syringe programs,No,n/a,0
Y,Guyana,GUY,Health,Prevalence of substance use disorders,Yes,"Problem Use of Marijuana (Smoked marijuana before midday; Smoked marijuana when you were alone; Had memory problems when you smoked marijuana; Friends or members of your family told you that you ought to reduce your marijuana use; Tried to reduce or stop your marijuana use without succeeding; Had problems because of your use of marijuana (argument, fight, accident, bad result at school) {Guyana National Household Drug Prevalence Survey, 2016, p.83} ~ CAST Scores for Respondents who smoked Marijuana in the last 12 months (No Risk of Problem Use, Low Risk of Problem Use, High Risk of Problem Use) {Guyana National Household Drug Prevalence Survey, 2016, p.84} ~ ",2
Y,Guyana,GUY,Health,Prevalence of psychiatric comorbidities,No,n/a,0
Y,Guyana,GUY,Health,Drug-related mortality,No,n/a,0
Y,Guyana,GUY,Health,Prevalence of drug-related infectious disease,No,n/a,0
Y,Guyana,GUY,Health,Proportion of people who use drugs who engage in risky consumption,No,n/a,0
Y,Guyana,GUY,Health,Proportion of people who use drugs who engage in safe consumption practices,No,n/a,0
Y,Guyana,GUY,Health,"Coverage of services for the prevention, testing, and treatment of bloodborne diseases",No,n/a,0
Y,Guyana,GUY,Health,Presence of specialised training for addiction care,No,n/a,0
Y,Guyana,GUY,Health,Presence of health harms related to drug use,Yes,"Negative Experiences from Drug and Alcohol Use (Thinking seriously about committing suicide) {Guyana National Household Drug Prevalence Survey, 2016, p.87} ~",1
Y,Guyana,GUY,Health,Presence of other health metrics,No,n/a,0
Y,Guyana,GUY,Peace and Security,"Prevalence of alcohol and drugs in accidents, and interventions to increase road safety",Yes,"Percentage of Sample driving under the influence of drug or drink (Drove a vehicle while under the influence of alcohol in the past 12 months; Drove a vehicle while under the influence of an illegal drug in the past 12 month) {Guyana National Household Drug Prevalence Survey, 2016, p.87} ~",1
Y,Guyana,GUY,Peace and Security,Annual number of public disorder and violent crime reports,Yes,"Negative Experiences from Drug and Alcohol Use (Getting into trouble with the police, Getting involved in an intense argument or fight, Having domestic problems, Taken advantage of sexually or having someone take liberties with you, Taking sexual advantage of someone or taking liberties with another person, Self-inflicting injuries) {Guyana National Household Drug Prevalence Survey, 2016, p.87} ~ ",1
Y,Guyana,GUY,Peace and Security,Number of non-lethal drug market violent events reported,No,n/a,0
Y,Guyana,GUY,Peace and Security,Number of drug market related homicides and disappearances,No,n/a,0
Y,Guyana,GUY,Peace and Security,Presence of other peace and security metrics,No,n/a,0
Y,Guyana,GUY,Development,Coverage of housing assistance for people who use drugs,No,n/a,0
Y,Guyana,GUY,Development,Coverage of social assistance for people who use drugs (not including housing),No,n/a,0
Y,Guyana,GUY,Development,Number of households enrolled in alternative development,No,n/a,0
Y,Guyana,GUY,Development,Presence of other development metrics,No,n/a,0
Y,Guyana,GUY,Human Rights,"Prevalence and incidence of infectious diseases in vulnerable populations (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Guyana,GUY,Human Rights,"Prevalence of vulnerable people who use drugs (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Guyana,GUY,Human Rights,Proportion of people who use drugs in prison that are receiving medication assisted treatment (MAT),No,n/a,0
Y,Guyana,GUY,Human Rights,Distribution of sterile injecting equipment in prisons,No,n/a,0
Y,Guyana,GUY,Human Rights,Presence of programs and services targeted towards women ,No,n/a,0
Y,Guyana,GUY,Human Rights,Presence of programs and services targeted towards people of color,No,n/a,0
Y,Guyana,GUY,Human Rights,Presence of challenges and/or harms experienced by people of color,No,n/a,0
Y,Guyana,GUY,Human Rights,"Presence of programs and services targeted towards vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Guyana,GUY,Human Rights,"Presence of challenges and/or harms experienced by vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Guyana,GUY,Human Rights,Presence of other human rights metrics,No,n/a,0
Y,Guyana,GUY,Demand Reduction,Prevalence of drug use by age,Yes,"Distribution of Average Age at First Use for Illegal Drugs (Crack, Ecstasy, Marijuana, Cocaine) {Guyana National Household Drug Prevalence Survey, 2016, p.75} ~",1
Y,Guyana,GUY,Demand Reduction,Prevalence of drug use by sex,No,n/a,0
Y,Guyana,GUY,Demand Reduction,Prevalence of drug use by type,Yes,"Distribution of Average Age at First Use for Illegal Drugs (Crack, Ecstasy, Marijuana, Cocaine) {Guyana National Household Drug Prevalence Survey, 2016, p.75} ~ Prevalence rates for marijuana use (Past year, Past month) {Guyana National Household Drug Prevalence Survey, 2016, p.76} ~ Frequency of Marijuana Use in the Population (Smoke marijuana daily or almost daily, Smoke marijuana monthly, Smoke marijuana weekly, Did not smoke marijuana in the last year) {Guyana National Household Drug Prevalence Survey, 2016, p.76} ~ % Frequency of Marijuana Use 30 days prior to the Survey {Guyana National Household Drug Prevalence Survey, 2016, p.77} ~ Incidence rates for marijuana use (One month incidence rate, One year incidence rate) {Guyana National Household Drug Prevalence Survey, 2016, p.82} ~ Lifetime Prevalence of drugs by type: Marijuana, Cocaine, Crack, Other Substances (E-cigarette, Grabba (Tobacco Leaf), Tranquilizers, Marijuana blunt laced with ecstasy, Hookah pipes (tobacco water pipes), Seasoned spliff/ Black Joint (marijuana mixed with cocaine), MDMA (Ecstasy, Molly, Adam, X-TC), Inhalants, Heroin, Analgesics, Amphetamine-type stimulants) {Guyana National Household Drug Prevalence Survey, 2016, p.76, p.85, p.86} ~",6
Y,Guyana,GUY,Demand Reduction,Number of people who use drugs,Yes,"Respondents Reporting Having a Chance to Use an Illegal Drug (% Yes, % No) {Guyana National Household Drug Prevalence Survey, 2016, p.48} ~ Respondents with family and friends who use illegal drugs (% Yes, % No) {Guyana National Household Drug Prevalence Survey, 2016, p.49} ~ Number of family and friends respondents have that use illegal drugs (one, two or more) {Guyana National Household Drug Prevalence Survey, 2016, p.49} ~",3
Y,Guyana,GUY,Demand Reduction,"Prevalence of drug use by mode of administration (oral, mucosa, inhalation, and injection)",No,n/a,0
Y,Guyana,GUY,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT)",Yes,"The number of clients treated at the Georgetown Public Hospital outpatient centre over the period January- September 2013. {National Drug Strategy Master Plan, 2016-2020, p.25} ~ Distribution of Persons Treated across Treatment Centres by Gender, 2015 {Annual Report, 2015, p.41} ~ Distribution of Persons Treated across Treatment Centres by Type of Drug, 2015 {Annual Report, 2015, p.44} ~ Treatment Centres (Pheonix, GPHC, Salvation Army) : Number of Persons Treated for Alcohol and drug related problems, Jan. 1 to Dec. 31, 2015 {Annual Report, 2015, p.45, p.46, p.47} ~ Treatment Centres (Pheonix, GPHC, Salvation Army): Distribution of Persons Treated for Substance Abuse by Type of Drug, 2015 {Annual Report, 2015, p.45, p.46, p.47} ~ Percentage of Respondents who used Alcohol and/or Drugs who received Treatment or felt the need for treatment (Received treatment for alcohol and/or drugs; Received treatment for alcohol of drugs in the past 12 months; Felt I needed help or treatment of some kind to reduce or stop drinking alcohol or taking drug in the past 12 months) {Guyana National Household Drug Prevalence Survey, 2016, p.88} ~ Type of Drug Respondents received Treatment for in the past 12 months {Guyana National Household Drug Prevalence Survey, 2016, p.89} ~ Treatment Settings (Outpatient health or rehabilitation; Office of a private practitioner; Rehabilitation center) {Guyana National Household Drug Prevalence Survey, 2016, p.89} ~ Reason why Respondents did not access help or treatment (I am not ready to stop using; I don’t know where to get treatment; I could not afford the treatment; No transportation, too far away; I could not find the type of treatment that I wanted; Treatment might have a negative effect on my job; Other; Treatment might cause neighbors to have a negative opinion of me; Treatment not covered on health care plan {Guyana National Household Drug Prevalence Survey, 2016, p.90} ~ Respondents who felt the need for Treatment for alcohol/drug use by Region {Guyana National Household Drug Prevalence Survey, 2016, p.91} ~",10
Y,Guyana,GUY,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT) by age",Yes,"Distribution of Persons Treated across Treatment Centres (Phoenix Centre, Salvation Army, Georgetown Hospital) by Age Category, 2015 {Annual Report, 2015, p.42, p.43} ~ ",1
Y,Guyana,GUY,Demand Reduction,Level of access to opioid substitution treatment and medication assisted treatment (OST/MAT),No,n/a,0
Y,Guyana,GUY,Demand Reduction,Level of coverage of inpatient treatment,No,n/a,0
Y,Guyana,GUY,Demand Reduction,Proportion of people who use drugs enrolled in voluntary treatment,No,n/a,0
Y,Guyana,GUY,Demand Reduction,Proportion of people who use drugs enrolled in coerced treatment,No,n/a,0
Y,Guyana,GUY,Demand Reduction,Proportion of people who use drugs enrolled in compulsory treatment,No,n/a,0
Y,Guyana,GUY,Demand Reduction,Presence of prevention programming in law enforcement,No,n/a,0
Y,Guyana,GUY,Demand Reduction,Presence of prevention programming in the media,No,n/a,0
Y,Guyana,GUY,Demand Reduction,Presence of prevention programming in schools,No,n/a,0
Y,Guyana,GUY,Demand Reduction,Presence of prevention programming in the workplace,No,n/a,0
Y,Guyana,GUY,Demand Reduction,Presence of prevention programming for youth and the community,No,n/a,0
Y,Guyana,GUY,Demand Reduction,Presence of other demand reduction metrics,Yes,"Negative Experiences from Drug and Alcohol Use (Performing poorly on an important test or project, Memory loss, Trying in vain to stop drinking or taking illicit drugs) {Guyana National Household Drug Prevalence Survey, 2016, p.87} ~ Respondents' Perception on whether Drug Taking had increased, remained the same, or declined in the past few years (Increased; Remained the same; Declined; Don't know) {Guyana National Household Drug Prevalence Survey, 2016, p.93} ~ Respondents' Perception on whether Drug Taking was going to get worse, remain the same, or decline in the coming years (It's going to get worse; It's going to remain the same; It's going to decline; Don't know; No response) {Guyana National Household Drug Prevalence Survey, 2016, p.94} ~ Respondents' Perception on whether the drug issue is among the core concerns of the Government (Yes; No; Don't know; No response) {Guyana National Household Drug Prevalence Survey, 2016, p.95} ~",4
Y,Guyana,GUY,Supply Reduction,Size and value of the illegal drug market,Yes,"Perception (%) of ease of access to drugs {Guyana National Household Drug Prevalence Survey, 2016, p.47, p.48} ~ Number of times Respondents had a chance to try an illegal drug (once, two or more times) {Guyana National Household Drug Prevalence Survey, 2016, p.48} ~ Percentage of respondents who were offered an illegal drug by Respondents with family or friends who use illegal drugs {Guyana National Household Drug Prevalence Survey, 2016, p.50} ~ The last time Respondents were offered an illegal drug (During the last 30 days, More than one month ago but less than one year ago, More than one year ago, I have never been offered) {Guyana National Household Drug Prevalence Survey, 2016, p.50} ~ The ways in which Respondents Accessed Marijuana (No response, You bought it, You got it for free or shared someone else's, You grew it yourself, Other, Don't know) {Guyana National Household Drug Prevalence Survey, 2016, p.78} ~ Area where Marijuana is bought [No response; Inside a public building (store, restaurant); Inside a home, apartment or dorm; Outside in a public area (parking or open space); Some other place; Don't Know) {Guyana National Household Drug Prevalence Survey, 2016, p.78} ~ Who provided the Marijuana that Respondents bought [No response, The same dealer (3 or more times); A new dealer each time; I look for it at the same venue every time; I look for it in a new venue everytime; Other; Don't know] {Guyana National Household Drug Prevalence Survey, 2016, p.79} ~ Area where Respondents got Marijuana for free [No response; Inside a public building (store, restaurant); Inside a school building; Outside on school property; Inside a home, apartment or dorm; Outside in a public area (parking lot); Some other place; Don’t know] {Guyana National Household Drug Prevalence Survey, 2016, p.80} ~ Who Provided Marijuana for Respondents Free (No response; A friend; A relative or family member; Someone I had just met or didn’t know well; Other, specify; Don’t know) {Guyana National Household Drug Prevalence Survey, 2016, p.81} ~ Other Types of Drugs sold at the Place where Marijuana is bought (Cocaine, Ecstasy) {Guyana National Household Drug Prevalence Survey, 2016, p.81} ~ Respondents’ Perception on the extent of Drug Dealing in their Neighbourhood (A great deal; Some; Little; None; Not known / no answer) {Guyana National Household Drug Prevalence Survey, 2016,p.93} ~",11
Y,Guyana,GUY,Supply Reduction,Level of procedures related to crop eradication,Yes,"Number of cannabis plants removed manually in region 6, region 4, and region 10 in 2014 {National Drug Strategy Master Plan, 2016-2020, p.9} ~ Areas Eradicated, Abandoned or otherwise removed from illicit cultivation by Geographic location {National Drug Strategy Master Plan, 2016-2020, p.10; Annual Report, 2015, p.21} ~",2
Y,Guyana,GUY,Supply Reduction,"Number of arrests, seizures, and offences",Yes,"Quantity of Drugs Seized in kilograms & grams by Type of Drug, Jan. 1 to Dec. 31, 2014 (Cocaine, Crack, Cannabis (plants), Leaf Cannabis (grass), MDMA (Ecstasy) & derivatives) {National Drug Strategy Master Plan, 2016-2020, p.11; Annual Report, 2015, p.7} ~ Number of Seizures by Type of Drug, Jan. 1 to Dec. 31, 2015 (Cannabis Plants, Cocaine HCl, Crack, Leaf Cannabis (grass)) {Annual Report, 2015, p.6, p.28} ~ Number of seizures by unit (Customs Anti Narcotic Unit, Guyana Police Force) and by Type of Drug, Jan.1 to Dec. 31, 2015 {Annual Report, 2015, p.13, p.17} ~ Quantity of Drugs Seized by unit (Customs Anti Narcotic Unit, Guyana Police Force, Guyana Revenue Authority) and by Type, Jan.1 to Dec.31, 2015 {Annual Report, 2015, p.14, p.18, p.28} ~ Number of drug related seizures of firearms for the period under review {Annual Report, 2015, p.20} ~ Number of cartridges or projectiles seized {Annual Report, 2015, p.20} ~ Areas where drugs were seized by Guyana Revenue Authority by Geographic Location in 2015 {Annual Report, 2015, p.29} ~",7
Y,Guyana,GUY,Supply Reduction,Level of law enforcement activity and interdiction in the market,Yes,"Number of training programs that the Customs Anti-Narcotic Unit (CANU) facilitated which targeted law enforcement population {Annual Report, 2015, p.16} ~ Number of training programmes facilitated by CANU that targeted custom officers {Annual Report, 2015, p.16} ~ The number of ranks from Law Enforcement agencies received training in Advance Narcotics Investigation; Profiling, Cargo, Passenger and Fast parcels; Seminar on Counter Narcotics for the Caribbean, and Asset Investigation and Recovery, for the period under review. {Annual Report, 2015, p.20} ~ Quantity of Dry Cannabis destroyed Jan 1 to Dec. 31, 2015 {Annual Report, 2015, p.22} ~",4
Y,Guyana,GUY,Supply Reduction,"Price, purity and potency of drugs, and related process indicators",No,n/a,0
Y,Guyana,GUY,Supply Reduction,Number of people engaged with the criminal justice system,Yes,"Persons Charged for Drug Possession by Type of Drug, Sex and Age Group, Jan. 1 to Dec. 31, 2014 (Crack, Marijuana) {National Drug Strategy Master Plan, 2016-2020, p.12; Annual Report, 2015, p.7, p.19} ~ Persons Convicted for Drug Possession by Type of Drug, Sex and Age Group, Jan. 1 to Dec. 31, 2014 (Crack, Marijuana) {National Drug Strategy Master Plan, 2016-2020, p.13; Annual Report, 2015, p.8, p.20} ~ Persons Charged for Drug Trafficking by Type of Drug, Sex and Age Group, Jan. 1 to Dec. 31, 2014 {National Drug Strategy Master Plan, 2016-2020, p.14; Annual Report, 2015, p.9} ~ Persons Convicted of Drug Trafficking by Type of Drug, Sex and Age Group, Jan. 1 to Dec. 31, 2014 {National Drug Strategy Master Plan, 2016-2020, p.15; Annual Report, 2015, p.11} ~ Persons charged, by unit (CANU, Guyana Police Force) for Drug trafficking by type of drug, gender and age group, Jan.1 to Dec. 31, 2015 {Annual Report, 2015, p.14, p.18} ~ Persons convicted, by unit (CANU, Guyana Police Force) for Drug trafficking by type of drug, gender and age group, Jan. 1 to Dec.31, 2015 {Annual Report, 2015, p.15, p.19} ~ Quantity of drugs for which persons were Remanded, Jan. 1 to Dec. 31, 2015 {Annual Report, 2015, p.23} ~ Drugs Offences for which persons were remanded, Jan. 1 to Dec. 31, 2015 (Trafficking, Possession, Cultivation, Smoking of Cannabis) {Annual Report, 2015, p.24} ~ Age and number of persons who were remanded for narcotic for the period Jan 1 to Dec 31, 2015 {Annual Report, 2015, p.25} ~ Quantity of drugs in grams for which persons were Convicted, Jan. 1 to Dec. 31, 2015 {Annual Report, 2015, p.26} ~ Type of Offence for which persons were Convicted, Jan. 1 to Dec. 31, 2015 (Possession, Trafficking, Cultivation) {Annual Report, 2015, p.26} ~ Age and number of persons who were convicted for narcotic for the period Jan.-Dec., 2015 {Annual Report, 2015, p.27} ~",12
Y,Guyana,GUY,Supply Reduction,Presence of other supply reduction metrics,Yes,"Respondents Views on Policy Relevant Issues: Agree/Disagree (Allow Marijuana to be used for medical and therapeutic purposes; Allow marijuana to be used for religious purposes (e.g. Rastafarians); Allow marijuana to be grown in limited amounts by individual households; Allow possession of marijuana in limited amounts, for personal use; Allow persons who are addicted to marijuana and other substances, who commit crimes such as theft, to be put into a court supervised drug treatment program instead of prison; Allow tourists to use marijuana for medical purposes, with a permit; Allow marijuana to be cultivated for scientific research) {Guyana National Household Drug Prevalence Survey, 2016, p.97} ~",1
Y,Guyana,GUY,International Cooperation,Level of engagement in international cooperation,No,n/a,0
Y,Nigeria,NGA,Health,Level of availability of harm reduction services and harm reduction scale up,No,n/a,0
Y,Nigeria,NGA,Health,Presence of needle and syringe programs,Yes,"90% of the general, key and vulnerable populations have access to safe injection practices by 2021. {National HIV/AIDS Strategic Framework, 2017-2021, p.22} ~ Proportion of health care facilities using reuse-prevention (auto-disable) injection equipment for therapeutic purposes {National HIV/AIDS Strategic Framework, 2017-2021, p.24} ~ Proportion of health care facilities with no stock-out of reuse-prevention (auto-disable) in the last three months {National HIV/AIDS Strategic Framework, 2017-2021, p.25} ~ Proportion of health care facilities where used injection equipment can be observed in places where they prevent exposure of health care workers to needle stick injuries {National HIV/AIDS Strategic Framework, 2017-2021, p.25} ~ Proportion of health care facilities with safety boxes in all injection areas {National HIV/AIDS Strategic Framework, 2017-2021, p.25} ~",5
Y,Nigeria,NGA,Health,Prevalence of substance use disorders,No,n/a,0
Y,Nigeria,NGA,Health,Prevalence of psychiatric comorbidities,No,n/a,0
Y,Nigeria,NGA,Health,Drug-related mortality,No,n/a,0
Y,Nigeria,NGA,Health,Prevalence of drug-related infectious disease,Yes,"estimated percent of people who inject drugs that account for new HIV diagnosis {National Drug Control Master Plan, 2015-2019, p.23; National HIV/AIDS Strategic Framework, 2017-2021, p.10} ~ HIV prevalence among PWID {National Drug Control Master Plan, 2015-2019, p.23; National HIV/AIDS Strategic Framework, 2017-2021, p.11} ~ HIV prevalence rate of non-injecting female drug users who also engaged in commercial sex work in Lagos {National Drug Control Master Plan, 2015-2019, p.23} ~ ",3
Y,Nigeria,NGA,Health,Proportion of people who use drugs who engage in risky consumption,No,n/a,0
Y,Nigeria,NGA,Health,Proportion of people who use drugs who engage in safe consumption practices,Yes,"90% of key and vulnerable populations adopt HIV risk reduction behaviour by 2021. {National HIV/AIDS Strategic Framework, 2017-2021, p.22} ~ % of PWID who used sterile needles consistently in the last 3 months {National HIV/AIDS Strategic Framework, 2017-2021, p.24} ~",2
Y,Nigeria,NGA,Health,"Coverage of services for the prevention, testing, and treatment of bloodborne diseases",Yes,"Number of coordinating platforms that take up TB and HIV issues for drug users {National Drug Control Master Plan, 2015-2019,p.43} ~ Number of guidelines, toolkits established {National Drug Control Master Plan, 2015-2019, p.44} ~ Number of practitioners who rate guidelines and toolkits as functional and user friendly {National Drug Control Master Plan, 2015-2019, p.44} ~ 90% of key and vulnerable populations have access to desired HIV prophylaxis by 2021 {National HIV/AIDS Strategic Framework, 2017-2021, p.22} ~ 100% of Nigerians have access to safe blood and blood products by 2021. {National HIV/AIDS Strategic Framework, 2017-2021, p.22} ~ % of key population using PrEP in priority population {National HIV/AIDS Strategic Framework, 2017-2021, p.24} ~ % of health facilities providing PrEP {National HIV/AIDS Strategic Framework, 2017-2021, p.24} ~ % of FWSS, MSM, PWID who tested for HIV and received their test results within the last 12 months {National HIV/AIDS Strategic Framework, 2017-2021, p.27, p.28} ~ % of HIV-negative FWSS, MSM, PWID who retested for HIV and received their test results within the last 12 months {National HIV/AIDS Strategic Framework, 2017-2021, p.28} ~ % of HIV-people screened for TB, syphilis, hepatitis B and Hepatitis C and received their test results within the last 12 months (disaggregated by disease) {National HIV/AIDS Strategic Framework, 2017-2021, p.28} ~ (Number and) % of health facilities providing (HIV Testing Services) HTS {National HIV/AIDS Strategic Framework, 2017-2021, p.28} ~ (Number and) % of health facilities with stock out of HIV test kits within the last 3 months {National HIV/AIDS Strategic Framework, 2017-2021, p.28} ~ (Number and) % of HTS centers with instituted quality improvement {National HIV/AIDS Strategic Framework, 2017-2021, p.28} ~",13
Y,Nigeria,NGA,Health,Presence of specialised training for addiction care,Yes,"Number of training events delivered to NGOs and drug user networks {National Drug Control Master Plan, 2015-2019, p.40} ~ Number of service providers trained {National Drug Control Master Plan, 2015-2019, p.42, p.44} ~ Number of training courses conducted across the states {National Drug Control Master Plan, 2015-2019, p.42, p.44} ~ Number of trained practitioners who rate the training as useful {National Drug Control Master Plan, 2015-2019, p.42} ~ Statistics of training outside the Agency in 2014 (Monthly trainings with the NHQs; Local (outside the Agency); International; Total) {Annual Report, 2014, p.53} ~",5
Y,Nigeria,NGA,Health,Presence of health harms related to drug use,No,n/a,0
Y,Nigeria,NGA,Health,Presence of other health metrics,Yes,"% of PWID who used condom use at last sexual intercourse {National HIV/AIDS Strategic Framework, 2017-2021, p.24} ~ Number of operational researches conducted {National Drug Control Master Plan, 2015-2019, p.46} ~ Number of operational research findings disseminated to service providers {National Drug Control Master Plan, 2015-2019, p.46} ~ Pain management guidelines for physicians developed {National Drug Control Master Plan, 2015-2019, p.52} ~ Number of medical school(s) having rational prescribing of narcotic drugs included in their curriculum {National Drug Control Master Plan, 2015-2019, p.53} ~",5
Y,Nigeria,NGA,Peace and Security,"Prevalence of alcohol and drugs in accidents, and interventions to increase road safety",No,n/a,0
Y,Nigeria,NGA,Peace and Security,Annual number of public disorder and violent crime reports,No,n/a,0
Y,Nigeria,NGA,Peace and Security,Number of non-lethal drug market violent events reported,No,n/a,0
Y,Nigeria,NGA,Peace and Security,Number of drug market related homicides and disappearances,No,n/a,0
Y,Nigeria,NGA,Peace and Security,Presence of other peace and security metrics,No,n/a,0
Y,Nigeria,NGA,Development,Coverage of housing assistance for people who use drugs,No,n/a,0
Y,Nigeria,NGA,Development,Coverage of social assistance for people who use drugs (not including housing),No,n/a,0
Y,Nigeria,NGA,Development,Number of households enrolled in alternative development,No,n/a,0
Y,Nigeria,NGA,Development,Presence of other development metrics,No,n/a,0
Y,Nigeria,NGA,Human Rights,"Prevalence and incidence of infectious diseases in vulnerable populations (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Nigeria,NGA,Human Rights,"Prevalence of vulnerable people who use drugs (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Nigeria,NGA,Human Rights,Proportion of people who use drugs in prison that are receiving medication assisted treatment (MAT),No,n/a,0
Y,Nigeria,NGA,Human Rights,Distribution of sterile injecting equipment in prisons,No,n/a,0
Y,Nigeria,NGA,Human Rights,Presence of programs and services targeted towards women ,No,n/a,0
Y,Nigeria,NGA,Human Rights,Presence of programs and services targeted towards people of color,No,n/a,0
Y,Nigeria,NGA,Human Rights,Presence of challenges and/or harms experienced by people of color,No,n/a,0
Y,Nigeria,NGA,Human Rights,"Presence of programs and services targeted towards vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"Number of new treatment and continuing care services established at community level and in selected prisons/borstal institues {National Drug Control Master Plan, 2015-2019, p.41} ~",1
Y,Nigeria,NGA,Human Rights,"Presence of challenges and/or harms experienced by vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Nigeria,NGA,Human Rights,Presence of other human rights metrics,Yes,"Number of NDLEA personnel trained in human rights and/or ethics {National Drug Control Master Plan, 2015-2019, p.35} ~ Review of NDLEA code of ethics completed {National Drug Control Master Plan, 2015-2019, p.35} ~ ",2
Y,Nigeria,NGA,Demand Reduction,Prevalence of drug use by age,Yes,"The lifetime prevalence and past year prevalence by type of drugs (non-prescription sedative, cannabis) among adults in Nigeria {National Drug Control Master Plan, 2015-2019, p.21} ~ ",1
Y,Nigeria,NGA,Demand Reduction,Prevalence of drug use by sex,No,n/a,0
Y,Nigeria,NGA,Demand Reduction,Prevalence of drug use by type,Yes,"The prevalence of drug use by type (cannabis, heroin, amphetamine, and cocaine) by region (North, South) {National Drug Control Master Plan, 2015-2019, p.21} ~ The lifetime prevalence, past 12 month prevalence, and past 30 day prevalence of drug use % [Tranquillisers (e.g., diazepam, lexotan); Heroin; Other opiates (e.g., morphine, codeine, pentazocin); Hallucinogen-Lysergic Acid Diethylamide (LSD); Other hallucinogens; Cannabis; Amphetamine; Methamphetamine; Ecstasy; Cocaine; Crack; Solvents and inhalants; Analgesics (e.g., paracetamol, aspirin); Non-prescription sedative; Other drugs (e.g., Sukudaya, Powerhorse); Injecting drug use] {National Drug Control Master Plan, 2015-2019, p.21, p.22} ~",2
Y,Nigeria,NGA,Demand Reduction,Number of people who use drugs,No,n/a,0
Y,Nigeria,NGA,Demand Reduction,"Prevalence of drug use by mode of administration (oral, mucosa, inhalation, and injection)",No,n/a,0
Y,Nigeria,NGA,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT)",Yes,"The number of patients treated across treatment centres by region (North, South) {National Drug Control Master Plan, 2015-2019, p.21} ~ The proportion of drug-related admissions that account for all admissions {National Drug Control Master Plan, 2015-2019, p.21} ~ Number of needs assessments conducted {National Drug Control Master Plan, 2015-2019, p.41} ~ Number of new treatment and continuing care services established at community level {National Drug Control Master Plan, 2015-2019, p.41} ~ Number of existing treatment and continuing care services upgraded {National Drug Control Master Plan, 2015-2019, p.41} ~ MOU on referral system for treatment and continuing care services between agencies signed {National Drug Control Master Plan, 2015-2019, p.41} ~ Number of guidelines, toolkits developed {National Drug Control Master Plan, 2015-2019, p.42} ~ Number of practitioners who rate the guidelines as functional and user-friendly {National Drug Control Master Plan, 2015-2019, p.42} ~ Number of reports regarding prevention and treatment data produced and disseminated {National Drug Control Master Plan, 2015-2019, p.46} ~ number of clients referred to the NHQ, and the number who were successfully counselled and discharged {Annual Report, 2014, p.49} ~ The number of drug dependent persons who were counselled in the various State Commands of the Agency across the nation {Annual Report, 2014, p.49} ~ Summary of counselling cases by command (number counselled, number referred, number concluded, number ongoing) {Annual Report, 2014, p.50; Crime Data - Drug Abuse and Enforcement, 2012-2016, p.82} ~ Counselling by geographical zone (number counselled, number referred, total cases handled) {Annual Report, 2014, p.52; Crime Data - Drug Abuse and Enforcement, 2012-2016, p.5, p.85} ~",13
Y,Nigeria,NGA,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT) by age",No,n/a,0
Y,Nigeria,NGA,Demand Reduction,Level of access to opioid substitution treatment and medication assisted treatment (OST/MAT),No,n/a,0
Y,Nigeria,NGA,Demand Reduction,Level of coverage of inpatient treatment,No,n/a,0
Y,Nigeria,NGA,Demand Reduction,Proportion of people who use drugs enrolled in voluntary treatment,No,n/a,0
Y,Nigeria,NGA,Demand Reduction,Proportion of people who use drugs enrolled in coerced treatment,No,n/a,0
Y,Nigeria,NGA,Demand Reduction,Proportion of people who use drugs enrolled in compulsory treatment,No,n/a,0
Y,Nigeria,NGA,Demand Reduction,Presence of prevention programming in law enforcement,No,n/a,0
Y,Nigeria,NGA,Demand Reduction,Presence of prevention programming in the media,Yes,"Number of mass media statements on drugs by high-level  {National Drug Control Master Plan, 2015-2019, p.40} ~ Number of media releases {National Drug Control Master Plan, 2015-2019, p.56} ~",2
Y,Nigeria,NGA,Demand Reduction,Presence of prevention programming in schools,Yes,"The average number of schools that were covered each year nationwide for preventive education activities {National Drug Control Master Plan, 2015-2019, p.23} ~ The number of schools that have functioning drug-free clubs {National Drug Control Master Plan, 2015-2019, p.23} ~",2
Y,Nigeria,NGA,Demand Reduction,Presence of prevention programming in the workplace,No,n/a,0
Y,Nigeria,NGA,Demand Reduction,Presence of prevention programming for youth and the community,Yes,"Number of guidelines, toolkits developed {National Drug Control Master Plan, 2015-2019, p.39} ~ Number of reviews of the different guidelines and manuals under-taken {National Drug Control Master Plan, 2015-2019, p.39} ~ Number of service providers trained {National Drug Control Master Plan, 2015-2019, p.39} ~ Number of training programmes conducted {National Drug Control Master Plan, 2015-2019, p.39} ~ Number of MDAs/organizations implementing prevention and sensitization programmes using the guidelines and toolkits developed {National Drug Control Master Plan, 2015-2019, p.40} ~ Number of prevention and sensitization programmes delivered {National Drug Control Master Plan, 2015-2019, p.40} ~ Number of drug user networks established {National Drug Control Master Plan, 2015-2019, p.40} ~ Number of high level visits/briefings {National Drug Control Master Plan, 2015-2019, p.40} ~",8
Y,Nigeria,NGA,Demand Reduction,Presence of other demand reduction metrics,No,n/a,0
Y,Nigeria,NGA,Supply Reduction,Size and value of the illegal drug market,Yes,"Airlines used by traffickers {Annual Report, 2014, p.36} ~ Monetary exhibit (type of currency and amount) {Annual Report, 2014, p.39} ~ Total number of drug cases by geopolitical zone {Crime Data - Drug Abuse and Enforcement, 2012-2016, p.81} ~",3
Y,Nigeria,NGA,Supply Reduction,Level of procedures related to crop eradication,Yes,"The number in hectares of cannabis plantations nationwide that were discovered and destroyed {National Drug Control Master Plan, 2015-2019, p.18, p.42} ~ National cannabis production survey completed {National Drug Control Master Plan, 2015-2019, p.33} ~ Percentage decrease in hectares under cannabis cultivation {National Drug Control Master Plan, 2015-2019, p.33} ~ Number of cannabis detection and eradication strategies implemented {National Drug Control Master Plan, 2015-2019, p.33} ~",4
Y,Nigeria,NGA,Supply Reduction,"Number of arrests, seizures, and offences",Yes,"The number of suspected drug offenders arrested in 2013 {National Drug Control Master Plan, 2015-2019, p.18} ~ The total quantity of drugs seized in 2013 by type of drug (cannabis, cannabis sativa, psychotropic substances, methamphetamine, heroin, amphetamine, ephedrine, cocaine) {National Drug Control Master Plan, 2015-2019, p.10, p.18; Annual Report, 2014, p.31, p.33, p.40, p.44} ~ Percentage increase in the number of cases resulting in asset forfeiture {National Drug Control Master Plan, 2015-2019, p.30} ~ Percentage increase in the net value of assets seized {National Drug Control Master Plan, 2015-2019, p.30} ~ Percentage increase in number of cases resulting in forfeiture orders {National Drug Control Master Plan, 2015-2019, p.31} ~ Increased percentage of mid- to high-level offenders arrested as a result of actionable intelligence {National Drug Control Master Plan, 2015-2019, p.32} ~ Number of products seized {National Drug Control Master Plan, 2015-2019, p.56} ~ Number of arrests {National Drug Control Master Plan, 2015-2019, p.10, p.56; Annual Report, 2014, p.28} ~ Arrests by geopolitical zones {Annual Report, 2014, p.30; Crime Data - Drug Abuse and Enforcement, 2012-2016, p.5, p.83} ~ Destination of drug couriers arrested at MMIA, Lagos {Annual Report, 2014, p.36} ~ % of the total numbers of arrested drug suspects that were youth {Annual Report, 2014, p.42} ~ The number of assets seized in kobo and USD {Annual Report, 2014, p.43} ~ The number of monetary forfeitures in naira and USD {Annual Report, 2014, p.44} ~ The number of vehicles and motorcycles seized {Annual Report, 2014, p.44} ~ Quantity of narcotic drugs seized (kg) by state and special command area 2012-2016 {Crime Data - Drug Abuse and Enforcement, 2012-2016, p.5 & p.84} ~ ",15
Y,Nigeria,NGA,Supply Reduction,Level of law enforcement activity and interdiction in the market,Yes,"Number of intelligence reports exchanged and/or shared with other agencies (between NFIU and NDLEA, between law enforcement agencies) {National Drug Control Master Plan, 2015-2019, p.30, p.34} ~ Number of NDLEA Commands networked to Intelligence databases {National Drug Control Master Plan, 2015-2019, p.32} ~ Number of policies and procedures developed to share and manage intelligence within NDLEA and with LEAs {National Drug Control Master Plan, 2015-2019, p.32} ~ Sentencing guidelines for proportionality of penalties for drug cases adopted {National Drug Control Master Plan, 2015-2019, p.29} ~ Asset management policy and procedures established {National Drug Control Master Plan, 2015-2019, p.29} ~ Number of NDLEA personnel, judicial officers and prosecutors trained (financial investigators, asset confiscation and money laundering investigation, asset forfeiture, investigation training, performance management) {National Drug Control Master Plan, 2015-2019, p.30, p.31, p.32, p.34, p.35} ~ Percentage increase in the number of officers in the NDLEA Directorate of Assets and Financial Investigations {National Drug Control Master Plan, 2015-2019, p.31} ~ Increased participation of NDLEA Commanders in monthly coordination meetings with other law enforcement agencies {National Drug Control Master Plan, 2015-2019, p.34} ~ Number of joint operations undertaken {National Drug Control Master Plan, 2015-2019, p.34} ~ Number of NDLEA officers veted {National Drug Control Master Plan, 2015-2019, p.35} ~ Percentage increase in number of unauthorised premise(s) identified and enforcement action taken annually {National Drug Control Master Plan, 2015-2019, p.51} ~ Number of regulation(s) and guideline(s) on narcotic drugs, psychotropic substances and precursors produced {National Drug Control Master Plan, 2015-2019, p.54} ~ Percentage number of companies monitored for compliance with regulation {National Drug Control Master Plan, 2015-2019, p.56} ~ Percentage increase in number of enforcement intervention in relation to diverted narcotic drugs, psychotropic substances and precursors {National Drug Control Master Plan, 2015-2019, p.56} ~ Number of visa applications received, cleared, disqualified, and pending {Annual Report, 2014, p.37 & p.38} ~  Public destruction of drugs exhibit by the number and types of drugs destroyed {Annual Report, 2014, p.41} ~ The number of prosecuted cases, the number of cases won, the number of cases discharged and acquitted, and the number of cases that were struck out due to death and jumping bail of the accused {National Drug Control Master Plan, 2015-2019, p.56; Annual Report, 2014, p.44} ~  Summary of prosecution by conviction rates (number of convictions, number discharged/acquitted, number struck out, total handled, success rate (%)) {Annual Report, 2014, p.45, p.46} ~ Number of convictions secured by the state, special area command 2012-2016 {Crime Data - Drug Abuse and Enforcement, 2012-2016, p.5 & p.86} ~",19
Y,Nigeria,NGA,Supply Reduction,"Price, purity and potency of drugs, and related process indicators",Yes,"The total number of analysis conducted on drug samples from the NHQ and from various commands nationwide (by drug type and number of samples analysed) {Annual Report, 2014, p.54 & p.55} ~",1
Y,Nigeria,NGA,Supply Reduction,Number of people engaged with the criminal justice system,Yes,"The number of Nigerian nationals that were deported from other countries over drug related offences {Annual Report, 2014, p.38} ~ Countries of deportation and number of Nigerian nationals deported from those countries {Annual Report, 2014, p.38} ~ Deportees by gender {Annual Report, 2014, p.39} ~ Number of suspects prosecuted by state, special area command 2012-2016 {Crime Data - Drug Abuse and Enforcement, 2012-2016, p.5 & p.87} ~ ",4
Y,Nigeria,NGA,Supply Reduction,Presence of other supply reduction metrics,Yes,"Development of dispensing guidelines for narcotic drugs {National Drug Control Master Plan, 2015-2019, p.52} ~ Development of national guidelines and instrument(s) for estimation and quantification of national needs of psychotropic substances and precursors produced {National Drug Control Master Plan, 2015-2019, p.49} ~ Number of national baseline survey(s) conducted (for each component) for estimation and quantification of psychotropic substances and precursors {National Drug Control Master Plan, 2015-2019, p.50} ~ Number of reviews of baseline data {National Drug Control Master Plan, 2015-2019, p.50} ~ Number of distribution centre(s) for narcotic drugs established in the six geo-political zones {National Drug Control Master Plan, 2015-2019, p.51} ~ Number of legislative acts reviewed and critically analyzed {National Drug Control Master Plan, 2015-2019, p.29} ~ Number of amendments proposed {National Drug Control Master Plan, 2015-2019, p.29} ~ Review of NDLEA performance management policy, procedures and instruments {National Drug Control Master Plan, 2015-2019, p.35} ~ Number of policy(s) on controlled medicines produced {National Drug Control Master Plan, 2015-2019, p.54} ~",9
Y,Nigeria,NGA,International Cooperation,Level of engagement in international cooperation,Yes,"Number of bilateral and multilateral agreements signed {National Drug Control Master Plan, 2015-2019, p.34} ~ Number of international joint investigations undertaken {National Drug Control Master Plan, 2015-2019, p.34} ~ Number of mutual legal assistance requests effected {National Drug Control Master Plan, 2015-2019, p.34} ~",3
Y,New Zealand,NZL,Health,Level of availability of harm reduction services and harm reduction scale up,No,n/a,0
Y,New Zealand,NZL,Health,Presence of needle and syringe programs,Yes,"Number of syringes distributed per person who inject drugs per year by needle and syringe programmes {Country Progress Report New Zealand 2014, 2015, p.5} ~ ",1
Y,New Zealand,NZL,Health,Prevalence of substance use disorders,Yes,"Approximate percentage of New Zealanders who will experience a substance use disorder at some stage in their lives {National Drug Policy 2015-2020, 2015, p.1, p.8, p.10} ~ approximate percentage of all health loss and of mental illness, mainly through substance use disorders experienced by New Zealanders due to AOD use {National Drug Policy 2015-2020, 2015, p.10} ~ People receiving a health-related benefit where primary diagnosis is listed as alcohol or substance abuse (march 2015 baseline number) {National Drug Policy 2015-2020, 2015, p.11} ~ Number of dependent users by type of drug (amphetamine-type stimulants, cannabinoids, hallucinogenic and psychedelic drugs, opioids, and sedative drugs) and total amount consumed and cost per user {The New Zealand Drug Harm Index, 2016, p.18, p.19, p.46} ~ Past-year prevalence of drug users reporting dependence by type of drug (methamphetamine, cannabis, ecstasy, opioids, total) {The New Zealand Drug Harm Index, 2016, p.47} ~ ",5
Y,New Zealand,NZL,Health,Prevalence of psychiatric comorbidities,Yes,"Percentage of cannabis users who reported harmful effects on mental health in last 12 months, by socio-demographics (sex, age distribution, ethnic group) {Cannabis Use 2012/13: New Zealand Health Survey, 2015, p.11, p.26} ~ ",1
Y,New Zealand,NZL,Health,Drug-related mortality,Yes,"deaths of people notified with AIDS by year of diagnosis or death {Country Progress Report New Zealand 2014, 2015, p.8, p.13} ~ In the figures for 2010, number of deaths out of total deaths that are recorded as due to overdose: number of overdose deaths that were allocated to the opioid & sedative drugs group; Of the remaining deaths, number of deaths that was allocated to hallucinogenic and psychedelic; The remaining number of deaths that were divided between the amphetamine-type stimulants group and the cannabinoids on the basis of the UNODC rankings {The New Zealand Drug Harm Index, 2016, p.20} ~ Personal harms by drug group (Amphetamine-type stimulants, Cannabinoids, Hallucinogenic and psychedelic drugs, Opioid and sedative drugs): Deaths per annum, Premature death, Loss of quality of life {The New Zealand Drug Harm Index, 2016, p.21, p.46} ~ ",3
Y,New Zealand,NZL,Health,Prevalence of drug-related infectious disease,Yes,"percentage reduced in the rate of hepatitis C infection among people who currently inject drugs due to introduction of the 1-for-1 needle exchange {National Drug Policy 2015-2020, 2015, p.11} ~Number of people newly diagnosed with HIV infection by year of diagnosis and likely mode of infection (IDU, homosexual IDU), New Zealand, 1985–2002 {HIV/AIDS Action Plan, 2003, p.6; Country Progress Report New Zealand 2014, 2015, p.9} ~ AIDS cases suspected mode of transmission (Injecting drug users, homosexual injecting drug users), 1983–2002 (n=772) {HIV/AIDS Action Plan, 2003, p.10} ~ Percentage of people who inject drugs who are living with HIV {Country Progress Report New Zealand 2014, 2015, p.5} ~ The number of people diagnosed with HIV among people who inject drugs with no other reported risk, by place and year of diagnosis {Country Progress Report New Zealand 2014, 2015, p.12} ~",5
Y,New Zealand,NZL,Health,Proportion of people who use drugs who engage in risky consumption,No,n/a,0
Y,New Zealand,NZL,Health,Proportion of people who use drugs who engage in safe consumption practices,Yes,"Percentage of people who inject drugs who reported using sterile injecting equipment the last time they injected {Country Progress Report New Zealand 2014, 2015, p.5} ~",1
Y,New Zealand,NZL,Health,"Coverage of services for the prevention, testing, and treatment of bloodborne diseases",Yes,"Percentage of people who inject drugs that have received an HIV test in the past 12 months and know their results {Country Progress Report New Zealand 2014, 2015, p.5} ~ ",1
Y,New Zealand,NZL,Health,Presence of specialised training for addiction care,No,n/a,0
Y,New Zealand,NZL,Health,Presence of health harms related to drug use,Yes,"Personal harms by drug group (Amphetamine-type stimulants, Cannabinoids, Hallucinogenic and psychedelic drugs, Opioid and sedative drugs): Estimated personal harm, Average harm per dependent) {The New Zealand Drug Harm Index, 2016, p.21} ~ Expert rankings of personal and community harms for dependent and casual users {The New Zealand Drug Harm Index, 2016, p.32} ~ Accidental poisoning by exposure to opioids (2011 baseline number) {National Drug Policy 2015-2020, 2015, p.11} ~ % of past-year drug users by type (cannabis, amphetamines) who reported having experienced injuries in the past 12 months due to their drug use and % of the total population aged 16–64 years it represents {Drug Use in New Zealand: Key Results of the 2007/08 New Zealand Alcohol and Drug Use Survey, 2010, p.64, p.93} ~ approximate percentage of New Zealand secondary school students who use substances at a level that are likely to cause them significant current harm and may cause long-term problems {National Drug Policy 2015-2020, 2015, p.1} ~",5
Y,New Zealand,NZL,Health,Presence of other health metrics,Yes,"Cannabis used for medicinal purposes was largely administered by smoking it in the form of a joint (% included), or through a water pipe (% included) or pipe (% included) {Cannabis Use 2012/13: New Zealand Health Survey, 2015, p.15} ~ Percentage of cannabis users who used cannabis to treat pain or other medical condition in last 12 month, by socio-demographic categories (sex, age distribution, age distribution in men and women, ethnic group) {Cannabis Use 2012/13: New Zealand Health Survey, 2015, p.14, p.30} ~ Percentage of people who inject drugs who report the use of a condom during their last sexual intercourse {Country Progress Report New Zealand 2014, 2015, p.5} ~ Estimated cost of: premature death, loss of quality of life; Total harm; Dependent users; Cost per user; by drug group (Amphetamine-type stimulants, Cannabinoids, Hallucinogenic and psychedelic, Opioids and sedative)  {The New Zealand Drug Harm Index, 2016, p.20, p.46} ~ Amount of money that has been estimated to cost the country per year by harmful use of AOD which includes: the cost to healthcare of responding to AOD related accidents, illnesses and injuries {National Drug Policy 2015-2020, 2015, p.2} ~",5
Y,New Zealand,NZL,Peace and Security,"Prevalence of alcohol and drugs in accidents, and interventions to increase road safety",Yes,"Proportion of past-year drug users reported having driven a car or another motor vehicle (such as a motorcycle or boat) while feeling under the influence of drugs in the past 12 months, by socio-demographic categories (sex, age distribution, ethnic group) (% included), by type of drug {Drug Use in New Zealand: Key Results of the 2007/08 New Zealand Alcohol and Drug Use Survey, 2010, p.23, p.24, p.25, p.54, p.90, p.192; Cannabis Use 2012/13: New Zealand Health Survey, 2015, p.23} ~ % of past-year drug users reported having worked while feeling under the influence of drugs in the past year by age group, sex and type of drug {Drug Use in New Zealand: Key Results of the 2007/08 New Zealand Alcohol and Drug Use Survey, 2010, p.25, p.26, p.55, p.90, p.192} ~ proportion of past-year drug users reported having operated machinery while feeling under the influence of drugs in the past 12 months by age group, sex and type of drug (% included): {Drug Use in New Zealand: Key Results of the 2007/08 New Zealand Alcohol and Drug Use Survey, 2010, p.26, p.27, p.56, p.90, p.192} ~ ",3
Y,New Zealand,NZL,Peace and Security,Annual number of public disorder and violent crime reports,Yes,"the proportion of individuals committing acquisitive crime while under the influence of drugs including % range: % in the case of heroin, % in the case of cannabis {The New Zealand Drug Harm Index, 2016, p.24} ~ Summary of specific community harms by drug group (Amphetamine-type stimulants, Cannabinoids, Hallucinogenic and psychedelic drugs, Opioid and sedative drugs): Family and friends, Acquisitive crime, Organized crime, Total {The New Zealand Drug Harm Index, 2016, p.29} ~ % of people reporting they had feared violence from the drug user and % acknowledging they had been worried in the past 12 months {The New Zealand Drug Harm Index, 2016, p.23} ~ ",3
Y,New Zealand,NZL,Peace and Security,Number of non-lethal drug market violent events reported,No,n/a,0
Y,New Zealand,NZL,Peace and Security,Number of drug market related homicides and disappearances,No,n/a,0
Y,New Zealand,NZL,Peace and Security,Presence of other peace and security metrics,Yes,"Estimated cost to the community of drug-related acquisitive crime (Amphetamine-type stimulants, Cannabinoids, Hallucinogenic and psychedelic drugs, Opioid and sedative drugs): Number of dependent users, Estimated harm, Cost per dependent {The New Zealand Drug Harm Index, 2016, p.25} ~ Estimated social cost and total harm per annum by drug user (Dependent: Social cost per user; Casual: social cost per user) and specific drug type (Methamphetamine, Heroin/homebake, Pharma-opioids, Cocaine, Synthetic cannabis, Pharma-sedatives, Amphetamine, Dexamphetamine, Ketamine, GHB, Pharma-stimulants, Cannabis, LSD, Ecstasy) {The New Zealand Drug Harm Index, 2016, p.33} ~ Summary of social costs, by drug group (Amphetamine-type stimulants, Cannabinoids, Hallucinogenic and psychedelic drugs, Opioid and sedative drugs) ($ million): Personal harm, Community harm, Intervention costs, Total social {The New Zealand Drug Harm Index, 2016, p.34} ~ Summary of social costs by user type: Total cost, dependent use, Total cost ($m): casual use, $ cost per dependent user, $ cost per casual user {The New Zealand Drug Harm Index, 2016, p.34} ~ Summary of specific community harms by drug group (Amphetamine-type stimulants, Cannabinoids, Hallucinogenic and psychedelic drugs, Opioid and sedative drugs): Reduced tax base, Total {The New Zealand Drug Harm Index, 2016, p.29} ~ Estimated harm to family and friends by drug group (Amphetamine-type stimulants, Cannabinoids, Hallucinogenic and psychedelic drugs, Opioid and sedative drugs): Number of dependent users, Estimated number of family and friends, Estimated harm {The New Zealand Drug Harm Index, 2016, p.23} ~ ",6
Y,New Zealand,NZL,Development,Coverage of housing assistance for people who use drugs,No,n/a,0
Y,New Zealand,NZL,Development,Coverage of social assistance for people who use drugs (not including housing),No,n/a,0
Y,New Zealand,NZL,Development,Number of households enrolled in alternative development,No,n/a,0
Y,New Zealand,NZL,Development,Presence of other development metrics,Yes,"Amount of money that has been estimated to cost the country per year by harmful use of AOD which includes: the cost of welfare payments for people who have become incapacitated through substance dependence {National Drug Policy 2015-2020, 2015, p.2} ~ Younger (aged 15–24 years) cannabis users reported harmful effects on work, studies or employment opportunities (% included) more frequently than older (aged 55+ years) cannabis users (% included) {Cannabis Use 2012/13: New Zealand Health Survey, 2015, p.10} ~ % of harmful effects experienced in lifetime due to own drug use by type of drugs (any drugs, cannabis, amphetamines, BZP party pill), among people who had ever used drugs and total population aged 16–64 years (unadjusted prevalence and estimated number of adults): Any harmful effect, Harmful effects on friendships or social life, Harmful effects on work, study or employment opportunities, Harmful effects on home life, Harmful effects on financial position, Had learning difficulties, Had a legal problem {Cannabis Use 2012/13: New Zealand Health Survey, 2015, p.9, p.25; Drug Use in New Zealand: Key Results of the 2007/08 New Zealand Alcohol and Drug Use Survey, 2010, p.36, p.37, p.63, p.64, p.90, p.92, p.93, p.194, p.195} ~ ",3
Y,New Zealand,NZL,Human Rights,"Prevalence and incidence of infectious diseases in vulnerable populations (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"Ethnicity of people diagnosed HIV positive between 1 January 1996 and 31 December 2002 (n= 840) {HIV/AIDS Action Plan, 2003, p.8} ~ Ethnicity of people with AIDS, 1983–2002 (n=772) {HIV/AIDS Action Plan, 2003, p.10} ~ ",2
Y,New Zealand,NZL,Human Rights,"Prevalence of vulnerable people who use drugs (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"Past year prevalence of drug use by type (any drug, cannabis, ecstasy, amphetamines, cocaine, hallucinogenic drugs, LSD or synthetic hallucinogens, naturally occurring hallucinogens, kava, GHB, nitrous oxide, BZP party pills), by sociodemographic categories (age, sex, ethnic group) {Cannabis Use 2012/13: New Zealand Health Survey, 2015, p.18, p.31; Drug Use in New Zealand: Key Results of the 2007/08 New Zealand Alcohol and Drug Use Survey, 2010, p.20, p.21, p.22, p.44, p.45, p.46, p.69, p.70, p.84, p.85, p.88, p.99, p.112, p.119, p.126, p.142, p.143, p.156, p.169, p.189, p.190; Amphetamine Use 2015/16:New Zealand Health Survey, 2016, p.2} ~ Prevalence of people who have reported using drugs at some point in their lifetime by type of drug (cannabis), by ethnic group and sex {Drug Use in New Zealand: Key Results of the 2007/08 New Zealand Alcohol and Drug Use Survey, 2010, p.40} ~ Prevalence of people who have reported ever using drugs, by age, sex, ethnic group and by type of drug (cannabis, ecstasy, amphetamines, cocaine, hallucinogenic drugs, LSD or synthetic hallucinogens, naturally occurring hallucinogens, kava, GHB, solvents, BZP party pills) {Drug Use in New Zealand: Key Results of the 2007/08 New Zealand Alcohol and Drug Use Survey, 2010, p.18, p.40, p.66, p.67, p.68, p.81, p.82, p.95, p.96, p.108, p.109, p.115, p.116, p.122, p.123, p.139, p.153, p.175, p.185, p.186} ~ Frequency (at least weekly; less than weekly; at least once in the last 12 months; daily; at least monthly) of drug use by type (cannabis, amphetamines, cocaine, prescription stimulants, hallucinogenic drugs, LSD or synthetic hallucinogens, naturally occurring hallucinogens, kava, prescription sedatives, opiates, BZP party pills), and by socio-demographic categories (sex, age, ethnic group) {Cannabis Use 2012/13: New Zealand Health Survey, 2015, p.2, p.19, p.20, p.21, p.22; Amphetamine Use 2015/16:New Zealand Health Survey, 2016, p.6; Drug Use in New Zealand: Key Results of the 2007/08 New Zealand Alcohol and Drug Use Survey, 2010, p.47, p.48, p.49, p.50, p.51, p.52, p.53, p.100, p.106, p.113, p.120, p.126, p.137, p.144, p.151, p.163, p.192} ~ Average age of first use of drugs by type and by ethnic group {Drug Use in New Zealand: Key Results of the 2007/08 New Zealand Alcohol and Drug Use Survey, 2010, p.42, p.188} ~ Ever used any drugs (any drug, stimulants, prescription stimulants, ketamine, any sedative, prescription sedatives, opiates, nitrous oxide, inhalants, solvents) for recreational purposes in lifetime, among total population aged 16–64 years, by ethnic group (European/Other, Māori, Pacific, Asian) and age {Drug Use in New Zealand: Key Results of the 2007/08 New Zealand Alcohol and Drug Use Survey, 2010, p.17, p.74, p.75, p.78, p.79, p.102, p.103, p.128, p.129, p.130, p.132, p.133, p.136, p.146, p.147, p.150, p.158, p.159, p.162, p.165, p.166, p.169, p.171, p.172, p.175} ~ Age of first use of drugs for recreational purposes, among people aged 16–64 years who had ever used drugs, by Māori/non-Māori ethnicity (age-standardized prevalence) {Drug Use in New Zealand: Key Results of the 2007/08 New Zealand Alcohol and Drug Use Survey, 2010, p.19} ~ Prevalence of people who have used cannabis at the same time as other drugs at least once in the past 12 months by ethnicity and drug type {Drug Use in New Zealand: Key Results of the 2007/08 New Zealand Alcohol and Drug Use Survey, 2010, p.58} ~ Prevalence of people who have ever injected drugs for recreational purposes in lifetime, past 12 months, by age group, sex and ethnicity {Drug Use in New Zealand: Key Results of the 2007/08 New Zealand Alcohol and Drug Use Survey, 2010, p.180} ~ ",9
Y,New Zealand,NZL,Human Rights,Proportion of people who use drugs in prison that are receiving medication assisted treatment (MAT),No,n/a,0
Y,New Zealand,NZL,Human Rights,Distribution of sterile injecting equipment in prisons,No,n/a,0
Y,New Zealand,NZL,Human Rights,Presence of programs and services targeted towards women ,No,n/a,0
Y,New Zealand,NZL,Human Rights,Presence of programs and services targeted towards people of color,Yes,"Prevalence of people who have ever used drugs by type (cannabis) that have received help to reduce their level of drug use at some point in their lifetime, in the past 12 months, by ethnic group {Drug Use in New Zealand: Key Results of the 2007/08 New Zealand Alcohol and Drug Use Survey, 2010, p.29, p.31, p.59, p.60} ~ ",1
Y,New Zealand,NZL,Human Rights,Presence of challenges and/or harms experienced by people of color,Yes,"Adjusted rate ratio: cannabis users who reported harmful effects on mental health in last 12 months (Māori vs non-Māori, Pacific vs non-Pacific) {Cannabis Use 2012/13: New Zealand Health Survey, 2015, p.26} ~ number of times Māori cannabis users were more likely to report legal problems from their use in the past year, after adjusting for age and sex differences {Cannabis Use 2012/13: New Zealand Health Survey, 2015, p.12} ~ Percentage of cannabis users who reported experiencing legal problems because of cannabis use in last 12 months, by socio-demographic categories (sex, age distribution, ethnic group) {Cannabis Use 2012/13: New Zealand Health Survey, 2015, p.27} ~ Prevalence of people who have ever used drugs that wanted to reduce their level of drug use but did not receive it, by ethnic group {Drug Use in New Zealand: Key Results of the 2007/08 New Zealand Alcohol and Drug Use Survey, 2010, p.33} ~ % of harmful effects experienced in lifetime due to own drug use by type of drugs (any drugs, cannabis, amphetamines, BZP party pill), among people who had ever used drugs and total population aged 16–64 years (unadjusted prevalence and estimated number of adults): Any harmful effect, Harmful effects on friendships or social life, Harmful effects on work, study or employment opportunities, Harmful effects on home life, Harmful effects on financial position, Had learning difficulties, Had a legal problem – by sex, age and ethnic group {Cannabis Use 2012/13: New Zealand Health Survey, 2015, p.24, p.25} ~",5
Y,New Zealand,NZL,Human Rights,"Presence of programs and services targeted towards vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,New Zealand,NZL,Human Rights,"Presence of challenges and/or harms experienced by vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"Adjusted rate ratio: cannabis users who reported harmful effects on mental health in last 12 months (Most vs least deprived) {Cannabis Use 2012/13: New Zealand Health Survey, 2015, p.26} ~ percentage of families with children in Child, Youth and Family care in which AOD misuse is a factor {National Drug Policy 2015-2020, 2015, p.11} ~",2
Y,New Zealand,NZL,Human Rights,Presence of other human rights metrics,No,n/a,0
Y,New Zealand,NZL,Demand Reduction,Prevalence of drug use by age,Yes,"Past year prevalence of drug use by type (any drug, cannabis, amphetamines, ecstasy, stimulants, cocaine, hallucinogenic drugs, LSD or synthetic hallucinogens, naturally occurring hallucinogens, kava, GHB, opiates, BZP party pills), by age, by sex {Cannabis Use 2012/13: New Zealand Health Survey, 2015, p.1, p.31; Amphetamine Use 2015/16: New Zealand Health Survey, 2016, p.2, p.3; Drug Use in New Zealand: Key Results of the 2007/08 New Zealand Alcohol and Drug Use Survey, 2010, p.20, p.22, p.43, p.44, p.46, p.47, p.49, p.69, p.71, p.77, p.84, p.86, p.87, p.98, p.99, p.111, p.113, p.118, p.120, p.125, p.142, p.144, p.155, p.163, p.189, p.191} ~ Number of different drugs used in the last 12 months, among past-year drug users and total population aged 16–64 years (unadjusted prevalence and estimated number of adults) {Drug Use in New Zealand: Key Results of the 2007/08 New Zealand Alcohol and Drug Use Survey, 2010, p.22} ~ Location of using drugs by type (amphetamines, BZP party pills) in the last 12 months, among past-year drug users aged 16–64 years (unadjusted prevalence) {Drug Use in New Zealand: Key Results of the 2007/08 New Zealand Alcohol and Drug Use Survey, 2010, p.89, p.191} ~ Prevalence of people who have reported using drugs at some point in their lifetime by type of drug (any drug, cannabis, ecstasy, cocaine), by age and by sex {Cannabis Use 2012/13: New Zealand Health Survey, 2015, p.2; Drug Use in New Zealand: Key Results of the 2007/08 New Zealand Alcohol and Drug Use Survey, 2010, p.16, p.39, p.41, p.65, p.66, p.94} ~ Prevalence of people who have reported ever using drugs, by age and sex, and by type of drug (cannabis, amphetamines, ecstasy, cocaine, hallucinogenic drugs, LSD or synthetic hallucinogens, naturally occurring hallucinogens, ketamine, kava, GHB, solvents, BZP party pills) {Cannabis Use 2012/13: New Zealand Health Survey, 2015, p.17; Drug Use in New Zealand: Key Results of the 2007/08 New Zealand Alcohol and Drug Use Survey, 2010, p.39, p.41, p.66, p.68, p.81, p.83, p.94, p.95, p.96, p.97, p.108, p.110, p.115, p.117, p.122, p.124, p.128, p.138, p.152, p.154, p.174, p.176, p.185, p.187} ~ Average age of first use of drugs by type (cannabis, ecstasy, amphetamines, cocaine, prescription stimulants, hallucinogenic drugs, naturally occurring hallucinogens, kava, GHB) {National Drug Policy 2015-2020, 2015, p.9; Drug Use in New Zealand: Key Results of the 2007/08 New Zealand Alcohol and Drug Use Survey, 2010, p.42, p.68, p.69, p.83, p.97, p.110, p.124, p.140, p.141, p.142, p.154, p.187} ~ Mean age of people who have used drugs once in the last 12 months by type of drug (amphetamines), and by sex {Amphetamine Use 2015/16:New Zealand Health Survey, 2016, p.6} ~ Summary of drug use for recreational purposes in the last 12 months and in lifetime, among the total population aged 16–64 years: Any drug (excluding alcohol, tobacco and BZP party pills); Cannabis; BZP party pills; Ecstasy; Any stimulant (amphetamines, cocaine/crack cocaine, prescription stimulants, ecstasy*); Amphetamines; Cocaine/crack cocaine; Prescription stimulants; Any hallucinogen (LSD and other synthetic hallucinogens, naturally occurring hallucinogens, ketamine, ecstasy*); LSD and other synthetic hallucinogens; Naturally occurring hallucinogens; Ketamine; Any sedative (kava, prescription sedatives, GHB); Kava; Prescription sedatives; GHB; Any opiate (prescription painkillers or opiates); Nitrous oxide; Inhalants; Solvents; Steroids {Drug Use in New Zealand: Key Results of the 2007/08 New Zealand Alcohol and Drug Use Survey, 2010, p.15} ~ Overall % of adults aged 16–64 years who had used drugs for recreational purposes at some time in their life and the number of adults aged 16–64 years in New Zealand this proportion equates to {Drug Use in New Zealand: Key Results of the 2007/08 New Zealand Alcohol and Drug Use Survey, 2010, p.16} ~ Ever used any drugs for recreational purposes in lifetime and past 12 months, among total population aged 16–64 years, by age group and gender and drug type (ecstasy, stimulants, amphetamines, prescription stimulants, ketamine, any sedative, prescription sedatives, opiates, nitrous oxide, inhalants, solvents) {Drug Use in New Zealand: Key Results of the 2007/08 New Zealand Alcohol and Drug Use Survey, 2010, p.16, p.17, p.71, p.73, p.74, p.76, p.77, p.79, p.89, p.101, p.102, p.105, p.128, p.130, p.132, p.134, p.135, p.136, p.137, p.146, p.148, p.149, p.150, p.158, p.160, p.161, p.162, p.165, p.167, p.168, p.171, p.174, p.176} ~ Age of first use of drugs by drug type for recreational purposes, among people aged 16–64 years who had ever used drugs, by gender {Drug Use in New Zealand: Key Results of the 2007/08 New Zealand Alcohol and Drug Use Survey, 2010, p.18, p.76, p.104, p.130, p.134, p.148, p.160, p.167, p.173, p.176} ~ Prevalence of people who have used drugs (cannabis, ecstasy, amphetamines, cocaine, BZP party pills) at the same time as other drugs at least once in the past 12 months by age, sex and drug type (Alcohol; Tobacco; BZP party pills; Ecstasy, amphetamines, cocaine or heroin; Ecstasy; Painkillers, antidepressants or sedatives; Amphetamines; Painkillers; Antidepressants; Cocaine; Sedatives; Heroin) {Drug Use in New Zealand: Key Results of the 2007/08 New Zealand Alcohol and Drug Use Survey, 2010, p.56, p.57, p.72, p.91, p.100, p.193} ~",12
Y,New Zealand,NZL,Demand Reduction,Prevalence of drug use by sex,Yes,"Past year prevalence of drug use by type (any drug, cannabis, amphetamines, ecstasy, stimulants, cocaine, hallucinogenic drugs, LSD or synthetic hallucinogens, naturally occurring hallucinogens, kava, GHB, opiates, BZP party pills), by age, by sex {Cannabis Use 2012/13: New Zealand Health Survey, 2015, p.1, p.31; Amphetamine Use 2015/16: New Zealand Health Survey, 2016, p.2, p.3; Drug Use in New Zealand: Key Results of the 2007/08 New Zealand Alcohol and Drug Use Survey, 2010, p.20, p.22, p.43, p.44, p.46, p.47, p.49, p.69, p.71, p.77, p.84, p.86, p.87, p.98, p.99, p.111, p.113, p.118, p.120, p.125, p.142, p.144, p.155, p.163, p.189, p.191} ~ Prevalence of people who have reported using drugs at some point in their lifetime by type of drug (any drug, cannabis, ecstasy, cocaine), by age and by sex {Cannabis Use 2012/13: New Zealand Health Survey, 2015, p.2; Drug Use in New Zealand: Key Results of the 2007/08 New Zealand Alcohol and Drug Use Survey, 2010, p.16, p.39, p.41, p.65, p.66, p.94} ~ Prevalence of people who have reported ever using drugs, by age and sex, and by type of drug (cannabis, amphetamines, ecstasy, cocaine, hallucinogenic drugs, LSD or synthetic hallucinogens, naturally occurring hallucinogens, ketamine, kava, GHB, solvents, BZP party pills) {Cannabis Use 2012/13: New Zealand Health Survey, 2015, p.17; Drug Use in New Zealand: Key Results of the 2007/08 New Zealand Alcohol and Drug Use Survey, 2010, p.39, p.41, p.66, p.68, p.81, p.83, p.94, p.95, p.96, p.97, p.108, p.110, p.115, p.117, p.122, p.124, p.128, p.138, p.152, p.154, p.174, p.176, p.185, p.187} ~ Mean age of people who have used drugs once in the last 12 months by type of drug (amphetamines), and by sex {Amphetamine Use 2015/16:New Zealand Health Survey, 2016, p.6} ~ Prevalence of people who have used drugs (cannabis, ecstasy, amphetamines, cocaine, BZP party pills) at the same time as other drugs at least once in the past 12 months by age, sex and drug type (Alcohol; Tobacco; BZP party pills; Ecstasy, amphetamines, cocaine or heroin; Ecstasy; Painkillers, antidepressants or sedatives; Amphetamines; Painkillers; Antidepressants; Cocaine; Sedatives; Heroin) {Drug Use in New Zealand: Key Results of the 2007/08 New Zealand Alcohol and Drug Use Survey, 2010, p.56, p.57, p.72, p.91, p.100, p.193} ~",5
Y,New Zealand,NZL,Demand Reduction,Prevalence of drug use by type,Yes,"Past year prevalence of drug use by type (any drug, cannabis, amphetamines, ecstasy, stimulants, cocaine, hallucinogenic drugs, LSD or synthetic hallucinogens, naturally occurring hallucinogens, kava, GHB, opiates, BZP party pills), by age, by sex {Cannabis Use 2012/13: New Zealand Health Survey, 2015, p.1, p.31; Amphetamine Use 2015/16: New Zealand Health Survey, 2016, p.2, p.3; Drug Use in New Zealand: Key Results of the 2007/08 New Zealand Alcohol and Drug Use Survey, 2010, p.20, p.22, p.43, p.44, p.46, p.47, p.49, p.69, p.71, p.77, p.84, p.86, p.87, p.98, p.99, p.111, p.113, p.118, p.120, p.125, p.142, p.144, p.155, p.163, p.189, p.191} ~ Number of different drugs used in the last 12 months, among past-year drug users and total population aged 16–64 years (unadjusted prevalence and estimated number of adults) {Drug Use in New Zealand: Key Results of the 2007/08 New Zealand Alcohol and Drug Use Survey, 2010, p.22} ~ Location of using drugs by type (amphetamines, BZP party pills) in the last 12 months, among past-year drug users aged 16–64 years (unadjusted prevalence) {Drug Use in New Zealand: Key Results of the 2007/08 New Zealand Alcohol and Drug Use Survey, 2010, p.23, p.46, p.89, p.191} ~ Prevalence of people who have reported using drugs at some point in their lifetime by type of drug (any drug, cannabis, ecstasy, cocaine), by age and by sex {Cannabis Use 2012/13: New Zealand Health Survey, 2015, p.2; Drug Use in New Zealand: Key Results of the 2007/08 New Zealand Alcohol and Drug Use Survey, 2010, p.16, p.39, p.41, p.65, p.66, p.94} ~ Prevalence of people who have reported ever using drugs, by age and sex, and by type of drug (cannabis, amphetamines, ecstasy, cocaine, hallucinogenic drugs, LSD or synthetic hallucinogens, naturally occurring hallucinogens, ketamine, kava, GHB, solvents, BZP party pills) {Cannabis Use 2012/13: New Zealand Health Survey, 2015, p.17; Drug Use in New Zealand: Key Results of the 2007/08 New Zealand Alcohol and Drug Use Survey, 2010, p.39, p.41, p.66, p.68, p.81, p.83, p.94, p.95, p.96, p.97, p.108, p.110, p.115, p.117, p.122, p.124, p.128, p.138, p.152, p.154, p.174, p.176, p.185, p.187} ~ Estimated ratio of people who have used drugs by type of drug (cannabis, ecstasy, amphetamines), and by age {National Drug Policy 2015-2020, 2015, p.1, p.8} ~ Average age of first use of drugs by type (cannabis, ecstasy, amphetamines, cocaine, prescription stimulants, hallucinogenic drugs, naturally occurring hallucinogens, kava, GHB) {National Drug Policy 2015-2020, 2015, p.9; Drug Use in New Zealand: Key Results of the 2007/08 New Zealand Alcohol and Drug Use Survey, 2010, p.42, p.68, p.69, p.83, p.97, p.110, p.124, p.140, p.141, p.142, p.154, p.187} ~ Summary of drug use for recreational purposes in the last 12 months and in lifetime, among the total population aged 16–64 years: Any drug (excluding alcohol, tobacco and BZP party pills); Cannabis; BZP party pills; Ecstasy; Any stimulant (amphetamines, cocaine/crack cocaine, prescription stimulants, ecstasy*); Amphetamines; Cocaine/crack cocaine; Prescription stimulants; Any hallucinogen (LSD and other synthetic hallucinogens, naturally occurring hallucinogens, ketamine, ecstasy*); LSD and other synthetic hallucinogens; Naturally occurring hallucinogens; Ketamine; Any sedative (kava, prescription sedatives, GHB); Kava; Prescription sedatives; GHB; Any opiate (prescription painkillers or opiates); Nitrous oxide; Inhalants; Solvents; Steroids {Drug Use in New Zealand: Key Results of the 2007/08 New Zealand Alcohol and Drug Use Survey, 2010, p.15} ~ Ever used any drugs for recreational purposes in lifetime and past 12 months, among total population aged 16–64 years, by age group and gender and drug type (ecstasy, stimulants, amphetamines, prescription stimulants, ketamine, any sedative, prescription sedatives, opiates, nitrous oxide, inhalants, solvents) {Drug Use in New Zealand: Key Results of the 2007/08 New Zealand Alcohol and Drug Use Survey, 2010, p.16, p.17, p.71, p.73, p.74, p.76, p.77, p.79, p.89, p.101, p.102, p.105, p.128, p.130, p.132, p.134, p.135, p.136, p.137, p.146, p.148, p.149, p.150, p.158, p.160, p.161, p.162, p.165, p.167, p.168, p.171, p.174, p.176} ~ Age of first use of drugs by drug type for recreational purposes, among people aged 16–64 years who had ever used drugs, by gender {Drug Use in New Zealand: Key Results of the 2007/08 New Zealand Alcohol and Drug Use Survey, 2010, p.18, p.76, p.104, p.130, p.134, p.148, p.160, p.167, p.173, p.176} ~ Prevalence of people who have used drugs (cannabis, ecstasy, amphetamines, cocaine, BZP party pills) at the same time as other drugs at least once in the past 12 months by age, sex and drug type (Alcohol; Tobacco; BZP party pills; Ecstasy, amphetamines, cocaine or heroin; Ecstasy; Painkillers, antidepressants or sedatives; Amphetamines; Painkillers; Antidepressants; Cocaine; Sedatives; Heroin) {Drug Use in New Zealand: Key Results of the 2007/08 New Zealand Alcohol and Drug Use Survey, 2010, p.56, p.57, p.72, p.91, p.100, p.193} ~ Estimated population by drug group (Amphetamine-type stimulants, Cannabinoids, Hallucinogenic and psychedelic drugs, Opioid and sedative drugs), adjusted for poly-drug use (casual, total) {The New Zealand Drug Harm Index, 2016, p.17} ~ Drug group(Amphetamine-type stimulants, Cannabinoids, Hallucinogenic and psychedelic drugs, Opioid and sedative drugs), user type(Dependent users, Casual users, All users, Average occasions, Total occasions, average dose (g) ) and total amount consumed {The New Zealand Drug Harm Index, 2016, p.18, p.19, p.44} ~",13
Y,New Zealand,NZL,Demand Reduction,Number of people who use drugs,Yes,"Over a lifetime, percentage of New Zealanders who will have tried an illegal drug {National Drug Policy 2015-2020, 2015, p.1} ~ ",1
Y,New Zealand,NZL,Demand Reduction,"Prevalence of drug use by mode of administration (oral, mucosa, inhalation, and injection)",Yes,"Prevalence of people who have ever injected drugs for recreational purposes in lifetime, past 12 months, by age group and sex {Drug Use in New Zealand: Key Results of the 2007/08 New Zealand Alcohol and Drug Use Survey, 2010, p.180} ~ Age of first injecting for recreational purposes by age group and sex {Drug Use in New Zealand: Key Results of the 2007/08 New Zealand Alcohol and Drug Use Survey, 2010, p.181, p.182} ~ percentage of people with hepatitis C virus infection that report a history of intravenous drug use {National Drug Policy 2015-2020, 2015, p.10} ~ ",3
Y,New Zealand,NZL,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT)",No,n/a,0
Y,New Zealand,NZL,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT) by age",Yes,"Prevalence of people who have ever used drugs by type (cannabis, amphetamines, BZP party pills) that have received help to reduce their level of drug use at some point in their lifetime, in the past 12 months, by age group, by sex {Cannabis Use 2012/13: New Zealand Health Survey, 2015, p.13, p.28; Drug Use in New Zealand: Key Results of the 2007/08 New Zealand Alcohol and Drug Use Survey, 2010, p.28, p.29, p.30, p.31, p.32, p.58, p.59, p.61, p.91, p.92, p.193} ~ Prevalence of people who have ever used drugs that wanted to reduce their level of drug use but did not receive it, by age group and sex, by type of drug (cannabis, amphetamines, BZP party pills) {Cannabis Use 2012/13: New Zealand Health Survey, 2015, p.13, p.29; National Drug Policy 2015-2020, 2015, p.14;  Drug Use in New Zealand: Key Results of the 2007/08 New Zealand Alcohol and Drug Use Survey, 2010, p.32, p.33, p.34, p.35, p.61, p.62, p.92, p.193} ~ Reasons for not having received help to reduce the level of drug use by age and sex and type of drug (cannabis) {Drug Use in New Zealand: Key Results of the 2007/08 New Zealand Alcohol and Drug Use Survey, 2010, p.35, p.62} ~ Sources of help to reduce the level of drug use in lifetime, among people aged 16–64 years who had ever received help to reduce their level of drug use (unadjusted prevalence): Drug and alcohol counsellor, Family member or friend, General practitioner (GP), Psychiatrist, psychologist or mental health service, Narcotics Anonymous or other support group, Detoxification program, Natural or alternative therapist, Māori or Pacific health service, Emergency department at a public hospital {Drug Use in New Zealand: Key Results of the 2007/08 New Zealand Alcohol and Drug Use Survey, 2010, p.30, p.61, p.91} ~",4
Y,New Zealand,NZL,Demand Reduction,Level of access to opioid substitution treatment and medication assisted treatment (OST/MAT),No,n/a,0
Y,New Zealand,NZL,Demand Reduction,Level of coverage of inpatient treatment,No,n/a,0
Y,New Zealand,NZL,Demand Reduction,Proportion of people who use drugs enrolled in voluntary treatment,No,n/a,0
Y,New Zealand,NZL,Demand Reduction,Proportion of people who use drugs enrolled in coerced treatment,Yes,"Among past-year drug users, % who reported that a relative or friend, or a doctor or another health worker had been concerned about them or suggested they cut down their use of  drugs (cannabis, amphetamines, BZP party pills) in the last 12 months and the % of the total population aged 16–64 years this proportion represents {Drug Use in New Zealand: Key Results of the 2007/08 New Zealand Alcohol and Drug Use Survey, 2010, p.62, p.92, p.193} ~ Percentage of drug users who reported someone being concerned about their drug use or suggested cutting down (Never; In the last 12 months; Earlier time) by type of drug (cannabis), by sex {Cannabis Use 2012/13: New Zealand Health Survey, 2015, p.27, p.28} ~ ",2
Y,New Zealand,NZL,Demand Reduction,Proportion of people who use drugs enrolled in compulsory treatment,No,n/a,0
Y,New Zealand,NZL,Demand Reduction,Presence of prevention programming in law enforcement,No,n/a,0
Y,New Zealand,NZL,Demand Reduction,Presence of prevention programming in the media,No,n/a,0
Y,New Zealand,NZL,Demand Reduction,Presence of prevention programming in schools,No,n/a,0
Y,New Zealand,NZL,Demand Reduction,Presence of prevention programming in the workplace,No,n/a,0
Y,New Zealand,NZL,Demand Reduction,Presence of prevention programming for youth and the community,Yes,"percentage of high school age students that thought it was okay for people their age to drink alcohol, and percentage that thought it was okay to use cannabis {National Drug Policy 2015-2020, 2015, p.14} ~ ",1
Y,New Zealand,NZL,Demand Reduction,Presence of other demand reduction metrics,Yes,"Cost of intervention by drug group (Amphetamine-type stimulants, Cannabinoids, Hallucinogenic and psychedelic drugs, Opioid and sedative drugs) and intervention type(Police/ Customs*, Courts/ Corrections, health) {The New Zealand Drug Harm Index, 2016, p.30} ~",1
Y,New Zealand,NZL,Supply Reduction,Size and value of the illegal drug market,Yes,"Reinvestment in organized crime by drug group (Amphetamine-type stimulants, Cannabinoids, Hallucinogenic and psychedelic drugs, Opioid and sedative drugs) and user type (Expenditure on illicit drugs ($m): Dependent, Casual; Reinvestment in organized crime ($m): Dependent, Casual, Total) {The New Zealand Drug Harm Index, 2016, p.26} ~ Reinvestment in organized crime per user(Number of users: Dependent, Casual; Reinvestment in organized crime per user $: Dependent, Casual, All users) by Drug group(Amphetamine-type stimulants, Cannabinoids, Hallucinogenic and psychedelic drugs, Opioid and sedative drugs) {The New Zealand Drug Harm Index, 2016, p.27} ~ Tax avoided by organized crime by tax type and source of income(Income derived from dependent users: tax avoided ($m), Income derived from casual users: tax avoided ($m), Income from all users) by drug group(Amphetamine-type stimulants, Cannabinoids, Hallucinogenic and psychedelic drugs, Opioid and sedative drugs) {The New Zealand Drug Harm Index, 2016, p.28} ~",3
Y,New Zealand,NZL,Supply Reduction,Level of procedures related to crop eradication,No,n/a,0
Y,New Zealand,NZL,Supply Reduction,"Number of arrests, seizures, and offences",No,n/a,0
Y,New Zealand,NZL,Supply Reduction,Level of law enforcement activity and interdiction in the market,Yes,"amount prevented of pseudoephedrine(in kg) and of ephedrine(in kg) from entering the country and being used in the domestic methamphetamine manufacturing process by New Zealand Police, the Organized and Financial Crime Agency of New Zealand and the New Zealand Customs Service {National Drug Policy 2015-2020, 2015, p.22} ~",1
Y,New Zealand,NZL,Supply Reduction,"Price, purity and potency of drugs, and related process indicators",No,n/a,0
Y,New Zealand,NZL,Supply Reduction,Number of people engaged with the criminal justice system,Yes,"Legal problems reported among male (% included) and female (% included) cannabis users {Cannabis Use 2012/13: New Zealand Health Survey, 2015, p.12} ~ Legal problems reported by people who use drugs by age (% included) {Cannabis Use 2012/13: New Zealand Health Survey, 2015, p.12} ~ During 2013/14 (i.e., fiscal year ending 30 June 2014) number of police proceedings for illicit drug possession or use against youth (aged 5–24) that were recorded, with approximately a quarter resulting in court action {National Drug Policy 2015-2020, 2015, p.9} ~",3
Y,New Zealand,NZL,Supply Reduction,Presence of other supply reduction metrics,Yes,"Amount of money that has been estimated to cost the country per year by harmful use of AOD which includes: the costs to the criminal justice system of enforcing AOD-related legislation {National Drug Policy 2015-2020, 2015, p.2} ~",1
Y,New Zealand,NZL,International Cooperation,Level of engagement in international cooperation,No,n/a,0
Y,Bangladesh,BGD,Health,Level of availability of harm reduction services and harm reduction scale up,Yes,"Number and % of MARPs reached with services (BCC, condoms/BCC, NSE) in past year: PWID {3rd National Strategic Plan for HIV and AIDS Response, 2011-2015, p.62} ~ Number of occasions that stock outs of essential drugs and commodities reported (reported separately for condoms) {3rd National Strategic Plan for HIV and AIDS Response, 2011-2015, p.67} ~ number of MARA/EVA reached with comprehensive risk reduction counseling services {National HIV Risk Reduction Strategy for MARA/EVA to HIV & AIDS in Bangladesh, 2013, p.34} ~ % of MARA/EVA that achieve effective coverage of condom services in target locations {National HIV Risk Reduction Strategy for MARA/EVA to HIV & AIDS in Bangladesh, 2013, p.35} ~",4
Y,Bangladesh,BGD,Health,Presence of needle and syringe programs,Yes,"% of MARA/EVA that achieve effective coverage of Needle and Syringe exchange services in target locations {National HIV Risk Reduction Strategy for MARA/EVA to HIV & AIDS in Bangladesh, 2013, p.35} ~  Number of occasions that stock outs of essential drugs and commodities reported (reported separately for Needles/syringes) {3rd National Strategic Plan for HIV and AIDS Response, 2011-2015, p.67} ~",2
Y,Bangladesh,BGD,Health,Prevalence of substance use disorders,Yes,"estimated number of people who use drugs that are to suffer from drug use disorders, and of those, number of people who inject drugs (PWID) {Annual Drug Report Bangladesh, 2016, p.63} ~ Percentage Age distribution of the drug abusers from 2012-2016 {Annual Drug Report Bangladesh, 2016, p.28} ~ percentage distribution of patients by principal drug of abuse from 2012-2016 {Annual Drug Report Bangladesh, 2016, p. 32} ~ % of drug addicts that are adolescents and youths {Annual Drug Report Bangladesh, 2016, p.57} ~",4
Y,Bangladesh,BGD,Health,Prevalence of psychiatric comorbidities,No,n/a,0
Y,Bangladesh,BGD,Health,Drug-related mortality,Yes,"an estimated number of drug-related deaths in 2014, corresponding to number of deaths of people aged 15-64 {Annual Drug Report Bangladesh, 2016, p.63} ~",1
Y,Bangladesh,BGD,Health,Prevalence of drug-related infectious disease,Yes,"Percentage of HIV prevalence amongst People Who Inject Drugs (PWID) {3rd National Strategic Plan for HIV and AIDS Response, 2011-2015, p.16, Annual Drug Report Bangladesh, 2016, p.63, National Harm Reduction Strategy for Drug Use and HIV 2004-2010, 2008, p.1} ~ Percentage of most at risk populations who are HIV infected: male and female PWID, FSW, MSW, MSM, Hijra(transgender) {3rd National Strategic Plan for HIV and AIDS Response, 2011-2015, p.60} ~  the % increase in HIV prevalence among IDUs by 2005-2006 in Central Bangladesh {National Harm Reduction Strategy for Drug Use and HIV 2004-2010, 2008, p.1} ~ % prevalence rates of Hepatitis C among IDUs {National Harm Reduction Strategy for Drug Use and HIV 2004-2010, 2008, p.7} ~ The % overall HIV prevalence among key populations of all ages {National HIV Risk Reduction Strategy for MARA/EVA to HIV & AIDS in Bangladesh, 2013, p.9} ~",5
Y,Bangladesh,BGD,Health,Proportion of people who use drugs who engage in risky consumption,Yes,"the overall % of people that reported common needle sharing {National Harm Reduction Strategy for Drug Use and HIV 2004-2010, 2008, p.6} ~ during the month prior to the survey,  the average number of times IDUs reported injecting using a working syringe {National HIV Risk Reduction Strategy for MARA/EVA to HIV & AIDS in Bangladesh, 2013, p.11} ~ ",2
Y,Bangladesh,BGD,Health,Proportion of people who use drugs who engage in safe consumption practices,Yes,"Percentage of PWID reporting use of new needle/syringe last time they injected {3rd National Strategic Plan for HIV and AIDS Response, 2011-2015, p.61, National HIV Risk Reduction Strategy for MARA/EVA to HIV & AIDS in Bangladesh, 2013, p.1} ~",1
Y,Bangladesh,BGD,Health,"Coverage of services for the prevention, testing, and treatment of bloodborne diseases",Yes,"Percentage of most at risk populations or emerging vulnerable populations who both correctly identify ways of preventing the sexual transmission of HIV and who reject major misconceptions about HIV transmission: PWID and Heroin smokers {3rd National Strategic Plan for HIV and AIDS Response, 2011-2015, p. 62} ~ % of more vulnerable populations reached through HIV interventions {3rd National Strategic Plan for HIV and AIDS Response, 2011-2015, p.63} ~ number of MARA / EVA connected via social media and linked to HIV services {National HIV Risk Reduction Strategy for MARA/EVA to HIV & AIDS in Bangladesh, 2013, p.34} ~ In terms of HIV testing, % of people that knew about a facility where they could be HIV tested and % of people that had been tested {National HIV Risk Reduction Strategy for MARA/EVA to HIV & AIDS in Bangladesh, 2013, p.11} ~ number of MARA/EVA reached through PE and linked to HIV services {National HIV Risk Reduction Strategy for MARA/EVA to HIV & AIDS in Bangladesh, 2013, p.34} ~ % of MARA/EVA that achieve effective coverage of HCT(HIV Counselling and Testing) services in target locations {National HIV Risk Reduction Strategy for MARA/EVA to HIV & AIDS in Bangladesh, 2013, p.34} ~ % of female MARA/EVA that achieve effective coverage of PPTCT(Prevention of Parent to Child Transmission) services in target locations {National HIV Risk Reduction Strategy for MARA/EVA to HIV & AIDS in Bangladesh, 2013, p.35} ~ number of reference group for MARA/EVA established {National HIV Risk Reduction Strategy for MARA/EVA to HIV & AIDS in Bangladesh, 2013, p.33} ~",8
Y,Bangladesh,BGD,Health,Presence of specialised training for addiction care,Yes,"Echo Training: ln total 144 participants from different background (doctor, nurse, recovered addict, clinic owner, clinical psychologist, psychologist etc.) were trained on universal treatment curriculum {Annual Drug Report Bangladesh, 2016, p. 53} ~ number of partners trained in bottleneck analysis of the access and utilization of key HIV and AIDS Intervention {National HIV Risk Reduction Strategy for MARA/EVA to HIV & AIDS in Bangladesh, 2013, p.36} ~ number of service providers trained {National HIV Risk Reduction Strategy for MARA/EVA to HIV & AIDS in Bangladesh, 2013, p.34} ~ ",3
Y,Bangladesh,BGD,Health,Presence of health harms related to drug use,Yes,"STI prevalence among all most at risk populations (for adults and young people): PWID and Heroin smokers {3rd National Strategic Plan for HIV and AIDS Response, 2011-2015, p.61} ~",1
Y,Bangladesh,BGD,Health,Presence of other health metrics,No,n/a,0
Y,Bangladesh,BGD,Peace and Security,"Prevalence of alcohol and drugs in accidents, and interventions to increase road safety",No,n/a,0
Y,Bangladesh,BGD,Peace and Security,Annual number of public disorder and violent crime reports,No,n/a,0
Y,Bangladesh,BGD,Peace and Security,Number of non-lethal drug market violent events reported,No,n/a,0
Y,Bangladesh,BGD,Peace and Security,Number of drug market related homicides and disappearances,No,n/a,0
Y,Bangladesh,BGD,Peace and Security,Presence of other peace and security metrics,Yes,"number of MARA/EVA enrolled care and support services for adolescent victims of exploitation, violence and abuse {National HIV Risk Reduction Strategy for MARA/EVA to HIV & AIDS in Bangladesh, 2013, p.33} ~ number and type of stakeholders reached to increase public awareness on exploitation, violence and abuse {National HIV Risk Reduction Strategy for MARA/EVA to HIV & AIDS in Bangladesh, 2013, p.33} ~",2
Y,Bangladesh,BGD,Development,Coverage of housing assistance for people who use drugs,No,n/a,0
Y,Bangladesh,BGD,Development,Coverage of social assistance for people who use drugs (not including housing),Yes,"% of all adolescent in vocation and entrepreneurial skills training that are MARA/EVA {National HIV Risk Reduction Strategy for MARA/EVA to HIV & AIDS in Bangladesh, 2013, p.36} ~ number of literacy, numeracy and life skills programme that is MARA/EVA sensitive {National HIV Risk Reduction Strategy for MARA/EVA to HIV & AIDS in Bangladesh, 2013, p.36} ~",2
Y,Bangladesh,BGD,Development,Number of households enrolled in alternative development,No,n/a,0
Y,Bangladesh,BGD,Development,Presence of other development metrics,Yes,"Educational status of the drug abusers from 2012-2016 {Annual Drug Report Bangladesh, 2016, p.29} ~ Distribution of patients by Employment Status, Self-income and Self-Occupation  from 2012-2016 {Annual Drug Report Bangladesh, 2016, p.30, p.31, p.53} ~ low levels of formal education among MARP/EVA: % of PWIDs(People With Injecting Disorders) {National HIV Risk Reduction Strategy for MARA/EVA to HIV & AIDS in Bangladesh, 2013, p.24} ~",3
Y,Bangladesh,BGD,Human Rights,"Prevalence and incidence of infectious diseases in vulnerable populations (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Bangladesh,BGD,Human Rights,"Prevalence of vulnerable people who use drugs (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"Drug prevention program in prison: estimated % of prison population that are identified as drug user but mostly they are treated as drug peddlers {Annual Drug Report Bangladesh, 2016, p.64} ~ ",1
Y,Bangladesh,BGD,Human Rights,Proportion of people who use drugs in prison that are receiving medication assisted treatment (MAT),No,n/a,0
Y,Bangladesh,BGD,Human Rights,Distribution of sterile injecting equipment in prisons,No,n/a,0
Y,Bangladesh,BGD,Human Rights,Presence of programs and services targeted towards women ,No,n/a,0
Y,Bangladesh,BGD,Human Rights,Presence of programs and services targeted towards people of color,No,n/a,0
Y,Bangladesh,BGD,Human Rights,Presence of challenges and/or harms experienced by people of color,No,n/a,0
Y,Bangladesh,BGD,Human Rights,"Presence of programs and services targeted towards vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"number of social protection programme with MARA/EVA sensitive indicators {National HIV Risk Reduction Strategy for MARA/EVA to HIV & AIDS in Bangladesh, 2013, p.33} ~",1
Y,Bangladesh,BGD,Human Rights,"Presence of challenges and/or harms experienced by vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Bangladesh,BGD,Human Rights,Presence of other human rights metrics,Yes,"% of education with positive attitude to MARA/EVA {National HIV Risk Reduction Strategy for MARA/EVA to HIV & AIDS in Bangladesh, 2013, p.36} ~",1
Y,Bangladesh,BGD,Demand Reduction,Prevalence of drug use by age,Yes,"Frequency distribution of Patients by Primary Drug, By Age etc. for 2012-2013 {Department of Narcotics Control, p.7} ~ The total estimated size after all adjustments for PWID in Bangladesh between aged 10- 24 yrs; Of these number of people that are in the age category 10-19 yrs. and 20-24 years {National HIV Risk Reduction Strategy for MARA/EVA to HIV & AIDS in Bangladesh, 2013, p.11} ~ number of young people, who are drug users, mostly Yaba (methamphetamine), that were surveyed, among which proportion of people that was in the age group of 10-18 years, average age of the respondents, with females being somewhat younger (18.5 yrs.) than males (19.6 yrs.) {National HIV Risk Reduction Strategy for MARA/EVA to HIV & AIDS in Bangladesh, 2013, p.14} ~ number of studies, survey and programme reports that are age disaggregated {National HIV Risk Reduction Strategy for MARA/EVA to HIV & AIDS in Bangladesh, 2013, p.32} ~ The mean age of first injecting drugs and first smoking heroin {National HIV Risk Reduction Strategy for MARA/EVA to HIV & AIDS in Bangladesh, 2013, p.11, p.12} ~",4
Y,Bangladesh,BGD,Demand Reduction,Prevalence of drug use by sex,Yes,"number of young people, who are drug users, mostly Yaba (methamphetamine), that were surveyed, among which proportion of people that was in the age group of 10-18 years, average age of the respondents, with females being somewhat younger (18.5 yrs.) than males (19.6 yrs.) {National HIV Risk Reduction Strategy for MARA/EVA to HIV & AIDS in Bangladesh, 2013, p.14} ~ % of male that reported taking Phensidyl before starting Yaba {National HIV Risk Reduction Strategy for MARA/EVA to HIV & AIDS in Bangladesh, 2013, p.14} ~",2
Y,Bangladesh,BGD,Demand Reduction,Prevalence of drug use by type,Yes,"the graphical presentation of three main drugs of abuse in Bangladesh(opioids, cannabinoids, stimulants) from 2012-2016 {Annual Drug Report Bangladesh, 2016, p.54} ~ Besides heroin, % of smokers that took other drugs in the last six months which includes cannabis, Phensidyle, Pethidine, yaba, and Cocktail (mixture of different drugs) {National HIV Risk Reduction Strategy for MARA/EVA to HIV & AIDS in Bangladesh, 2013, p.12} ~ % of the respondents admitted to taking other drugs before they started taking Yaba. Cannabis was found to be the most common drug to start with (% included) while certain % of people used tablets {National HIV Risk Reduction Strategy for MARA/EVA to HIV & AIDS in Bangladesh, 2013, p.14} ~ proportion of people that admitted to injecting drugs before they took Yaba {National HIV Risk Reduction Strategy for MARA/EVA to HIV & AIDS in Bangladesh, 2013, p.14} ~  % of male that reported taking Phensidyl before starting Yaba {National HIV Risk Reduction Strategy for MARA/EVA to HIV & AIDS in Bangladesh, 2013, p.14} ~ Frequency distribution of Patients by Primary Drug, By Age etc. for 2012-2013 {Department of Narcotics Control, p.7} ~ number of young people, who are drug users, mostly Yaba (methamphetamine), that were surveyed, among which proportion of people that was in the age group of 10-18 years, average age of the respondents, with females being somewhat younger (18.5 yrs.) than males (19.6 yrs.) {National HIV Risk Reduction Strategy for MARA/EVA to HIV & AIDS in Bangladesh, 2013, p.14} ~ The total estimated size after all adjustments for PWID in Bangladesh between aged 10- 24 yrs; Of these number of people that are in the age category 10-19 yrs. and 20-24 years {National HIV Risk Reduction Strategy for MARA/EVA to HIV & AIDS in Bangladesh, 2013, p.11} ~",8
Y,Bangladesh,BGD,Demand Reduction,Number of people who use drugs,Yes,"the estimated number of total drug users in the country {National Harm Reduction Strategy for Drug Use and HIV 2004-2010, 2008, p.5} ~  Number of estimated NIDUs (Non-Injecting Drug Users) in Bangladesh {National HIV Risk Reduction Strategy for MARA/EVA to HIV & AIDS in Bangladesh, 2013, p.11} ~",2
Y,Bangladesh,BGD,Demand Reduction,"Prevalence of drug use by mode of administration (oral, mucosa, inhalation, and injection)",Yes,"Distribution of Patients by Route of Administration of Drugs in Bangladesh (smoking, swallowing, nasal inhalation, injection, others) from 2013-2016 {Annual Drug Report Bangladesh, 2016, p.54} ~ the number of people that are believed to be injecting drug users (IDUs) out of the estimated number of total drug users {National Harm Reduction Strategy for Drug Use and HIV 2004-2010, 2008, p.5} ~ approximate % of drug users that are starting to inject with each passing year over the past five years {National Harm Reduction Strategy for Drug Use and HIV 2004-2010, 2008, p.6} ~ The mean age of first injecting drugs and first smoking heroin {National HIV Risk Reduction Strategy for MARA/EVA to HIV & AIDS in Bangladesh, 2013, p.11, p.12} ~  Proportion of people who reported that they had also injected drugs in the last six months; includes an estimated average {National HIV Risk Reduction Strategy for MARA/EVA to HIV & AIDS in Bangladesh, 2013, p.12} ~ estimated number of people who use drugs that are to suffer from drug use disorders, and of those, number of people who inject drugs (PWID) {Annual Drug Report Bangladesh, 2016, p .63} ~ The total estimated size after all adjustments for PWID in Bangladesh between aged 10- 24 yrs; Of these number of people that are in the age category 10-19 yrs. and 20-24 years {National HIV Risk Reduction Strategy for MARA/EVA to HIV & AIDS in Bangladesh, 2013, p.11} ~",7
Y,Bangladesh,BGD,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT)",Yes,"the number of treatment seekers for heroin addiction & how much it has increased during 2016 in comparison with the previous year {Annual Drug Report Bangladesh, 2016, p.21} ~ Patients admitted to treatment services for Yaba; Heroin; Phensedyl; Cannabis; Buprenorphine; Alcohol; Sedative, hypnotic and tranquilizer; and Pethidine addiction from 2011-2016 {Annual Drug Report Bangladesh, 2016, p. 21, p. 23, p. 24, p. 26, p. 27, p. 34} ~ Number of Patients (outpatient, total) in private treatment centers from 1990 to 2016 {Department of Narcotics Control, p.7} ~ According to the information of Directory for Drug Treatment and Rehabilitation Centers, NGOs are providing treatment and rehabilitation support through 172 drug treatment and rehabilitation centers in Bangladesh {Annual Drug Report Bangladesh, 2016, p.63} ~",4
Y,Bangladesh,BGD,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT) by age",No,n/a,0
Y,Bangladesh,BGD,Demand Reduction,Level of access to opioid substitution treatment and medication assisted treatment (OST/MAT),Yes,"number of OST clinics in Dhaka, and number of PWIDs covered Who Inject Drugs) {Annual Drug Report Bangladesh, 2016, p.51} ~ Prevalence of coverage of existing OST programmes in Bangladesh, and number of PWIDs covered. {Annual Drug Report Bangladesh, 2016, p.51} ~ ",2
Y,Bangladesh,BGD,Demand Reduction,Level of coverage of inpatient treatment,Yes,"The government has planned to establish more six treatment and rehabilitation centers with facilities of 50 beds in each divisional headquarters {Annual Drug Report Bangladesh, 2016, p.52} ~ Number of Patients (inpatient, total) in private treatment centers from 1990 to 2016 {Department of Narcotics Control, p.7} ~",2
Y,Bangladesh,BGD,Demand Reduction,Proportion of people who use drugs enrolled in voluntary treatment,No,n/a,0
Y,Bangladesh,BGD,Demand Reduction,Proportion of people who use drugs enrolled in coerced treatment,No,n/a,0
Y,Bangladesh,BGD,Demand Reduction,Proportion of people who use drugs enrolled in compulsory treatment,No,n/a,0
Y,Bangladesh,BGD,Demand Reduction,Presence of prevention programming in law enforcement,Yes,"number of law enforcement agencies(and agents) trained on the special protection needs and appropriate measures for MARA/EVA {National HIV Risk Reduction Strategy for MARA/EVA to HIV & AIDS in Bangladesh, 2013, p.33} ~",1
Y,Bangladesh,BGD,Demand Reduction,Presence of prevention programming in the media,Yes,"Statistics on Preventive and Awareness Programmes: Prevention Education and Publication (Production & distribution of anti-narcotics posters, Distribution of anti-narcotics leaflets, Distribution of anti-narcotics stickers, souvenir, bulletin)from 2013-2016 {Annual Drug Report Bangladesh, 2016, p.49} ~",1
Y,Bangladesh,BGD,Demand Reduction,Presence of prevention programming in schools,Yes,"Statistics on Preventive and Awareness Programmes: Prevention Education and Publication (Anti-narcotics discussion meetings, Anti-narcotics class speech at schools and colleges, Forming of anti-drug committee in Educational institute) from 2013-2016 {Annual Drug Report Bangladesh, 2016, p.49} ~",1
Y,Bangladesh,BGD,Demand Reduction,Presence of prevention programming in the workplace,No,n/a,0
Y,Bangladesh,BGD,Demand Reduction,Presence of prevention programming for youth and the community,Yes,"number of MARA/EVA reached through sports for development and linked to services {National HIV Risk Reduction Strategy for MARA/EVA to HIV & AIDS in Bangladesh, 2013, p.34} ~",1
Y,Bangladesh,BGD,Demand Reduction,Presence of other demand reduction metrics,Yes,"Primary causes of drug abuse of the patients under treatment programs (Curiosity, influence of friends, Desire to get easy Pleasure, Psychological disorder, Adverse atmosphere in the family, Easy access to drugs, Unemployment, Frustration, Lack of drug awareness, Complication about Treatment) from 2011-2016 {Annual Drug Report Bangladesh, 2016, p.27} ~",1
Y,Bangladesh,BGD,Supply Reduction,Size and value of the illegal drug market,Yes,"Points of entry and routes of smuggling drugs from Myanmar to Bangladesh and from India to Bangladesh western border (Indian State of West Bengal), northern border and Eastern border (Indian States of Assam, Tripura and Mizoram) {Annual Drug Report Bangladesh, 2016, p.35, p.36, p.37} ~ Some New Routes of Phensedyl Trafficking {Annual Drug Report Bangladesh, 2016, p.37} ~ Statistics of Cases made by DNC Since 1990 to 2016 {Department of Narcotics Control, p.3} ~ % of cannabis that comprises all of the cases detected by the DNC during 2016 {Annual Drug Report Bangladesh, 2016, p.18} ~",4
Y,Bangladesh,BGD,Supply Reduction,Level of procedures related to crop eradication,Yes,"Production of morphine (injection and tablet) and Pethidine in Bangladesh from 2010-2016 {Annual Drug Report Bangladesh, 2016, p.33, p.34} ~  ",1
Y,Bangladesh,BGD,Supply Reduction,"Number of arrests, seizures, and offences",Yes,"Statistics on Mobile Court Operation by DNC (raids, cases, arrested, conviction, acquittal) from 2011-2016 {Annual Drug Report Bangladesh, 2016, p.46} ~ District & Division wise Statistics on Number of Cases and Seizure of Drugs (Heroin, Codeine (Phensedyl), Cannabis, ATS (Yaba), Buprenorphine) by the DNC(Department of Narcotics Control) in 2016 {Annual Drug Report Bangladesh, 2016, p.11} ~ Statistics on the seizure of drugs (Heroin, Codeine preparation (Bottle), Codeine (loose), Cannabis (in kg), Cannabis plant, ATS (Yaba), Buprenorphine) by all agencies in Bangladesh from 2011 to 2016 {Annual Drug Report Bangladesh, 2016, p.15} ~ Number of seizures and cases of ATS (Yaba) by DNC in Bangladesh in 2016 {Annual Drug Report Bangladesh, 2016, p.16} ~ Number of cases and seizures of Heroin; Phensedyl; Cannabis; Buprenorphine; and Yaba by DNC in Bangladesh in 2016 {Annual Drug Report Bangladesh, 2016, p.17, p.18, p.19} ~ Seizure of Heroin; Phensedyl (Bottles); cannabis; Buprenorphine (Ampoule) by all law enforcement agencies in Bangladesh from 2010-2016 {Annual Drug Report Bangladesh, 2016, p. 22, p. 23, p. 24} ~ amount of seizures of Indian originated opium in Bangladesh during 2012, 2013 & 2014 {Annual Drug Report Bangladesh, 2016, p.33} ~ According to the data from DNC, percentage of Yaba seized from Chittagong Metropolitan area {Annual Drug Report Bangladesh, 2016, p.35} ~  Number(pieces) of Yaba seized and  number of  accused arrested from Shapla Chattar of Motijheel, Dhaka on  January 7, 2016 {Annual Drug Report Bangladesh, 2016, p.38} ~ number(pieces) of  Yaba  and 7.65 bore Automatic Pistol seized with number of accused arrested from posta of Chalkbazar Dhaka on  February 29,2016 {Annual Drug Report Bangladesh, 2016, p.38} ~ amount of opium seized with number of accused arrested from Chakbazar Zaman hotel of Chittagonj Metropolitan area on March 8, 2016 {Annual Drug Report Bangladesh, 2016, p.38} ~ amount of Cannabis seized with number of accused arrested from Choranol of Burichang, Comilla on 21 March,2016 {Annual Drug Report Bangladesh, 2016, p.38} ~ Statistics of [...] and arrests by DNC from 2011-2016 {Annual Drug Report Bangladesh, 2016, p.43} ~ Statistics of the cases and arrests by all law enforcement agencies from 2011-2016 {Annual Drug Report Bangladesh, 2016, p.43} ~ the increase in cannabis amount seized in 2015 compared to 2014 {Annual Drug Report Bangladesh, 2016, p.58} ~ On average, the approximate total number of yearly arrests for drug related offences in Bangladesh {Annual Drug Report Bangladesh, 2016, p. 70} ~ Statistics on the Seizure of Drugs (Poppy Plant Opium, Heroin, Cocaine, Codeine Preparation(Bottle), Codeine (Loose), Cannabis Plant, Injecting Drug (Ampule), ATS Yaba) by all Agencies in Bangladesh from 2010-2016 {Department of Narcotics Control, p.3} ~ Statistics of Seizures made by DNC since 1990(quantity seized from 2014 to 2016) {Department of Narcotics Control, p.3} ~ Seizure of Money, Vehicles etc. by DNC in Connection with Drug Offences from 2011 to 2016 {Annual Drug Report Bangladesh, 2016, p.15} ~  number(pieces) of Yaba and a Pick-up Van seized with number of  accused arrested from Kotwali of Chittagong Metropolitan area on December 6,2016 {Annual Drug Report Bangladesh, 2016, p.38} ~ amount of Cannabis seized with number of accused arrested and accused that were absconding from Kasba of Brahmanbaria on 20 December, 2016 {Annual Drug Report Bangladesh, 2016, p.38} ~ amount of Cannabis and a private car seized with number of accused arrested from Gomoti Beribadh of Adarsha Sadar, Comilla on 21 March,2016 {Annual Drug Report Bangladesh, 2016, p.38} ~ amount of Cocaine Seized with one accused arrested called Chias Espejo Jullin from Hazrat Shahjalal International Airport of Dhaka on 08 December,2016 {Annual Drug Report Bangladesh, 2016, p.38} ~ Offenses and punishment under the Narcotics Control Act, 1990 (illicit import, export, manufacture, processing, sale, distribution, purchase, transport, shipment, storage, possession, warehousing, use, etc. of drugs/precursor and alcohol, Any operation of drugs or precursors without license/permit/pass, issue of license/permit/pass to restricted persons, Prescription of drugs without lawful authority, illicit Possession of apparatus/utensils/ingredients for manufacture/processing drugs/precursors, Allowing land, house, apparatus, utensils, transport for committing offences of drugs/precursors, Violation of the conditions of license/permit/pass, Search, seizure or arrest for harassment/abatement/conspiracy/financing/patronizing, Non-cooperation of law Enforcement personnel in implementing Narcotics/Precursor laws) {Annual Drug Report Bangladesh, 2016, p.41} ~",24
Y,Bangladesh,BGD,Supply Reduction,Level of law enforcement activity and interdiction in the market,Yes,"Statistics of the raids from 2011-2016 {Annual Drug Report Bangladesh, 2016, p.43} ~ Statistics on Mobile Court Operation by DNC (raids, cases, arrested, conviction, acquittal) from 2011-2016 {Annual Drug Report Bangladesh, 2016, p.46} ~",2
Y,Bangladesh,BGD,Supply Reduction,"Price, purity and potency of drugs, and related process indicators",Yes,"Statistics of Chemical Analysis(positive report, negative report and total report) per month in 2016 {Annual Drug Report Bangladesh, 2016, p.59} ~ Number of Chemical Examination Reports of the Narcotics Drug (sample) from 2002 to 2016 {Department of Narcotics Control, p.6} ~ Result of Monthly Chemical Examination(positive, negative and total), 2016 {Department of Narcotics Control, p.6} ~ ",3
Y,Bangladesh,BGD,Supply Reduction,Number of people engaged with the criminal justice system,Yes,"Statistics of Accused made by DNC Since 1990 to 2016 {Department of Narcotics Control, p.3} ~ Disposal of Cases (conviction and acquittal rate), Conviction/Acquittal of accused,  Pending cases from 2012-2016 {Annual Drug Report Bangladesh, 2016, p.45} ~ Statistics on Mobile Court Operation by DNC (raids, cases, arrested, conviction, acquittal) from 2011-2016 {Annual Drug Report Bangladesh, 2016, p.46} ~ Trial Cases: Number of Cases (no. of cases and no. of accused: convicted and acquitted) disposed in the court from 2001 to 2016 {Department of Narcotics Control, p.4} ~ Statistics on Mobile Court from 2010 to 2016 {Department of Narcotics Control, p.5} ~",5
Y,Bangladesh,BGD,Supply Reduction,Presence of other supply reduction metrics,Yes," Number of License by type (Narcotics Drug: Pathedine & Morphine, Precursor Chemicals, Psychotropic Substances, Non Govt. Treatment & Rehabilitation Centre) up to 2016 {Department of Narcotics Control, p.1} ~ import of Acetone; Toluene; Methyl; Ethyl; Ketone; Potassium permanganate; Pseudoephedrine; ephedrine; Acetic Anhydride from 2014 to 2016 {Annual Drug Report Bangladesh, 2016, p.60, p.61, p.62; Department of Narcotics Control, p.2} ~",2
Y,Bangladesh,BGD,International Cooperation,Level of engagement in international cooperation,No,n/a,0
Y,United States,USA,Health,Level of availability of harm reduction services and harm reduction scale up,Yes,"percent of SUD treatment facilities support provision of [...] extended release naltrexone delivered by programs certified by SAMSHA {National Drug Control Strategy, 2016, p.21} ~ ",1
Y,United States,USA,Health,Presence of needle and syringe programs,No,n/a,0
Y,United States,USA,Health,Prevalence of substance use disorders,Yes,"number of Americans 12 and older needed specialty SUD treatment {National Drug Control Strategy, 2016, p.16} ~ Estimated Numbers (thousands) and Percentages of Illicit Drug Dependence or Abuse in the Past Year, by State or Jurisdiction, Aged 12 or Older, Annual Averages for 2002–2003 to 2013-2014 {National Drug Control Strategy: Data Supplement, 2016, p.108, p.109} ~ ",2
Y,United States,USA,Health,Prevalence of psychiatric comorbidities,No,n/a,0
Y,United States,USA,Health,Drug-related mortality,Yes,"Reduce drug-induced deaths by 15% {National Drug Control Strategy, 2016, p.5; The Obama Administration's Inaugural Strategy, 2010, p.6} ~ The number of Americans on average who died from a drug overdose every day in 2014, including the number per day from opioids. {National Drug Control Strategy, 2016, p.64} ~ The number of drug overdose deaths in 2014, and the number of drug overdose deaths that involved heroin; natural and semi-synthetic opioids and methadone; synthetic opioids other than methadone (both illicitly-manufactured and pharmaceutical fentanyl) {National Drug Control Strategy, 2016, p.64} ~ rate of drug overdose deaths {National Drug Control Strategy, 2016, p.64} ~ Number of Deaths from Drug-Induced Causes and Age-Adjusted Death Rates (Deaths per 100,000 Population)by Sex and Race, 1979–2014 {National Drug Control Strategy: Data Supplement, 2016, p.54, p.55} ~ Specific Drugs Involved in All and Unintentional Drug Poisoning Deaths and , 1999-2014 {National Drug Control Strategy: Data Supplement, 2016, p.56, p.57} ~ Drug Poisoning Deaths Involving Specific Drugs among Males and Females 1999-2014 {National Drug Control Strategy: Data Supplement, 2016, p.58, p.59} ~ Deaths from Drug Poisoning and Other Injury Causes, 1999–2014 {National Drug Control Strategy: Data Supplement, 2016, p.60} ~ Estimated Number of Deaths of Persons with AIDS by Sex and Transmission Category, 1994–2013 {National Drug Control Strategy: Data Supplement, 2016, p.64} ~ Number of Deaths and Age-Adjusted Death Rates (Deaths per 100,000 Population) from Drug-Induced Causes, by State or Jurisdiction, 1999–2014 {National Drug Control Strategy: Data Supplement, 2016, p.116, p.118} ~ Number of Deaths and Age-Adjusted Death Rates (Deaths per 100,000 Population) from Drug Poisoning Total and Involving Prescription Drugs, Opioid, Opioid Analgesics; Heroin; and Cocaine by State or Jurisdiction, 1999–2014 {National Drug Control Strategy: Data Supplement, 2016, p.120, p.122, p.124, p.126, p.128, p.130, p.132, p.134, p.136, p.138, p.140, p.142 } ~ Number of Drug Poisoning Death and Age-Adjusted Death Rates (Deaths per 100,000 Population)  in Large Counties, 1999–2014 {National Drug Control Strategy: Data Supplement, 2016, p.167, p.168} ~",12
Y,United States,USA,Health,Prevalence of drug-related infectious disease,Yes,"Reduce drug-related morbidity (HIV infections attributable to drug use) by 15% {National Drug Control Strategy, 2016, p.5; The Obama Administration's Inaugural Strategy, 2010, p.6} ~ Estimated Incidence of Human Immunodeficiency Virus Infection by Transmission Category, 2006-2010 {National Drug Control Strategy: Data Supplement, 2016, p.62} ~ Persons Diagnosed with Human Immunodeficiency Virus Infection by Transmission Category and Year of Diagnosis (Estimates), 2008-2014 {National Drug Control Strategy: Data Supplement, 2016, p.62} ~ Estimated Number of Persons Living with AIDS by Sex and Transmission Category, 1994–2012 {National Drug Control Strategy: Data Supplement, 2016, p.63} ~ Reported Tuberculosis Cases and Percent of Cases in Injecting and Non-Injecting Drug Users, 1996–2014 {National Drug Control Strategy: Data Supplement, 2016, p.65} ~ Reported Acute Hepatitis Cases, 1997–2014 {National Drug Control Strategy: Data Supplement, 2016, p.66} ~",6
Y,United States,USA,Health,Proportion of people who use drugs who engage in risky consumption,No,n/a,0
Y,United States,USA,Health,Proportion of people who use drugs who engage in safe consumption practices,No,n/a,0
Y,United States,USA,Health,"Coverage of services for the prevention, testing, and treatment of bloodborne diseases",No,n/a,0
Y,United States,USA,Health,Presence of specialised training for addiction care,No,n/a,0
Y,United States,USA,Health,Presence of health harms related to drug use,Yes,"Reduce drug-related morbidity (Emergency room visits for drug misuse abuse) by 15% {National Drug Control Strategy, 2016, p.5; The Obama Administration's Inaugural Strategy, 2010, p.6} ~ Illicit Drugs in Drug-Related Emergency Department Visits, 2004 – 2011 {National Drug Control Strategy: Data Supplement, 2016, p.61} ~ Emergency Department Visits Involving Nonmedical Use of Pharmaceuticals, 2004 – 2011 {National Drug Control Strategy: Data Supplement, 2016, p.61} ~ Estimated Number of Emergency Visits for Drug Misuse and Abuse (total, mention of cocaine, mention of heroin, mention of marijuana, and mention of methamphetamine), by Metropolitan Area, 2004–2011 {National Drug Control Strategy: Data Supplement, 2016, p. 164, p.165, p.166} ~",4
Y,United States,USA,Health,Presence of other health metrics,Yes,"Economic Costs to Society of Drug Abuse, (Health, Crime and Productivity) 1992–2002 (2002 $, Millions) {National Drug Control Strategy: Data Supplement, 2016, p.53} ~ Estimated Economic Costs of Drug Abuse, States and Jurisdictions, and 25 Metropolitan Statistical Areas 2002 {National Drug Control Strategy: Data Supplement, 2016, p.144, p.162} ~",2
Y,United States,USA,Peace and Security,"Prevalence of alcohol and drugs in accidents, and interventions to increase road safety",Yes,"Reduce the prevalence of drugged driving by 10% {National Drug Control Strategy, 2016, p.5; The Obama Administration's Inaugural Strategy, 2010, p.6} ~ the ratio of drivers that tested positive for at least one drug that could affect safety in 2014 {National Drug Control Strategy, 2016, p.61} ~ the number of drivers with marijuana in their system in 2015 {National Drug Control Strategy, 2016, p.61} ~ percent of high school seniors reported driving after smoking marijuana {National Drug Control Strategy, 2016, p.61} ~ Prevalence of Drugs among Weekend Nighttime Drivers, 2007, 2013-2014 and 2015 {National Drug Control Strategy: Data Supplement, 2016, p.72, National Drug Control Strategy, 2016, p.61} ~ Drug Testing and Drug Test Results among Fatally Injured Drivers, 2005-2014 {National Drug Control Strategy: Data Supplement, 2016, p.72} ~ Driving after Substance Use among High School Seniors, 2001-2014 {National Drug Control Strategy: Data Supplement, 2016, p.73} ~ Driving Under the Influence of Any Illicit Drug in the Past Year among Persons Aged 16 or Older, By Demographic Subgroup, 2002-2014 {National Drug Control Strategy: Data Supplement, 2016, p.74} ~ ",8
Y,United States,USA,Peace and Security,Annual number of public disorder and violent crime reports,Yes,"Substance Use and Delinquent Behavior among Juveniles, 1997 {National Drug Control Strategy: Data Supplement, 2016, p.45} ~ Total Crime, Violent Crime, and Property Crime, 1989–2015 {National Drug Control Strategy: Data Supplement, 2016, p.67} ~ ",2
Y,United States,USA,Peace and Security,Number of non-lethal drug market violent events reported,No,n/a,0
Y,United States,USA,Peace and Security,Number of drug market related homicides and disappearances,No,n/a,0
Y,United States,USA,Peace and Security,Presence of other peace and security metrics,Yes,"Economic Costs to Society of Drug Abuse, (Health, Crime and Productivity) 1992–2002 (2002 $, Millions) {National Drug Control Strategy: Data Supplement, 2016, p.53} ~",1
Y,United States,USA,Development,Coverage of housing assistance for people who use drugs,No,n/a,0
Y,United States,USA,Development,Coverage of social assistance for people who use drugs (not including housing),No,n/a,0
Y,United States,USA,Development,Number of households enrolled in alternative development,No,n/a,0
Y,United States,USA,Development,Presence of other development metrics,Yes,"Economic Costs to Society of Drug Abuse, (Health, Crime and Productivity) 1992–2002 (2002 $, Millions) {National Drug Control Strategy: Data Supplement, 2016, p.53} ~ Illicit Drug Use by Current Employment Status (Full-time, Part-time, Unemployed, Other), 2002–2014 (Percent Prevalence) {National Drug Control Strategy: Data Supplement, 2016, p.22} ~",2
Y,United States,USA,Human Rights,"Prevalence and incidence of infectious diseases in vulnerable populations (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,United States,USA,Human Rights,"Prevalence of vulnerable people who use drugs (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"Drug Use among Inmates of Jails, State Prisons, and Federal Prisons {National Drug Control Strategy: Data Supplement, 2016, p.49} ~ Substance Use in the Past Month among Females Aged 15 to 44, by Pregnancy Status and Age, 2002-2003 to 2013-2014 (by type of drug) {National Drug Control Strategy: Data Supplement, 2016, p.44} ~ Percentage of Adult Male Booked Arrestees Who Tested Positive for Any Drug, Marijuana, Cocaine, Opiates, and Methamphetamine by Location, 2000–2013 {National Drug Control Strategy: Data Supplement, 2016, p.162, p.163, p.164} ~",3
Y,United States,USA,Human Rights,Proportion of people who use drugs in prison that are receiving medication assisted treatment (MAT),No,n/a,0
Y,United States,USA,Human Rights,Distribution of sterile injecting equipment in prisons,No,n/a,0
Y,United States,USA,Human Rights,Presence of programs and services targeted towards women ,No,n/a,0
Y,United States,USA,Human Rights,Presence of programs and services targeted towards people of color,No,n/a,0
Y,United States,USA,Human Rights,Presence of challenges and/or harms experienced by people of color,No,n/a,0
Y,United States,USA,Human Rights,"Presence of programs and services targeted towards vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,United States,USA,Human Rights,"Presence of challenges and/or harms experienced by vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,United States,USA,Human Rights,Presence of other human rights metrics,No,n/a,0
Y,United States,USA,Demand Reduction,Prevalence of drug use by age,Yes,"Decrease the 30-day prevalence of drug use among 12- to 17-year olds by 15% {National Drug Control Strategy, 2016, p.5; The Obama Administration's Inaugural Strategy, 2010, p.6} ~ Decrease the lifetime prevalence of 8th graders who have used illicit drugs by 15% {National Drug Control Strategy, 2016, p.5; The Obama Administration's Inaugural Strategy, 2010, p.6} ~ Decrease the 30-day prevalence of drug use among young adults aged 18-25 by 10% {National Drug Control Strategy, 2016, p.5; The Obama Administration's Inaugural Strategy, 2010, p.6} ~ number of current heroin users aged 12 and older {National Drug Control Strategy, 2016, p.64} ~ Substance Use in the Past Month among Males and Females by Arrest Status in the Past Year, Aged 18 or Older, Annual Averages for 2003-2005 to 2012-2014 {National Drug Control Strategy: Data Supplement, 2016, p.46} ~ Illicit Drug Use in the Past Month among Probationers and Persons under Parole or Supervised Release in the Past Year, Aged 18 or Older, 2002–2013 {National Drug Control Strategy: Data Supplement, 2016, p.47, p.48} ~ Estimated Number of Users and Percentages Reporting Use of Selected Illegal Drugs, 1979–2014 by age (Ages 12 or older, Ages 12-17) and type of drug (Current use of any illicit drug, Current marijuana use, Current cocaine use, Lifetime methamphetamine use, Lifetime inhalant use) {National Drug Control Strategy: Data Supplement, 2016, p.19, p.20} ~ Number of Past-Year Initiates among Persons Aged 12 or Older, 2002–2014 (Thousands) by type of drug {National Drug Control Strategy: Data Supplement, 2016, p.24} ~ Average Age at First Use among Past-Year Initiates of Substance Use, Aged 12 to 49: 2002 to 2014 {National Drug Control Strategy: Data Supplement, 2016, p.25} ~ Trends in Lifetime Prevalence of Selected Substances (Any illicit drug, Marijuana/Hashish, Alcohol, Cigarettes) among 8th, 10th, and 12th Graders, 1991-2015 (Percent Prevalence) {National Drug Control Strategy: Data Supplement, 2016, p.27} ~ Trends in 30-Day Prevalence of Selected Drugs among 8th, 10th, and 12th Graders, 1991–2015 (Percent Prevalence) (Any illicit drug, Marijuana/Hashish, Inhalants; Hallucinogens; LSD; Cocaine; Amphetamines; Alcohol; Approximate NS) {National Drug Control Strategy: Data Supplement, 2016, p.28, p.29, p.30} ~ Percentage of High School Students Who Reported Engaging in Drug-Related Behaviors by Sex, Race/Ethnicity, and Grade, 1993–2015 {National Drug Control Strategy: Data Supplement, 2016, p.35} ~ Percentage of Alternative High School Students Who Used Selected Drugs by Sex, Race/Ethnicity, and Grade, 1998 (youth and type of drug) {National Drug Control Strategy: Data Supplement, 2016, p.40} ~ Past-Month Drug Use for Youth Aged 12–21, by Age, Dropout Status, Type of Drug Used, and Race/Ethnicity: 1992 (Percent Prevalence) {National Drug Control Strategy: Data Supplement, 2016, p.40} ~ Substance Use in the Past Month among Persons (Total), Males, and Females, Aged 18 to 22, by College Enrollment Status, 2002-2014 (Percent Prevalence) (by type of drug) {National Drug Control Strategy: Data Supplement, 2016, p.41, p.42, p.43} ~ Substance Use in the Past Month by Veteran Status, Aged 18 or Older: Annual Averages for 2002-2004 to 2012-2014 {National Drug Control Strategy: Data Supplement, 2016, p.50} ~ Number and Percentage of Substance Users in the Past Month by Veteran Status, Aged 18 or Older, 2002-2014 (Thousands) {National Drug Control Strategy: Data Supplement, 2016, p.51, p.52} ~Estimated Numbers (Thousands) and Percentages of Past Month Users of Any Illicit Drug, Marijuana, Cocaine, and Nonmedical Users of Pain Relievers by State or Jurisdiction, Aged 12 or Older, Annual Averages for 2002–2003 to 2013-2014 {National Drug Control Strategy: Data Supplement, 2016, p.93, p.94, p.95, p.96, p.97, p.98, p.99, p.100} ~ Percentage of High School Students Who Used Marijuana, Cocaine, and Selected Other Illicit Drugs by Sex, Race/Ethnicity, and Grade, 1990–2015 {National Drug Control Strategy: Data Supplement, 2016, p.31, p.32, p.33} ~ Percentage of High School Students Who Used Marijuana in the Past Month, Who Ever Used Cocaine, Took Prescription Drugs or Steroids without a Doctor’s Prescription by State and Selected Cities, 2001-2015 {National Drug Control Strategy: Data Supplement, 2016, p.101, p.102, p.103, p.104, p.157, p.158, p.159, p.159} ~ ",20
Y,United States,USA,Demand Reduction,Prevalence of drug use by sex,Yes,"Substance Use in the Past Month among Males and Females by Arrest Status in the Past Year, Aged 18 or Older, Annual Averages for 2003-2005 to 2012-2014 {National Drug Control Strategy: Data Supplement, 2016, p.46} ~ Percentage of Adult Male Booked Arrestees Who Tested Positive for Any Drug, Marijuana, Cocaine, Opiates, and Methamphetamine by Location, 2000–2013 {National Drug Control Strategy: Data Supplement, 2016, p.162, p.163, p.164} ~ Percentage of High School Students Who Reported Engaging in Drug-Related Behaviors by Sex, Race/Ethnicity, and Grade, 1993–2015 {National Drug Control Strategy: Data Supplement, 2016, p.35} ~ Percentage of Alternative High School Students Who Used Selected Drugs by Sex, Race/Ethnicity, and Grade, 1998 (youth and type of drug) {National Drug Control Strategy: Data Supplement, 2016, p.40} ~ Substance Use in the Past Month among Persons (Total), Males, and Females, Aged 18 to 22, by College Enrollment Status, 2002-2014 (Percent Prevalence) (by type of drug) {National Drug Control Strategy: Data Supplement, 2016, p.41, p.42, p.43} ~",4
Y,United States,USA,Demand Reduction,Prevalence of drug use by type,Yes,"Reduce the number of chronic drug users by 15%, by type of drug (Cocaine, Heroin, Methamphetamine, Marijuana) {National Drug Control Strategy, 2016, p.5; The Obama Administration's Inaugural Strategy, 2010, p.6} ~ proportion of those who misused prescription drugs {National Drug Control Strategy, 2016, p.64} ~ number of individuals initiating non-medical use of prescription pain medications. {National Drug Control Strategy, 2016, p.64} ~ number of current heroin users aged 12 and older {National Drug Control Strategy, 2016, p.64} ~ Estimated Number of Users and Percentages Reporting Use of Selected Illegal Drugs, 1979–2014 by age (Ages 12 or older, Ages 12-17) and type of drug (Current use of any illicit drug, Current marijuana use, Current cocaine use, Lifetime methamphetamine use, Lifetime inhalant use) {National Drug Control Strategy: Data Supplement, 2016, p.19, p.20} ~ Estimated Numbers and Percentages Reporting Nonmedical Use of Psychotherapeutic Drugs, 2002–2014 {National Drug Control Strategy: Data Supplement, 2016, p.21} ~ Percentages Testing Positive for Specific Drugs in the General U.S. Workforce, 1997–2015 (Marijuana, Cocaine, Amphetamines, Benzodiazepines, Barbiturates, Methadone, Opiates, Oxycodones and Oxymorphones, 6-AM, PCP, Propoxyphene {National Drug Control Strategy: Data Supplement, 2016, p.23} ~ Number of Past-Year Initiates among Persons Aged 12 or Older, 2002–2014 (Thousands) by type of drug {National Drug Control Strategy: Data Supplement, 2016, p.24} ~ Estimated Number of Chronic and Occasional Users of Cocaine and Heroin, 1988–2010 (Thousands) {National Drug Control Strategy: Data Supplement, 2016, p.26} ~ Trends in Lifetime Prevalence of Selected Substances (Any illicit drug, Marijuana/Hashish, Alcohol, Cigarettes) among 8th, 10th, and 12th Graders, 1991-2015 (Percent Prevalence) {National Drug Control Strategy: Data Supplement, 2016, p.27} ~ Trends in 30-Day Prevalence of Selected Drugs among among 8th, 10th, and 12th Graders, 1991–2015 (Percent Prevalence) (Any illicit drug, Marijuana/Hashish, Inhalants; Hallucinogens; LSD; Cocaine; Amphetamines; Alcohol; Approximate NS) {National Drug Control Strategy: Data Supplement, 2016, p.28, p.29, p.30} ~ Percentage of High School Students Who Used Marijuana, Cocaine, and Selected Other Illicit Drugs  by Sex, Race/Ethnicity, and Grade, 1990–2015 {National Drug Control Strategy: Data Supplement, 2016, p.31, p.32, p.33} ~ Percentage of Alternative High School Students Who Used Selected Drugs by Sex, Race/Ethnicity, and Grade, 1998 (youth and type of drug) {National Drug Control Strategy: Data Supplement, 2016, p.40} ~ Past-Month Drug Use for Youth Aged 12–21, by Age, Dropout Status, Type of Drug Used, and Race/Ethnicity: 1992 (Percent Prevalence) {National Drug Control Strategy: Data Supplement, 2016, p.40} ~ Substance Use in the Past Month among Persons (Total), Males, and Females, Aged 18 to 22, by College Enrollment Status, 2002-2014 (Percent Prevalence) (by type of drug) {National Drug Control Strategy: Data Supplement, 2016, p.41, p.42, p.43} ~ Use of Selected Illicit Drugs among Active-Duty Military Personnel, 2002, 2005, and 2008 (Percent Using) {National Drug Control Strategy: Data Supplement, 2016, p.49} ~ Estimated Numbers (Thousands) and Percentages of Past Month Users of Any Illicit Drug, Marijuana, Cocaine, and Nonmedical Users of Pain Relievers by State or Jurisdiction, Aged 12 or Older, Annual Averages for 2002–2003 to 2013-2014 {National Drug Control Strategy: Data Supplement, 2016, p.93, p.94, p.95, p.96, p.97, p.98, p.99, p.100} ~ Percentage of High School Students Who Used Marijuana in the Past Month, Who Ever Used Cocaine, Took Prescription Drugs or Steroids without a Doctor’s Prescription by State and Selected Cities, 2001-2015 {National Drug Control Strategy: Data Supplement, 2016, p.101, p.102, p.103, p.104, p.157, p.158, p.159, p.159} ~ Percentage of Adult Male Booked Arrestees Who Tested Positive for Any Drug, Marijuana, Cocaine, Opiates, and Methamphetamine by Location, 2000–2013 {National Drug Control Strategy: Data Supplement, 2016, p.162, p.163, p.164} ~ ",19
Y,United States,USA,Demand Reduction,Number of people who use drugs,Yes,"Use of Selected Illicit Drugs among Active-Duty Military Personnel, 2002, 2005, and 2008 (Percent Using) {National Drug Control Strategy: Data Supplement, 2016, p.49} ~ Illicit Drug Use among Active-Duty Military Personnel, By Service, 1980–2008 (Percent Using) {National Drug Control Strategy: Data Supplement, 2016, p.50} ~ Domestic Drug Consumption, 1996–2010 (Metric Tons) {National Drug Control Strategy: Data Supplement, 2016, p.90} ~",2
Y,United States,USA,Demand Reduction,"Prevalence of drug use by mode of administration (oral, mucosa, inhalation, and injection)",No,n/a,0
Y,United States,USA,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT)",Yes,"Number and Percentage of Selected Primary Substances of Abuse for Treatment Admissions, 1997-2014 {National Drug Control Strategy: Data Supplement, 2016, p.80, p.81} ~ Number of Clients in Any Substance Abuse Treatment (includes clients with drug problems only, alcohol problems only, and both drug and alcohol problems) and Drug Abuse Treatment (Includes clients with drug problems only and both drug and alcohol problems), by State or Jurisdiction, 2000–2013 {National Drug Control Strategy: Data Supplement, 2016, p.112, p.114} ~ ",2
Y,United States,USA,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT) by age",Yes,"number of Americans 12 and older needed specialty SUD treatment, and of these individuals, the number who did not receive it in the past year {National Drug Control Strategy, 2016, p.16} ~ percent of Americans who needed treatment for a SUD received treatment at a specialty facility {National Drug Control Strategy, 2016, p.21} ~ One-Day Census of Clients in Substance Abuse Treatment, by Facility Ownership, by Type of Care and Age Group 1980–2013 {National Drug Control Strategy: Data Supplement, 2016, p.75, p.76} ~ Estimated Number of Persons Aged 12 or Older Who Needed and Received Treatment for an Illicit Drug Problem in the Past Year, by Age Group and Gender, and by Hispanic Origin/Race, 2002–2013 (Thousands) {National Drug Control Strategy: Data Supplement, 2016, p.78, p.79} ~ Estimated Numbers (Thousands) and Percentages of Persons Aged 12 or Older Needing but Not Receiving Treatment for an Illicit Drug Problem in the Past Year, by State or Jurisdiction, Annual Averages for 2002–2003 to 2013-2014 {National Drug Control Strategy: Data Supplement, 2016, p.110, p.111} ~",5
Y,United States,USA,Demand Reduction,Level of access to opioid substitution treatment and medication assisted treatment (OST/MAT),Yes,"percent of SUD treatment facilities support provision of methadone, buprenorphine, or extended release naltrexone delivered by programs certified by SAMSHA {National Drug Control Strategy, 2016, p.21} ~ Substance Abuse Treatment Facilities with Opioid Treatment Programs and Clients Receiving Methadone or Buprenorphine, 20041 to 2014 {National Drug Control Strategy: Data Supplement, 2016, p.77} ~ ",2
Y,United States,USA,Demand Reduction,Level of coverage of inpatient treatment,No,n/a,0
Y,United States,USA,Demand Reduction,Proportion of people who use drugs enrolled in voluntary treatment,No,n/a,0
Y,United States,USA,Demand Reduction,Proportion of people who use drugs enrolled in coerced treatment,No,n/a,0
Y,United States,USA,Demand Reduction,Proportion of people who use drugs enrolled in compulsory treatment,No,n/a,0
Y,United States,USA,Demand Reduction,Presence of prevention programming in law enforcement,No,n/a,0
Y,United States,USA,Demand Reduction,Presence of prevention programming in the media,No,n/a,0
Y,United States,USA,Demand Reduction,Presence of prevention programming in schools,No,n/a,0
Y,United States,USA,Demand Reduction,Presence of prevention programming in the workplace,Yes,"Percentages Testing Positive for Specific Drugs in the General U.S. Workforce, 1997–2015 (Marijuana, Cocaine, Amphetamines, Benzodiazepines, Barbiturates, Methadone, Opiates, Oxycodones and Oxymorphones, 6-AM, PCP, Propoxyphene {National Drug Control Strategy: Data Supplement, 2016, p.23} ~ ",1
Y,United States,USA,Demand Reduction,Presence of prevention programming for youth and the community,Yes,"Trends in Harmfulness of Drugs as Perceived by Youth (Aged 12 to 17), 2002-2014 (Percentage Reporting “Great Risk”1 associated with …smoke marijuana once a month; smoke marijuana once or twice a week; use cocaine once a month; use cocaine once or twice a week; try heroin once or twice; use heroin once or twice a week) {National Drug Control Strategy: Data Supplement, 2016, p.36} ~ Trends in Harmfulness of Drugs as Perceived by 8th-Graders, 10th-Graders,12th-Graders, 1991–2015 (Percentage Saying “Great Risk” to ""How much do you think people risk harming themselves (physically or in other ways) if they . . ."" try marijuana once or twice; smoke marijuana occasionaly; smoke marijuana regularly; try crack once or twice; take crack occasionaly; try cocaine powder once or twice; take cocaine powder occasionaly) {National Drug Control Strategy: Data Supplement, 2016, p.37, p.38, p.39} ~",2
Y,United States,USA,Demand Reduction,Presence of other demand reduction metrics,No,n/a,0
Y,United States,USA,Supply Reduction,Size and value of the illegal drug market,No,n/a,0
Y,United States,USA,Supply Reduction,Level of procedures related to crop eradication,Yes,"Eradicated Domestic Cannabis, by Plant Type (Number of Plots or Grows; Plants in Thousands), 1985–2015 {National Drug Control Strategy: Data Supplement, 2016, p.89} ~ Eradicated Indoor and Outdoor Grow Sites of Domestic Cannabis, Cultivated Outdoor Cannabis Plants, and Total Cultivated Plants, by State, 2002–2015 {National Drug Control Strategy: Data Supplement, 2016, p.145, p.147, p.149, p.151, p.153} ~",2
Y,United States,USA,Supply Reduction,"Number of arrests, seizures, and offences",Yes,"Total Estimated Arrests and Drug Arrests, 1989-2013 {National Drug Control Strategy: Data Supplement, 2016, p.68} ~ Number and Rates (Per 100,000 Population) of Arrests and Drug Arrests, By Race, 1980-2012 {National Drug Control Strategy: Data Supplement, 2016, p.69, p.70} ~ Seizures of Cocaine, Heroin, Cannabis, and Methamphetamine, 1989–2015 {National Drug Control Strategy: Data Supplement, 2016, p.88} ~ Domestic Seizures of MDMA, 2001–2013 {National Drug Control Strategy: Data Supplement, 2016, p.90} ~ Methamphetamine Seizure Incidents,1 by State, 2000–2015 {National Drug Control Strategy: Data Supplement, 2016, p.155} ~",5
Y,United States,USA,Supply Reduction,Level of law enforcement activity and interdiction in the market,No,n/a,0
Y,United States,USA,Supply Reduction,"Price, purity and potency of drugs, and related process indicators",Yes,"Average Price and Purity of Cocaine and Crack, Heroin, Methamphetamine, and Marijuana  in the United States, 1981–2012 (2012 Dollars) {National Drug Control Strategy: Data Supplement, 2016, p.83, p.84, p.85, p.86} ~ Average Cannabinoid Concentrations of Tested Cannabis from Federal Seizure and State and Local Eradication Samples, 1995–2015 (Number of Samples Tested and Percent Concentrations) {National Drug Control Strategy: Data Supplement, 2016, p.87} ~ Drugs Most Commonly and Less Commonly Identified by State and Local Forensic Laboratories, 2002-2015 (Number of Reports) {National Drug Control Strategy: Data Supplement, 2016, p.91, p.92} ~",3
Y,United States,USA,Supply Reduction,Number of people engaged with the criminal justice system,Yes,"Adult Drug Offenders in State or Federal Prisons, 1989–2013 {National Drug Control Strategy: Data Supplement, 2016, p.71} ~",1
Y,United States,USA,Supply Reduction,Presence of other supply reduction metrics,Yes,"Drug User Expenditures and Availability - Total U.S. Expenditures on Illicit Drugs, 1988–2010, per type of drug ($ Billions) {National Drug Control Strategy: Data Supplement, 2016, p.82} ~",1
Y,United States,USA,International Cooperation,Level of engagement in international cooperation,No,n/a,0
Y,Myanmar,MMR,Health,Level of availability of harm reduction services and harm reduction scale up,No,n/a,0
Y,Myanmar,MMR,Health,Presence of needle and syringe programs,Yes,"prevalence of people who inject drugs who were reached by NSPs in Southeast Asia {Sub-Regional Action Plan On Drug Control, 2011-2013, p.6; Mekong MOU on Drug Control Sub-Regional Action Plan On Drug Control Draft Version, 2014-2016, p.10} ~ the number of needles and syringes distributed {National Strategic Plan on HIV AIDS, 2016-2020, p.36; National Strategic Plan on HIV AIDS, 2016-2020, p.66} ~ The number of sterile needles and syringes that were distributed free of charge to people who inject drugs in 2015 {National Strategic Plan on HIV AIDS, 2016-2020, p.67} ~ Number of sterile injecting equipment distributed to people who inject drugs in the last 12 months {National Strategic Plan on HIV AIDS, 2016-2020, p.124} ~",4
Y,Myanmar,MMR,Health,Prevalence of substance use disorders,No,n/a,0
Y,Myanmar,MMR,Health,Prevalence of psychiatric comorbidities,No,n/a,0
Y,Myanmar,MMR,Health,Drug-related mortality,No,n/a,0
Y,Myanmar,MMR,Health,Prevalence of drug-related infectious disease,Yes,"HIV prevalence among people (young people and adults) who inject drugs (PWID) {National Strategic Plan on HIV AIDS, 2016-2020, p.28, p.34; Sub-Regional Action Plan On Drug Control, 2011-2013, p.6; Mekong MOU on Drug Control Sub-Regional Action Plan On Drug Control Draft Version, 2014-2016, p.10} ~ Trend of new infections by key populations (PWID) 1990-2020 {National Strategic Plan on HIV AIDS, 2016-2020, p.29} ~ New HIV infections among key populations (PWID) at risk in Myanmar, 2015 {National Strategic Plan on HIV AIDS, 2016-2020, p.30} ~ HIV prevalence among PWID in selected geographical locations, 2010-2014 {National Strategic Plan on HIV AIDS, 2016-2020, p.30, p.31} ~ HIV prevalence among male PWID respondents- IBBS and HSS results (2014) {National Strategic Plan on HIV AIDS, 2016-2020, p.32} ~ HIV prevalence among male PWID respondents by age, IBBS, 2014 {National Strategic Plan on HIV AIDS, 2016-2020, p.35} ~ The prevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) among people who inject drugs {National Strategic Plan on HIV AIDS, 2016-2020, p.38} ~ Patients coinfected with HIV and HBV, HIV and HCV: by key population, coinfected with HIV and HBV (%), Coinfected with HIV and HCV (%) {National Strategic Plan on HIV AIDS, 2016-2020, p.38} ~ Number of new infections per 1000 PWID among the uninfected population of PWID {National Strategic Plan on HIV AIDS, 2016-2020, p.124} ~",9
Y,Myanmar,MMR,Health,Proportion of people who use drugs who engage in risky consumption,Yes,"the proportion of new infections among male people who inject drugs through use of contaminated injecting equipment {National Strategic Plan on HIV AIDS, 2016-2020, p.29} ~ In 2014, estimates of the proportion of people who inject drugs who reported ever having used a previously used needle by region: Mandalay, Waingmaw and Kalay {National Strategic Plan on HIV AIDS, 2016-2020, p.67} ~",2
Y,Myanmar,MMR,Health,Proportion of people who use drugs who engage in safe consumption practices,Yes,"% of people who inject drugs reporting the use of sterile injecting equipment the last time they injected {National Strategic Plan on HIV AIDS, 2016-2020, p.124} ~",1
Y,Myanmar,MMR,Health,"Coverage of services for the prevention, testing, and treatment of bloodborne diseases",Yes,"Prevalence and number of priority populations (PWID, SW, MSM, prisoners, migrants and PLHIV) reached by HIV prevention programmes {National Strategic Plan on HIV AIDS, 2016-2020, p.66, p.124} ~ the prevalence of priority populations including sex workers, men who have sex with men, people who inject drugs, transgender people, prisoners and migrants have access to HIV combination prevention services {National Strategic Plan on HIV AIDS, 2016-2020, p.17, p.43} ~ Estimated Effective Prevention Coverage based upon service data 2014: by priority population, reached coverage (%), tested coverage (%) {National Strategic Plan on HIV AIDS, 2016-2020, p.36} ~ prevalence of people living with HIV who know their status {National Strategic Plan on HIV AIDS, 2016-2020, p.43} ~ prevalence of people living with HIV who know their status and receive treatment {National Strategic Plan on HIV AIDS, 2016-2020, p.43} ~ prevalence of people on treatment that have achieved viral suppression {National Strategic Plan on HIV AIDS, 2016-2020, p.43} ~ Prevalence of people from priority populations received a test in the last 12 months and know their results, by sex {National Strategic Plan on HIV AIDS, 2016-2020, p.66, p.67} ~ Number and prevalence of people who inject drugs received an HIV test and who know the result {National Strategic Plan on HIV AIDS, 2016-2020, p.124} ~ The number of ex-drug addicts who participated in the awareness raising on drugs and HIV/AIDS in the after-care services from the Yangon region, Nay Pyi Taw, Mandalay Region, Sagaing Region, Mon State, Southern Shan Stat, the total number {Myanmar Narcotics Control Annual Report, 2016, p.90} ~",9
Y,Myanmar,MMR,Health,Presence of specialised training for addiction care,Yes,"Opening training in the year of 2016 {Myanmar Narcotics Control Annual Report, 2016, p.93} ~ Provision of training and workshop on Drug Abuse Prevention and Treatment {Myanmar Narcotics Control Annual Report, 2016, p.83} ~ The number of trainees at the Mandalay Social Rehabilitation Centre, the Lashio Social Rehabilitation Centre, Kyaing Tone Social Rehabilitation Centre, Tachileik Social Rehabilitation Centre, Myitkyina Social Rehabilitation Centre, (Shwepyithar) Youth Correction Centre, the total number of trainees rehabilitated {Myanmar Narcotics Control Annual Report, 2016, p.89} ~ ",3
Y,Myanmar,MMR,Health,Presence of health harms related to drug use,No,n/a,0
Y,Myanmar,MMR,Health,Presence of other health metrics,No,n/a,0
Y,Myanmar,MMR,Peace and Security,"Prevalence of alcohol and drugs in accidents, and interventions to increase road safety",No,n/a,0
Y,Myanmar,MMR,Peace and Security,Annual number of public disorder and violent crime reports,No,n/a,0
Y,Myanmar,MMR,Peace and Security,Number of non-lethal drug market violent events reported,No,n/a,0
Y,Myanmar,MMR,Peace and Security,Number of drug market related homicides and disappearances,No,n/a,0
Y,Myanmar,MMR,Peace and Security,Presence of other peace and security metrics,No,n/a,0
Y,Myanmar,MMR,Development,Coverage of housing assistance for people who use drugs,No,n/a,0
Y,Myanmar,MMR,Development,Coverage of social assistance for people who use drugs (not including housing),No,n/a,0
Y,Myanmar,MMR,Development,Number of households enrolled in alternative development,Yes,"Activities of Alternative Development Sector By State (Kachin State, Kayah State, Chin State, Shan State) and Border Zone (Pa-O Self Administered Zone Border, Pa-Laung Self Administered Zone Border, Danu Self Administered Zone Border, Kokang Self-Administered Zone Border, Wa Self-Administered Zone Border): Measures taken for the development of border areas and national races by the border areas development fund in 2016: A. Roads / Bridges (in Nos and Budget allowed) B. Education (in Nos and Budget allowed) C. Water Supply (in Nos and Budget allowed) D. Energy (in Nos and Budget allowed) E. Religious Affairs (in Nos and Budget allowed) {Myanmar Narcotics Control Annual Report, 2016, p.52, p.53, p.54, p.55} ~ Activities of Crop Substitution Sector: Project Sites for the fourth five-year plan areas of Drug Elimination by state and number of townships {Myanmar Narcotics Control Annual Report, 2016, p.58} ~ Activities of Crop Substitution Sector: Achievements: Number of staff involved (by type of staff) {Myanmar Narcotics Control Annual Report, 2016, p.58} ~ Activities of Crop Substitution Sector: Achievements: establishment of agricultural extension camps (in nos) {Myanmar Narcotics Control Annual Report, 2016, p.58} ~ Activities of Crop Substitution Sector: Achievements: the provision of annual crop seeds, perennial crop saplings (by type and nos) {Myanmar Narcotics Control Annual Report, 2016, p.58, p.59} ~ Activities of Crop Substitution Sector: Achievements: Using of Fertilizers and Pesticides (by type and MT/Liter/Kilo) {Myanmar Narcotics Control Annual Report, 2016, p.59} ~ Activities of Crop Substitution Sector: Achievements: A) Conduct Demonstration Plots (by type and Acre) B) Perennial Crops Demonstration Plots (by type and acre) {Myanmar Narcotics Control Annual Report, 2016, p.59} ~ Activities of Crop Substitution Sector: Achievements: Provide Agriculture Extension a) Technology Trainings (in nos) {Myanmar Narcotics Control Annual Report, 2016, p.60} ~ Activities of Crop Substitution Sector: Achievements: Extent of cultivation A) Annual crops (by type and number of acres) B) Perennial Crops (by type and number of acres) {Myanmar Narcotics Control Annual Report, 2016, p.60} ~ Activities of Crop Substitution Sector: Achievements: Using of D.O.A fund (by type of activity, unit, and achievment) {Myanmar Narcotics Control Annual Report, 2016, p.61} ~ The number of village chicken provided for professional livestock farming {Myanmar Narcotics Control Annual Report, 2016, p.65} ~ The number in Kyats of Veterinary drugs provided to serve the animal health care for 70 townships {Myanmar Narcotics Control Annual Report, 2016, p.65} ~ Prevention and treatment of the Livestock Diseases for poppy eradication in 51 project areas: by area, number of cattle & buffalo, number of pigs, and number of poultry {Myanmar Narcotics Control Annual Report, 2016, p.66} ~ Treatment of the Livestock Diseases for poppy eradication in 51 project areas: by area, number of cattle and buffalo, number of pigs, and number of poultry {Myanmar Narcotics Control Annual Report, 2016, p.68} ~ Fish Seed Stocking List For Anti-narcotics Service: by place, stocking gate, silver barb, grass crap, rohu {Myanmar Narcotics Control Annual Report, 2016, p.70} ~ Pollination: Total number of Bee Hives, Crops, and number of acres {Myanmar Narcotics Control Annual Report, 2016, p.70} ~ Training: Quantity, Place, Total Trainees {Myanmar Narcotics Control Annual Report, 2016, p.70} ~ Technical Supporting: Place and Quantity {Myanmar Narcotics Control Annual Report, 2016, p.70} ~ the amount of money provided in loans for: Farming, Livestock, Small scale training and grocery shops, Production, Services, Other loans {Myanmar Narcotics Control Annual Report, 2016, p.153} ~",19
Y,Myanmar,MMR,Development,Presence of other development metrics,No,n/a,0
Y,Myanmar,MMR,Human Rights,"Prevalence and incidence of infectious diseases in vulnerable populations (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Myanmar,MMR,Human Rights,"Prevalence of vulnerable people who use drugs (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Myanmar,MMR,Human Rights,Proportion of people who use drugs in prison that are receiving medication assisted treatment (MAT),No,n/a,0
Y,Myanmar,MMR,Human Rights,Distribution of sterile injecting equipment in prisons,No,n/a,0
Y,Myanmar,MMR,Human Rights,Presence of programs and services targeted towards women ,No,n/a,0
Y,Myanmar,MMR,Human Rights,Presence of programs and services targeted towards people of color,No,n/a,0
Y,Myanmar,MMR,Human Rights,Presence of challenges and/or harms experienced by people of color,No,n/a,0
Y,Myanmar,MMR,Human Rights,"Presence of programs and services targeted towards vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"Prevalence and number of priority populations (Sex workers, Men who have sex with men, prisoners, migrants and people living with HIV) reached by HIV prevention programmes {National Strategic Plan on HIV AIDS, 2016-2020, p.66, p.124} ~ the prevalence of priority populations including sex workers, men who have sex with men, people who inject drugs, transgender people, prisoners and migrants have access to HIV combination prevention services {National Strategic Plan on HIV AIDS, 2016-2020, p.17, p.43} ~ ",2
Y,Myanmar,MMR,Human Rights,"Presence of challenges and/or harms experienced by vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"Prevalence of people living with, at risk of and affected by HIV report no discrimination, especially in health, education and workplace settings {National Strategic Plan on HIV AIDS, 2016-2020, p.43} ~ ",1
Y,Myanmar,MMR,Human Rights,Presence of other human rights metrics,No,n/a,0
Y,Myanmar,MMR,Demand Reduction,Prevalence of drug use by age,No,n/a,0
Y,Myanmar,MMR,Demand Reduction,Prevalence of drug use by sex,No,n/a,0
Y,Myanmar,MMR,Demand Reduction,Prevalence of drug use by type,Yes,"Production and use of amphetamine-type stimulants (ATS) {Mekong MOU on Drug Control Sub-Regional Action Plan On Drug Control Draft Version, 2014-2016, p.7} ~",1
Y,Myanmar,MMR,Demand Reduction,Number of people who use drugs,No,n/a,0
Y,Myanmar,MMR,Demand Reduction,"Prevalence of drug use by mode of administration (oral, mucosa, inhalation, and injection)",Yes,"Total number of new admission by method of drug use {Myanmar Narcotics Control Annual, Report, 2016, p.80} ~ population size estimate of people who inject drugs in 2014 {National Strategic Plan on HIV AIDS, 2016-2020, p.46} ~",2
Y,Myanmar,MMR,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT)",Yes,"number of major and minor drug treatment centres (DTCs) {Myanmar Narcotics Control Annual Report, 2016, p.75} ~ number of treatment facilities by type (youth correction centres, township hospitals, border area hospitals, social rehabilitation centers run by the department of social welfare, centre based rehabilitation) {Myanmar Narcotics Control Annual Report, 2016, p.75, p.76, p.87} ~ Total number of New admission by Gender and region/state {Myanmar Narcotics Control Annual Report, 2016, p.76} ~ Total number of new admissions by type of drug use {Myanmar Narcotics Control Annual Report, 2016, p.79} ~ Total number of new admission by method of drug use {Myanmar Narcotics Control Annual, Report, 2016, p.80} ~ total number of new admissions by other sociodemographic characteristics (education, religion, occupation) {Myanmar Narcotics Control Annual Report, 2016, p.80, p.81} ~ The number of ex-drug addicts attending after-care services from Yangon, Mandalay, Lashio, Kyaingtone, and total number {Myanmar Narcotics Control Annual Report, 2016, p.90} ~ The list of social counselling in the year of 2016: Yangon, Mandalay, Myitkyina, Tachileik, Kyaingtone, Lashio, Total {Myanmar Narcotics Control Annual Report, 2016, p.94} ~ number of drug users who received home visit care {Myanmar Narcotics Control Annual Report, 2016, p.150} ~ Temporarily stopped Rehabilitation Centers {Myanmar Narcotics Control Annual Report, 2016, p.89} ~",10
Y,Myanmar,MMR,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT) by age",Yes,"Total number of new admissions by age {Myanmar Narcotics Control Annual Report, 2016, p.79} ~ The number of Youth Correction Centers run by Central Committee for Drug Abuse Control {Myanmar Narcotics Control Annual Report, 2016, p.87} ~ number of youth rehabilitation centres {Myanmar Narcotics Control Annual Report, 2016, p.75} ~ ",3
Y,Myanmar,MMR,Demand Reduction,Level of access to opioid substitution treatment and medication assisted treatment (OST/MAT),Yes,"prevalence of people who inject opiates in Southeast Asia that were reached with OST {Sub-Regional Action Plan On Drug Control, 2011-2013, p.7; Mekong MOU on Drug Control Sub-Regional Action Plan On Drug Control Draft Version, 2014-2016, p.11} ~ number of methadone maintenance therapy centres {Myanmar Narcotics Control Annual Report, 2016, p.76; National Strategic Plan on HIV AIDS, 2016-2020, p.67} ~ the number of methadone clinics in Yangon, Mandalay, Kachin State, Shan State, and Sagaing Region. {Myanmar Narcotics Control Annual Report, 2016, p.77} ~ The total number of people currently taking methadone by the end of December 2016 {Myanmar Narcotics Control Annual Report, 2016, p.77} ~ Methadone centres and opening dates {Myanmar Narcotics Control Annual Report, 2016, p.82} ~ Total number of admissions in methadone clinics by region/division, first admission, second and above, and total {Myanmar Narcotics Control Annual Report, 2016, p.83} ~ the number of people who inject drugs that have received MMT {National Strategic Plan on HIV AIDS, 2016-2020, p.67, p.124} ~ % of individuals receiving methadone maintenance therapy for at least 6 months {National Strategic Plan on HIV AIDS, 2016-2020, p124} ~ The number of PWID receiving methadone maintenance therapy (MMT) or oral substitution therapy (OST) {National Strategic Plan on HIV AIDS, 2016-2020, p.66} ~ Prevalence of individuals receive MMT/OST for at least six months {National Strategic Plan on HIV AIDS, 2016-2020, p.66} ~",10
Y,Myanmar,MMR,Demand Reduction,Level of coverage of inpatient treatment,No,n/a,0
Y,Myanmar,MMR,Demand Reduction,Proportion of people who use drugs enrolled in voluntary treatment,No,n/a,0
Y,Myanmar,MMR,Demand Reduction,Proportion of people who use drugs enrolled in coerced treatment,Yes,"number of drug users referred to detox centres {Myanmar Narcotics Control Annual Report, 2016, p.150} ~",1
Y,Myanmar,MMR,Demand Reduction,Proportion of people who use drugs enrolled in compulsory treatment,Yes,"The number of people who use drugs who are located in Compulsory Centres for Drug Users (CCDU) in Southeast Asia {Sub-Regional Action Plan On Drug Control, 2011-2013, p.7} ~ ",1
Y,Myanmar,MMR,Demand Reduction,Presence of prevention programming in law enforcement,No,n/a,0
Y,Myanmar,MMR,Demand Reduction,Presence of prevention programming in the media,Yes,"The number of prevention activities carried out by the mass media sector (educative talks, wall-sheet displays, photo exhibitions, pamphlets distributed) {Myanmar Narcotics Control Annual Report, 2016, p.99} ~ The number of  prevention activities broadcasted by Myanmar Radio and Television (news, articles, educative songs, stories, youth programmes, programmes, mottos, educative talks, knowledges, instigations) {Myanmar Narcotics Control Annual Report, 2016, p.99, p.100} ~ Activities of News and Periodicals Enterprise (in number of times): News, Editorials, Articles, Photo News, Mottos, and Interviews {Myanmar Narcotics Control Annual Report, 2016, p.100} ~ Activities of Printing and Publishing Department (in number of times): Articles in Thuta Padetha Magazine, Poems, Story {Myanmar Narcotics Control Annual Report, 2016, p.100} ~ Activities of the Public Relations and Psychological Warfare Directorate Office (in number of times): Myawady TV news, TV Spot, Story, Songs, Article, Poems, Cartoon, Editorials, Interview, Program, Short Novel, Comic Strip, Funny {Myanmar Narcotics Control Annual Report, 2016, p.100} ~",5
Y,Myanmar,MMR,Demand Reduction,Presence of prevention programming in schools,Yes,"The prevalence of drug and disease lessons taught at the primary school level {Myanmar Narcotics Control Annual Report, 2016, p.96} ~ The prevalence of Cause and Effect of drug use lessons, the prevalence of Disease prevention and nutrition lessons and the prevalence of HIV/AIDS lessons that are taught in Secondary level {Myanmar Narcotics Control Annual Report, 2016, p.96} ~ The number of university students from 53 universities, the number of college students from 23 education colleges, the number of students from 6020 basic education schools that participate in drug preventive education talks, at the International Day Against Drug Abuse & Illicit Trafficking {Myanmar Narcotics Control Annual Report, 2016, p.98} ~ the number of Education Sessions provided about drug use and its consequences {Myanmar Narcotics Control Annual Report, 2016, p.145} ~",4
Y,Myanmar,MMR,Demand Reduction,Presence of prevention programming in the workplace,No,n/a,0
Y,Myanmar,MMR,Demand Reduction,Presence of prevention programming for youth and the community,Yes,"the number of times awareness raising was provided for a number of people {Myanmar Narcotics Control Annual Report, 2016, p.150} ~",1
Y,Myanmar,MMR,Demand Reduction,Presence of other demand reduction metrics,No,n/a,0
Y,Myanmar,MMR,Supply Reduction,Size and value of the illegal drug market,Yes,"Production and use of amphetamine-type stimulants (ATS) {Mekong MOU on Drug Control Sub-Regional Action Plan On Drug Control Draft Version, 2014-2016, p.7} ~ Source precursors for ATS production in Myanmar and their origin {Mekong MOU on Drug Control Sub-Regional Action Plan On Drug Control Draft Version, 2014-2016, p.7} ~ Drug trafficking routes by type of drug (opium, caffeine, pseudo-ephedrine, heroin/stimulant tablets, Amphetamine-type stimulants) {Myanmar Narcotics Control Annual Report, 2016, p.104, p.105, p.107, p.108; Mekong MOU on Drug Control Sub-Regional Action Plan On Drug Control Draft Version, 2014-2016, p.7, p.8; Sub-Regional Action Plan On Drug Control, 2011-2013, p.14} ~ Confiscation of assets related to narcotics drug crimes and confiscated from January 1 to December 31, 2016: by monetary worth of asset (in Kyat) {Myanmar Narcotics Control Annual Report, 2016, p.134} ~ ",4
Y,Myanmar,MMR,Supply Reduction,Level of procedures related to crop eradication,Yes,"Illicit Crop Monitoring Program (ICMP) in Myanmar (in number of hectares) {Myanmar Narcotics Control Annual Report, 2016, p.102; Sub-Regional Action Plan On Drug Control, 2011-2013, p.13} ~ The prevalence of opium production by state and region (Shan state, Kachin State, in Sagaing Region, in Mandalay Region, and Kayah State) - in 2016 {Myanmar Narcotics Control Annual Report, 2016, p.103; Myanmar Opium Survey, 2017, p.iv, p.13} ~ Destruction of Poppy Fields in Regions and States (2015-2016) (in acres and hectares) {Myanmar Narcotics Control Annual Report, 2016, p.134} ~ Total opium poppy cultivation (ha) {Myanmar Opium Survey, 2017, p.iv, p.4, p.7; Sub-Regional Action Plan On Drug Control, 2011-2013, p.8; Mekong MOU on Drug Control Sub-Regional Action Plan On Drug Control Draft Version, 2014-2016, p.12} ~ Opium poppy cultivation by State and region (ha) (Shan State, Kachin State) {Myanmar Opium Survey, 2017, p.iv, p.7; Mekong MOU on Drug Control Sub-Regional Action Plan On Drug Control Draft Version, 2014-2016, p.12} ~ Total potential production of dry opium (mt) {Myanmar Opium Survey, 2017, p.iv, p.14} ~ Average opium yield (kg/ha) {Myanmar Opium Survey, 2017, p.iv, p.12} ~ Total opium poppy eradication reported by the Government of Myanmar (ha) {Myanmar Opium Survey, 2017, p.iv, p.19; Mekong MOU on Drug Control Sub-Regional Action Plan On Drug Control Draft Version, 2014-2016, p.12} ~ Opium poppy cultivation density, Myanmar (2012 – 2017) {Myanmar Opium Survey, 2017, p.10} ~ Potential opium yield by region (kg/ha), 2015 and 2017 {Myanmar Opium Survey, 2017, p.9, p.12} ~ Eradication reported for 2017 with cultivation density (2012 – 2017), Myanmar {Myanmar Opium Survey, 2017, p.20} ~",11
Y,Myanmar,MMR,Supply Reduction,"Number of arrests, seizures, and offences",Yes,"The number of seizures (in kilos, in number of tablets and in cases) by type of drug (amphetamine type stimulants – ATS Pill, opium, opiates, heroin, stimulant tablets, caffeine, tablets containing pseudo-ephedrine, ethyl ether, ephedrine, acetic anhydride, sulphuric acid, hydrochloric acid, acetone) {Myanmar Narcotics Control Annual Report, 2016, p.105, p.106, p.107, p.108, p.109, p.137; Myanmar Opium Survey, 2017, p.22, p.23; Sub-Regional Action Plan On Drug Control, 2011-2013, p.8} ~ the number (in kilos and in cases, in tablets and in cases) by region and township (Kachin State, Sagaing Region, Shan State, Mandalay Region, and Yangon Region, Kut Kai Township, Pan Taung Township, Pyigyitagon Township, Yathae Taung Township, Tachileik Township, Mingalardon Township, Loi Lin Township, Kyaing Tong Township, Kalaw Township, Meiktilar Township) and type of drug (heroin, stimulant tablets) {Myanmar Narcotics Control Annual Report, 2016, p.105, p.106} ~ The number of seizures of products seized from opium refineries in 2016 {Myanmar Narcotics Control Annual Report, 2016, p.110} ~ Seizures on each places conducted by the special operations {Myanmar Narcotics Control Annual Report, 2016, p.110} ~ The narcotic drugs seized by the Tatmadaw, Myanmar Police Force and Anti-Narcotics Task Forces in 2016 (by number of cases and weight): opium, heroin, stimulant tablets, marijuana, solidified opium oil, inferior opium, ICE, Speciosa Powder, Speciosa, Stimulant Powder, Brown Opium Powder, Opium Oil Liquid, Ecstasy, Heroin Liquid, Opium Liquid, Tramadol, Tramadol Injection, Buprenorphine, Buprenorphine Injection, Diazepam, Diazepam Injection, Alprazolam tablets, Loprazepam tablets , Morphine Injection, Methadone, Fentanyl Injection, Costic, Phenol, Bone Charcoal, Ephedrine, Caffeine, Pseudoephedrine, Pseudoephedrine Powder, Sodium Carbonate, Ammonium Chloride, Acid Solid, Ammonium Hydroxide, Sulphuric Acid, Hydrochloric Acid, Phosphorica Acid, Chlorofoul, Acetic Anhydride, Ethyl/ Ether, Acetone, Speciosa Liquid, Ketamine, Failure to register, Other cases, total cases {Myanmar Narcotics Control Annual Report, 2016, p.132} ~ Confiscation of assets related to narcotics drug crimes and confiscated from January 1 to December 31, 2016: by type of asset, quantity of asset {Myanmar Narcotics Control Annual Report, 2016, p.134} ~ ",6
Y,Myanmar,MMR,Supply Reduction,Level of law enforcement activity and interdiction in the market,No,n/a,0
Y,Myanmar,MMR,Supply Reduction,"Price, purity and potency of drugs, and related process indicators",Yes,"Opium farm‐gate price {Myanmar Opium Survey, 2017, p.16} ~ ",1
Y,Myanmar,MMR,Supply Reduction,Number of people engaged with the criminal justice system,Yes,"The total number of offenders, in the total number of drug cases that were arrested and taken into legal action in 2016 {Myanmar Narcotics Control Annual Report, 2016, p.103} ~ ",1
Y,Myanmar,MMR,Supply Reduction,Presence of other supply reduction metrics,Yes,"the number of persons that have been assigned in three sub-divisions and (50) anti-narcotic units {Myanmar Narcotics Control Annual Report, 2016, p.104} ~ Reported conflicts in Myanmar, 2016‐2017 {Myanmar Opium Survey, 2017, p.11} ~ ",2
Y,Myanmar,MMR,International Cooperation,Level of engagement in international cooperation,Yes,"The number of local and International Trainings, Meetings, and Workshops {Myanmar Narcotics Control Annual Report, 2016, p.84, p.147} ~ In cooperation with the CCDAC and UNODC, the following (4) projects have been implementing: (a) Support of Uprooted People in Loilen Township, 9 village Tracts (b) Food Security Programme for Myanmar, 6 Village Tracts in Hopone Township (c) Increasing Food Security and Promoting Licit Crop Production and Small Farmer Enterprise Development in Lao PDR and in Pin Lon Township in Myanmar (d) Illicit Crop Monitoring Programme, ICMP {Myanmar Narcotics Control Annual Report, 2016, p.163} ~ The Activities on Myanmar - Thailand Sustainable Alternative Development Programme {Myanmar Narcotics Control Annual Report, 2016, p.163} ~ the number of participants who attend training provided by International Organizations {Myanmar Narcotics Control Annual Report, 2016, p.164} ~ The number of meetings, the number of meetings in hours, and the number of participants in those meetings {Myanmar Narcotics Control Annual Report, 2016, p.164} ~ The number of meetings hosted by Myanmar {Myanmar Narcotics Control Annual Report, 2016, p.162} ~ The number of offenders from Myanmar to China that were extradited, in Thailand handed over to Myanmar, to Myanmar from Thailand {Myanmar Narcotics Control Annual Report, 2016, p.108} ~ ",7
Y,Luxembourg,LUX,Health,Level of availability of harm reduction services and harm reduction scale up,Yes,"the number of users in specialized treatment, who are also involved in harm reduction services {Stratégie et plan d’action gouvernementaux en matière de lutte contre les drogues d’acquisition illicite et les addictions associées, 2015-2019, p.5}~ number of contacts in low threshold facilities: proportion of clients aged between 25 and 34 years, proportion of clients aged 35 and more is observed, and proportion of clients that are females {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013 p.10; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.20}~ Low threshold admissions/10 {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.73; see figure 4.3, National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.99}~ The number of contacts indexed by low threshold agencies {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.88; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.21; see table 5.1,National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.111}~ ‘Table 7.1 provides an insight in clients’ and occupation statistics of the ABRIGADO services since their opening and for 2009, 2010, 2011, 2012 and 2013 respectively: Number of user contracts signed, Number of users episodes, Number of injections, […] Day Time Services (Number of clients), Night Time Services (Number of different residents) {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.103}~ number of IDU entered treatment or use low-threshold offers {National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.23}~ Clients statistics of ABRIGADO centre services (2005-2015): Supervised consumption room, Number of user contracts signed, Number of users episodes, Number of injections, […] Day care, Number of clients, Night shelter, Number of different residents {see table 7.1, National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.129}~",7
Y,Luxembourg,LUX,Health,Presence of needle and syringe programs,Yes,"The number of syringes distributed in the framework of the national needle exchange programme {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.10; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.22}~ Return rates of used syringes {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.10; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.22}~ Syringes distribution/10 {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.73; see figure 4.3, National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.99}~ Number of sterile syringes that are distributed and recollected {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.88}~ National needle exchange programme (NEP) 1996-2015 including specialised agencies, vending machines and supervised injection room: Distributed syringes, Collected syringes {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.106; see table 7.2, National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.131}~ ",5
Y,Luxembourg,LUX,Health,Prevalence of substance use disorders,Yes,"Prevalence of problematic drug use (PDU) {Stratégie et plan d’action gouvernementaux en matière de lutte contre les drogues d’acquisition illicite et les addictions associées, 2015-2019, p.4; 2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.8, p.69, p.71; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.20, p.98}~ The mean age of indexed PDU {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.8; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.19}~ Main characteristics of PDU indexed by the national drug monitoring system, RELIS (valid percentage): Mean age - Primary drug: opiates, cocaine, others - Poly drug use – Primary Opiates Administration Mode {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.74; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.100}~ male/female ratio of the PDU population {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.8; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.19}~ number of PDU person-contacts: users have been indexed by national specialised drug demand reduction agencies {National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.19}~",5
Y,Luxembourg,LUX,Health,Prevalence of psychiatric comorbidities,No,n/a,0
Y,Luxembourg,LUX,Health,Drug-related mortality,Yes,"drug related deaths {Stratégie et plan d’action gouvernementaux en matière de lutte contre les drogues d’acquisition illicite et les addictions associées, 2015-2019, p.5}~ The number of fatal overdose cases (overdose deaths per 100,000 inhabitants) {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013,p.9, p.71, p.73, p.104; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.21, p.103, p.129}~ Number of acute drug deaths {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.12, p.97; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.23, p.121}~ number police and drug-related deaths registers. {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.71}~ Age distribution of direct drug death cases indexed from 1992 to 2015 {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.98; see table 6.5, National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.123}~ Mean age of acute drug overdose victims (1992-2015) {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.98; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.21, p.123}~ Gender distribution of direct drug-related death cases (1992 - 2015) (%) {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.98; see figure 6.6, National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.122} ~ ",7
Y,Luxembourg,LUX,Health,Prevalence of drug-related infectious disease,Yes,"The HIV/AIDS prevalence {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.9, p.74, p.91; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.20, p.100}~ HIV infection rate among drug using population (HIV rate in problem drug users and injection drug users) {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.71, p.93; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.20, p.117, p.118}~ AIDS infection rate among drug using population (AIDS rate in problem drug users and injection drug users) {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.93; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.118}~ The prevalence of infection of HCV (hepatitis C) {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.9, p.74; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.24, p.100}~ HCV infection rate among drug using population (HCV rate in problem drug users and injection drug users) {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.94; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.119}~ average proportion of IDU in newly diagnosed HIV cases {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013 p.9, p.91; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.20, p.116}~ Prevalence of hepatitis B surface antigens (HbsAg), antibodies to hepatitis B core antigen (anti-HBc), hepatitis C virus (anti-HCV), and HIV (anti-HIV 1 and 2) in PDU and ever-injectors according to national recruitment settings {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.92; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.117}~ ",7
Y,Luxembourg,LUX,Health,Proportion of people who use drugs who engage in risky consumption,No,n/a,0
Y,Luxembourg,LUX,Health,Proportion of people who use drugs who engage in safe consumption practices,Yes,"Proportion of treatment demanders who have never shared syringes during their lifetime, and have not shared syringes in the last month. {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.86}~",1
Y,Luxembourg,LUX,Health,"Coverage of services for the prevention, testing, and treatment of bloodborne diseases",No,n/a,0
Y,Luxembourg,LUX,Health,Presence of specialised training for addiction care,No,n/a,0
Y,Luxembourg,LUX,Health,Presence of health harms related to drug use,Yes,"Clients statistics of ABRIGADO centre services (2005-2015): Number of non-fatal overdoses With loss of consciousness and Without loss of consciousness, Number of fatal overdoses, Medical emergency interventions {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.103; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.129}~ Proportion of treatment demanders who have experienced one or more overdoses {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.86}~ Non-fatal, medically assisted drug overdoses in RELIS respondents (2004-2015) (valid %) {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.108; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.134}~ ",3
Y,Luxembourg,LUX,Health,Presence of other health metrics,No,n/a,0
Y,Luxembourg,LUX,Peace and Security,"Prevalence of alcohol and drugs in accidents, and interventions to increase road safety",No,n/a,0
Y,Luxembourg,LUX,Peace and Security,Annual number of public disorder and violent crime reports,No,n/a,0
Y,Luxembourg,LUX,Peace and Security,Number of non-lethal drug market violent events reported,No,n/a,0
Y,Luxembourg,LUX,Peace and Security,Number of drug market related homicides and disappearances,No,n/a,0
Y,Luxembourg,LUX,Peace and Security,Presence of other peace and security metrics,No,n/a,0
Y,Luxembourg,LUX,Development,Coverage of housing assistance for people who use drugs,Yes,"MIFA housing project, the metric used: changes in the number of beneficiaries {Stratégie et plan d’action gouvernementaux en matière de lutte contre les drogues d’acquisition illicite et les addictions associées, 2015-2019, p.29}~ The residential status of PDU: proportion of PDUs reporting stable accommodation {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.10; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.21}~  Last known housing situation of problem drug users. 2009-2015 (valid %): Stable accommodation, Unstable accommodation, In institution, Homeless {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.110; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.136}~ ",3
Y,Luxembourg,LUX,Development,Coverage of social assistance for people who use drugs (not including housing),Yes,"Primary source of income of problem drug users (1995 - 2015): Autonomy, Social Welfare, Illegal Income, Other {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.111; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p. 137}~ ",1
Y,Luxembourg,LUX,Development,Number of households enrolled in alternative development,No,n/a,0
Y,Luxembourg,LUX,Development,Presence of other development metrics,Yes,"The unemployment rate in problem drug users {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.10, p.111; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.21}~ proportion of active respondents reporting a stable job situation (e.g. long term contract) {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.10; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.21}~ Educational level of RELIS respondents (2013): Number of Concluded Levels and number of non-concluded levels, categorized by: Primary School, Secondary School, High School {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.112; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.21, p.138}~ Professional inactivity rate in problem drug users (1996 - 2015) {see figure 8.2, National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.137}~ ",4
Y,Luxembourg,LUX,Human Rights,"Prevalence and incidence of infectious diseases in vulnerable populations (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"HIV rate in current IDU prisoners (Schlink 1998) {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.93} ~",1
Y,Luxembourg,LUX,Human Rights,"Prevalence of vulnerable people who use drugs (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"proportion of indexed non-native problematic drug users (PDU) {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.8; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.19}~",1
Y,Luxembourg,LUX,Human Rights,Proportion of people who use drugs in prison that are receiving medication assisted treatment (MAT),Yes,"Number of prisoners receiving opioid substitution treatment (2013): Methadone, Subutex, Total Persons {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.121}~ Clients in prison receiving treatment (OST): Ratio of male vs female, Mean age of treatment demanders, Ratio of natives vs non-natives, Education level: completion of primary or secondary school, Proportion experiencing one or more overdoses, Proportion reporting they have never shared syringes in their lifetime, or reported having not used syringes in the past month {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.122}~",2
Y,Luxembourg,LUX,Human Rights,Distribution of sterile injecting equipment in prisons,Yes,"Needle exchange programme (NEP) in prison (CPL) 2005-2013: Distributed injection kits, Distributed syringes {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.106}~ ",1
Y,Luxembourg,LUX,Human Rights,Presence of programs and services targeted towards women ,No,n/a,0
Y,Luxembourg,LUX,Human Rights,Presence of programs and services targeted towards people of color,Yes,"Ratio of natives vs non-natives in treatment {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.86}~ ",1
Y,Luxembourg,LUX,Human Rights,Presence of challenges and/or harms experienced by people of color,No,n/a,0
Y,Luxembourg,LUX,Human Rights,"Presence of programs and services targeted towards vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Luxembourg,LUX,Human Rights,"Presence of challenges and/or harms experienced by vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Luxembourg,LUX,Human Rights,Presence of other human rights metrics,No,n/a,0
Y,Luxembourg,LUX,Demand Reduction,Prevalence of drug use by age,Yes,"Percentage of youngsters aged 15 years reporting first cannabis use before 15 years {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.7; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.18}~ Lifetime prevalence according to age (valid %) {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.35, p.37; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.47, p.54, p.55}~ Current and lifetime prevalence of drug use by type (cannabis, ecstasy, LSD, cocaine, heroin, amphetamine-type stimulants, opiates, solvents/glues, mushrooms) according to age (%) {National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.18; 2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.36, p.38, p.39, p.40, p.42; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.48, p.51, p.52, p.56, p.57, p.58, p.61}~ Lifetime and last 12 months prevalence of any drug by age categories (valid %) {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.38; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.47, p.56}~ Last 12 months prevalence of illicit drug use according to type of drugs and age categories. {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.40, p.42; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.48, p.59, p.61}~ Last 30 days prevalence according to type of drugs (psychoactive substances, cannabis, heroin, cocaine, ecstasy, LSD, psilocybin), and age categories {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.42; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.48, p.60, p.61, p.63}~ The first use of illicit substances – mean and median age of onset {National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.18; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.19, p.50}~",7
Y,Luxembourg,LUX,Demand Reduction,Prevalence of drug use by sex,Yes,"Lifetime, past 12 months and past 30 days prevalence of cannabis use according to gender. {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.43; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.49, p.62, p.63}~ Cannabis prevalence (male/female ratio) {National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.18}~",2
Y,Luxembourg,LUX,Demand Reduction,Prevalence of drug use by type,Yes,"Use of psychoactive substances during the last two weeks by partygoers {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.45, p.46; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.68}~ Percentage of youngsters aged 15 years reporting first cannabis use before 15 years {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.7; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.18}~ Current and lifetime prevalence of drug use by type (cannabis, ecstasy, LSD, cocaine, heroin, amphetamine-type stimulants, opiates, solvents/glues, mushrooms) according to age (%) {National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.18; 2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.36, p.38, p.39, p.40, p.42; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.48, p.51, p.52, p.56, p.57, p.58, p.61}~ Last 12 months prevalence of illicit drug use according to type of drugs, and age categories. {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.40, p.42; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.48, p.59, p.61}~ Last 30 days prevalence according to type of drugs (psychoactive substances, cannabis, heroin, cocaine, ecstasy, LSD, psilocybin), and age categories {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.42; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.48, p.60, p.61, p.63}~ Lifetime, past 12 months and past 30 days prevalence of cannabis use according to gender. {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.43; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.49, p.62, p.63}~ Cannabis prevalence (male/female ratio) {National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.18}~ The prevalence of cocaine use as primary drug {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.9; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.20}~ The proportion and rates of poly-drug use {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.9; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.20, p.23}~ Substance consumed during the last 2 weeks {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.65}~ ",10
Y,Luxembourg,LUX,Demand Reduction,Number of people who use drugs,Yes,"Serial prevalence studies of intensive drug use - Investigations in recreational, festive and youth environments {Stratégie et plan d’action gouvernementaux en matière de lutte contre les drogues d’acquisition illicite et les addictions associées, 2015-2019, p.19}~ Number of people who have used at least one illicit substance during the past year {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.6}~ National drug prevalence in the general population {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.7; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.18}~ Absolute prevalence and prevalence rates according to selected sub-groups – Grand-Duchy of Luxembourg (1997 – 2009): General population, Injecting Drug users {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.71, p.72}~",4
Y,Luxembourg,LUX,Demand Reduction,"Prevalence of drug use by mode of administration (oral, mucosa, inhalation, and injection)",Yes,"Absolute prevalence of injection drug use {Stratégie et plan d’action gouvernementaux en matière de lutte contre les drogues d’acquisition illicite et les addictions associées, 2015-2019, p.4; 2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.8, p.69; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.20, p.96}~ The ratio of injecting opiates versus inhalation mode {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.9; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.20}~ ",2
Y,Luxembourg,LUX,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT)",Yes,"Number of drug treatment demanders: Outpatient: Drug Free {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.85; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.111}~ number of users who have been indexed by national specialised drug demand reduction agencies {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.8}~ Proportion of first treatment demanders {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.86}~ The prevalence of drug use-related treatment demands by type of drug (cocaine, heroin, cannabis) {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013,p.9, p.86; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.20}~ Ratio of male/females in treatment in treatment {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.86}~ Previous contacts with psychiatric services of RELIS indexed drug users. 1998- 2013 {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.95; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.119}~ Reasons for psychiatric care demands 1996-2013: Number in counselling, Number in confinement, Number in detoxification, Number in emergency, Other {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.95; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.120}~ number of PDU entered treatment or use low-threshold offers {National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.23}~ Geographical coverage of specialised drug agencies in the Grand Duchy of Luxembourg {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.80; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.101}~ Ratio of clients in treatment who have completed a primary or complementary degree, secondary school, and those who have obtained a higher degree {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.86} ~ Ratio of clients in treatment who report stable employment against those who are inactive or unemployed {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.86}~ JDH Consultation and Online Services: Usage statistics and number of referrals to conventional therapeutic care {Stratégie et plan d’action gouvernementaux en matière de lutte contre les drogues d’acquisition illicite et les addictions associées, 2015-2019, p.25} ~ For the JDH Parenting Services, the metric used: Reduced waiting list {Stratégie et plan d’action gouvernementaux en matière de lutte contre les drogues d’acquisition illicite et les addictions associées, 2015-2019, p.27} ~",13
Y,Luxembourg,LUX,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT) by age",Yes,"The number of adult outpatient clients {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.9, p.86; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.20}~ ",1
Y,Luxembourg,LUX,Demand Reduction,Level of access to opioid substitution treatment and medication assisted treatment (OST/MAT),Yes,"Percentage of opiate users in substitution treatment {Stratégie et plan d’action gouvernementaux en matière de lutte contre les drogues d’acquisition illicite et les addictions associées, 2015-2019, p.8}~ Diacetylmorphine Assisted Treatment Program (TADIAM) 'Substitute House', the metric used: statistics of how many people are using the program {Stratégie et plan d’action gouvernementaux en matière de lutte contre les drogues d’acquisition illicite et les addictions associées, 2015-2019, p. 29}~ Number of substitution treatment demanders {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.9, p.73, p.85, p.86; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.20; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.111}~ Prevalence Substitution treatment {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.73; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.20; see figure 4.3, National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.99}~ number of patients in structured JDH substitution programme: proportion of clients who are first substitution treatment demander {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.87}~ Outpatient prescription of substitution drugs by the national network of licensed MDs /(1999-2013): Number of indexed patients (double counting controlled), Number of licensed GPs (double counting controlled {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.87; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.113}~ Age distribution (%) of patients substituted by the national network of licensed MDs (2008-2014): 15-19; 20-24; 25-29; 30-34; 35-39; 40-44; 45-49; 50-54; 55-59; 60-64 {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.88; see table 5.3, National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.113}~ proportion of female substitution treatment demanders {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.87}~",8
Y,Luxembourg,LUX,Demand Reduction,Level of coverage of inpatient treatment,Yes,"Number of drug treatment demanders: Inpatient: Specialised, and Hospital Care, (Contacts) {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.85; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.20, p.111}~ Number of adult clients in inpatient clinics {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.9, p.86; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.111}~ The number of adult hospital based treatments {National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.20}~ ",3
Y,Luxembourg,LUX,Demand Reduction,Proportion of people who use drugs enrolled in voluntary treatment,No,n/a,0
Y,Luxembourg,LUX,Demand Reduction,Proportion of people who use drugs enrolled in coerced treatment,Yes,"Clients core statistics IMPULS 2000 – 2013: Number of episodes, Referral from the criminal Justice system, Gender distribution, Age distribution, Main substance involved {2014 National Report (2013 data) to the EMCDDA by the Reitox National Focal Point “Grand Duchy of Luxembourg"", 2013, p.119; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.145}~",1
Y,Luxembourg,LUX,Demand Reduction,Proportion of people who use drugs enrolled in compulsory treatment,No,n/a,0
Y,Luxembourg,LUX,Demand Reduction,Presence of prevention programming in law enforcement,Yes,"Information channels used in the past year to be informed about the effects and risks of illicit drugs: Police, not been informed at all {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.61; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.85, p.86}~ Information sources on new substances: from the police, I have not been informed at all {see figure 3.3, National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.86}~",2
Y,Luxembourg,LUX,Demand Reduction,Presence of prevention programming in the media,Yes,"Potential sources of information: from internet, media campaigns, drug and/or alcohol telephone helpline, not been informed at all {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.60, p.61; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.85, p.86}~ Information sources on new substances: from a drug and/or telephone helpline, I have not been informed at all, through media campaign(s), found the information on the internet {see figure 3.3, National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.86}~",2
Y,Luxembourg,LUX,Demand Reduction,Presence of prevention programming in schools,Yes,"Evaluation by questionnaire on content, method and presentation - schooling {Stratégie et plan d’action gouvernementaux en matière de lutte contre les drogues d’acquisition illicite et les addictions associées, 2015-2019, p.23}~ Information channels used in the past year to be informed about the effects and risks of illicit drugs: School prevention programme, not been informed at all {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.61; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.85, p.86}~ Information sources on new substances: through a school prevention programme, I have not been informed at all {see figure 3.3, National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.86}~",3
Y,Luxembourg,LUX,Demand Reduction,Presence of prevention programming in the workplace,Yes,"Potential sources of information about illicit drugs and drug use: someone at school or work {National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.85}~",1
Y,Luxembourg,LUX,Demand Reduction,Presence of prevention programming for youth and the community,Yes,"Potential sources of information: friends, parents or relatives, doctor, nurse or another health, social or youth worker, specialised drug counsellor or drug centre, not been informed at all professional,  {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.60, p.61; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.85, p.86}~ Information sources on new substances: from parents or relatives, from friends, I have not been informed at all {National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.86}~",2
Y,Luxembourg,LUX,Demand Reduction,Presence of other demand reduction metrics,No,n/a,0
Y,Luxembourg,LUX,Supply Reduction,Size and value of the illegal drug market,Yes,"The total number of persons involved in traffic {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.11; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.22}~ Ease of acquisition of drugs in Luxembourg (2002/2004): Near where I Live, In or near my school or college, At parties, In pubs/clubs {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.125; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.154}~ Ease of acquisition of drugs in Luxembourg (2008, 2011, 2014): Ease of access to heroin (if desired), Ease of access to cocaine (if desired), Ease of access to ecstasy (if desired), Ease of access to cannabis (if desired), Ease of access to alcohol (if desired), Ease of access to tobacco (if desired), Scale: very difficult, fairly difficult, fairly easy, very easy, dk/na {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.125, p.126, p.127; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.154}~ The origin of illicit drugs consumed in the G.-D. of Luxembourg {National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.23}~ The proportion of non-natives involved in drug trafficking {National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.23}~ The total number of persons involved in drug possession {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.11}~",6
Y,Luxembourg,LUX,Supply Reduction,Level of procedures related to crop eradication,No,n/a,0
Y,Luxembourg,LUX,Supply Reduction,"Number of arrests, seizures, and offences",Yes,"Number of arrests and foreclosures {Stratégie et plan d’action gouvernementaux en matière de lutte contre les drogues d’acquisition illicite et les addictions associées, 2015-2019, p.35; 2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.11}~ quantity of illicit substances seized (heroin, cocaine, ecstasy, cannabis) {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.10, p.129; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.22, p.156}~ Number of drug seizures by type (cannabis, heroin, ecstasy, cocaine) {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.11, p.129; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.157}~ Arrests broken down by type of reporting institution (1995-2013): S.p.J, Gendarmerie, Police, Customs, Total {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.116; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.142}~ Number of offenders involved in seizures according to type of offence (1988-2015): Traffic, Traffic and/or use, Traffic and use, Traffic and/or use of heroin, Traffic and use of heroin {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.130; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.157}~ The number of police records for presumed offences {National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.22}~ The number of arrests for presumed drug offenses {National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.22}~ ",7
Y,Luxembourg,LUX,Supply Reduction,Level of law enforcement activity and interdiction in the market,Yes,"Number of actions made by police and customs at customs check {Stratégie et plan d’action gouvernementaux en matière de lutte contre les drogues d’acquisition illicite et les addictions associées, 2015-2019, p.33}~ Number of national law enforcement interventions (1995-2015): Number of Drug Law enforcement Records & Number of Offenders classified by S.p.J, gendarmerie, Police, Customs, Total {Stratégie et plan d’action gouvernementaux en matière de lutte contre les drogues d’acquisition illicite et les addictions associées, 2015-2019, p.33; 2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.116}~ Number of training sessions and number of participants {Stratégie et plan d’action gouvernementaux en matière de lutte contre les drogues d’acquisition illicite et les addictions associées, 2015-2019, p.33}~ The number of police records {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.11}~",4
Y,Luxembourg,LUX,Supply Reduction,"Price, purity and potency of drugs, and related process indicators",Yes,"Price per unit evolution at the street level (1994-2013): Cannabis, Hashish, Marijuana, Cocaine, Heroin (brown), STA, Ecstasy, LSD {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.130; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.23, p.158}~ Purity of drugs at street level (1994-2013): Cannabis (THC), marijuana, hashish, Cocaine, Heroin (brown), STA, Ecstasy: MDMA, MDEA, MDA, Psylocine {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.131; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.23; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.159}~ ",2
Y,Luxembourg,LUX,Supply Reduction,Number of people engaged with the criminal justice system,Yes,"number of drug law offenders by supply reduction agencies {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.8, p.85; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.19, p.111}~ Number of people in conflict with the judicial system due to illicit drug {Stratégie et plan d’action gouvernementaux en matière de lutte contre les drogues d’acquisition illicite et les addictions associées, 2015-2019, p.5}~ The number of drug law offenders {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.11, p.71, p.73; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.22, p.99}~ Ratio (%) of male and female offenders – and ratio (%) of native vs non-native offenders {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.11, p.75; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.22, p.23}~ Proportion of offenders who are recidivists {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.76}~  Distribution of drug law offenders (‘prévenus’) according to first offence and underage status (1992-2013): First Time Offenders, Offenders underage {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.117; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.144}~ Distribution (%) of first drug law offenders (use and use/traffic) according to substance involved ad minima (1992-2013): Heroin, Cocaine, Amphetamines, Type ‘Ecstasy’, Illicitly acquired medications, Substitution Substances {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.117}~ General and DELIT ‘STUP’ admissions in both national prisons (1989 – 2013): New entries (total) and New “STUP” entries {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.120; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.146}~ percentage of minors (< 18 years) among first drug law offenders {2014 national report to the EMCDDA by the REITOX National Focal Point “Grand Duchy of Luxembourg”, 2013, p.11; National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.22}~ The total number of persons involved in drug possession offences {National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.22}~ Number of first drug law offenders {National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.22}~ Number of PDU coming into contact with law enforcement agencies {National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.23}~ Number of new admissions into prison related to drug law offenses {National report on the state of the drugs phenomenon: Grand Duchy of Luxembourg, 2016, p.23}~ ",13
Y,Luxembourg,LUX,Supply Reduction,Presence of other supply reduction metrics,No,n/a,0
Y,Luxembourg,LUX,International Cooperation,Level of engagement in international cooperation,Yes,"Number of participations documented. {Stratégie et plan d’action gouvernementaux en matière de lutte contre les drogues d’acquisition illicite et les addictions associées, 2015-2019, p.35}~",1
Y,Italy,ITA,Health,Level of availability of harm reduction services and harm reduction scale up,Yes,"No. of phials distributed. {National Action Plan on Drugs, 2010-2013, p.80} ~ No. of phials used. {National Action Plan on Drugs, 2010-2013, p.80} ~ No. courses organised. {National Action Plan on Drugs, 2010-2013, p.80} ~ No. of participants. {National Action Plan on Drugs, 2010-2013, p.80} ~ Availability of take-home naloxone programs {Italy Country Drug Report, 2017, p.11} ~ Prevent and reduce the risk of death by overdose - Presence of protocols and No. of drug addicts informed. {National Action Plan on Drugs, 2010-2013, p.80} ~",6
Y,Italy,ITA,Health,Presence of needle and syringe programs,Yes,"Availability of Needle and Syringe Programs {Italy Country Drug Report, 2017, p.11} ~",1
Y,Italy,ITA,Health,Prevalence of substance use disorders,Yes,"new subjects arrived with problems related to the use of substances {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.58} ~ No. new patients with dependency or use of NPS/year {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.87} ~ prevalence of students using cannabis that have a consumption that can be defined as problematic. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.30} ~ Prevalence of problematic cannabis users. Year 2009-2016 {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.35} ~ total number of patients with problematic substance use {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.58} ~ number of high risk opioid users {Italy Country Drug Report, 2017, p.1, p.7, p.19} ~ ",6
Y,Italy,ITA,Health,Prevalence of psychiatric comorbidities,No,n/a,0
Y,Italy,ITA,Health,Drug-related mortality,Yes,"No. of notifications to the National Early Warning System divided by Region. {National Action Plan on Drugs, 2010-2013, p.77} ~ Incidence/Number of drug-related deaths. {National Action Plan on Drugs, 2010-2013, p.81, Italy Country Drug Report, 2017, p.1} ~ Time trend in the number of drug-related deaths detected by the RS of the Ministry of the Interior and the ISTAT's RGM. Years 2007-2016 {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.98} ~ Time trend of standardized mortality rates total, by sex (male, female, total) and by age group (15-24, 25-34, 35-44, 45-54, 55-64) per 1,000,000 residents of deaths with initial drug related cause. Years 2005-2014. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.99, p.128} ~ Standardized mortality rates by region of residence and gender per 1,000,000 residents of deaths with initial drug related cause. Year 2014. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.99} ~ Standardized rates of drug-related mortality by macro-area of residence and gender per 1,000,000 residents. Year 2014. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.128} ~ Five-year trend of deaths due to drug abuse by sex and age group. Years 2012-2016 {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.127} ~ Drug-Induced deaths by gender (%) {Italy Country Drug Report, 2017, p.9} ~ Trends in the number of drug induced deaths (2006-2015) {Italy Country Drug Report, 2017, p.9} ~ Prevalence of drug related deaths, and prevalence of deaths with opioids present {Italy Country Drug Report, 2017, p.9} ~ Age distribution of deaths in 2015 {Italy Country Drug Report, 2017, p.9} ~ Drug-induced mortality rates among adults (15-64 years) (Cases per million population) {Italy Country Drug Report, 2017, p.9 & p.19} ~ ",12
Y,Italy,ITA,Health,Prevalence of drug-related infectious disease,Yes,"number of HIV/AIDS cases {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.viii} ~ prevalence of female students infected with hepatitis, HIV, AIDS  {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.ix} ~ Number of acute viral hepatitis cases (Hepatitis A, Hepatitis B, Hepatitis C) {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.viii, p.78} ~ Percentage of drug users that tested positive for HIV, HBV,  HCV {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.78, p.80, p.82} ~ ratio of all treatment users that were tested positive for HCV {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.82} ~ Number of cases of acute viral hepatitis (A, B, C and Delta) in drug addicts, by year of onset of symptoms. Years 1991-2016 {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.84} ~ Socio-demographic characteristics of cases of acute viral hepatitis in drug addicts. Years 2012-2016 (total) {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.84} ~ Prevalence of HAV, HBV and HCV infection in 2016 {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.85} ~ prevalence of HAV and HBV due to inhalation drug use {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.85} ~ prevalence of HCV due to intravenous drug use, and intravenous + inhalation drug use {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.85} ~ Absolute value and percentage of cases of acute viral hepatitis in drug addicts due to risk factors (≥ 3 sexual partners, Tattooing, Piercing, Cohabitant HBsAg, Cohabitant HCV, Journey to endemic area for hepatitis A, Positive for HIV). Years 2010-2016. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.85} ~ Percent distribution of new diagnoses of HIV infection among IDUs by gender and by age group. Years 2010-2015. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.86, p.87} ~ Percentage distribution of new AIDS diagnoses among IDUs by age group. Year 2015. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.88} ~ Percentage distribution of new AIDS cases among IDUs according to gender. Years 2004-2015. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.88} ~ The prevalent cases of AIDS among IDUs. Years 1994-2013. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.89} ~ Distribution (%) of new diagnoses of HIV infection among IDUs. Years 2010-2015. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.125} ~ Newly diagnosed HIV cases attributed to injecting drug use (cases per million population) {Italy Country Drug Report, 2017, p.1, p.8, & p.19} ~ National Estimates of HIV and HCV antibody prevalence among people who inject drugs {Italy Country Drug Report, 2017, p.8} ~ HIV and HCV prevalence among PWID* (%) {Italy Country Drug Report, 2017, p.19} ~",19
Y,Italy,ITA,Health,Proportion of people who use drugs who engage in risky consumption,No,n/a,0
Y,Italy,ITA,Health,Proportion of people who use drugs who engage in safe consumption practices,No,n/a,0
Y,Italy,ITA,Health,"Coverage of services for the prevention, testing, and treatment of bloodborne diseases",Yes,"In 2016, the total number of users that were treated in the SerD who were tested for HIV, HBV and HCV. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.78} ~ the ratio of drug users currently in treatment that were tested for infectious diseases {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.80} ~ Percentage of drug users that were tested for HIV, HBV, and HCV  {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.80, p.82} ~ ratio of all treatment users that were tested positive for HBV {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.81} ~ Number and percentage of drug-addicted users treated in the SerD and tested for HBV and HCV according to the injected substance (heroin, cocaine). Year 2016 {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.82} ~ Injection tests among consumers - Year 2015. Reasons for testing (At SerD's suggestion, Sexualization committees at risk, hospital admission, prison / community, routine checks, unknown, following STIs, HIV symptoms Related) {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.89} ~",6
Y,Italy,ITA,Health,Presence of specialised training for addiction care,Yes,"No. training courses activated and No. operators trained regarding the objective of Supplement and coordinate reintegration work among the various local agencies (Treatment services and Therapeutic communities, local and provincial administrations, hospitals, business associations) {National Action Plan on Drugs, 2010-2013, p.85} ~ No. competent physicians updated {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.96} ~ No. courses organised/year and No. participants regarding the objective of organising of periodic updated courses and/or information events for operators of Departments for Addictions in order to update their knowledge relative to the NPS and thus, increase their diagnostic capacity relative to NPS use among patients receiving these services {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.95} ~ No. courses activated/year to update the personnel operating in the Departments for Addictions {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.100} ~ No. of courses activated and no. of participants regarding the objective of reduce drug-related mortality {National Action Plan on Drugs, 2010-2013, p.77} ~",5
Y,Italy,ITA,Health,Presence of health harms related to drug use,Yes,"Patients in emergency room - Recording of typical and/or atypical symptoms: Frequency of symptoms relative to the substance {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.93} ~ Patients undergoing treatment in Departments for Addictions - Specifically, populations using cocaine and THC: Neurocognitive consequences, Other consequences to the body (heart, lungs, liver, etc.) {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.93} ~ No. cases of acute intoxication/year {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.89} ~ No. of overdose cases in at-risk groups. {National Action Plan on Drugs, 2010-2013, p.80} ~ Incidence of infections {National Action Plan on Drugs, 2010-2013, p.81} ~",5
Y,Italy,ITA,Health,Presence of other health metrics,Yes,"No. of programs of organisational integration regarding the objective of Increase the integration of the prevention of drug-related diseases with treatment initiatives {National Action Plan on Drugs, 2010-2013, p.80} ~ Activation of research projects on actual mortality rates related to NPS - No. projects activated and No. publications created {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.107} ~ number of major drug related diagnosis recoveries and prevalence by gender {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.vi} ~ No. projects activated and publications created regarding research projects on toxicity of NPS and on treatments {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.107} ~ Realisation of a specific study regarding the objective of reducing the potential of treatments becoming chronic {National Action Plan on Drugs, 2010-2013, p.78} ~",5
Y,Italy,ITA,Peace and Security,"Prevalence of alcohol and drugs in accidents, and interventions to increase road safety",Yes,"drivers checked for alcohol and drugs. {National Action Plan on Drugs, 2010-2013, p.68, p.102} ~ No. positives/negatives on tests {National Action Plan on Drugs, 2010-2013, p.68, p.102} ~ No. licences withdrawn {National Action Plan on Drugs, 2010-2013, p.68, p.102} ~ No. of research projects and studies activated regarding the objective of activate highway control programs for the prevention of alcohol and drug-related accident {National Action Plan on Drugs, 2010-2013, p.68} ~ Percentage of acts, additions and changes realised on the basis of those proposals. {National Action Plan on Drugs, 2010-2013, p.98} ~ No. checks carried out. {National Action Plan on Drugs, 2010-2013, p.102} ~ No. of vehicles sequestered {National Action Plan on Drugs, 2010-2013, p.102} ~ Prevalence of road accidents with injuries to people detected by Carabinieri and Traffic Police is drug-related. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.78} ~ number of criminal proceedings initiated by the Public Prosecutor's Office in 2014 (last data available) for driving under the influence of drugs {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.78} ~ number of contraventions for driving under the influence of drugs. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.96} ~ No. psychological-physical changes related to taking NPS correctly identified/year regarding drivers of vehicles on the road {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.103} ~",11
Y,Italy,ITA,Peace and Security,Annual number of public disorder and violent crime reports,No,n/a,0
Y,Italy,ITA,Peace and Security,Number of non-lethal drug market violent events reported,No,n/a,0
Y,Italy,ITA,Peace and Security,Number of drug market related homicides and disappearances,No,n/a,0
Y,Italy,ITA,Peace and Security,Presence of other peace and security metrics,No,n/a,0
Y,Italy,ITA,Development,Coverage of housing assistance for people who use drugs,No,n/a,0
Y,Italy,ITA,Development,Coverage of social assistance for people who use drugs (not including housing),Yes,"No. of new accesses to services for social and work reintegration {National Action Plan on Drugs, 2010-2013, p.81} ~ No. existing specific regional plans and quantity of funds dedicated to reintegration work {National Action Plan on Drugs, 2010-2013, p.83} ~ No. of specific programs of rehabilitation and no. and types of specific programs of social reintegration and work reintegration activated at Addiction Departments {National Action Plan on Drugs, 2010-2013, p.83} ~ No. of organisations belonging to the national reintegration network. {National Action Plan on Drugs, 2010-2013, p.83} ~ Quantity of funds dedicated to reintegration projects. {National Action Plan on Drugs, 2010-2013, p.83} ~ No. of operating units active with standardised procedures and specific rehabilitation programs (% of total of operating units). {National Action Plan on Drugs, 2010-2013, p.84} ~ No. training courses, No. participants activated, and No. people trained to Improve the education and professional skills of drug addicts in treatment {National Action Plan on Drugs, 2010-2013, p.84} ~ No. operating units created in Addiction Departments {National Action Plan on Drugs, 2010-2013, p.84} ~ No. orientation services for rehabilitation and reintegration in Treatment services and therapeutic communities. {National Action Plan on Drugs, 2010-2013, p.84} ~ No. companies and public administrations involved {National Action Plan on Drugs, 2010-2013, p.85} ~ No. contracts allocated to social cooperatives per annum {National Action Plan on Drugs, 2010-2013, p.85} ~ No. companies involved and no. agreements signed to encourage the reintegration of drug addicts into the work cycle of ordinary companies {National Action Plan on Drugs, 2010-2013, p.85} ~  No. organisations and No. active self-financing organisations created which deal with social and work reintegration {National Action Plan on Drugs, 2010-2013, p.86} ~ No. structures involved which are part of the network for the rehabilitation and reintegration into society and No. Regions and Autonomous Provinces which take part {National Action Plan on Drugs, 2010-2013, p.86} ~ No. people integrated into work/No. people involved in reintegration activities. {National Action Plan on Drugs, 2010-2013, p.86} ~ No. of underage drug-users who have entered the penal circuit and make use of the educational accompaniment service and programs of orientation / training / protected work integration {National Action Plan on Drugs, 2010-2013, p.103} ~ No. and type of projects / programs / initiatives activated regarding rehabilitation programs more on the enhancement of the minor’s personal, social and civil identity  {National Action Plan on Drugs, 2010-2013, p.103} ~ ",17
Y,Italy,ITA,Development,Number of households enrolled in alternative development,No,n/a,0
Y,Italy,ITA,Development,Presence of other development metrics,Yes,"Regional distribution of income (%) held by drug addicts in 2016 {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.73} ~",1
Y,Italy,ITA,Human Rights,"Prevalence and incidence of infectious diseases in vulnerable populations (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Italy,ITA,Human Rights,"Prevalence of vulnerable people who use drugs (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"number of prison population that are addicted to drugs {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.58} ~ Trend of the percentage of drug addicts detained at December 31 of each year, compared to the total number of prisoners. Years 2006-2016. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.72} ~ Trend in the percentage of entries of drug-addicted prisoners, compared to the total number of prisoners. Years 2006-2016. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.73} ~",3
Y,Italy,ITA,Human Rights,Proportion of people who use drugs in prison that are receiving medication assisted treatment (MAT),No,n/a,0
Y,Italy,ITA,Human Rights,Distribution of sterile injecting equipment in prisons,No,n/a,0
Y,Italy,ITA,Human Rights,Presence of programs and services targeted towards women ,Yes,"No. protocols and guidelines produced regarding the objective of activate diversified treatments and environments for minors and, at the same time, activate environments and treatments suitable for females {National Action Plan on Drugs, 2010-2013, p.75} ~ Draft specific guidelines and informative material on gender oriented prevention to be disseminated in socio-healthcare structures - No. and type of materials produced and level of dissemination. {National Action Plan on Drugs, 2010-2013, p.67} ~ Disseminate information on situations of specific risk for women in relation to the use of drugs and alcohol, and on “sexual assault” -  No. women involved. {National Action Plan on Drugs, 2010-2013, p.67} ~ Create training courses for young women for the early identification of situations of risk and the correct way to handle them - No. training courses for young women {National Action Plan on Drugs, 2010-2013, p.67} ~ Develop programs dedicated to the phenomenon of the very young age group who exchange sex for drugs - No. of programs activated per individual Region and Autonomous Province {National Action Plan on Drugs, 2010-2013, p.67} ~ Develop programs dedicated to the phenomenon of the very young age group who exchange sex for drugs  - No. of programs activated per individual Region and Autonomous Province {National Action Plan on Drugs, 2010-2013, p.67} ~ Activate easily accessible info-points and info-lines - No. of female drug addicts contacted {National Action Plan on Drugs, 2010-2013, p.81} ~ Existence of specific programs for women {National Action Plan on Drugs, 2010-2013, p.81} ~ No. of prostitute drug addicts included in liberation programs. {National Action Plan on Drugs, 2010-2013, p.81} ~ No. of female drug addicts subjected to gynecological checks. {National Action Plan on Drugs, 2010-2013, p.81} ~ No. of female drug addicts with assisted pregnancies. {National Action Plan on Drugs, 2010-2013, p.81} ~ ",11
Y,Italy,ITA,Human Rights,Presence of programs and services targeted towards people of color,Yes,"No. foreign minors who use cultural mediation. {National Action Plan on Drugs, 2010-2013, p.112} ~ ",1
Y,Italy,ITA,Human Rights,Presence of challenges and/or harms experienced by people of color,No,n/a,0
Y,Italy,ITA,Human Rights,"Presence of programs and services targeted towards vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"Draft prevention programs aimed at young prisoners - No. of prevention programs realised {National Action Plan on Drugs, 2010-2013, p.69} ~ No. of people who have made use of trial custody (art. 94 Presidential Decree no. 309/90) per Region. {National Action Plan on Drugs, 2010-2013,  p.78} ~ Definition of an adequate and well-defined organisation to guarantee suitable treatments, including in prison - Realisation of a joint technical proposal (guidelines) {National Action Plan on Drugs, 2010-2013, p.78} ~ No. of prisons with specific anti-overdose programs on leaving prison. {National Action Plan on Drugs, 2010-2013, p.78} ~  No. patients admitted to the therapy program in prison. {National Action Plan on Drugs, 2010-2013, p.80} ~ ",5
Y,Italy,ITA,Human Rights,"Presence of challenges and/or harms experienced by vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Italy,ITA,Human Rights,Presence of other human rights metrics,No,n/a,0
Y,Italy,ITA,Demand Reduction,Prevalence of drug use by age,Yes,"prevalence and number of students that have consumed at least one illegal substance in the last year total and by type of drug (cannabis, spice, new psychoactive substance, cocaine, heroin, opioids) {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.vi} ~ prevalence of students that have used Spice {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.viii} ~ consumption of at least one illegal substance among female students; in life (%); in the last year (%) {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.ix} ~ prevalence of NPS or spice use among female students {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.ix} ~  percentage of students of upper secondary schools that have experienced at least one illegal psychoactive substance, and the percentage of those who have experienced New Psychoactive Substances {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.ix} ~ Prevalence of the population aged between 15 and 64 and between 15 and 34 that have tried at least one illegal psychoactive substance during their lifetime {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.30} ~ Prevalence of Italian students that have tried at least one illegal substance, the most used is Cannabis (%) followed by SPICE (synthetic cannabis) (%). {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.30} ~ Prevalence of Italian Students that have used at least one New Psychoactive Substance (NPS), and the prevalence of students who took a substance without knowing what it was, and % of them that repeated the experience 10 or more times. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.30} ~ % of students who are consumers of illicit drugs during the year and are poly-drug users {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.30} ~ trends of consumption of new psychoactive substances among male and female students {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.30} ~ Percentages of consumers of at least one narcotic substance in the general population and among young adults, in life and in the last 12 months. Year 2017. (consumed at least once in their life, consumed in the last 12 months) {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.32} ~ Consumer trends in the last 12 months of cannabis, cocaine, or opioids in the general population and young adults (2005-2006, 2007-2008, 2010-2011, 2013-2014, 2017). Year 2017. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.33} ~ Trends in use of substances in students life time, % of use in students of life time by sex {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.34} ~ prevalence of drug use at least once in students lifetime, by type of drug (SPICE, stimulants, Cocaine, NPS, hallucinogens, opioids) {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.34} ~ Prevalence of cannabis, spice, NPS, cocaine, heroin, stimulant, hallucinogens consumption by sex and age (15, 16, 17, 18, 19) {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.35, p.37, p.38, p.39, p. 40, p. 41} ~ The lifetime prevalence of drug use, the prevalence of drug use at least once in the last year or in the last month, and prevalence of frequent drug use in the past month by students, by age and substance classes. Year 2016. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.122} ~ Prevalence of students who have used NPS least once in their lifetime by substance. Year 2016. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.123} ~ Time trend of the FUS, PDS and the percentage of consumers in the last 30 days among students (15-19 years). Years 2006-2016. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.123} ~ Prevalence of cannabis, cocaine, MDMA, amphetamine use in young adults (15-34 years) in the last year {Italy Country Drug Report, 2017, p.1} ~ Estimates of last-year cannabis, cocaine, MDMA, amphetamine use by age (15-24, 25-34, 35-44, 45-54, 55-64) and by sex {Italy Country Drug Report, 2017, p.5} ~ Substance use among 15- to 16- year-old school students in Italy in the past 30 days (Cigarettes, Alcohol, Heavy Episodic Drinking, Cannabis, Illicit drugs other than cannabis, Tranquilisers without prescription, Inhalants, New Psychoactive Substances) {Italy Country Drug Report, 2017, p.6} ~ cannabis, cocaine, MDMA, amphetamine - Lifetime prevalence of use (schools), Last year prevalence of use (young adults and all adults, %) {Italy Country Drug Report, 2017, p. 6, p.18} ~ Mean age of first cannabis, cocaine, heroin, amphetamine use {Italy Country Drug Report, 2017, p.7} ~ General Population - GPS Survey (questionnaires 19-64): Prevalence of use in the student population (PY, PM) {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.92} ~ Time trend of the FUS, PDS indices and percentages of consumers in the last 30 days of psychoactive substances in the student population. Years 2006-2016. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.52} ~ Prevalence of frequent consumption by minors (15-17 years) in the last 30 days per substance (Cannabis, Cocaine, Heroin, Stimulants, Hallucinogens). Years 2007 - 2016 {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017,p.56} ~",26
Y,Italy,ITA,Demand Reduction,Prevalence of drug use by sex,Yes,"consumption of at least one illegal substance among female students; in life (%); in the last year (%) {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.ix} ~ prevalence of NPS or spice use among female students {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.ix} ~ trends of consumption of new psychoactive substances among male and female students {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.30} ~ Trends in use of substances in students life time, % of use in students of life time by sex {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.34} ~ Prevalence of cannabis, spice, NPS, cocaine, heroin, stimulant, hallucinogens consumption by sex and age (15, 16, 17, 18, 19) {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.35, p.37, p.38, p.39, p. 40, p. 41} ~ Distribution of SPICE consumption by sex {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.37} ~ Estimates of last-year cannabis, cocaine, MDMA, amphetamine use by age (15-24, 25-34, 35-44, 45-54, 55-64) and by sex {Italy Country Drug Report, 2017, p.5} ~",7
Y,Italy,ITA,Demand Reduction,Prevalence of drug use by type,Yes,"prevalence of students that have consumed at least one illegal substance in the last year by type of drug (cannabis, spice, new psychoactive substance, cocaine, heroin, opioids) {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.vi} ~ prevalence of the general population that have consumed at least one illegal substance in the last year by type of drug (cannabis, spice, new psychoactive substance, cocaine, heroin, opioids) {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.vi} ~ Furthermore, reports for cannabis possession for personal use account for 80% of total {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.vii} ~ prevalence of students that have used Spice {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.viii} ~ prevalence of NPS or spice use among female students {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.ix} ~ percentage of students of upper secondary schools that have experienced at least one illegal psychoactive substance, and the percentage of those who have experienced New Psychoactive Substances {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.ix} ~ Prevalence of Italian students that have tried at least one illegal substance, the most used is Cannabis (%) followed by SPICE (synthetic cannabis) (%). {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.30} ~ Prevalence of Italian Students that have used at least one New Psychoactive Substance (NPS), and the prevalence of students who took a substance without knowing what it was, and % of them that repeated the experience 10 or more times. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.30} ~ the ""double list"" substances detected {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.30} ~ In 2016 of the almost 50,000 soldiers subjected to toxicological examination for drug use, % was positive: among these % were detected the presence of cannabinoids, for % of opiates and for % of cocaine. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.30} ~ trends of consumption of new psychoactive substances among male and female students {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.30} ~ Percentages of consumers of at least one narcotic substance in the general population and among young adults, in life and in the last 12 months. Year 2017. (consumed at least once in their life, consumed in the last 12 months) {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.32} ~ Consumer trends in the last 12 months of cannabis, cocaine, or opioids in the general population and young adults (2005-2006, 2007-2008, 2010-2011, 2013-2014, 2017). Year 2017. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.33} ~ Trends in use of substances in students life time, % of use in students of life time by sex {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.34} ~ prevalence of drug use at least once in students lifetime, by type of drug (SPICE, stimulants, Cocaine, NPS, hallucinogens, opioids) {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.34} ~ Distribution of SPICE consumption by sex {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.37} ~ Prevalence and frequency of cannabis, spice, cathinones, salvia divinorum, cocaine, heroin, stimulant and hallucinogens consumption {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.35, p.36, p.37, p.38, p.39, p.40, p.41, p.42} ~ Distribution% of positivity for substances detected in double list. Years 2003-2016. (Positive in double list (% on positives), THC (%), Cocaine (%), Morphine/Oxycodone (%), Amphetamine / phentermine (%), Buprenorphine (%)) {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.47} ~ Drug use among the military personnel of the Armed Forces and the Carabinieri Army - Year 2016 by type of drug (Cannabinoids, Opioids, Amphetamine, Cocaine, Benzodiazepines) {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.49} ~ Prevalence of individuals who consume only opiates/cocaine/cannabis, consume opiates/cocaine/cannabis and another drug, consume opiates/cocaine/cannabis and 2 or more other drugs {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.68} ~ new user trend with primary and/or secondary opiates/cocaine/cannabis 2012-2016 {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.68, p.69} ~ The lifetime prevalence of drug use, the prevalence of drug use at least once in the last year or in the last month, and prevalence of frequent drug use in the past month by students, by age and substance classes. Year 2016. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.122} ~ Prevalence of students who have used NPS least once in their lifetime by substance. Year 2016. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.123} ~ Distribution (%) of users according to the primary substance of abuse. Year 2016. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.125} ~ Prevalence of cannabis, cocaine, MDMA, amphetamine use in young adults (15-34 years) in the last year {Italy Country Drug Report, 2017, p.1} ~ Estimates of last-year cannabis, cocaine, MDMA, amphetamine use by age (15-24, 25-34, 35-44, 45-54, 55-64) and by sex {Italy Country Drug Report, 2017,p.5} ~ cannabis, cocaine, MDMA, amphetamine - Lifetime prevalence of use (schools), Last year prevalence of use (young adults and all adults, %) {Italy Country Drug Report, 2017, p. 6, p.18} ~ High-risk opioid use (rate/1 000) {Italy Country Drug Report, 2017} ~ Prevalence of use of NPS (investigation on the general population and at risk populations, Analysis of metabolites of NPS in wastewater of the “Aquadrugs”-DPA network {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.87} ~ Types of substances identified in subjects participating in raves {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.89} ~ ",30
Y,Italy,ITA,Demand Reduction,Number of people who use drugs,Yes,"total prevalence and number of the general population that have consumed at least one illegal substance in the last year {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.vi} ~  Postal Packages in Transit - NPS sent by supplier to customers by postal couriers: Prevalence of use in the general population (PY, PM) {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.92} ~ ",2
Y,Italy,ITA,Demand Reduction,"Prevalence of drug use by mode of administration (oral, mucosa, inhalation, and injection)",No,n/a,0
Y,Italy,ITA,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT)",Yes,"Patients undergoing treatment in Departments for Addictions - Specifically, populations using cocaine and THC: Prevalence of positive results, Method of use {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.93} ~ number of individuals who were treated by private services and reintegrated to the community {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.58} ~ Improve the quality and effectiveness of Treatments - Realisation of a joint technical proposal (guidelines). {National Action Plan on Drugs, 2010-2013, p.76} ~ No. Protocols of collaboration existing between emergency units and DDD. {National Action Plan on Drugs, 2010-2013, p.77} ~ No. of support initiatives activated. {National Action Plan on Drugs, 2010-2013, p.66} ~ Level of customer satisfaction. {National Action Plan on Drugs, 2010-2013, p.68} ~ Quantity of financing allocated. {National Action Plan on Drugs, 2010-2013, p.73} ~ Provision of specific funds for specific types of users {National Action Plan on Drugs, 2010-2013, p.73} ~ No. specific regional plans on treatment and drug-related diseases. {National Action Plan on Drugs, 2010-2013, p.73} ~ Quantity of funds available. {National Action Plan on Drugs, 2010-2013, p.73} ~ No. of Regions and Autonomous Provinces which have implemented in concrete terms the agreements/total no. of Regions and Autonomous Provinces {National Action Plan on Drugs, 2010-2013, p.73} ~ No. of Regions which have completed the implementation / total Regions which should have completed it. {National Action Plan on Drugs, 2010-2013, p.73} ~ Judgment on the level of integration by managers of non-profit organisations and managers of public services. {National Action Plan on Drugs, 2010-2013, p.74} ~ No. of protocols activated / No. of protocols which may be activated. {National Action Plan on Drugs, 2010-2013, p.74} ~ Lag-time between drug use and first contact with services {National Action Plan on Drugs, 2010-2013, p.74} ~ No. of new accesses to services. {National Action Plan on Drugs, 2010-2013, p.74} ~ No. of operating units with active outreach programs. {National Action Plan on Drugs, 2010-2013, p.74} ~ No. of foreign drug addicts in treatment at services/total no. of drug addicts in treatment. {National Action Plan on Drugs, 2010-2013, p.74} ~ No. occasional / habitual users in contact with services and their progress over time. {National Action Plan on Drugs, 2010-2013, p.75} ~ No. of operators trained. {National Action Plan on Drugs, 2010-2013, p.75} ~ No. of parents involved in the treatment programs. {National Action Plan on Drugs, 2010-2013, p.75} ~ No. of services which support “parent notification”. {National Action Plan on Drugs, 2010-2013, p.75} ~ Realisation of a joint technical proposal (guidelines). {National Action Plan on Drugs, 2010-2013, p.76} ~ No. of operating units participating in the project to assess outcomes. {National Action Plan on Drugs, 2010-2013, p.76} ~ No. of services and communities which record customer satisfaction. {National Action Plan on Drugs, 2010-2013, p.76} ~ Average level of satisfaction. {National Action Plan on Drugs, 2010-2013, p.76} ~ No. of cooperation protocols existing between Mental Health Departments and Addiction Departments. {National Action Plan on Drugs, 2010-2013, p.77} ~ No. of supplemented treatments / No. treatments carried out by the services. {National Action Plan on Drugs, 2010-2013, p.78} ~ Length of treatments in relation to the outcome. {National Action Plan on Drugs, 2010-2013, p.78} ~ No. of new accesses to treatment services and to therapeutic communities {National Action Plan on Drugs, 2010-2013, p.81} ~ No. of support programs for the families of drug addicts activated. {National Action Plan on Drugs, 2010-2013, p.82} ~ No. protocols / agreements / collaborations with the local health authority, local authorities and/or competent services. {National Action Plan on Drugs, 2010-2013, p.103} ~ prevalence of users in treatment by sex (male, female) {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.vi} ~ prevalence of first time treatment entrants {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.vi} ~ prevalence of users already in treatment {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.vi} ~ number and prevalence of female students in treatment by type of drug (opioids, cocaine, cannabis {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.ix} ~ number of SerD outpatient offices and number of private social-rehabilitative facilities {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.58} ~ Prevalence of cocaine users seeking treatment {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.58} ~ prevalence of cannabis users in treatment who do not use any other substances {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.58} ~ number of people in treatment by private services {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.58} ~ number of individuals employed by the SerD {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.60} ~ The system of Public Services for Addictions. Year 2016. 1) regional distribution of staff and locations. 2) Prevalence of staff by type (Administrative, Educators, Social Workers, Psychologists, Nurses, Doctors) {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.61} ~ Distribution of private social rehabilitation partner structures accredited by type. Update as of December 31st 2016. (Residential, Semi-Residential, Outpatient) {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.62} ~ Regional distribution of the number of existing social rehabilitative partner structures per 100,000 residents. Update as of December 31st 2016. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.62} ~ Total number of users in treatment {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.64} ~ Drug users treated in the SerD. Regional rate on 10,000 residents and by primary and/or secondary substance. Year 2016 (region, first-time treatment entrant, already in treatment, total {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.66, p.67} ~ Distribution of users treated in SerD by primary substance. Years 1996 - 2006 - 2016. (opioids, cannabinoids, cocaine or crack) {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.68} ~ Trends for primary opioid use among new treatment entrants and already in treatment 2012-2016 {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.68} ~ Prevalence of new treatment entrants and individuals already in treatment who consume opioids, cocaine, or cannabis and prevalence of use by sex {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.68, p. 69} ~ Number of treatments and number of treatments per user by type of treatment granted to users of drug users treated in the SerD. Year 2016. (Pharmaceuticals, Inclusion in Therapeutic Community, Psychosocial, Healthcare, Other, Total) {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.70} ~ Regional distribution of the number of persons in treatment at private social rehabilitative structures for 100,000 residents. Data recorded as of 31 December 2016. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.71} ~ Distribution of subjects being treated by type of structure. Data recorded as of 31 December 2016. (Residential, Semi-Residential, Outpatient) {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.71} ~ Prevalence of therapeutic reliance by positive outcomes (%) and negative outcomes (%) {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.75} ~ Distribution (%) of admissions with drug-related major diagnoses by type of substance (excluding admissions with mixed or unspecified substances). Year 2015. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.127} ~ number of treatment entrants by primary drug (Cannabis, Amphetamines, Cocaine, Heroin, Other) {Italy Country Drug Report, 2017, p.1} ~ number of all treatment entrants, new treatment entrants, entering treatment by sex (%), mean age at first treatment entry, and, trends in number of first-time treatment entrants, by type of drug (cannabis, cocaine, heroin, amphetamine) {Italy Country Drug Report, 2017, p.7} ~ number of specialised treatment centers (outpatient) {Italy Country Drug Report, 2017, p.12} ~ Trends in percentage of clients entering specialised drug treatment, by primary drug in Italy {Italy Country Drug Report, 2017, p.13} ~ Percentage of all treatment entrants and first-time treatment entrants (%) by type of drug (cannabis, cocaine, MDMA, opioids, amphetamine) {Italy Country Drug Report, 2017, p.18, p.19} ~ Treatment Demand: All Clients & First Time Clients {Italy Country Drug Report, 2017, p.19} ~ Patients undergoing treatment in Departments for Addictions - Specifically, populations using cocaine and THC: Prevalence of positive results and Method of use {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.93} ~ No. new patients with dependency or use of NPS/year {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.87} ~ Types of treatment units {National Action Plan on Drugs, 2010-2013, p.84} ~ Patients in emergency room - Collection of biological liquids: Mixtures/Combined Substances {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.93} ~ Patients in emergency room - Collection of biological liquids: Georeferencing of acute intoxications {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.93} ~ Patients in emergency room - Collection of substances given by the patient at admission to the healthcare professionals: Matching with active ingredients found in biological samples {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.93} ~ 3.5.1. Type of NPS detected in subjects treated for the primary use of other substances {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.100} ~",67
Y,Italy,ITA,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT) by age",Yes,"No. of structures which specialise in accepting minors with dual diagnosis. {National Action Plan on Drugs, 2010-2013, p.103} ~ No. treatment service operators in Youth Courts. {National Action Plan on Drugs, 2010-2013, p.103} ~ No. minors who have used the joint treatment {National Action Plan on Drugs, 2010-2013, p.103} ~ Percentage of minors in the SerD who requested the first treatment and who used before the age of 15 or between 15 and 19 years. Years 2014-2016. (Heroin, Cocaine, or Cannabis; Age of first treatment; Age of first use) {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.54} ~ average age of heroin users who seek treatment {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.58} ~ prevalence of users already in treatment and their average age {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.58, p.64, p.viii} ~ Prevalence of first-time treatment entrants and their average age {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.64} ~ Number of females and males in treatment (prevalence users already in treatment & average age, prevalence of first time treatment entrants & average age) {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.64} ~ Age of the subjects being treated by year (1996, 2006, 2016) {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.65} ~ Age of male and female subjects already in treatment & age of first-time male treatment entrants being treated by year (1996, 2006, 2016) {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.65} ~  Age of first use and first treatment of drug users treated in the SerD by type of user and gender (n.24.121). Year 2016. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.70} ~ Average age of users treated in SerD by type. Years 1996-2006-2016. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.124} ~ Distribution of users treated in the SerD by type (first time treatment entrants, already in treatment) by age group. Year 2016. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.124} ~ Distribution (%) of directly drug-related female admissions by age group. Year 2015. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.126} ~ No. of minors tested and percentage found positive {National Action Plan on Drugs, 2010-2013, p.66} ~ average age of users in treatment {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.viii} ~ number of female students in treatment and prevalence of female students in treatment by type of drug (opioids, cocaine, cannabis) {p.ix} ~",17
Y,Italy,ITA,Demand Reduction,Level of access to opioid substitution treatment and medication assisted treatment (OST/MAT),Yes,"Opioid substitution treatment in Italy: proportions of clients in OST by medication (methadone, buprenorphine) and trends of the total number of clients {Italy Country Drug Report, 2017, p.13} ~ Clients in substitution treatment {Italy Country Drug Report, 2017, p.1 & p.19} ~",2
Y,Italy,ITA,Demand Reduction,Level of coverage of inpatient treatment,Yes,"No. of new accesses to treatment services and to therapeutic communities. {National Action Plan on Drugs, 2010-2013, p.81} ~ Hospitalizations discharges connected with the use of substances (minors on the left axis, total right axis). Years 2009 - 2015 by age (less than 15 years of age, 15-17 years of age, Minors, Total) {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.53} ~ Prevalence of minors hospitalized by substance and age. Years 2010 and 2015 {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.53} ~ Number of drug-related hospitalizations, and the rate of hospitalizations (per 100,000 residents) {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.78} ~ Average age of those with the highest hospitalization rates {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.78} ~ Time trend of hospitalization rates for hospitalizations with a related major drug diagnosis or with a major or secondary drug-related diagnosis. Standardized rates for 100,000 residents. By sex (Male, Female, Total) and Age-specific (15-24, 25-34, 35-44, 45-54, 55-64). Years 2011-2015. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.92, p. 94} ~ Drug related hospitalizations. Year 2015. By age (<15, 15-24, 25-34, 35-44, 45-54, 55-64, >64), by sex (Male, Female), and by substance (% mixed or unspecified substances, % known substances), (Opioids, Cocaine, Cannabinoids, Stimulants, Hallucinogens), (% main drug related diagnosis, % Primary or secondary drug correlates) {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.93} ~ Percentage distribution of hospitalizations with main drug-related diagnosis and type of substance (excluding admissions with mixed or unspecified substances) by gender (Fig.2.1.3a: males, Fig.2.1.3b: females). Year 2015. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.93} ~ Regional distribution of hospitalization rates for hospitalizations with a related major drug diagnosis or with a major or secondary drug-related diagnosis. Standardized rates for 100,000 residents. Year 2015. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.95} ~ Regional distribution (%) of female hospitalization rates for drug-related hospitalizations. Year 2015. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.126} ~ number of therapeutic communities (inpatient) {Italy Country Drug Report, 2017, p.12} ~ Patients hospitalised in wards - Pediatric Wards or Psychiatric Wards: Prevalence of positive results {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.93} ~ No. of minors included in therapeutic and specialist communities. {National Action Plan on Drugs, 2010-2013, p.103} ~",13
Y,Italy,ITA,Demand Reduction,Proportion of people who use drugs enrolled in voluntary treatment,Yes,"No. of Regions and Autonomous Provinces which have guidelines explicitly containing the possibility of free choice. {National Action Plan on Drugs, 2010-2013, p.76} ~",1
Y,Italy,ITA,Demand Reduction,Proportion of people who use drugs enrolled in coerced treatment,Yes,"No. operating units which have adopted, and operate according to, the guidelines. {National Action Plan on Drugs, 2010-2013, p.104} ~ Percentage of acts, additions and changes realised on the basis of those proposals. {National Action Plan on Drugs, 2010-2013, p.91} ~ total number of alternative measures taken instead of prison {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.vii} ~ prevalence of alternative measures taken instead of prison by gender {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.vii} ~ number of detained drug users who have taken advantage of alternative measures {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.58} ~  Distribution of alternative measures by sex and age (18-24, 25-34, 35-44, 45-54, 54 and older) {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.75} ~ Regional distribution of convicted drug addicts who have taken advantage of an alternative measure. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.75} ~ Distribution of women who accepted alternative measures by age groups. Year 2016 {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.130} ~ Prevalence of drug addicts in alternative measure are female. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.130} ~ Trends in the number of drug users in prison that have decided to accept alternative measures. Year 2007-2016 {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.74} ~",10
Y,Italy,ITA,Demand Reduction,Proportion of people who use drugs enrolled in compulsory treatment,Yes,"Trial assignments in special cases and public service work for drug addicts. Punctual surveys at December 31st. Years 2007-2016. (Trial assignment in special cases (Drug addicts), Work of Public Utility (Drug addicts)) {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.74} ~ ",1
Y,Italy,ITA,Demand Reduction,Presence of prevention programming in law enforcement,Yes,"number of projects admitted by the DPA concerning the area of intervention on the prevention of alcohol-drug road accidents correlated (addressed to the population aged 14-35) {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.102} ~ Projects eligible for funding scope: II-Prevention of the incidental alcohol-related drug street. Number of projects eligible for financing {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.110} ~ Organisation of annual technical-scientific updated courses on the topic of NPS and their detection - No. courses organised/year and n. participant {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.94} ~ No. reference poison control centres {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.95} ~ courses and/or information events for operators of Departments for Addictions in order to update their knowledge relative to the NPS - No. courses organised/year and No. participants {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.96} ~ Better direct prevention programs towards the problem of early use of alcohol (first drug), tobacco and medical drugs - No. checks undertaken at places of entertainment and meeting points for young people and No. checks on the ban of the sale and supply of alcoholic drinks to minors aged under 16{National Action Plan on Drugs, 2010-2013, p.67} ~",6
Y,Italy,ITA,Demand Reduction,Presence of prevention programming in the media,Yes,"No. of items in the press and on TV and radio nationally and in each Region and Autonomous Province, in keeping with these guidelines. {National Action Plan on Drugs, 2010-2013, p.65} ~ No. of anti-drug initiatives on social networks {National Action Plan on Drugs, 2010-2013, p.65} ~ No. agreements/MoUs with communication agencies. {National Action Plan on Drugs, 2010-2013, p.66} ~ No. of TV and radio programs which deal with drugs per annum, and per network {National Action Plan on Drugs, 2010-2013, p.66} ~ No. of accesses to websites and No. updates per annum {National Action Plan on Drugs, 2010-2013, p.72} ~ No. of projects that have received funding and No. of projects eligible for funding concerning the intervention area III on Prevention of unmonitored use of the Internet by minors (addressed to young people aged 11-18). {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.102, p.110} ~ No. posts added and No. followers/friends on social network {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.99} ~ No. Apps developed and No. downloads of each App {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.98, p.99} ~ No. materials created {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.99} ~ ",9
Y,Italy,ITA,Demand Reduction,Presence of prevention programming in schools,Yes,"No. of specific projects dedicated to the school and to families {National Action Plan on Drugs, 2010-2013, p.66} ~ No. of schools involved {National Action Plan on Drugs, 2010-2013, p.66, p.70} ~ No. educators involved {National Action Plan on Drugs, 2010-2013, p.68} ~ No. of school training plans containing drug prevention programs. {National Action Plan on Drugs, 2010-2013, p.70} ~ No. students involved {National Action Plan on Drugs, 2010-2013, p.70} ~ No. teachers involved. {National Action Plan on Drugs, 2010-2013, p.70} ~ No. prevention products realised. {National Action Plan on Drugs, 2010-2013, p.70} ~ No. of ICC active in relation to the no. of schools. {National Action Plan on Drugs, 2010-2013, p.70} ~ Trends in the number of higher education institutions have planned to carry out days / activities specifically dedicated to the prevention of the consumption of psychoactive substances {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.102} ~ Estimated percentages of frequent consumers of AT LEAST ONE ILLEGAL SUBSTANCE among students and percentage of schools that have organized / programmed activities of prevention of psychoactive consumption. ESPAD®Italia 2009-2016 {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.115} ~ Provision of interventions in schools in Italy (No Provision, Rare Provision, Limited Provision, Extensive Provision, Full Provision) {Italy Country Drug Report, 2017, p.10} ~  Organisation of information events for parents - No. school institutions involved, No. events organised/year, No. teachers involved, No. participating parents, No. materials supplied {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.98} ~",12
Y,Italy,ITA,Demand Reduction,Presence of prevention programming in the workplace,Yes,"Reduce the number of alcohol or drug related workplace accidents (No. of Regions which have activated control procedures and effective cover, No. training courses activated, No. people checked, No. positives/negatives to tests, No. of circulars and guidelines produced and disseminated) {National Action Plan on Drugs, 2010-2013, p.69} ~  Special populations already subjected to mandatory screening for traditional drugs (Workers with at risks tasks, drivers of vehicles): Prevalence of positive results {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.93} ~ No. NPS added to the regulations on health testing to detect the use of drugs or psychotropic substances for workers with at risk tasks {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.103} ~ Subjects tested and percentage of positive tests among the military of the Armed Forces and the Carabinieri. Year 2016. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.48} ~  ",4
Y,Italy,ITA,Demand Reduction,Presence of prevention programming for youth and the community,Yes,"Guarantee organisational conditions and availability of human, technological, logistical and financial resources adequate for prevention work (Level of funds set aside by each Region for drug and alcohol addiction, No. Regions which have specific plans for prevention, No. of dedicated human resources, Level of finance for the new fund and no. of specific projects activated {National Action Plan on Drugs, 2010-2013, p.65} ~ Activate programs for early detection of “first use” drug use by minors and of drug users who are not yet addicts - No. course participants, No. training courses activated, No. of families involved {National Action Plan on Drugs, 2010-2013, p.66} ~ No. of operators trained regarding the objective of increase contacts with occasional and habitual users who have not yet developed an addiction {National Action Plan on Drugs, 2010-2013, p.75} ~ Promote prevention initiatives against the abuse of dietary supplements, the use of steroids and other performance enhancing drugs above all in gyms - No. agreements signed with gym owners associations {National Action Plan on Drugs, 2010-2013, p.71} ~ Realise permanent communication and information campaign aimed at differentiated targets and coordinated with regional campaigns (No. of events organised, No. people involved and reached {National Action Plan on Drugs, 2010-2013, p.65} ~ No. Regions that adhere to the coordination of information campaigns {National Action Plan on Drugs, 2010-2013, p.65} ~ Level of integration of the drug and alcohol campaigns {National Action Plan on Drugs, 2010-2013, p.65} ~ No. of “early detection” programs activated {National Action Plan on Drugs, 2010-2013, p.66} ~ Better direct prevention programs towards the problem of early use of alcohol (first drug), tobacco and medical drugs - No. agreements signed with associations for pediatricians and family doctors {National Action Plan on Drugs, 2010-2013, p.67} ~ Better direct prevention programs towards the problem of early use of alcohol (first drug), tobacco and medical drugs - No. of specific projects activated in regional areas, types of programs activated {National Action Plan on Drugs, 2010-2013, p.67} ~ Activate and direct prevention programs at parents and educators (No. adults involved, No. educators involved, Types of programs activated, Level of customer satisfaction) {National Action Plan on Drugs, 2010-2013, p.68} ~ Promote initiatives to involve places of entertainment (clubs, pubs, etc.) (No. initiatives realized, No. premises involved, No. people reached) {National Action Plan on Drugs, 2010-2013, p.71} ~  Distribution (%) of students who consider substance use to be VERY risky. Year 2016. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.123} ~ Redirection of prevention strategies of public services in response to new drug takers and development of the phenomenon (No. operating units involved, No. of selective prevention programs activated, No. of national guidelines produced and disseminated) {National Action Plan on Drugs, 2010-2013, p.69} ~ No. of local permanent prevention programs activated. {National Action Plan on Drugs, 2010-2013, p.70} ~ No. human resources trained {National Action Plan on Drugs, 2010-2013, p.70} ~ Guide and use of psychoactive substances among students. ""You think that using drugs can affect motor vehicle accidents?"" Prevalence of minors and adults who do not agree with that statement {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.97} ~ Guide and use of psychoactive substances among students. ""Have you ever driven a vehicle while under the influence of drugs and caused an accident?"" Prevalence of minors and adults, by sex, who answered ""yes"" to that statement. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.97} ~ Guide and use of psychoactive substances among students. ""In the last year, have you ever driven under the influence of drugs?"" Prevalence of minors and adults, by sex, who answered ""yes"" to that statement. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.97} ~ Guide and use of psychoactive substances among students. ""In the last year, have you ever been in a car and / or motorcycle driven by someone who was under the influence of drugs?"". Prevalence of minors and adults, by sex, who answered ""yes"" to that statement. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.97} ~ Regional distribution (%) of institutes that have organized specific activities to prevent the consumption of psychoactive substances. ESPAD®Italia 2016. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.111} ~ Trend of the percentages of the institutes that have organized specific activities to prevent the consumption of substances. Percentage of the institutes that have organized specific activities to prevent substance use 2007-2016 {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.113} ~ Regional distribution (%) of institutes that have carried out at least one prevention project (figure on the left) and percentage of institutes that have dealt with the issues of consumption of psychoactive, legal and illegal substances (right). ESPAD®Italia 2016 {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.114} ~ Percentage distribution of the main Managers for the implementation of the prevention project (teachers, psychologists, peer group, educators, social assists, doctors, FFOO). ESPAD®Italia 2016 {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.114} ~ Promotion of prevention activities through the involvement of civil society organisations - No. participating bodies {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.100} ~ Of the 806 athletes subjected to doping control, % were positive and % of the latter were positive to the so-called ""double list"" substances {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.30} ~ Athletes subjected to doping controls, positive and positive results in double list. Years 2003-2016 {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.46} ~",27
Y,Italy,ITA,Demand Reduction,Presence of other demand reduction metrics,Yes,"Research to reform services in order to bring them more into line with and suitable to the transformation of the phenomenon of drug addiction in Italy - No. of participants in the working group (level of agreement) and Realisation of a joint technical proposal (guidelines) {National Action Plan on Drugs, 2010-2013, p.74} ~ Factors associated positively and negatively with the consumption of substances (""at risk""); (""protective"") {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.112} ~ Degree of agreement on guidelines among the clinical centres belonging to NEWS {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.95} ~ No. coordination meetings/year {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.111} ~ Public expenditure related to illicit drugs in Italy (Demand Reduction and Supply Reduction) {Italy Country Drug Report, 2017, p.3} ~ Percent of drug-related public expenditure that is of Italy’s GDP {Italy Country Drug Report, 2017, p.3} ~",6
Y,Italy,ITA,Supply Reduction,Size and value of the illegal drug market,Yes,"Percentage distribution of final consumption expenditure by type of substance (Cannabis, Cocaine, Heroin, Other Drugs). Year 2014. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.7} ~ No. of notifications to the National Early Warning System divided by Region. {National Action Plan on Drugs, 2010-2013, p.77} ~ No. notifications sent to the System {National Action Plan on Drugs, 2010-2013, p.102} ~ Average time for notification {National Action Plan on Drugs, 2010-2013, p.102} ~ No. of notifications circulated out of total no. of notifications received. {National Action Plan on Drugs, 2010-2013, p.102} ~ number of widespread warnings and the number of new psychoactive substances that have been reported {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.2} ~ Substances reported by type and countries. Year 2016 {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.13} ~ Percentage distribution of the reported substance (Hashish, Marijuana, Cannabis Plant, Cocaine, Heroin, Synthetic Drugs, Other Drugs). Year 2016. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.17} ~ Percentage distribution by reporting substance of the reported subjects: (New reported, Already reported). Year 2016. (Opioids, Cocaine, Stimulants, Other Substances, Cannabinoids) {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.27} ~ Regional distribution of the number of people reported, per reporting place, per 100,000 residents. Update to April 20, 2017. Year 2016. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.27} ~ Prevalence of obtaining substances (Stimulants, Hallucinogens, Cocaine, Cannabis) via the web. Year 2016. (knowledge of places finding the substance, Finding Substance In the Web) {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.43} ~ No. websites detected/year {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.88} ~  No. smart shops detected/year {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.88} ~ No. NPS detected/year {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.88} ~ Types of substances detected {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.89} ~ No. warnings activated for Italian cases {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.90} ~. No. warnings activated {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.90} ~ No. NPS reported {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.90} ~ Internet NPS offer - Specialised Websites: List of published NPS, No. accesses to site, No. orders, Financial flow detected, credit cards monitoring {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.92} ~  Internet NPS offer - Recovery samples of NPS (simulated order): Other NPS output on the market, No. controlled packages, No. positive packages {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.92} ~ the number of reports about new substances appearing for the first time that have been sent to the EMCDDA {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.2} ~",21
Y,Italy,ITA,Supply Reduction,Level of procedures related to crop eradication,No,n/a,0
Y,Italy,ITA,Supply Reduction,"Number of arrests, seizures, and offences",Yes,"No. arrests. {National Action Plan on Drugs, 2010-2013, p.99} ~ No. seizures. {National Action Plan on Drugs, 2010-2013, p.99} ~ Quantity of drugs seized by type. {National Action Plan on Drugs, 2010-2013, p.99} ~ No. seizures of synthetic drugs made. {National Action Plan on Drugs, 2010-2013, p.99} ~ No. of seizures and deliveries intercepted. {National Action Plan on Drugs, 2010-2013, p.100} ~ prevalence of seizures by type of drug (Cannabis, Hashish, NPS, Cocaine, Opioids) {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.vi} ~ total amount of drug seizures in kilograms {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.vi} ~ number of individuals in the state of arrest {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.vii} ~ The quantities of cannabis seized correspond, in fact, more than 90% of the total number of seizures {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.vii} ~ the % of new psychoactive substances (NPS) seized in relation to the total % of drugs seized {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.viii} ~ trends in the quantities of substances seized {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.2, p.5} ~ Distribution of quantities seized by substance. Year 2016. (Cannabis, Hashish, Cocaine, Other Drugs, Heroin, Synthetic Drugs) {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.5} ~ Regional distribution of quantities of seized substances. Year 2016. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.5} ~ The number in doses and the regional distribution of doses (n.) Of seized synthetic substances. Year 2016. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.6} ~ Prevalence of synthetic drugs seized at the border and on national territory {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.6} ~ Prevalence of drug related offences in 2016 that are female {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.128} ~ Top 5 drugs seized ranked according to quantities in kilograms {Italy Country Drug Report, 2017, p.1} ~ Number of seizures and quantities Seized by drug (Methamphetamine, MDMA, Heroin, Herbal Cannabis, Cocaine, Cannabis Resin, Cannabis Plants, Amphetamine) {Italy Country Drug Report, 2017, p.16, p.18} ~ Number of reports of offences {Italy Country Drug Report, 2017, p.19} ~ Offences for use/possession {Italy Country Drug Report, 2017, p.19} ~ 1.2.2. No. of substances/products seized and financial estimate of the traffic blocked {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.88} ~ 1.2.3. No. seizures performed/year {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.88} ~ 1.2.3. Amount of substance seized/year financial estimate for the trafficking blocked {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.88} ~ Seizures by Law Enforcement - Substances Seized: Companies and Georeferencing of the seizure {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.93} ~ No. of vehicles confiscated. {National Action Plan on Drugs, 2010-2013, p.68} ~ ",25
Y,Italy,ITA,Supply Reduction,Level of law enforcement activity and interdiction in the market,Yes,"Monitoring and detection to prevent illegal musical events (illegal rave parties) where there is a high probability of use and trafficking of NPS - No. illegal rave parties identified, No. prevented illegal rave parties, No. illegal rave parties managed, Types of substances identified in subjects participating in raves {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.89} ~ Maintain and increase the ordinary activities to combat drug production, trafficking and dealing - No. operations. {National Action Plan on Drugs, 2010-2013, p.99} ~ Monitor the Internet in order to obtain a constantly updated framework of the drugs phenomenon on the Net - No. of operations carried out on the Internet, No. of valid items of information identified, No. of online pharmacies identified and monitored. {National Action Plan on Drugs, 2010-2013, p.100} ~ Identify an appropriate allocation of resources and encourage the choice of the methods and techniques to combat drug - No. situation points produced and information notes {National Action Plan on Drugs, 2010-2013, p.100} ~ Continue planning and organisation of training courses to improve the operational and analytical skills of police involved in combating drugs - No. of courses started, Monitoring of courses undertaken and number of participants, Assessment of satisfaction of the participants {National Action Plan on Drugs, 2010-2013, p.101} ~ No. of laboratories which collaborate in the System out of total no. of the existing laboratories. {National Action Plan on Drugs, 2010-2013, p.102} ~ number of anti-drug operations {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.vi} ~ prevalence of anti-drug operations that have occured in border areas {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.2} ~ trends of Anti-drug operations. Years 2006-2016. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.4} ~ Regional distribution of anti-drug operations. Year 2016. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.4} ~ Reports sent to and transmitted by the National Early Warning System (INPUT & OUTPUT). EMCDDA Communications, EMCDDA Alerts, Law Enforcement, Collaboration Centers, Alert Updates, 3 Grades Alerts, Information, 2 Grades Alerts, 1 Grades Alerts 1 {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.11} ~ Measures adopted by the Prefectures - UTG following notification by art. 75 of Presidential Decree 309/90 for the type of provision. Year 2016. (Filing of documents, Administrative sanctions, Therapeutic program request, Formal invitation, Art. 121) {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.27} ~ Number of operations, number of reported minors and number of reported minors per 100 operations. Years 2006 - 2016 {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.55} ~ 1.2.1. No. sites shut down/year {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.88} ~ 1.2.2. No. smart shops shut down/year {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.88} ~ 1.2.4. No. intercepted postal packages/year {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.89} ~ 1.2.4. No. postal packages containing NPS/No. intercepted packages {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.89} ~ 1.3.1. No. of NPS purchases intercepted/year {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.89} ~ 1.6.1. No. collaborative centres involved {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.90} ~ 1.6.2. No. consultations/year {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.90} ~ 4.2.1. No. ordinances activated/year {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.101} ~ 4.3.1. No. activations of the Consumer Code activated/year {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.102} ~ 4.4.1. No. activations RAPEX/year {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.102} ~ 4.4.2. No. activations RASFF/year {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.102} ~ 4.5.2. No. Prot. DOS adopted at a national level {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.102} ~ 5.1.1. No. updating events organised /year {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.104} ~ 5.1.2. No. training and updating events organised/year {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.104} ~ 5.2.1. No. commercial businesses shutdown {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.104} ~ 5.2.1. No. commercial businesses controlled {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.104} ~ 5.3.1. No. investigations performed/year {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.105} ~ 5.4.1. No. investigations performed/year {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.105} ~ 5.5.1. No. packages containing NPS/No. intercepted packages {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.105} ~ number of charges {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.vii} ~",33
Y,Italy,ITA,Supply Reduction,"Price, purity and potency of drugs, and related process indicators",Yes,"No. of new drugs identified and sent for listing. {National Action Plan on Drugs, 2010-2013, p.100} ~ Number of samples tested and percentages of active substance detected in the samples of analyzed substances (Cannabis Resin, Cannabis in Leaves, Heroin, Cocaine, Crack, Methamphetamine). Year 2016 {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.8} ~ Time trend of the average percentage of active ingredient detected in the samples of substances analyzed (Cannabis Resin, Cannabis in Leaves, Heroin, Cocaine, Crack, Methamphetamine). Year 2013-2016 {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.8} ~ The Reporting Forms accompanied, where possible, by analytical data (photos of the findings, in cases of intoxication, from the clinical data collected) concerned the identification of the following molecules. (Kratom, 3-MeO-PCP, DOM, 4-EMC, Mesembrina, 25I-NB4Ome, 4F-MPH, 2-MeO-difenidina, Descloroketamina) {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.12} ~ Potency (%) and Price (EUR/g) or (EUR/tablet) of Heroin, Cocaine, MDMA (mg/tablet), Amphetamine, Cannabis Resin  (% of THC) and Herbal Cannabis (% of THC) {Italy Country Drug Report, 2017, p.17} ~ Potency and Price per gram of herbal and resin cannabis (% THC) (minimum and maximum values registered) {Italy Country Drug Report, 2017, p.18} ~ Purity (%) and Price per gram or tablet (EUR) of Cocaine, amphetamine, heroin, and MDMA (minimum and maximum values registered) {Italy Country Drug Report, 2017, p.18} ~ Student Population - SPS Survey (questionnaires, ages: 15-18): Concentration of active ingredients, Concentration of metabolites {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.92} ~  Wastewater - Analysis of wastewater 18 cities: Concentration of active ingredients, Concentration of metabolites {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.92} ~ Persons who died in driving accidents - Investigation by forensic medicine institutes on biological liquids: type of molecule and concentration {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.93} ~ 2.1.1. No. reference standards distributed/year {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.94} ~ 2.1.1. No. of laboratories that have received reference standards/year {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.94} ~ 2.1.2. Degree of consent on guidelines among laboratories belonging to the NEWS analytical network {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.94} ~ 2.1.4. No. new laboratories belonging to NEWS/year {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.95} ~ 5.1.3. No. devices of materials acquired {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.104} ~ 5.1.3. N. substances detected {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.104} ~ 5.6.1. Degree of distribution of the use of devices {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.105} ~ Degree of distribution of the use of new devices available for the onsite detection of NPS in biological samples {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.97} ~",18
Y,Italy,ITA,Supply Reduction,Number of people engaged with the criminal justice system,Yes,"number of convictions for drug related offenses {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.vii} ~ number of detained individuals of the prison population for drug related offenses {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.vii} ~ number of people reported to the Judicial Authority {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.2} ~ ratio of individuals reported to the judicial authority that are male, and their age {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.2} ~ number of individuals convicted of crimes of production, trafficking and possession of drugs and / or conspiracy to drug trafficking of these (artt.73 and / or 74 of Presidential Decree 309/90). {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.2} ~ prevalence of the prison population that is represented by the inmates for drug-related offenses (artt.73 and / or 74 of Presidential Decree 309/90) {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.2} ~ New entries for art.73 of Presidential Decree 309/90, % of which is represented by foreigners; prevalence out of the total number of prisoners for related drug offenses {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.2} ~ The prevalence of minors charged by the Social Services of Juvenile Justice for drug-related offenses out of the total number of subjects charged; the number of minors that took advantage of the alternative measures. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.2} ~ Number of admissions to criminal institutes, the percent for drug-related offenses; the number of children in the community. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.2} ~ The trend in the number of subjects reported to the Prefect for possession for personal use of drugs; the % of the reports that are for the possession of cannabinoids, cocaine, opioids, and other illegal substances. Prevalence of those reported are under 30 years of age. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.2} ~ Number and Regional distribution of reported violations of Presidential Decree 309/90 {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.16} ~  Sentenced with final sentence for the crimes referred to in Articles. 73 and / or 74 of Presidential Decree 309/1990 per year of the committed crime (the same year, 1 year before, 2 years before, 3 years before, 4 years before, 5 or more years before), for the age (less than 18, 18-24, 25-34, 35-54, 55 and above) of the committed crime and nationality (italian, foreigner). Year 2016 {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.18, p.19} ~ Convictions for drug related offenses: summary of data. Year 2016 1) Year of the Crime: % before 2014, Year 2015, Year 2016. 2) prevalence of italians (aged 35-54 years), and prevalence of foreigners (aged 25-34 years). 3) prevalence of condemnation in the degree. 4) prevalence of recidivism {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.18} ~ Regional distribution of convicted persons with final sentence for crimes art. 73 and / or 74 of Presidential Decree 309/90. Year 2016. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.19} ~ Total present inmates and offenses in violation of Presidential Decree 309/90 at the end of the year. Years 2006-2016 (Prisoners present, Article 73 of Presidential Decree 309/90, Articles 73 and 74 of Presidential Decree 309/90, Article 74 of Presidential Decree 309/90, Total Presidential Decree 309/90,% of total attendance) {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.20} ~ Trend of the percentage of prisoners for art. 73 of Presidential Decree 309/90, compared to the total number of prisoners. Years 2006-2016 {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.21} ~ Total admissions and offenses in violation of art. 73 of Presidential Decree 309/90. Years 2006-2016 {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.21} ~ Subjects held for art. 73 of Presidential Decree 309/90 related drugs. Year 2016 1) Prevalence of Prison population 2) prevalence of italians (median age 40-44), and prevalence of foreigners (median age 30-34). {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.21} ~ Regional distribution of the percentage of prisoners for art.73 Presidential Decree 309/90. Year 2016. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.22} ~ Prisoners present at the end of the year and entered by freedom. Totals, foreigners and for crimes in violation of art. 73 of Presidential Decree 309/90. Years 2006-2016. (Prisoners present at the end of the year, Prisoners present at the end of the year for Article 73 of Presidential Decree 309/90, Entry into freedom during the year, Entry into freedom for the year pursuant to Article 73 of Presidential Decree 309/90) {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.22} ~ Percentage of subjects charged by the Social Services Offices Juvenile Justice for crimes in violation of Presidential Decree 309/90 and subsequent amendments with respect to the total amount taken in charge. Years 2012-2016. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.23} ~ Subjects charged by the Offices of Social Service of Juvenile Justice - total and for crimes in violation of Presidential Decree 309/90 and s.m.i. Years 2012-2016 (Number, Total, For offenses in violation of Presidential Decree 309/90 Total Assigned for the first time, Already charged from previous periods) {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.23} ~ Percentage distribution by age groups of the subjects who have used the provision for suspension of the trial and put to the test for crimes in violation of Presidential Decree 309/90 and s.m.i. Year 2016. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.24} ~ Percentage of entry into penal institutions and therapeutic communities for crimes in violation of Presidential Decree 309/90 and s.m.i. compared to total admissions. Years 2012-2016. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.24} ~ Percentage of entry into the penal institution of foreign subjects compared to total admissions in violation of Presidential Decree 309/90 and s.m.i. Years 2012-2016. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.24} ~ Minors in the penal circuit. 1) Crimes 309/90, Entries in the Criminal Institutes, Placements in Community. 2)% offenses 309/90. 3) prevalence of italians, prevalence of foreigners. 4) prevalence of males and females {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.25} ~ Percentage of entry into the Community of foreign subjects compared to the total number of entries in violation of Presidential Decree 309/90 and s.m.i. Years 2012-2016. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.25} ~ Time trend of the number of people reported pursuant to art. 75 of Presidential Decree 309/90. Years 2007-2016. (Total reported, minors) {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.26} ~ Percentage distribution by age groups of the reported subjects: new reported in the year and already reported in previous years. Year 2016. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.26} ~ Number of operations, number of reported minors and number of reported minors per 100 operations. Years 2006 - 2016 {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.55} ~ Number of open proceedings against minors for art. 73 of DPR 309/90, number of accused minors and number of charged for minor procedure (secondary axis on the right) {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.55} ~ number of subjects in custody {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.58} ~ Prevalence of revocations (negative trends, new legal position / absence of legal and criminal requirements, commission of crimes, unavailability, other reasons) {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.75} ~ Distribution of women reported for age groups and by region. Year 2016. {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.129, p.130} ~ Prevalence of females convicted for drug related offenses and by age groups {Relazione Annuale Al Parlamento Sullo Stato Delle Tossicodipendenze In Italia, 2017, p.129, p.130} ~ number of drug law offenders (use/possession, supply) {Italy Country Drug Report, 2017, p.1& p.4} ~",36
Y,Italy,ITA,Supply Reduction,Presence of other supply reduction metrics,Yes,"No. decrees for the addition of NPS in Tables of Presidential Decree 309/90 {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.101} ~. Existence of a risk assessment procedure {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.101} ~ No. amendments of implemented laws {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.102} ~ No. notices sent/No. updates made to the regulations {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.106} ~ Organise technical-scientific training and updating to support Magistrates in managing the phenomenon of NPS - No. events organised {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.106} ~ Development of rapid screening tests for detection of NPS - No. projects activated and No. publications created {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.107} ~ Activation of research projects on new modalities of online marketing of NPS (illegal market) and on its prevention - No. projects activated {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.108} ~ Public expenditure related to illicit drugs in Italy (Demand Reduction and Supply Reduction) {Italy Country Drug Report, 2017, p.3} ~ Percentage of acts, additions and changes realized on legislation, combating drugs and youth justice {National Action Plan on Drugs, 2010-2013, p.91, p.92, p. 93, p. 94, p. 95, p. 96, p. 97, p. 98} ~",9
Y,Italy,ITA,International Cooperation,Level of engagement in international cooperation,Yes,"Establish/intensify cooperative links with countries where drugs are produced or which are located on drug-trafficking routes - No. of the negotiations started/agreements concluded, Check on the state of implementation of the agreements concluded, No. of courses started, Monitoring of courses undertaken, Assessment of satisfaction of participants {National Action Plan on Drugs, 2010-2013, p.101} ~ Intensify and develop the internal and international operational coordination among the organisations responsible for combating drugs - No. convergences in coordination and No. operational activations. {National Action Plan on Drugs, 2010-2013, p.99} ~ No. international collaborations activated {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.109} ~ No. reports transmitted {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.109} ~ No. projects activated {National action plan for the prevention of distribution of New Psychoactive Substances and demand on the internet, 2013, p.110} ~",5
Y,United Kingdom,GBR,Health,Level of availability of harm reduction services and harm reduction scale up,Yes,"Availability of take-home naloxone programs {United Kingdom Country Drug Report, 2017, p.11} ~ ",1
Y,United Kingdom,GBR,Health,Presence of needle and syringe programs,Yes,"Availability of needle and syringe programs {United Kingdom Country Drug Report, 2017, p.11} ~ ",1
Y,United Kingdom,GBR,Health,Prevalence of substance use disorders,Yes,"estimates of the number of benefit claimants that are dependent on drugs or alcohol {Drug Strategy Reducing Demand, Restricting Supply, Building Recovery: Supporting People to Live a Drug Free Life, 2010, p.4} ~",1
Y,United Kingdom,GBR,Health,Prevalence of psychiatric comorbidities,Yes,"prevalence of people in community substance misuse treatment who also experience mental illness {Drug Strategy, 2017, p.5} ~ mental health – a joint outcome measure for individuals who have cooccurring mental health conditions {Drug Strategy, 2017, p.37} ~ ",2
Y,United Kingdom,GBR,Health,Drug-related mortality,Yes,"number of deaths from drug misuse registered in England and Wales {Drug Strategy, 2017, p.5; An evaluation of the Government's Drug Strategy 2010, 2017, p.26; Drug Strategy 2010 Evaluation Framework – evaluating costs and benefits, 2013, p.19; Deaths related to drug poisoning in England and Wales: 2016 registrations, 2016, p.22, p.23} ~ Percentage of drug misuse deaths, by underlying cause and sex, deaths registered in 2016 {Deaths related to drug poisoning in England and Wales: 2016 registrations, 2016, p.8} ~ number of drug-related deaths {Drug Strategy, 2017, p.32; United Kingdom Country Drug Report, 2017, p.9} ~ numbers of drug-related deaths, including on release from prison. {Drug Strategy, 2017, p.37} ~ prevalence of patients in mental health treatment who died by suicide and had a history of drug misuse between 2004-2014, and prevalence of those who were in contact with treatment services {Drug Strategy, 2017, p.33} ~ Age-standardised mortality rates for deaths related to drug misuse, by type of substance and by sex, deaths registered in 1993 to 2016 (rate per million) {Deaths related to drug poisoning in England and Wales: 2016 registrations, 2016, p.5, p.10, p.13; United Kingdom Country Drug Report, 2017, p.9 & p.19} ~ Age-standardised mortality rate for deaths related to drug misuse, by country and region, registered in 2016 {Deaths related to drug poisoning in England and Wales: 2016 registrations, 2016, p.19} ~ Number of deaths from drug poisoning and drug misuse, by sex, deaths registered in 2016 {Deaths related to drug poisoning in England and Wales: 2016 registrations, 2016, p.6} ~ Number of drug-related deaths where selected substances (heroin, morphine, tramadol, cocaine, fentanyl, oxycodone, paracetamol, propranolol, new psychoactive substances, mephedrone) were mentioned on the death certificate, deaths registered in England and Wales, 2012 to 2016 {Deaths related to drug poisoning in England and Wales: 2016 registrations, 2016, p.12, p.15, p.16, p.17, p.18; United Kingdom Country Drug Report, 2017, p.9} ~ Number of overdose deaths {United Kingdom Country Drug Report, 2017, p.1} ~ Gender distribution of drug induced deaths in the United Kingdom {United Kingdom Country Drug Report, 2017, p.9} ~ Average registration delay for deaths relating to drug misuse, by country, deaths registered 1993 to 2016 {Deaths related to drug poisoning in England and Wales: 2016 registrations, 2016, p.20} ~",12
Y,United Kingdom,GBR,Health,Prevalence of drug-related infectious disease,Yes,"rates of blood borne viruses {Drug Strategy, 2017, p.37} ~ Newly diagnosed HIV cases attributed to injecting drug use (cases per million population) {United Kingdom Country Drug Report, 2017, p.8 & p.19} ~ HIV antibody prevalence among people who inject drugs (sub-national estimates) {United Kingdom Country Drug Report, 2017, p.8} ~  HCV antibody prevalence among people who inject drugs (Sub-national estimates) {United Kingdom Country Drug Report, 2017, p.8} ~ HIV prevalence among PWID* (%) {United Kingdom Country Drug Report, 2017, p.1, p.19} ~ HCV prevalence among PWID* (%) {United Kingdom Country Drug Report, 2017, p.19} ~",6
Y,United Kingdom,GBR,Health,Proportion of people who use drugs who engage in risky consumption,No,n/a,0
Y,United Kingdom,GBR,Health,Proportion of people who use drugs who engage in safe consumption practices,No,n/a,0
Y,United Kingdom,GBR,Health,"Coverage of services for the prevention, testing, and treatment of bloodborne diseases",No,n/a,0
Y,United Kingdom,GBR,Health,Presence of specialised training for addiction care,No,n/a,0
Y,United Kingdom,GBR,Health,Presence of health harms related to drug use,No,n/a,0
Y,United Kingdom,GBR,Health,Presence of other health metrics,No,n/a,0
Y,United Kingdom,GBR,Peace and Security,"Prevalence of alcohol and drugs in accidents, and interventions to increase road safety",No,n/a,0
Y,United Kingdom,GBR,Peace and Security,Annual number of public disorder and violent crime reports,Yes,"estimates/prevalence of all acquisitive crime that are committed by heroin, cocaine, or crack cocaine users {Drug Strategy Reducing Demand, Restricting Supply, Building Recovery: Supporting People to Live a Drug Free Life, 2010, p.6; Drug Strategy, 2017, p.12} ~ prevalence of acquisitive crime {Drug Strategy, 2017, p.27} ~",2
Y,United Kingdom,GBR,Peace and Security,Number of non-lethal drug market violent events reported,No,n/a,0
Y,United Kingdom,GBR,Peace and Security,Number of drug market related homicides and disappearances,No,n/a,0
Y,United Kingdom,GBR,Peace and Security,Presence of other peace and security metrics,No,n/a,0
Y,United Kingdom,GBR,Development,Coverage of housing assistance for people who use drugs,Yes,"estimates of the number of people a year who have contact with homelessness services, substance misuse services and the criminal justice system {Drug Strategy, 2017, p.35} ~ homelessness and housing – a joint outcome measure between homelessness/housing support services and drug and alcohol treatment providers to ensure that appropriate housing and housing-related support is given to those who need it {Drug Strategy, 2017, p.37} ~ Housing situation of new presentations to treatment, England {An evaluation of the Government's Drug Strategy 2010, 2017, p.184; Adult substance misuse statistics from the National Drug Treatment Monitoring System (NDTMS), 2016/17, p.31} ~ Change in housing status between start of treatment and review, 2010/11 to 2014/15, England {An evaluation of the Government's Drug Strategy 2010, 2017, p.185} ~ ",4
Y,United Kingdom,GBR,Development,Coverage of social assistance for people who use drugs (not including housing),Yes,"employment – a joint outcome measure between public employment services and drug and alcohol treatment providers, and other associated measures which give more consideration to distance travelled towards the labour market e.g. volunteering, training and meaningful activity {Drug Strategy, 2017,p.37} ~ Change in employment status between start of treatment and review, England {An evaluation of the Government's Drug Strategy 2010, 2017, p.185; Adult substance misuse statistics from the National Drug Treatment Monitoring System (NDTMS), 2016/17, p.43; Drug Strategy, 2017, p.37} ~ estimated prevalence of heroin or crack cocaine users that are on benefits {Drug Strategy Reducing Demand, Restricting Supply, Building Recovery: Supporting People to Live a Drug Free Life, 2010, p.23} ~ ",3
Y,United Kingdom,GBR,Development,Number of households enrolled in alternative development,No,n/a,0
Y,United Kingdom,GBR,Development,Presence of other development metrics,Yes,"Education and employment status of all young people starting treatment in 2016-17 {Young People’s Statistics from the National Drug Treatment Monitoring System (NDTMS), 2016/17, p.22} ~",1
Y,United Kingdom,GBR,Human Rights,"Prevalence and incidence of infectious diseases in vulnerable populations (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,United Kingdom,GBR,Human Rights,"Prevalence of vulnerable people who use drugs (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,United Kingdom,GBR,Human Rights,Proportion of people who use drugs in prison that are receiving medication assisted treatment (MAT),No,n/a,0
Y,United Kingdom,GBR,Human Rights,Distribution of sterile injecting equipment in prisons,No,n/a,0
Y,United Kingdom,GBR,Human Rights,Presence of programs and services targeted towards women ,No,n/a,0
Y,United Kingdom,GBR,Human Rights,Presence of programs and services targeted towards people of color,No,n/a,0
Y,United Kingdom,GBR,Human Rights,Presence of challenges and/or harms experienced by people of color,No,n/a,0
Y,United Kingdom,GBR,Human Rights,"Presence of programs and services targeted towards vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,United Kingdom,GBR,Human Rights,"Presence of challenges and/or harms experienced by vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,United Kingdom,GBR,Human Rights,Presence of other human rights metrics,No,n/a,0
Y,United Kingdom,GBR,Demand Reduction,Prevalence of drug use by age,Yes,"Presenting substance of under 25s for opiate and/or crack, and for other substances {Adult substance misuse statistics from the National Drug Treatment Monitoring System (NDTMS), 2016/17, p.48} ~ prevalence of people in England and Wales reported using a drug in the last year by age group (11-15, 16-24, 16-59) {Drug Strategy, 2017, p.4; Drug Strategy 2010 Evaluation Framework – evaluating costs and benefits, 2013, p.19; Drug Misuse: Findings from the 2016/17 Crime Survey for England and Wales, 2016/17, p.2, p.9, p.15} ~ Prevalence of people reported having used drugs (any drug, cannabis, ecstasy, powder cocaine, NPS, amphetamines, heroin, crack) in the past year by age group (11-15, 16-24, 16-59) {Drug Strategy, 2017, p.4, p.6, p.27; An evaluation of the Government's Drug Strategy 2010, 2017, p.24; Drug Misuse: Findings from the 2016/17 Crime Survey for England and Wales, 2016/17, p.4, p.5, p.18, p.25; United Kingdom Country Drug Report, 2017, p.1, p.5, p.18, p.19; Drug Strategy 2010 Evaluation Framework – evaluating costs and benefits, 2013, p.19} ~ Proportion of 16 to 59 year olds reporting use of any drug in the last year by wellbeing measures, 2016/17 CSEW {Drug Misuse: Findings from the 2016/17 Crime Survey for England and Wales, 2016/17, p.20} ~ NPS use in the last year, by frequency of visits to events in the last month (a pub or bar, nightclub or disco) 16 to 59 and 16 to 24 year olds, 2016/17 CSEW {Drug Misuse: Findings from the 2016/17 Crime Survey for England and Wales, 2016/17, p.25, p.26} ~ Types of NPS used on the last occasion, by adults aged 16 to 59, 2016/17 CSEW {Drug Misuse: Findings from the 2016/17 Crime Survey for England and Wales, 2016/17, p.27} ~ NPS use in the last year, by frequency of alcohol consumption in the last month, 16 to 59 and 16 to 24 year olds, 2016/17 CSEW {Drug Misuse: Findings from the 2016/17 Crime Survey for England and Wales, 2016/17, p.26} ~ Proportion of people reporting use of selected drugs (NPS, cannabis, amphetamines) in the last year by sex and age (16-24, 25-29, 16-59) {Drug Misuse: Findings from the 2016/17 Crime Survey for England and Wales, 2016/17, p.16, p.24; United Kingdom Country Drug Report, 2017, p.1, p.5} ~ Trends in drug use in the last month by age group (16-24, 16-59) {Drug Misuse: Findings from the 2016/17 Crime Survey for England and Wales, 2016/17, p.7} ~ Mean age of first drug use by type of drug (cannabis, cocaine, heroin, amphetamine) {United Kingdom Country Drug Report, 2017, p.7} ~ Frequency of drug use by type (cannabis, ecstasy, cocaine powder), and by age (16-24, 16-59) { Drug Strategy, 2017, p.6; Drug Misuse: Findings from the 2016/17 Crime Survey for England and Wales, 2016/17, p.11, p.12, p.13} ~ ",11
Y,United Kingdom,GBR,Demand Reduction,Prevalence of drug use by sex,Yes,"Proportion of people reporting use of selected drugs (NPS, cannabis, amphetamines) in the last year by sex and age (16-24, 25-29, 16-59) {Drug Misuse: Findings from the 2016/17 Crime Survey for England and Wales, 2016/17, p.16, p.24; United Kingdom Country Drug Report, 2017, p.1, p.5} ~ ",1
Y,United Kingdom,GBR,Demand Reduction,Prevalence of drug use by type,Yes,"Presenting substance of under 25s for opiate and/or crack, and for other substances {Adult substance misuse statistics from the National Drug Treatment Monitoring System (NDTMS), 2016/17, p.48} ~ Estimates of number of illicit drug users (Ever taken; Last year; Past month),16-59 year olds, by  class of drugs (Class A type drugs; Class A/B type drugs; Class B type drugs; Class B/C type drugs; Class C type drugs; Class not classified type drugs){Drug Strategy Reducing Demand, Restricting Supply, Building Recovery: Supporting People to Live a Drug Free Life, 2010, p.5} ~ Prevalence of people reported having used drugs (any drug, cannabis, ecstasy, powder cocaine, NPS, amphetamines, heroin, crack) in the past year by age group (11-15, 16-24, 16-59) {Drug Strategy, 2017, p.4, p.6, p.27; An evaluation of the Government's Drug Strategy 2010, 2017, p.24; Drug Misuse: Findings from the 2016/17 Crime Survey for England and Wales, 2016/17, p.4, p.5, p.18, p.25; United Kingdom Country Drug Report, 2017, p.1, p.5, p.18, p.19; Drug Strategy 2010 Evaluation Framework – evaluating costs and benefits, 2013, p.19} ~ NPS use in the last year, by frequency of visits to events in the last month (a pub or bar, nightclub or disco) 16 to 59 and 16 to 24 year olds, 2016/17 CSEW {Drug Misuse: Findings from the 2016/17 Crime Survey for England and Wales, 2016/17, p.25, p.26} ~ Types of NPS used on the last occasion, by adults aged 16 to 59, 2016/17 CSEW {Drug Misuse: Findings from the 2016/17 Crime Survey for England and Wales, 2016/17, p.27} ~ NPS use in the last year, by frequency of alcohol consumption in the last month, 16 to 59 and 16 to 24 year olds, 2016/17 CSEW {Drug Misuse: Findings from the 2016/17 Crime Survey for England and Wales, 2016/17, p.26} ~ Proportion of people reporting use of selected drugs (NPS, cannabis, amphetamines) in the last year by sex and age (16-24, 25-29, 16-59) {Drug Misuse: Findings from the 2016/17 Crime Survey for England and Wales, 2016/17, p.16, p.24; United Kingdom Country Drug Report, 2017, p.1, p.5} ~ National estimates of last year prevalence of high-risk opioid use (rate per 1000 population) {United Kingdom Country Drug Report, 2017, p.1, p.7, p.19} ~ Mean age of first drug use by type of drug (cannabis, cocaine, heroin, amphetamine) {United Kingdom Country Drug Report, 2017, p.7} ~ Frequency of drug use by type (cannabis, ecstasy, cocaine powder), and by age (16-24, 16-59) { Drug Strategy, 2017, p.6; Drug Misuse: Findings from the 2016/17 Crime Survey for England and Wales, 2016/17, p.11, p.12, p.13} ~ ",10
Y,United Kingdom,GBR,Demand Reduction,Number of people who use drugs,Yes,"Overall prevalence of illicit and other harmful drug use {Drug Strategy, 2017, p.6} ~",1
Y,United Kingdom,GBR,Demand Reduction,"Prevalence of drug use by mode of administration (oral, mucosa, inhalation, and injection)",Yes,"Injecting status of new presentations to treatment 2016-17 {Adult substance misuse statistics from the National Drug Treatment Monitoring System (NDTMS), 2016/17, p.30} ~ Injecting drug use (cases rate/1 000 population) {United Kingdom Country Drug Report, 2017, p.19} ~",2
Y,United Kingdom,GBR,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT)",Yes,"number of people who received treatment for drug misuse in 2015-2016 {Drug Strategy, 2017, p.4; Adult substance misuse statistics from the National Drug Treatment Monitoring System (NDTMS), 2016/17, p.44} ~ Treatment demand: % of all treatment entrants & of first time treatment entrants {United Kingdom Country Drug Report, 2017, p.19} ~ Change in use of cited substance for clients with a review TOP/AOR in the year who reported using at the start of treatment {Adult substance misuse statistics from the National Drug Treatment Monitoring System (NDTMS), 2016/17, p.41} ~ the proportion of clients facilitated to access mutual aid or peer support {Drug Strategy, 2017,p.37} ~ proportion of clients leaving treatment free from dependence and not returning for six months and for twelve months. {Drug Strategy, 2017, p.6; Adult substance misuse statistics from the National Drug Treatment Monitoring System (NDTMS), 2016/17, p.54} ~ treatment following release from prison or picked up in the community within three weeks of release. {Drug Strategy the rate of individuals either discharged successfully from, 2017, p.37} ~ Proportion of opiate and non opiate clients in treatment leaving treatment successfully, England, 2009/10 to 2014/15 {An evaluation of the Government's Drug Strategy 2010, 2017, p.25} ~ Clients retained to treatment for more than 12 weeks or successfully completing treatment in 2016-17 {Adult substance misuse statistics from the National Drug Treatment Monitoring System (NDTMS), 2016/17, p.36} ~ Last status of all clients in treatment since 2005-06 (Retained at March 31st 2017, Subtotal exited, Subtotal treatment complete) {Adult substance misuse statistics from the National Drug Treatment Monitoring System (NDTMS), 2016/17, p.55} ~ Of those presenting for drug treatment for the first time over a three- year period, the proportion who had successfully completed treatment and not returned by the end of that period {Drug Strategy 2010 Evaluation Framework – evaluating costs and benefits, 2013, p.19} ~ Number of previous treatment journeys for those retained in treatment 31 March 2017 (Continuous journey, Second journey, Third journey, More than three journeys) {Adult substance misuse statistics from the National Drug Treatment Monitoring System (NDTMS), 2016/17, p.56} ~ % increase of referrals to treatment services in the first month {Drug Strategy, 2017, p.27} ~ Length of time in prescribing for clients in continuous prescribing treatment 2016-17 {Adult substance misuse statistics from the National Drug Treatment Monitoring System (NDTMS), 2016/17, p.35} ~ ",13
Y,United Kingdom,GBR,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT) by age",Yes,"number of people (adults, young people) who use drugs that are in treatment by main type of drug (heroin, crack cocaine, cannabis, amphetamine, MDMA, opioids) {Drug Strategy Reducing Demand, Restricting Supply, Building Recovery: Supporting People to Live a Drug Free Life, 2010, p.6; Adult substance misuse statistics from the National Drug Treatment Monitoring System (NDTMS), 2016/17, p.16, p.17, p.19, p.60; Young People’s Statistics from the National Drug Treatment Monitoring System (NDTMS), 2016/17, p.17, p.18, p.19, p.36, p.37, p.39; An evaluation of the Government's Drug Strategy 2010, 2017, p.144; Drug Strategy 2010 Evaluation Framework – evaluating costs and benefits, 2013, p.19; United Kingdom Country Drug Report, 2017, p.1, p.7, p.13, p.18, p.19} ~ number of people who access treatment for substance misuse by age (young people, adults) and type of treatment {Drug Strategy Reducing Demand, Restricting Supply, Building Recovery: Supporting People to Live a Drug Free Life, 2010, p.8; Adult substance misuse statistics from the National Drug Treatment Monitoring System (NDTMS), 2016/17, p.33, p.34; United Kingdom Country Drug Report, 2017, p.12} ~ Age and gender of all people (young people, adults) in treatment (number) {Young People’s Statistics from the National Drug Treatment Monitoring System (NDTMS), 2016/17, p.13, p.14, p.27, p.33; Adult substance misuse statistics from the National Drug Treatment Monitoring System (NDTMS), 2016/17, p.20, p.22; Drug Strategy 2010 Evaluation Framework – evaluating costs and benefits, 2013, p.19; Young People’s Statistics from the National Drug Treatment Monitoring System (NDTMS), 2016/17, p.29, p.30} ~ Number of people in treatment by age group, sex and type of drug (cannabis, cocaine, heroin, amphetamine) and sex {United Kingdom Country Drug Report, 2017, p.7} ~ proportion of the most problematic drug users who are accessing treatment and how long they have to wait in doing so {Drug Strategy, 2017, p.6, p.32, p.36; Adult substance misuse statistics from the National Drug Treatment Monitoring System (NDTMS), 2016/17, p.54; Young People’s Statistics from the National Drug Treatment Monitoring System (NDTMS), 2016/17, p.28} ~ Prevalence of young people accessing specialist substance misuse services were not in education, training or employment, and the proportion of which were ""looked after children"" {Drug Strategy, 2017, p.10} ~ The average age of people in treatment {Drug Strategy, 2017, p.14; Adult substance misuse statistics from the National Drug Treatment Monitoring System (NDTMS), 2016/17, p.20} ~ Age of all clients in treatment 2016-17 {Adult substance misuse statistics from the National Drug Treatment Monitoring System (NDTMS), 2016/17, p.20} ~ Age and presenting substance of new presentations to treatment (opiates, crack cocaine, NPS, mephedrone, club drugs) {Adult substance misuse statistics from the National Drug Treatment Monitoring System (NDTMS), 2016/17, p.28, p.29, p.47, p.49, p.50, p.51, p.52, p.53, p.57, p.58; An evaluation of the Government's Drug Strategy 2010, 2017, p.27; Drug Strategy 2010 Evaluation Framework – evaluating costs and benefits, 2013, p.19} ~ Drug users mean age at a first treatment entry by type of drug (cannabis, cocaine, heroin, amphetamine) {United Kingdom Country Drug Report, 2017, p.7} ~ Sociodemographic characteristics of new presentations to treatment by age group (young people, adults) (ethnicity, disability, religion, sexual orientation) {Adult substance misuse statistics from the National Drug Treatment Monitoring System (NDTMS), 2016/17, p.23, p.24, p.25, p.26; Young People’s Statistics from the National Drug Treatment Monitoring System (NDTMS), 2016/17, p.15} ~ Source of referral of all treatment episodes 2016-17 {Young People’s Statistics from the National Drug Treatment Monitoring System (NDTMS), 2016/17, p.21} ~ Length of latest treatment episode 2016-17 {Young People’s Statistics from the National Drug Treatment Monitoring System (NDTMS), 2016/17, p.31} ~ Treatment exit reasons for clients not retained in treatment by age (adults, young people) {Adult substance misuse statistics from the National Drug Treatment Monitoring System (NDTMS), 2016/17, p.38; Young People’s Statistics from the National Drug Treatment Monitoring System (NDTMS), 2016/17, p.32, p.41} ~ Individual and multiple vulnerabilities identified among all young people starting treatment in 2016-17 {Young People’s Statistics from the National Drug Treatment Monitoring System (NDTMS), 2016/17, p.25, p.26} ~ ",15
Y,United Kingdom,GBR,Demand Reduction,Level of access to opioid substitution treatment and medication assisted treatment (OST/MAT),Yes,"Availability of heroin-assisted treatment {United Kingdom Country Drug Report, 2017, p.11} ~ Opioid substitution treatment in England and Wales: proportions of clients in OST by medication (methadone, buprenorphine) and trends of the total number of clients (2006-2015) {United Kingdom Country Drug Report, 2017, p.1, p.13, p.19} ~",2
Y,United Kingdom,GBR,Demand Reduction,Level of coverage of inpatient treatment,Yes,"hospital admissions related to drug misuse {Drug Strategy, 2017, p.37} ~  Interventions received by clients in treatment 2016-17 (adult and young people) (inpatient and outpatient) {Adult substance misuse statistics from the National Drug Treatment Monitoring System (NDTMS), 2016/17, p.33, p.34; Young People’s Statistics from the National Drug Treatment Monitoring System (NDTMS), 2016/17, p.30} ~ Total number of individuals in settings (overlap between 5.2.1 and 5.2.2) (Inpatient unit and residential) {Adult substance misuse statistics from the National Drug Treatment Monitoring System (NDTMS), 2016/17, p.35} ~ Drug treatment in England and Wales: settings (inpatient: hospital based residential drug treatment, residential drug treatment) and number treated {United Kingdom Country Drug Report, 2017, p.12} ~",4
Y,United Kingdom,GBR,Demand Reduction,Proportion of people who use drugs enrolled in voluntary treatment,Yes,"Source of referral into treatment, new presentations to treatment 2016-17 (voluntary) {Adult substance misuse statistics from the National Drug Treatment Monitoring System (NDTMS), 2016/17, p.27} ~ ",1
Y,United Kingdom,GBR,Demand Reduction,Proportion of people who use drugs enrolled in coerced treatment,Yes,"Source of referral into treatment, new presentations to treatment 2016-17 (coerced) {Adult substance misuse statistics from the National Drug Treatment Monitoring System (NDTMS), 2016/17, p.27} ~ ",1
Y,United Kingdom,GBR,Demand Reduction,Proportion of people who use drugs enrolled in compulsory treatment,Yes,"Source of referral into treatment, new presentations to treatment 2016-17 (compulsory) {Adult substance misuse statistics from the National Drug Treatment Monitoring System (NDTMS), 2016/17, p.27} ~ ",1
Y,United Kingdom,GBR,Demand Reduction,Presence of prevention programming in law enforcement,Yes,crime and offending – a joint outcome measure with relevant criminal justice partners to understand the support provided to drug-misusing offenders and its impact on reoffending {p.37} ~ ,1
Y,United Kingdom,GBR,Demand Reduction,Presence of prevention programming in the media,Yes,"Number of FRANK website visitors, phone calls and emails, 2003/04 to 2014/15 {An evaluation of the Government's Drug Strategy 2010, 2017, p.67} ~ ",1
Y,United Kingdom,GBR,Demand Reduction,Presence of prevention programming in schools,Yes,"Provision of interventions in schools in the United Kingdom (expert ratings) (0 – No information available, 1 – No provision, 2 – Rare provision, 3 – Limited Provision, 4 – Extensive Provision, 5 – Full provision) {United Kingdom Country Drug Report, 2017, p.10} ~ ",1
Y,United Kingdom,GBR,Demand Reduction,Presence of prevention programming in the workplace,No,n/a,0
Y,United Kingdom,GBR,Demand Reduction,Presence of prevention programming for youth and the community,No,n/a,0
Y,United Kingdom,GBR,Demand Reduction,Presence of other demand reduction metrics,Yes,"Estimated central government spend on the Drug Strategy 2010, early intervention activity group, England, 2010/11 to 2014/15 {An evaluation of the Government's Drug Strategy 2010, 2017, p.45; Drug Strategy 2010 Evaluation Framework – evaluating costs and benefits, 2013, p.21} ~ Central government spend and value for money of media and information activity {An evaluation of the Government's Drug Strategy 2010, 2017, p.71; Drug Strategy 2010 Evaluation Framework – evaluating costs and benefits, 2013, p.21} ~ Estimates of central government spend on non treatment rehabilitation initiatives relating to drug misuse under the Drug Strategy 2010, 2010/11 to 2014/15 {An evaluation of the Government's Drug Strategy 2010, 2017, p.197} ~ Estimates of central government spend on adult drug misuse services (excluding prisons168), England, 2010/11 to 2014/15 {An evaluation of the Government's Drug Strategy 2010, 2017, p.159} ~ Estimated benefits of structured adult drug treatment, England, 2010/11 to 2014/15 {An evaluation of the Government's Drug Strategy 2010, 2017, p.162} ~ Public expenditure related to illicit drugs in the United Kingdom (% demand reduction, % supply reduction) {United Kingdom Country Drug Report, 2017, p.3} ~ ",6
Y,United Kingdom,GBR,Supply Reduction,Size and value of the illegal drug market,Yes,"the estimated value of the illicit drug market in the UK {Drug Strategy Reducing Demand, Restricting Supply, Building Recovery: Supporting People to Live a Drug Free Life, 2010, p.14} ~ The amount of money (in millions of £) that has been recovered from drug traffickers through confiscation orders and cash seized from drug traffickers in the last three years. In the last three years {Drug Strategy Reducing Demand, Restricting Supply, Building Recovery: Supporting People to Live a Drug Free Life, 2010, p.16} ~ Source of drugs (including NPS) when last taken, by proportion of last year users who thought that drugs were easy to obtain, England and Wales, 2011/12 CSEW {An evaluation of the Government's Drug Strategy 2010, 2017, p.95; Drug Misuse: Findings from the 2016/17 Crime Survey for England and Wales, 2016/17, p.28} ~ Ease of obtaining illegal drugs (including NPS) within 24 hours, by age, adults aged 16 to 59, 2016/17 CSEW {Drug Misuse: Findings from the 2016/17 Crime Survey for England and Wales, 2016/17, p.30, p.32} ~ Ease of obtaining illegal drugs within 24 hours, by drug use in last year, adults aged 16 to 59, 2016/17 CSEW {Drug Misuse: Findings from the 2016/17 Crime Survey for England and Wales, 2016/17, p.31} ~ ",5
Y,United Kingdom,GBR,Supply Reduction,Level of procedures related to crop eradication,No,n/a,0
Y,United Kingdom,GBR,Supply Reduction,"Number of arrests, seizures, and offences",Yes,"Number of drug offences, and number of drug seizures, England and Wales, 2005/06 to 2014/15 {An evaluation of the Government's Drug Strategy 2010, 2017, p.29; Drug Strategy 2010 Evaluation Framework – evaluating costs and benefits, 2013, p.19; United Kingdom Country Drug Report, 2017, p.1, p.16, p.19} ~ Number of seizures by police forces and Border Force for all class A and all drug types, England and Wales, 2006/07 to 2014/15 {An evaluation of the Government's Drug Strategy 2010, 2017, p.90} ~ Number of people arrested for drug offences, England and Wales, 2001/02 to 2014/15 {An evaluation of the Government's Drug Strategy 2010, 2017, p.91} ~ Prevalence of drug law offences by type (Use/possession, supply reduction, other) {United Kingdom Country Drug Report, 2017, p.4 & p.19} ~ Drug seizures in the United Kingdom: quantities seized by type of drug (Methamphetamine, MDMA, Heroin, Herbal Cannabis, Cocaine, Cannabis resin, Cannabis plants, Amphetamine) {United Kingdom Country Drug Report, 2017, p.16; Drug Strategy 2010 Evaluation Framework – evaluating costs and benefits, 2013, p.18, p.19} ~ Number of drug seizures by type of drug (Cannabis resin, herbal cannabis, cocaine, amphetamine, MDMA, heroin) {United Kingdom Country Drug Report, 2017, p.18, p.19} ~ Drug assets and seizures – those seized both abroad and within the UK by the National Crime Agency (NCA) {Drug Strategy 2010 Evaluation Framework – evaluating costs and benefits, 2013, p.19} ~ Net confiscation receipts for drug trafficking offences from the Joint Asset Recovery Database, England and Wales, 2005/06 to 2014/15 {An evaluation of the Government's Drug Strategy 2010, 2017, p.94} ~",8
Y,United Kingdom,GBR,Supply Reduction,Level of law enforcement activity and interdiction in the market,Yes,"Proportion of stop and searches that were drug related, England and Wales, 2001/02 to 2014/15 {An evaluation of the Government's Drug Strategy 2010, 2017, p.93} ~ Number of convictions for drug offences in England and Wales {Drug Strategy 2010 Evaluation Framework – evaluating costs and benefits, 2013, p.19} ~",2
Y,United Kingdom,GBR,Supply Reduction,"Price, purity and potency of drugs, and related process indicators",Yes,"wholesale price of cocaine/kilogram {Drug Strategy Reducing Demand, Restricting Supply, Building Recovery: Supporting People to Live a Drug Free Life, 2010, p.6} ~ Historic price for wholesale and street level purchasing of drugs in the UK, 2005 to 2014 {An evaluation of the Government's Drug Strategy 2010, 2017, p.85} ~ Purity adjusted price of cocaine powder per gram and heroin per gram in the UK, 2003 to 2013 (indexed to 2003) {An evaluation of the Government's Drug Strategy 2010, 2017, p.87} ~ Price of drugs by type (cannabis resin, herbal cannabis, heroin, cocaine, crack, amphetamine, MDMA) {Drug Strategy, 2017, p.27; United Kingdom Country Drug Report, 2017, p.17, p.18, p.19; Drug Strategy 2010 Evaluation Framework – evaluating costs and benefits, 2013, p.19} ~ Potency (%) of drugs by type (herbal cannabis, cannabis resin) {United Kingdom Country Drug Report, 2017, p.17 & p.18} ~ Purity of drugs by type (heroin, crack, cocaine, amphetamine, MDMA) {Drug Strategy, 2017, p.27; United Kingdom Country Drug Report, 2017, p.17 & p.19; Drug Strategy 2010 Evaluation Framework – evaluating costs and benefits, 2013, p.19} ~ ",6
Y,United Kingdom,GBR,Supply Reduction,Number of people engaged with the criminal justice system,Yes,"Number of drug law offenders {United Kingdom Country Drug Report, 2017, p.4; Drug Strategy 2010 Evaluation Framework – evaluating costs and benefits, 2013, p.19} ~ ",1
Y,United Kingdom,GBR,Supply Reduction,Presence of other supply reduction metrics,Yes,"The social and economic cost of drug supply in England and Wales {Drug Strategy, 2017, p.4} ~ Public expenditure related to illicit drugs in the United Kingdom (% demand reduction, % supply reduction) {United Kingdom Country Drug Report, 2017, p.3} ~",2
Y,United Kingdom,GBR,International Cooperation,Level of engagement in international cooperation,Yes,"Drug assets and seizures – those seized both abroad and within the UK by the National Crime Agency (NCA) {Drug Strategy 2010 Evaluation Framework – evaluating costs and benefits, 2013, p.19} ~",1
Y,Colombia,COL,Health,Level of availability of harm reduction services and harm reduction scale up,Yes,"Number of condoms distributed in a kit or without a kit {Plan nacional de respuesta al consumo emergente de heroína y otras drogas por vía inyectada, 2013, p.29, p.53} ~ Number of condoms and hygiene kits delivered {Plan nacional de respuesta al consumo emergente de heroína y otras drogas por vía inyectada, 2013, p.47} ~",2
Y,Colombia,COL,Health,Presence of needle and syringe programs,Yes,"Number of kits distributed {Plan nacional de respuesta al consumo emergente de heroína y otras drogas por vía inyectada, 2013, p.29, p.52} ~ Number of syringes returned to program {Plan nacional de respuesta al consumo emergente de heroína y otras drogas por vía inyectada, 2013, p.52} ~",2
Y,Colombia,COL,Health,Prevalence of substance use disorders,Yes,"The ratio of Colombians who abuse alcohol, depend on it, and abuses of other substances (National Mental Health Study 2004). {Política Nacional Para La Reduccíon Del Consumo De Sustancias Psicoactivas Y Su Impacto, 2007, p.13} ~ Number of people who were abusing or dependent on illegal substances {Plan Nacional Para La Promocion de la salud, la prevención, y la atención del consumo de sustancias psicoactivas, 2014-2021, p.14} ~",2
Y,Colombia,COL,Health,Prevalence of psychiatric comorbidities,Yes,"The ratio of Colombians that have experienced some alteration in their mental health recently.  The % of substance use disorders, anxiety disorders and mood disorders. {Política Nacional Para La Reduccíon Del Consumo De Sustancias Psicoactivas Y Su Impacto, 2007, p.13} ~ ",1
Y,Colombia,COL,Health,Drug-related mortality,Yes,"Estimates about overdoses, CES series 2011-2014 / Quintero 2012 (Have you ever had an overdose; Have you ever seen an overdose; Know of someone who has died overdose) {La heroina en Colombia: Produccion, uso e impacto, en la salud publica, 2015, p.81} ~ Estimates around the evolution of overdose, CES series 2011-2014 / Quintero 2012 {La heroina en Colombia: Produccion, uso e impacto, en la salud publica, 2015, p.82} ~",2
Y,Colombia,COL,Health,Prevalence of drug-related infectious disease,Yes,"Frequencies of HIV prevalence among PWID by cities (Bogota; Cucuta; Cali; Pereira; Medellin; Armenia) {Plan nacional de respuesta al consumo emergente de heroína y otras drogas por vía inyectada, 2013, p.10; La heroina en Colombia: Produccion, uso e impacto, en la salud publica, 2015, p.84} ~ Frequencies of HCV prevalence among PWID by cities (Bogota, Cucuta, Pereira, Medellin, Armenia) {La heroina en Colombia: Produccion, uso e impacto, en la salud publica, 2015, p.85} ~ ",2
Y,Colombia,COL,Health,Proportion of people who use drugs who engage in risky consumption,Yes,"Estimates of circumstances and events associated with the injection, CES 2014 series (Have you ever injected with a syringe ""homemade"" or ""spells""? Have you ever been injected by a person who charges to inject? of a mixture of drugs that other people were also sharing? Have you shared cotton, rinse water or spoons with other people when you were injecting? Have you divided the mixture with another person by passing it through a syringe? with syringes that had the drug mixture ready or pre-mixed by someone you know ?; Has someone tried to sell you a syringe with the ready-to-use drug mixture?) {La heroina en Colombia: Produccion, uso e impacto, en la salud publica, 2015, p.76} ~ Frequencies and estimates of use of non-sterile equipment, by cities and studies (Bogotá; Medellín; Pereira; Cali; Cúcuta; Armenia ) {La heroina en Colombia: Produccion, uso e impacto, en la salud publica, 2015, p.78} ~ Estimation of reasons for using non-sterile equipment, CES 2014 series (They are expensive; because I know who I share with; because I cleaned it before; I did not have equipment) {La heroina en Colombia: Produccion, uso e impacto, en la salud publica, 2015, p.79} ~ Estimate to whom you have donated equipment previously used by you, CES 2014 series (A stranger, Close friend, Sex partner or not) {La heroina en Colombia: Produccion, uso e impacto, en la salud publica, 2015, p.80} ~ Estimation of final disposition of used syringes, CES series 2011-2014 / Quintero 2012 (He saved it to use it again; he threw it in a container; he left it on the floor; he threw it into the toilet / spout; he put it in a jar / jar and discarded) {La heroina en Colombia: Produccion, uso e impacto, en la salud publica, 2015, p.80} ~ Estimates of groups with which it has been injected sometime, CES series 2011-2014 (Someone who lived with HIV; Someone who had hepatitis; MSM that was injected) {La heroina en Colombia: Produccion, uso e impacto, en la salud publica, 2015, p.83} ~ ",6
Y,Colombia,COL,Health,Proportion of people who use drugs who engage in safe consumption practices,Yes,"% of consumers enrolled in the program, who used new syringes the last time they injected drugs {Plan nacional de respuesta al consumo emergente de heroína y otras drogas por vía inyectada, 2013, p.52} ~ % Of heroin users and IDUs adopting lower risk practices (i.e., condom use in late RS, use of new syringe in last consumption episode) {Plan nacional de respuesta al consumo emergente de heroína y otras drogas por vía inyectada, 2013, p.45, p.55} ~ % Of consumers transitioning to SPA or less risky modes of use {Plan nacional de respuesta al consumo emergente de heroína y otras drogas por vía inyectada, 2013, p.45, p.56} ~  Elements and injection practices integrated by beneficiaries of the CAMBIE program, Pereira (ATS, 2015) (""Cook"" the substance; Use sterile water; Use the bowl; Use the filter; Filter the substance; Inject in clean / bright places; Alcohol wipe; Cleans any area and hands; Alternate veins) {La heroina en Colombia: Produccion, uso e impacto, en la salud publica, 2015, p.77} ~",4
Y,Colombia,COL,Health,"Coverage of services for the prevention, testing, and treatment of bloodborne diseases",Yes,"% Of consumers that adequately identifies practices to prevent HIV / HCV infection / transmission {Plan nacional de respuesta al consumo emergente de heroína y otras drogas por vía inyectada, 2013, p.45, p.56} ~ Number of people consulted {Plan nacional de respuesta al consumo emergente de heroína y otras drogas por vía inyectada, 2013, p.47} ~ Number and % of people who agreed to get tested for HIV / HCV after counseling {Plan nacional de respuesta al consumo emergente de heroína y otras drogas por vía inyectada, 2013, p.47} ~ Number and % of people tested for HIV / HCV / STI / TB {Plan nacional de respuesta al consumo emergente de heroína y otras drogas por vía inyectada, 2013, p.43, p.54} ~ % Of people with adherence to treatment (according to diagnosis - for HIV / HCV / STI / TB) after 6 months of onset {Plan nacional de respuesta al consumo emergente de heroína y otras drogas por vía inyectada, 2013, p.54} ~ Number and % of services in which the early intervention program is offered including VCT {Plan nacional de respuesta al consumo emergente de heroína y otras drogas por vía inyectada, 2013, p.42} ~ Number of people detected and intervened early (x group) {Plan nacional de respuesta al consumo emergente de heroína y otras drogas por vía inyectada, 2013, p.43} ~ Number of people entering the route and followed up {Plan nacional de respuesta al consumo emergente de heroína y otras drogas por vía inyectada, 2013, p.43} ~ Number of people reached by health education strategies (consumption and sexual practices of risk, HIV, viral hepatitis, other STIs, promotion of VCT, transitions between consumptions) {Plan nacional de respuesta al consumo emergente de heroína y otras drogas por vía inyectada, 2013, p.44} ~ Number of even operators involved in actions {Plan nacional de respuesta al consumo emergente de heroína y otras drogas por vía inyectada, 2013, p.44}~ HIV knowledge estimates, CES 2012 and 2014 series (I did not know if I was at any risk of HIV; before I injected I did not know about HIV; belief that HIV is transmitted in public toilets; belief that HIV is transmitted by sharing food; belief that HIV is transmitted through insect bites; has participated in IEC HIV prevention U12M; knows someone who lives with HIV; has not heard about HIV) {La heroina en Colombia: Produccion, uso e impacto, en la salud publica, 2015, p.86} ~",11
Y,Colombia,COL,Health,Presence of specialised training for addiction care,Yes,"Number and characterization of people trained in overdose management {Plan nacional de respuesta al consumo emergente de heroína y otras drogas por vía inyectada, 2013, p.55} ~ Number of services / people trained in the use of tools {Plan nacional de respuesta al consumo emergente de heroína y otras drogas por vía inyectada, 2013, p.41} ~",2
Y,Colombia,COL,Health,Presence of health harms related to drug use,No,n/a,0
Y,Colombia,COL,Health,Presence of other health metrics,Yes,"% Of consumers who used condoms in their last sexual relationship with a non-habitual partner {Plan nacional de respuesta al consumo emergente de heroína y otras drogas por vía inyectada, 2013, p.53} ~ % of consumers who regularly use condoms with different sexual partners {Plan nacional de respuesta al consumo emergente de heroína y otras drogas por vía inyectada, 2013, p.54} ~ Estimates of high-risk sexual events and condom use, CES series 2011-2014 (Sex with casual partner last 6 months; Never used condom with casual partner; Sex exchange for drugs / money; Used condom in last exchange) {La heroina en Colombia: Produccion, uso e impacto, en la salud publica, 2015, p.83} ~ Main source of income in the last 6 months CES series (frequencies%) (Sex work) {La heroina en Colombia: Produccion, uso e impacto, en la salud publica, 2015, p.62} ~ ",4
Y,Colombia,COL,Peace and Security,"Prevalence of alcohol and drugs in accidents, and interventions to increase road safety",No,n/a,0
Y,Colombia,COL,Peace and Security,Annual number of public disorder and violent crime reports,Yes,"Estimates places where the injection began, CES Series 2011-2014 (Street, In public place, In a ""pot"" In partner / friend / acquaintance house, Your own home) {La heroina en Colombia: Produccion, uso e impacto, en la salud publica, 2015, p.70} ~",1
Y,Colombia,COL,Peace and Security,Number of non-lethal drug market violent events reported,Yes,"Number of Persons of the security forces, wounded in combat against drugs in Colombia (2005 - 2011): What’s New (Policemen, Eradicators PONAL), PONAL eradicators (5 amputees), Wounded (Soldiers (01 amputees), eradicators FF.MM) {Política Nacional contra las Drogas, 2010-2014, p.27} ~",1
Y,Colombia,COL,Peace and Security,Number of drug market related homicides and disappearances,Yes,"Table 1. Number of Persons of the security forces, killed in combat against drugs in Colombia (2005 - 2011): Deaths (Soldiers, Eradicators FF.MM, Cops (26 amputees), PONAL eradicators (5 amputees), {Política Nacional contra las Drogas, 2010-2014, p.27} ~ Homicide rate, forced displacement and hectares with coca crops at national level 2000-2013 {Bases del Plan Nacional de Desarrollo, 2014-2018, p.1}~",2
Y,Colombia,COL,Peace and Security,Presence of other peace and security metrics,Yes,"The % of risks and damages associated with the use of highly dangerous substances, such as heroin or other psychotropic substances {Política Nacional Para La Reduccíon Del Consumo De Sustancias Psicoactivas Y Su Impacto, 2007, p.14} ~ Main source of income in the last 6 months CES series (frequencies%) (Theft) {La heroina en Colombia: Produccion, uso e impacto, en la salud publica, 2015, p.62} ~ ",2
Y,Colombia,COL,Development,Coverage of housing assistance for people who use drugs,No,n/a,0
Y,Colombia,COL,Development,Coverage of social assistance for people who use drugs (not including housing),No,n/a,0
Y,Colombia,COL,Development,Number of households enrolled in alternative development,Yes,"Number of Families cared for in alternative development: Baseline in 2013 = 8535: Goal for 2018 = 40,000 {Bases del Plan Nacional de Desarrollo, 2014-2018, p.385} ~ Number of supported alternative development organizations: Baseline in 2013 = 75: Goal for 2018 = 190 {Bases del Plan Nacional de Desarrollo, 2014-2018, p.385} ~ ",2
Y,Colombia,COL,Development,Presence of other development metrics,Yes,"Main source of income in the last 6 months CES series (frequencies%) (Employment, Retake, Independent, Street vendor) {La heroina en Colombia: Produccion, uso e impacto, en la salud publica, 2015, p.62} ~ Affiliation regime (Non-affiliated, Subsidized, Contributory), CES series (Armenia, Bogotá, Cúcuta, Medellín), 2014 (frequencies) {La heroina en Colombia: Produccion, uso e impacto, en la salud publica, 2015, p.66} ~ ",2
Y,Colombia,COL,Human Rights,"Prevalence and incidence of infectious diseases in vulnerable populations (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Colombia,COL,Human Rights,"Prevalence of vulnerable people who use drugs (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Colombia,COL,Human Rights,Proportion of people who use drugs in prison that are receiving medication assisted treatment (MAT),No,n/a,0
Y,Colombia,COL,Human Rights,Distribution of sterile injecting equipment in prisons,No,n/a,0
Y,Colombia,COL,Human Rights,Presence of programs and services targeted towards women ,No,n/a,0
Y,Colombia,COL,Human Rights,Presence of programs and services targeted towards people of color,No,n/a,0
Y,Colombia,COL,Human Rights,Presence of challenges and/or harms experienced by people of color,No,n/a,0
Y,Colombia,COL,Human Rights,"Presence of programs and services targeted towards vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"% Of local communities involved in stigma and discrimination reduction activities, prepared for action {Plan nacional de respuesta al consumo emergente de heroína y otras drogas por vía inyectada, 2013, p.50} ~",1
Y,Colombia,COL,Human Rights,"Presence of challenges and/or harms experienced by vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Colombia,COL,Human Rights,Presence of other human rights metrics,Yes,"Number of people who have used some of the tools to exercise their rights {Plan nacional de respuesta al consumo emergente de heroína y otras drogas por vía inyectada, 2013, p.49} ~ Number of consumers who recorded having lived social inclusion actions by their local community {Plan nacional de respuesta al consumo emergente de heroína y otras drogas por vía inyectada, 2013, p.50} ~ ",2
Y,Colombia,COL,Demand Reduction,Prevalence of drug use by age,Yes,"Past year prevalence of marijuana use among school children {Plan Nacional Para La Promocion de la salud, la prevención, y la atención del consumo de sustancias psicoactivas, 2014-2021, p.16} ~ % of university students who have consumed marijuana at least once in their life {Política Nacional Para La Reduccíon Del Consumo De Sustancias Psicoactivas Y Su Impacto, 2007, p.13} ~ The % of young children who have consumed psychotropic substances {Política Nacional Para La Reduccíon Del Consumo De Sustancias Psicoactivas Y Su Impacto, 2007, p.14} ~ The number of heroin consumers in schools {Política Nacional Para La Reduccíon Del Consumo De Sustancias Psicoactivas Y Su Impacto, 2007, p.14} ~ Rate of consumption of 18-25 year olds (%) and rate of consumption of 25-34 year olds (%) {Política Nacional contra las Drogas, 2010-2014, p.41} ~ % of the population, and high school students that consumes bazuco – 2011 {Plan Nacional Para La Promocion de la salud, la prevención, y la atención del consumo de sustancias psicoactivas, 2014-2021, p.25} ~ % of the population that has ever used drugs, including adolescents {Plan Nacional Para La Promocion de la salud, la prevención, y la atención del consumo de sustancias psicoactivas, 2014-2021, p.14} ~ Average age of onset for youth to consume illicit substances, such as marijuana and cocaine (National Mental Health Survey, 2004) {Política Nacional Para La Reduccíon Del Consumo De Sustancias Psicoactivas Y Su Impacto, 2007, p.13} ~ Average age at which people use heroin – 2009,2010,2011 {Plan nacional de respuesta al consumo emergente de heroína y otras drogas por vía inyectada, 2013, p.9} ~ The number of school children who have experimented with cocaine at least once – 2004 {Política Nacional Para La Reduccíon Del Consumo De Sustancias Psicoactivas Y Su Impacto, 2007, p.13} ~ Comparative recent use of heroin and basuco in university population (PRADICAN, 2012) {p.51} ~ ",11
Y,Colombia,COL,Demand Reduction,Prevalence of drug use by sex,No,n/a,0
Y,Colombia,COL,Demand Reduction,Prevalence of drug use by type,Yes,"Lifetime prevalence (%) of drug use by type of drug (marijuana, cocaine, heroin) {Política Nacional Para La Reduccíon Del Consumo De Sustancias Psicoactivas Y Su Impacto, 2007, p.13, p.14} ~ Past year prevalence of marijuana use among school children {Plan Nacional Para La Promocion de la salud, la prevención, y la atención del consumo de sustancias psicoactivas, 2014-2021, p.16} ~ The prevalence (number) of people who have consumed heroin in the last month, and in the last year – 2009 {Plan nacional de respuesta al consumo emergente de heroína y otras drogas por vía inyectada, 2013, p.9} ~ The proportion (%) of individuals who have used drugs by drug type (bazuco, solvents and/or inhalants, synthetic ecstasy) {Política Nacional Para La Reduccíon Del Consumo De Sustancias Psicoactivas Y Su Impacto, 2007, p.14} ~ % of people who have consumed drugs at least once in their lifetime, and the % of people who have consumed drugs at least once in the past year, by type of drug (marijuana, cocaine, bazuco, ecstasy, heroin) {Política Nacional contra las Drogas, 2010-2014, p.39, p.40; Plan nacional de respuesta al consumo emergente de heroína y otras drogas por vía inyectada, 2013, p.9; Política Nacional Para La Reduccíon Del Consumo De Sustancias Psicoactivas Y Su Impacto, 2007, p.13} ~ % of university students who have consumed marijuana at least once in their life {Política Nacional Para La Reduccíon Del Consumo De Sustancias Psicoactivas Y Su Impacto, 2007, p.13} ~ The % of young children who have consumed psychotropic substances {Política Nacional Para La Reduccíon Del Consumo De Sustancias Psicoactivas Y Su Impacto, 2007, p.14} ~ The number of heroin consumers in schools {Política Nacional Para La Reduccíon Del Consumo De Sustancias Psicoactivas Y Su Impacto, 2007, p.14} ~ % of the population, and high school students that consumes bazuco – 2011 {Plan Nacional Para La Promocion de la salud, la prevención, y la atención del consumo de sustancias psicoactivas, 2014-2021, p.25} ~ Prevalence (%) of drug use by type (heroin, solvents and/or inhalants) in Colombia {Plan nacional de respuesta al consumo emergente de heroína y otras drogas por vía inyectada, 2013, p.8} ~ Average age of onset for youth to consume illicit substances, such as marijuana and cocaine (National Mental Health Survey, 2004) {Política Nacional Para La Reduccíon Del Consumo De Sustancias Psicoactivas Y Su Impacto, 2007, p.13} ~ Average age at which people use heroin – 2009,2010,2011 {Plan nacional de respuesta al consumo emergente de heroína y otras drogas por vía inyectada, 2013, p.9} ~ The number of school children who have experimented with cocaine at least once – 2004 {Política Nacional Para La Reduccíon Del Consumo De Sustancias Psicoactivas Y Su Impacto, 2007, p.13} ~ Estimated number of people who used heroin at some time in their lives (National Studies (1992-2013) {La heroina en Colombia: Produccion, uso e impacto, en la salud publica, 2015, p.50} ~ Estimated number of people who used heroin in the last year and in the last month (National Studies (2008-2013) {La heroina en Colombia: Produccion, uso e impacto, en la salud publica, 2015, p.50} ~ Comparative recent use of heroin and basuco in university population (PRADICAN, 2012) {p.51} ~ Prevalence estimates of drug use 30 days before injecting for the first time by type of drug (Mix of heroin and cocaine; Pure heroin; Pure Cocaine; Methamphetamines; Heroin combined with other drugs; Other stimulants: Basuco; Benzodiazepines and other sedatives; Neuroleptic antidepressants; Diazepam (valium); Marijuana; Alcohol; Ecstasy; Other synthetic drugs; Inhalants (boxers); Hallucinogens (acids, fungi), CES studies series, 2011 and 2014 {La heroina en Colombia: Produccion, uso e impacto, en la salud publica, 2015, p.68} ~ Drugs people have used in the past 6 months (not injected) (Mix of heroin and cocaine, pure Heroin, pure Cocaine, Heroin combined with other drugs, Marijuana, Alcohol, Basuco) {La heroina en Colombia: Produccion, uso e impacto, en la salud publica, 2015, p.71} ~ ",18
Y,Colombia,COL,Demand Reduction,Number of people who use drugs,Yes,"% of the population that has used illicit drugs over the past year {Política Nacional contra las Drogas, 2010-2014, p.39} ~ Illegal substance use from 1996-2013 {Plan Nacional Para La Promocion de la salud, la prevención, y la atención del consumo de sustancias psicoactivas, 2014-2021, p.3} ~",2
Y,Colombia,COL,Demand Reduction,"Prevalence of drug use by mode of administration (oral, mucosa, inhalation, and injection)",Yes,"Estimate the number of IDUs in Colombia {Plan nacional de respuesta al consumo emergente de heroína y otras drogas por vía inyectada, 2013, p.68} ~  Number of people who inject drugs and who were contacted by the studies {La heroina en Colombia: Produccion, uso e impacto, en la salud publica, 2015, p.56} ~ Weighted population of people who inject themselves by cities (Medellin, Cali, Pereira, Cucuta, Armenia, Bogota), CES 2014 series {La heroina en Colombia: Produccion, uso e impacto, en la salud publica, 2015, p.58} ~ Distribution of PWID by age ranges (25-34; 18-24), CES series (Medellin, Cali, Pereira, Cucuta, Armenia, Bogota) 2011-2014 (estimates) {La heroina en Colombia: Produccion, uso e impacto, en la salud publica, 2015, p.61} ~ Average age of PWIDs by cities (Medellin, Cali, Pereira, Cucuta, Armenia, Bogota), 2014 {La heroina en Colombia: Produccion, uso e impacto, en la salud publica, 2015, p.61} ~ Estimates of the circumstances in which the injection began, CES Series 2011-2014 (Couple / sexual partner, only / only, close friend) {La heroina en Colombia: Produccion, uso e impacto, en la salud publica, 2015, p.69} ~ Main reasons for injecting the first time, Quintero (2012) and CES Series, 2011 and 2014 (estimates) (he was depressed, thought he would achieve better effect, curiosity) {La heroina en Colombia: Produccion, uso e impacto, en la salud publica, 2015, p.70} ~ Drugs that have been injected in the past 6 months (Mix of heroin and cocaine, pure Heroin, pure Cocaine, Heroin combined with other drugs, Benzodiazepines, Valium, Alcohol) {La heroina en Colombia: Produccion, uso e impacto, en la salud publica, 2015, p.71} ~ Drugs injected in the last six months: CES 2014 series (frequencies): At least once a week / almost daily (Mix of heroin and cocaine, pure Heroin, pure Cocaine, Heroin combined with other SPA) {La heroina en Colombia: Produccion, uso e impacto, en la salud publica, 2015, p.72} ~ Drugs injected in the last six months: CES 2014 series (frequencies): 2 or more times a day (mixture of heroin and cocaine, pure heroin, pure cocaine, heroin combined with other SPA) {La heroina en Colombia: Produccion, uso e impacto, en la salud publica, 2015, p.72} ~ Frequency with which has been injected per month, in the last 6 months, CES series 2014 (About once a day, 2-3 times daily almost daily, 4 or more times a day) {La heroina en Colombia: Produccion, uso e impacto, en la salud publica, 2015, p.74} ~ Estimates of occurrence of injection in ""pots"", CES series 2014 (He has injected someone into a ""pot""; It has been injected into a ""pot"") {La heroina en Colombia: Produccion, uso e impacto, en la salud publica, 2015, p.75} ~ ",12
Y,Colombia,COL,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT)",Yes,"% of users interviewed for the Diagnosis of Centers for Drug Abuse - DAC in 2004 being treated precisely for their heroin consumption {Política Nacional Para La Reduccíon Del Consumo De Sustancias Psicoactivas Y Su Impacto, 2007, p.14} ~ Number of people receiving treatment for heroin in the region of Antioquia - 2008 {Política Nacional contra las Drogas, 2010-2014, p.40} ~ % Of services with teams formed according to local mapping {Plan nacional de respuesta al consumo emergente de heroína y otras drogas por vía inyectada, 2013, p.41} ~ %, Number and characterization of persons receiving assisted detoxification with drugs at levels where it is implemented locally {Plan nacional de respuesta al consumo emergente de heroína y otras drogas por vía inyectada, 2013, p.62} ~ % Of people who have received mental health evaluation {Plan nacional de respuesta al consumo emergente de heroína y otras drogas por vía inyectada, 2013, p.57} ~ Number of people referred to services of secondary and tertiary level of complexity / attended at first level and / or community services for management of comorbidity (in mental and physical health) {Plan nacional de respuesta al consumo emergente de heroína y otras drogas por vía inyectada, 2013, p.57} ~ % Of people whose case has been taken care of in more than two points of the network and in each point there has been resolution and reference to the following one {Plan nacional de respuesta al consumo emergente de heroína y otras drogas por vía inyectada, 2013, p.57} ~ Number of people receiving counseling {Plan nacional de respuesta al consumo emergente de heroína y otras drogas por vía inyectada, 2013, p.43} ~ Estimates on the use of health services, CES 2012 and 2014 series (You have visited a doctor in the last year; You would have difficulty accessing health services; You have avoided using services for fear of police; You have visited a doctor more than a year ago; I would have difficulty accessing health services for SPA) {La heroina en Colombia: Produccion, uso e impacto, en la salud publica, 2015, p.89} ~ Heroin as the main reason for consultation {La heroina en Colombia: Produccion, uso e impacto, en la salud publica, 2015, p.53} ~",10
Y,Colombia,COL,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT) by age",No,n/a,0
Y,Colombia,COL,Demand Reduction,Level of access to opioid substitution treatment and medication assisted treatment (OST/MAT),Yes,"%, Number and characterization of persons receiving median and long term maintenance with medications {Plan nacional de respuesta al consumo emergente de heroína y otras drogas por vía inyectada, 2013, p.62}  ",1
Y,Colombia,COL,Demand Reduction,Level of coverage of inpatient treatment,No,n/a,0
Y,Colombia,COL,Demand Reduction,Proportion of people who use drugs enrolled in voluntary treatment,Yes,"Number and % of services in which the early intervention program is offered including voluntary counselling and testing (VCT) {Plan nacional de respuesta al consumo emergente de heroína y otras drogas por vía inyectada, 2013, p.42} ~ ",1
Y,Colombia,COL,Demand Reduction,Proportion of people who use drugs enrolled in coerced treatment,No,n/a,0
Y,Colombia,COL,Demand Reduction,Proportion of people who use drugs enrolled in compulsory treatment,No,n/a,0
Y,Colombia,COL,Demand Reduction,Presence of prevention programming in law enforcement,Yes,"Main prevention programs developed in Colombia during 2012 and 2013 (number of subjects in each programme): Prevention Bus and Prevention Citadel (National Police) {Plan Nacional Para La Promocion de la salud, la prevención, y la atención del consumo de sustancias psicoactivas, 2014-2021, p.9} ~",1
Y,Colombia,COL,Demand Reduction,Presence of prevention programming in the media,Yes,"Number of media and media people sensitized and trained in the topic {Plan nacional de respuesta al consumo emergente de heroína y otras drogas por vía inyectada, 2013, p.65} ~",1
Y,Colombia,COL,Demand Reduction,Presence of prevention programming in schools,Yes,"Main prevention programs developed in Colombia during 2012 and 2013 (number of subjects in each programme): Healthy Schools Program {Plan Nacional Para La Promocion de la salud, la prevención, y la atención del consumo de sustancias psicoactivas, 2014-2021, p.9} ~ Number of people reached by the pedagogical strategy {Plan nacional de respuesta al consumo emergente de heroína y otras drogas por vía inyectada, 2013, p.49} ~ ",2
Y,Colombia,COL,Demand Reduction,Presence of prevention programming in the workplace,No,n/a,0
Y,Colombia,COL,Demand Reduction,Presence of prevention programming for youth and the community,Yes,"Main prevention programs developed in Colombia during 2012 and 2013 (number of subjects in each programme): DARE Program, Life Skills Program - Lions Educating, Prevention and mitigation in the hands of young people, Strong Families Program, Caring Communities Program, Total {Plan Nacional Para La Promocion de la salud, la prevención, y la atención del consumo de sustancias psicoactivas, 2014-2021, p.9} ~ % Of communities in which members are actively involved in the development of health education actions {Plan nacional de respuesta al consumo emergente de heroína y otras drogas por vía inyectada, 2013, p.51} ~",2
Y,Colombia,COL,Demand Reduction,Presence of other demand reduction metrics,Yes,"% Of local operators systematically adopting biosecurity practices {Plan nacional de respuesta al consumo emergente de heroína y otras drogas por vía inyectada, 2013, p.46} ~ Percentage who do not live with their parents / mothers CES series (Armenia, Bogotá, Cúcuta, Pereira, Medellín), 2014 (frequencies) {La heroina en Colombia: Produccion, uso e impacto, en la salud publica, 2015, p.65} ~",2
Y,Colombia,COL,Supply Reduction,Size and value of the illegal drug market,Yes,"% of cocaine sheets sold in 2005 to 2006 {Política Nacional contra las Drogas, 2010-2014, p.28} ~ % of producers engaging in the sale of cocaine in 2005 and 2009 {Política Nacional contra las Drogas, 2010-2014, p.28} ~ A reduction in the production of cocaine % in 2008 and 2009 {Política Nacional contra las Drogas, 2010-2014, p.31} ~ availability of illicit drugs for export: this indicator reflects the supply of cocaine, the reduction of coca crops, seizures of cocaine {Política Nacional contra las Drogas, 2010-2014, p.36} ~ Average cocaine production between 2004-2009 in tons, the amount of seizures (in tons) {Política Nacional contra las Drogas, 2010-2014, p.36} ~ The availability of cocaine for export % {Política Nacional contra las Drogas, 2010-2014, p.37} ~ The number of assets involving urban and rural companies, vehicles, aircraft, and motor boats between 2002-2010 {Política Nacional contra las Drogas, 2010-2014, p.47} ~ % of population exposed to heroin use in 2008 {Plan Nacional Para La Promocion de la salud, la prevención, y la atención del consumo de sustancias psicoactivas, 2014-2021, p.25} ~ Main source of income in the last 6 months CES series (frequencies%) (Drug sales) {La heroina en Colombia: Produccion, uso e impacto, en la salud publica, 2015, p.62} ~ Estimated number of people who have sold drugs, syringes or charged for injections, CES series 2011-2014 {La heroina en Colombia: Produccion, uso e impacto, en la salud publica, 2015, p.63} ~",10
Y,Colombia,COL,Supply Reduction,Level of procedures related to crop eradication,Yes,"Homicide rate, forced displacement and hectares with coca crops at national level 2000-2013 {Bases del Plan Nacional de Desarrollo, 2014-2018, p.1}~ Number of hectares for coca cultivation {Política Nacional contra las Drogas, 2010-2014, p.26, p.31; Bases del Plan Nacional de Desarrollo, 2014-2018, p.337, p.385} ~ Number of cocaleros in 2011 {Política Nacional contra las Drogas, 2010-2014, p.27} ~ Number of hectares of illicit crops on indigenous reserves in 2010 {Política Nacional contra las Drogas, 2010-2014, p.28} ~ A reduction in the productivity of coca crops (tons/ha/year sheet) in 2005, and in 2008 {Política Nacional contra las Drogas, 2010-2014, p.31} ~ The rate of declination of cultivated coca hectares since 2010 {Bases del Plan Nacional de Desarrollo, 2014-2018, p.337} ~ Territories served free of illicit crops (sidewalks): Baseline in 2013 = 284: Goal for 2018 = 1400 {p.385}~ Number of Hectares eradicated - Mobile Eradication Groups: Baseline in 2013 = 10,000: Goal for 2018 = 36,000 {Bases del Plan Nacional de Desarrollo, 2014-2018, p.385}~ Number of potential production of cocaine hydrochloride (Tons): Baseline in 2013 = 290: Goal for 2018 = 230 {Bases del Plan Nacional de Desarrollo, 2014-2018, p.385} ~ Poppy crops cultivated in Colombia by department (Nariño, Cauca, Huila, Tolima, Cesar, Cauca Valley, La Guajira, Caquetá, Putumayo, Total), 2005 - 2014 (in hectares) {La heroina en Colombia: Produccion, uso e impacto, en la salud publica, 2015, p.26} ~ Evolution of heroin production potential in Colombia, 2002-2014 {La heroina en Colombia: Produccion, uso e impacto, en la salud publica, 2015, p.27} ~",11
Y,Colombia,COL,Supply Reduction,"Number of arrests, seizures, and offences",Yes,"The total volume of seizures of liquid inputs (million gallons) and solid inputs (million kilograms) for the period of 2002-2010 {Política Nacional contra las Drogas, 2010-2014, p.32} ~ Average annual seizure in million gallons, and million kilograms, and the average annual growth (%) {Política Nacional contra las Drogas, 2010-2014, p.32} ~ Number of annual average seizures of cocaine and marijuana {Política Nacional contra las Drogas, 2010-2014, p.36} ~ Distribution cocaine seizures, nature of the place 2010 (%): on-site production, river, water territories, international waters, terminal ports, airport, internal transit {Política Nacional contra las Drogas, 2010-2014, p.37} ~ Number of aircraft seizures and boat seizures between 2002 and 2010 {Política Nacional contra las Drogas, 2010-2014, p.38} ~ The number (in tons) of cocaine seized in 2013, and its estimated value in $US {Bases del Plan Nacional de Desarrollo, 2014-2018, p.337} ~ The number of mines that were being illegally exploited, and that were eventually suspended, 2013 {Bases del Plan Nacional de Desarrollo, 2014-2018, p.337} ~",7
Y,Colombia,COL,Supply Reduction,Level of law enforcement activity and interdiction in the market,Yes,"The number of sentences issued for domain extinction between 2002-2010 {Política Nacional contra las Drogas, 2010-2014, p.47} ~ The number of laboratories dismantled in 2008 {Política Nacional contra las Drogas, 2010-2014, p.33} ~ ",2
Y,Colombia,COL,Supply Reduction,"Price, purity and potency of drugs, and related process indicators",No,n/a,0
Y,Colombia,COL,Supply Reduction,Number of people engaged with the criminal justice system,Yes,"The number of people caught by the diversion of chemical substances, and the number of people convicted between 2007 and 2010 {Política Nacional contra las Drogas, 2010-2014, p.32} ~",1
Y,Colombia,COL,Supply Reduction,Presence of other supply reduction metrics,Yes,"the value added of the coca-cocaine chain contributed to 0.8% of GDP in 1999, then increased to 1.4% in 2001 and since then has dropped to 0.3% in 2009. {Política Nacional contra las Drogas, 2010-2014, p.45} ~ ",1
Y,Colombia,COL,International Cooperation,Level of engagement in international cooperation,No,n/a,0
Y,Thailand,THA,Health,Level of availability of harm reduction services and harm reduction scale up,No,n/a,0
Y,Thailand,THA,Health,Presence of needle and syringe programs,Yes,"prevalence of people who inject drugs who were reached by NSPs in Southeast Asia {Sub-Regional Action Plan On Drug Control, 2011-2013, p.6; Mekong MOU on Drug Control Sub-Regional Action Plan On Drug Control Draft Version, 2014-2016, p.10} ~ ",1
Y,Thailand,THA,Health,Prevalence of substance use disorders,Yes,"To reduce number of drug addicts {National Narcotics Control Policy on Kingdom's Unity for Victory over Drugs Strategy, 2011, np; Thailand Narcotics Control Annual Report, 2013, p.16} ~",1
Y,Thailand,THA,Health,Prevalence of psychiatric comorbidities,No,n/a,0
Y,Thailand,THA,Health,Drug-related mortality,No,n/a,0
Y,Thailand,THA,Health,Prevalence of drug-related infectious disease,Yes,"HIV prevalence among people who use drugs {Sub-Regional Action Plan On Drug Control, 2011-2013, p.6} ~ HIV prevalence among people who inject drugs (PWID) {Mekong MOU on Drug Control Sub-Regional Action Plan On Drug Control Draft Version, 2014-2016, p.10} ~",2
Y,Thailand,THA,Health,Proportion of people who use drugs who engage in risky consumption,No,n/a,0
Y,Thailand,THA,Health,Proportion of people who use drugs who engage in safe consumption practices,No,n/a,0
Y,Thailand,THA,Health,"Coverage of services for the prevention, testing, and treatment of bloodborne diseases",No,n/a,0
Y,Thailand,THA,Health,Presence of specialised training for addiction care,Yes,"Number of monks participating in drug control trainer development {Thailand Narcotics Control Annual Report, 2013, p.77} ~ ",1
Y,Thailand,THA,Health,Presence of health harms related to drug use,No,n/a,0
Y,Thailand,THA,Health,Presence of other health metrics,No,n/a,0
Y,Thailand,THA,Peace and Security,"Prevalence of alcohol and drugs in accidents, and interventions to increase road safety",No,n/a,0
Y,Thailand,THA,Peace and Security,Annual number of public disorder and violent crime reports,Yes,"Prevalence of criminal cases that were drug related crimes {Thailand Narcotics Control Annual Report, 2013, p.16} ~ The ratio of drug related crimes compared to all other crimes {Thailand Narcotics Control Annual Report, 2013, p.31} ~ ",2
Y,Thailand,THA,Peace and Security,Number of non-lethal drug market violent events reported,No,n/a,0
Y,Thailand,THA,Peace and Security,Number of drug market related homicides and disappearances,No,n/a,0
Y,Thailand,THA,Peace and Security,Presence of other peace and security metrics,No,n/a,0
Y,Thailand,THA,Development,Coverage of housing assistance for people who use drugs,No,n/a,0
Y,Thailand,THA,Development,Coverage of social assistance for people who use drugs (not including housing),Yes,"The number of out-of-school youths that are provided with working skills {Thailand Narcotics Control Annual Report, 2013, p.78} ~ The number of firms that employ ex-drug users {Thailand Narcotics Control Annual Report, 2013, p.79} ~",2
Y,Thailand,THA,Development,Number of households enrolled in alternative development,No,n/a,0
Y,Thailand,THA,Development,Presence of other development metrics,No,n/a,0
Y,Thailand,THA,Human Rights,"Prevalence and incidence of infectious diseases in vulnerable populations (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Thailand,THA,Human Rights,"Prevalence of vulnerable people who use drugs (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Thailand,THA,Human Rights,Proportion of people who use drugs in prison that are receiving medication assisted treatment (MAT),No,n/a,0
Y,Thailand,THA,Human Rights,Distribution of sterile injecting equipment in prisons,No,n/a,0
Y,Thailand,THA,Human Rights,Presence of programs and services targeted towards women ,No,n/a,0
Y,Thailand,THA,Human Rights,Presence of programs and services targeted towards people of color,No,n/a,0
Y,Thailand,THA,Human Rights,Presence of challenges and/or harms experienced by people of color,No,n/a,0
Y,Thailand,THA,Human Rights,"Presence of programs and services targeted towards vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"The number of prisoners that were taken to the treatment and rehabilitation system {Thailand Narcotics Control Annual Report, 2013, p.69} ~ The number of prisons across the country that have adopted the treatment and rehabilitation {Thailand Narcotics Control Annual Report, 2013, p.69} ~ ",2
Y,Thailand,THA,Human Rights,"Presence of challenges and/or harms experienced by vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Thailand,THA,Human Rights,Presence of other human rights metrics,No,n/a,0
Y,Thailand,THA,Demand Reduction,Prevalence of drug use by age,Yes,"biggest group of drug users age range {Thailand Narcotics Control Annual Report, 2013, p.25} ~ ",1
Y,Thailand,THA,Demand Reduction,Prevalence of drug use by sex,No,n/a,0
Y,Thailand,THA,Demand Reduction,Prevalence of drug use by type,Yes,"Production and use of amphetamine-type stimulants (ATS) {Mekong MOU on Drug Control Sub-Regional Action Plan On Drug Control Draft Version, 2014-2016, p.7} ~",1
Y,Thailand,THA,Demand Reduction,Number of people who use drugs,Yes,"profiles of drug abusers would systematically be recorded. {National Narcotics Control Policy on Kingdom's Unity for Victory over Drugs Strategy, 2011, np} ~ To reduce number of drug abusers {National Narcotics Control Policy on Kingdom's Unity for Victory over Drugs Strategy, 2011, np; Thailand Narcotics Control Annual Report, 2013, p.16} ~",2
Y,Thailand,THA,Demand Reduction,"Prevalence of drug use by mode of administration (oral, mucosa, inhalation, and injection)",No,n/a,0
Y,Thailand,THA,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT)",Yes,"The total number of drug abusers/addicts registered for treatment around the country {Thailand Narcotics Control Annual Report, 2013, p.23, p.33} ~ The ratio of drug patient per population {Thailand Narcotics Control Annual Report, 2013, p.34} ~ Prevalence of drug users/addicts that registered for drug treatment by type of drug (methamphetamine, cannabis, kratom, heroin) {Thailand Narcotics Control Annual Report, 2013, p.34} ~ Careers of drug users/addicts who received treatment: employed (%), unemployed (%), agricultrual workers (%), and students (%) {Thailand Narcotics Control Annual Report, 2013, p.34} ~ Proportion of new drug patients of all drug patients {Thailand Narcotics Control Annual Report, 2013, p.34} ~ The number of drug users that entered treatment programmes and number of drug patients discharged after treatment completion {Thailand Narcotics Control Annual Report, 2013, p.40} ~ Within the year 2013, proper treatment must be provided to 300,000 users/addicts. As well as aftercare service will be provided to 560,000 released drug users/addicts during 2012-2013 aiming to reduce the relapsing rate {Thailand Narcotics Control Annual Report, 2013, p.68} ~ The number of religious places certified as drug treatment and rehabilitation centre and being help centre providing by religion network {Thailand Narcotics Control Annual Report, 2013, p.70} ~ The number of mosques all around the country that have joined the treatment and rehabilitation project for drug users {Thailand Narcotics Control Annual Report, 2013, p.70} ~ The number of addicts that have been taken to Muslim way of drug treatment and rehabilitation {Thailand Narcotics Control Annual Report, 2013, p.70} ~ The number of provinces, districts and mosques to persuade drug users to Muslim drug treatment and rehabilitation system as well as to perform vigilance system in the community {Thailand Narcotics Control Annual Report, 2013, p.70} ~ ",11
Y,Thailand,THA,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT) by age",Yes,"Prevalence of drug users registered for drug treatment programmes (below 15 years, 15-24, 25-29) {Thailand Narcotics Control Annual Report, 2013, p.34} ~ number of at-risk youth taken to behaviour modification programs {Thailand Narcotics Control Annual Report, 2013, p.78} ~",2
Y,Thailand,THA,Demand Reduction,Level of access to opioid substitution treatment and medication assisted treatment (OST/MAT),Yes,"prevalence of people who inject opiates in Southeast Asia that were reached with OST {Sub-Regional Action Plan On Drug Control, 2011-2013, p.7; Mekong MOU on Drug Control Sub-Regional Action Plan On Drug Control Draft Version, 2014-2016, p.11} ~ ",1
Y,Thailand,THA,Demand Reduction,Level of coverage of inpatient treatment,No,n/a,0
Y,Thailand,THA,Demand Reduction,Proportion of people who use drugs enrolled in voluntary treatment,Yes,"Within the first year of the government, proper treatments must be provided through three existing drug treatment systems including voluntary system, compulsory system and correctional system with an aim to reduce 400,000 drug abusers/addicts with 80% of no relapsing. {National Narcotics Control Policy on Kingdom's Unity for Victory over Drugs Strategy, 2011, np} ~ Prevalence of drug users registered for the voluntary drug treatment programme {Thailand Narcotics Control Annual Report, 2013, p.34} ~ ",2
Y,Thailand,THA,Demand Reduction,Proportion of people who use drugs enrolled in coerced treatment,Yes,"Within the first year of the government, proper treatments must be provided through three existing drug treatment systems including voluntary system, compulsory system and correctional system with an aim to reduce 400,000 drug abusers/addicts with 80% of no relapsing. {National Narcotics Control Policy on Kingdom's Unity for Victory over Drugs Strategy, 2011, np} ~ ",1
Y,Thailand,THA,Demand Reduction,Proportion of people who use drugs enrolled in compulsory treatment,Yes,"The number of people who use drugs who are located in Compulsory Centres for Drug Users (CCDU) in Southeast Asia {Sub-Regional Action Plan On Drug Control, 2011-2013, p.7} ~ Within the first year of the government, proper treatments must be provided through three existing drug treatment systems including voluntary system, compulsory system and correctional system with an aim to reduce 400,000 drug abusers/addicts with 80% of no relapsing. {National Narcotics Control Policy on Kingdom's Unity for Victory over Drugs Strategy, 2011, np} ~ Prevalence of drug users registered for the compulsory drug treatment programme {Thailand Narcotics Control Annual Report, 2013, p.34} ~ ",3
Y,Thailand,THA,Demand Reduction,Presence of prevention programming in law enforcement,No,n/a,0
Y,Thailand,THA,Demand Reduction,Presence of prevention programming in the media,No,n/a,0
Y,Thailand,THA,Demand Reduction,Presence of prevention programming in schools,Yes,"The number of schools that have put in place drug prevention programmes to teach students to be aware of the dangers of drugs and encourage them to participate in various programs of recreational activities and life skills training {Thailand Narcotics Control Annual Report, 2013, p.40} ~ To build up immunity to drug risk groups of 1.5 million primary students of grade 5 and 6 {Thailand Narcotics Control Annual Report, 2013, p.68} ~ To encourage 11,490 schools to put in drug prevention program vigilance {Thailand Narcotics Control Annual Report, 2013, p.68} ~ ",3
Y,Thailand,THA,Demand Reduction,Presence of prevention programming in the workplace,Yes,"To support 2,000 industrial estates to take part in drug prevention and vigilance system in the workplace {Thailand Narcotics Control Annual Report, 2013, p.68} ~ The number of firms that screen employees for drug users and take drug users to drug treatment {Thailand Narcotics Control Annual Report, 2013, p.79} ~ The number of firms that arrange drug control activities for their employees {Thailand Narcotics Control Annual Report, 2013, p.79} ~ The number of firms that arrange drug control activities for risk groups of foreign employees {Thailand Narcotics Control Annual Report, 2013, p.79} ~ The number of firms that meet drug control standard {Thailand Narcotics Control Annual Report, 2013, p.79} ~",5
Y,Thailand,THA,Demand Reduction,Presence of prevention programming for youth and the community,Yes,"Total number of communities/villages that were targeted to be strengthened. {National Narcotics Control Policy on Kingdom's Unity for Victory over Drugs Strategy, 2011, np; Thailand Narcotics Control Annual Report, 2013, p.39} ~ number of families attend family strengthening activities {Thailand Narcotics Control Annual Report, 2013, p.78} ~",2
Y,Thailand,THA,Demand Reduction,Presence of other demand reduction metrics,No,n/a,0
Y,Thailand,THA,Supply Reduction,Size and value of the illegal drug market,Yes,"Reduce illicit trafficking in narcotic drugs and psychotropic substances (as well as precursor chemicals) in, to and from the sub-region {Sub-Regional Action Plan On Drug Control, 2011-2013, p.14; Mekong MOU on Drug Control Sub-Regional Action Plan On Drug Control Draft Version, 2014-2016, p.7, p.8} ~ Origin of ATS trafficked in the GMS {Mekong MOU on Drug Control Sub-Regional Action Plan On Drug Control Draft Version, 2014-2016, p.7} ~ In doing so, a national drug intelligence centre must be strengthened and utilized at its full capacity, drug criminal networks in every province must be disrupted, at least 10,000 cases of asset forfeiture must be closed, drug trafficking by prison gangs must be reduced and the corrupt state official must face a harsh punishment. Measures on asset forfeiture, money laundering and taxation must be utilized in an integrated manner in tackling major drug traffickers. {National Narcotics Control Policy on Kingdom's Unity for Victory over Drugs Strategy, 2011, np} ~ The ratio of drug traffickers per populations {Thailand Narcotics Control Annual Report, 2013, p.31} ~ The number of drug trafficking cases to be involved with a number of imprisoned drug traffickers {Thailand Narcotics Control Annual Report, 2013, p.32} ~ Production of amphetamine-type stimulants (ATS) {Mekong MOU on Drug Control Sub-Regional Action Plan On Drug Control Draft Version, 2014-2016, p.7} ~ The number of methamphetamine producing sources {Thailand Narcotics Control Annual Report, 2013, p.27} ~ The total number of drug cases {Thailand Narcotics Control Annual Report, 2013, p.22} ~ The number of drug trafficking cases {Thailand Narcotics Control Annual Report, 2013, p.31} ~ Number of cases by narcotic substances during 2006-2013: Ya-ba, Heroin, Ecstasy, Ketamine, Cocaine, Dried marijuana, kratom plant, Ice {Thailand Narcotics Control Annual Report, 2013, p.51} ~ Number of cases by Narcotic Substances excluded Yaba during 2006-2013 {Thailand Narcotics Control Annual Report, 2013, p.51} ~ Type of drug smuggled through Thailand by border area (northeastern border, eastern border, western border, southern border) {Thailand Narcotics Control Annual Report, 2013, p.27} ~ Methods of drug smuggling across borders {Thailand Narcotics Control Annual Report, 2013, p.27} ~ number of villages that have reported of being involved in drug trafficking activities {Thailand Narcotics Control Annual Report, 2013, p.28} ~ Most common form of drug smuggling inside a country {Thailand Narcotics Control Annual Report, 2013, p.29} ~  The average age of drug traffickers {Thailand Narcotics Control Annual Report, 2013, p.31} ~ ",16
Y,Thailand,THA,Supply Reduction,Level of procedures related to crop eradication,Yes,"prevalence of poppy cultivation (%) and in hectares in Southeast Asia {Sub-Regional Action Plan On Drug Control, 2011-2013, p.8} ~ the number in hectares of opium poppy crops that the Governments of Lao, PDR, Myanmar and Thailand have collectively eradicated {Mekong MOU on Drug Control Sub-Regional Action Plan On Drug Control Draft Version, 2014-2016, p.12} ~ The total areas of opium cultivation in hectares {Thailand Narcotics Control Annual Report, 2013, p.26} ~ Opium cultivation in hectares in Chiang Mai, Tak, and Mae Hong Son {Thailand Narcotics Control Annual Report, 2013, p.26} ~ The total number in hectares of opium eradication {Thailand Narcotics Control Annual Report, 2013, p.26} ~ prevalence (%) of the whole illicit cultivation in the country eradicated {Thailand Narcotics Control Annual Report, 2013, p.26} ~ Areas of cannabis cultivation {Thailand Narcotics Control Annual Report, 2013, p.26} ~ The number in rais (acres) of kratom plant found in forest preservation areas in Satoon province which could not be cut {Thailand Narcotics Control Annual Report, 2013, p.27} ~ Statistics on Opium cultivation areas during 2011/2012-2012/2013 season {Thailand Narcotics Control Annual Report, 2013, p.64} ~ Statistics on opium cultivation areas by provinces {Thailand Narcotics Control Annual Report, 2013, p.64} ~",10
Y,Thailand,THA,Supply Reduction,"Number of arrests, seizures, and offences",Yes,"The number of drug seizures (units may vary) by type of drug (heroin, methamphetamine pills, ice or crystalized methamphetamine, cannabis, cannabis resin, kratom, acetic acid, sodium bicarbonate, hydrochloric acid, pseudo ephedrine preparations) {Sub-Regional Action Plan On Drug Control, 2011-2013, p.9; Thailand Narcotics Control Annual Report, 2013, p.22, p.23} ~ Levels of opiate seizures at significant levels in 2011 and 2012 {Mekong MOU on Drug Control Sub-Regional Action Plan On Drug Control Draft Version, 2014-2016, p.8} ~ The illicit drugs seized at these checkpoints: Yaba (tablets), Ice (kilograms), cannabis (tons), opium (kilograms), cocaine (kilograms), codeine (bottles), kratom plant (kilograms) {Thailand Narcotics Control Annual Report, 2013, p.31} ~ The number of times that major methamphetamine seizures took place, and the total amount of seized tablets {Thailand Narcotics Control Annual Report, 2013, p.31} ~ Statistics on drug seizures (units may vary) during 2006-2013 by type of drug (Yaba, Ice, Dried-cannabis, Kratom, Heroin, Ecstasy, Cocaine, Ketamine {Thailand Narcotics Control Annual Report, 2013, p.52, p.54, p.55, p.56, p.57, p.58, p.59} ~ Statistics on Asset Forfeiture during 2005-2013 {Thailand Narcotics Control Annual Report, 2013, p.61} ~ The number of drug smugglers arrested at 111 check points in 74 districts of 34 provinces {Thailand Narcotics Control Annual Report, 2013, p.31} ~ The prevalence of new drug traffickers who got arrested for the first time that represent the % of all arrested drug traffickers/smugglers throughout the country {Thailand Narcotics Control Annual Report, 2013, p.31} ~ The prevalence of male drug traffickers of all arrested drug traffickers {Thailand Narcotics Control Annual Report, 2013, p.31} ~ The total number of officers that have been arrested for assisting arrested criminals with drug cases: disaggregated by type of officer (military officers, police officers, local administration officials, teachers, correctional officers, and public service officers) {Thailand Narcotics Control Annual Report, 2013, p.32} ~ The number of ethnic minorities that have been arrested under the charge of drug smuggler {p.28} ~",11
Y,Thailand,THA,Supply Reduction,Level of law enforcement activity and interdiction in the market,Yes,"Drug trafficking and cross-border security in the region {Mekong MOU on Drug Control Sub-Regional Action Plan On Drug Control Draft Version, 2014-2016, p.8} ~ The number in kilograms of destroyed seized drugs {Thailand Narcotics Control Annual Report, 2013, p.23} ~ The number of major criminal drug cases that must be further investigated {Thailand Narcotics Control Annual Report, 2013, p.41} ~",3
Y,Thailand,THA,Supply Reduction,"Price, purity and potency of drugs, and related process indicators",Yes,"The average price of a methamphetamine (yaba) tablet in baht {Thailand Narcotics Control Annual Report, 2013, p.24} ~ The price in baht of drugs by type (Ice, kiah, cocaine, marijuana, opium) {Thailand Narcotics Control Annual Report, 2013, p.24, p.26} ~ ",2
Y,Thailand,THA,Supply Reduction,Number of people engaged with the criminal justice system,Yes,"The number of at-risk youth put on probation {Thailand Narcotics Control Annual Report, 2013, p.78} ~ The prevalence of juvenile offenders that are drug related and prevalence of juvenile offenders that are drug related disaggregated by type of drug user {Thailand Narcotics Control Annual Report, 2013, p.72} ~ The total number of drug offenders {Thailand Narcotics Control Annual Report, 2013, p.22} ~ The number of drug cases and offenders throughout the country during 2006-2013 {Thailand Narcotics Control Annual Report, 2013, p.50} ~",4
Y,Thailand,THA,Supply Reduction,Presence of other supply reduction metrics,No,n/a,0
Y,Thailand,THA,International Cooperation,Level of engagement in international cooperation,No,n/a,0
Y,Uruguay,URY,Health,Level of availability of harm reduction services and harm reduction scale up,No,n/a,0
Y,Uruguay,URY,Health,Presence of needle and syringe programs,No,n/a,0
Y,Uruguay,URY,Health,Prevalence of substance use disorders,Yes,"Problematic users of marijuana by sex, place of residence and age range (in percentage). Uruguay 2014 {VI Encuesta Nacional en Hogares sobre Consumo de Drogas, 2016, p.70} ~ Prevalence in the last 12 months, percentage of problematic drug users (pdu) by type of drug (tobacco, marijuana, alcohol, cocaine) {VI Encuesta Nacional en Hogares sobre Consumo de Drogas, 2016, p.101} ~",2
Y,Uruguay,URY,Health,Prevalence of psychiatric comorbidities,No,n/a,0
Y,Uruguay,URY,Health,Drug-related mortality,No,n/a,0
Y,Uruguay,URY,Health,Prevalence of drug-related infectious disease,No,n/a,0
Y,Uruguay,URY,Health,Proportion of people who use drugs who engage in risky consumption,No,n/a,0
Y,Uruguay,URY,Health,Proportion of people who use drugs who engage in safe consumption practices,No,n/a,0
Y,Uruguay,URY,Health,"Coverage of services for the prevention, testing, and treatment of bloodborne diseases",No,n/a,0
Y,Uruguay,URY,Health,Presence of specialised training for addiction care,Yes,"the number of technicians and professionals were trained in the subject of different offers organized or supported by the JND. These include professional training specialized, postgraduate university and training aimed at local actors {Annual Report year, 2016, p.2} ~ the number of technicians trained/received a diploma in Community Treatment in agreement with the Center Latin American Human Economy (CLAEH) {Annual Report year, 2016, p.3} ~ The number of technicians trained who work in direct attention of adolescents {Annual Report year, 2016, p.12} ~ Expansion of the offer of training to institutions referents: program ASSIST DIT, accompaniment in the implementation of experiences, together with ASSE RAP and IM; the number of top-level technicians who participated in attention of ASSE and network of polyclinics of IM, of the programs for People Deprived of Liberty (PPL) and National Directorate of the Liberated (DINALI) {Annual Report year, 2016, p.12} ~ The total number of technicians trained to strengthen the role of the REL {Inserción social: Evaluación de resultados obtenidos por personas derivadas a proyectos de inserción social, 2011-2014, p.9} ~",5
Y,Uruguay,URY,Health,Presence of health harms related to drug use,No,n/a,0
Y,Uruguay,URY,Health,Presence of other health metrics,No,n/a,0
Y,Uruguay,URY,Peace and Security,"Prevalence of alcohol and drugs in accidents, and interventions to increase road safety",No,n/a,0
Y,Uruguay,URY,Peace and Security,Annual number of public disorder and violent crime reports,Yes,"Transaction risks according to those who bought directly. Uruguay 2014 (theft) {VI Encuesta Nacional en Hogares sobre Consumo de Drogas, 2016, p.95} ~",1
Y,Uruguay,URY,Peace and Security,Number of non-lethal drug market violent events reported,Yes,"Transaction risks according to those who bought directly. Uruguay 2014 (Physical violence) {VI Encuesta Nacional en Hogares sobre Consumo de Drogas, 2016, p.95} ~",1
Y,Uruguay,URY,Peace and Security,Number of drug market related homicides and disappearances,Yes,"Transaction risks according to those who bought directly. Uruguay 2014 (death) {VI Encuesta Nacional en Hogares sobre Consumo de Drogas, 2016, p.95} ~",1
Y,Uruguay,URY,Peace and Security,Presence of other peace and security metrics,No,n/a,0
Y,Uruguay,URY,Development,Coverage of housing assistance for people who use drugs,No,n/a,0
Y,Uruguay,URY,Development,Coverage of social assistance for people who use drugs (not including housing),Yes,"The projects to which they were all derived with personalized accompaniment and personal project construction are (%): Job training courses by INEFOP with the possibility of social labor insertion - Cupos modality and Building Roads, Social cooperative member, CUPOS URUGUAY WORKS: Montevido - Salto - Artigas, Competitive funds: Montevido - Salto - Artigas - Maldonado, Orientation Workshops for Social Insertion, Other individual projects: Montevido - Salto, Training courses in COCAP, Work internship with training in OSE Trades - INEFOP Montevido and Rivera, Fiber optic courses by MIDES-ANTEl with the possibility of labor insertion {Inserción social: Evaluación de resultados obtenidos por personas derivadas a proyectos de inserción social, 2011-2014, p.5} ~ The prevalence of those who achieved labor insertion and support of the total interviewees, a year after having been referred {Inserción social: Evaluación de resultados obtenidos por personas derivadas a proyectos de inserción social, 2011-2014, p.7} ~ The prevalence of those who received work training and then left it {Inserción social: Evaluación de resultados obtenidos por personas derivadas a proyectos de inserción social, 2011-2014, p.8} ~ The percentage of those who do not complete their work training due to relapse {Inserción social: Evaluación de resultados obtenidos por personas derivadas a proyectos de inserción social, 2011-2014, p.8} ~ Activity evaluation for those who managed to finish the project: Yes; Yes, with interruptions; No, for other reasons; No, due to relapses (Current situation of participants who did not complete the relapse process); No, to get a job {Inserción social: Evaluación de resultados obtenidos por personas derivadas a proyectos de inserción social, 2011-2014, p.8} ~ The prevalence of projects associated with an educational reference {Inserción social: Evaluación de resultados obtenidos por personas derivadas a proyectos de inserción social, 2011-2014, p.9} ~ How REL (%) helped you: Labor activities; Personal support; Throughout; To finish the course; To improve the links; To maintain the treatment; Other positive without specifying; Social activities; Health; He did not get to know him, he did not start Project; Job search; Economic, tickets, other supports; Sport activities; Habits linked to the hygiene of a person; In nothing; In communication, use of language; Self esteem {Inserción social: Evaluación de resultados obtenidos por personas derivadas a proyectos de inserción social, 2011-2014, p.9} ~ Labor Education Reference with Training in Drugs (REL) - Lessons learned from the proposal (%): Nothing / did not like / not anymore; Work experience / learned job / got a job; ""Open your eyes"" / that all depends on one; It helped with the treatment; Other positive answers {Inserción social: Evaluación de resultados obtenidos por personas derivadas a proyectos de inserción social, 2011-2014, p.10} ~ The prevalence of interviewees who are working one and a half years later after having been referred to an insertion project {Inserción social: Evaluación de resultados obtenidos por personas derivadas a proyectos de inserción social, 2011-2014, p.13} ~ Formality and stability of labor (%): work formally; have been working for more than 3 months; total interviewees working {Inserción social: Evaluación de resultados obtenidos por personas derivadas a proyectos de inserción social, 2011-2014, p.13} ~ Reasons why the social insertion proposal was useful for the current job (%): A lot of help to get ahead; Motivation to work; It gave him opportunities; Other positive answers; Competencies in the world of work; He went to work for the course or linked to the course or Project {Inserción social: Evaluación de resultados obtenidos por personas derivadas a proyectos de inserción social, 2011-2014, p.13} ~ number of people who participated in projects of social insertion in drugs {Annual Report year, 2016, p.7} ~ Number of people referred to social insertion projects during the period of July 2011-2014 {Inserción social: Evaluación de resultados obtenidos por personas derivadas a proyectos de inserción social, 2011-2014, p.4} ~ The number of treatment and care services that these people (people participating in social insertion projects) were derived from {Inserción social: Evaluación de resultados obtenidos por personas derivadas a proyectos de inserción social, 2011-2014, p.4} ~ The prevalence of young people who suffered some relapse during the project process, and the proportion who managed to finish the project {Inserción social: Evaluación de resultados obtenidos por personas derivadas a proyectos de inserción social, 2011-2014, p.7} ~",15
Y,Uruguay,URY,Development,Number of households enrolled in alternative development,No,n/a,0
Y,Uruguay,URY,Development,Presence of other development metrics,Yes,"Educational level of people referred to social inclusion projects 2011-2014 (%): 1st or 2nd year of high school or UTU, Complete primary or less, 6th year of high school or more education, 4th or 5th year of high school, 3rd year of high school or UTU {Inserción social: Evaluación de resultados obtenidos por personas derivadas a proyectos de inserción social, 2011-2014, p.7} ~ The prevalence of people who did not complete a basic cycle of schooling {Inserción social: Evaluación de resultados obtenidos por personas derivadas a proyectos de inserción social, 2011-2014, p.7} ~ What things have you considered after going through the Insertion project? (% of responses): Do not steal; Nothing; Exit Forward / Recover lost; Fix house / buy car; Living alone / becoming independent; Take up studies; Improve links : family / friends, being a mother, taking care of children; Work / Work stability / finish internship / improve {Inserción social: Evaluación de resultados obtenidos por personas derivadas a proyectos de inserción social, 2011-2014, p.12} ~ What helped you go through the project (social insertion) (%): Feel better with yourself; Get a job; Relations with the family; Keep the treatment; Interpersonal relationships, socialization; Relations with friends; Many things / everything; Other positives; Living alone; Find a partner; Distracted, clearing the mind, less free time; Nothing; Couple relationships; Finish something; Study {Inserción social: Evaluación de resultados obtenidos por personas derivadas a proyectos de inserción social, 2011-2014, p.14} ~ Activity that the person performs one year after going through the proposal of social insertion (%): Work; Do sports; Meet with friends; Go out to dance; Go to the movies, theater, stage, etc.; Study; Enjoy family, take care of family; Sale with partner; Theater, painting, gardening; Watch movies in the house; Fix the house; Church, religious or voluntary activities; Cooperativism; Comes out; Look for work {Inserción social: Evaluación de resultados obtenidos por personas derivadas a proyectos de inserción social, 2011-2014, p.14} ~ The prevalence of those who expressed interest in participating in another proposal for social inclusion {Inserción social: Evaluación de resultados obtenidos por personas derivadas a proyectos de inserción social, 2011-2014, p.14} ~ Total budget allocated to social insertion policies for people in treatment (Institution, Period (year), Budget ($)) {Inserción social: Evaluación de resultados obtenidos por personas derivadas a proyectos de inserción social, 2011-2014, p.5} ~ Profile of the participants - Table : sex (male; female; total) & Percentage {Inserción social: Evaluación de resultados obtenidos por personas derivadas a proyectos de inserción social, 2011-2014, p.6} ~ Profile of participants: Percentage of women per year of registration 2011-2014 {Inserción social: Evaluación de resultados obtenidos por personas derivadas a proyectos de inserción social, 2011-2014, p.6} ~ Profile of participants: Ages & Percentage (Up to 17 years old; 18 to 24 years old; 25 to 2 9 years; 30 to 39 years; 40 or more years; total) {Inserción social: Evaluación de resultados obtenidos por personas derivadas a proyectos de inserción social, 2011-2014, p.6} ~ Table: Period (year), number of people derived from projects, JND Budget Executed, and the budget of other institutions {Inserción social: Evaluación de resultados obtenidos por personas derivadas a proyectos de inserción social, 2011-2014, p.4} ~ the level of education among consumers in the last 12 months {Mercado Regulado Del Cannabis, 2018, p.4} ~ ",12
Y,Uruguay,URY,Human Rights,"Prevalence and incidence of infectious diseases in vulnerable populations (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Uruguay,URY,Human Rights,"Prevalence of vulnerable people who use drugs (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Uruguay,URY,Human Rights,Proportion of people who use drugs in prison that are receiving medication assisted treatment (MAT),No,n/a,0
Y,Uruguay,URY,Human Rights,Distribution of sterile injecting equipment in prisons,No,n/a,0
Y,Uruguay,URY,Human Rights,Presence of programs and services targeted towards women ,No,n/a,0
Y,Uruguay,URY,Human Rights,Presence of programs and services targeted towards people of color,No,n/a,0
Y,Uruguay,URY,Human Rights,Presence of challenges and/or harms experienced by people of color,No,n/a,0
Y,Uruguay,URY,Human Rights,"Presence of programs and services targeted towards vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Uruguay,URY,Human Rights,"Presence of challenges and/or harms experienced by vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Uruguay,URY,Human Rights,Presence of other human rights metrics,Yes,"Number of participants at the 2nd Regional Meeting on Human Rights and Drug Policy {Annual Report year, 2016, p.6} ~ ",1
Y,Uruguay,URY,Demand Reduction,Prevalence of drug use by age,Yes,"the number of people between 18 and 65 years old who consumed ""marijuana"" at least once in the 12 months prior to the date of the study {Mercado Regulado Del Cannabis, 2018, p.2} ~ the proportion of people who purchase marijuana for consumption by age (18-29, 30-44, 45 and older) {Mercado Regulado Del Cannabis, 2018, p.4} ~ Consumption of tranquilizers, with and without medical prescription, according to age and sex (percentage of positive responses). Uruguay 2014. {VI Encuesta Nacional en Hogares sobre Consumo de Drogas, 2016, p.60} ~ Lifetime prevalence of marijuana, alcohol, and tobacco use according to risk perception. Middle school students Uruguay, 2014 (%) {VI Encuesta Nacional Sobre Consumo de Drogas en Estudiantes de Enseñanza Media, 2014, p.66; VI Encuesta Nacional en Hogares sobre Consumo de Drogas, 2016, p.93} ~ Lifetime prevalence of marijuana use by people who have never consumed alcohol or tobacco in their life. Middle school students Uruguay, 2003-2014 (%) {VI Encuesta Nacional Sobre Consumo de Drogas en Estudiantes de Enseñanza Media, 2014, p.55} ~ Lifetime prevalence of hypnotics, antidepressants and stimulants, with and without medical prescription, according to sex and age. Uruguay 2014. {VI Encuesta Nacional en Hogares sobre Consumo de Drogas, 2016, p.61} ~ Lifetime prevalence of substance use in high school students by type of substance, Uruguay, 2014 (%) {VI Encuesta Nacional Sobre Consumo de Drogas en Estudiantes de Enseñanza Media, 2014, p.18} ~ Past 12 month prevalence by type of substance according to age. Middle school students Uruguay, 2014 (%) {VI Encuesta Nacional Sobre Consumo de Drogas en Estudiantes de Enseñanza Media, 2014, p.19, p.20, p.24, p.26, p.51, p.59, p.71, p.77} ~ Amount of drugs consumed in the last year. Middle school students Uruguay, 2014 (% of total consumers) (one, two, three, four or more) {VI Encuesta Nacional Sobre Consumo de Drogas en Estudiantes de Enseñanza Media, 2014, p.21} ~ Past 12 month prevalence by substance according to sex and age . Middle school students Uruguay, 2014 (%) {VI Encuesta Nacional Sobre Consumo de Drogas en Estudiantes de Enseñanza Media, 2014, p.22, p.49, p.52} ~ Past 12 month prevalence according to sex and area of residence. Tobacco and marijuana. Middle school students Uruguay, 2014 (%) {VI Encuesta Nacional Sobre Consumo de Drogas en Estudiantes de Enseñanza Media, 2014, p.22} ~ Past 12-month prevalence of drug use (tranquilizer, stimulant) according to medical prescription and sex. Middle school students Uruguay 2014 (%) {VI Encuesta Nacional Sobre Consumo de Drogas en Estudiantes de Enseñanza Media, 2014, p.49, p.50} ~ Past 30-day prevalence by type of substance according to sex, region of residence and age. Middle school students Uruguay, 2014 (%) {VI Encuesta Nacional Sobre Consumo de Drogas en Estudiantes de Enseñanza Media, 2014, p.29} ~ Profile of new marijuana users in the last 12 months. Uruguay 2014. (Sex, Age, Geographical Area) {VI Encuesta Nacional en Hogares sobre Consumo de Drogas, 2016, p.66} ~ Average age of first-time use according to drug type (marijuana, cocaine). Uruguay 2014 {VI Encuesta Nacional en Hogares sobre Consumo de Drogas, 2016, p.67, p.76; VI Encuesta Nacional Sobre Consumo de Drogas en Estudiantes de Enseñanza Media, 2014, p.30} ~ Average age of first-time use by type of substance according to sex and area of residence. Middle school students Uruguay, 2014 {VI Encuesta Nacional Sobre Consumo de Drogas en Estudiantes de Enseñanza Media, 2014, p.30} ~ Proportion of students who started consumption before age 15 according to substance. Middle school students Uruguay, 2014 {VI Encuesta Nacional Sobre Consumo de Drogas en Estudiantes de Enseñanza Media, 2014, p.31} ~ Frequency of drug use (marijuana, cocaine) in the last year according to age range (in percentage). Uruguay 2014. (Once only, Sometimes during the last 12 months, Sometimes monthly, Sometimes weekly, Daily) {VI Encuesta Nacional en Hogares sobre Consumo de Drogas, 2016, p.69; VI Encuesta Nacional Sobre Consumo de Drogas en Estudiantes de Enseñanza Media, 2014, p.54, p.62} ~ Frequency of consumption in the last 12 months, according to sex and area of residence. Middle school students Uruguay, 2014 (%) (Only once, Sometimes in the last 12 months, Sometimes monthly, Sometimes weekly, Daily) {VI Encuesta Nacional Sobre Consumo de Drogas en Estudiantes de Enseñanza Media, 2014, p.53, p.69} ~ Frequency of consumption reached by ex-marijuana users. Middle school students Uruguay, 2014 (%) (Only once, Sometimes in the last 12 months, Sometimes monthly, Sometimes weekly, Daily) {VI Encuesta Nacional Sobre Consumo de Drogas en Estudiantes de Enseñanza Media, 2014, p.54} ~ Students with high risk of problematic marijuana use according to the frequency of consumption of the substance in the last year. Middle school students Uruguay 2014. (%) {VI Encuesta Nacional Sobre Consumo de Drogas en Estudiantes de Enseñanza Media, 2014, p.57, p.58} ~ Risk of problematic use of marijuana, according to sex, age and geographical area. Middle school students Uruguay, 2014 (%) {VI Encuesta Nacional Sobre Consumo de Drogas en Estudiantes de Enseñanza Media, 2014, p.56} ~ Students with high risk of problematic marijuana use according to the age of substance use. Middle school students Uruguay, 2014 (%) {VI Encuesta Nacional Sobre Consumo de Drogas en Estudiantes de Enseñanza Media, 2014, p.59} ~ Students according to the number of friends who use marijuana. Middle school students Uruguay, 2014 (%) (None, Less than half, Half of my friends, All or almost all, I do not know, Total) {VI Encuesta Nacional Sobre Consumo de Drogas en Estudiantes de Enseñanza Media, 2014, p.60} ~ Consumption of substances according to age and level of parental involvement. Middle school students Uruguay, 2014 (%) {VI Encuesta Nacional Sobre Consumo de Drogas en Estudiantes de Enseñanza Media, 2014, p.75, p.76} ~ Marijuana use in the last thirty days as tolerated by parents. Middle school students Uruguay, 2014. {VI Encuesta Nacional Sobre Consumo de Drogas en Estudiantes de Enseñanza Media, 2014, p.78} ~",26
Y,Uruguay,URY,Demand Reduction,Prevalence of drug use by sex,Yes,"prevalence of male registered purchasers among marijuana consumers in the last 12 months {Mercado Regulado Del Cannabis, 2018, p.4} ~ Consumption of tranquilizers, with and without medical prescription, according to age and sex (percentage of positive responses). Uruguay 2014. {VI Encuesta Nacional en Hogares sobre Consumo de Drogas, 2016, p.60} ~ Lifetime prevalence of hypnotics, antidepressants and stimulants, with and without medical prescription, according to sex and age. Uruguay 2014. {VI Encuesta Nacional en Hogares sobre Consumo de Drogas, 2016, p.61} ~ Lifetime prevalence tranquilizer use according to sex and medical prescription. Middle school students Uruguay, 2014 (%) {VI Encuesta Nacional Sobre Consumo de Drogas en Estudiantes de Enseñanza Media, 2014, p.48} ~ indicators of drug use (tranquilizer use, marijuana use, cocaine) according to sex and place of residence (in percentage). Uruguay 2014. (Consumption at some time in life, Consumption in the last 12 months, Consumption in the last 30 days) {VI Encuesta Nacional en Hogares sobre Consumo de Drogas, 2016, p.60, p.65, p.75} ~ Past 12 month prevalence by substance according to sex and age . Middle school students Uruguay, 2014 (%) {VI Encuesta Nacional Sobre Consumo de Drogas en Estudiantes de Enseñanza Media, 2014, p.22, p.49, p.52} ~ Past 12 month prevalence according to sex and area of residence. Tobacco and marijuana. Middle school students Uruguay, 2014 (%) {VI Encuesta Nacional Sobre Consumo de Drogas en Estudiantes de Enseñanza Media, 2014, p.22} ~ Past 12-month prevalence of drug use (tranquilizer, stimulant) according to medical prescription and sex. Middle school students Uruguay 2014 (%) {VI Encuesta Nacional Sobre Consumo de Drogas en Estudiantes de Enseñanza Media, 2014, p.49, p.50} ~ Past 30-day prevalence by type of substance according to sex, region of residence and age. Middle school students Uruguay, 2014 (%) {VI Encuesta Nacional Sobre Consumo de Drogas en Estudiantes de Enseñanza Media, 2014, p.29} ~ Profile of new marijuana users in the last 12 months. Uruguay 2014. (Sex, Age, Geographical Area) {VI Encuesta Nacional en Hogares sobre Consumo de Drogas, 2016, p.66} ~ Average age of first-time use by type of substance according to sex and area of residence. Middle school students Uruguay, 2014 {VI Encuesta Nacional Sobre Consumo de Drogas en Estudiantes de Enseñanza Media, 2014, p.30} ~ Frequency of consumption in the last 12 months, according to sex and area of residence. Middle school students Uruguay, 2014 (%) (Only once, Sometimes in the last 12 months, Sometimes monthly, Sometimes weekly, Daily) {VI Encuesta Nacional Sobre Consumo de Drogas en Estudiantes de Enseñanza Media, 2014, p.53, p.69} ~ Risk of problematic use of marijuana, according to sex, age and geographical area. Middle school students Uruguay, 2014 (%) {VI Encuesta Nacional Sobre Consumo de Drogas en Estudiantes de Enseñanza Media, 2014, p.56} ~ Consumption of substances according to sex and level of involvement of parents. Middle school students Uruguay, 2014 (%) {VI Encuesta Nacional Sobre Consumo de Drogas en Estudiantes de Enseñanza Media, 2014, p.77} ~ Ratio between the total number of males who consumed in the last 12 months and the total number of women with the same behavior. (marijuana, cocaine) {VI Encuesta Nacional en Hogares sobre Consumo de Drogas, 2016, p.71, p.77} ~ ",15
Y,Uruguay,URY,Demand Reduction,Prevalence of drug use by type,Yes,"the number of people between 18 and 65 years old who consumed ""marijuana"" at least once in the 12 months prior to the date of the study {Mercado Regulado Del Cannabis, 2018, p.2} ~ prevalence of male registered purchasers among marijuana consumers in the last 12 months {Mercado Regulado Del Cannabis, 2018, p.4} ~ the distribution of those who consume marijuana by place of residence {Mercado Regulado Del Cannabis, 2018, p.4} ~ Consumption of tranquillizers at some time in the life according to prescription. Uruguay 2014. (By medical prescription; He took them on his own: First he was prescribed and then on his own) {VI Encuesta Nacional en Hogares sobre Consumo de Drogas, 2016, p.58} ~ the proportion of people who purchase marijuana for consumption by age (18-29, 30-44, 45 and older) {Mercado Regulado Del Cannabis, 2018, p.4} ~ Consumption of tranquilizers, with and without medical prescription, according to age and sex (percentage of positive responses). Uruguay 2014. {VI Encuesta Nacional en Hogares sobre Consumo de Drogas, 2016, p.60} ~ Lifetime prevalence of marijuana, alcohol, and tobacco use according to risk perception. Middle school students Uruguay, 2014 (%) {VI Encuesta Nacional Sobre Consumo de Drogas en Estudiantes de Enseñanza Media, 2014, p.66; VI Encuesta Nacional en Hogares sobre Consumo de Drogas, 2016, p.93} ~ Lifetime prevalence of marijuana use by people who have never consumed alcohol or tobacco in their life. Middle school students Uruguay, 2003-2014 (%) {VI Encuesta Nacional Sobre Consumo de Drogas en Estudiantes de Enseñanza Media, 2014, p.55} ~ Lifetime prevalence of hypnotics, antidepressants and stimulants, with and without medical prescription, according to sex and age. Uruguay 2014. {VI Encuesta Nacional en Hogares sobre Consumo de Drogas, 2016, p.61} ~ Lifetime prevalence of substance use in high school students by type of substance, Uruguay, 2014 (%) {VI Encuesta Nacional Sobre Consumo de Drogas en Estudiantes de Enseñanza Media, 2014, p.18} ~ Lifetime prevalence of the consumption of other drugs. Uruguay 2014 (Hallucinogens, Hashish, Inhalants, Base paste, Ketamine, Crack, Poppers s / d, Heroin, Morphine (spm), Opium, Other) {VI Encuesta Nacional en Hogares sobre Consumo de Drogas, 2016, p.84} ~ Lifetime prevalence tranquilizer use according to sex and medical prescription. Middle school students Uruguay, 2014 (%) {VI Encuesta Nacional Sobre Consumo de Drogas en Estudiantes de Enseñanza Media, 2014, p.48} ~ Lifetime prevalence, past 12 month prevalence, past 30 day prevalence of drug use (marijuana use, tranquilizer use with and without medical prescription, stimulant use with and without medical prescription, cocaine, ATS) according to the age group (percentage of positive responses). Uruguay 2014. {VI Encuesta Nacional en Hogares sobre Consumo de Drogas, 2016, p.58, p.64, p.65, p.66, p.74, p.80, p.88; VI Encuesta Nacional Sobre Consumo de Drogas en Estudiantes de Enseñanza Media, 2014, p.47, p.50, p.51, p.62} ~ indicators of drug use (tranquilizer use, marijuana use, cocaine) according to sex and place of residence (in percentage). Uruguay 2014. (Consumption at some time in life, Consumption in the last 12 months, Consumption in the last 30 days) {VI Encuesta Nacional en Hogares sobre Consumo de Drogas, 2016, p.60, p.65, p.75} ~ Past 12 month prevalence by type of substance according to age. Middle school students Uruguay, 2014 (%) {VI Encuesta Nacional Sobre Consumo de Drogas en Estudiantes de Enseñanza Media, 2014, p.19, p.20, p.24, p.26, p.51, p.59, p.71, p.77} ~ Past 12 month prevalence by substance according to sex and age . Middle school students Uruguay, 2014 (%) {VI Encuesta Nacional Sobre Consumo de Drogas en Estudiantes de Enseñanza Media, 2014, p.22, p.49, p.52} ~ Past 12 month prevalence according to sex and area of residence. Tobacco and marijuana. Middle school students Uruguay, 2014 (%) {VI Encuesta Nacional Sobre Consumo de Drogas en Estudiantes de Enseñanza Media, 2014, p.22} ~ Past 12 month prevalence of by type of substance according to region and geographical area of residence. Middle School Students. Uruguay 2014 (%) {VI Encuesta Nacional Sobre Consumo de Drogas en Estudiantes de Enseñanza Media, 2014, p.25, p.27, p.28, p.53} ~ Past 12-month prevalence of drug use (tranquilizer, stimulant) according to medical prescription and sex. Middle school students Uruguay 2014 (%) {VI Encuesta Nacional Sobre Consumo de Drogas en Estudiantes de Enseñanza Media, 2014, p.49, p.50} ~ Consumption of drugs (tranquilizers, antidepressants, marijuana, cocaine, ecstasy) in the last 12 months according to level of consumption (low, medium, high) Uruguay 2014. {VI Encuesta Nacional en Hogares sobre Consumo de Drogas, 2016, p.60, p.61, p.65, p.75, p.81} ~ Past 30-day prevalence by type of substance according to sex, region of residence and age. Middle school students Uruguay, 2014 (%) {VI Encuesta Nacional Sobre Consumo de Drogas en Estudiantes de Enseñanza Media, 2014, p.29} ~ Profile of new marijuana users in the last 12 months. Uruguay 2014. (Sex, Age, Geographical Area) {VI Encuesta Nacional en Hogares sobre Consumo de Drogas, 2016, p.66} ~ Average age of first-time use according to drug type (marijuana, cocaine). Uruguay 2014 {VI Encuesta Nacional en Hogares sobre Consumo de Drogas, 2016, p.67, p.76; VI Encuesta Nacional Sobre Consumo de Drogas en Estudiantes de Enseñanza Media, 2014, p.30} ~ Average age of first-time use by type of substance according to sex and area of residence. Middle school students Uruguay, 2014 {VI Encuesta Nacional Sobre Consumo de Drogas en Estudiantes de Enseñanza Media, 2014, p.30} ~ Frequency of drug use (marijuana, cocaine) in the last year according to age range (in percentage). Uruguay 2014. (Once only, Sometimes during the last 12 months, Sometimes monthly, Sometimes weekly, Daily) {VI Encuesta Nacional en Hogares sobre Consumo de Drogas, 2016, p.69; VI Encuesta Nacional Sobre Consumo de Drogas en Estudiantes de Enseñanza Media, 2014, p.54, p.62} ~ Frequency of consumption reached by ex-marijuana users. Middle school students Uruguay, 2014 (%) (Only once, Sometimes in the last 12 months, Sometimes monthly, Sometimes weekly, Daily) {VI Encuesta Nacional Sobre Consumo de Drogas en Estudiantes de Enseñanza Media, 2014, p.54} ~ Frequency of drug consumption (marijuana, cocaine) in ex-consumers and consumers in the last 12 months. Uruguay 2014. (Only tried once or twice, Once only, Sometimes per year, Sometimes monthly, Sometimes weekly, Daily) {VI Encuesta Nacional en Hogares sobre Consumo de Drogas, 2016, p.68, p.77} ~ Students with high risk of problematic marijuana use according to the frequency of consumption of the substance in the last year. Middle school students Uruguay 2014. (%) {VI Encuesta Nacional Sobre Consumo de Drogas en Estudiantes de Enseñanza Media, 2014, p.57, p.58} ~ Risk of problematic use of marijuana, according to sex, age and geographical area. Middle school students Uruguay, 2014 (%) {VI Encuesta Nacional Sobre Consumo de Drogas en Estudiantes de Enseñanza Media, 2014, p.56} ~ Students with high risk of problematic marijuana use according to the age of substance use. Middle school students Uruguay, 2014 (%) {VI Encuesta Nacional Sobre Consumo de Drogas en Estudiantes de Enseñanza Media, 2014, p.59} ~ Students according to the number of friends who use marijuana. Middle school students Uruguay, 2014 (%) (None, Less than half, Half of my friends, All or almost all, I do not know, Total) {VI Encuesta Nacional Sobre Consumo de Drogas en Estudiantes de Enseñanza Media, 2014, p.60} ~ Marijuana use in the last thirty days as tolerated by parents. Middle school students Uruguay, 2014. {VI Encuesta Nacional Sobre Consumo de Drogas en Estudiantes de Enseñanza Media, 2014, p.78} ~ Ratio between the total number of males who consumed in the last 12 months and the total number of women with the same behavior. (marijuana, cocaine) {VI Encuesta Nacional en Hogares sobre Consumo de Drogas, 2016, p.71, p.77} ~ Proportion of people who started consumption in the last 12 months on the total population that could potentially have done so (marijuana, cocaine) {VI Encuesta Nacional en Hogares sobre Consumo de Drogas, 2016, p.71, p.77} ~ People of the environment who know of people who consume marijuana. Uruguay 2014. (Friends who use marijuana, Most friends (whether or not they use marijuana), Father and / or mother, Brothers, Other relatives, Co-workers, Study partners, Couple, Children, Known, Other, Do not know /does not answer) {VI Encuesta Nacional en Hogares sobre Consumo de Drogas, 2016, p.89} ~ Professionals who prescribed tranquilizers consumed at some time in his life. Uruguay 2014 (General practitioner, Psychiatrist, Other specialist) {VI Encuesta Nacional en Hogares sobre Consumo de Drogas, 2016, p.58} ~",36
Y,Uruguay,URY,Demand Reduction,Number of people who use drugs,Yes,"Consumption situation one year after the Social Insertion proposal was made - Situation of consumption of the participants in the projects at the time of the evaluation (%): Consume more than before; Does not consume; Consume sporadically {Inserción social: Evaluación de resultados obtenidos por personas derivadas a proyectos de inserción social, 2011-2014, p.10} ~ Proportion of consumers in the last 12 months over the total of those who have ever consumed in life (except those who started this year) (marijuana, cocaine). {VI Encuesta Nacional en Hogares sobre Consumo de Drogas, 2016, p.71, p.77} ~ ",2
Y,Uruguay,URY,Demand Reduction,"Prevalence of drug use by mode of administration (oral, mucosa, inhalation, and injection)",No,n/a,0
Y,Uruguay,URY,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT)",No,n/a,0
Y,Uruguay,URY,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT) by age",No,n/a,0
Y,Uruguay,URY,Demand Reduction,Level of access to opioid substitution treatment and medication assisted treatment (OST/MAT),No,n/a,0
Y,Uruguay,URY,Demand Reduction,Level of coverage of inpatient treatment,No,n/a,0
Y,Uruguay,URY,Demand Reduction,Proportion of people who use drugs enrolled in voluntary treatment,No,n/a,0
Y,Uruguay,URY,Demand Reduction,Proportion of people who use drugs enrolled in coerced treatment,No,n/a,0
Y,Uruguay,URY,Demand Reduction,Proportion of people who use drugs enrolled in compulsory treatment,No,n/a,0
Y,Uruguay,URY,Demand Reduction,Presence of prevention programming in law enforcement,No,n/a,0
Y,Uruguay,URY,Demand Reduction,Presence of prevention programming in the media,No,n/a,0
Y,Uruguay,URY,Demand Reduction,Presence of prevention programming in schools,No,n/a,0
Y,Uruguay,URY,Demand Reduction,Presence of prevention programming in the workplace,No,n/a,0
Y,Uruguay,URY,Demand Reduction,Presence of prevention programming for youth and the community,No,n/a,0
Y,Uruguay,URY,Demand Reduction,Presence of other demand reduction metrics,Yes,"The number of people who participated in the Academic Debate Seminar on Drugs {Annual Report year, 2016, p.3} ~ Student statements about the reasons why they tried marijuana. Middle school students Uruguay, 2014 (%) (Curiosity; Environment; Upset staff; I do not know; Others) {VI Encuesta Nacional Sobre Consumo de Drogas en Estudiantes de Enseñanza Media, 2014, p.61} ~",2
Y,Uruguay,URY,Supply Reduction,Size and value of the illegal drug market,Yes,"number of reports made by the Early Warning System {Annual Report year, 2016, p.4} ~ Number of open cases of illicit trafficking and money laundering for identification of assets and precautionary measure {Annual Report year, 2016, p.17} ~ Ease of access according to substance. Uruguay 2014. (It would be easy for him, it would be difficult, but he could get, he could not get, he does not know) (Marijuana, Cocaine, Base Paste, Ecstasy, Methamphetamines) {VI Encuesta Nacional en Hogares sobre Consumo de Drogas, 2016, p.90; VI Encuesta Nacional Sobre Consumo de Drogas en Estudiantes de Enseñanza Media, 2014, p.60} ~ Direct offer of marijuana. Uruguay 2014 (Never offered, Yes to try, Yes to buy, Yes to try and buy) {VI Encuesta Nacional en Hogares sobre Consumo de Drogas, 2016, p.90; VI Encuesta Nacional Sobre Consumo de Drogas en Estudiantes de Enseñanza Media, 2014, p.60} ~ Most common form of obtaining marijuana from consumers in the last 12 months. Uruguay 2014. {VI Encuesta Nacional en Hogares sobre Consumo de Drogas, 2016, p.94} ~ Origin of the marijuana that they gave him. Uruguay 2014. (Obtained from the illegal market; Is from self-cultivation of a friend / acquaintance / relative; Does not know / does not answer) {VI Encuesta Nacional en Hogares sobre Consumo de Drogas, 2016, p.94} ~ ",6
Y,Uruguay,URY,Supply Reduction,Level of procedures related to crop eradication,No,n/a,0
Y,Uruguay,URY,Supply Reduction,"Number of arrests, seizures, and offences",Yes,"the number of phones seized and confiscated {Annual Report year, 2016, p.19} ~ Total drug seizures and averages per year by type (marijuana, cannabis plants, cocaine, pasta base) {Indicadores de control de la oferta: Informe, 2012, p.6, p.7, p.8, p.9} ~Seizures and Procedures per year. (Ecstasy - LSD - Hashis - Heroin) {Indicadores de control de la oferta: Informe, 2012, p.11} ~ Comparison of seizures and procedures performed 2008-2012 {Indicadores de control de la oferta: Informe, 2012, p.18} ~ Seizures and Procedures by region- year 2012 {Indicadores de control de la oferta: Informe, 2012, p.20} ~ Number and type of assets seized and made available to the JND during this Period (Source: Confiscated Property Fund - JND / SND) {Annexes, p.2} ~ Substances Seized in kilograms, years 2005 to 2011 (Marijuana, Cocaine, Pasta Base, Coca Leaves, Ecstasy, Hashish, Heroin, LSD) {Annexes, p.5} ~ Substances seized for the years 2000-2012 {Indicadores de control de la oferta: Informe, 2012, p.21} ~ Detained (most freed processed) per year and monthly average and by procedure. {Indicadores de control de la oferta: Informe, 2012, p.12} ~ Percentage of detainees (processed more liberated) men * {Indicadores de control de la oferta: Informe, 2012, p.13} ~ Total detainees (most freed processed) by sex and year. {Indicadores de control de la oferta: Informe, 2012, p.13} ~ Detained and prosecuted - years 2008-2012 {Indicadores de control de la oferta: Informe, 2012, p.20} ~ Detained and processed by region - year 2012 {Indicadores de control de la oferta: Informe, 2012, p.20} ~ The number and proportion of persons detained and processed, years 2005 to 2011 {Annexes, p.5} ~",14
Y,Uruguay,URY,Supply Reduction,Level of law enforcement activity and interdiction in the market,Yes,"number of cases formalized and monitored under the JND agreement - National Housing Agency (ANV) - Banco Hipotecario del Uruguay (BHU) {Annual Report year, 2016, p.14} ~ Number of cases registered in the new system of Forfeited Assets {Annual Report year, 2016, p.17} ~ Number of cases registered in 2016 {Annual Report year, 2016, p.17} ~ Number of cases closed {Annual Report year, 2016, p.17, p.18} ~ Number of cases entered by Brigades pending validation {Annual Report year, 2016, p.18} ~ number of cases canceled {Annual Report year, 2016, p.18} ~ Number of people who participated in the training session on ""Proceeds of assets since their seizure until its confiscation "", organized by the FBD, from the Public Ministry and Prosecutor (MPyF), Judicial Branch (Judges Criminal Lawyers), MI (DGRTID and Anti-Drug Brigades) and members of the FBD {Annual Report year, 2016, p.18} ~ Number of participations in the training sessions for seizure and confiscation of goods, organized by DIVIN 7 and 9 November {Annual Report year, 2016, p.18} ~ Number of people who participated in II Seminar Regional Workshop, organized by the FBD together with the PAHO / WHO, with the aim of establishing a field of exchange between actors involved (MPyF, Judicial Branch, MI, MDN, MEC, BROU, ANRTCI and FBD). {Annual Report year, 2016, p.18} ~ Total number of procedures a year {Indicadores de control de la oferta: Informe, 2012, p.4} ~ Total procedures and monthly average (per year). {Indicadores de control de la oferta: Informe, 2012, p.4} ~ Distribution of procedures by semester. {Indicadores de control de la oferta: Informe, 2012, p.5} ~",12
Y,Uruguay,URY,Supply Reduction,"Price, purity and potency of drugs, and related process indicators",No,n/a,0
Y,Uruguay,URY,Supply Reduction,Number of people engaged with the criminal justice system,Yes,"number of cases whose first indictment was in 2016 {Annual Report year, 2016, p.18} ~ Total processed year and monthly average {Indicadores de control de la oferta: Informe, 2012, p.14} ~ Annual average of Processed by procedure and percentage of processed over total of detainees {Indicadores de control de la oferta: Informe, 2012, p.14} ~ Evolution of the relationship processed / detained. (% of processed over total of detainees). {Indicadores de control de la oferta: Informe, 2012, p.15} ~ Percentage of defendants on detentions controlled by sex {Indicadores de control de la oferta: Informe, 2012, p.15} ~ Relationship processed / detained by sex and year. {Indicadores de control de la oferta: Informe, 2012, p.16} ~ Transaction risks according to those who bought directly. Uruguay 2014 (Legal / police / arrest issues; Poor product quality; Unspecific (insecurity, pressure)) { VI Encuesta Nacional en Hogares sobre Consumo de Drogas, 2016, p.95} ~",7
Y,Uruguay,URY,Supply Reduction,Presence of other supply reduction metrics,Yes,"the department with the highest and lowest level of registered purchasers and number of purchasers registered {Mercado Regulado Del Cannabis, 2018, p.4} ~ Daily register of purchasers in pharmacy (accumulated values) 05/02/17 to 04/05/18 {Mercado Regulado Del Cannabis, 2018, p.5} ~ Distribution of purchasers according to place of residence. (%) {Mercado Regulado Del Cannabis, 2018, p.6} ~ Distribution of purchasers according to activity condition (Informal, Private, Public, No Activity, No data, Do not know / do not answer, Total). (%) {Mercado Regulado Del Cannabis, 2018, p.7} ~ Profile of registered acquirers (Male; Female; 18 - 29 years old; 30-44 years old; 45-65 years old; 66 and over; Montevideo; Interior; Informal Work; Activity in the Private sector; Activity in the Public sector; Activity) to buy in pharmacy and from those purchasers who made a purchase at least once in the period 19/7/2017 to 04/05/2018 (Total purchasers authorized to buy, Purchasing purchasers) {Mercado Regulado Del Cannabis, 2018, p.8} ~ number of people who are authorized to access marijuana in a regulated manner {Mercado Regulado Del Cannabis, 2018, p.2} ~ the number of people who make up the register of purchasers in pharmacies {Mercado Regulado Del Cannabis, 2018, p.2} ~ the number of people who are registered as auto growers {Mercado Regulado Del Cannabis, 2018, p.2} ~ the number of people who are registered as members of 90 Membership Clubs. {Mercado Regulado Del Cannabis, 2018, p.2} ~ prevalence of population directly involved in the regulated market {Mercado Regulado Del Cannabis, 2018, p.2} ~ the number of people registered and the total number of people in the regulated market according to modality. Information at 04/05/2018 (Autocultivadores, Acquireres, Clubs) {Mercado Regulado Del Cannabis, 2018, p.3} ~ Registration of self-cultivators - number and percent (Approved and current, Cancellation of the procedure, Low, Denied, Pending, Suspended) {Mercado Regulado Del Cannabis, 2018, p.9} ~ Monthly records of self-cultivators (August 2014-February 2018) {Mercado Regulado Del Cannabis, 2018, p.10} ~ Register self-cultivators (monthly accumulated values; August 2014-February 2018) {Mercado Regulado Del Cannabis, 2018, p.10} ~ Profile of self-cultivators: Distribution by sex (Absolute number and percent) (Male; Woman; No data). {Mercado Regulado Del Cannabis, 2018, p.11} ~ Profile of self-cultivators: Distribution by age (Absolute number and percent) (18-29, 30-44, 45-65, 66 and older, No Data) {Mercado Regulado Del Cannabis, 2018, p.12} ~ profile of self-cultivators: Distribution by place of residence (Absolute number and percent) (Artigas; Canelones, Cerro Largo, Colonia, Durazno, Flores, Florida, Lavalleja, Maldonado, Montevideo, Paysandú, Rio Negro, Rivera, Rocha, Salto, San José, Soriano, Tacuarembó, Treinta y Tres, No Data, Total) {Mercado Regulado Del Cannabis, 2018, p.13} ~ Legal relationship with the domicile declared for self-cultivation (Tenant, Owner, Other) (Absolute Number and Percent) {Mercado Regulado Del Cannabis, 2018, p.14} ~ Number of cannabis clubs applications that have been processed {Mercado Regulado Del Cannabis, 2018, p.15} ~ Number of approved cannabis clubs {Mercado Regulado Del Cannabis, 2018, p.15} ~ The proportion of cannabis clubs in Montevideo {Mercado Regulado Del Cannabis, 2018, p.15} ~ The number of people who are registered and qualified as members of the cannabis clubs {Mercado Regulado Del Cannabis, 2018, p.15} ~ Registration status (number of cases and percent) with the IRCCA (Approved, Denied, In process, Observed, Pending, Total) {Mercado Regulado Del Cannabis, 2018, p.15} ~ The number of applications approved per year {Mercado Regulado Del Cannabis, 2018, p.16} ~ The number and percent of clubs registered by region, and the number and percent of clubs by region {Mercado Regulado Del Cannabis, 2018, p.16} ~ Registration status of club members (Approved, Discharged, Denied, Disabled by term, Pending) (Number and percent of cases) {Mercado Regulado Del Cannabis, 2018, p.17} ~ Number of clubs, members in total and average per club {Mercado Regulado Del Cannabis, 2018, p.17} ~ Applications for registration per year (approved and current) {Mercado Regulado Del Cannabis, 2018, p.18} ~ Relationship of the civil association with the address provided (Tenant, Others, Owner, Total) (number of cases and percent) {Mercado Regulado Del Cannabis, 2018, p.18} ~ Origin of the marijuana that they gave him. Uruguay 2014. (Obtained from the illegal market; Is from self-cultivation of a friend / acquaintance / relative; Does not know / does not answer) {VI Encuesta Nacional en Hogares sobre Consumo de Drogas, 2016, p.94} ~ Probability of use of access mechanism (Pharmacies; Self-cultivation; Membership Club) to regulated marijuana (in percentage). Uruguay 2014. (Surely use it, probably use it, probably not use it, probably not use it, do not know / do not answer) {VI Encuesta Nacional en Hogares sobre Consumo de Drogas, 2016, p.95} ~ Perception of marijuana users in the last 12 months on the impact of market regulation on general and personal consumption (in percentage). Uruguay 2014. * (Increases, stays the same, stays the same, descends, does not know / does not answer) {VI Encuesta Nacional en Hogares sobre Consumo de Drogas, 2016, p.96} ~ Perception of non-users of marijuana in the last 12 months on the impact of market regulation on general and personal consumption (in percentage). Uruguay 2014. * (Increases, stays the same, does not influence to consume, descends, does not know / does not answer) {VI Encuesta Nacional en Hogares sobre Consumo de Drogas, 2016, p.97} ~ number of self-cultivators (registered per year, accumulated) 2014-2017 {Annual Report, 2017, p.10} ~ Membership clubs (annual ratings, accumulated) 2014-2017 {Annual Report, 2017, p.11} ~ acquirers registered in 2017 (registered acquirers per month, accumulated) {Annual Report, 2017, p.11} ~",36
Y,Uruguay,URY,International Cooperation,Level of engagement in international cooperation,No,n/a,0
Y,Ecuador,ECU,Health,Level of availability of harm reduction services and harm reduction scale up,No,n/a,0
Y,Ecuador,ECU,Health,Presence of needle and syringe programs,No,n/a,0
Y,Ecuador,ECU,Health,Prevalence of substance use disorders,Yes,"CAST (cannabis consumption) test results by region, sex and age group [%] (Does not exist, Low level, Moderate level, High level) {IV Estudio nacional sobre uso de drogas en población de 12 a 65 años, 2014, p.18, Cuarta encuesta nacional sobre uso de drogas en estudiantes de 12 a 17 años, 2012, p.47} ~ Possible abuse of marijuana according to the CAST scale by city (%) {Cuarta encuesta nacional sobre uso de drogas en estudiantes de 12 a 17 años, 2012, p.74} ~",2
Y,Ecuador,ECU,Health,Prevalence of psychiatric comorbidities,Yes,"Number of first-time visits for mental disorders and behavior due to the use and consumption of alcohol, tobacco and other drugs until 2021 {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.89} ~",1
Y,Ecuador,ECU,Health,Drug-related mortality,Yes,"number of deaths related to drug use in Ecuador, and the prevalence of total deaths nationwide {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.18} ~ number of drug-related deaths reported in Ecuador in 2015, the proportion of drug-related deaths of the total number of deaths in Ecuador {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.36} ~ The gross mortality rate due to drug use per million inhabitants {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.36, p.89} ~ Damages associated with drug use [%] (Is there a person in your family who has died from alcohol or other drugs? Is there a person in your family who has suffered an overdose due to drug use?) {V Estudio nacional sobre uso de drogas en población de 12 a 65 años, 2014, p.25} ~ Number of deaths or serious injuries associated with consumption {Costo del fenómeno de las drogas en Ecuador, 2015, p.5} ~ Costs of premature deaths in terms of productivity {Costo del fenómeno de las drogas en Ecuador, 2015, p.8} ~",6
Y,Ecuador,ECU,Health,Prevalence of drug-related infectious disease,No,n/a,0
Y,Ecuador,ECU,Health,Proportion of people who use drugs who engage in risky consumption,No,n/a,0
Y,Ecuador,ECU,Health,Proportion of people who use drugs who engage in safe consumption practices,No,n/a,0
Y,Ecuador,ECU,Health,"Coverage of services for the prevention, testing, and treatment of bloodborne diseases",No,n/a,0
Y,Ecuador,ECU,Health,Presence of specialised training for addiction care,Yes,"Number of public servants sensitized and trained in prevention of UyCPD. {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.87} ~ Number of DECE professionals trained on routes and detection and referral protocols. {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.87} ~ Number of trained health professionals {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.87} ~ Total number of officials with technical skills to handle drug problems {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.87} ~",4
Y,Ecuador,ECU,Health,Presence of health harms related to drug use,Yes,"Damages associated with drug use [%] (Is there a person in your family who was left with a physical disability as a result of an accident produced by a person under the influence of alcohol or other drugs?) { V Estudio nacional sobre uso de drogas en población de 12 a 65 años, 2014, p.25} ~ Outpatient care 2015 for causes related to drugs (morbidity) # attentions: Hypotension due to drugs (I952); Fetus and newborn affected by maternal drug addiction (P044); Neonatal symptoms of abstinence due to maternal drug addiction (P961); Finding opiate drugs in the blood (R781); Finding cocaine in the blood (R782); Finding other potentially addictive drugs in the blood (R784); Finding psychotropic drugs in the blood (R785); Finding abnormal levels of heavy metals in the blood (R787); Finding of unspecified substance that is not normally found in the blood (R789); Poisoning by narcotics and psychodysleptics [hallucinogens]: opium (T400); Poisoning by narcotics and psychodysleptics [hallucinogens]: heroin (T401); Poisoning by narcotics and psychodysleptics [hallucinogens]: other opioids (T402); Poisoning by narcotics and psychodysleptics [hallucinogens]: methadone (T403); Poisoning by narcotics and psychodysleptics [hallucinogens]: other synthetic narcotics (T404); Poisoning by narcotics and psychodisleptics [hallucinogens]: cocaine (T405); Poisoning by narcotics and psychodysleptics [hallucinogens]: other narcotics and those not specified (T406); Poisoning by narcotics and psychodysleptics [hallucinogens]: cannabis (derivatives) (T407); Poisoning by narcotics and psychodysleptics [hallucinogens]: lysergic acid [LSD] (T408); Poisoning by narcotics and psychodysleptics [hallucinogens]: other psychodisleptics and the unspecified [hallucinogens] (T409); Poisoning by psychotropic drugs, not classified elsewhere: psychostimulants with potential abuse (T436); Poisoning by psychotropic drugs, not elsewhere classified: other psychotropic drugs, not classified elsewhere (T438); Poisoning by psychotropic drugs, not elsewhere classified: unspecified psychotropic drug (T439) {Costo del fenómeno de las drogas en Ecuador, 2015,  p.17} ~ Number of [...] serious injuries associated with consumption {Costo del fenómeno de las drogas en Ecuador, 2015, p.5} ~ ",3
Y,Ecuador,ECU,Health,Presence of other health metrics,Yes,"Economic loss due to morbidity {Costo del fenómeno de las drogas en Ecuador, 2015, p.9} ~ Costs associated with the phenomenon of drugs in Ecuador in 2015 (Health care costs) {Costo del fenómeno de las drogas en Ecuador, 2015, p.11} ~",2
Y,Ecuador,ECU,Peace and Security,"Prevalence of alcohol and drugs in accidents, and interventions to increase road safety",Yes,"The number of trained personnel of the Traffic Control Unit for Internal Consumption (UCTCI) {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.90} ~ The number of re-adapted bases of the UCTCI {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.90} ~ The number of bases equipped with the UCTCI {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.90} ~ Damages associated with drug use [%] (Is there a person in your family who has suffered an accident as a result of alcohol or other drugs? Have you had any traffic accidents due to alcohol consumption? Is there a person in your family who was left with a physical disability as a result of an accident produced by a person under the influence of alcohol or other drugs?) {IV Estudio nacional sobre uso de drogas en población de 12 a 65 años, 2014, p.25} ~ The number of traffic accidents caused by the consumption of alcohol and other drugs by month in 2015 (C06) {Costo del fenómeno de las drogas en Ecuador, 2015, p.25} ~ Cost of traffic accidents 2015 (Traffic accidents, Number of accidents Cost (USD)) {Costo del fenómeno de las drogas en Ecuador, 2015, p.25} ~",6
Y,Ecuador,ECU,Peace and Security,Annual number of public disorder and violent crime reports,Yes,"ratio of women reported being victims of some type of gender violence throughout their lives. {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021,  p.35} ~ prevalence of women in treatment for problematic drug use that have suffered some kind of gender violence {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.35} ~ Intrafamily violence associated with drugs by region, sex and age [%] (They insulted him while his family member was under the influence of some drug / alcohol; he was offended or denigrated while his family member was under the influence of a drug / alcohol; with hitting him or throwing him out of the house while his family member was under the influence of some drug / alcohol, they humiliated or belittled him while his family member was under the influence of some drug / alcohol, he received physical abuse while his family member was under the influence of some drug / alcohol; He received psychological abuse while his family member was under the influence of a drug / alcohol, they ignored him or did not give him attention while his family member was under the influence of a drug / alcohol) {IV Estudio nacional sobre uso de drogas en población de 12 a 65 años, 2014, p.25} ~ The cost of damages to vehicles in 2015 {Costo del fenómeno de las drogas en Ecuador, 2015, p.24} ~ Destruction of physical asset {Costo del fenómeno de las drogas en Ecuador, 2015, p.8} ~",5
Y,Ecuador,ECU,Peace and Security,Number of non-lethal drug market violent events reported,No,n/a,0
Y,Ecuador,ECU,Peace and Security,Number of drug market related homicides and disappearances,No,n/a,0
Y,Ecuador,ECU,Peace and Security,Presence of other peace and security metrics,Yes,"Costs associated with the phenomenon of drugs in Ecuador in 2015 (Property damage) {Costo del fenómeno de las drogas en Ecuador, 2015, p.11} ~",1
Y,Ecuador,ECU,Development,Coverage of housing assistance for people who use drugs,No,n/a,0
Y,Ecuador,ECU,Development,Coverage of social assistance for people who use drugs (not including housing),No,n/a,0
Y,Ecuador,ECU,Development,Number of households enrolled in alternative development,Yes,"Number of multisector interventions for preventive alternative development to illicit activities related to drugs {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.90} ~",1
Y,Ecuador,ECU,Development,Presence of other development metrics,Yes,"the proportion of the GDP that reflects the socio-economic phenomenon of drugs {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.17} ~  Evolution of the Unified Basic Salary (2006-2017) {Costo del fenómeno de las drogas en Ecuador, 2015, p.27} ~ Costs associated with the phenomenon of drugs in Ecuador in 2015 (Labor costs-productivity) {Costo del fenómeno de las drogas en Ecuador, 2015, p.11} ~ Loss of labor productivity due to: definitive absenteeism (Cause; Age of death; People; Lost years; Present value according to lost years (USD); Annual cost (USD)); temporary absenteeism due to hospital discharges (by Cause, Expenses, Average, Days of Stay, Annual Cost (USD)); temporary absenteeism due to residential treatment (by Basic Salary; Unified 2015 (USD); Duration of treatment (months) # people; Total cost (USD))(processed) by State of cause; # of people; temporary absenteeism due to detention time (months) (by Basic salary; Unified 2015 (USD); Total cost (USD)) {Costo del fenómeno de las drogas en Ecuador, 2015, p.28, p.30, p.32} ~ Present value of lost work productivity by temporary absences (sentenced) by Scale; # of people; Minimum sentence time (years); Present value; according to lost years (USD); Annual cost (USD) {Costo del fenómeno de las drogas en Ecuador, 2015, p.32} ~ Absenteeism costs and loss of labor productivity (premature deaths (definitive absenteeism); Hospital expenditures; Residential treatment; People processed; Sentenced people) {Costo del fenómeno de las drogas en Ecuador, 2015, p.33} ~",6
Y,Ecuador,ECU,Human Rights,"Prevalence and incidence of infectious diseases in vulnerable populations (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Ecuador,ECU,Human Rights,"Prevalence of vulnerable people who use drugs (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Ecuador,ECU,Human Rights,Proportion of people who use drugs in prison that are receiving medication assisted treatment (MAT),No,n/a,0
Y,Ecuador,ECU,Human Rights,Distribution of sterile injecting equipment in prisons,No,n/a,0
Y,Ecuador,ECU,Human Rights,Presence of programs and services targeted towards women ,Yes,"prevalence of women in treatment for problematic drug use that have suffered some kind of gender violence {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.35} ~ The number of girls [...] at risk of addiction who receive attention for prevention of the problematic use of psychoactive substances during the year 2018 {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.89} ~ Cost of medical care related to drugs (hospital discharges): Maternal care for (presumed) fetal injury due to drugs (O355); Fetus and newborn affected by maternal drug addiction (P044); Neonatal symptoms of abstinence due to maternal drug addiction (P961) {Costo del fenómeno de las drogas en Ecuador, 2015, p.21} ~",3
Y,Ecuador,ECU,Human Rights,Presence of programs and services targeted towards people of color,No,n/a,0
Y,Ecuador,ECU,Human Rights,Presence of challenges and/or harms experienced by people of color,No,n/a,0
Y,Ecuador,ECU,Human Rights,"Presence of programs and services targeted towards vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Ecuador,ECU,Human Rights,"Presence of challenges and/or harms experienced by vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Ecuador,ECU,Human Rights,Presence of other human rights metrics,No,n/a,0
Y,Ecuador,ECU,Demand Reduction,Prevalence of drug use by age,Yes,"the average age of onset of drug use among 1st - 3rd baccalaureate students {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.17} ~The prevalence of students reported having used marijuana/cocaine/heroin in the last year {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.17} ~  Decrease the prevalence of last year of consumption of any illicit drug in students of 9th grade of Basic Education, 1st and 3rd of Baccalaureate of the National System of Education from 12.65% to 11.65% by 2021. {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.27} ~  the annual prevalence of cocaine, pasta base and heroin consumption among students {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.33} ~ average age of onset total and by drug type marijuana/cocaine/pasta base/heroin/amphetamine-type stimulants consumption {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.34, III Estudio epidemiológico andino sobre consumo de drogas en la población universitaria de Ecuador, 2016, p.66} ~ Delay the average age of the first consumption of 14 years to 15.5 years of marijuana, cocaine, heroin and base paste students of 9th grade of EGB, 1st and 3rd Bavhillerato of the National Education System {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.87} ~ Decrease the percentage of consumers (Prevalence of Consumption) in 8% for any drug in students of 9th grade of EGB, 1st and 3rd year of Baccalaureate of the National Education System {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.87} ~ Prevalence of last year of marijuana/synthetic cannabinoids/cocaine/inhalants use according to age groups (years) and sex {III Estudio epidemiológico andino sobre consumo de drogas en la población universitaria de Ecuador, 2016, p.52, p.57, p.59, p.71, p.87, p.88, p.90, p.91} ~ Age of first marijuana/synthetic cannabinoids/cocaine/pasta base/ use according to sex (Sex, Average, 25th Percentile, Medium, 75th Percentile) {III Estudio epidemiológico andino sobre consumo de drogas en la población universitaria de Ecuador, 2016 , p.52, p.57, p.59, p.62} ~ Profile of marijuana users in the last year compared to the profile of the population studied (Region, Sex, Age groups, Level of education) {IV Estudio nacional sobre uso de drogas en población de 12 a 65 años, 2014, p.16} ~ Percentage of students who reported using stimulants and tranquillizers without a prescription during the last year according to sex and age at the national level (%) {Cuarta encuesta nacional sobre uso de drogas en estudiantes de 12 a 17 años, 2012, p.43} ~ Categorization of use of inhalants/marijuana/pasta base/cocaine/heroin/ by age and sex at the national level (%) (Experimental use, Occasional use, Regular use, Frequent use, Intense use) {Cuarta encuesta nacional sobre uso de drogas en estudiantes de 12 a 17 años, 2012, p.44, p.45, p.48, p.50, p.52} ~ Average age of first use of inhalants/marijuana/cocaine/pasta base/heroin per city (years) {Cuarta encuesta nacional sobre uso de drogas en estudiantes de 12 a 17 años, 2012, p.70, p.73, p.78, p.81, p.84} ~  Last year prevalence of consumption of any illicit drug, by sex and age group {III Estudio epidemiológico andino sobre consumo de drogas en la población universitaria de Ecuador, 2016, p.77} ~ ",14
Y,Ecuador,ECU,Demand Reduction,Prevalence of drug use by sex,Yes,"Indicators of consumption of any drug according to sex (Prevalence: Life, Year, Month) {III Estudio epidemiológico andino sobre consumo de drogas en la población universitaria de Ecuador, 2016, p.77} ~ Last year prevalence of consumption of any illicit drug, by sex and age group {III Estudio epidemiológico andino sobre consumo de drogas en la población universitaria de Ecuador, 2016, p.77} ~ The annual prevalence of marijuana/cocaine/pasta base/heroin consumption by sex and total and at the territorial level {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.33, p.34} ~ Indicators of marijuana/synthetic cannabinoids/cocaine/pasta base/ecstasy/ATS/inhalants/(LSD, Fungi, Ketamine, Heroin, Hashish, Crack, Opium, Morphine, H, GHB), use by sex (Prevalence & Incidence: Life, Year, Month) {III Estudio epidemiológico andino sobre consumo de drogas en la población universitaria de Ecuador, 2016, p.51, p.57, p.58, p.62, p.65, p.66, p.71, p.72, p.93, p.94, p.95} ~ Prevalence of last year of marijuana/synthetic cannabinoids/cocaine/inhalants use according to age groups (years) and sex {III Estudio epidemiológico andino sobre consumo de drogas en la población universitaria de Ecuador, 2016, p.52, p.57, p.59, p.71, p.87, p.88, p.90, p.91} ~ Age of first marijuana/synthetic cannabinoids/cocaine/pasta base/ use according to sex (Sex, Average, 25th Percentile, Medium, 75th Percentile) {III Estudio epidemiológico andino sobre consumo de drogas en la población universitaria de Ecuador, 2016 , p.52, p.57, p.59, p.62} ~  Prevalence of marijuana use by region, sex and age group {IV Estudio nacional sobre uso de drogas en población de 12 a 65 años, 2014, p.16} ~ Profile of marijuana users in the last year compared to the profile of the population studied (Region, Sex, Age groups, Level of education) {IV Estudio nacional sobre uso de drogas en población de 12 a 65 años, 2014, p.16} ~ Percentage of students who reported using stimulants and tranquillizers without a prescription during the last year according to sex and age at the national level (%) {Cuarta encuesta nacional sobre uso de drogas en estudiantes de 12 a 17 años, 2012, p.43} ~  Categorization of use of inhalants/marijuana/pasta base/cocaine/heroin/ by age and sex at the national level (%) (Experimental use, Occasional use, Regular use, Frequent use, Intense use) {Cuarta encuesta nacional sobre uso de drogas en estudiantes de 12 a 17 años, 2012, p.44, p.45, p.48, p.50, p.52} ~ Indicators of consumption of any drug according to sex (Prevalence: Life, Year, Month) {III Estudio epidemiológico andino sobre consumo de drogas en la población universitaria de Ecuador, 2016, p.77} ~  Last year prevalence of consumption of any illicit drug, by sex and age group {III Estudio epidemiológico andino sobre consumo de drogas en la población universitaria de Ecuador, 2016, p.77} ~ ",12
Y,Ecuador,ECU,Demand Reduction,Prevalence of drug use by type,Yes,"prevalence of students reported having used marijuana/cocaine/heroin in the last year {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.17} ~ annual prevalence of marijuana/cocaine/pasta base/heroin consumption by sex and total and at the territorial level {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.33, p.34} ~ annual prevalence of cocaine, pasta base and heroin consumption among students {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.33} ~ average age of onset for marijuana/cocaine/pasta base/heroin/amphetamine-type stimulants consumption {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.34, III Estudio epidemiológico andino sobre consumo de drogas en la población universitaria de Ecuador, 2016, p.66} ~ Indicators of marijuana/synthetic cannabinoids/cocaine/pasta base/ecstasy/ATS/inhalants/(LSD, Fungi, Ketamine, Heroin, Hashish, Crack, Opium, Morphine, H, GHB), use by sex (Prevalence & Incidence: Life, Year, Month) {III Estudio epidemiológico andino sobre consumo de drogas en la población universitaria de Ecuador, 2016, p.51, p.57, p.58, p.62, p.65, p.66, p.71, p.72, p.93, p.94, p.95} ~ Prevalence of last year of marijuana/synthetic cannabinoids/cocaine/inhalants use according to age groups (years) and sex {III Estudio epidemiológico andino sobre consumo de drogas en la población universitaria de Ecuador, 2016, p.52, p.57, p.59, p.71, p.87, p.88, p.90, p.91} ~ Age of first marijuana/synthetic cannabinoids/cocaine/pasta base/ use according to sex (Sex, Average, 25th Percentile, Medium, 75th Percentile) {III Estudio epidemiológico andino sobre consumo de drogas en la población universitaria de Ecuador, 2016 , p.52, p.57, p.59, p.62} ~ Prevalence of marijuana use by region, sex and age group {IV Estudio nacional sobre uso de drogas en población de 12 a 65 años, 2014, p.16} ~ Profile of marijuana users in the last year compared to the profile of the population studied (Region, Sex, Age groups, Level of education) {IV Estudio nacional sobre uso de drogas en población de 12 a 65 años, 2014, p.16} ~ Percentage of students who reported using stimulants and tranquillizers without a prescription during the last year according to sex and age at the national level (%) {Cuarta encuesta nacional sobre uso de drogas en estudiantes de 12 a 17 años, 2012, p.43} ~ Categorization of use of inhalants/marijuana/pasta base/cocaine/heroin/ by age and sex at the national level (%) (Experimental use, Occasional use, Regular use, Frequent use, Intense use) {Cuarta encuesta nacional sobre uso de drogas en estudiantes de 12 a 17 años, 2012, p.44, p.45, p.48, p.50, p.52} ~ Intense or Heavy use of inhalants/marijuana/pasta base/ cocaine/heroin by city (%) {Cuarta encuesta nacional sobre uso de drogas en estudiantes de 12 a 17 años, 2012, p.69, p.73, p.77, p.80, p.84} ~ Average age of first use of inhalants/marijuana/cocaine/pasta base/heroin per city (years) {Cuarta encuesta nacional sobre uso de drogas en estudiantes de 12 a 17 años, 2012, p.70, p.73, p.78, p.81, p.84} ~ Prevalence of lifetime, yearly and monthly use of any drug, by drug (Prevalence: Life, Year, Month) {III Estudio epidemiológico andino sobre consumo de drogas en la población universitaria de Ecuador, 2016, p.76} ~",14
Y,Ecuador,ECU,Demand Reduction,Number of people who use drugs,Yes,"Categorization of the use of illegal drugs at the national level with the percentage of the population represented (%) {Boletín Informativo Observando, 2013, p.5} ~",1
Y,Ecuador,ECU,Demand Reduction,"Prevalence of drug use by mode of administration (oral, mucosa, inhalation, and injection)",No,n/a,0
Y,Ecuador,ECU,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT)",Yes,"Number of first-time visits for mental disorders and behavior due to the use and consumption of alcohol, tobacco and other drugs until 2021 {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.89} ~ the number of cases in ambulatory care between January - July 2017 related to the consumption or prevention of drug use and consumption {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.35} ~ The prevalence of men and women who received ambulatory care related to the consumption or prevention of drug use and consumption between January-July 2017 {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.35} ~  The provinces with the highest rate of ambulatory care per 10,000 people for marijuana/cocaine/heroin consumption {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.36} ~  Subsequent consultations of mental disorders and behavior due to the use and consumption of alcohol, tobacco and other drugs by 2021 {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.89} ~ Number of people from priority care groups, with problematic drug use referred for attention (with follow-up and accompaniment) {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.89} ~ Number of people with problematic drug use treated {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.89} ~ Outpatient care 2015 for causes related to drugs (morbidity) # attentions: Mental and behavioral disorders due to opioid use (F11); Mental and behavioral disorders due to the use of cannabinoids (F12); Mental and behavioral disorders due to the use of sedatives or hypnotics (F13); Mental and behavioral disorders due to the use of cocaine (F14); Mental and behavioral disorders due to the use of other stimulants, including caffeine (F15); Mental and behavioral disorders due to the consumption of hallucinogens (F16); Mental and behavioral disorders due to the use of volatile solvents (F18); Mental and behavioral disorders due to the use of multiple drugs or other psychotropic substances (F19) {Costo del fenómeno de las drogas en Ecuador, 2015, p.17} ~ Outpatient care 2015 for causes related to drugs (prevention): Rehabilitation of the drug addict (Z503); Attention for other rehabilitation procedures (Z508); Consultation for counseling and surveillance for drug abuse (Z715) {Costo del fenómeno de las drogas en Ecuador, 2015, p.19} ~ Outpatient care 2015 for causes related to drugs (prevention): Problems related to the use of drugs (Z722) {Costo del fenómeno de las drogas en Ecuador, 2015, p.19} ~ Cost of outpatient care for alcohol and other drugs: # ambulatory care; Cost for attention (USD); Total cost (USD) {Costo del fenómeno de las drogas en Ecuador, 2015, p.20} ~ Number of treatment requests in public and private institutions {Costo del fenómeno de las drogas en Ecuador, 2015, p.5} ~ Number of hospital admissions / discharges by consumption and duration {Costo del fenómeno de las drogas en Ecuador, 2015, p.7} ~ Number of people in treatment, type of treatment and duration of it {Costo del fenómeno de las drogas en Ecuador, 2015, p.7} ~",14
Y,Ecuador,ECU,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT) by age",Yes,"The average age of those receiving ambulatory care between January - July 2017 {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.35} ~ The prevalence of outpatient treatment patients who received care due to heroin/poly-drug use, and their average age {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.35, p.36} ~ Percentage of students who have or have not received any type of drug treatment, ever in their lives by sex (Yes, for alcohol, Yes, for drugs, Yes, for alcohol and drugs, No, have never been in treatment, Do not consume alcohol or other drugs) {III Estudio epidemiológico andino sobre consumo de drogas en la población universitaria de Ecuador, 2016, p.79} ~ Institutions that the population identifies that provide treatment to people with problems of drug use [%] (Alcoholics Anonymous and / or Narcotics Anonymous, Ministry of Public Health, Ministry of Justice, Human Rights and Worship, CONSEP, Ministry of Economic and Social Inclusion, All, Recovery Centers, National Police, Other institutions) and by region, sex and age [%] {IV Estudio nacional sobre uso de drogas en población de 12 a 65 años, 2014, p.23} ~",4
Y,Ecuador,ECU,Demand Reduction,Level of access to opioid substitution treatment and medication assisted treatment (OST/MAT),No,n/a,0
Y,Ecuador,ECU,Demand Reduction,Level of coverage of inpatient treatment,Yes,"The number of cases recorded for hospital discharges related to drug use in 2015 {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.36} ~ The provinces with the highest rate of hospital discharges due to cocaine/heroin  use per 10,000 people {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.36} ~ Cost of medical care related to drugs (hospital discharges): Mental and behavioral disorders due to opioid use (F11); Mental and behavioral disorders due to the use of cannabinoids (F12); Mental and behavioral disorders due to the use of sedatives or hypnotics (F13); Mental and behavioral disorders due to the use of cocaine (F14); Mental and behavioral disorders due to the use of other stimulants, including caffeine (F15); Mental and behavioral disorders due to the consumption of hallucinogens (F16); Mental and behavioral disorders due to the use of volatile solvents (F18); Mental and behavioral disorders due to the use of multiple drugs or other psychotropic substances (F19) {Costo del fenómeno de las drogas en Ecuador, 2015, p.21} ~ Cost of medical care related to drugs (hospital discharges): Poisoning by narcotics and psychodysleptics [hallucinogens]: opium (T400); Poisoning by narcotics and psychodysleptics [hallucinogens]: heroin (T401); Poisoning by narcotics and psychodysleptics [hallucinogens]: other opioids (T402); Poisoning by narcotics and psychodysleptics [hallucinogens]: other synthetic narcotics (T404); Poisoning by narcotics and psychodisleptics [hallucinogens]: cocaine (T405); Poisoning by narcotics and psychodysleptics [hallucinogens]: other narcotics and those not specified (T406); Poisoning by narcotics and psychodysleptics [hallucinogens]: cannabis (T407); Poisoning by narcotics and psychodysleptics [hallucinogens]: other psychodisleptics and the unspecified [hallucinogens] (T409); Poisoning by tricyclic and tetracyclic antidepressants (T430); Poisoning by antidepressants inhibitors of monoaminoxidase (T431); Poisoning by other antidepressants and by unspecified (T432); Poisoning by antipsychotics and neuroleptics phenothiazines (T433); Poisoning by butyrophenone and thioxanthenic neuroleptics (T434); Poisoning by other antipsychotics and neuroleptics and by those not specified (T435); Poisoning by psychotropic drugs, not elsewhere classified: psychostimulants with potential abuse (T236); Poisoning by psychotropic drugs, not elsewhere classified: other psychotropic drugs, not classified elsewhere (T438); Poisoning by psychotropic drugs, not elsewhere classified: unspecified psychotropic drug (T439); Toxic effect of other substances and those not specified: paints and dyes, not elsewhere classified (T656) {Costo del fenómeno de las drogas en Ecuador, 2015, p.21} ~ Cost of residential treatment for alcohol and other drug use in 2015: Central Sector; # people in treatment; Total cost (USD) {Costo del fenómeno de las drogas en Ecuador, 2015, p.20} ~ Cost of medical care related to drugs (hospital discharges): Abuse of substances that do not cause dependence (F55) {Costo del fenómeno de las drogas en Ecuador, 2015, p.21} ~ Cost of medical care related to drugs (hospital discharges): Finding opiate drugs in the blood (R781); Finding of unspecified substance that is not normally found in the blood (R789) {Costo del fenómeno de las drogas en Ecuador, 2015, p.21} ~ Costs associated with health care% (Ambulatory care, Residential treatment, Hospital expenses) {Costo del fenómeno de las drogas en Ecuador, 2015, p.23} ~",8
Y,Ecuador,ECU,Demand Reduction,Proportion of people who use drugs enrolled in voluntary treatment,No,n/a,0
Y,Ecuador,ECU,Demand Reduction,Proportion of people who use drugs enrolled in coerced treatment,No,n/a,0
Y,Ecuador,ECU,Demand Reduction,Proportion of people who use drugs enrolled in compulsory treatment,No,n/a,0
Y,Ecuador,ECU,Demand Reduction,Presence of prevention programming in law enforcement,No,n/a,0
Y,Ecuador,ECU,Demand Reduction,Presence of prevention programming in the media,Yes,"Main sources of information on drugs nationwide (%) (Internet, Newspapers or magazines, Family, Television, Teachers, Professionals, Friends) {Cuarta encuesta nacional sobre uso de drogas en estudiantes de 12 a 17 años, 2012, p.56; Boletín Informativo Observando, 2013, p.12} ~",1
Y,Ecuador,ECU,Demand Reduction,Presence of prevention programming in schools,Yes,"Number of physical education coordinators and teachers trained on anti doping at the national level. {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.87} ~ Number of beneficiaries of the higher education community trained {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.88} ~ Number of students of the Student Participation Program that choose the theme ""prevention of drug use and consumption"" {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.88} ~ Number of students enrolled in the Student Participation Program {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.88} ~  Number of children and adolescents at risk of addiction, linked in the education system {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.89} ~ Percentage of students who received some type of orientation or formal prevention course on drug use during high school or university by sex (% received information or courses,% received formal programs) {III Estudio epidemiológico andino sobre consumo de drogas en la población universitaria de Ecuador, 2016, p.78} ~ Percentage of students that believe or not that there should be a university policy to prevent drug use by sex (Yes, Maybe, No) {III Estudio epidemiológico andino sobre consumo de drogas en la población universitaria de Ecuador, 2016, p.79} ~ Main sources of information on drugs % (Television, Friends, Internet, Family members, Teachers, Newspapers or magazines, Professionals) {Boletín Informativo Observando, 2013, p.12, Cuarta encuesta nacional sobre uso de drogas en estudiantes de 12 a 17 años, 2012, p.56} ~ Perception of preventive activities or subjects in the school (%) (Actions or activities are developed on the prevention of drug abuse; Teachers deal with content or topics on how to avoid using drugs; There are teachers who work on the prevention of drug use; Considers it important that the school develop activities on the prevention of drug abuse, the school has educational materials on the prevention of drug abuse, the authorities show interest in developing activities on prevention of drug abuse) {Boletín Informativo Observando, 2013, p.12} ~ Perception of students on whether activities are carried out at the school or preventive courses are given at the national level (%) (Actions or activities are being developed on the prevention of drug abuse; Teachers deal with content or topics on how to avoid using drugs; teachers who work on drug prevention, considers it important that the school develops activities on the prevention of drug abuse, the school has educational materials on prevention of drug abuse, the authorities show interest in developing activities on prevention of misuse of drugs) {Cuarta encuesta nacional sobre uso de drogas en estudiantes de 12 a 17 años, 2012, p.57} ~ Perception that in the school preventive activities are carried out by city (%) {Cuarta encuesta nacional sobre uso de drogas en estudiantes de 12 a 17 años, 2012, p.87} ~",11
Y,Ecuador,ECU,Demand Reduction,Presence of prevention programming in the workplace,Yes,"Number of participants in virtual courses in the field of education, employment, higher education {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.87} ~ Number of employers, employees and trained workers {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.87} ~ Total number of beneficiaries of the private sector with technical skills to handle the drug problem {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.87} ~",3
Y,Ecuador,ECU,Demand Reduction,Presence of prevention programming for youth and the community,Yes,"Number of priority families from vulnerable groups (users of the services), sensitized in the prevention of UyCPD {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.87} ~ Number of families of students trained in the Prevention of Drug Use, Alcohol and Tobacco (Educating in family) {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.87} ~ The number of families that have benefited through the Strong Families program {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.87} ~ The total number of families sensitized in drug use prevention {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.87} ~ Number of adolescents and young people from priority attention groups, sensitized to the prevention of UyCPD {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.88} ~ Number of students with harmonious coexistence and culture of peace {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.88} ~ Number of children, adolescents and young people aware of drug use prevention {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.88} ~ The number of beneficiaries of Ecuador's program activities {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.88} ~ Number of children from 7 to 15 years old who participate in Formative Schools {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.88} ~ Number of Students from 12 to 17 years old who join extracurricular activities {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.88} ~ Percentage of students that participate in activities of good use of free time {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.88} ~ The number of people who have participated in activities for the good use of their free time {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.88} ~ The number of girls, boys and adolescents at risk of addiction who receive attention for prevented the problematic use of psychoactive substances during the year 2018 {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.89} ~ The number of families with children and adolescents at risk of addiction, assisted with tools to combat the problem {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.89} ~ The number of Girls, boys and adolescents who stop using SPA (Psychoactive Substances) during the year 2018 {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.89} ~ Perception of a higher risk of marijuana/cocaine/pasta base/ecstasy/methamphetamine/LSD   use according to sex and/or age group (1 or 2 times consumption, frequent consumption) {III Estudio epidemiológico andino sobre consumo de drogas en la población universitaria de Ecuador, 2016, p.53, p.54, p.60, p.63, p.64, p.67, p.68, p.69, p.73, p.74} ~ Perception of a higher risk (%) in 1 or 2 episodes of use or frequent use of marijuana/cocaine, by sex, years 2009, 2012 and 2016 {III Estudio epidemiológico andino sobre consumo de drogas en la población universitaria de Ecuador, 2016, p.89, p.90, p.92} ~ General perceptions of drug use (Alcohol hurts, Drug use creates health problems, If I knew my child used drugs, I would seek professional help, If I knew my child used drugs, I would go to a recovery center; according to parents taking their children to a drug recovery center; there is a relationship between drug use and crime; the use of drugs transforms people into delinquents) {IV Estudio nacional sobre uso de drogas en población de 12 a 65 años, 2014, p.5} ~ High risk perception of (%): Use cocaine frequently; Use heroin frequently; Smoking marijuana frequently; Aspirate solvents frequently; Use ecstasy frequently; Smoking base paste or basuco frequently; Getting drunk with alcoholic beverages; Cigarette smoking frequently; Aspirate solvents once or twice; Use heroin once or twice; Use ecstasy once or twice; Smoking base paste or basuco once or twice; Snort cocaine once or twice; Smoking marijuana once or twice {IV Estudio nacional sobre uso de drogas en población de 12 a 65 años, 2014, p.7} ~ The population considers that prevention is [%]: Preventing someone from consuming; Inform about drugs and their consequences; Prevent risks associated with uses; Reduction of damages associated to the use and consumption; Promote alternative activities {IV Estudio nacional sobre uso de drogas en población de 12 a 65 años, 2014, p.22} ~ What is considered as prevention by region, sex and age [%] (Prevent someone from consuming; Inform about drugs and their consequences; Prevent risks associated with uses; Reduction of damages associated to the use and consumption; Promote alternative activities) {IV Estudio nacional sobre uso de drogas en población de 12 a 65 años, 2014, p.22} ~ Who should provide information on prevention by region, sex and age [%] (Schools, Parents, The media, Workplaces, Church or religious groups, Friends) {IV Estudio nacional sobre uso de drogas en población de 12 a 65 años, 2014, p.22} ~ Knowledge of the use of drugs in the family (%) (yes; no) {Boletín Informativo Observando, 2013, p.11} ~ Main sources of information on drugs% (Television, Friends, Internet, Family members, Teachers, Newspapers or magazines, Professionals) {Boletín Informativo Observando, 2013, p.12, Cuarta encuesta nacional sobre uso de drogas en estudiantes de 12 a 17 años, 2012, p.56} ~ Preferred means to receive information about drugs % (Through lectures and conferences, Television and / or radio, Internet in general, Manuals, brochures, etc. Social Networks, Newspapers and / or magazines) {Boletín Informativo Observando, 2013, p.12, Cuarta encuesta nacional sobre uso de drogas en estudiantes de 12 a 17 años, 2012, p.57} ~ Risk perception of the use of tranquilizers and stimulants without a prescription, by city (%) and at national level (%) [Test tranquilizers without prescription one or twice (such as Diazepan, Valium, Clonazepan, Rohypnol or others); Take tranquilizers without a prescription sometimes (occasionally / occasionally, such as Diazepan, Valium, Clonazepan, Rohypnol or others); Take tranquilizers without a prescription frequently (such as Ritalin, Cidrín or others); Try stimulants without a prescription once or twice (such as Ritalin, Cidrín or others); Take stimulants without a prescription sometimes (occasionally / occasionally such as Ritalin, Cidrín or others); Take stimulants without a prescription frequently (such as Ritalin, Cidrín or others)] {Cuarta encuesta nacional sobre uso de drogas en estudiantes de 12 a 17 años, 2012, p.42, p.65} ~ Knowledge of the use of drugs in the family nationwide (%) (yes, no) {Cuarta encuesta nacional sobre uso de drogas en estudiantes de 12 a 17 años, 2012, p.56} ~ Perceived risk of frequent use of stimulants without a prescription/inhalants/marijuana/cocaine/pasta base/ecstasy  by city (%) {Cuarta encuesta nacional sobre uso de drogas en estudiantes de 12 a 17 años, 2012,p.66, p.67, p.71, p.75, p.79, p.82} ~ Perception of the importance of prevention activities per city (%) {Cuarta encuesta nacional sobre uso de drogas en estudiantes de 12 a 17 años, 2012, p.87} ~",29
Y,Ecuador,ECU,Demand Reduction,Presence of other demand reduction metrics,Yes,"Government costs to reduce the supply and demand of drugs in 2015 (Prevention, Articulation of integral care, Control of the offer, Judicial system) {Costo del fenómeno de las drogas en Ecuador, 2015, p.16} ~ Outpatient care 2015 for causes related to drugs (prevention): Family history of abuse of other psychoactive substances (2813); Personal history of psychoactive substance abuse (Z864); Personal history of narcotic agent allergy (Z885) {Costo del fenómeno de las drogas en Ecuador, 2015, p.19} ~ Annual cost of rehabilitation for persons prosecuted and sentenced for drug-related offenses in 2015 (State of cause; # of persons; Time (months); Daily cost (USD); Total cost (USD)) {Costo del fenómeno de las drogas en Ecuador, 2015, p.15} ~ ",3
Y,Ecuador,ECU,Supply Reduction,Size and value of the illegal drug market,Yes,"prevalence of students that considered it easy to obtain marijuana/cocaine/heroin/pasta base {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.17} ~ the number of reported incidents of drug sales reported to the Integrated Security System ECU-911 {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.37} ~ the total number of drug trafficking cases, and the proportion of which were micro-trafficking cases {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.37} ~ Regions where marijuana/cocaine/pasta base seizures were reported most frequently (%) {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.37} ~ Most frequent locations/regions where students were offered marijuana, cocaine, pasta base and heroin {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.37} ~ Decrease the accessibility of marijuana/cocaine/heroin/pasta base in students of 9th grade of EGB, 1st and 3rd of Baccalaureate of the National System of National Education (%) {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p. 90} ~ Perception of easiness to get marijuana/cocaine/pasta base/synthetic drugs (ecstasy, methamphetamine, amphetamine), inhalants and LSD, nationwide, by sex and age group, by city, and percentage who have received the related drug offer {III Estudio epidemiológico andino sobre consumo de drogas en la población universitaria de Ecuador, 2016, p.54, p.55, p.61, p.64, p.65, p.69, p.70, p.74, p.75; IV Estudio nacional sobre uso de drogas en población de 12 a 65 años, 2014, p.19; Boletín Informativo Observando, 2013, p.6, p.7, p.8, Cuarta encuesta nacional sobre uso de drogas en estudiantes de 12 a 17 años, 2012, p.46, p.49, p.51, p.68, p.72, p.76, p.79, p.82, p.85} ~ Easiness of getting drugs by region, sex and age group [%] (Marijuana, Inhalants, Cocaine, Heroin, Ecstasy, Cocaine base paste, methamphetamines) {IV Estudio nacional sobre uso de drogas en población de 12 a 65 años, 2014, p.19} ~ Drug offering during the last 30 days [%] (Marijuana, Cocaine, Heroin, Cocaine pasta base, Ecstasy, Inhalables, Methamphetamines) total and  by sex and age [%] {IV Estudio nacional sobre uso de drogas en población de 12 a 65 años, 2014, p. 19 p.20} ~ How do people get the drugs that they used during the last year? [%] (On the street (from a microtraficante); Sells them or gives away a friend or relative; In bars, karaokes or discos; Sells them or gives them a friend from work; Buys them by phone; Buys them through a friend or family, at public events (concerts, football matches), buy them through a friend from work, buy them online) and  by region, sex and age [%]{IV Estudio nacional sobre uso de drogas en población de 12 a 65 años, 2014, p.21} ~ Where and how do they get drugs nationwide (%) (On the street or around of my school; At my school; From a provider that I know; A friend gives them to me; At parties or places of fun; Otherwise) {Boletín Informativo Observando, 2013, p.9, Cuarta encuesta nacional sobre uso de drogas en estudiantes de 12 a 17 años, 2012, p.53} ~ Places where drugs are used (%) (Parties or places of entertainment, Elsewhere, On the street or in parks, In my house, a relative's or my friend's house, Concerts) {Boletín Informativo Observando, 2013, p.10, Cuarta encuesta nacional sobre uso de drogas en estudiantes de 12 a 17 años, 2012, p.54} ~ Last offer of marijuana/cocaine/pasta base/ecstasy  (During the last 30 days, More than 1 year ago, More than 1 month but less than 1 year ago, I have never been offered) and by city {Boletín Informativo Observando, 2013, p.6, p.7, p.8, Cuarta encuesta nacional sobre uso de drogas en estudiantes de 12 a 17 años, 2012, p.46, p.49, p.51,p.68, p.72, p.76, p.80, p. 83, p.85} ~ ",13
Y,Ecuador,ECU,Supply Reduction,Level of procedures related to crop eradication,Yes,"Coca crops in the Andean Region (Bolivia, Peru, Colombia (a), Colombia (b), Ecuador), 1997 - 2009 (hectores). {Informe Técnico de Indicadores de Cultivos Ilícitos en Ecuador, 2010, p.9} ~ Density of coca crops in the Andean Region 2010 (hectores / km ^ 2) {Informe Técnico de Indicadores de Cultivos Ilícitos en Ecuador, 2010, p.11} ~ Sample areas for the monitoring of coca crops in Ecuador, 2010 {Informe Técnico de Indicadores de Cultivos Ilícitos en Ecuador, 2010, p.13} ~ Overflight of verification with Geo Video in Sucumbios, 2010 {Informe Técnico de Indicadores de Cultivos Ilícitos en Ecuador, 2010, p.15} ~ Overflight of verification with Geo Video in Carchi and Esmeraldas, 2010 {Informe Técnico de Indicadores de Cultivos Ilícitos en Ecuador, 2010, p.17} ~ Eradication of coca/marijuana/poppy plants plants 2010. (Number of plants by region) {Informe Técnico de Indicadores de Cultivos Ilícitos en Ecuador, 2010, p.19, p.20, p.21} ~ Comparison of the eradication of coca/marijuana/poppy plants plants 2009 - 2010 (number of plants) {Informe Técnico de Indicadores de Cultivos Ilícitos en Ecuador, 2010, p.22, p.23} ~ Coca, Marijuana and poppy eradication points, 2010. (mapped geographically) {Informe Técnico de Indicadores de Cultivos Ilícitos en Ecuador, 2010, p.24} ~",8
Y,Ecuador,ECU,Supply Reduction,"Number of arrests, seizures, and offences",Yes,"The total number in grams of drugs seized, of which the proportion (%) was marijuana, pasta base, cocaine, and heroin {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.37} ~ Number of people detained for drug-related offences {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.37} ~ Of the total number of people deprived of liberty, the proportion of the male prison population and the proportion of the female prison population that are related to drug offenses. {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.37} ~ Drug seized 2008 - 2010 (Kg) (Cocaine, PBC, Heroin, Marijuana) {Informe Técnico de Indicadores de Cultivos Ilícitos en Ecuador, 2010, p.25} ~ Arrests for the carriage and consumption of psychoactive substances {Costo del fenómeno de las drogas en Ecuador, 2015, p.8} ~ Number of prisoners for the commission of crimes and crimes associated with consumption {Costo del fenómeno de las drogas en Ecuador, 2015, p.9} ~",6
Y,Ecuador,ECU,Supply Reduction,Level of law enforcement activity and interdiction in the market,Yes,"Percentage of SCSF management activities controlled. Include in the POA {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.90} ~ Percentage of companies with codes of conduct for the proper management of SCSF subscribed {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.90} ~ The number of joint interdiction interventions to prevent trafficking of SCSF for illicit drug production {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.90} ~ Number of personnel trained in SCSF control processes in areas of border, ports and airports in the year 2018 {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.90} ~ Number of certified servers involved in the retention, deposit, custody, transfer and final disposal of SCSF {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.90} ~ The percent of licit management of scheduled substances subject to control (SCSF) {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.90} ~ The percent of commitment and co-responsibility of natural and legal persons that handle SCSF {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.90} ~ Number of staff trained in the management, custody and control of SCSF {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.90} ~ Destruction of laboratories for drug processing 2010 (Number of laboratories destroyed by year 2008-2010) {Informe Técnico de Indicadores de Cultivos Ilícitos en Ecuador, 2010, p.26} ~",9
Y,Ecuador,ECU,Supply Reduction,"Price, purity and potency of drugs, and related process indicators",Yes,"Average monthly spending on drugs of those who consumed them during the last 12 months by region, sex and age group {IV Estudio nacional sobre uso de drogas en población de 12 a 65 años, 2014, p.20} ~  Money spent per month on drugs nationwide (%) (less than 5 dollars, between 5 and 10 dollars, between 11 and 20 dollars, between 21 and 30 dollars, more than 31 dollars) {Cuarta encuesta nacional sobre uso de drogas en estudiantes de 12 a 17 años, 2012, p.55; Boletín Informativo Observando, 2013, p.11} ~",2
Y,Ecuador,ECU,Supply Reduction,Number of people engaged with the criminal justice system,Yes,"number of people apprehended for micro-trafficking cases {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.37} ~ Number of people prosecuted or sentenced for drug-related crimes in 2015 {Costo del fenómeno de las drogas en Ecuador, 2015, p.14} ~ Number of people sentenced for drug-related crimes by scale (Minimum, Medium, High, Great) in 2015 {Costo del fenómeno de las drogas en Ecuador, 2015, p.14} ~ Number of convictions and time of conviction for drug trafficking {Costo del fenómeno de las drogas en Ecuador, 2015, p.6} ~",4
Y,Ecuador,ECU,Supply Reduction,Presence of other supply reduction metrics,Yes,"The number of staff trained by the Joint Information and Coordination Unit (UICC) {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.90} ~ The number of re-adaptated UICC infrastructure {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.90} ~ The amount of equipment of the UICC {Plan Nacional de Prevención Integral y Control del Fenómeno Socio Económico de las Drogas, 2017-2021, p.90} ~ Government costs to reduce the supply and demand of drugs in 2015 (Prevention, Articulation of integral care, Control of the offer, Judicial system) {Costo del fenómeno de las drogas en Ecuador, 2015, p.16} ~",4
Y,Ecuador,ECU,International Cooperation,Level of engagement in international cooperation,No,n/a,0
Y,Czechia,CZE,Health,Level of availability of harm reduction services and harm reduction scale up,Yes,"Number and proportion of problem drug users (PDUs) in contact with harm reduction programmes {The National Drug Policy Strategy, 2010-2018, p.29} ~ Number of low-threshold programs in the Czech Republic {The National Drug Policy Strategy, 2010-2018, p.40} ~ Number of drug users in contact with low-threshold programs in the Czech Republic {The National Drug Policy Strategy, 2010-2018, p.40; Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.178} ~ Number of injecting drug users in contact with low-threshold facilities {The National Drug Policy Strategy, 2010-2018, p.40} ~ Proportion of injecting drug users who have used low-threshold services {The National Drug Policy Strategy, 2010-2018, p.40} ~ Structure of drug treatment respondents / problem and intervention provided in 2016 (Low threshold services) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.146} ~ Number of low-threshold programs in the monitoring of infection testing in 2016 {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.158; Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.184 } ~ Number of selected programmes of low-threshold programs in l 2006-2016, in thous. (Hygienic Service; Individual Counseling; Crisis Intervention; Food Service; Group Counseling; Exchange Program; Medical Treatment) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.179; The National Drug Policy Strategy, 2010-2018, p.46} ~ Distribution of gelatin capsules in low-threshold programs in 2008-2016 {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.183} ~ Number treated in low-threshold agencies {Czech Republic Country Drug Report, 2017, p.12} ~",10
Y,Czechia,CZE,Health,Presence of needle and syringe programs,Yes,"Number of exchange programs {The National Drug Policy Strategy, 2010-2018, p.40; Czech Republic Country Drug Report, 2017, p.11} ~ Number of exchanges in the exchange program {The National Drug Policy Strategy, 2010-2018, p.40} ~ Number of exchange programs and issued needles and syringes in the Czech Republic in 1998-2016 {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.180} ~ Number of distributed needles and syringes in exchange programs {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.181; The National Drug Policy Strategy, 2010-2018, p.40; Czech Republic Country Drug Report, 2017, p.1 & p.19} ~ Number of distributed needles and syringes in regions of the Czech Republic in 2016 per 1 million population aged 15-64 {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.182} ~ Trend distribution of injection needles (sets) and development of estimated number of injecting drug users in the Czech Republic, 2005-2016 {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.182} ~ ",6
Y,Czechia,CZE,Health,Prevalence of substance use disorders,Yes,"Estimate of problem drug users (opiates, heroin, Subutex, pervitin) {The National Drug Policy Strategy, 2010-2018, p.29; Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.98, p.102} ~ Mean values of prevalence estimates of problematic use of pervitin and opioids by the multiplication method using data from low-threshold programs in l 2002-2016 (Problem users total, opioid users, pervitin users, Injecting drug users) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.96} ~ Estimated number of problem drug users in 2016 by drugs and regions {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.97, p.98, p.144} ~ Estimation of the number of pathological players, problem users of alcohol, cannabis, opioids and pervitin in 2016 from a survey by doctors extrapolating to the population and total number of physicians of the Czech Republic {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.100, p.101} ~ Respondents 15-64 Response Responses to CAST (Cannabis Abuse Screening Test) Screening Issues - National Research 2016, in% (Pre-noon Use, Seclusion, Memory Problems, Family Criticized Usage, Discontinued Testing, Problems in Use) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.108} ~ ",5
Y,Czechia,CZE,Health,Prevalence of psychiatric comorbidities,No,n/a,0
Y,Czechia,CZE,Health,Drug-related mortality,Yes,"Fatal overdoses by type of drugs (Inhalants; Opiates/Opioids; Amphetamines (pervitin); Cocaine; MDMA; Hallucinogens; Cannabis; Illegal drugs and inhalants in total; Psychotropic pills; Psychotropic pills including benzodiazepines; Not ascertained; total) {The National Drug Policy Strategy, 2010-2018, p.38; Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.169; Czech Republic Country Drug Report, 2017, p.1, p.9} ~ Deaths with the presence of selected drugs (Pervitin; THC; Opiates/Opioids; Inhalants; MDMA; Cocaine) detected by forensic medicine departments in the Czech Republic {The National Drug Policy Strategy, 2010-2018, p.41} ~ Fatal Drug Overdoses in 2016 in a Special Registry by Drug, Age, Gender, and Region {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.168, p.169} ~ Death due to drugs detected in forensic medicine departments in 2016 by selected drug groups and causes of death {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.170} ~ Fatal Drug Overdoses by Selection B and Extended Selection B in the general registry of deaths by drug, age, and gender groups {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.171, p.172} ~ The mortality rate of patients according to the registry of substitution treatment in 2000-2016 {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.174} ~ Gender distribution of drug induced deaths {Czech Republic Country Drug Report, 2017, p.9} ~ Age distribution of deaths in 2015 {Czech Republic Country Drug Report, 2017, p.9} ~ Drug-induced mortality rates among adults (15-64 years) (cases per million population) {Czech Republic Country Drug Report, 2017, p.9 & p.19} ~",9
Y,Czechia,CZE,Health,Prevalence of drug-related infectious disease,Yes,"Reported incidence of infectious diseases in 2004-2008 (HIV/AIDS - in total; HIV/AIDS - including IDUs; HIV/AIDS - including IDUs and homo-/bisexual intercourse; HIV/AIDS - % IDUs + IDUs h/b) {The National Drug Policy Strategy, 2010-2018, p.38; Czech Republic Country Drug Report, 2017, p.1, p.19} ~ Reported incidence of infectious diseases in 2004-2008 (Acute and chronic HCV - in total; Acute and chronic HCV - including IDUs; Acute and chronic HCV - % IDUs) {The National Drug Policy Strategy, 2010-2018, p.38, p.41; Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.154; Czech Republic Country Drug Report, 2017, p.19} ~ Reported incidence of infectious diseases in 2004-2008 (HBV - in total; HBV - including IDUs; HBV - % IDUs) {The National Drug Policy Strategy, 2010-2018, p.38; Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.154} ~ Number of newly detected HIV cases by 2016 according to transfer method {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.153} ~ Average age of injecting drug users who reported HBV and HCV in 1997-2016 {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.154} ~ The reported incidence of HAV total and injecting drug users in 1997-2016 {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.155} ~ Reported incidence of syphilis total, injecting drug users and alcohol users in 2000-2016 {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.156} ~ The reported incidence of gout total, injecting drug users and alcohol users in 2000-2016 {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.156} ~ Reported incidence of TB total, among alcohol and drug users in 1997-2016 {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.157} ~ National estimates of HIV antibody prevalence among people who inject drugs {Czech Republic Country Drug Report, 2017, p.8} ~ National estimates of HCV antibody prevalence among people who inject drugs {Czech Republic Country Drug Report, 2017, p.8} ~ Newly diagnosed HIV cases related to injecting drug use (cases/million population, Source: ECDC) {Czech Republic Country Drug Report, 2017, p.8 & p.19} ~ ",12
Y,Czechia,CZE,Health,Proportion of people who use drugs who engage in risky consumption,Yes,"Sharing of needles and syringes at any time in the past reported by injecting drug users demanding treatment in 2002-2008 (Number of IDUs, Number of those sharing, sharing (%)) {The National Drug Policy Strategy, 2010-2018, p.41; Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.164} ~ Treatment demands in 2016 by drug use and needle and syringe sharing,% {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.142} ~ Risk behaviors in the sentenced population in 2010-2016 (injects drugs sometimes in life, injected drugs prior to the onset of VTOS***, Needle sharing sometimes in life) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.220} ~",3
Y,Czechia,CZE,Health,Proportion of people who use drugs who engage in safe consumption practices,No,n/a,0
Y,Czechia,CZE,Health,"Coverage of services for the prevention, testing, and treatment of bloodborne diseases",Yes,"Testing of injecting drug users for HIV antibodies in 2004-2008 as shown by laboratory surveillance , by type of test (blood tests; saliva tests; total) and by Number (tests; positive results; positive results permille) {The National Drug Policy Strategy, 2010-2018, p.39} ~ Results of testing for infections (HIV; HCV; HBV; Syphilis) among injecting drug users in low-threshold facilities in 2008 (Type of test; Number of testing programmes; Number of tests; Number of persons) {The National Drug Policy Strategy, 2010-2018, p.39} ~ Number of tests for infections (HIV; HBV; HCV; Syphilis; Total) and the number of low-threshold facilities performing such tests (Number of tests, nummber of programmes) in 2004-2008 {The National Drug Policy Strategy, 2010-2018, p.40} ~ Number of tests for infectious diseases performed among clients of low-threshold programmes in 2004-2008 by type of infectious disease (HIV; HBV, HCV, Syphilis, Total) {The National Drug Policy Strategy, 2010-2018, p.42} ~ The results of the screening of injecting drug users for HIV antibodies in 1997-2016 (Total number of tests; Number of tests with a positive result) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.157} ~ Results of testing drug users for infectious diseases in low-threshold programs in 2016 {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.158} ~ Results of Drug Testing of HCV Users in Low-threshold Facilities in 2016: by Region {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.159} ~ Results of testing patients in NRLUD for HIV, HBV and HCV in 2016 {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.160} ~ The results of testing injecting drug users on HIV, HAV, HBV and HCV in the Treatment Request Register in 2003-2014 and in NRLUD in 2015 and 2016 {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.161} ~ Seroprevalence of HCV in treated patients in substitution treatment in 2010-2016, in% {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.161} ~ The trend of selected serological indicators of HIV, HBV and HCV in tested injecting injecting drug users in 2010-2016, in% {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.162} ~ Client Testing - The number of IDU requesting testing for HBV, HCV and HIV in the Treatment Request Register in 2004-2016, and proportion (%) of those tested {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.185} ~",12
Y,Czechia,CZE,Health,Presence of specialised training for addiction care,No,n/a,0
Y,Czechia,CZE,Health,Presence of health harms related to drug use,Yes,"Drug-related intoxication in the Czech Republic in the years 2005-2016 registered by the Hygienic Service by type of drug {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.165} ~ Number of hospitalizations for drug intoxication in acute care hospitals in 2005-2016 {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.165} ~ ",2
Y,Czechia,CZE,Health,Presence of other health metrics,Yes,"Medicinal/therapeutic use of cannabis by sex and age groups - study National Research 2016, in % (lifetime prevalence, prevalence in the past 12 months) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.54} ~ Lifetime prevalence of cannabis use for medical reasons in people aged 15 and over - National Research 2016, in % {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.55} ~ Form of Cannabis Use for Medical Purposes - Study National Research 2016 (In the form of healing ointment, in hemp cosmetics, in the form of hemp oil, in the form of hemp extract, smoked alone, smoked in a mixture with tobacco, food, drink, suppository, vaporizer, in a different form) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.55} ~ Source of Last Hemp for Treatment - Study National Research 2016,% of respondents who reported the use of hemp for medical purposes (In a pharmacy without a prescription, I got from a friend, relative, acquaintance, partner (other than grooming), Developed person close, I got from other person (other than grown up), Prescription pharmacy, I grew up alone, Over the Internet, Other way) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.56} ~ Estimation of Health Insurance Company Expenditures on dg. F10 and dg. F11-F19 by type of care in 2008-2015, in millions of CZK {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.43} ~",5
Y,Czechia,CZE,Peace and Security,"Prevalence of alcohol and drugs in accidents, and interventions to increase road safety",Yes,"Accident on roads in the Czech Republic in 2003-2016 - influence of alcohol and other drugs {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.167} ~ ",1
Y,Czechia,CZE,Peace and Security,Annual number of public disorder and violent crime reports,Yes,"Average severity of occurrence of socially negative phenomena in socially excluded localities monitored in 2013-2017 (Criminal property, Prostitution, Crime force) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.195} ~ Incidence of theft or other criminal offense for the purpose of acquiring funds for drug or gambling at some time in the year.  in% {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.215} ~ Number of crimes committed under the influence of alcohol and other drugs in the period 2003-2016 {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.214} ~ ",3
Y,Czechia,CZE,Peace and Security,Number of non-lethal drug market violent events reported,No,n/a,0
Y,Czechia,CZE,Peace and Security,Number of drug market related homicides and disappearances,No,n/a,0
Y,Czechia,CZE,Peace and Security,Presence of other peace and security metrics,No,n/a,0
Y,Czechia,CZE,Development,Coverage of housing assistance for people who use drugs,Yes,"The housing status of those who use drugs {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.191} ~ The type of housing of those who use drugs lived in, in 2016 (Others, In Prison, In Facilities, With Friends or Other Persons, With a Partner / Child, With a Parent / Family, Same) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.192} ~ Average severity of occurrence of socially negative phenomena in socially excluded localities monitored in 2013-2017 (Low quality housing) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.195} ~",3
Y,Czechia,CZE,Development,Coverage of social assistance for people who use drugs (not including housing),No,n/a,0
Y,Czechia,CZE,Development,Number of households enrolled in alternative development,No,n/a,0
Y,Czechia,CZE,Development,Presence of other development metrics,Yes,"The level of education of those who use drugs {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.190} ~ The employment status of those who use drugs {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.190} ~ Average severity of occurrence of socially negative phenomena in socially excluded localities monitored in 2013-2017 (Low education / qualifications, Unemployment, truancy) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.195} ~",3
Y,Czechia,CZE,Human Rights,"Prevalence and incidence of infectious diseases in vulnerable populations (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Czechia,CZE,Human Rights,"Prevalence of vulnerable people who use drugs (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"Risk behaviors in the sentenced population in 2010-2016 (injects drugs in prison, Needle sharing in prison) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.220} ~ Lifetime prevalence of drug use among prisoners in 2010-2016, in% {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.218} ~ Drug use sometimes while in prison in 2010-2016 {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.219} ~ The extent of drug use among minorities - study Health and addictive substances among minorities, in % (lifetime prevalence, past 12 month prevalence, past 30 days, prevalence) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.75} ~ Comparison of the prevalence of drug use by type of drug in the last 12 months in the National Research 2016 Study and Health and Addictive Substance among minorities after the transfer to the general population structure by sex and age {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.77} ~ Prevalence of drug use among convicts in the last 12 months in 2010-2016, in% by type of drug {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.218} ~ Prevalence of drug use among convicts in the last 30 days in 2010-2016, in% by type of drug {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.219} ~ The nationality of those who use drugs {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.191} ~ The average prevalence of drug use in socially excluded localities monitored in 2013-2017 {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.196} ~",9
Y,Czechia,CZE,Human Rights,Proportion of people who use drugs in prison that are receiving medication assisted treatment (MAT),Yes,"Number of people in substitution treatment in prison according to prisons in 2011-2016 {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.222} ~ Average length of treatment (in months) by prisons in 2011-2016 {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.222} ~ ",2
Y,Czechia,CZE,Human Rights,Distribution of sterile injecting equipment in prisons,No,n/a,0
Y,Czechia,CZE,Human Rights,Presence of programs and services targeted towards women ,No,n/a,0
Y,Czechia,CZE,Human Rights,Presence of programs and services targeted towards people of color,No,n/a,0
Y,Czechia,CZE,Human Rights,Presence of challenges and/or harms experienced by people of color,No,n/a,0
Y,Czechia,CZE,Human Rights,"Presence of programs and services targeted towards vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes," Number of persons treated for selected infectious diseases in facilities of custody and punishment in the Czech Republic in 2016 {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.186} ~ Overview of certified programs by type l. 2011-2017 (addiction services in jail) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.119} ~ Outpatient addictive care network in 2016 - Number of programs (Advice and Treatment in Prisons) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.125} ~ Number of addictive drug users in outpatient addictological programs in 2016 (Prisons) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.127} ~ Nonprofit organizations providing drug services in prisons, number of visits and number of demonstrators in custody or imprisonment in 2016 {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.223} ~ The number, capacity and utilization of drug-free zones and specialized departments for voluntary treatment in prisons in l. 2006-2016 {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.221} ~ ",6
Y,Czechia,CZE,Human Rights,"Presence of challenges and/or harms experienced by vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Czechia,CZE,Human Rights,Presence of other human rights metrics,Yes,"whether people who use drugs have children or live with children in 2016 {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.192} ~",1
Y,Czechia,CZE,Demand Reduction,Prevalence of drug use by age,Yes,"The lifetime drug use in the general population - study National Research 2016, by age, sex and type of drug (Any illegal drug total; Cannabis; Ecstasy; Pervitin; Cocaine; Heroin; LSD; Hallucinogenic mushrooms; Ketamine; Poppers; New psychoactive substances; Volatile substances; Anabolic steroids, Amphetamines) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.51, p.60, p.62, p.63; Czech Republic Country Drug Report, 2017, p.18, p.19} ~ Lifetime prevalence of cannabis use for recreational in people aged 15 and over - National Research 2016, in % {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.55} ~ The prevalence of drug use in the last 12 months, by age, sex and type of drug (Any illegal drug total; Cannabis; Ecstasy; Pervitin; Cocaine; Heroin; LSD; Hallucinogenic mushrooms; Ketamine; Poppers; New psychoactive substances; Volatile substances; Anabolic steroids, Amphetamines) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.49, p.51, p.52, p.60, p.62, p.64, p.65; The National Drug Policy Strategy, 2010-2018, p.32, p.49, p.52; Czech Republic Country Drug Report, 2017, p.1, p.5, p.18, p.19} ~ The prevalence of drug use in the past 30 days in the general population - study National Research 2016, by age, sex and type of drug (Any illegal drug total; Cannabis; Ecstasy; Pervitin; Cocaine; Heroin; LSD; Hallucinogenic mushrooms; Ketamine; Poppers; New psychoactive substances; Volatile substances; Anabolic steroids) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.51, p.60, p.62; The National Drug Policy Strategy, 2010-2018, p.32} ~ Prevalence of substance use among 16 year-old students in the ESPAD survey (%) by sex and type of substances (Any illicit drug; Any drug other than cannabis; Cannabis; Inhalants; Magic Mushrooms, other than natural hallucinogens; Ecstasy; LSD; Pervitin; Heroin, Opiates; Cocaine, Tranquilisers/Sedatives; Anabolics) {The National Drug Policy Strategy, 2010-2018, p.33, p.35} ~ Proportion of 16-year-old students having their first experience with the use of legal and illegal drugs at the age of 13 or younger as shown by the ESPAD survey, by type of substance (Cigarettes - first cigarette; -daily; Alcohol (at least one drink); Beer; Wine; Spirits; Drunk; Cannabis (marijuana or hashish); Amphetamines; Ecstasy; Inhalants; Tranquilisers/sedatives) {The National Drug Policy Strategy, 2010-2018, p.33} ~ Selected drug substance use by type indicators among 16-year-old students - Comparison of ESPAD 2015 and ESPAD 2016 validation study, in % (Lifetime prevalence of illicit drug use, Prevalence in the last 12 months, Prevalence in the last 30 days) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.71, p.72; Czech Republic Country Drug Report, 2017, p.6} ~ Prevalence of psychoactive drugs and volatile substances use by sex and age groups - National Research 2016,% {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.46} ~ Proportion of people who use drugs by type of drug and age groups in 2016,% {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.147} ~ Frequency of cannabis use in the last 12 months by sex and age group,% (Every day or almost every day (5-7 times a week), Several times a week (3-4 times a week), Once or twice a week, Several times a month (2-3 times a month), Once a month, Less often than once a month) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.54} ~ The results of the CAST Screening Scale to estimate Intensive forms of cannabis use in the general population and among respondents who have used cannabis in the last 12 months, by sex and age group - National Research 2016,% (In the general population aged 15-64, Between respondents who have used cannabis in the last 12 months) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.109, p.110} ~  Intensive and risky use of addictive substances in the population of the Czech Republic aged 15-64 - study National Research 2016, in% and extrapolation to total population (Intensive and risky use of addictive substances in the population of the Czech Republic aged 15-64 - study National Research 2016, in% and extrapolation to total population - cannabis use {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.111, p.112} ~",12
Y,Czechia,CZE,Demand Reduction,Prevalence of drug use by sex,Yes,"The lifetime drug use in the general population - study National Research 2016, by age, sex and type of drug (Any illegal drug total; Cannabis; Ecstasy; Pervitin; Cocaine; Heroin; LSD; Hallucinogenic mushrooms; Ketamine; Poppers; New psychoactive substances; Volatile substances; Anabolic steroids, Amphetamines) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.51, p.60, p.62, p.63; Czech Republic Country Drug Report, 2017, p.18, p.19} ~ The prevalence of drug use in the last 12 months, by age, sex and type of drug (Any illegal drug total; Cannabis; Ecstasy; Pervitin; Cocaine; Heroin; LSD; Hallucinogenic mushrooms; Ketamine; Poppers; New psychoactive substances; Volatile substances; Anabolic steroids, Amphetamines) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.49, p.51, p.52, p.60, p.62, p.64, p.65; The National Drug Policy Strategy, 2010-2018, p.32, p.49, p.52; Czech Republic Country Drug Report, 2017, p.1, p.5, p.18, p.19} ~ The prevalence of drug use in the past 30 days in the general population - study National Research 2016, by age, sex and type of drug (Any illegal drug total; Cannabis; Ecstasy; Pervitin; Cocaine; Heroin; LSD; Hallucinogenic mushrooms; Ketamine; Poppers; New psychoactive substances; Volatile substances; Anabolic steroids) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.51, p.60, p.62; The National Drug Policy Strategy, 2010-2018, p.32} ~ Prevalence of substance use among 16 year-old students in the ESPAD survey (%) by sex and type of substances (Any illicit drug; Any drug other than cannabis; Cannabis; Inhalants; Magic Mushrooms, other than natural hallucinogens; Ecstasy; LSD; Pervitin; Heroin, Opiates; Cocaine, Tranquilisers/Sedatives; Anabolics) {The National Drug Policy Strategy, 2010-2018, p.33, p.35} ~ Prevalence of psychoactive drugs and volatile substances use by sex and age groups - National Research 2016,% {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.46} ~ Frequency of cannabis use in the last 12 months by sex and age group,% (Every day or almost every day (5-7 times a week), Several times a week (3-4 times a week), Once or twice a week, Several times a month (2-3 times a month), Once a month, Less often than once a month) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.54} ~ The results of the CAST Screening Scale to estimate Intensive forms of cannabis use in the general population and among respondents who have used cannabis in the last 12 months, by sex and age group - National Research 2016,% (In the general population aged 15-64, Between respondents who have used cannabis in the last 12 months) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.109, p.110} ~  ",7
Y,Czechia,CZE,Demand Reduction,Prevalence of drug use by type,Yes,"Prevalence of Drug Use in the General Population - Citizenship Survey 2016, in %, by type of drug and prevalence (lifetime, past 12 months, and past 30 days) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.62} ~ The lifetime drug use in the general population - study National Research 2016, by age, sex and type of drug (Any illegal drug total; Cannabis; Ecstasy; Pervitin; Cocaine; Heroin; LSD; Hallucinogenic mushrooms; Ketamine; Poppers; New psychoactive substances; Volatile substances; Anabolic steroids, Amphetamines) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.51, p.60, p.62, p.63; Czech Republic Country Drug Report, 2017, p.18, p.19} ~ Lifetime prevalence of cannabis use for recreational in people aged 15 and over - National Research 2016, in % {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.55} ~ The prevalence of drug use in the last 12 months, by age, sex and type of drug (Any illegal drug total; Cannabis; Ecstasy; Pervitin; Cocaine; Heroin; LSD; Hallucinogenic mushrooms; Ketamine; Poppers; New psychoactive substances; Volatile substances; Anabolic steroids, Amphetamines) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.49, p.51, p.52, p.60, p.62, p.64, p.65; The National Drug Policy Strategy, 2010-2018, p.32, p.49, p.52; Czech Republic Country Drug Report, 2017, p.1, p.5, p.18, p.19} ~ The prevalence of drug use in the past 30 days in the general population - study National Research 2016, by age, sex and type of drug (Any illegal drug total; Cannabis; Ecstasy; Pervitin; Cocaine; Heroin; LSD; Hallucinogenic mushrooms; Ketamine; Poppers; New psychoactive substances; Volatile substances; Anabolic steroids) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.51, p.60, p.62; The National Drug Policy Strategy, 2010-2018, p.32} ~ Prevalence of substance use among 16 year-old students in the ESPAD survey (%) by sex and type of substances (Any illicit drug; Any drug other than cannabis; Cannabis; Inhalants; Magic Mushrooms, other than natural hallucinogens; Ecstasy; LSD; Pervitin; Heroin, Opiates; Cocaine, Tranquilisers/Sedatives; Anabolics) {The National Drug Policy Strategy, 2010-2018, p.33, p.35} ~ Proportion of 16-year-old students having their first experience with the use of legal and illegal drugs at the age of 13 or younger as shown by the ESPAD survey, by type of substance (Cigarettes - first cigarette; -daily; Alcohol (at least one drink); Beer; Wine; Spirits; Drunk; Cannabis (marijuana or hashish); Amphetamines; Ecstasy; Inhalants; Tranquilisers/sedatives) {The National Drug Policy Strategy, 2010-2018, p.33} ~ Selected drug substance use by type indicators among 16-year-old students - Comparison of ESPAD 2015 and ESPAD 2016 validation study, in % (Lifetime prevalence of illicit drug use, Prevalence in the last 12 months, Prevalence in the last 30 days) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.71, p.72; Czech Republic Country Drug Report, 2017, p.6} ~ Lifetime, 12-month, and 30-day prevalence rates of substance use among dance partygoers, by type of substance (Alcohol, Cannabis, Ecstasy, Pervitin, Magic Mushrooms, Poppers, LSD, Cocaine, Heroin, GHB) {The National Drug Policy Strategy, 2010-2018, p.34} ~ Consumption of illegal drugs in 2003 and 2008 by type of drug (Cannabis (g); Ecstasy (tbl); LSD (pcs); Pervitin (g); Heroin (g); Subutex (g); Cocaine (g)) {The National Drug Policy Strategy, 2010-2018, p.37} ~ Prevalence of psychoactive drugs and volatile substances use by sex and age groups - National Research 2016,% {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.46} ~ Proportion of people who use drugs by type of drug and age groups in 2016,% {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.147} ~ Frequency of cannabis use in the last 12 months by sex and age group,% (Every day or almost every day (5-7 times a week), Several times a week (3-4 times a week), Once or twice a week, Several times a month (2-3 times a month), Once a month, Less often than once a month) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.54} ~ The results of the CAST Screening Scale to estimate Intensive forms of cannabis use in the general population and among respondents who have used cannabis in the last 12 months, by sex and age group - National Research 2016,% (In the general population aged 15-64, Between respondents who have used cannabis in the last 12 months) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.109, p.110} ~  National estimates of last year prevalence of high-risk opioid use (rate per 1000 population) {Czech Republic Country Drug Report, 2017, p.1, p.7} ~",15
Y,Czechia,CZE,Demand Reduction,Number of people who use drugs,No,n/a,0
Y,Czechia,CZE,Demand Reduction,"Prevalence of drug use by mode of administration (oral, mucosa, inhalation, and injection)",Yes,"Estimate of injecting users {The National Drug Policy Strategy, 2010-2018, p.29; Czech Republic Country Drug Report, 2017,p.19} ~ The proportion of people in treatment who inject drugs (heroin, pervitin, buprenorphine) (drug treatment demand register maintained by the Public Health Service) {The National Drug Policy Strategy, 2010-2018, p.30; Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.163} ~ Applicants for treatment in 2016 based on the drug (s) and mode of administration, in% {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.141} ~ ",3
Y,Czechia,CZE,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT)",Yes,"Number of problem drug users (opiate, pervitin, injecting drug users) by type of treatment facility (Psychiatric facilities, Drug treatment demand register maintained by the Public Health Service, Final reports of outpatient treatment programmes covered by subsidy proceedings administered by the GCDPC's Secretariat) {The National Drug Policy Strategy, 2010-2018, p.30} ~ Number of addictive drug users/patients in outpatient addictological programs in 2016 (Outpatient treatment, Crisis centers, Psychotherapeutic centers, Special care programs, Contact Centers and Field Programs) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.127, p.139, p.150; Czech Republic Country Drug Report, 2017, p.12} ~ Selected services aftercare programs and the number of interventions performed in 2014-2016 (Individual counseling; Individual psychotherapy; Information service; Sociotherapy; Social work; Telephone, written and internet consultancy; Tests for the presence of drugs; Group psychotherapy; Group counseling; Crisis intervention) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.200} ~ Applicants for treatment in 2016 by primary (primary) drug / problem and mode of administration (Stimulants, Opioids, Cannabis, Sedative & hypnotics, Hallucinogens, Volatile substances, Others) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.139, p.141} ~ Number of treatment demands in 2016 by primary (primary) drug / problem {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.140} ~ Availability of addictological services according to regional reports in 2016 {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.120} ~ After-care services in the Social Services Providers (outpatient and inpatient) Register as of August 21, 2017 {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.199} ~ Number, Capacity (persons, beds), and Occupancy (number of persons) of Day care centres, Outpatient healthcare facilities, Detoxification units, and sobering up stations, psychiatric hospitals, psychiatric departments in hospitals, psychiatric hospitals for children {The National Drug Policy Strategy, 2010-2018, p.43} ~ Structure of treatment demands related to illicit drugs in 2016: by region {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.145} ~ Structure of drug treatment respondents / problem and intervention provided in 2016 (Other option, Crisis intervention, Counseling, Detoxification, Treatment without supportive pharmacotherapy, Treatment including supportive pharmacotherapy) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.146} ~ Overview of certified programs by type l. 2011-2017 (detoxification, outreach programs, and counseling services, outpatient care programs, short-term and medium-term inpatient treatment, residential care in therapeutic community, aftercare programs) {The National Drug Policy Strategy, 2010-2018, p.46; Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.119} ~ Outpatient addictive care network in 2016 - Number of programs (Sobering Stations, Outpatient Treatment, Crisis Centers, Psychotherapeutic Establishments, Special Follow-up Programs) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.125} ~ Pedagogical-Psychological Counseling Centers (PPP) and Educational Care Centers (SEN): by region {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.88} ~ Number of outpatient clinics by 22 May 2017 by region {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.118} ~ Frequency of primary drug use among all treatment applicants in 2016 {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.141} ~ Primary drug among clients aftercare programs subsidized CGDPC in. 2016 in% (Pervitin, Heroin, Cannabis, Other opioids, Other substances, Buprenorphine, Cocaine / crack) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.200} ~ Proportion of people with drug / problem by type of drug and gender disaggregated by those in treatment, and those seeking treatment in 2016 {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.147} ~ Prevalence of treatment entrants by type of drug (Cannabis, Amphetamines, Cocaine, Heroin, Other) {Czech Republic Country Drug Report, 2017, p.1} ~ prevalence of drug users (cannabis, cocaine, heroin, amphetamines) entering treatment by sex {Czech Republic Country Drug Report, 2017, p.7} ~ number of all drug users (cannabis, cocaine, heroin, amphetamines, MDMA, opioids) in treatment {Czech Republic Country Drug Report, 2017, p.7, p.18, p.19} ~ number of first time drug treatment entrants (cannabis, cocaine, heroin, amphetamines, MDMA, opioids) {Czech Republic Country Drug Report, 2017, p.7, p.18, p.19} ~ Trends in percentage of clients entering specialised drug treatment, by primary drug in the Czech Republic (Amphetamines, Opioids, Cannabis, Other drugs, Cocaine) {Czech Republic Country Drug Report, 2017, p.13} ~ Treatment demand: All clients {Czech Republic Country Drug Report, 2017, p.19} ~ Treatment demand: First time clients {Czech Republic Country Drug Report, 2017, p.19} ~",25
Y,Czechia,CZE,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT) by age",Yes,"The number of all treatment requests per 100 thousand. population aged 15-64 years in the Czech Republic in 2016 by region {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.145} ~ Average age of first treatment demands - Users according to drug of choice (Opiate users, Pervitin Users, Cannabis users, Cocaine users, Heroin users, Amphetamine users) {The National Drug Policy Strategy, 2010-2018, p.31; Czech Republic Country Drug Report, 2017, p.7} ~ Share of treatment demands by age and gender in 2016 {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.146} ~",3
Y,Czechia,CZE,Demand Reduction,Level of access to opioid substitution treatment and medication assisted treatment (OST/MAT),Yes,"Estimated number of Subutex users (substitution treatment) - estimated by the NFP {The National Drug Policy Strategy, 2010-2018, p.31} ~ Numbers of treatment demands in relation to the use of Subutex as a drug of choice (drug treatment demand register maintained by the Public Health Service) {The National Drug Policy Strategy, 2010-2018, p.31} ~ Number of patients registered with specialised substitution centres (NRULIUS, the Substitution Treatment Register operated by the Institute of Health Information and Statistics of the Czech Republic) {The National Drug Policy Strategy, 2010-2018, p.31; Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.127} ~ Consumption of Subutex in the Czech Republic (grams) (Inspectorate for Narcotic and Psychotropic Substances, Czech Ministry of Health) {The National Drug Policy Strategy, 2010-2018, p.31} ~ Number, Capacity (persons, beds) and Occupancy (number of persons) of Substitution (methadone) centres, Buprenorphine substitution in outpatient centres {The National Drug Policy Strategy, 2010-2018, p.44} ~ Overview of certified programs by type l. 2011-2017 (substitution treatment) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.119} ~ Outpatient addictive care network in 2016 - Number of programs (Substitution Treatment) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.125} ~ Number of facilities providing opiate substitution treatment and number of clients reported to NRLUD in 2016 {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.129; Czech Republic Country Drug Report, 2017, p.1, p.19} ~ Number of patients in opioid substitution treatment according to drug type and regions (Metadone, Buprenorphine monopreparations, Suboxone (buprenorphine and naloxone), Total) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.130; Czech Republic Country Drug Report, 2017, p.13} ~ Coverage of problem opioid users with opioid replacement therapy in 2016 by region of the facility {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.131} ~ Completed episodes of opiate substitution treatment by reason of termination and the county of residence in 2016, in% {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.131} ~ Substitution doctors and the number of patients in substitution in the Survey of Doctors of the Czech Republic 2016 {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.132} ~ Estimation of the number of opiate replacement patients in general practitioners for adults and for children and adolescents in 2016 {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.132} ~ Reporting patients in substitution treatment to the National Registry of Drug Users in 2016 {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.133} ~ Imported (methadone) and distributed (buprenorphine) amounts of substituents in 1999-2016 {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.134} ~ The amount of buprenorphine distributed in preparations containing only buprenorphine and in the composite composition in combination with naloxone in 2008-2016, in grams {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.134} ~ Development of the number of applicants and of first in NRLUD in l. 2015 and 2016 by type of drug (All treatment applicants, First-time treatment applicants) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.149} ~ Number of patients in substitution treatment reported in NRLUD in 2000-2016 {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.149} ~ Assess the situation of clients (Psychological health, Physical health, Social functioning, Relations with loved ones, Conflict with the law, Overall quality of life) reported in NRLUD at the beginning and end of treatment according to areas {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.151} ~ ",19
Y,Czechia,CZE,Demand Reduction,Level of coverage of inpatient treatment,Yes,"Number, Capacity (persons, beds) and occupancy (number of persons) of by type of treatment (specialised residential treatment facilities for children at risk of drug addiction (special education establishments); Aftercare programmes, and therapeutic communities; Detoxification units in prison, Drug-free zones in prisons, Departments for differentiated serving of sentence, and Departments for serving of compulsory drug/alcohol treatment in prisons) {The National Drug Policy Strategy, 2010-2018, p.44, p.45} ~ Number of certified programmes as of 31 June 2009: Detoxification, short- and medium-term inpatient treatment, residential care in therapeutic communities {The National Drug Policy Strategy, 2010-2018, p.46} ~ Number of addictive bed-care facilities in 2016 (Detoxification, Psychiatric bed care, Therapeutic communities, Special education facilities, protected housing) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.136; Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.138} ~ Number of users of addictive substances in residential addictology programs in 2016 (Detoxification, Psychiatric bed care, Therapeutic communities, Special education facilities) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.137; Czech Republic Country Drug Report, 2017, p.12} ~ Number of patients hospitalized for drug detoxification by type drug in 2016 (Cocaine, Volatile substances, Hallucinogens, Other psychoactive substances, Cannabis, Sedatives and hypnotics, Opioids, Other stimulants than cocaine (pervitin), Combination of substances) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.137} ~ Number of patients treated by type of program (Bed Care, Therapeutic Communities) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.139} ~ Treatment demands in 2016 by drug use and needle and syringe sharing,% {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.142} ~ Number of treatment demands by base and other drug / issue in 2016 {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.143} ~ Number of hospitalizations for disorders caused by the use of addictive substances in 2000-2016 {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.150} ~ Number of hospitalizations for those under the influence of addictive substances in the period 2002-2016 {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.166} ~ After-care services in the Social Services Providers (outpatient and inpatient) Register as of August 21, 2017 {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.199} ~ ",11
Y,Czechia,CZE,Demand Reduction,Proportion of people who use drugs enrolled in voluntary treatment,Yes,"Applicants for treatment by drug use (problem) and source of treatment recommendations in 2016 (Alone) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.148} ~",1
Y,Czechia,CZE,Demand Reduction,Proportion of people who use drugs enrolled in coerced treatment,Yes,"Applicants for treatment by drug use (problem) and source of treatment recommendations in 2016 (Others; Educational facility / program; Probationary and mediation service; Court; Police; Other social services; Addictology service; Family or close person; Practitioner ; Other Health Service) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.148} ~",1
Y,Czechia,CZE,Demand Reduction,Proportion of people who use drugs enrolled in compulsory treatment,Yes,"The number, capacity and utilization of drug-free zones and specialized departments for compulsory treatment in prisons in l. 2006-2016 {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.221} ~ Number, Capacity (persons, beds) and Occupancy (number of persons) of Detoxification units in prison, Drug-free zones in prisons, Departments for differentiated serving of sentence, and Departments for serving of compulsory drug/alcohol treatment in prisons {The National Drug Policy Strategy, 2010-2018, p.45} ~ Applicants for treatment by drug use (problem) and source of treatment recommendations in 2016 (Others; Educational facility / program; Probationary and mediation service; Court; Police; Other social services; Addictology service; Family or close person; Practitioner ; Other Health Service) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.148} ~ Number of protective treatments imposed in 2006-2016 (compulsory) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.211} ~ ",4
Y,Czechia,CZE,Demand Reduction,Presence of prevention programming in law enforcement,Yes,"Acceptability of testing or use of addictive substances, in % (Medicines for pain or sedation, Tobacco, Alcohol, Cannabis drugs, other drugs) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.69} ~ ",1
Y,Czechia,CZE,Demand Reduction,Presence of prevention programming in the media,No,n/a,0
Y,Czechia,CZE,Demand Reduction,Presence of prevention programming in schools,Yes,"Provision of interventions in schools in the Czech Republic (expert ratings) (0 - No information available; 1 - No provision; 2 - Rare provision; 3 - Limited provision; 4 - Extensive provision; 5 - full provision) {Czech Republic Country Drug Report, 2017, p.10} ~ ",1
Y,Czechia,CZE,Demand Reduction,Presence of prevention programming in the workplace,No,n/a,0
Y,Czechia,CZE,Demand Reduction,Presence of prevention programming for youth and the community,Yes,"Risk of the use of addictive substances once or twice in a lifetime as perceived by young people - ""great risk"" responses (%), ESPAD, by type of substance (Cigarettes (a pack or more per day); Alcohol (5+ drinks over the weekend); Cannabis (Marijuana or hashish); Amphetamines; Ecstasy; Inhalants) {The National Drug Policy Strategy, 2010-2018, p.34} ~ Certified programmes of specific primary prevention by regions, the number of towns/cities, agencies, and types of programmes as of the end of 2008 (Number of towns/cities; Number of agencies; Number of programmes; Type of programme - CUR, ECUR, EI, EP, ED) {The National Drug Policy Strategy, 2010-2018, p.35} ~ Comparison of the subjective perception of risks associated with the use of addictive substances between 2012 and 2016, in % (No risk, Small risk, Medium risk, Big risk) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.57, p.58} ~ Respondents' views on what should be done to reduce drug problems - Citizenship Survey 1996, 2006 and 2016, in % (Expand the various forms of assistance to those affected, More support for prevention, education and education, Strengthen sanctions for drug use and spread, Nothing should be done) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.66} ~ Citizens' attitudes towards the provision of services to drug users - comparison of years 2009-2017,% of respondents who agree (Drug-dependent counseling should be provided free of charge, Every drug addict has a chance to cure, Drug addiction treatment should be free of charge for a limited number of attempts, Drug-dependent syringes should be provided free of charge, Treatment of drug addicts should be free of charge, The work of street workers does not make sense, it is useless.) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.68} ~Ranking of substances by hazard subjectively evaluated by visitors to dance events, average on scale 1 (low hazard) to 10 (high hazard) (Pervitin/Amphetamine, Opioids, GHB, New Psychoactive Substance, Ketamine, Alcohol, Cocaine, Poppers, Ecstasy, Magic Mushrooms, LSD, THC) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.78} ~ Number of certified primary risk prevention programs with a focus on addictology prevention: by region, 2016 {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.82} ~",7
Y,Czechia,CZE,Demand Reduction,Presence of other demand reduction metrics,Yes,"Marital status of those who use drugs {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.189} ~ Occurrence of risk behavior in schools in the Central Bohemian region and South Moravian Region in the school years 2011/2012 to 2015/2016 (in% of schools where the phenomenon occurred / solved) (Absenteism from school, smoking, bullying, thefts, vandalism, cyberbullying, alcohol, other addictive substances, eating disorders, Risk behavior in transport, Hazardous sexual behavior, Torture and abuse of the child, Extremism & racism, netolism (virtual drugs), Risky sports, Playing gambling, Effect of sects, other) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.85} ~ Average severity of occurrence of socially negative phenomena in socially exlcuded localities monitored in 2013-2017 (Drug use in socially excluded localities, Indebtedness, Use of illicit drugs and volatile drugs, Insufficient hygiene, playing gambling, usury) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.195} ~ Public expenditures on drug services in relation to GDP and state budget expenditure in 1998-2009 {The National Drug Policy Strategy, 2010-2018, p.51} ~ Developments in co-funding of drug policy projects as part of subsidy proceedings administered by the Government Council for Drug Policy Coordination, 2001-2010 {The National Drug Policy Strategy, 2010-2018, p.52} ~ Total expenditures of the Czech Ministry of Education earmarked for drug policy as part of Programmes I, II, and III in the period 2004-2008 {The National Drug Policy Strategy, 2010-2018, p.34} ~ Funding of public services comprising the prevention and treatment network in 1996-2010 {The National Drug Policy Strategy, 2010-2018, p.50} ~ Expenditure on drug policy from the state budget and local budget by sector in 2010-2016, in thous. CZK {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.34, p.35, p.36, p.41} ~ Comparison of expenditures from public budgets by service category in 2013-2016, in thous. CZK {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.36} ~  Expenditure on drug policy from local budgets in 2016 by service category, in thous. CZK {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.39, p.42} ~ Payments from municipal / regional budgets to the New Czech Republic Foundation Fund for the implementation of the Revolution Train project on their territory in 2016-2017 (as of October 10, 2017 according to the Register of Contracts) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.87} ~ the number of aftercare programs subsidized by the National Drug Commission in 2007-2016 {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.200} ~ Public expenditure related to illicit drugs in the Czech Republic (% demand reduction) {Czech Republic Country Drug Report, 2017, p.3} ~",13
Y,Czechia,CZE,Supply Reduction,Size and value of the illegal drug market,Yes,"Proportion of students who find the drugs under consideration easily or quite easily available (ESPAD, %) by type (Cannabis, Ecstasy, Pervitin) {The National Drug Policy Strategy, 2010-2018, p.36} ~ Frequency of drugs ever offered to respondents included in a general population survey (not once, 1-2 times, 3-5 times, 6-9 times, 10-19 times, 20-39 times, 40 or more, total) {The National Drug Policy Strategy, 2010-2018, p.49} ~ Method of obtaining psychoactive drugs (Sedative, hypnotics; Opioid analgesics) among respondents who have used drugs in the last 12 months - National Research 2016, in % (Another way; Through the Internet; From a friend; In a pharmacy without a prescription; On medical prescription) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.49} ~ The average incidence of drug crime in socially excluded areas in 2015-2017 (Sale of pervitin, Sale of hemp, Cannabis cultivation, Production of pervitin, Sale or manufacture of others drugs, Heroin sales) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.197} ~ Subjectively perceived availability of drugs in prison in 2012-2016 {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.217} ~",5
Y,Czechia,CZE,Supply Reduction,Level of procedures related to crop eradication,Yes,"The average incidence of drug crime in socially excluded areas in 2015-2017 (Cannabis cultivation) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.197} ~ ",1
Y,Czechia,CZE,Supply Reduction,"Number of arrests, seizures, and offences",Yes,"Quantity of the precursors and medicines containing pseudoephedrine and intended for pervitin production seized, cooking labs detected, and pervitin seized in 2004-2008. Seizures by type of drug: ephedrine (g); pseudoephedrine (g); modafen (tbl); nurofren stop grip (tbl); panadol plus grip (tbl); number of cooking labs; pervitin (g) {The National Drug Policy Strategy, 2010-2018, p.47} ~ Number and quantity of seizures of main drug types in 2004-2008 (Marijuana, Pervitin, Heroin, Cannabis Plants, Hashish, Ecstasy, Cocaine, LSD, amphetamine) {The National Drug Policy Strategy, 2010-2018, p.47; Czech Republic Country Drug Report, 2017, p.1, p.16, p.18, p.19} ~ Number of seizures and quantities of individual drugs seized in the framework of criminal proceedings in 2007-2016, and in the context of infringement procedure in 2014-16 {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.229} ~ The number of individual tablets of medicines containing pseudoephedrine seized in 2011-2016 {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.230} ~ Development of the number of primary drug offenses (DTC) and the proportion of all detected crimes (TC) l. 2002-2016 (Identified HP; Number of drug-related offenses; Proportion of drug-related offenses detected (%) Number of drug-related offenses per 100 thousand. Pers. 15 -64 years) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.204} ~ Number of primary drug offenses detected by individual facts in 2006-2016 (Total; Spread of drug addiction; Holding for own use; Cultivation for own use; Holding of articles for production; Production, smuggling and sale) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.205; Czech Republic Country Drug Report, 2017, p.1, p.4, p.19} ~ The primary drug offenses in 2016 per 100 thousand population aged 15-64: by region {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.209} ~ Drug offenses discussed in 2016 by Penal Code section, the age of the offender and counties {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.212} ~ Perpetrators of drug offenses detected in 2016 by drugs {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.213} ~ Evolution of the number of identified criminal offenses and the proportion of offenses committed under the influence of addictive substances in the period 2006-2016 {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.213} ~ Number of persons arrested, prosecuted, accused and convicted for primary drug offenses in 2002-2006 {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.204} ~ The number of persons arrested for offenses of illegal handling of narcotic and psychotropic substances and objects for their production in 2006-2016 by drugs {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.207} ~ Number of persons imprisoned for primary drug offenses and selected offenses in relation to the use of addictive substances as at 31 December of the year (2007-2016) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.216} ~ Number of persons detained by individual drugs and type of primary drug crime in 2016 {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.206} ~ ",14
Y,Czechia,CZE,Supply Reduction,Level of law enforcement activity and interdiction in the market,Yes,"Number of pervitin cooking labs and marijuana plantations detected by the Police of the Czech Republic in 2004-2008 {The National Drug Policy Strategy, 2010-2018, p.48} ~ Major penalties imposed for drug-related offenses in the primary 2016 according to individual crimes (Unconditional imprisonment, conditional imprisonment, home confinement, community service, prohibition of activity, forfeiture of property, monetary penalty, forfeiture of property, expulsion, ban on residence) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.210} ~ The volume of drugs containing pseudoephedrine sold in pharmacies in the Czech Republic (Graph of Medicinal products ...) and repaired by the repressive authorities (graph of the Medicines ...) in 2007-2016 {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.226} ~",3
Y,Czechia,CZE,Supply Reduction,"Price, purity and potency of drugs, and related process indicators",Yes,"Average and most common (modus) prices of drugs (Marijuana (g); Hashish (g); Ecstasy (tablets); Pervitin (g); Heroin (g); Cocaine (g); LSD (doses)) {The National Drug Policy Strategy, 2010-2018, p.49; Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.232; Czech Republic Country Drug Report, 2017, p.17, p.18, p.19} ~ Average drug purity by type (Marijuana, Hashish, Ecstasy, Pervitin, Heroin, Cocaine) {The National Drug Policy Strategy, 2010-2018, p.49; Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.232; Czech Republic Country Drug Report, 2017, p.17, p.18, p.19} ~ ",2
Y,Czechia,CZE,Supply Reduction,Number of people engaged with the criminal justice system,Yes,"Number of persons prosecuted, charged, and sentenced in relation to drug-related offences (Number of those prosecuted; as reported by the National Drug Headquarters; as reported by the Police of the Czech Republic (criminal statistics record system); as reported by the Ministry of Justice; Number of those charged (Ministry of Justice); Number of those sentenced (Ministry of Justice)) {The National Drug Policy Strategy, 2010-2018, p.48} ~ Number of persons arrested, prosecuted, accused and convicted for primary drug offenses in 2002-2006 {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.204} ~ Number of persons apprehended, prosecuted, accused and convicted for drug offenses by individual offenses in 2016 (The number of persons arrested, prosecuted, charged and convicted for drug offenses by individual offenses in the year. 2016 (Arrest, prosecution (PP PCR) Prosecuted (MS) Defendants; Convictions) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.205} ~ Number of prosecuted persons broken down by primary drug and criminal offenses in 2016 {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.207} ~ Number of persons indicted by individual drugs and primary drug offenses in 2016 {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.208} ~ Detected primary drug crimes and prosecuted persons in 2016: by region {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.208} ~ Development of the number of people sentenced for drug-related offenses and the composition of sanctions imposed in 2007-2016 {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.210} ~ Reported drug offenders in the Czech Republic (Number of drug law offences & number of drug offenders) {Czech Republic Country Drug Report, 2017, p.4} ~",7
Y,Czechia,CZE,Supply Reduction,Presence of other supply reduction metrics,Yes,"Public expenditure related to illicit drugs in the Czech Republic (% supply reduction) {Czech Republic Country Drug Report, 2017, p.3} ~ Respondents' views on how the society should build on people using drugs - Citizenship Survey 1996, 2006 and 2016, in % (Do not restrict it because there is no reason to do so. Tolerate, but protect others from them. Suffer, but ask them to go to heal. To prosecute and consider their behavior and activity to be criminal.) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.66} ~ Consensus of respondents with societal tolerance of cannabis use, by age and sex - Study Citizens 1996, 2006 and 2016, in % (Yes (answers ""definitely yes"" and ""rather yes""), No (answers ""definitely not"" and ""rather not""), I do not know) {Výroční zpráva o stavu ve věcech drog v České republice v roce, 2016, p.66, p.67} ~ ",3
Y,Czechia,CZE,International Cooperation,Level of engagement in international cooperation,No,n/a,0
Y,Philippines,PHL,Health,Level of availability of harm reduction services and harm reduction scale up,No,n/a,0
Y,Philippines,PHL,Health,Presence of needle and syringe programs,No,n/a,0
Y,Philippines,PHL,Health,Prevalence of substance use disorders,No,n/a,0
Y,Philippines,PHL,Health,Prevalence of psychiatric comorbidities,No,n/a,0
Y,Philippines,PHL,Health,Drug-related mortality,Yes,"Total number of Filipinos who have died from AIDS {Philippine Anti-Illegal Drug Strategy, 2018, p.19} ~ Number of reported deaths among those who were infected through the sharing of needles {Philippine Anti-Illegal Drug Strategy, 2018, p.19} ~ Number of drug-related mortality (ex. drug overdose) {Philippine Anti-Illegal Drug Strategy, 2018, p.81} ~",3
Y,Philippines,PHL,Health,Prevalence of drug-related infectious disease,Yes,"Number of new HIV infections reported {National Anti-Drug Plan of Action, 2015-2020, p.10; Philippine Anti-Illegal Drug Strategy, 2018, p.18} ~ HIV prevalence {National Anti-Drug Plan of Action, 2015-2020, p.10; Philippine Anti-Illegal Drug Strategy, 2018, p.19} ~ Prevalence of new HIV infections among PWID {National Anti-Drug Plan of Action, 2015-2020, p.10} ~ Incidence of HIV/AIDS among PWID {Philippine Anti-Illegal Drug Strategy, 2018, p.19} ~",4
Y,Philippines,PHL,Health,Proportion of people who use drugs who engage in risky consumption,No,n/a,0
Y,Philippines,PHL,Health,Proportion of people who use drugs who engage in safe consumption practices,No,n/a,0
Y,Philippines,PHL,Health,"Coverage of services for the prevention, testing, and treatment of bloodborne diseases",Yes,"Drug Prevention Services subsumed and included in the Primary Health Care/Inter Local Health Zones with the following components: 1) Screening and referral system; 2) With broad range of available services and modalities at the community level including HIV/AIDS prevention and other commorbidities; 3) Client feedback system {Philippine Anti-Illegal Drug Strategy, 2018, p.74} ~ ",1
Y,Philippines,PHL,Health,Presence of specialised training for addiction care,Yes,"Number of Government and Private treatment facilities with at least one staff who completed Certification program on drug prevention and treatment {Philippine Anti-Illegal Drug Strategy, 2018, p.76} ~ Number of treatment center staff, social and health workers with trainings in community drug prevention and treatment {Philippine Anti-Illegal Drug Strategy, 2018, p.78} ~ ",2
Y,Philippines,PHL,Health,Presence of health harms related to drug use,No,n/a,0
Y,Philippines,PHL,Health,Presence of other health metrics,No,n/a,0
Y,Philippines,PHL,Peace and Security,"Prevalence of alcohol and drugs in accidents, and interventions to increase road safety",No,n/a,0
Y,Philippines,PHL,Peace and Security,Annual number of public disorder and violent crime reports,No,n/a,0
Y,Philippines,PHL,Peace and Security,Number of non-lethal drug market violent events reported,No,n/a,0
Y,Philippines,PHL,Peace and Security,Number of drug market related homicides and disappearances,No,n/a,0
Y,Philippines,PHL,Peace and Security,Presence of other peace and security metrics,No,n/a,0
Y,Philippines,PHL,Development,Coverage of housing assistance for people who use drugs,No,n/a,0
Y,Philippines,PHL,Development,Coverage of social assistance for people who use drugs (not including housing),Yes,"Drug surrenderers, recovering drug dependents and convicted drug offenders who served prison terms have access to appropriate interventions and livelihood assistance {Philippine Anti-Illegal Drug Strategy, 2018, p.23} ~ Number of individuals provided with appropriate skills training, education and livelihood assistance, and after care services: Drug surrenderers; Recovering drug dependents; and Convicted drug offenders who served prison terms {Philippine Anti-Illegal Drug Strategy, 2018, p.80} ~ Subsidy/Reimbursement system established {Philippine Anti-Illegal Drug Strategy, 2018, p.75} ~",3
Y,Philippines,PHL,Development,Number of households enrolled in alternative development,Yes,"increased number of Alternative Development programs {National Anti-Drug Plan of Action, 2015-2020, p.31} ~ increased number of identified marijuana cultivating communities/barangays involved in Alternative Development projects {National Anti-Drug Plan of Action, 2015-2020, p.31} ~  increased participation of LGUs and other stakeholders in Alternative Development projects (such as but not limited to allocation of funds, passage of ordinances, conduct of advocacy programs, etc) {National Anti-Drug Plan of Action, 2015-2020, p.32} ~ Implementation of the updated National Plan of Action (2006) on the eradication of marijuana plantations through Alternative Development {National Anti-Drug Plan of Action, 2015-2020, p.32} ~ Number of alternative development programs funded by the DDB {Annual Report, 2016, p.20} ~ Income of drug affected LGUs and communities from alternative development programs increased {Philippine Anti-Illegal Drug Strategy, 2018, p.23} ~ Number of barangays provided with alternative development programs {Philippine Anti-Illegal Drug Strategy, 2018, p.79} ~ Number of individuals provided with alternative development programs gainfully employed: Drug surrenderers; Recovering drug dependents; and Convicted drug offenders who served prison terms {Philippine Anti-Illegal Drug Strategy, 2018, p.80} ~",8
Y,Philippines,PHL,Development,Presence of other development metrics,Yes,"Employment status of drug users {National Anti-Drug Plan of Action, 2015-2020, p.8; Annual Report, 2016, p.3; Philippine Anti-Illegal Drug Strategy, 2018, p.17} ~ Educational attainment of drug users {National Anti-Drug Plan of Action, 2015-2020, p.8; Annual Report, 2016, p.3; Philippine Anti-Illegal Drug Strategy, 2018, p.17} ~ Economic status of drug users {Annual Report, 2016, p.3} ~ average monthly family income {Philippine Anti-Illegal Drug Strategy, 2018, p.17} ~ Number of household from affected LGUs and communities with legitimate source of income {Philippine Anti-Illegal Drug Strategy, 2018, p.79} ~ Average household income of drug-affected LGUs and municipalities from legitimate source {Philippine Anti-Illegal Drug Strategy, 2018, p.80} ~",6
Y,Philippines,PHL,Human Rights,"Prevalence and incidence of infectious diseases in vulnerable populations (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Philippines,PHL,Human Rights,"Prevalence of vulnerable people who use drugs (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Philippines,PHL,Human Rights,Proportion of people who use drugs in prison that are receiving medication assisted treatment (MAT),No,n/a,0
Y,Philippines,PHL,Human Rights,Distribution of sterile injecting equipment in prisons,No,n/a,0
Y,Philippines,PHL,Human Rights,Presence of programs and services targeted towards women ,No,n/a,0
Y,Philippines,PHL,Human Rights,Presence of programs and services targeted towards people of color,No,n/a,0
Y,Philippines,PHL,Human Rights,Presence of challenges and/or harms experienced by people of color,No,n/a,0
Y,Philippines,PHL,Human Rights,"Presence of programs and services targeted towards vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Philippines,PHL,Human Rights,"Presence of challenges and/or harms experienced by vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Philippines,PHL,Human Rights,Presence of other human rights metrics,No,n/a,0
Y,Philippines,PHL,Demand Reduction,Prevalence of drug use by age,Yes,"Mean age of drug users {National Anti-Drug Plan of Action, 2015-2020, p.8; Annual Report, 2016, p.3; Philippine Anti-Illegal Drug Strategy, 2018, p.17} ~ Prevalence of drug use (regardless of drug type) among: 1. General population (categorized by age); [...] 4. Youth (in-school and out-of-school) {Philippine Anti-Illegal Drug Strategy, 2018, p.73} ~",2
Y,Philippines,PHL,Demand Reduction,Prevalence of drug use by sex,Yes,"Male to female ratio of drug users {National Anti-Drug Plan of Action, 2015-2020, p.8; Annual Report, 2016, p.3; Philippine Anti-Illegal Drug Strategy, 2018, p.17} ~ ",1
Y,Philippines,PHL,Demand Reduction,Prevalence of drug use by type,Yes,"Nature of drug taking (mono or poly drug use) {National Anti-Drug Plan of Action, 2015-2020, p.8; Annual Report, 2016 p.3; Philippine Anti-Illegal Drug Strategy, 2018, p.17} ~ Drugs/Substances of abuse {Annual Report, 2016 p.3; Philippine Anti-Illegal Drug Strategy, 2018, p.17} ~ ",2
Y,Philippines,PHL,Demand Reduction,Number of people who use drugs,Yes,"Identified drug users in the community but no known drug pushers in the area {National Anti-Drug Plan of Action, 2015-2020, p.8} ~ number of drug users {National Anti-Drug Plan of Action, 2015-2020, p.27; Philippine Anti-Illegal Drug Strategy, 2018, p.17} ~ Duration of drug taking of drug users {Annual Report, 2016, p.3; Philippine Anti-Illegal Drug Strategy, 2018, p.17} ~ Prevalence of drug use (regardless of drug type) among: [...] 2. Elected officials and Government workers; 3. Law enforcers; [...] 5. People living with HIV/AIDS; 6. Individuals working in vulnerable occupations (e.g. long-haul drivers, pilots, health service providers, and call center agents) {Philippine Anti-Illegal Drug Strategy, 2018, p.73} ~",4
Y,Philippines,PHL,Demand Reduction,"Prevalence of drug use by mode of administration (oral, mucosa, inhalation, and injection)",No,n/a,0
Y,Philippines,PHL,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT)",Yes,"Increased awareness and access to treatment, rehabilitation and after-care services {National Anti-Drug Plan of Action, 2015-2020, p.27} ~ Number/percent of outpatient admissions by sex {Annual Report, 2016, p.3} ~ Number/Percent of total admissions by sex {Annual Report, 2016, p.3} ~ Marital status of those admitted into treatment {Annual Report, 2016, p.4} ~ Number of admissions in outpatient treatment {Annual Report, 2016, p.19} ~ Total number of admissions registered {Philippine Anti-Illegal Drug Strategy, 2018, p.17} ~ Number of new cases registered in treatment {Philippine Anti-Illegal Drug Strategy, 2018, p.17} ~ Number of relapsed/re-admitted cases to treatment {Philippine Anti-Illegal Drug Strategy, 2018, p.17} ~ Number of people who have sought treatment in outpatient facilities {Philippine Anti-Illegal Drug Strategy, 2018, p.17} ~ Communities have access to appropriate and responsive community-based drug abuse interventions and aftercare at the barangay/municipal levels {Philippine Anti-Illegal Drug Strategy, 2018, p.23} ~ Percentage of municipalities/cities with community-based treatment and rehabilitation program {Philippine Anti-Illegal Drug Strategy, 2018, p.74} ~ Number of drug users who availed and completed community-based drug abuse interventions and aftercare {Philippine Anti-Illegal Drug Strategy, 2018, p.74} ~  Number of service providers recognized {Philippine Anti-Illegal Drug Strategy, 2018, p.75} ~ Number of Health Providers providing Drug Prevention Services with the following components: 1) Screening and referral system; 2) With broad range of available services and modalities at the community level; 3) Client feedback system {Philippine Anti-Illegal Drug Strategy, 2018, p.75} ~ Number of drug users with three or less readmittance {Philippine Anti-Illegal Drug Strategy, 2018, p.76} ~",15
Y,Philippines,PHL,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT) by age",No,n/a,0
Y,Philippines,PHL,Demand Reduction,Level of access to opioid substitution treatment and medication assisted treatment (OST/MAT),No,n/a,0
Y,Philippines,PHL,Demand Reduction,Level of coverage of inpatient treatment,Yes,"Total number of admissions in rehabilitation facilities {National Anti-Drug Plan of Action, 2015-2020, p.10} ~ Reasons for declining admissions in rehabilitation facilities {National Anti-Drug Plan of Action, 2015-2020, p.10} ~ Number/Percent of new admissions by sex (female/male) {Annual Report, 2016, p.3} ~ Number/percent of re-admissions by sex {Annual Report, 2016, p.3} ~ Number of new admissions in residential facilities {Annual Report, 2016, p.19} ~ Number of re-admissions in residential facilities {Annual Report, 2016, p.19} ~ Percentage of municipalities/cities with community-based treatment and rehabilitation program {Philippine Anti-Illegal Drug Strategy, 2018, p.74} ~ Total amount allocated annually for rehabilitation facilities {Philippine Anti-Illegal Drug Strategy, 2018, p.75} ~ Accreditation system for rehabilitation program service providers established {Philippine Anti-Illegal Drug Strategy, 2018, p.75} ~",9
Y,Philippines,PHL,Demand Reduction,Proportion of people who use drugs enrolled in voluntary treatment,No,n/a,0
Y,Philippines,PHL,Demand Reduction,Proportion of people who use drugs enrolled in coerced treatment,No,n/a,0
Y,Philippines,PHL,Demand Reduction,Proportion of people who use drugs enrolled in compulsory treatment,No,n/a,0
Y,Philippines,PHL,Demand Reduction,Presence of prevention programming in law enforcement,Yes,"Number of people who participated in the Seminar-Workshop for Judges, Prosecutors and Law Enforcers {Annual Report, 2016, p.15} ~ The number of law-enforcement officers who benefitted from a Seminar on Anti-Illegal Drug Operations and Investigation {Annual Report, 2016, p.17} ~ Number of individuals tested and confirmed positive for drug use: Students; Drivers; Out-of-school youth; Applicants for: Firearms license, Drivers’ license, Employment (local and overseas) {Philippine Anti-Illegal Drug Strategy, 2018, p.77} ~ Number of DDB staff trained on: Policy development; Program Management; Monitoring and Evaluation; Evidence-based practices; Stakeholders’ Engagement {Philippine Anti-Illegal Drug Strategy, 2018, p.78} ~ Number of law enforcers, prosecutors and judges oriented on procedures and protocols on handling drug cases {Philippine Anti-Illegal Drug Strategy, 2018, p.83} ~",5
Y,Philippines,PHL,Demand Reduction,Presence of prevention programming in the media,Yes,"Increased number of information, education and communication materials produced and distributed {National Anti-Drug Plan of Action, 2015-2020, p.33} ~ Enhanced information technology, networks and systems {National Anti-Drug Plan of Action, 2015-2020, p.33} ~ Help Line for Users and At-risk individuals established {Philippine Anti-Illegal Drug Strategy, 2018, p.75} ~ ",3
Y,Philippines,PHL,Demand Reduction,Presence of prevention programming in schools,Yes,"The number of new seminars launched for youth in schools about the dangers of drug abuse {Annual Report, 2016, p.11} ~ The number of coordinators and teachers gathered for the seminar on drug abuse prevention program {Annual Report, 2016, p.12} ~ The number of children who benefitted from the Campus Tour on Drug Prevention for Kids {Annual Report, 2016, p.12} ~ The number of elementary school students who benefitted from the Self-Discovery Seminar for Kids {Annual Report, 2016, p.12} ~ The number of elementary school students who joined the story telling competition {Annual Report, 2016, p.12} ~ The number of students who participated in the Provincial Inter-School Stage Play Competition {Annual Report, 2016, p.12} ~ The number of new DARE police officers was enlisted. {Annual Report, 2016, p.16} ~ Individuals have access to various drug prevention services and programs in the workplace and in institutions of learning {Philippine Anti-Illegal Drug Strategy, 2018, p.23} ~ Number of guidance counselors and school officials trained on early detection, identification, and referral {Philippine Anti-Illegal Drug Strategy, 2018, p.76} ~ Percentage of schools with functional PDE programs {Philippine Anti-Illegal Drug Strategy, 2018, p.77} ~ Number of students trained on life skills {Philippine Anti-Illegal Drug Strategy, 2018, p.77} ~ Number of students referred for drug assessment and intervention {Philippine Anti-Illegal Drug Strategy, 2018, p.77} ~ Number of students referred for interventions who completed their schooling {Philippine Anti-Illegal Drug Strategy, 2018, p.77} ~ Number of students subjected to random drug testing: High school & College {Philippine Anti-Illegal Drug Strategy, 2018, p.77} ~ Number of students referred to treatment facilities: High school & College {Philippine Anti-Illegal Drug Strategy, 2018, p.77} ~ Monitoring and evaluation system established for PDE programs at the school level {Philippine Anti-Illegal Drug Strategy, 2018, p.81} ~",16
Y,Philippines,PHL,Demand Reduction,Presence of prevention programming in the workplace,Yes,"increased number of organizations implementing anti-drug advocacy and capacity-building programs {National Anti-Drug Plan of Action, 2015-2020, p.27} ~ Increased partnerships with stakeholders/NGOs {National Anti-Drug Plan of Action, 2015-2020, p.33} ~ Compliance status of establishments in the implementation of Drug-Free Workplace Program {Annual Report, 2016 p.13} ~ Drug Abuse Prevention Seminar in the Workplace {Annual Report, 2016, p.14} ~ Number of transport personnel who participated in Drug Abuse Prevention Seminar for Transport Groups {Annual Report, 2016, p.14} ~ The number of National Service Training Program Coordinators trained on drug abuse prevention education {Annual Report, 2016, p.17} ~ The number of drub abuse prevention workers trained In partnership with the Colombo Plan and the International Centre for Certification and Education of Addiction Professionals (ICCE) {Annual Report, 2016, p.18} ~ The number of treatment and rehabilitation program directors and personnel who have undergone training for the Implementation of the OPLAN SAGIP {Annual Report, 2016, p.18} ~ Individuals have access to various drug prevention services and programs in the workplace and in institutions of learning {Philippine Anti-Illegal Drug Strategy, 2018, p.23} ~ Number of government companies with existing and operational drug-free policies and programs based on RA No.9165 {Philippine Anti-Illegal Drug Strategy, 2018, p.76} ~ Number of private companies with existing and operational drug-free policies and programs based on RA No. 9165 {Philippine Anti-Illegal Drug Strategy, 2018, p.76} ~ Number of government employees who attended Preventive Drug Education advocacy programs {Philippine Anti-Illegal Drug Strategy, 2018, p.76} ~ Number of private employees who attended Preventive Drug Education advocacy programs {Philippine Anti-Illegal Drug Strategy, 2018, p.76} ~",13
Y,Philippines,PHL,Demand Reduction,Presence of prevention programming for youth and the community,Yes,"Increased number of programs/projects/activities completed {National Anti-Drug Plan of Action, 2015-2020, p.27} ~ The number of beneficiaries enlisted for the Drug Abuse Prevention Program for Out-of-School-Youth {Annual Report, 2016, p.12} ~ The number of artists who participated in Street Artists No to Drugs {Annual Report, 2016, p.12} ~ Number of participants who attended Systematic Training for Effective Parenting or STEP {Annual Report, 2016, p.14} ~ The number of invited probationers, parolees and family member to participate in two Parent-Youth Resource Against Drug Abuse (PYRADA) activities. {Annual Report, 2016, p.14} ~ The number of people who participated in the Life Skills Enhancement Training {Annual Report, 2016, p.15} ~ The number of people who participated in the Orientation Seminar on Drug Abuse Prevention for Faith-based Organization {Annual Report, 2016, p.16} ~ The number of people who participated in Programs for Anti-Drug Abuse Councils {Annual Report, 2016, p.17} ~ The number of senior citizens that were enlisted as anti-drug advocates {Annual Report, 2016, p.18} ~ Public satisfaction rating on war on drugs {Philippine Anti-Illegal Drug Strategy, 2018, p.73} ~ Percentage of barangays with functional Barangay Anti-Drug Abuse Council (BADAC) {Philippine Anti-Illegal Drug Strategy, 2018, p.74} ~ Percentage of municipalities with functional Municipal Anti-Drug Abuse Council (MADAC) {Philippine Anti-Illegal Drug Strategy, 2018, p.74} ~ Percentage of cities with functional City Anti-Drug Abuse Council (CADAC) {Philippine Anti-Illegal Drug Strategy, 2018, p.74} ~ Percentage of provinces with functional Provincial Anti-Drug Abuse Council (PADAC) {Philippine Anti-Illegal Drug Strategy, 2018, p.74} ~ Department of Interior and Local Government policy integrating drug programs in Seal of Good Governance Award (balance scorecard) {p.75} ~ Number of faith-based organizations, foundations and non-government organizations engaged in drug use prevention and control {Philippine Anti-Illegal Drug Strategy, 2018, p.75} ~ Number of civil society organizations involved in community-based drug abuse interventions and aftercare {Philippine Anti-Illegal Drug Strategy, 2018, p.75} ~ Number of community-based drug programs monitored and evaluated {Philippine Anti-Illegal Drug Strategy, 2018, p.75} ~ Number of trained Barkada Kontra Droga members {Philippine Anti-Illegal Drug Strategy, 2018, p.77} ~ Number of Barkada Kontra Droga Chapters in the Philippines {Philippine Anti-Illegal Drug Strategy, 2018, p.77} ~ Percentage of BADAC members trained on drug prevention and control {Philippine Anti-Illegal Drug Strategy, 2018, p.78} ~ Percentage of MADAC members trained on drug prevention and control {Philippine Anti-Illegal Drug Strategy, 2018, p.78} ~ Percentage of CADAC members trained on drug prevention and control {Philippine Anti-Illegal Drug Strategy, 2018, p.78} ~ Percentage of PADAC members trained on drug prevention and control {Philippine Anti-Illegal Drug Strategy, 2018, p.78} ~ Number of implementing agencies’ staff trained on monitoring and evaluation and evidence-based practices {Philippine Anti-Illegal Drug Strategy, 2018, p.79} ~ Number of advocacy activities on drug abuse prevention and control developed and conducted by implementing agencies {Philippine Anti-Illegal Drug Strategy, 2018, p.79} ~",26
Y,Philippines,PHL,Demand Reduction,Presence of other demand reduction metrics,Yes,"Civil status of drug users {National Anti-Drug Plan of Action, 2015-2020, p.8; Philippine Anti-Illegal Drug Strategy, 2018, p.17} ~ increased number of studies, researchers completed {National Anti-Drug Plan of Action, 2015-2020, p.27} ~ Place of residence {Philippine Anti-Illegal Drug Strategy, 2018, p.17} ~ Number of drug interventions assessed and evaluated jointly by the DDB and implementing units {Philippine Anti-Illegal Drug Strategy, 2018, p.81} ~",4
Y,Philippines,PHL,Supply Reduction,Size and value of the illegal drug market,Yes,"Suspected existence of at least one drug laboratory, warehouse, den, dive or resort (Frequency) {National Anti-Drug Plan of Action, 2015-2020, p.8} ~ At least one suspected pusher/trafficker operating in the community (frequency) {National Anti-Drug Plan of Action, 2015-2020, p.8} ~ Drug concealment methods {National Anti-Drug Plan of Action, 2015-2020, p.9} ~ New forms of drugs {National Anti-Drug Plan of Action, 2015-2020, p.9} ~ The newest drug syndicate to be found operating the country {National Anti-Drug Plan of Action, 2015-2020, p.9} ~ Prevalence of the barangay's population affected by the drug market (seriously affected, moderately affected, slightly affected) {National Anti-Drug Plan of Action, 2015-2020, p.8; Annual Report, 2016, p.7; Philippine Anti-Illegal Drug Strategy, 2018, p.19} ~ Prevalence of drug affectation in the national capital region, Zamboanga Peninsula, Central Visayas, Central Luzon, and Caraga) {Philippine Anti-Illegal Drug Strategy, 2018, p.19} ~ Percentage/Number  of barangays declared drug-free {Philippine Anti-Illegal Drug Strategy, 2018, p.73, p.82} ~ Value of drugs seized in seaports and airports {Philippine Anti-Illegal Drug Strategy, 2018, p.83} ~",9
Y,Philippines,PHL,Supply Reduction,Level of procedures related to crop eradication,Yes,"Number of marijuana plantation sites eradicated {National Anti-Drug Plan of Action, 2015-2020, p.8; Annual Report, 2016, p.7} ~ The number in hectares of marijuana crops eradicated {Annual Report, 2016, p.7} ~ Number of plantation sites used for illicit drugs {Philippine Anti-Illegal Drug Strategy, 2018, p.79} ~",3
Y,Philippines,PHL,Supply Reduction,"Number of arrests, seizures, and offences",Yes,"Number of drug arrests {National Anti-Drug Plan of Action, 2015-2020, p.8} ~ Number of drug seizures {National Anti-Drug Plan of Action, 2015-2020, p.8} ~ Prevalence of the arrested drug personalities from the dismantled shabu laboratories that are Chinese nationals {National Anti-Drug Plan of Action, 2015-2020, p.9} ~ The number in kilograms of seizures of shabu in crystalline form and liquid form {National Anti-Drug Plan of Action, 2015-2020, p.10; Annual Report, 2016, p.7} ~ Number of drug personalities arrested {Annual Report, 2016, p.6} ~ The number of elected officials, law enforcers, and employees of government that were arrested during anti-drug operations {Annual Report, 2016, p.7} ~ LGUs and communities are more vigilant in reporting drug offenses in their neighborhood {Philippine Anti-Illegal Drug Strategy, 2018, p.23} ~ Number of reports to PDEA hotlines that led to arrests {Philippine Anti-Illegal Drug Strategy, 2018, p.82} ~ Total kilograms of drugs seized by drug type {Philippine Anti-Illegal Drug Strategy, 2018, p.82} ~ Number of drug offenders arrested {Philippine Anti-Illegal Drug Strategy, 2018, p.83} ~ Number of foreign nationals arrested due to drug offenses (ex. drug couriers) {National Anti-Drug Plan of Action, 2015-2020, p.9; Philippine Anti-Illegal Drug Strategy, 2018, p.83} ~ Volume of drugs seized in seaports and airports {Philippine Anti-Illegal Drug Strategy, 2018, p.23, p.83} ~",12
Y,Philippines,PHL,Supply Reduction,Level of law enforcement activity and interdiction in the market,Yes,"Number of jail cell inspections {National Anti-Drug Plan of Action, 2015-2020, p.13} ~ Number of anti-drug operations {National Anti-Drug Plan of Action, 2015-2020, p.25; Annual Report, 2016, p.6} ~ Number of clandestine laboratories and chemical warehouses that were dismantled {National Anti-Drug Plan of Action, 2015-2020, p.8; Annual Report, 2016, p.6} ~ The number of drug cases that were filed for 2016 {Annual Report, 2016, p.7} ~ Number of illegal drug activity reported and acted upon {Philippine Anti-Illegal Drug Strategy, 2018, p.82} ~ Total kilograms of drugs destroyed by drug type {Philippine Anti-Illegal Drug Strategy, 2018, p.82} ~ Total amount of money of drug dealers freezed by AMLC {Philippine Anti-Illegal Drug Strategy, 2018, p.82} ~ Total amount of money and properties of drug dealers forfeited in favor of the government {Philippine Anti-Illegal Drug Strategy, 2018, p.82} ~",8
Y,Philippines,PHL,Supply Reduction,"Price, purity and potency of drugs, and related process indicators",No,n/a,0
Y,Philippines,PHL,Supply Reduction,Number of people engaged with the criminal justice system,Yes,"Prosecution and conviction rate of drug offenders increased {Philippine Anti-Illegal Drug Strategy, 2018, p.23} ~ Number of drug offenders convicted {Philippine Anti-Illegal Drug Strategy, 2018, p.83} ~",2
Y,Philippines,PHL,Supply Reduction,Presence of other supply reduction metrics,Yes,"Number of professionals violating issuances of the Board {Philippine Anti-Illegal Drug Strategy, 2018, p.81} ~ Number of pharmaceuticals and chemical companies violating issuances of the Board {Philippine Anti-Illegal Drug Strategy, 2018, p.81} ~ ",2
Y,Philippines,PHL,International Cooperation,Level of engagement in international cooperation,Yes,"enhanced collaboration with foreign counterparts {National Anti-Drug Plan of Action, 2015-2020, p.35} ~ Number of International Training Programs, Workshops, Meetings and Conferences {Annual Report, 2016, p.22} ~ Number of international engagements participated in {Philippine Anti-Illegal Drug Strategy, 2018, p.81} ~ Number of international activities initiated for sharing of best practices in drug prevention and control {Philippine Anti-Illegal Drug Strategy, 2018, p.81} ~ Number of submitted reports/compliance to international commitments {Philippine Anti-Illegal Drug Strategy, 2018, p.82} ~ Number of submitted proposals for funding and implementation of ASEAN {Philippine Anti-Illegal Drug Strategy, 2018, p.82} ~ Number of study tours from ASEAN/international partners in drug prevention and control {Philippine Anti-Illegal Drug Strategy, 2018, p.82} ~ Number of MOU signed in bilateral agreements {Philippine Anti-Illegal Drug Strategy, 2018, p.82} ~ Number of tie-up projects with other countries {Philippine Anti-Illegal Drug Strategy, 2018, p.82} ~",9
Y,Bolivia,BOL,Health,Level of availability of harm reduction services and harm reduction scale up,No,n/a,0
Y,Bolivia,BOL,Health,Presence of needle and syringe programs,No,n/a,0
Y,Bolivia,BOL,Health,Prevalence of substance use disorders,No,n/a,0
Y,Bolivia,BOL,Health,Prevalence of psychiatric comorbidities,No,n/a,0
Y,Bolivia,BOL,Health,Drug-related mortality,No,n/a,0
Y,Bolivia,BOL,Health,Prevalence of drug-related infectious disease,No,n/a,0
Y,Bolivia,BOL,Health,Proportion of people who use drugs who engage in risky consumption,No,n/a,0
Y,Bolivia,BOL,Health,Proportion of people who use drugs who engage in safe consumption practices,No,n/a,0
Y,Bolivia,BOL,Health,"Coverage of services for the prevention, testing, and treatment of bloodborne diseases",No,n/a,0
Y,Bolivia,BOL,Health,Presence of specialised training for addiction care,No,n/a,0
Y,Bolivia,BOL,Health,Presence of health harms related to drug use,No,n/a,0
Y,Bolivia,BOL,Health,Presence of other health metrics,No,n/a,0
Y,Bolivia,BOL,Peace and Security,"Prevalence of alcohol and drugs in accidents, and interventions to increase road safety",No,n/a,0
Y,Bolivia,BOL,Peace and Security,Annual number of public disorder and violent crime reports,No,n/a,0
Y,Bolivia,BOL,Peace and Security,Number of non-lethal drug market violent events reported,No,n/a,0
Y,Bolivia,BOL,Peace and Security,Number of drug market related homicides and disappearances,No,n/a,0
Y,Bolivia,BOL,Peace and Security,Presence of other peace and security metrics,No,n/a,0
Y,Bolivia,BOL,Development,Coverage of housing assistance for people who use drugs,No,n/a,0
Y,Bolivia,BOL,Development,Coverage of social assistance for people who use drugs (not including housing),No,n/a,0
Y,Bolivia,BOL,Development,Number of households enrolled in alternative development,No,n/a,0
Y,Bolivia,BOL,Development,Presence of other development metrics,No,n/a,0
Y,Bolivia,BOL,Human Rights,"Prevalence and incidence of infectious diseases in vulnerable populations (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Bolivia,BOL,Human Rights,"Prevalence of vulnerable people who use drugs (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Bolivia,BOL,Human Rights,Proportion of people who use drugs in prison that are receiving medication assisted treatment (MAT),No,n/a,0
Y,Bolivia,BOL,Human Rights,Distribution of sterile injecting equipment in prisons,No,n/a,0
Y,Bolivia,BOL,Human Rights,Presence of programs and services targeted towards women ,No,n/a,0
Y,Bolivia,BOL,Human Rights,Presence of programs and services targeted towards people of color,No,n/a,0
Y,Bolivia,BOL,Human Rights,Presence of challenges and/or harms experienced by people of color,No,n/a,0
Y,Bolivia,BOL,Human Rights,"Presence of programs and services targeted towards vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"Approval of policies to provide services for people with drug addiction and homeless. {Fight Strategy Against the Drug Trafficking and Control of Coca Crops, 2016-2020, p.71} ~",1
Y,Bolivia,BOL,Human Rights,"Presence of challenges and/or harms experienced by vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Bolivia,BOL,Human Rights,Presence of other human rights metrics,No,n/a,0
Y,Bolivia,BOL,Demand Reduction,Prevalence of drug use by age,No,n/a,0
Y,Bolivia,BOL,Demand Reduction,Prevalence of drug use by sex,No,n/a,0
Y,Bolivia,BOL,Demand Reduction,Prevalence of drug use by type,Yes,"Prevalence of consumed substances according to 2007 and 2013 studies (Tranquilizers; Stimulants; Inhalants; Marijuana; Cocaine; cocaine paste/base; Ecstasy) {Fight Strategy Against the Drug Trafficking and Control of Coca Crops, 2016-2020, p.58; Annual Report, 2017, p.54} ~ Consumption of alcohol and other drugs reduced by 5%. {Fight Strategy Against the Drug Trafficking and Control of Coca Crops, 2016-2020, p.71} ~ ",2
Y,Bolivia,BOL,Demand Reduction,Number of people who use drugs,No,n/a,0
Y,Bolivia,BOL,Demand Reduction,"Prevalence of drug use by mode of administration (oral, mucosa, inhalation, and injection)",No,n/a,0
Y,Bolivia,BOL,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT)",Yes,"Creation and operation of Network for Comprehensive Prevention, Treatment, Rehabilitation and Social Reintroduction of People suffering from Addiction. {Fight Strategy Against the Drug Trafficking and Control of Coca Crops, 2016-2020, p.71} ~ Creation of departmental committees for prevention, treatment, rehabilitation and social reinsertion. {Fight Strategy Against the Drug Trafficking and Control of Coca Crops, 2016-2020, p.71} ~ Implementation of treatment, rehabilitation and social reinsertion system {Fight Strategy Against the Drug Trafficking and Control of Coca Crops, 2016-2020, p.71} ~ ",3
Y,Bolivia,BOL,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT) by age",No,n/a,0
Y,Bolivia,BOL,Demand Reduction,Level of access to opioid substitution treatment and medication assisted treatment (OST/MAT),No,n/a,0
Y,Bolivia,BOL,Demand Reduction,Level of coverage of inpatient treatment,No,n/a,0
Y,Bolivia,BOL,Demand Reduction,Proportion of people who use drugs enrolled in voluntary treatment,No,n/a,0
Y,Bolivia,BOL,Demand Reduction,Proportion of people who use drugs enrolled in coerced treatment,No,n/a,0
Y,Bolivia,BOL,Demand Reduction,Proportion of people who use drugs enrolled in compulsory treatment,No,n/a,0
Y,Bolivia,BOL,Demand Reduction,Presence of prevention programming in law enforcement,Yes,"Number of control and monitoring workshops for social organizations producing the coca leaf in the Cochabamba and Yungas Tropics of La Paz {Annual Report, 2017, p.89} ~ type of prevention activities carried out by the The Special Force to Combat Drug Trafficking (preventive talks, information fairs and student demonstrations) {Annual Report, 2017, p.114} ~",2
Y,Bolivia,BOL,Demand Reduction,Presence of prevention programming in the media,No,n/a,0
Y,Bolivia,BOL,Demand Reduction,Presence of prevention programming in schools,Yes,"Number of students at the secondary level have been trained {Annual Report, 2017, p.32} ~ Number of student mobilizations carried out to strengthen drug prevention {Annual Report, 2017, p.32} ~ Number of students sensitized on issues of drug prevention {Annual Report, 2017, p.83} ~ Number of teachers and municipal officials sensitized on issues of drug prevention in the municipalities of Oruro, Potosí, Villazón, Yacuiba and Sucre. {Annual Report, 2017, p.83} ~",4
Y,Bolivia,BOL,Demand Reduction,Presence of prevention programming in the workplace,No,n/a,0
Y,Bolivia,BOL,Demand Reduction,Presence of prevention programming for youth and the community,Yes,"Number of meetings held and number of public and subnational institutes who participated in in the field of municipal and departmental prevention {Annual Report, 2017, p.54} ~ Number of departments that permanently launch the ""United Youth Against Drugs"" Campaigns {Annual Report, 2017, p.114} ~ Thirty (30) Fairs, Workshops and / or Seminars on the Revaluation of the Coca Leaf organized and developed. {Estrategia Nacional De Desarrollo Integral Con Coca, 2011-2015, p.62, p.73} ~ Thirty (30) documents and / or brochures on the Revaluation of the Coca Leaf produced, published and distributed. {Estrategia Nacional De Desarrollo Integral Con Coca, 2011-2015, p.62, p.73} ~ ",4
Y,Bolivia,BOL,Demand Reduction,Presence of other demand reduction metrics,Yes,"% progress at the strategy level in demand reduction {Annual Report, 2017, p.76} ~ ",1
Y,Bolivia,BOL,Supply Reduction,Size and value of the illegal drug market,Yes,"Number of reports with data on drug trafficking that were consolidated {Annual Report, 2017, p.75} ~ New products derived from the Coca Leaf inserted in the market. {Estrategia Nacional De Desarrollo Integral Con Coca,  2011-2015, p.58} ~",2
Y,Bolivia,BOL,Supply Reduction,Level of procedures related to crop eradication,Yes,"net reduction of coca crops (% and hectares) {Fight Strategy Against the Drug Trafficking and Control of Coca Crops, 2016-2020, p.56} ~ the net reduction of surplus coca crops (%) {Annual Report, 2017, p.30} ~ Net reduction of 70% of the cultivated area of Coca Leaf. {Estrategia Nacional De Desarrollo Integral Con Coca, 2011-2015, p.60, p.74} ~ Surface reduction of coca crops in Bolivia (in hectares) {Fight Strategy Against the Drug Trafficking and Control of Coca Crops, 2016-2020, p.59; Coca Cultivation Reduction, 2015, np} ~ Surface area in hectares of coca crops cultivated (1996-2015) {Coca Cultivation Reduction, 2015, np} ~ Eradication of coca crops illegal production areas and protected areas. {Fight Strategy Against the Drug Trafficking and Control of Coca Crops, 2016-2020, p.72} ~ hectares of crops eradicated {Annual Report, 2017, p.17} ~ Hectares of illegal and surplus coca eradicated {Annual Report, 2017, p.60} ~ hectares of coca crops eradicated by joint task force (YUNGAS; APOLO; CHAPARE; TOTAL) {Annual Report, 2017, p.126} ~ Rationalization and eradication of coca crops From January 1 to December 31, 2017 Expressed in hectares (has.) {Annual Report, 2017, p.190} ~ Number of protected areas nationwide where coca cultivation was identified {Annual Report, 2017, p.38} ~ hectares of coca cultivation identified in the protected areas {Annual Report, 2017, p.38} ~ hectares of coca-crop cultivation {Annual Report, 2017, p.37, p.86} ~ Prevalence of coca cultivated in the following areas (hectares): Yungas regions of La Paz, the Tropic of Cochabamba and the northern provinces of La Paz {Annual Report, 2017, p.32, p.37-38, p.86; Estrategia Nacional De Desarrollo Integral Con Coca, 2011-2015, p.28, p.29} ~ Number in tons of coca leaf produced {Annual Report, 2017, p.38} ~ total value of the estimated production of coca leaf {Annual Report, 2017, p.38} ~ value of the estimated production of coca leaf as a percentage of GDP, and GDP of the agricultural sector {Annual Report, 2017, p.38} ~ Number of reports identifying new coca crops - GISCOCA. {Annual Report, 2017, p.87} ~ Map of regions cultivating Coca (2009) {Estrategia Nacional De Desarrollo Integral Con Coca, 2011-2015, p.27} ~ density of coca cultivation and national parks, Bolivia (2009) {Estrategia Nacional De Desarrollo Integral Con Coca, 2011-2015, p.51} ~ Number of families evicted for cultivating illegal coca {Annual Report, 2017, p.45} ~ % progress at the strategy level in the control of surplus coca crops {Annual Report, 2017, p.76} ~",22
Y,Bolivia,BOL,Supply Reduction,"Number of arrests, seizures, and offences",Yes,"number of seized drugs by type [cocaine base/paste (tns); cocaine hydrochloride (tns); total cocaine (grs); MARIJUANA cremated in plantations (tn); marijuanna intended for dispensing seized (tns); total marijuana (grs); solid chemical substances (tns); liquid chemical substances (m3); coca leaf retention (tns)] {Fight Strategy Against the Drug Trafficking and Control of Coca Crops, 2016-2020, p.56; Annual Report, 2017, p.13, p.59, p.112; Drug Interdiction, 2015, np} ~ Number in tons of drugs confiscated {Annual Report, 2017, p.59} ~ Number of drugs seized by month [cocaine base (tns); cocaine hydrochloride (tns); marijuana (tns); solid substances (tns); liquid substances (cubic meters); cocaine leaves (tns)] {Annual Report, 2017, p.184, p.185, p.186, p.187} ~ Number of arrests {Fight Strategy Against the Drug Trafficking and Control of Coca Crops, 2016-2020, p.56} ~ Number of people apprehended {Annual Report, 2017, p.13} ~ Number of people apprehended who were involved in cocaine factories and drug refining laboratories {Annual Report, 2017, p.60} ~ Number of people arrested by nationality (Bolivian, Foreigners, Total) {Annual Report, 2017, p.112, p.191} ~ Number of People Apprehended by month {Annual Report, 2017, p.189} ~ Number of people apprehended for drug trafficking (1996-2015) {Drug Interdiction, 2015, np} ~ Type of weapons seized {Annual Report, 2017, p.102, p.103} ~ Number of vehicles, properties, and aircrafts seized {Annual Report, 2017, p.59, p.112} ~ ",11
Y,Bolivia,BOL,Supply Reduction,Level of law enforcement activity and interdiction in the market,Yes,"number of interdiction operations carried out nationally {Fight Strategy Against the Drug Trafficking and Control of Coca Crops, 2016-2020, p.56; Annual Report, 2017, p.12, p.31, p.111; Drug Interdiction, 2015, np} ~ Interdiction efforts to combat illicit trafficking of controlled substances increase by 20%. {Fight Strategy Against the Drug Trafficking and Control of Coca Crops, 2016-2020, p.69} ~ Number of operations implemented by month {Annual Report, 2017, p.184} ~ Number of laboratories, factories and clandestine tracks destroyed {Fight Strategy Against the Drug Trafficking and Control of Coca Crops, 2016-2020, p.56; Annual Report, 2017, p.13, p.112, p.187} ~ Number of factories destroyed by month {Annual Report, 2017, p.188} ~ Prevalence of marijuana or cocaine hydrochloride that was incinerated or destroyed {Annual Report, 2017, p.13} ~ The number of public events held where drugs were destroyed {Annual Report, 2017, p.13} ~ Number of cocaine factories and drug refining laboratories destroyed {Annual Report, 2017, p.60} ~ Appropriate ratified legislation to combat drug trafficking {Fight Strategy Against the Drug Trafficking and Control of Coca Crops, 2016-2020, p.69} ~ Number of new laws drafted to better regulate controlled substances and combat drug trafficking {Annual Report, 2017, p.120} ~ Number of police officers that have been trained in the ""Garras del Valor"" International Counter-Narcotics Training Center {Annual Report, 2017, p.32} ~ Number of anti-drug canines and their guides trained {Annual Report, 2017, p.32} ~ Number of anti-drug agents trained in different areas of anti-drug control {Annual Report, 2017, p.32} ~ Number of police officers that have been sent to be trained abroad {Annual Report, 2017, p.32} ~ Institutions combating drug trafficking fortified with equipment, technology, facilities, specialized training and studies to combat illicit drug trafficking. {Fight Strategy Against the Drug Trafficking and Control of Coca Crops, 2016-2020, p.69} ~ Number of inspections carried out in companies operating controlled chemical substances {Annual Report, 2017, p.31, p.93} ~ ",16
Y,Bolivia,BOL,Supply Reduction,"Price, purity and potency of drugs, and related process indicators",No,n/a,0
Y,Bolivia,BOL,Supply Reduction,Number of people engaged with the criminal justice system,No,n/a,0
Y,Bolivia,BOL,Supply Reduction,Presence of other supply reduction metrics,Yes,"% progress at the strategy level in supply reduction {Annual Report, 2017, p.76} ~ Companies and/or natural persons who produce, export and import controlled chemical precursors, psychotropic and narcotics, duly monitored {Fight Strategy Against the Drug Trafficking and Control of Coca Crops, 2016-2020, p.69} ~ The number of registrations for chemical substances for industrial use by companies {Annual Report, 2017, p.93} ~ Total Companies and / or registered persons {Annual Report, 2017, p.93} ~ Number of licenses granted for exports, imports, production and completion of operations. {Annual Report, 2017, p.31, p.94} ~ Number of Local Purchase Authorization issued by the DGSC {Annual Report, 2017, p.94} ~ Roadmap statistics for transport {Annual Report, 2017, p.95} ~ number of District and Regional offices that the DGSC is currently in charge of (legal use of chemical substances). {Annual Report, 2017, p.98} ~ Stable, controlled coca production {Fight Strategy Against the Drug Trafficking and Control of Coca Crops, 2016-2020, p.72} ~ Rationing of excess coca crops in legal production areas through dialogue concertation and respect for human rights. {Fight Strategy Against the Drug Trafficking and Control of Coca Crops, 2016-2020, p.72} ~ Coca producers’ social organizations implement their mechanisms for Community Coca Control {Fight Strategy Against the Drug Trafficking and Control of Coca Crops, 2016-2020, p.72} ~ hectares of coca crops cultivated per family, whose production is controlled by the Sindicato del Polígono 7 and the FELCN to avoid its diversion to drug trafficking. {Annual Report, 2017, p.46} ~ Marketing of the coca leaf authorized by DIGCOIN, Bolivia 2009 {Estrategia Nacional De Desarrollo Integral Con Coca, 2011-2015, p.48} ~ Coca surface rationalized with social control. {Estrategia Nacional De Desarrollo Integral Con Coca, 2011-2015, p.58} ~ Number of social organizations involved with the dynamics of rationalization with social control. {Estrategia Nacional De Desarrollo Integral Con Coca, 2011-2015, p.58} ~ Coca Leaf cultivation surfaces under agroecological certification. {Estrategia Nacional De Desarrollo Integral Con Coca, 2011-2015, p.58} ~ Volume of industrialized Coca Leaf {Estrategia Nacional De Desarrollo Integral Con Coca, 2011-2015, p.58} ~ Number of productive projects implemented. {Estrategia Nacional De Desarrollo Integral Con Coca, 2011-2015, p.60} ~ 3,000 plots of agro-ecological Coca introduced and cultivated. {Estrategia Nacional De Desarrollo Integral Con Coca, 2011-2015, p.61, p.73} ~ 1,000 metric tons of organic Coca produced. {Estrategia Nacional De Desarrollo Integral Con Coca, 2011-2015, p.61, p.73} ~ 3,000 families benefited {Estrategia Nacional De Desarrollo Integral Con Coca, 2011-2015, p.61, p.73} ~ 12,000 indirect jobs generated {Estrategia Nacional De Desarrollo Integral Con Coca, 2011-2015, p.61, p.73} ~ A comprehensive research center for the Coca Leaf implemented. {Estrategia Nacional De Desarrollo Integral Con Coca, 2011-2015, p.62, p.73} ~ Four (4) scientific research agreements signed and managed. {Estrategia Nacional De Desarrollo Integral Con Coca, 2011-2015, p.62, p.73} ~ Four (4) industrialization projects of the Coca Leaf implemented. {Estrategia Nacional De Desarrollo Integral Con Coca, 2011-2015, p.62, p.73} ~ One Regulation for the Industrialization of the Coca Leaf elaborated. {Estrategia Nacional De Desarrollo Integral Con Coca, 2011-2015, p.62, p.73} ~ Two (2) Social Enterprises of Industrialization of the Coca Leaf constituted and in operation. {Estrategia Nacional De Desarrollo Integral Con Coca, 2011-2015, p.62, p.73} ~ A Regulation for the Control of the Production and Commercialization of the Coca Leaf elaborated and approved. {Estrategia Nacional De Desarrollo Integral Con Coca, 2011-2015, p.62, p.73} ~ Fifteen (15) additional Coca Leaf Control Stations built, equipped and in operation. {Estrategia Nacional De Desarrollo Integral Con Coca, 2011-2015, p.62, p.73} ~ Equipment and modern technological resources and installations for the Operative Strategic Command “Lt. Gironda” {Fight Strategy Against the Drug Trafficking and Control of Coca Crops, 2016-2020, p.72} ~ ",30
Y,Bolivia,BOL,International Cooperation,Level of engagement in international cooperation,Yes,"% progress at the strategy level in shared international responsibility {Annual Report, 2017, p.76} ~ Reduction in Drug Control Budget Financed by U.S. Government and Increase in National Treasury Budget (in millions of Bolivianos) {Fight Strategy Against the Drug Trafficking and Control of Coca Crops, 2016-2020, p.55} ~ Number of international agreements signed {Fight Strategy Against the Drug Trafficking and Control of Coca Crops, 2016-2020, p.60} ~ Consolidation and enforcement of bilateral, regional and multilateral agreements. {Fight Strategy Against the Drug Trafficking and Control of Coca Crops, 2016-2020, p.74} ~ Number of agreements strengthened with all countries Borders such as: Peru, Brazil, Argentina, Paraguay and Chile {Annual Report, 2017, p.43, p.58, p.68, p.71} ~ Number of bilateral meetings held {Annual Report, 2017, p.67} ~ Number of multilateral meetings held {Annual Report, 2017, p.72} ~ Number of monitoring and evaluation reports on compliance with the agreements and commitments reached in the mixed commissions have been carried out. {Annual Report, 2017, p.32} ~ Regionalized combat against drug trafficking {Fight Strategy Against the Drug Trafficking and Control of Coca Crops, 2016-2020, p.74} ~ Number of days the representatives of the Plurinational State of Bolivia and the government of the Republic of Chile, addressed issues related to the problem of drugs in six technical working groups with content related to: Reduction of Supply, Related Offenses, Legal Cooperation , Demand reduction, Integral / Alternative Development and Methodologies to Follow-up Agreements. {Annual Report, 2017, p.15} ~ Number of operations completed {Annual Report, 2017, p.58} ~ Type of drugs seized in the 1st. Joint Trinational Operation ""Control of Narcotrafficking in Border Zones"" between Bolivia - Chile - Argentina (cocaine base/paste, cocaine hydrochloride, marijuana, coca leaf diverted to drug trafficking, synthetic drugs, units of drugs, liquid chemicals) {Annual Report, 2017, p.71} ~ Number of people of different nationalities apprehended in the Joint Trinational Operation ""Control of Narcotrafficking in Border Zones"" between Bolivia, Chile, and Argentina {Annual Report, 2017, p.71} ~ ",13
Y,Turkey,TUR,Health,Level of availability of harm reduction services and harm reduction scale up,No,n/a,0
Y,Turkey,TUR,Health,Presence of needle and syringe programs,No,n/a,0
Y,Turkey,TUR,Health,Prevalence of substance use disorders,Yes,"Prevalence of chronic drug use by age (general population above 15 years of age; adolescents aged 14-19 years; university youth aged 19-25 years) % reduction according to current situation {Uyuşturucu ile Mücadele Ulusal Strateji Belgesi, 2018-2023, p.9, p.10} ~ Number of high-risk opioid users (rate/1000) {Turkey Country Drug Report, 2017, p.1, p.5, p.16, p.17} ~",2
Y,Turkey,TUR,Health,Prevalence of psychiatric comorbidities,No,n/a,0
Y,Turkey,TUR,Health,Drug-related mortality,Yes,"The prevalence of drug induced deaths by gender {Turkish Drug Report, 2018, p.48; Turkey Country Drug Report, 2017, p.8} ~ Age distribution of deaths in 2015 (Turkey relative to the rest of the EU) {Turkish Drug Report, 2018, p.49; Turkey Country Drug Report, 2017, p.8} ~ Prevalence of deaths with opioids present in the toxicology report {Turkey Country Drug Report, 2017, p.8} ~ Drug-induced mortality rates among adults (15-64 years) { Uyuşturucu ile Mücadele Ulusal Strateji Belgesi, 2018-2023, p.10; Turkey Country Drug Report, 2017, p.1, p.8, p.16, p.17} ~ Number of drug related death by nationality (foreigner, Turkish citizen) {Turkish Drug Report, 2018, p.48} ~ Distribution of drug related deaths by years {Turkish Drug Report, 2018, p.48} ~ Number and percent of drug-related deaths due to synthetic cannabinoids {Turkish Drug Report, 2018, p.49} ~ Distribution of poly-substance and synthetic cannabinoids use in drug related deaths {Turkish Drug Report, 2018, p.49} ~",8
Y,Turkey,TUR,Health,Prevalence of drug-related infectious disease,Yes,"Prevalence of HIV and HCV related to drug use; % reduction according to current situation {Uyuşturucu ile Mücadele Ulusal Strateji Belgesi, 2018-2023, p.10; Turkey Country Drug Report, 2017, p.7, p.17} ~ Number of cases of hepatitis B virus (HBV), hepatitis C virus (HCV) and HIV among people who inject drugs (PWID) who have been admitted to treatment centres. {Turkey Country Drug Report, 2017, p.7} ~ Newly diagnosed HIV cases related to injecting drug use (cases/million population, Source: ECDC) {Turkey Country Drug Report, 2017, p.1, p.7, p. 16, p.17} ~ HIV and HCV prevalence among PWID* (%) {Turkey Country Drug Report, 2017, p. 16} ~",4
Y,Turkey,TUR,Health,Proportion of people who use drugs who engage in risky consumption,No,n/a,0
Y,Turkey,TUR,Health,Proportion of people who use drugs who engage in safe consumption practices,No,n/a,0
Y,Turkey,TUR,Health,"Coverage of services for the prevention, testing, and treatment of bloodborne diseases",Yes,"The number of inpatient treatment patients who used drugs by injection that received scan tests for HIV and viral hepatitis {Turkish Drug Report, 2018, p.38} ~ Distribution of scan test results which are applied to the users who use drugs by injection among people receiving treatment (Hepatitis B; Hepatitis C; HIV; Negative Result) {Turkish Drug Report, 2018, p.39} ~",2
Y,Turkey,TUR,Health,Presence of specialised training for addiction care,Yes,"The number of health staff who have received SAMBA (Tobacco, Alcohol and Drug Addiction) Training within “Certificated Training Program for Staff Working in Drug Addiction Treatment {Turkish Drug Report, 2018, p.23} ~ The number of emergency medical specialists in 81 provinces that were trained to give the ""Emergency Approach for Drug Use Disorder"" training to others. {Turkish Drug Report, 2018, p.23} ~ The number of doctors and other health officers that were trained in 81 provinces for the Emergency Approach for Drug Use Disorder {Turkish Drug Report, 2018, p.23} ~ the number of family doctors trained to support the early diagnosis establishing and guidance service providing and out-patients who are not highly addicted are ensured {Turkish Drug Report, 2018, p.31} ~ Number of psycho-social aid experts and psycho-social service officers and all receiving officers who received training within the “Mental Health and Addiction Services in Penal Institution Project"" {Turkish Drug Report, 2018, p.42} ~ the number of psycho-social service experts working in the detention houses, who were given SAMBA training {Turkish Drug Report, 2018, p.44} ~ ",6
Y,Turkey,TUR,Health,Presence of health harms related to drug use,No,n/a,0
Y,Turkey,TUR,Health,Presence of other health metrics,No,n/a,0
Y,Turkey,TUR,Peace and Security,"Prevalence of alcohol and drugs in accidents, and interventions to increase road safety",No,n/a,0
Y,Turkey,TUR,Peace and Security,Annual number of public disorder and violent crime reports,No,n/a,0
Y,Turkey,TUR,Peace and Security,Number of non-lethal drug market violent events reported,No,n/a,0
Y,Turkey,TUR,Peace and Security,Number of drug market related homicides and disappearances,Yes,"number of soldiers that were martyred in the operations carried out {Turkish Drug Report, 2018, p.46} ~",1
Y,Turkey,TUR,Peace and Security,Presence of other peace and security metrics,No,n/a,0
Y,Turkey,TUR,Development,Coverage of housing assistance for people who use drugs,No,n/a,0
Y,Turkey,TUR,Development,Coverage of social assistance for people who use drugs (not including housing),No,n/a,0
Y,Turkey,TUR,Development,Number of households enrolled in alternative development,No,n/a,0
Y,Turkey,TUR,Development,Presence of other development metrics,No,n/a,0
Y,Turkey,TUR,Human Rights,"Prevalence and incidence of infectious diseases in vulnerable populations (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Turkey,TUR,Human Rights,"Prevalence of vulnerable people who use drugs (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"Number of children outside the education system who use drugs; % decrease over current situation {Uyuşturucu ile Mücadele Ulusal Strateji Belgesi, 2018-2023, p.29} ~",1
Y,Turkey,TUR,Human Rights,Proportion of people who use drugs in prison that are receiving medication assisted treatment (MAT),No,n/a,0
Y,Turkey,TUR,Human Rights,Distribution of sterile injecting equipment in prisons,No,n/a,0
Y,Turkey,TUR,Human Rights,Presence of programs and services targeted towards women ,No,n/a,0
Y,Turkey,TUR,Human Rights,Presence of programs and services targeted towards people of color,No,n/a,0
Y,Turkey,TUR,Human Rights,Presence of challenges and/or harms experienced by people of color,No,n/a,0
Y,Turkey,TUR,Human Rights,"Presence of programs and services targeted towards vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"The ratio of the number of positive news in drug news reports to the number of negative news; % increase according to current situation {Uyuşturucu ile Mücadele Ulusal Strateji Belgesi, 2018-2023, p.39} ~ the number of prisoners and convicted people in total attended in profession occupational and technical training {Turkish Drug Report, 2018, p.44} ~",2
Y,Turkey,TUR,Human Rights,"Presence of challenges and/or harms experienced by vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Turkey,TUR,Human Rights,Presence of other human rights metrics,No,n/a,0
Y,Turkey,TUR,Demand Reduction,Prevalence of drug use by age,Yes,"The prevalence of drug use by age (general population over 15 years); % reduction according to current situation {Uyuşturucu ile Mücadele Ulusal Strateji Belgesi, 2018-2023, p.9} ~ The rate of people who have tried drugs at least once by age (general population over 15 years of age; young people aged 14-19; university students aged 19-25 years); % reduction according to current situation {Uyuşturucu ile Mücadele Ulusal Strateji Belgesi, 2018-2023, p.9, p.10} ~ The prevalence of drug use in the last month by age (among young people who continue their education between the ages of 14-19; university youth aged 19-25) % reduction according to current situation {Uyuşturucu ile Mücadele Ulusal Strateji Belgesi, 2018-2023, p.9, p.10} ~ The prevalence of drug use in the last year by age (young people aged 14-19; university youth aged 19-25 years) % reduction according to current situation {Uyuşturucu ile Mücadele Ulusal Strateji Belgesi, 2018-2023, p.9, p.10} ~ Drug use in young adults (15-34 years) by type of drug (cannabis, amphetamines, MDMA, Cocaine) in the last year {Turkey Country Drug Report, 2017, p.1, p.15, p.16, p.17} ~  2011 Estimates of cannabis, amphetamines and MDMA/ecstasy use among people 15-64 years of age {Turkey Country Drug Report, 2017, p.5, p.15} ~ Proportion of high school students aged 14 to 19 years old who have tried any drug {Turkey Country Drug Report, 2017, p. 5} ~ Proportion of high school students aged 14 to 19 years old who have tried cannabis {Turkey Country Drug Report, 2017, p. 5} ~ Mean age of first drug use by type of drug (cannabis, cocaine, heroin, amphetamines) {Turkey Country Drug Report, 2017, p.6} ~ Distribution according to age of first use among treated people (<15; 15-19; 20-24; 25-29; 30-34; 35-39; 40-144; 45-49; 50-54; 55-59; 60-64; >/=65) {Turkish Drug Report, 2018, p.37} ~ Distribution according to average age of first-use among treated people (%) {Turkish Drug Report, 2018, p.38} ~",11
Y,Turkey,TUR,Demand Reduction,Prevalence of drug use by sex,No,n/a,0
Y,Turkey,TUR,Demand Reduction,Prevalence of drug use by type,Yes,"Drug use in young adults (15-34 years) by type of drug (cannabis, amphetamines, MDMA, Cocaine) in the last year {Turkey Country Drug Report, 2017, p.1, p.15, p.16, p.17} ~ 2011 Estimates of cannabis, amphetamines and MDMA/ecstasy use among people 15-64 years of age {Turkey Country Drug Report, 2017, p.5, p.15} ~ Proportion of high school students aged 14 to 19 years old who have tried cannabis {Turkey Country Drug Report, 2017, p. 5} ~ Mean age of first drug use by type of drug (cannabis, cocaine, heroin, amphetamines) {Turkey Country Drug Report, 2017, p.6} ~",4
Y,Turkey,TUR,Demand Reduction,Number of people who use drugs,Yes,"The amount of drug use per 1000 people obtained by Waste Water Analysis; % reduction according to current situation {Uyuşturucu ile Mücadele Ulusal Strateji Belgesi, 2018-2023, p.10} ~ ",1
Y,Turkey,TUR,Demand Reduction,"Prevalence of drug use by mode of administration (oral, mucosa, inhalation, and injection)",No,n/a,0
Y,Turkey,TUR,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT)",Yes,"Frequency of application to counseling centers; % increase according to current situation {Uyuşturucu ile Mücadele Ulusal Strateji Belgesi, 2018-2023, p.27} ~ Consulting, removal, rehabilitation and social integration centers level of public awareness; % increase according to current situation {Uyuşturucu ile Mücadele Ulusal Strateji Belgesi, 2018-2023, p.27} ~ Satisfaction rate of service providers from counseling, purification, rehabilitation and social cohesion centers; % {Uyuşturucu ile Mücadele Ulusal Strateji Belgesi, 2018-2023, p.27} ~ The rate of applying to the treatment centers from the people who applied to the counseling centers; % {Uyuşturucu ile Mücadele Ulusal Strateji Belgesi, 2018-2023, p.27} ~ The prevalence of treatment for patients with high-risk substance use disorder; % {Uyuşturucu ile Mücadele Ulusal Strateji Belgesi, 2018-2023, p.28} ~ Frequency of treatment in chronic substance users; % {Uyuşturucu ile Mücadele Ulusal Strateji Belgesi, 2018-2023, p.28} ~ 3-month sobriety rate; % {Uyuşturucu ile Mücadele Ulusal Strateji Belgesi, 2018-2023, p.28} ~ 6-month sobriety rate; % {Uyuşturucu ile Mücadele Ulusal Strateji Belgesi, 2018-2023, p.28} ~ 1-year sobriety rate; % {Uyuşturucu ile Mücadele Ulusal Strateji Belgesi, 2018-2023, p.28} ~ Number of entrants to emergency hospital services due to drugs; % decrease over current situation {Uyuşturucu ile Mücadele Ulusal Strateji Belgesi, 2018-2023, p.28} ~ The rate at which the patients who applied to the treatment center completed the purification treatment and entered the rehabilitation phase; % {Uyuşturucu ile Mücadele Ulusal Strateji Belgesi, 2018-2023, p.28} ~ The rate of inclusion of beginners in the process of social cohesion; % {Uyuşturucu ile Mücadele Ulusal Strateji Belgesi, 2018-2023, p.28} ~ The rate of students entering the integrated treatment system during the first, middle and high school education; % {Uyuşturucu ile Mücadele Ulusal Strateji Belgesi, 2018-2023, p.29} ~ The number of clinics in hospitals that have psychiatry services that offer addiction treatment {Turkish Drug Report, 2018, p.22} ~ Number of Treatment Centre {Turkish Drug Report, 2018, p.35} ~ Number of Provinces Where Treatment Centre is Available {Turkish Drug Report, 2018, p.35} ~ The total number of outpatients who applied to treatment centers in 2017 when alcohol and nicotine usage according to diagnosis codes are excluded. {Turkish Drug Report, 2018, p.35} ~ Distribution of outpatients by years {Turkish Drug Report, 2018, p.35} ~ Distribution of patients who applied to treatment centers in 2017 (%) (Never Previously Treated; Previously Treated) {Turkish Drug Report, 2018, p.36} ~ Number of applications in polyclinics giving outpatient service by type of dependence [F11 (Opioid Dependence); F12 (Cannabinoid Dependence); F13 (sedative, hypnotic dependence); F14 (Cocaine dependence); F15 (Caffeine and other stimulant dependence); F16 (Hallucinogen dependence); F18 (Inhalant (volatile and thinner) dependence); F19 (multiple drug use and other psychoactive substances)] {Turkish Drug Report, 2018, p.37} ~ Distribution of people who received treatment by genders (%) (male, female) {Turkish Drug Report, 2018, p.37} ~ Distribution of education level of people who receive treatment (%) (No education; 1-8 years; 9-12 years; Higher Education) {Turkish Drug Report, 2018, p.38} ~ Distribution of employment status of people who receive treatment (%) (Unemployed; Regular Job; No Regular Job; Student; Economically Inactive; Other) {Turkish Drug Report, 2018, p.38} ~ Treatment entrants by primary drug (%): Cannabis, Amphetamines, Cocaine, Heroin, MDMA {Turkey Country Drug Report, 2017, p.1, p.6, p.15, p.16} ~ Drug users entering treatment: first time entrants by type of drug (cannabis, cocaine, heroin, amphetamines, MDMA) {Turkey Country Drug Report, 2017, p.6, p.15, p.16} ~ Proportion of men and women entering treatment by type of drug (cannabis, cocaine, heroin, amphetamines) {Turkey Country Drug Report, 2017, p.6} ~ Number of people treated in outpatient specialized treatment centres {Turkey Country Drug Report, 2017, p.11} ~ Percentage of clients entering specialized drug treatment by primary drug {Turkey Country Drug Report, 2017, p. 11} ~ Treatment Demand: All clients (2015) {Turkey Country Drug Report, 2017, p. 16} ~ Treatment Demand: First-time Clients (2015) {Turkey Country Drug Report, 2017, p.16}~ ",30
Y,Turkey,TUR,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT) by age",Yes,"Mean age at first treatment entrant by type of drug (cannabis, cocaine, heroin, amphetamines) {Turkey Country Drug Report, 2017, p.6} ~ Distribution of patients by age (%) (<15; 15-19; 20-24; 25-29; 30-34; 35-39; 40-144; 45-49; 50-54; 55-59; 60-64; >/=65) {Turkish Drug Report, 2018, p.37} ~ average age of people requesting treatment {Turkish Drug Report, 2018, p.37} ~",3
Y,Turkey,TUR,Demand Reduction,Level of access to opioid substitution treatment and medication assisted treatment (OST/MAT),Yes,"Number of opioid substitution treatment clients {Turkey Country Drug Report, 2017, p.1, p.16} ~ Proportion of clients receiving OST with a buprenorphine-based medication {Turkey Country Drug Report, 2017, p. 11} ~ ",2
Y,Turkey,TUR,Demand Reduction,Level of coverage of inpatient treatment,Yes,"Number of people treated in inpatient hospital-based residential drug treatment {Turkey Country Drug Report, 2017, p.11} ~ Total number of inpatient bed availability {Turkish Drug Report, 2018, p.35} ~ Number of treatment centers in Turkey that offer inpatient treatment services {Turkish Drug Report, 2018, p.35} ~ The number of application made to inpatient treatment centers {Turkish Drug Report, 2018, p.35} ~ Distribution of inpatients by years {Turkish Drug Report, 2018, p.36} ~ The number of people who applied again for inpatient treatment {Turkish Drug Report, 2018, p.36} ~ Distribution of inpatients by first 10 province of residence in 2017 {Turkish Drug Report, 2018, p.36} ~ Number of inpatients by type of dependence [F11 (Opioid Dependence); F12 (Cannabinoid Dependence); F13 (sedative, hypnotic dependence); F14 (Cocaine dependence); F15 (Caffeine and other stimulant dependence); F16 (Hallucinogen dependence); F18 (Inhalant (volatile and thinner) dependence); F19 (multiple drug use and other psychoactive substances)] {Turkish Drug Report, 2018, p.37} ~",8
Y,Turkey,TUR,Demand Reduction,Proportion of people who use drugs enrolled in voluntary treatment,No,n/a,0
Y,Turkey,TUR,Demand Reduction,Proportion of people who use drugs enrolled in coerced treatment,No,n/a,0
Y,Turkey,TUR,Demand Reduction,Proportion of people who use drugs enrolled in compulsory treatment,Yes,"The total number of outpatients received within probation service {Turkish Drug Report, 2018, p.35} ~ The number of convicted and prisoners who participated in SAMBA. {Turkish Drug Report, 2018, p.44} ~ The number of convicted people and prisoners who joined in Individual Interview {Turkish Drug Report, 2018, p.44} ~ The number of convicted people and prisoners who joined in group studies {Turkish Drug Report, 2018, p.44} ~",4
Y,Turkey,TUR,Demand Reduction,Presence of prevention programming in law enforcement,Yes,"The number of citizens who have benefitted from the Narcotic Training Truck (Narco-TIR) Project {Turkish Drug Report, 2018, p.20} ~ The number of staff working at central and local authorities who received Narcoguide training {Turkish Drug Report, 2018, p.20} ~ The number of citizens that were reached with the activities of “NARCO-POINT” carried out in Şanlıurfa, Bursa, Mersin, Bolu, Çorum, Bingöl and Yalova. {Turkish Drug Report, 2018, p.21} ~ The number of trainings that were organized in SAMBA, Anger Management Program, Change for Life, Young SAMBA and other and the number of staff who benefited from them (Ministry of Justice – General Directorate of Prisons and Detention Houses – Head of Probation Services Department) {Turkish Drug Report, 2018, p.45} ~ ",4
Y,Turkey,TUR,Demand Reduction,Presence of prevention programming in the media,Yes,"% Of the stakeholder using the common communication strategy {Uyuşturucu ile Mücadele Ulusal Strateji Belgesi, 2018-2023, p.39} ~ The number of public spots that were broadcasted with messages regarding alcohol, tobacco products and drug addiction and awareness were created. {Turkish Drug Report, 2018, p.25} ~ The number of local media staff trained in addiction communication and the role of media within the frame of addiction {Turkish Drug Report, 2018, p.26} ~ the number of calls received through the Hot Line for Counselling and Support on Fight against Drug (ALO 191) {Turkish Drug Report, 2018, p.31} ~ The number of staff working at the Hot Line for Counselling and Support on Fight against Drug (Alo 191) {Turkish Drug Report, 2018, p.32} ~ The Number of Service Count of the People Receiving Service from Alo 191 Counselling and Support Line on Fight against Drug from the beginning of the Project Until the end of 2017 {Turkish Drug Report, 2018, p.32} ~ Issues and the Number of Service Count of the People Receiving Service from Alo 191 Counselling and Support Line on Fight against Drug within 2017 (treatment requests; Support request (communication, motivational interview and food craving, family/addicted); Info request on mandatory treatment; Info request on AMATEM/ÇEMATEM; Info and treatment request on having suspicion on people who are less than 18; Info request on Social Security/SGK/lack of financial situation; Guidance of emergency in health; Info on substances; Info on alcohol dependence; Info and guidance on selling or usage of notified drug trafficking; Info request on probation services; Complaints; Thanking; Request after treatment of drug addiction (work and etc.); Violence; Training request (schools, training center for prevention of drug use); Use of vehicle (legal procedures for driving under the influence of alcohol) {Turkish Drug Report, 2018, p.33} ~ ",7
Y,Turkey,TUR,Demand Reduction,Presence of prevention programming in schools,Yes,"Students who attend compulsory education receive awareness training within the scope of the fight against drugs {Uyuşturucu ile Mücadele Ulusal Strateji Belgesi, 2018-2023, p.26} ~ % Of the parents of students attending compulsory education to receive awareness training in the fight against drugs {Uyuşturucu ile Mücadele Ulusal Strateji Belgesi, 2018-2023, p.26} ~ % Of university students who have been contacted in the context of the fight against drugs {Uyuşturucu ile Mücadele Ulusal Strateji Belgesi, 2018-2023, p.26} ~ awareness rate in the field of education people about the dangers of drugs {Uyuşturucu ile Mücadele Ulusal Strateji Belgesi, 2018-2023, p.27} ~ the number of students reached in prevention activities at the class level {Turkish Drug Report, 2018, p.26} ~ the number of parents reached in prevention activities {Turkish Drug Report, 2018, p.26} ~ the number of teachers reached in prevention activities {Turkish Drug Report, 2018, p.26} ~ The number of Trainings and practitioner trainings {Turkish Drug Report, 2018, p.26} ~ the number of guidance and counselling teachers who received training within the Turkish Fight Against Drugs Project {Turkish Drug Report, 2018, p.26} ~ the number of guidance and counselling teachers who voluntarily participated in “School-Based Short Intervention Program for Use of Tobacco, Alcohol and Substances – Preventions for Addiction (OBM) Pilot Training” {Turkish Drug Report, 2018, p.27} ~ the number of students awarded with the Turkish Lira within the scope of Healthy Generation Healthy Future Competition by type of school (primary school, secondary school, and high school) {Turkish Drug Report, 2018, p.28} ~ the number of students who participated in the “Slogan Contest on Drug Use Prevention” and “Banner Competition on Drug Use Prevention” which was organized in coordination with Head of Counter Narcotics Department under Turkish National Police in order to inform and raise awareness of society in fight against drug. {Turkish Drug Report, 2018, p.29} ~ The number of works from the Motto Competition and Poster Competition deemed worthy to award {Turkish Drug Report, 2018, p.29} ~ ",13
Y,Turkey,TUR,Demand Reduction,Presence of prevention programming in the workplace,Yes,"Cumulative % of people who work in the field of drugs {Uyuşturucu ile Mücadele Ulusal Strateji Belgesi, 2018-2023, p.26} ~ % Of those who received refresher training from those who received in-service training within the scope of the fight against drugs {Uyuşturucu ile Mücadele Ulusal Strateji Belgesi, 2018-2023, p.27} ~ % Of the staff informed by contact with the drug {Uyuşturucu ile Mücadele Ulusal Strateji Belgesi, 2018-2023, p.27} ~ The number of staff working at İŞKUR in profession counselling in the country that completed the Online Basic Training on Addiction organized by Green Crescent and İŞKUR under the Ministry of Labour and Social Security {Turkish Drug Report, 2018, p.24} ~ The number of tradesmen reached by the health messenger project {Turkish Drug Report, 2018, p.30} ~ ",5
Y,Turkey,TUR,Demand Reduction,Presence of prevention programming for youth and the community,Yes,"The level of public awareness of drugs; % increase according to current situation {Uyuşturucu ile Mücadele Ulusal Strateji Belgesi, 2018-2023, p.39} ~ The level of public awareness of the activities carried out; % increase according to current situation {Uyuşturucu ile Mücadele Ulusal Strateji Belgesi, 2018-2023, p.39} ~ The level of positive perception in the general population over the age of 15 years, on the effectiveness of anti-drug studies (prevention of supply, education, counseling, treatment and rehabilitation, social cohesion, judicial sanctions); % increase according to current situation {Uyuşturucu ile Mücadele Ulusal Strateji Belgesi, 2018-2023, p.40} ~ The level of anxiety that the drug (frequency of use, supply, treatment, judicial sanctions) creates on society; In the general population over 15 years of age; % decrease over current situation {Uyuşturucu ile Mücadele Ulusal Strateji Belgesi, 2018-2023, p.40} ~ The number of staff that were trained by 538 modules in 2017 within Module on Public Training/Risk of Drug Use and Prevention from Drug Addiction which was realized by the Ministry of Family and Social Policies in 2014. {Turkish Drug Report, 2018, p.24} ~ The number of people who attended Formatter Training on Fight against Addiction in Turkey within the protocol signed between the Ministry of Family and Social Policies and Turkish Green Crescent Society {Turkish Drug Report, 2018, p.24} ~ The number of children and youngsters reached through Green Crescent Camp Activities to increase awareness on the struggle against addiction {Turkish Drug Report, 2018, p.26} ~ The number of volunteers involved in Green Crescent Camp Activities {Turkish Drug Report, 2018, p.26} ~ The number of university students who participated in spring and summer camps in 2017 which was coordinated by Volunteer Young Green Crescent Scouting Leader. {Turkish Drug Report, 2018, p.26} ~ ",9
Y,Turkey,TUR,Demand Reduction,Presence of other demand reduction metrics,No,n/a,0
Y,Turkey,TUR,Supply Reduction,Size and value of the illegal drug market,Yes,"The proportion of all criminal incidents due to drug use, criminal cases across the country; % reduction according to current situation {Uyuşturucu ile Mücadele Ulusal Strateji Belgesi, 2018-2023, p.10} ~ The ratio of the amount of drug caught at the customs gates of our country to the amount of national total catching,% increase according to the current situation {Uyuşturucu ile Mücadele Ulusal Strateji Belgesi, 2018-2023, p.16} ~ Total number of drug related incidents by years and by type of drug (total, heroin, cannabis, cocaine, ecstasy, coptagon, methamphetamine, synthetic cannabinoids) {Turkish Drug Report, 2018, p.11-p.18} ~ Breakdown of total number of drug related incidents by crime for 2016 and by type of drug (total, heroin, cannabis, cocaine, ecstasy, coptagon, methamphetamine, synthetic cannabinoids); TCK (Turkish Penal Code) 191 (crimes of drug use and possession.), TCK 188 (crimes of drug supply), Law No. 2313 Relating to Control of Psychotrope Substances, Law No. 3298 {Turkish Drug Report, 2018, p.11-p.18} ~",4
Y,Turkey,TUR,Supply Reduction,Level of procedures related to crop eradication,Yes,"Production Amount of Opium Raw Material Equivalent to Morphine in Turkey [Production (kg); Cultivation (ha)] {Turkish Drug Report, 2018, p.8} ~",1
Y,Turkey,TUR,Supply Reduction,"Number of arrests, seizures, and offences",Yes,"The number of drug offenses made by capturing cargo; % increase according to current situation {Uyuşturucu ile Mücadele Ulusal Strateji Belgesi, 2018-2023, p.16} ~ Total number of suspects arrested in connection with drug related incidents in 2016 and by type pf drug (heroin, cannabis, cocaine, ecstasy, coptagon, methamphetamine, synthetic cannabinoids) {Turkish Drug Report, 2018, p.11-18} ~ Amount of drugs seized by type (kg) (heroin, cannabis, cocaine, ecstasy, coptagon, methamphetamine, synthetic cannabinoids) in 2014, 2015, 2016 {Turkish Drug Report, 2018, p.11-18; Turkey Country Drug Report, 2017, p.1, p.13-p.16} ~ Number of drug seizures in Turkey by type of drug (total, herbal cannabis, cannabis resin, cocaine, amphetamine, MDMA, heroin) {Turkey Country Drug Report, 2017, p.13, p.15, p.16} ~ Breakdown of total number of suspects arrested in connection with drug related incidents by crime for 2016; TCK (Turkish Penal Code) 191 (crimes of drug use and possession.), TCK 188 (crimes of drug supply), Law No. 2313 Relating to Control of Psychotrope Substances, Law No. 3298 {Turkish Drug Report, 2018, p.11-18} ~ Reported drug law offence and offenders in Turkey: use/possession (%), supply (%) {Turkey Country Drug Report, 2017, p.1, p.4, p.16} ~ Number of reports of offences (2015) {Turkey Country Drug Report, 2017, p.16} ~ Distribution of Dossiers Continuing on Probation Measures (2017) (Drug related offences; other offences) {Turkish Drug Report, 2018, p.45; Turkey Country Drug Report, 2017, p.12} ~ Amount of cannabis kg, heroin gr, cocaine gr, ecstasy pills, hemp plant seized operation carried out by security forces against PKK/KCK terrorist organizations {Turkish Drug Report, 2018, p.46} ~ The number of suspects that were arrested in the operations carried out {Turkish Drug Report, 2018, p.46} ~ Number of weapons seized (long barrel machine guns; guns; handmade explosives; stolen vehicles; ammonium nitrate) {Turkish Drug Report, 2018, p.46} ~",11
Y,Turkey,TUR,Supply Reduction,Level of law enforcement activity and interdiction in the market,Yes,"Number of narcotic incidents that were intervened upon; % increase according to current situation {Uyuşturucu ile Mücadele Ulusal Strateji Belgesi, 2018-2023, p.15} ~ Number of suspects intervened by law enforcement; % increase according to current situation {Uyuşturucu ile Mücadele Ulusal Strateji Belgesi, 2018-2023, p.15} ~ Number of drug operations performed throughout the country; % increase according to current situation {Uyuşturucu ile Mücadele Ulusal Strateji Belgesi, 2018-2023, p.15} ~ Number of crashed drug organizations; % increase according to current situation {Uyuşturucu ile Mücadele Ulusal Strateji Belgesi, 2018-2023, p.16} ~ The number of provinces that have active NARCOTEAM projects to combat drug trafficking crimes {Turkish Drug Report, 2018, p.19} ~ The number of provinces that have implemented Field Control Projects to combat the availability of drugs at the street level {Turkish Drug Report, 2018, p.19} ~ The number of staff and narcotic detection dogs who were trained on narcotic substances {Turkish Drug Report, 2018, p.20} ~ Number of staff from the Gendarmerie and Coast Guard Academy who received Anti-Smuggling and Organized Crime training (KOM), Fight Against Drug training, Special Computer Equipped Mobile Training and “Computer Aided Training (BİDEM)” intended for Fight Against Drug Smuggling {Turkish Drug Report, 2018, p.20} ~ total number of operations carried out by the security forces against PKK/KCK terrorist organization {Turkish Drug Report, 2018, p.46} ~",9
Y,Turkey,TUR,Supply Reduction,"Price, purity and potency of drugs, and related process indicators",Yes,"Purified Price for retail sale of drugs throughout the country; % increase according to current situation {Uyuşturucu ile Mücadele Ulusal Strateji Belgesi, 2018-2023, p.16} ~ Price (EUR/g) by type of drug (cannabis resin, herbal cannabis, heroin, cocaine, amphetamine, MDMA) {Turkey Country Drug Report, 2017, p.14, p.15, p.16} ~ Potency (%THC) and purity (%) by type of drug (cannabis resin, herbal cannabis, heroin, cocaine, amphetamine, MDMA (mg/tablet)) {Turkey Country Drug Report, 2017, p.14, p.15, p.16} ~",3
Y,Turkey,TUR,Supply Reduction,Number of people engaged with the criminal justice system,Yes,"Number of transactions for drug crimes committed via the Internet; % increase according to current situation {Uyuşturucu ile Mücadele Ulusal Strateji Belgesi, 2018-2023, p.15} ~ In the process, the closure rate for those receiving drug offense under the law of the sites that promote the formation; % increase according to current situation {Uyuşturucu ile Mücadele Ulusal Strateji Belgesi, 2018-2023, p.15} ~ Individuals under probation, within 5 years of drug-related crime detection rate; % decrease over current situation {Uyuşturucu ile Mücadele Ulusal Strateji Belgesi, 2018-2023, p.16} ~ Distribution of total number of convict-prisoners in penal institutions and the number of convict-prisoners related to drug crimes in penal intuitions by years {Turkish Drug Report, 2018, p.40} ~",4
Y,Turkey,TUR,Supply Reduction,Presence of other supply reduction metrics,No,n/a,0
Y,Turkey,TUR,International Cooperation,Level of engagement in international cooperation,No,n/a,0
Y,Chile,CHL,Health,Level of availability of harm reduction services and harm reduction scale up,No,n/a,0
Y,Chile,CHL,Health,Presence of needle and syringe programs,No,n/a,0
Y,Chile,CHL,Health,Prevalence of substance use disorders,Yes,"the ratio of people who use marijuana that report some degree of addiction {Estrategia Nacional Sobre Drogas, 2009-2018, p.8} ~  prevalence of marijuana dependence in the last year {Estrategia Nacional Sobre Drogas, 2009-2018, p.8} ~ number of people dependent on coca paste/cocaine {Estrategia Nacional Sobre Drogas, 2009-2018, p.8} ~ Severity Level of Drug Use (dependent, abuse, problematic), Chile 2006-2016 by type of drug (marijuana, cocaine, pasta base) {Twelfth National Study of Drugs in the General Population of Chile, 2016, p.39, p.40} ~ Evolution of the percentage of consumers with high risk marijuana use in the last year, according to sex, level of schooling and administrative unit. Chile, 2009-2017 {Twelfth National Drug Study in School Population of Chile, 2017, p.32, p.33} ~",5
Y,Chile,CHL,Health,Prevalence of psychiatric comorbidities,No,n/a,0
Y,Chile,CHL,Health,Drug-related mortality,No,n/a,0
Y,Chile,CHL,Health,Prevalence of drug-related infectious disease,No,n/a,0
Y,Chile,CHL,Health,Proportion of people who use drugs who engage in risky consumption,No,n/a,0
Y,Chile,CHL,Health,Proportion of people who use drugs who engage in safe consumption practices,No,n/a,0
Y,Chile,CHL,Health,"Coverage of services for the prevention, testing, and treatment of bloodborne diseases",No,n/a,0
Y,Chile,CHL,Health,Presence of specialised training for addiction care,No,n/a,0
Y,Chile,CHL,Health,Presence of health harms related to drug use,No,n/a,0
Y,Chile,CHL,Health,Presence of other health metrics,No,n/a,0
Y,Chile,CHL,Peace and Security,"Prevalence of alcohol and drugs in accidents, and interventions to increase road safety",Yes,"Prevalence (%) of Drug Use while Driving by Sex, Age and Socioeconomic Level, Chile 2012-2016: Proportion that declares to have driven under the influence of the specified drug in the last 12 months (marijuana, other drugs) {Twelfth National Study of Drugs in the General Population of Chile, 2016, p.43} ~",1
Y,Chile,CHL,Peace and Security,Annual number of public disorder and violent crime reports,Yes,"Evolution Perception of Problems in the Residency District, Chile 2010-2016 (%) by type (drug trafficking, house burglaries, scratches on the walls, damage to lighting, or similar things, drug use in public places as in the street or squares; Assaults or robberies in the streets; Young unemployed doing nothing in the corners; Shooting and violent actions with firearms; clandestine sale of alcohol) {Twelfth National Study of Drugs in the General Population of Chile, 2016, p.43} ~ Evolution of Perception of Problems in the Residence District according to the Socioeconomic Level, Chile 2014-2016: Proportion that declares a lot / enough occurrence of the phenomena on the list (%) (Drug trafficking; House burglary; Scratching on the walls; to the lighting; Consumption of drugs in public places; Assaults or robberies in the streets; Young unemployed people doing nothing in the corners; Shooting and violent actions with firearms; Clandestine sale of alcohol) {Twelfth National Study of Drugs in the General Population of Chile, 2016, p.44} ~ Evolution of Perception of Problems in the Residence District, by region (Arica and Parinacota; Tarapacá; Antofagasta; Atacama; Coquimbo; Valparaíso; Metropolitana de Santiago; Libertador Bernardo O’Higgins; Maule; Biobío; Araucanía; Los Ríos; Los Lagos; Aysén del General Carlos Ibáñez del Campo; Magallanes y Antártica Chilena) 2012-2016 (%) (Drug trafficking; House burglary; Scratching on the walls; to the lighting; Consumption of drugs in public places; Assaults or robberies in the streets; Young unemployed people doing nothing in the corners; Shooting and violent actions with firearms; Clandestine sale of alcohol) {Twelfth National Study of Drugs in the General Population of Chile, 2016, p.58, p.66, p.74, p.82, p.90, p.98; p.106, p.114, p.122, p.130, p.138, p.146, p.154, p.162, p.170} ~",3
Y,Chile,CHL,Peace and Security,Number of non-lethal drug market violent events reported,No,n/a,0
Y,Chile,CHL,Peace and Security,Number of drug market related homicides and disappearances,No,n/a,0
Y,Chile,CHL,Peace and Security,Presence of other peace and security metrics,No,n/a,0
Y,Chile,CHL,Development,Coverage of housing assistance for people who use drugs,No,n/a,0
Y,Chile,CHL,Development,Coverage of social assistance for people who use drugs (not including housing),No,n/a,0
Y,Chile,CHL,Development,Number of households enrolled in alternative development,No,n/a,0
Y,Chile,CHL,Development,Presence of other development metrics,No,n/a,0
Y,Chile,CHL,Human Rights,"Prevalence and incidence of infectious diseases in vulnerable populations (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Chile,CHL,Human Rights,"Prevalence of vulnerable people who use drugs (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"The prevalence of inmates who have a history of drug abuse (cocaine, coca paste) {Estrategia Nacional Sobre Drogas, 2009-2018, p.8} ~ the proportion of youth under 25 years of age and adult offenders who enter the prison system with a dependency syndrome {Estrategia Nacional Sobre Drogas, 2009-2018, p.8} ~",2
Y,Chile,CHL,Human Rights,Proportion of people who use drugs in prison that are receiving medication assisted treatment (MAT),No,n/a,0
Y,Chile,CHL,Human Rights,Distribution of sterile injecting equipment in prisons,No,n/a,0
Y,Chile,CHL,Human Rights,Presence of programs and services targeted towards women ,No,n/a,0
Y,Chile,CHL,Human Rights,Presence of programs and services targeted towards people of color,No,n/a,0
Y,Chile,CHL,Human Rights,Presence of challenges and/or harms experienced by people of color,No,n/a,0
Y,Chile,CHL,Human Rights,"Presence of programs and services targeted towards vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Chile,CHL,Human Rights,"Presence of challenges and/or harms experienced by vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Chile,CHL,Human Rights,Presence of other human rights metrics,No,n/a,0
Y,Chile,CHL,Demand Reduction,Prevalence of drug use by age,Yes,"Ratio of minors, and youth between the ages of 19-25 have tried marijuana in the last year {Estrategia Nacional Sobre Drogas, 2009-2018, p.7} ~ Proportion of drug use in youth under the age of 25 by type of drug (marijuana, coca paste, cocaine) {Estrategia Nacional Sobre Drogas, 2009-2018, p.7} ~ Prevalence of drug use by type (marijuana, processed marijuana (paraguayan), green marijuana, Skunk or high power marijuana, cocaine hydrochloride, pasta base) in the last year by age {Twelfth National Study of Drugs in the General Population of Chile, 2016, p.24-p.26} ~ Evolution Prevalence of Consumption of Tranquilizers without a Prescription and Analgesics without a Prescription in the Last Year by Sex, Age and Socioeconomic Level, Chile 2010-2016 (%) {Twelfth National Study of Drugs in the General Population of Chile, 2016, p.30} ~ Evolution Incidence Rate Consumption of Major Substances (marijuana, pasta base, cocaine) in the Last Year by Age, Chile 2014-2016 (%) {Twelfth National Study of Drugs in the General Population of Chile, 2016, p.31} ~ Average Days of Drug Use by type (marijuana, cocaine) in the Last Month by Sex, Age and Socioeconomic Level, Chile 2002-2016 {Twelfth National Study of Drugs in the General Population of Chile, 2016, p.37, p.38} ~  Evolution Prevalence Drugs in the Home by type (marijuana, cocaine, pasta base) according to Sex, Age and Socioeconomic Level, Chile 2000-2016 (%) {Twelfth National Study of Drugs in the General Population of Chile, 2016, p.42, p.43} ~ Evolution Prevalence of Drug Use by type (Marijuana, Cocaine) in the Last Year by Sex and Age, and by region (Arica and Parinacota; Tarapacá; Atacama; Coquimbo; Valparaíso; Metropolitana de Santiago; Libertador Bernardo O’Higgins; Maule; Biobío; Araucanía; Los Ríos; Los Lagos; Aysén del General Carlos Ibáñez del Campo; Magallanes y Antártica Chilena) 1994-2016 (%) {Twelfth National Study of Drugs in the General Population of Chile, 2016, p.55, p.63, p.64, p.71, p.78, p.79, p.86, p.87, p.94, p.95, p.103, p.104, p.110, p.111, p.119, p.126, p.127, p.134, p.135, p.142, p.143, p.151, p.152, p.158, p.159, p.166, p.167} ~ Prevalence of age of onset of drug use by type (marijuana, cocaine, pasta base, inhalants, tranquilizers without a prescription) by sex. Chile, 2001-2017 School Population {Twelfth National Drug Study in School Population of Chile, 2017, p.30, p.33, p.34, p.35, p.36} ~ Evolution of the prevalence of drug use in the last year by type (marijuana, cocaine, pasta base, inhalants, tranquilizers without a prescription), according to sex, school level and administrative unit. Chile, 2001-2017 School Population {Twelfth National Drug Study in School Population of Chile, 2017, p.31, p.34, p.35, p.36, p.37} ~ The past year prevalence rate of drug use by main substances, according to sex, schooling level and administrative unit. Chile, 2015-2017 (Marijuana, Cocaine, Pasta Base) {Twelfth National Drug Study in School Population of Chile, 2017, p.39} ~ Average number of days of drug use by type (marijuana, cocaine) in the last month, by sex, schooling level and administrative unit. Chile, 2003-2017 {Twelfth National Drug Study in School Population of Chile, 2017, p.40} ~ Frequency of marijuana use in the last year (Ten or more times in the last year; Once or twice in the last year), by sex, schooling level and administrative unit. Chile, 2003-2017 {Twelfth National Drug Study in School Population of Chile, 2017, p.40, p.41} ~ Evolution of the prevalence of drug use (marijuana, cocaine, inhalants, tranquilizers without a prescription) in the last year, according to sex and schooling level by region (Arica and Parinacota; Tarapacá; Antofagasta; Atacama; Coquimbo; Valparaíso; Metropolitana de Santiago; Libertador Bernardo O’Higgins; Maule; Biobío; Araucanía; Los Ríos; Los Lagos; Aysén del General Carlos Ibáñez del Campo; Magallanes y Antártica Chilena), 2009-2017 {Twelfth National Drug Study in School Population of Chile, 2017, p.56-58, p.64-67, p.73-76, p.82-85, p.91-94, p.100-102, p.109-112, p.118-121, p.127-130, p.136-138, p.145-148, p.154-156, p.162-165, p.171-174, p.180-182} ~ Average age of onset of consumption, by region (Arica and Parinacota; Tarapacá; Antofagasta; Atacama; Coquimbo; Valparaíso; Metropolitana de Santiago; Libertador Bernardo O’Higgins; Maule; Biobío; Araucanía; Los Ríos; Los Lagos; Aysén del General Carlos Ibáñez del Campo; Magallanes y Antártica Chilena), 2009-2017 {Twelfth National Drug Study in School Population of Chile, 2017, p.59, p.67, p.76, p.86, p.94, p.103, p.112, p.121, p.130, p.139, p.148, p.156, p.166, p.174, p.183} ~ ",15
Y,Chile,CHL,Demand Reduction,Prevalence of drug use by sex,Yes,"Prevalence of drug use by type of drug (marijuana, processed marijuana (paraguayan), green marijuana, Skunk or high power marijuana, cocaine hydrochloride, pasta base) in the last year by sex {Twelfth National Study of Drugs in the General Population of Chile, 2016, p.24-p.26, p.31} ~ Evolution Prevalence of Consumption of Tranquilizers without a Prescription and Analgesics Without a Medical Prescription in the Last Year by Sex, Age and Socioeconomic Level, Chile 2010-2016 (%) {Twelfth National Study of Drugs in the General Population of Chile, 2016, p.30} ~ Average Days of Drug Use by type (marijuana, cocaine) in the Last Month by Sex, Age and Socioeconomic Level, Chile 2002-2016 {Twelfth National Study of Drugs in the General Population of Chile, 2016, p.37, p.38} ~ Evolution Prevalence of Drugs in the Home by type (marijuana, cocaine, pasta base) according to Sex, Age and Socioeconomic Level, Chile 2000-2016 (%) {Twelfth National Study of Drugs in the General Population of Chile, 2016, p.42, p.43} ~ Evolution Prevalence of Drug Use by type (Marijuana, Cocaine) in the Last Year by Sex and Age, and by region (Arica and Parinacota; Tarapacá; Atacama; Coquimbo; Valparaíso; Metropolitana de Santiago; Libertador Bernardo O’Higgins; Maule; Biobío; Araucanía; Los Ríos; Los Lagos; Aysén del General Carlos Ibáñez del Campo; Magallanes y Antártica Chilena) 1994-2016 (%) {Twelfth National Study of Drugs in the General Population of Chile, 2016, p.55, p.63, p.64, p.71, p.78, p.79, p.86, p.87, p.94, p.95, p.103, p.104, p.110, p.111, p.119, p.126, p.127, p.134, p.135, p.142, p.143, p.151, p.152, p.158, p.159, p.166, p.167} ~ Prevalence of age of onset of drug use by type (marijuana, cocaine, pasta base, inhalants, tranquilizers without a prescription) by sex. Chile, 2001-2017 School Population {Twelfth National Drug Study in School Population of Chile, 2017, p.30, p.33, p.34, p.35, p.36} ~ Evolution of the prevalence of drug use in the last year by type (marijuana, cocaine, pasta base, inhalants, tranquilizers without a prescription), according to sex, school level and administrative unit. Chile, 2001-2017 School Population {Twelfth National Drug Study in School Population of Chile, 2017, p.31, p.34, p.35, p.36, p.37} ~ Types of marijuana (pressed, green, green transgenic) consumed in the last year, by sex and administrative unit. Chile, 2015-2017 School Population {Twelfth National Drug Study in School Population of Chile, 2017, p.32} ~ The past year prevalence rate of drug use by main substances, according to sex, schooling level and administrative unit. Chile, 2015-2017 (Marijuana, Cocaine, Pasta Base) {Twelfth National Drug Study in School Population of Chile, 2017, p.39} ~ Average number of days of drug use by type (marijuana, cocaine) in the last month, by sex, schooling level and administrative unit. Chile, 2003-2017 {Twelfth National Drug Study in School Population of Chile, 2017, p.40} ~ Frequency of marijuana use in the last year (Ten or more times in the last year; Once or twice in the last year), by sex, schooling level and administrative unit. Chile, 2003-2017 {Twelfth National Drug Study in School Population of Chile, 2017, p.40, p.41} ~ Evolution of the prevalence of drug use (marijuana, cocaine, inhalants, tranquilizers without a prescription) in the last year, according to sex and schooling level by region (Arica and Parinacota; Tarapacá; Antofagasta; Atacama; Coquimbo; Valparaíso; Metropolitana de Santiago; Libertador Bernardo O’Higgins; Maule; Biobío; Araucanía; Los Ríos; Los Lagos; Aysén del General Carlos Ibáñez del Campo; Magallanes y Antártica Chilena), 2009-2017 {Twelfth National Drug Study in School Population of Chile, 2017, p.56-58, p.64-67, p.73-76, p.82-85, p.91-94, p.100-102, p.109-112, p.118-121, p.127-130, p.136-138, p.145-148, p.154-156, p.162-165, p.171-174, p.180-182} ~ ",12
Y,Chile,CHL,Demand Reduction,Prevalence of drug use by type,Yes,"Ratio of minors, and youth between the ages of 19-25 have tried marijuana in the last year {Estrategia Nacional Sobre Drogas, 2009-2018, p.7} ~ Proportion of drug use in youth under the age of 25 by type of drug (marijuana, coca paste, cocaine) {Estrategia Nacional Sobre Drogas, 2009-2018, p.7} ~ the prevalence of Chilean people who have tried marijuana at least once in their lives {Estrategia Nacional Sobre Drogas, 2009-2018, p.7} ~ the number of cases reporting frequent use of coca paste and cocaine {Estrategia Nacional Sobre Drogas, 2009-2018, p.8} ~ Evolution Prevalence of drug use by type (marijuana, cocaine hydrochloride, pasta base), Chile 1994-2016 (%) (Lifetime, Age, Month) {Plan Nacional contra el Narcotráfico, 2014-2020, p.12; Twelfth National Study of Drugs in the General Population of Chile, 2016, p.23, p.25, p.31; Informe, 2017, p.43} ~ Prevalence of drug use by type of drug (marijuana, processed marijuana (paraguayan), green marijuana, Skunk or high power marijuana, cocaine hydrochloride, pasta base) and by socioeconomic status {Twelfth National Study of Drugs in the General Population of Chile, 2016, p.24-p.26} ~ Lifetime prevalence of other drugs (Tranquilizers; Inhalables; Stimulants; Ecstasy; Hallucinogens; Analgesics; Hashish; Synthetic marijuana) {Twelfth National Study of Drugs in the General Population of Chile, 2016, p.29} ~ Past-year prevalence of other drugs use (Tranquilizers; Inhalables; Stimulants; Ecstasy; Hallucinogens; Analgesics; Hashish; Synthetic marijuana) {Twelfth National Study of Drugs in the General Population of Chile, 2016, p.30} ~ Evolution Prevalence of Consumption of Tranquilizers without a Prescription and Analgesics Without a Medical Prescription in the Last Year by Sex, Age and Socioeconomic Level, Chile 2010-2016 (%) {Twelfth National Study of Drugs in the General Population of Chile, 2016, p.30} ~ Average Days of Drug use by type (Marijuana, Cocaine) in the Last Month, Chile 2002-2016 {Twelfth National Study of Drugs in the General Population of Chile, 2016, p.38} ~ Evolution Percentage Reporting Drug Use in the Home by type (marijuana, cocaine, pasta base), Chile 2000-2016 {Twelfth National Study of Drugs in the General Population of Chile, 2016, p.42, p.43} ~ Evolution Prevalence of drug use by type (Marijuana, Cocaine, Tranquilizers without a Medical Prescription, Analgesics without a Prescription) in the Last Year according to Regions, Chile 2014-2016 (%) {Twelfth National Study of Drugs in the General Population of Chile, 2016, p.47, p.48} ~ Evolution Prevalence of Drug Consumption (lifetime prevalence; past year prevalence; past month prevalence) by type (marijuana, cocaine) and by region (Arica and Parinacota; Tarapacá; Antofagasta; Atacama; Coquimbo; Valparaíso; Metropolitana de Santiago; Libertador Bernardo O’Higgins; Maule; Biobío; Araucanía; Los Ríos; Los Lagos; Aysén del General Carlos Ibáñez del Campo; Magallanes y Antártica Chilena) 1994-2016 {Twelfth National Study of Drugs in the General Population of Chile, 2016, p.54, p.55 p.62, p.63, p.70, p.71, p.78, p.79, p.86, p.87, p.94, p.95, p.102, p.103, p.110, p.111, p.119, p.126, p.127, p.134, p.135, p.142, p.143, p.150, p.151, p.159, p.166, p.167} ~ Evolution Prevalence of Drug use by type (Marijuana, Cocaine) in the Last Year relative to national levels, and by region (Arica and Parinacota; Tarapacá; Antofagasta; Atacama; Coquimbo; Valparaíso; Metropolitana de Santiago; Libertador Bernardo O’Higgins; Maule; Biobío; Araucanía; Los Ríos; Los Lagos; Aysén del General Carlos Ibáñez del Campo; Magallanes y Antártica Chilena) 1994-2016 (%) {Twelfth National Study of Drugs in the General Population of Chile, 2016, p.54, p.55, p.63, p.70, p.71, p.78, p.79, p.86, p.87, p.94, p.95, p.102, p.103, p.110, p.111, p.119, p.126, p.127, p.134, p.135, p.142, p.143, p.150, p.151, p.158, p.159, p.166, p.167} ~ Evolution of the prevalence of drug use by type (marijuana, cocaine, pasta base, inhalants, tranquilizers without a prescription) use sometime in life, last year and last month in the School Population. Chile, 2001-2017 {Twelfth National Drug Study in School Population of Chile, 2017, p.30, p.33, p.34, p.35, p.37} ~ Evolution of the prevalence of drug use in the last year by type (marijuana, cocaine, pasta base, inhalants, tranquilizers without a prescription), according to sex, school level and administrative unit. Chile, 2001-2017 School Population {Twelfth National Drug Study in School Population of Chile, 2017, p.31, p.34, p.35, p.36, p.37} ~ Evolution of types of marijuana consumed more frequently in the last year. Chile, 2011-2017 {Twelfth National Drug Study in School Population of Chile, 2017, p.31} ~ Types of marijuana (pressed, green, green transgenic) consumed in the last year, by sex and administrative unit. Chile, 2015-2017 School Population {Twelfth National Drug Study in School Population of Chile, 2017, p.32} ~ The past year prevalence rate of drug use by main substances (Marijuana, Cocaine, Pasta Base). Chile 2001-2017 {Twelfth National Drug Study in School Population of Chile, 2017, p.37} ~ The past year prevalence rate of drug use by main substances, according to sex, schooling level and administrative unit. Chile, 2015-2017 (Marijuana, Cocaine, Pasta Base) {Twelfth National Drug Study in School Population of Chile, 2017, p.39} ~ Average number of days of drug use by type (marijuana, cocaine) in the last month, by sex, schooling level and administrative unit. Chile, 2003-2017 {Twelfth National Drug Study in School Population of Chile, 2017, p.40} ~ Frequency of marijuana use in the last year (Ten or more times in the last year; Once or twice in the last year), by sex, schooling level and administrative unit. Chile, 2003-2017 {Twelfth National Drug Study in School Population of Chile, 2017, p.40, p.41} ~ Evolution of the prevalence of drug use by type (tranquilizers without a prescription; inhalants, marijuana, cocaine) in the last year, according to regions. Chile, 2015-2017 {Twelfth National Drug Study in School Population of Chile, 2017, p.48, p.49, p.50} ~ Evolution of the prevalence of drug use by type (marijuana, cocaine, inhalants, tranquilizers without a prescription) by lifetime, last year and last month in the School Population by region of (Arica and Parinacota; Tarapacá; Antofagasta; Atacama; Coquimbo; Valparaíso; Metropolitana de Santiago; Libertador Bernardo O’Higgins; Maule; Biobío; Araucanía; Los Ríos; Los Lagos; Aysén del General Carlos Ibáñez del Campo; Magallanes y Antártica Chilena), 2009-2017 {p.55-58, p.64-66, p.73-75, p.82-85, p.91-93, p.99-102, p.108-111, p.117-120, p.127-129, p.135-138, p.145-147, p.153-155, p.162-165, p.170-173, p.179-182} ~ Evolution of the prevalence of drug use by type (marijuana, cocaine, inhalants, tranquilizers without a prescription) in the last year in School Population relative to national level by region (Arica and Parinacota; Tarapacá; Antofagasta; Atacama; Coquimbo; Valparaíso; Metropolitana de Santiago; Libertador Bernardo O’Higgins; Maule; Biobío; Araucanía; Los Ríos; Los Lagos; Aysén del General Carlos Ibáñez del Campo; Magallanes y Antártica Chilena) 2009-2017 {p.56-58, p.64-67, p.73-75, p.82-85, p.91-93, p.100-102, p.109-111, p.118-120, p.127-129, p.136-138, p.145-147, p.153-156, p.162-165, p.171-173, p.181-182} ~ Estimation of the volume of marijuana consumed in Chile, years 2004, 2006, 2008 and 2010 {Informe, 2017, p.43 p.44} ~ Evolution of the prevalence of last year use of marijuana and total cocaine, according to indicators of parental involvement. Chile, 2013-2017 (Parents know where they are; Attentive parents at school; Parents meet close friends) {p.45, p.46} ~",27
Y,Chile,CHL,Demand Reduction,Number of people who use drugs,No,n/a,0
Y,Chile,CHL,Demand Reduction,"Prevalence of drug use by mode of administration (oral, mucosa, inhalation, and injection)",No,n/a,0
Y,Chile,CHL,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT)",Yes,"The proportion of the dependent population who has not had treatment or felt any need for treatment {Estrategia Nacional Sobre Drogas, 2009-2018, p.8} ~",1
Y,Chile,CHL,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT) by age",No,n/a,0
Y,Chile,CHL,Demand Reduction,Level of access to opioid substitution treatment and medication assisted treatment (OST/MAT),No,n/a,0
Y,Chile,CHL,Demand Reduction,Level of coverage of inpatient treatment,No,n/a,0
Y,Chile,CHL,Demand Reduction,Proportion of people who use drugs enrolled in voluntary treatment,No,n/a,0
Y,Chile,CHL,Demand Reduction,Proportion of people who use drugs enrolled in coerced treatment,No,n/a,0
Y,Chile,CHL,Demand Reduction,Proportion of people who use drugs enrolled in compulsory treatment,No,n/a,0
Y,Chile,CHL,Demand Reduction,Presence of prevention programming in law enforcement,Yes,"Evolution Approval of Drug Control Policies, Chile 2008-2016: Proportion that declares to be in agreement / in accordance with the policies of the heading (%) (Suspend the trial to those who have committed crimes for the first time in exchange for entering treatment; Give the same penalty to those who traffic with marijuana that those who traffic in cocaine or pasta base; Criminalizing the possession and consumption of marijuana even in small quantities and for personal use) {Twelfth National Study of Drugs in the General Population of Chile, 2016, p.44} ~   ",1
Y,Chile,CHL,Demand Reduction,Presence of prevention programming in the media,No,n/a,0
Y,Chile,CHL,Demand Reduction,Presence of prevention programming in schools,No,n/a,0
Y,Chile,CHL,Demand Reduction,Presence of prevention programming in the workplace,No,n/a,0
Y,Chile,CHL,Demand Reduction,Presence of prevention programming for youth and the community,Yes,"Evolution of Risk Perception, Chile 2000-2016: Proportion that declares great risk with respect to consumption (%) (Experimental marijuana; Frequent marijuana; Experimental cocaine; Frequent cocaine; Experimental of pasta base; Frequent pasta base) {Estrategia Nacional Sobre Drogas, 2009-2018, p.8; Twelfth National Study of Drugs in the General Population of Chile, 2016, p.32} ~  Distribution of Support for Measures to be Reinforced by the Authority according to Gender, Age and Socioeconomic Level, Chile 2016 Proportion that indicates measure stated (% (Increase punishment to traffickers; Establish a punishment for consumers; Develop prevention campaigns in schools ; Campaigning through the media; Increase police resources; Deliver larger funds for treatment and rehabilitation; Implement actions that facilitate the inclusion of vulnerable people; Inform and educate adults to avoid consumption in children and adolescents) {Twelfth National Study of Drugs in the General Population of Chile, 2016, p.45} ~ Evolution of Risk Perception by type of drug (marijuana, cocaine, pasta base), by region (Arica and Parinacota; Tarapacá; Antofagasta; Atacama; Coquimbo; Valparaíso; Metropolitana de Santiago; Libertador Bernardo O’Higgins; Maule; Biobío; Araucanía; Los Ríos; Los Lagos; Aysén del General Carlos Ibáñez del Campo; Magallanes y Antártica Chilena) 2000-2016 Proportion that declares great risk regarding consumption% (Experimental use, Frequent use) {Twelfth National Study of Drugs in the General Population of Chile, 2016, p.57, p.65, p.73, p.81, p.89, p.97, p.105, p.113, p.121, p.129, p.137, p.145, p.153, p.161, p.169; Twelfth National Drug Study in School Population of Chile, 2017, p.59, p.68, p.77, p.86, p.95, p.104, p.113, p.122, p.131, p.140, p.149, p.157, p.166, p.175, p.184} ~ Evolution of risk perception for drug use (marijuana, cocaine). (Experimental use (once or twice in life); Frequent use (once or twice a week)); Chile, 2001-2017 {Twelfth National Drug Study in School Population of Chile, 2017, p.41} ~ Evolution of parental disapproval against the use of marijuana and alcohol. Chile, 2001-2017 (Proportion stating that parents would be extremely upset) {Twelfth National Drug Study in School Population of Chile, 2017, p.45} ~ Evolution of the main attitudes regarding marijuana. Chile, 2003-2017 (Low addictive potency of marijuana; Try marijuana once or twice does not hurt; Most young people smoke marijuana) {Twelfth National Drug Study in School Population of Chile, 2017, p.47} ~ Evolution of indicators associated with parental disapproval by region (Arica and Parinacota; Tarapacá; Antofagasta; Atacama; Coquimbo; Valparaíso; Metropolitana de Santiago; Libertador Bernardo O’Higgins; Maule; Biobío; Araucanía; Los Ríos; Los Lagos; Aysén del General Carlos Ibáñez del Campo; Magallanes y Antártica Chilena), 2001-2017 (Has tested marijuana) {Twelfth National Drug Study in School Population of Chile, 2017, p.60, p.69, p.78, p.87, p.96, p.105, p.114, p.123, p.132, p.141, p.150, p.158, p.167, p.176, p.185} ~",7
Y,Chile,CHL,Demand Reduction,Presence of other demand reduction metrics,No,n/a,0
Y,Chile,CHL,Supply Reduction,Size and value of the illegal drug market,Yes,"perception of consumption, possession and drug trafficking in neighborhoods and schools {Estrategia Nacional Sobre Drogas, 2009-2018, p.12} ~ The proportion of sentences for active laundering where the base crime was the trafficking of drugs {Plan Nacional contra el Narcotráfico, 2014-2020, p.22} ~ Prevalence of people who are affected by micro-trafficking. Total country 2011-2013 {Plan Nacional contra el Narcotráfico, 2014-2020, p.30} ~ Perception of insecurity and drugs: impact of drug trafficking on citizens. {Plan Nacional contra el Narcotráfico, 2014-2020, p.57, p.58} ~ Perception Ease of Access to Drugs According to Adolescents, Chile 1994-2016: Proportion of individuals who declare that it would be easy to get drugs (marijuana, cocaine, pasta base) {Plan Nacional contra el Narcotráfico, 2014-2020, p.13; Twelfth National Study of Drugs in the General Population of Chile, 2016, p.34} ~ Evolution Ease of Access to Marijuana, Cocaine and Base Pasta, by region (Arica and Parinacota; Tarapacá; Antofagasta; Atacama, Coquimbo; Valparaíso; Metropolitana de Santiago; Libertador Bernardo O’Higgins; Maule; Biobío; Araucanía; Los Ríos; Los Lagos; Aysén del General Carlos Ibáñez del Campo; Magallanes y Antártica Chilena) 1994-2016 Proportion of individuals who declare that it would be easy for them to obtain drugs (%) {Twelfth National Study of Drugs in the General Population of Chile, 2016, p.57, p.66, p.73, p.81, p.89, p.97; p.106, p.113, p.121, p.129, p.137, p.145, p.154, p.161, p.169} ~ Exposure to Drug Offer by type (Marijuana, Cocaine, Pasta Base) in the Last Year by Sex, Age and Socioeconomic Level, Chile 2002-2016. Proportion of individuals who claim to have received at least one offer of drugs by type (marijuana, cocaine, pasta base) in the last year (%) {Estrategia Nacional Sobre Drogas, 2009-2018, p.12; Twelfth National Study of Drugs in the General Population of Chile, 2016, p.35, p.36; Twelfth National Drug Study in School Population of Chile, 2017, p.43, p.44} ~ Exposure to Drug Offers in the Last Year, by region (Arica and Parinacota; Tarapacá; Antofagasta; Atacama; Coquimbo; Valparaíso; Metropolitana de Santiago; Libertador Bernardo O’Higgins; Maule; Biobío; Araucanía; Los Ríos; Los Lagos; Aysén del General Carlos Ibáñez del Campo; Magallanes y Antártica Chilena) 2002-2016: Proportion of individuals who declare to have received at least one offer of the drug in the last year (marijuana, cocaine, pasta base) {Twelfth National Study of Drugs in the General Population of Chile, 2016, p.57, p.66, p.73, p.81, p.89, p.97, p.106, p.113, p.121, p.129, p.137, p.145, p.154, p.161, p.169} ~ Location where drugs were last offered in the past 12 Months, Chile 2012-2016: Proportion that declares place of last offer of drugs by type (marijuana, cocaine, pasta base) in last 12 months (In the house; In the neighborhood or commune; In place of study or work; In surroundings of place of studies or work; At a party, together, disco, recitals; Online, mail or chat; Somewhere else) {Twelfth National Study of Drugs in the General Population of Chile, 2016, p.36} ~ Routes of access to Tranquilizers without Prescription, by Socioeconomic Level, Chile 2016 (%) (I bought it in a pharmacy with a prescription from another person; I bought it in a free fair or market, it was passed to me by my partner / partner, a family member and / or friend; they passed it to me in the office; I was in my house and I took it; I got it in another way) {Twelfth National Study of Drugs in the General Population of Chile, 2016, p.37} ~ Evolution of the perception of drug use, carrying and trafficking in the school environment, according to administrative dependence. Chile, 2005-2017 (He has seen drug trafficking in the vicinity of the school, he has seen drug use within the school) {Twelfth National Drug Study in School Population of Chile, 2017, p.46} ~ Evolution of place of last offer of marijuana. Chile, 2013-2017 Proportion that declares place of last offer of marijuana (House, School, School surroundings, At a party, board, disco, recitals, Surroundings of the house, House of a friend, Through internet, mail or chatting; I have never been offered) {Twelfth National Drug Study in School Population of Chile, 2017, p.43} ~ Evolution of contact of last offer of marijuana. Chile, 2013-2017: Proportion that states the type of person who offered you marijuana (Some family member, Some friend or spouse, Someone who you know but he's not your friend; Someone you do not know) {Twelfth National Drug Study in School Population of Chile, 2017, p.44} ~ Evolution of the perception of drug use, carrying and trafficking in the school environment, according to administrative dependence. Chile, 2005-2017 (He has seen drug trafficking in the vicinity of the school, he has seen drug use within the school) {Twelfth National Drug Study in School Population of Chile, 2017, p.46} ~ Evolution of availability and supply indicators (marijuana, cocaine, pasta base), by region (Arica and Parinacota; Tarapacá; Antofagasta; Atacama; Coquimbo; Valparaíso; Metropolitana de Santiago; Libertador Bernardo O’Higgins; Maule; Biobío; Araucanía; Los Ríos; Los Lagos; Aysén del General Carlos Ibáñez del Campo; Magallanes y Antártica Chilena), 2009-2017 (Year Offer, Accessibility) {Twelfth National Drug Study in School Population of Chile, 2017, p.60, p.68, p.77, p.87, p.95, p.104, p.113, p.122, p.131, p.140, p.149, p.157, p.167, p.175, p.184} ~ Topographical map of Comuna of Cerro Navia, Santiago de Chile & Puente Alto, Santiago. Drug trafficking crimes 2005-2010 & 2011-2016 {Informe, 2017, p.28-29} ~ Comuna de Puento Alto & Comuna de Calama: High Bridge commune. Levels of high (level 4/red), Medium (Level 3/orange), Low (level 2/light green) and normal (Level 1/dark green) of concentration of drug trafficking activity. Period 2005-2010 & 2011-2016 {Informe, 2017, p.33-34, p.36-37} ~ THE RESULT AT NATIONAL LEVEL AND BY COMMUNITY for level of drug trafficking (level 1, 2, 3, or 4) {Informe, 2017, p.40} ~ During the past 12 months, how often would you say the following situation occurs in your neighborhood: Drug sales (Never; Almost never; Frequently; Always; Do not know; No data; No response; Total) Period 2015, 2016 {Informe, 2017, p.43} ~ Monitoring drug trafficking routes for Cripy Marijuana {Informe, 2017, p.69, p.74-p.77} ~ Number of LSD sales in Casinos {Informe, 2017, p.83} ~ Number of drug trafficking cases in penitentiary enclosures {Informe, 2017, p.83} ~",22
Y,Chile,CHL,Supply Reduction,Level of procedures related to crop eradication,No,n/a,0
Y,Chile,CHL,Supply Reduction,"Number of arrests, seizures, and offences",Yes,"The number of arrests reported for drug law violations by police control agencies {Estrategia Nacional Sobre Drogas, 2009-2018, p.9} ~ The number of drug seizures by type (kg) (marijuana, cocaine hydrochloride, coca paste, processed marijuana, marijuana plants, pharmaceutical drugs) {Estrategia Nacional Sobre Drogas, 2009-2018, p.9; Plan Nacional contra el Narcotráfico, 2014-2020, p.24, p.55, p.56, p.58; Informe, 2017, p.8} ~ The number of drug seizures {Estrategia Nacional Sobre Drogas, 2009-2018, p.12} ~ The number of traffic arrests {Estrategia Nacional Sobre Drogas, 2009-2018, p.12} ~ Prevalence of people arrested for drug use. Total country 2006-2014 {Plan Nacional contra el Narcotráfico, 2014-2020, p.13} ~ Distribution by macrozones (RM; Norte; Centro; Sur). Confiscation of drugs by type (cocaine; coca paste/base; processed marijuana; marijuana plants; pharmaceutical drugs). Total country 2014 {Plan Nacional contra el Narcotráfico, 2014-2020, p.26} ~ The number of weapons seized in police procedures (firearms, sharp weapons) {Plan Nacional contra el Narcotráfico, 2014-2020, p.30, p.55, p.56, p.58} ~ Number of patrimonial investigations initiated in relation to drug trafficking {Plan Nacional contra el Narcotráfico, 2014-2020, p.58} ~ Amount of goods seized (furniture, real estate, vehicles, luxury goods, etc.) {Plan Nacional contra el Narcotráfico, 2014-2020, p.58} ~ Seizures of drugs by type (Cocaine Hydrochloride, Pasta Base, Marijuana) by region in Chile {Informe, 2017, p.9-p.11} ~ The amount of money seized in Chilean Pesos by region and year {Informe, 2017, p.12} ~ Number of vehicles seized according to the quarterly reports of the regional prosecutors {Informe, 2017, p.14} ~ Number of drug law offenses for 2006-2016 {Informe, 2017, p.17} ~ Drug seizures conducted by type of law enforcement body (border security; customs; road control; security in airports) and types of drugs seized {Informe, 2017, p.82-83} ~ Total amount of synthetic drugs seized by type [Ecstasy (Unit); Ketamine (Grams); LSD (Grams); Fenmetrazine (Grams); LSD (Unit); Metcathinone (Grams); NBOMe (Unit); NBOMe (Grams); Psilocybin (Grams); Psilocybin (Unit); 4-Bromine-2,5-Dimethoxyamfetamine (double) (Unit); 4 IODO 2.5 Dimetoxifenetilamina (2c-1) (Unit); Dimetiltriptamina (Grams); 6 EAPB (Unit); 6-EAPB (Grams); Amphetamines (Grams); Amphetamines (Unit); Ecstasy (Grams)] {p.84} ~ Quantitative Analysis of Synthetic Drugs (Undefined) (quantity) {Informe, 2017, p.85} ~ Seizures of Synthetic Drugs by Area and Unit {Informe, 2017, p.86} ~ 2016-2017. Drug Seizures by Type (marijuana, pasta base, cocaine, synthetic drugs, controlled drugs, ephedrine) in grams, AVANDAZA (Quillagua; Colchane; Chacalluta; Puerto Arica; Loa) {Informe, 2017, p.90, p.92, p.94-95, p.97, p.99, p.101, p.102, p.104-p.106, p.109} ~ 2016-2017. Customs; Advanced Name; Gross weight, for drug seizures by type (marijuana, pasta base, cocaine, synthetic drugs, controlled drugs, ephedrine) {Informe, 2017, p.91, p.93-97, p.100, p.102-p.104, p.107-109} ~ ",19
Y,Chile,CHL,Supply Reduction,Level of law enforcement activity and interdiction in the market,Yes,"the total number of police procedures per violation of the Drug Law of 2014 {Plan Nacional contra el Narcotráfico, 2014-2020, p.23} ~ Crimes admitted to the Public Ministry by drug law, 2011-2014 (Microtrafficking; Trafficking; Other illegal activities; Total drug law violations) {Plan Nacional contra el Narcotráfico, 2014-2020, p.29} ~ Number of police procedures by type of crime (flagrant crimes, arrest warrants and other classifications) {Plan Nacional contra el Narcotráfico, 2014-2020, p.55, p.56, p.58} ~ the number of criminal organizations dismantled/disrupted according to the background provided by the Public Prosecutor's Office {Plan Nacional contra el Narcotráfico, 2014-2020, p.55, p.56, p.58} ~",4
Y,Chile,CHL,Supply Reduction,"Price, purity and potency of drugs, and related process indicators",Yes,"The self-declared price of drugs by type (marijuana, coca paste, and cocaine). {Estrategia Nacional Sobre Drogas, 2009-2018, p.12} ~ ",1
Y,Chile,CHL,Supply Reduction,Number of people engaged with the criminal justice system,Yes,"the proportion of people currently serving a sentence in prison that have committed a drug-related crime by age (adults, adolescents) {Estrategia Nacional Sobre Drogas, 2009-2018, p.9} ~ The number of people serving a sentence in a closed environment, and its proportion relative to the total prison population. {Estrategia Nacional Sobre Drogas, 2009-2018, p.9} ~ Distribution of detainees by type of infraction to drug law. (% Trafficking; % Consumption; % Possession; % Other causes) Total country 2014 {Plan Nacional contra el Narcotráfico, 2014-2020, p.13} ~ Number of detainees by type (micro trafficking, possession, consumption, illegal cultivation and other causes) {Plan Nacional contra el Narcotráfico, 2014-2020, p.55, p.56, p.58} ~  The number of people charged by the Regional Prosecutor's Office by regions in Chile, 2009-2016 {Informe, 2017, p.18} ~ The number of people sentenced to a Detention Hearing Control (ACD), 2009-2016 by region in Chile {Informe, 2017, p.22} ~ The total number of people sentenced per year and the trend in the period 2009-2016 {Informe, 2017, p.22} ~ The breakdown of convicts by type of crime, 2006-2016 (Elab culture; Microtraffic; Other Crimes; Traffic) {Informe, 2017, p.23} ~ Total number of people convicted of offenses and the trend in the period. {Informe, 2017, p.24} ~ The types of judgments received for drug crimes 2009-2016 (Final condemnatory sentence; Absolutory final judgment; Definitive dismissal; Temporary dismissal; Conditional suspension of the procedure; Definitive dismissal; Reparatory agreement; Faculty not to investigate; Subtotal judicial exit; Provisional file; Decision not to persevere; Principle of opportunity; Incompetence; Subtotal non-judicial exit; Administrative cancellation; Grouping to another case; Other causes of term; Other causes of suspension) {Informe, 2017, p.25} ~ ",10
Y,Chile,CHL,Supply Reduction,Presence of other supply reduction metrics,Yes,"The number of complaints about drug crimes by type (total; elab culture; microtraffic; other crimes; traffic) {Informe, 2017, p.15, p.16, p.21} ~ ",1
Y,Chile,CHL,International Cooperation,Level of engagement in international cooperation,No,n/a,0
Y,India,IND,Health,Level of availability of harm reduction services and harm reduction scale up,No,n/a,0
Y,India,IND,Health,Presence of needle and syringe programs,No,n/a,0
Y,India,IND,Health,Prevalence of substance use disorders,Yes,"Prevalence of people who are addicted to drugs by type of drug (cannabis, opiates) {National Drug Demand Reduction Policy, 2013, p.4} ~",1
Y,India,IND,Health,Prevalence of psychiatric comorbidities,No,n/a,0
Y,India,IND,Health,Drug-related mortality,No,n/a,0
Y,India,IND,Health,Prevalence of drug-related infectious disease,No,n/a,0
Y,India,IND,Health,Proportion of people who use drugs who engage in risky consumption,No,n/a,0
Y,India,IND,Health,Proportion of people who use drugs who engage in safe consumption practices,No,n/a,0
Y,India,IND,Health,"Coverage of services for the prevention, testing, and treatment of bloodborne diseases",No,n/a,0
Y,India,IND,Health,Presence of specialised training for addiction care,No,n/a,0
Y,India,IND,Health,Presence of health harms related to drug use,No,n/a,0
Y,India,IND,Health,Presence of other health metrics,No,n/a,0
Y,India,IND,Peace and Security,"Prevalence of alcohol and drugs in accidents, and interventions to increase road safety",No,n/a,0
Y,India,IND,Peace and Security,Annual number of public disorder and violent crime reports,No,n/a,0
Y,India,IND,Peace and Security,Number of non-lethal drug market violent events reported,No,n/a,0
Y,India,IND,Peace and Security,Number of drug market related homicides and disappearances,No,n/a,0
Y,India,IND,Peace and Security,Presence of other peace and security metrics,No,n/a,0
Y,India,IND,Development,Coverage of housing assistance for people who use drugs,No,n/a,0
Y,India,IND,Development,Coverage of social assistance for people who use drugs (not including housing),No,n/a,0
Y,India,IND,Development,Number of households enrolled in alternative development,No,n/a,0
Y,India,IND,Development,Presence of other development metrics,No,n/a,0
Y,India,IND,Human Rights,"Prevalence and incidence of infectious diseases in vulnerable populations (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,India,IND,Human Rights,"Prevalence of vulnerable people who use drugs (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,India,IND,Human Rights,Proportion of people who use drugs in prison that are receiving medication assisted treatment (MAT),No,n/a,0
Y,India,IND,Human Rights,Distribution of sterile injecting equipment in prisons,No,n/a,0
Y,India,IND,Human Rights,Presence of programs and services targeted towards women ,No,n/a,0
Y,India,IND,Human Rights,Presence of programs and services targeted towards people of color,No,n/a,0
Y,India,IND,Human Rights,Presence of challenges and/or harms experienced by people of color,No,n/a,0
Y,India,IND,Human Rights,"Presence of programs and services targeted towards vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,India,IND,Human Rights,"Presence of challenges and/or harms experienced by vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,India,IND,Human Rights,Presence of other human rights metrics,No,n/a,0
Y,India,IND,Demand Reduction,Prevalence of drug use by age,No,n/a,0
Y,India,IND,Demand Reduction,Prevalence of drug use by sex,No,n/a,0
Y,India,IND,Demand Reduction,Prevalence of drug use by type,Yes,"The prevalence of drug use within the preceding month by type of drug (cannabis, opiates, any illicit drug) {National Drug Demand Reduction Policy, 2013, p.3} ~",1
Y,India,IND,Demand Reduction,Number of people who use drugs,Yes,"The number of projected drug users in India by type of drug (cannabis, opiates) {National Drug Demand Reduction Policy, 2013, p.4} ~",1
Y,India,IND,Demand Reduction,"Prevalence of drug use by mode of administration (oral, mucosa, inhalation, and injection)",Yes,"The prevalence of injecting drug users within the preceding month {National Drug Demand Reduction Policy, 2013, p.3} ~ ",1
Y,India,IND,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT)",Yes,"The number of drug-de-addiction centres that the Ministry of Health and Family Welfare runs in various government hospitals across the country {National Policy on Narcotic Drugs and Psychotropic Substances, 2012, p.22} ~ The number of Non-Governmental Organisations, Deaddiction-cum-Rehabilitation Centres, De-addiction Camps, and Counselling and Awareness Centres that the Ministry of Social Justice and Empowerement implements {National Policy on Narcotic Drugs and Psychotropic Substances, 2012, p.22} ~",2
Y,India,IND,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT) by age",No,n/a,0
Y,India,IND,Demand Reduction,Level of access to opioid substitution treatment and medication assisted treatment (OST/MAT),No,n/a,0
Y,India,IND,Demand Reduction,Level of coverage of inpatient treatment,No,n/a,0
Y,India,IND,Demand Reduction,Proportion of people who use drugs enrolled in voluntary treatment,No,n/a,0
Y,India,IND,Demand Reduction,Proportion of people who use drugs enrolled in coerced treatment,No,n/a,0
Y,India,IND,Demand Reduction,Proportion of people who use drugs enrolled in compulsory treatment,No,n/a,0
Y,India,IND,Demand Reduction,Presence of prevention programming in law enforcement,Yes,"Number of trainings conducted by NCB {Annual Report, 2017, p.47} ~ The number of personnel Trained by NCB {Annual Report, 2017, p.47} ~ The number of Computer Based Training (CBT) centres set up by the NCB in coordination with the UNODC {Annual Report, 2017, p.47} ~ Number of CBT trainings conducted by NCB {Annual Report, 2017, p.48; Narcocontrol: A journal of the narcotics bureau, 2015, p.19} ~ Number of personnel trained in CBT training {Annual Report, 2017, p.48; Narcocontrol: A journal of the narcotics bureau, 2015, p.19} ~ Number of Zone-wise Trainings conducted by NCB {Annual Report, 2017, p.48; Narcocontrol: A journal of the narcotics bureau, 2015, p.18} ~ Number of personnel trained in training by zone {Annual Report, 2017, p.48; Narcocontrol: A journal of the narcotics bureau, 2015, p.18} ~ CBT Locations - Narcotics Control Bureau. {Annual Report, 2017, p.49} ~ Total amount disbursed to the states since inception of the scheme in 2004. {Annual Report, 2017, p.50} ~ The number of courses for training that the NCB organized {Narcocontrol: A journal of the narcotics bureau, 2015, p.17} ~ The total number of personnel working in various Central/State agencies trained {Narcocontrol: A journal of the narcotics bureau, 2015, p.17} ~ NCB Drug museum visits (Date, Number of participants, Organisation Participated) {Narcocontrol: A journal of the narcotics bureau, 2015, p.19} ~",12
Y,India,IND,Demand Reduction,Presence of prevention programming in the media,No,n/a,0
Y,India,IND,Demand Reduction,Presence of prevention programming in schools,Yes,"The number of awareness and educational programmes in various schools/colleges across the country. {Annual Report, 2017, p.53} ~",1
Y,India,IND,Demand Reduction,Presence of prevention programming in the workplace,No,n/a,0
Y,India,IND,Demand Reduction,Presence of prevention programming for youth and the community,Yes,"The number of awareness and educational programmes as part of drug demand reduction activities {Annual Report, 2017, p.53} ~ Awareness programs by zone (Number of awareness programs and number of people who participated) {Narcocontrol: A journal of the narcotics bureau, 2015, p.20} ~",2
Y,India,IND,Demand Reduction,Presence of other demand reduction metrics,No,n/a,0
Y,India,IND,Supply Reduction,Size and value of the illegal drug market,Yes,"Diversion of drugs by type (opium; precursor chemicals and other controlled substances; ephedrine/pseudoephedrine; pharmaceutical preparations and prescription drugs containing psychotropic substances; non-scheduled drugs) {Annual Report, 2017, p.11} ~ Monitoring of drug trafficking routes by type of drug (opium, heroin, cannabis, hashish, cocaine, psychotropic substances, synthetic drugs, ketamine, pseudo-ephedrine) {Annual Report, 2017, p.11, p.13, p.16, p.19, p.22, p.25, p.29, p.31, p.36} ~ Number of drug cases by type (opium, heroin, cannabis, hashish, cocaine, ketamine, ephedrine/pseudoephedrine, Acetic Anhydride) in India {Annual Report, 2017, p.12, p.15, p.18, p.21, p.24, p.33, p.37, p.38} ~ Number of facilities for the illicit manufacturing of drugs detected {Annual Report, 2017, p.80} ~ Number of illicit internet pharmacies/facilities detected {Annual Report, 2017, p.81} ~ Value of property forfeited (Rs.) and number of cases {Annual Report, 2017, p.82} ~ Value of property frozen (Rs.) and number of cases {Annual Report, 2017, p.82} ~",7
Y,India,IND,Supply Reduction,Level of procedures related to crop eradication,Yes,"Number in hectares of areas licensed for the licit cultivation of opium poppy {Annual Report, 2017, p.26} ~ Number in hectares of areas harvested for the licit cultivation of opium poppy {Annual Report, 2017, p.26} ~ Year-wise destruction of Illicit Poppy Cultivation in India in the last five years. (figure in acres) {Annual Report, 2017, p.27} ~ Year-wise destruction of Illicit Cannabis in India in last five years. (acres) {Annual Report, 2017, p.28} ~ Destruction of poppy plant area (in acres) {Annual Report, 2017, p.80} ~ Destruction of cannabis plant area (in acres) {Annual Report, 2017, p.80} ~ Destruction Of Illicit Poppy Cultivation by state (in acres) {Annual Report, 2017, p.27; Narcocontrol: A journal of the narcotics bureau, 2015, p.11} ~ Destruction of Illicit Cannabis Cultivation by state (in acres) {Narcocontrol: A journal of the narcotics bureau, 2015, p.11} ~",8
Y,India,IND,Supply Reduction,"Number of arrests, seizures, and offences",Yes,"The number of drug seizures in kgs by type (opium, morphine, heroin, ganja, Hashish, Cocaine, Methaqualone, Ephedrine, Acetic Anhydride, Amphetamine-type stimulants, Ketamine) {Annual Report, 2017, p.80} ~ The number of drug seizure cases by type (opium, morphine, heroin, ganja, Hashish, Cocaine, Methaqualone, Ephedrine, Acetic Anhydride, Amphetamine-type stimulants, Ketamine) {Annual Report, 2017, p.80} ~ State-Wise drug seizures for the year {Annual Report, 2017, p.14, p.17, p.20, p.23, p.25, p.30, p.31, p.33, p.37, p.84} ~ Number of seizures by agency (All India, Narcotics Control Bureau, Directorate of Revenue Intelligence, Custom and Central Excise, Central Bureau of Narcotics, Police, Excise, Others) {Annual Report, 2017, p.82} ~ Quantity of drugs seized by agency (All India, Narcotics Control Bureau, Directorate of Revenue Intelligence, Custom and Central Excise, Central Bureau of Narcotics, Police, Excise, Others) by type of drug (opium, morphine, heroin, ganja, hashish, cocaine, methaqualone, ephedrine, acetic anhydride, ATS) {Annual Report, 2017, p.14, p.17, p.20, p.23, p.25, p.38, p.82} ~ The number of significant seizures by the NCB Zone-Wise (Date, Zone, Drug, Quantity) {Narcocontrol: A journal of the narcotics bureau, 2015, p.3-p.7} ~ Number of drugs seized (kgs) and people arrested from clandestine laboratories and factories {Annual Report, 2017, p.34} ~ Number of drugs seized and people arrested through the illicit internet {Annual Report, 2017, p.40} ~ The number of person arrested including foreigners {Annual Report, 2017, p.80} ~ Number of foreigners arrested {Annual Report, 2017, p.80; Narcocontrol: A journal of the narcotics bureau, 2015, p.8} ~ Number of people arrested for the illicit manufacturing of drugs {Annual Report, 2017, p.80} ~ Number of persons from illicit internet pharmacies/facilities arrested {Annual Report, 2017, p.81} ~ Airport-wise total number of cases (IGI Delhi; Bangalore (Karnataka); Madurai (Karnataka); Chennai (TamilNadu); Trichy (TamilNadu); Mumbai (Maharashtra); Kolkata (West Bengal); Ernakulam (Kerala); Goa (UT); Andman & Nicobar (Island); Dehradun (Uttranchal); Ahmedabad (Gujarat); Mangalore (Karnataka); Total Cases) {Annual Report, 2017, p.86} ~ Airport-wise seizure for the year by seizure date, airport, agency, number and nationality of arrested persons, name of drug, quantity (kgs), sourced from, destined to. {Annual Report, 2017, p.86} ~ The number of foreigners arrested for the year (nationality, total persons arrested, persons arrested by NCB) {Annual Report, 2017, p.88} ~ Persons arrested by Each Zone of Narcotics Control Bureau (Indians, Foreigners) {Narcocontrol: A journal of the narcotics bureau, 2015, p.8} ~ Significant Seizures by other Organisations (Assam Rifles, Border Security Force, Central Bureau of Narcotics, Customs, Customs Preventive, Customs Air Intelligence Unit, Directorate of Revenue Intelligence, Sashatra Seema Bal, State Police) {Narcocontrol: A journal of the narcotics bureau, 2015, p.8-p.10} ~ Arrest in India Agency wise (Indians, Foreigners) {Narcocontrol: A journal of the narcotics bureau, 2015, p.11} ~",18
Y,India,IND,Supply Reduction,Level of law enforcement activity and interdiction in the market,Yes,"the number of cases that law enforcement agencies have booked where drugs were purchased through dark net. {Annual Report, 2017, p.41} ~ That number of controlled delivery operations that were conducted by law enforcement agencies {Annual Report, 2017, p.41} ~ Disposal of seized narcotic drugs and psychotropic substances by type of drug (opium, morphine, heroin, ganja, hashish, cocaine, methaqualone, ephedrine, acetic anhydride, amphetamine {Annual Report, 2017, p.42, p.82} ~ No’s of detention orders (PITNDPS Act, 1988) {Annual Report, 2017, p.80} ~ Destruction of illicit manufacturing facilities by type of drug (heroin, morphine, opium, acetic anhydride, other substances, methaqualone, anthranilic acid, N-acetyl anthranilic acid, amphetamine, methamphetamine, ephedrine/pseudoephedrine, ketamine, toluene, acetone, di-ethyl ether) {Annual Report, 2017, p.80} ~ The number of illicit internet pharmacies/facilities dismantled (psychotropic tablets (nos), tablets (kgs) {Annual Report, 2017, p.81} ~ Year-wise DD Kit distributed by NCB during the last five years. (figure in no.s) (Narcotic Drug Detection Kits; Precursors Detection Kits; Ketamine Detection Kits) {Annual Report, 2017, p.52} ~ Zone-wise DD kit distributed by NCB during the year 2017. (figure in no.s) (Narcotic Drug Detection Kits; Precursors Detection Kits; Ketamine Detection Kits) {Annual Report, 2017, p.52} ~ The number of standard size Narcotics Drug Detection Kits, Precursors Chemical Detection kits, and Ketamine Detection Kits procured {Narcocontrol: A journal of the narcotics bureau, 2015, p.19} ~ ",9
Y,India,IND,Supply Reduction,"Price, purity and potency of drugs, and related process indicators",No,n/a,0
Y,India,IND,Supply Reduction,Number of people engaged with the criminal justice system,Yes,"Number of persons prosecuted {Annual Report, 2017, p.80} ~ Number of persons convicted {Annual Report, 2017, p.80} ~ Number of persons acquited {Annual Report, 2017, p.80} ~ Number of persons detained {Annual Report, 2017, p.80} ~ ",4
Y,India,IND,Supply Reduction,Presence of other supply reduction metrics,Yes,"NCB OFFICE MAP LOCATIONS {Annual Report, 2017, p.71} ~ The sanctioned strength of the NCB {Annual Report, 2017, p.71} ~ The number of residential flats purchased for the construction of NCB offices in India {Annual Report, 2017, p.72} ~ The number of officers/officials that were taken on deputation {Narcocontrol: A journal of the narcotics bureau, 2015, p.22} ~ The number of conferences/training programs held in India by state {Narcocontrol: A journal of the narcotics bureau, 2015, p.13-p.15} ~ Lead Intelligence Agency (LIA) Meetings attended by NCB Zones {Narcocontrol: A journal of the narcotics bureau, 2015, p.16} ~ Regional Economic Intelligence Council (REIC) Meetings attended by NCB Zones {Narcocontrol: A journal of the narcotics bureau, 2015, p.16} ~ State level Multi Agency Centre (SMAC) Meetings attended by NCB Zones {Narcocontrol: A journal of the narcotics bureau, 2015, p.16} ~",8
Y,India,IND,International Cooperation,Level of engagement in international cooperation,Yes,"The number of monthly and quarterly meetings of NCORD held at NCB Hqrs., New Delhi. {Annual Report, 2017, p.59} ~ NCB participates in different multilateral platforms for international coordination. The name of each multilateral meeting attended {Annual Report, 2017, p.61-p.63} ~ The countries that the Govt. of India has signed Bilateral Agreement for mutual cooperation in reducing demand, and preventing illicit trafficking in narcotic drugs, psychotropic substances and precursor chemicals {Annual Report, 2017, p.63} ~ The number of bilateral meetings where the focus was on drug matters and delegation was led by NCB {Annual Report, 2017, p.63} ~ The number of bilateral meetings, where drug was one of the agenda items and delegation was led by non-NCB agency. {Annual Report, 2017, p.64} ~ Meetings that were attended by the NCB for regular intelligence sharing through field level and border level meetings with many neighbouring countries on regular basis. {Annual Report, 2017, p.64} ~ Visits by delegations {Annual Report, 2017, p.64} ~ The number of countries that India has signed with for Mutual Legal Assistance Treaties {Annual Report, 2017, p.66} ~ The number of countries that India has signed with for extradition treaties {Annual Report, 2017, p.66} ~ The number of countries that India has extradition arrangements on the basis of reciprocity with {Annual Report, 2017, p.66} ~ The number of reports that the NCB submits to Vienna {Annual Report, 2017, p.67} ~ The number of Tanzanian Drug Law Enforcement Officers at National academy of Customs, Indirect Taxes and Narcotics (NACIN) that were trained by the NCB {Annual Report, 2017, p.67} ~ The number of International Conferences/ Training Programs {Narcocontrol: A journal of the narcotics bureau, 2015, p.12} ~",13
Y,Iran,IRN,Health,Level of availability of harm reduction services and harm reduction scale up,No,n/a,0
Y,Iran,IRN,Health,Presence of needle and syringe programs,No,n/a,0
Y,Iran,IRN,Health,Prevalence of substance use disorders,Yes,"percent reduction in the rate of addiction by relevant bodies in the course of the enforcement of the law {The Comprehensive National Plan, 2017-2021, p.13, p.20} ~ ",1
Y,Iran,IRN,Health,Prevalence of psychiatric comorbidities,No,n/a,0
Y,Iran,IRN,Health,Drug-related mortality,Yes,"percent reduction in addicts’ mortality rate till the end of the plan and preventing the spread of high-risk behaviors as well as lethal and infectious diseases amongst high-risk addicts {The Comprehensive National Plan, 2017-2021, p.21} ~ Ratio of drug-related deaths to all cases of unnatural deaths {Islamic Republic of Iran's Drug Control Activities, 2018, p.8} ~ percent of cases of unnatural deaths that were referred to the legal medicine organization throughout the country were due to the consumption of narcotic drugs and psychotropic substances. {Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.18} ~ Number of individuals who have lost their lives due to drug abuse during nine months in 2017 {Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.18} ~ Rate of drug-related mortality based on gender (female, male, 3rd Qtr, 4th Qtr) in 2017 (cases referred to the Legal Medicine Organization) {Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.19} ~",5
Y,Iran,IRN,Health,Prevalence of drug-related infectious disease,Yes,"Ratio of IDUs contaminated with HIV/AIDS to the total number of persons contaminated with HIV/AIDS {Islamic Republic of Iran's Drug Control Activities, 2018, p.8} ~ Prevalence of IDUs who have HIV (Registered cases in the first 6 months of 2017) {Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.17} ~ Number and percentage of HIV positive persons based on gender (female, male, total) {Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.17} ~ Trend indicating HIV transmission (IDU) 2001-2017 {Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.18} ~",4
Y,Iran,IRN,Health,Proportion of people who use drugs who engage in risky consumption,No,n/a,0
Y,Iran,IRN,Health,Proportion of people who use drugs who engage in safe consumption practices,No,n/a,0
Y,Iran,IRN,Health,"Coverage of services for the prevention, testing, and treatment of bloodborne diseases",No,n/a,0
Y,Iran,IRN,Health,Presence of specialised training for addiction care,No,n/a,0
Y,Iran,IRN,Health,Presence of health harms related to drug use,No,n/a,0
Y,Iran,IRN,Health,Presence of other health metrics,No,n/a,0
Y,Iran,IRN,Peace and Security,"Prevalence of alcohol and drugs in accidents, and interventions to increase road safety",No,n/a,0
Y,Iran,IRN,Peace and Security,Annual number of public disorder and violent crime reports,No,n/a,0
Y,Iran,IRN,Peace and Security,Number of non-lethal drug market violent events reported,Yes,"Number of armed clashes with drug traffickers {Islamic Republic of Iran's Drug Control Activities, 2018, p.3} ~ Number of disabled persons (1979-2018) dedicated to the relentless campaign against the scourge of illicit drugs {Islamic Republic of Iran 40 years on the front line of the combat against the world drug problem, 1979-2018, p.4} ~",2
Y,Iran,IRN,Peace and Security,Number of drug market related homicides and disappearances,Yes,"Number of drug control martyrs {Islamic Republic of Iran's Drug Control Activities, 2018, p.3; Islamic Republic of Iran 40 years on the front line of the combat against the world drug problem, 1979-2018, p.4} ~ ",1
Y,Iran,IRN,Peace and Security,Presence of other peace and security metrics,No,n/a,0
Y,Iran,IRN,Development,Coverage of housing assistance for people who use drugs,Yes,"Number of night shelters providing services throughout the country till the end of 1396 (Iranian calendar/ March 2018) {Islamic Republic of Iran 40 years on the front line of the combat against the world drug problem, 1979-2018,  p.14} ~ ",1
Y,Iran,IRN,Development,Coverage of social assistance for people who use drugs (not including housing),Yes,"Number of recovered addicts covered by vocational training program {Islamic Republic of Iran's Drug Control Activities, 2018, p.10; Islamic Republic of Iran 40 years on the front line of the combat against the world drug problem, 1979-2018, p.17} ~ Allocating funds for supporting social entrepreneurs and job creation for recovered addicts (in millions of Rials) {Islamic Republic of Iran's Drug Control Activities, 2018, p.10} ~ Number of sustainable employment capacities for recovered addicts in collaboration with social entrepreneurs {Islamic Republic of Iran's Drug Control Activities, 2018, p.10} ~ Number of Job creation projects offered by NGOs {Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.23} ~ Number of approved projects {Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.23} ~ Number of Created job capacities for people {Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.23} ~ Number of Persons who have given up addiction and have jobs {Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.23} ~ Number of sessions held by the committee for employment and empowerment {Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.23} ~ Number of technical meetings on employment {Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.23} ~ Number of technical and vocational trainings {The Comprehensive National Plan, 2017-2021, p.21; Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.23} ~ Number of workshops set up for job creation {The Comprehensive National Plan, 2017-2021, p.21; Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.23} ~ ",11
Y,Iran,IRN,Development,Number of households enrolled in alternative development,No,n/a,0
Y,Iran,IRN,Development,Presence of other development metrics,No,n/a,0
Y,Iran,IRN,Human Rights,"Prevalence and incidence of infectious diseases in vulnerable populations (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Iran,IRN,Human Rights,"Prevalence of vulnerable people who use drugs (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Iran,IRN,Human Rights,Proportion of people who use drugs in prison that are receiving medication assisted treatment (MAT),No,n/a,0
Y,Iran,IRN,Human Rights,Distribution of sterile injecting equipment in prisons,No,n/a,0
Y,Iran,IRN,Human Rights,Presence of programs and services targeted towards women ,No,n/a,0
Y,Iran,IRN,Human Rights,Presence of programs and services targeted towards people of color,No,n/a,0
Y,Iran,IRN,Human Rights,Presence of challenges and/or harms experienced by people of color,No,n/a,0
Y,Iran,IRN,Human Rights,"Presence of programs and services targeted towards vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Iran,IRN,Human Rights,"Presence of challenges and/or harms experienced by vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Iran,IRN,Human Rights,Presence of other human rights metrics,No,n/a,0
Y,Iran,IRN,Demand Reduction,Prevalence of drug use by age,Yes,"Prevalence of the use of narcotic drugs and psychotropic substances in the general population (15-64 years old) {The Comprehensive National Plan, 2017-2021, p.20; Islamic Republic of Iran's Drug Control Activities, 2018, p.8} ~",1
Y,Iran,IRN,Demand Reduction,Prevalence of drug use by sex,No,n/a,0
Y,Iran,IRN,Demand Reduction,Prevalence of drug use by type,No,n/a,0
Y,Iran,IRN,Demand Reduction,Number of people who use drugs,No,n/a,0
Y,Iran,IRN,Demand Reduction,"Prevalence of drug use by mode of administration (oral, mucosa, inhalation, and injection)",No,n/a,0
Y,Iran,IRN,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT)",Yes,"percent increase for treatment services and harms reduction till the end of the plan (5 percent every year) {The Comprehensive National Plan, 2017-2021, p.20} ~ percent increase in the average rate of addicts’ retention in the process of treatment through the qualitative enhancement of treatment methods, harms reduction and expanding diverse social supports in accordance with global and scientific standards till the end of the plan {The Comprehensive National Plan, 2017-2021, p.20} ~ Increasing the number of treatment clinics and qualitative enhancement of treatment and harms reduction methods {The Comprehensive National Plan, 2017-2021, p.22} ~ Number of treatment and harms reduction clinics {Islamic Republic of Iran's Drug Control Activities, 2018, p.8; Islamic Republic of Iran 40 years on the front line of the combat against the world drug problem, 1979-2018, p.12; Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.14} ~ Number of treatment, rehab and harm reduction clinics, based on governmental or non-governmental sections {Islamic Republic of Iran's Drug Control Activities, 2018, p.11} ~ The number of Outpatient centers for drug abuse treatment (2009-2017) {Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.14} ~ Number of Drop-in centers and outreach teams (2013-2017) {Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.15} ~ Number of TC centers, residential centers for medium-term stay, DICs, outreach teams, and mobile centers providing services throughout the country till the end of 1396 (Iranian calendar/ March 2018) {Islamic Republic of Iran 40 years on the front line of the combat against the world drug problem, 1979-2018, p.14} ~ Number of individuals admitted by treatment and harms reduction clinics {Islamic Republic of Iran's Drug Control Activities, 2018, p.8; Islamic Republic of Iran 40 years on the front line of the combat against the world drug problem, 1979-2018, p.13} ~ Ratio of drug abusers under treatment and harms reduction to the total number of drug abusers {Islamic Republic of Iran's Drug Control Activities, 2018, p.8} ~ Persons undergoing treatment at clinics [MMT; BMT; Outpatient detox; Inpatient detox; DIC Centres; Mobile teams; Shelters; Therapeutic Communities; Medium term residential units; total] (Number of admitted persons, number of centres, number of teams) {Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.16} ~ Number of individuals who received treatment and harms reduction services in 2017 in accordance with para 2 of article 16 of the Anti-Narcotics Act {Islamic Republic of Iran 40 years on the front line of the combat against the world drug problem, 1979-2018, p.16} ~",12
Y,Iran,IRN,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT) by age",No,n/a,0
Y,Iran,IRN,Demand Reduction,Level of access to opioid substitution treatment and medication assisted treatment (OST/MAT),No,n/a,0
Y,Iran,IRN,Demand Reduction,Level of coverage of inpatient treatment,Yes,"Persons undergoing treatment at clinics [MMT; BMT; Outpatient detox; Inpatient detox; DIC Centres; Mobile teams; Shelters; Therapeutic Communities; Medium term residential units; total] (Number of admitted persons, number of centres, number of teams) {Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.16} ~ Number of TC centers, residential centers for medium-term stay, DICs, outreach teams, and mobile centers providing services throughout the country till the end of 1396 (Iranian calendar/ March 2018) {Islamic Republic of Iran 40 years on the front line of the combat against the world drug problem, 1979-2018, p.14} ~",2
Y,Iran,IRN,Demand Reduction,Proportion of people who use drugs enrolled in voluntary treatment,No,n/a,0
Y,Iran,IRN,Demand Reduction,Proportion of people who use drugs enrolled in coerced treatment,No,n/a,0
Y,Iran,IRN,Demand Reduction,Proportion of people who use drugs enrolled in compulsory treatment,No,n/a,0
Y,Iran,IRN,Demand Reduction,Presence of prevention programming in law enforcement,Yes,"Number of person-case organized training activities for the staff active in the field of drug control {Islamic Republic of Iran's Drug Control Activities, 2018, p.13} ~ Number offering training on primary prevention at military centers {Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.10} ~",2
Y,Iran,IRN,Demand Reduction,Presence of prevention programming in the media,Yes,"Number of National hotline for addiction counseling {Islamic Republic of Iran's Drug Control Activities, 2018, p.5; Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.10} ~ Number of cyber networks and mobile apps with the aim of promoting a community-based approach towards drug control developed {Islamic Republic of Iran's Drug Control Activities, 2018, p.12; Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.23} ~ Number of activities by the press {Islamic Republic of Iran's Drug Control Activities, 2018, p.13} ~ Number of sessions providing news coverage {Islamic Republic of Iran's Drug Control Activities, 2018, p.13} ~ Number of cases generating contents in cyberspace {Islamic Republic of Iran's Drug Control Activities, 2018, p.13} ~ percent growth of media programs aimed at raising public awareness {Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.9} ~ Number Organizing training courses by making use of cyberspace {Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.11} ~ Number of holding media campaigns on the topic of a community-based approach {Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.23} ~ Number of websites, weblogs, etc. with a focus on a community based approach created {Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.23} ~ Providing counselling on prevention and treatment via the national addiction hotline and the number of calls responded too {Islamic Republic of Iran 40 years on the front line of the combat against the world drug problem, 1979-2018, p.11} ~  Number of radio and TV programs broadcasted via provincial and national channels aimed at raising awareness and enhancing the technical knowledge in the field drug control {Islamic Republic of Iran's Drug Control Activities, 2018, p.5; Islamic Republic of Iran 40 years on the front line of the combat against the world drug problem, 1979-2018, p.11} ~",11
Y,Iran,IRN,Demand Reduction,Presence of prevention programming in schools,Yes,"Number of individuals covered by cultural and preventive activities at educational centers comprising students at schools and universities {Islamic Republic of Iran's Drug Control Activities, 2018, p.5} ~ percent growth in the number of students covered by health advocacy programs as well as life skills and empowerment. {Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.9} ~ Number of preventive community-based programs at elementary and high schools {Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.10; Islamic Republic of Iran 40 years on the front line of the combat against the world drug problem, 1979-2018, p.9} ~ Number Offering training on self-care skills at elementary schools {Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.10; Islamic Republic of Iran 40 years on the front line of the combat against the world drug problem, 1979-2018, p.9} ~ Number Offering training on necessary skills to counter drugs at high schools {Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.10; Islamic Republic of Iran 40 years on the front line of the combat against the world drug problem, 1979-2018, p.9} ~ Number of Programs for risk-free high schools {Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.10; Islamic Republic of Iran 40 years on the front line of the combat against the world drug problem, 1979-2018, p.9} ~ Number of Preventive programs for kindergartens {Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.10} ~ Number of Programs on addiction prevention at dormitories and educational centers {Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.10; Islamic Republic of Iran 40 years on the front line of the combat against the world drug problem, 1979-2018, p.9} ~ Number Organizing training workshops on prevention for incoming students {Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.10} ~ Number Organizing training workshops for managers, teachers, instructors and school counselors {Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.10} ~ Number Organizing training workshops for professors, instructors and university counselors {Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.10} ~ Number of student circles established providing assistance in the field of mental health with a focus on preventing addiction at academic centers {Islamic Republic of Iran 40 years on the front line of the combat against the world drug problem, 1979-2018, p.10} ~",12
Y,Iran,IRN,Demand Reduction,Presence of prevention programming in the workplace,Yes,"Number of individuals covered by cultural and preventive activities at work places {Islamic Republic of Iran's Drug Control Activities, 2018, p.5} ~ percent growth of prevention programs in communities and work places {Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.9} ~ Number offering training on drug abuse prevention for laborers as well as individuals working at industrial centers {Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.10} ~ Number of Civil servants participating in 6-hour trainings on primary prevention {Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.10; Islamic Republic of Iran 40 years on the front line of the combat against the world drug problem, 1979-2018, p.11} ~ Number Organizing training workshops for clerics and eulogists {Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.11} ~ Number of Signing MoUs with other organizations {Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.23} ~ Number of employees and labourers at administrative and work places who received prevention coverage {Islamic Republic of Iran 40 years on the front line of the combat against the world drug problem, 1979-2018, p.11} ~",7
Y,Iran,IRN,Demand Reduction,Presence of prevention programming for youth and the community,Yes,"Number of individuals covered by cultural and preventive activities within their families {Islamic Republic of Iran's Drug Control Activities, 2018, p.5} ~ Number of family members including healthy and risk-prone families who received training on life skills, raising children and preventing drug abuse in families {Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.10; Islamic Republic of Iran 40 years on the front line of the combat against the world drug problem, 1979-2018, p.9} ~ Number Offering training on life skills for families of prisoners, solders in prisoners {Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.10} ~ Number of individuals covered by cultural and preventive activities at rural and urban communities {Islamic Republic of Iran's Drug Control Activities, 2018, p.5} ~ Number Offering community-based training on addiction prevention in rural and urban communities {Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.10} ~ Number of organized festivals, seminars and technical exhibitions {Islamic Republic of Iran's Drug Control Activities, 2018, p.10; Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.23; Islamic Republic of Iran 40 years on the front line of the combat against the world drug problem, 1979-2018, p.17} ~ Number of training workshops at national, regional and provincial level {Islamic Republic of Iran's Drug Control Activities, 2018, p.10} ~ Number of ambassadors publicizing a community-based approach towards drug control {Islamic Republic of Iran's Drug Control Activities, 2018, p.10; Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.23} ~ number of benefactors, activists and ambassadors of a community-based approach for fighting drugs covering areas such as prevention, treatment, harms reduction, job-creation, entrepreneurship and social protection {Islamic Republic of Iran 40 years on the front line of the combat against the world drug problem, 1979-2018, p.17} ~Number of organized technical meetings with governmental and non-governmental institutes as well as NGOs for developing public participation {Islamic Republic of Iran's Drug Control Activities, 2018, p.10} ~ Number of NGOs by type (cultural, treatment, protection) ranked as a level 1, 2, or 3 {Islamic Republic of Iran's Drug Control Activities, 2018, p.11; Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.21} ~ Number of training workshops provided by NGOs {Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.22} ~ Number of trained persons at workshops per hour {Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.22} ~ Number of think tank sessions {Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.22} ~ Number of NGOs active in the field of drug demand reduction {Islamic Republic of Iran 40 years on the front line of the combat against the world drug problem, 1979-2018, p.16} ~ Number of projects run by NGOs in the fields of prevention, treatment, harms reduction and social protection who received financial support {Islamic Republic of Iran 40 years on the front line of the combat against the world drug problem, 1979-2018, p.17} ~ Number of athletic contests (marathon, cycling, sports in communities) as well as family hikes with the motto of a healthy society free from addiction {Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.10} ~ Number of rural gyms in underprivileged rural areas of the country provided with equipment aimed at encouraging sports activities creating social exuberance and joyfulness and at the same time reducing social harms associated with drugs in rural areas {Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.11; Islamic Republic of Iran 40 years on the front line of the combat against the world drug problem, 1979-2018, p.10} ~ Number of education packages produced for content productioon aimed at raising awareness in the field of prevention for all target group {Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.11, p.22} ~ Number of educated specialized staff through organizing training workshops on primary prevention {Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.11} ~ Number of interactive sessions with benefactors and social activists {Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.23} ~ Number of issuing statements concerning the community-based approach {Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.23} ~",22
Y,Iran,IRN,Demand Reduction,Presence of other demand reduction metrics,Yes,"percent increase in the rate of participation by NGOs within the national network for empowerment of NGOs as social assets in the field of drug control {The Comprehensive National Plan, 2017-2021, p.21} ~ percent reduction in drug demand and supply till the end of the plan {The Comprehensive National Plan, 2017-2021, p.21} ~ percent increase in managerial capabilities and responding to the needs through amending the approaches, promoting information technology, structural, statistical, financial, manpower, logistical and supervisory systems related to the process of drug control till the end of the plan {The Comprehensive National Plan, 2017-2021, p.21} ~ Number of organized technical meetings, seminars as well as research-oriented and scientific conferences in the field of science of addiction at provincial, national and international levels {Islamic Republic of Iran's Drug Control Activities, 2018, p.12} ~ Number of publishing research-based and scientific journals in Farsi and English {Islamic Republic of Iran's Drug Control Activities, 2018, p.13} ~ Number of technical committees covering all aspects of drug control and the number of participating executive bodies at provincial and national levels. {Islamic Republic of Iran's Drug Control Activities, 2018, p.14} ~ The total number of general policies, general objectives, strategies, quantitative objectives and executive policies aimed at supply reduction, demand reduction, and managerial/sectorial policies {Islamic Republic of Iran's Drug Control Activities, 2018, p.15} ~ Number of research projects undertaken and their titles {Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.38} ~",8
Y,Iran,IRN,Supply Reduction,Size and value of the illegal drug market,Yes,"value in Rials of confiscated movable and immovable properties {Islamic Republic of Iran 40 years on the front line of the combat against the world drug problem, 1979-2018, p.3} ~ value in Rials of intercepted properties belonging to smugglers involved in drug-related crimes {Islamic Republic of Iran 40 years on the front line of the combat against the world drug problem, 1979-2018, p.3} ~ ",2
Y,Iran,IRN,Supply Reduction,Level of procedures related to crop eradication,No,n/a,0
Y,Iran,IRN,Supply Reduction,"Number of arrests, seizures, and offences",Yes,"The total number in tons of different types of narcotic drugs and psychotropic substances seized {Islamic Republic of Iran's Drug Control Activities, 2018, p.2; Islamic Republic of Iran 40 years on the front line of the combat against the world drug problem, 1979-2018, p.5} ~ % of drug seizures by type of drug (Heroin, Morphine, Opium, Hashish, Methamphetamine, Others) {Islamic Republic of Iran's Drug Control Activities, 2018, p.3} ~ Number of Drug Seizures and Measures against drug trafficking in kgs (Heroin, Morphine, Opium, Hashish, Methamphetamine, Other drugs, total, precursor chemicals) {Islamic Republic of Iran's Drug Control Activities, 2018, p.3; Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.27} ~ Number of seized vehicles against drug trafficking {Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.27, p.29} ~ Number of seized weapons against drug trafficking {Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.29} ~Number in tons of seized chemical precursors {Islamic Republic of Iran 40 years on the front line of the combat against the world drug problem, 1979-2018, p.5} ~ ratio of drug seizures to armed clashes {Islamic Republic of Iran 40 years on the front line of the combat against the world drug problem, 1979-2018, p.7} ~ Number of arrested drug traffickers and distributors {Islamic Republic of Iran's Drug Control Activities, 2018, p.3} ~ Number of confiscated properties (immovable properties; movable properties (vehicles, others)) {Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.30} ~ Number of forfeited properties (immovable properties; movable properties (vehicles; others)) {Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.30} ~ ",10
Y,Iran,IRN,Supply Reduction,Level of law enforcement activity and interdiction in the market,Yes,"number of operations that were conducted against drug traffickers and international rings involved in the drug supply, drug transit and smuggling in the region {Islamic Republic of Iran's Drug Control Activities, 2018, p.2} ~ Number of operations and clashes against drug trafficking {Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.29} ~ Number of operations conducted against drug traffickers and number of networks involved in the transit of narcotic drugs, psychotropic substances and precursors dismantled (1989-2017) {Islamic Republic of Iran 40 years on the front line of the combat against the world drug problem, 1979-2018, p.5} ~ The number of rings, groups and active local, regional and international networks dismantled {Islamic Republic of Iran's Drug Control Activities, 2018, p.2} ~ Number of dismantled rings and networks involved in the transit and supply of narcotic drugs, psychotropic substances and precursors {Islamic Republic of Iran's Drug Control Activities, 2018, p.3; Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.29} ~ Number of dismantled kitchen labs against drug trafficking {Concise report on the activities of the Islamic Republic of Iran in combating the world drug problem, 2017, p.29; Islamic Republic of Iran 40 years on the front line of the combat against the world drug problem, 1979-2018, p.5} ~ Number of intercepted light and heavy weapons {Islamic Republic of Iran's Drug Control Activities, 2018, p.3} ~ Number of vehicles and light and semi-heavy weapons intercepted {Islamic Republic of Iran 40 years on the front line of the combat against the world drug problem, 1979-2018, p.3} ~ Number in kilometers of embankments, barbed wire, canals and other physical and electronic barriers placed along the eastern and western to prevent the entry of narcotic drugs from Afghanistan {Islamic Republic of Iran 40 years on the front line of the combat against the world drug problem, 1979-2018, p.3} ~ ",9
Y,Iran,IRN,Supply Reduction,"Price, purity and potency of drugs, and related process indicators",No,n/a,0
Y,Iran,IRN,Supply Reduction,Number of people engaged with the criminal justice system,Yes,"Handling the cases of drug-related offenders and classifying drug-related inmates {The Comprehensive National Plan, 2017-2021, p.20} ~ Average number of drug-related inmates {Islamic Republic of Iran's Drug Control Activities, 2018, p.3} ~ number of drug-related offenders incarcerated, and % of the said individuals that were sent to prison based on court ruling; {Islamic Republic of Iran 40 years on the front line of the combat against the world drug problem, 1979-2018, p.4} ~ Prevalence of inmates in prison that constitute drug-related inmates {Islamic Republic of Iran 40 years on the front line of the combat against the world drug problem, 1979-2018, p.6} ~ Number of drug-related inmates that were put in prisons during the period of 1979-2017 {Islamic Republic of Iran 40 years on the front line of the combat against the world drug problem, 1979-2018, p.6} ~",5
Y,Iran,IRN,Supply Reduction,Presence of other supply reduction metrics,Yes,"percent reduction in drug demand and supply till the end of the plan {The Comprehensive National Plan, 2017-2021, p.21} ~ The total number of general policies, general objectives, strategies, quantitative objectives and executive policies aimed at supply reduction, demand reduction, and managerial/sectorial policies {Islamic Republic of Iran's Drug Control Activities, 2018, p.15} ~ Number of NGOs active in the field of drug control {Islamic Republic of Iran's Drug Control Activities, 2018, p.10} ~ Number of cases conducting research activities in order to adopt a scientific approach toward drug control {Islamic Republic of Iran's Drug Control Activities, 2018, p.13} ~",4
Y,Iran,IRN,International Cooperation,Level of engagement in international cooperation,No,n/a,0
Y,Kazakhstan,KAZ,Health,Level of availability of harm reduction services and harm reduction scale up,Yes,"Number of organisations by type of treatment centre (low-threshold services (trust centers) - direct coverage) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.45} ~ Number of beds available by treatment center (low-threshold services (trust centers) - direct coverage) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.45} ~ Number of patients by type of treatment center (low-threshold services (trust centers) - direct coverage) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.45} ~ Number of injecting drug users who applied individually to the trust centres (harm reduction) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.72, p.74} ~ Number of IDUs who received preventive services at least once {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.72, p.74} ~ Number of IDUs who received preventive programmes by region {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.74, p.75} ~ % of IDUs who received services in field conditions (outreach workers and mobile trust centres) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.73, p.75} ~ ~ Number of trust centre functioning in the republic (% of which were under the auspices of the AIDS Centres; within non-governmental organisations; in treatment and preventive organisations; within mobile trust centres; trust centres located in other organisations {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.73} ~ Number of trust centres operating by region {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.73} ~",9
Y,Kazakhstan,KAZ,Health,Presence of needle and syringe programs,Yes,"Number of needles/syringes distributed among IDUs (per IDU involved in preventive programmes) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.9, p.73} ~ Number of syringes distributed in the trust centres {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.75} ~ Provision of IDUs with syringes (RC AIDS) by region {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.76} ~",3
Y,Kazakhstan,KAZ,Health,Prevalence of substance use disorders,Yes,"reduction of the level of drug addiction of the population, the number of people per 100 thousand population {Sectoral program on combating drug addiction and drug trafficking in the Republic of Kazakhstan, 2012-2016, np; Implementation of sectoral program of fight against drug abuse and drug trafficking in the Republic of Kazakhstan, 2012-2016, p.139} ~ number of people who are dependent on drugs by age (up to 14 years inclusive; 15-17 years old; 18-30 years old) {Sectoral program on combating drug addiction and drug trafficking in the Republic of Kazakhstan, 2012-2016, np} ~ the number of people living in narcological records with harmful consumption and drug addiction (The number of people per 100,000 population) {Sectoral program on combating drug addiction and drug trafficking in the Republic of Kazakhstan, 2012-2016, np; Implementation of sectoral program of fight against drug abuse and drug trafficking in the Republic of Kazakhstan, 2012-2016, p.1} ~ Number of addicts (population aged 7-55 years old) by type of drug (opiate addicts, cannabinoid addicts, addicted to other drugs) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.19} ~ Number of persons registered with the narcological service, categorised by diagnosis indicated in the International Statistical Classification of Diseases and Related Health Problems (ICD-10) (F11-Opioid related disorders; F12-Cannabis related disorders; F13-Sedative, hypnotic, or anxiolytic related disorders; F14-Cocaine related disorders; F15-Other stimulant related disorders; F16-Hallucinogen related disorders; F18-Inhalant related disorders; F19-Other psychoactive substance related disorders) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.22} ~",5
Y,Kazakhstan,KAZ,Health,Prevalence of psychiatric comorbidities,No,n/a,0
Y,Kazakhstan,KAZ,Health,Drug-related mortality,Yes,"number of registered drug users who died {Program of fight against drug addiction and drug business in the Republic of Kazakhstan, 2009-2011, np; National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.9} ~ annual mortality rate of drug consumers {Program of fight against drug addiction and drug business in the Republic of Kazakhstan, 2009-2011, np} ~ number of drug-related deaths by region (Almaty, Pavlodar, East Kazakhstan, Zhambyl, Kostanay, North Kazakhstan) {Sectoral program on combating drug addiction and drug trafficking in the Republic of Kazakhstan, 2012-2016, np} ~ Total deaths caused by intoxication with psychoactive substances per 1000 members of the total population {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.67, p.70} ~ Total deaths caused by intoxication with psychoactive substances in women per 1000 members of the total population {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.67} ~ Total deaths caused by intoxication with psychoactive substances in children (under 14 years of age; 15-17 years of age) per 1000 members of the total population {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.67} ~ Number of deaths caused by drug consumption, determined by the Forensic Medicine Centre of the Republic of Kazakhstan and its regional offices (Number of autopsies; Number of positive results of chemical and toxicological) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.67} ~ Number of deaths caused by drug consumption, determined by the Forensic Medicine Centre of the Republic of Kazakhstan and its regional offices (Violent deaths, total; Mechanical trauma; Mechanical Asphyxia; Extreme Temperatures; Electrical Injury; Intoxications, including by psychoactive substances; Non-violent deaths, total) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.68} ~ The percentage of mortality of by sex (female, male) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.68} ~ Reason of death - poisoning with narcotic and psychotropic substances by type (number of deaths) (Heroin; Opium alkaloids; Tramadol; Tetrahydrocannabinol; Derivates of 1,4-benzodiazipine; derivates of pehnothiazine; amphetamine; phenobarbital; lozapine-25; diphenylhydramine; phinlepsine (carbamazepine); ephedrine; tropicamide; permitted analgesics (codeine-containing); unestablished substance) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.69} ~ Relative risk of mortality among the population of substance users to the expected number of deaths among the general population by sex (male, female) and by age (under 14; 15-17; 18-34; 35-60; > 60) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.70} ~ ",11
Y,Kazakhstan,KAZ,Health,Prevalence of drug-related infectious disease,Yes,"the number of HIV-infected contaminants, AIDS, hepatitis, and tuberculosis-related drug addicts {Program of fight against drug addiction and drug business in the Republic of Kazakhstan, 2009-2011, np; Sectoral program on combating drug addiction and drug trafficking in the Republic of Kazakhstan, 2012-2016, np; National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.9, p.59, p.61-p.63} ~ Syphilis prevalence among IDUs {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.9, p.63} ~ Prevalence of infectious disease by type (HIV, HCV, HBV) among those who had not used a shared needle/syringe relative to those who had used a shared needle/syringe {p.54, p.55} ~ Percentage of identified cases of HIV infection transmitted through heterosexual transmission or intravenous injection categorised by region {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.57} ~ Number of detected cases of HIV infection with the parenteral route of transmission categorised by regions {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.60} ~ Prevalence of infectious diseases by type (HIV, HCV, syphilis) (%) among IDUs categorized by regions {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.61, p.63, p.64, p.78} ~ The average republican indicator of HIV prevalence for male injecting drug users and for female IDUs {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.62} ~ Prevalence of syphilis by age (under 25 years; 25 years and older) and by sex (male, female) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.64} ~",8
Y,Kazakhstan,KAZ,Health,Proportion of people who use drugs who engage in risky consumption,Yes,"% of IDUs indicated that they had used a shared needles/syringes for injecting (not within the last 30 days; within the last 30 days) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.54} ~ ",1
Y,Kazakhstan,KAZ,Health,Proportion of people who use drugs who engage in safe consumption practices,Yes,"% of IDUs indicated that they had never used a shared needle/syringe for injecting {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.54, p.62} ~ ",1
Y,Kazakhstan,KAZ,Health,"Coverage of services for the prevention, testing, and treatment of bloodborne diseases",Yes,"Number of injecting drug users registered in the narcological dispensaries who were examined for HIV infection {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.58} ~ Percentage of all IDUs covered by the HIV prevention programmes (i.e., those who received syringes and/or condoms and know where they can be tested for HIV during a year) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.74} ~ Coverage of IDUs who received psychosocial consulting with testing for HIV infection {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.77} ~ Number of HIV-positive persons who were detected among IDUs involved in preventive programmes {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.78} ~ The volume of injecting drug users testing in the health care organisations (%) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.78} ~ Number of examinations for HIV-infections {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.78} ~ ",6
Y,Kazakhstan,KAZ,Health,Presence of specialised training for addiction care,Yes,"Number of specialists in the narcological sphere who have the relevant certificates (narcologists; children narcologists; psychotherapists; medical psychologists; psychologists; social workers) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.42} ~",1
Y,Kazakhstan,KAZ,Health,Presence of health harms related to drug use,Yes,"Comorbidities according to ICD-19 among patients treated (%) (Toxic damag of liver - K71; Toxic encephalopathy - G92; Alcoholic disease of liver - K70; Cardiomyopathy-I42; Common and puromucous chronic bronchitis - J41; Chronic tubulointerstticial nephritis - N11; Acute respiratory infection of upper respiratory tract-J06; Other diseases of pancreatic gland - K86) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.64} ~ Total intoxications per 1000 of all population {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.66} ~ Total intoxications in women per 1000 of all population {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.66} ~ Total intoxications in children  (under the age of 14; 15-17 years) per 1000 of all population {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.66} ~ ",4
Y,Kazakhstan,KAZ,Health,Presence of other health metrics,Yes,"Prevalence of injecting drug users who accepted behavior reducing the risk of HIV infection transmission via the sexual route, i.e., those who use condoms {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.62} ~ Proportion of IDUs who used condoms during their last episode of intercourse by age group (under 25 years; older 25 years) and by sex (male, female) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.62} ~",2
Y,Kazakhstan,KAZ,Peace and Security,"Prevalence of alcohol and drugs in accidents, and interventions to increase road safety",Yes,"Number of persons held administratively liable for driving vehicles in a state of drug intoxication, as well as for allowing a person in a state of drug intoxication to drive a vehicle {Sectoral program on combating drug addiction and drug trafficking in the Republic of Kazakhstan, 2012-2016, np; National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.81} ~",1
Y,Kazakhstan,KAZ,Peace and Security,Annual number of public disorder and violent crime reports,Yes,"prevalence of people committing crimes against private property {Program of fight against drug addiction and drug business in the Republic of Kazakhstan, 2009-2011, np; National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.81} ~ Number of crimes committed against the person {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.81} ~ Number of crimes committed against the health of the population and morality {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.81} ~",3
Y,Kazakhstan,KAZ,Peace and Security,Number of non-lethal drug market violent events reported,Yes,"number of drug related-crimes organized by criminal groups {Sectoral program on combating drug addiction and drug trafficking in the Republic of Kazakhstan, 2012-2016, np} ~ ",1
Y,Kazakhstan,KAZ,Peace and Security,Number of drug market related homicides and disappearances,No,n/a,0
Y,Kazakhstan,KAZ,Peace and Security,Presence of other peace and security metrics,No,n/a,0
Y,Kazakhstan,KAZ,Development,Coverage of housing assistance for people who use drugs,No,n/a,0
Y,Kazakhstan,KAZ,Development,Coverage of social assistance for people who use drugs (not including housing),Yes,"Number of children aged under 18 years old from lower income families that are covered by a financial allowance {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.29} ~ Proportion of the total amount of allowances that were allocated to children residing in rural areas {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.29} ~ The amount deducted from the general education fund for the provision of assistance to socially unprotected pupils {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.32} ~",3
Y,Kazakhstan,KAZ,Development,Number of households enrolled in alternative development,No,n/a,0
Y,Kazakhstan,KAZ,Development,Presence of other development metrics,Yes,"Living conditions of clients who were treated (all clients; treated for the first time) (with family, with relatives, with partner, alone, homeless, not known) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.50} ~ Occupations of clients who were treated (all clients, treated for the first time) (irregular occupation, regular employment, student, unemployed, disabled, other, not known) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.50} ~ Education level of clients who were treated (Never educated, Elementary education, Secondary education, Higher education, not known) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.50} ~",3
Y,Kazakhstan,KAZ,Human Rights,"Prevalence and incidence of infectious diseases in vulnerable populations (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"Prevalence of infectious disease by type (Hepatitis C, HIV) among inmates who inject drugs {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.36, p.60} ~ ",1
Y,Kazakhstan,KAZ,Human Rights,"Prevalence of vulnerable people who use drugs (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"Proportion of inmates injecting drugs who used a shared syringe for injecting drugs {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.37} ~ Number of people per 10,000 members of the prison population who are registered as drug addicts {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.25, p.83; Implementation of sectoral program of fight against drug abuse and drug trafficking in the Republic of Kazakhstan, 2012-2016, p.81} ~ The percentage of women among persons with a drug addiction in institutions of confinement {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.25} ~ Prevalence of drug addicts registered in institutions of confinement by age (18-24 years; 25-29 years; 30-39 years; 40-49 years; 50 years and older) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.25} ~ The rate of IDUs among all drug-addicted inmates observed in the penitentiary system {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.25, p.36} ~",5
Y,Kazakhstan,KAZ,Human Rights,Proportion of people who use drugs in prison that are receiving medication assisted treatment (MAT),No,n/a,0
Y,Kazakhstan,KAZ,Human Rights,Distribution of sterile injecting equipment in prisons,Yes,"Proportion of inmates injecting drugs who used a disinfectant solution for processing their syringes {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.37} ~ Number of disinfectant tablets (18 per 1 person) and condoms (10 per 1 person) distributed in the penitentiary system {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.85} ~",2
Y,Kazakhstan,KAZ,Human Rights,Presence of programs and services targeted towards women ,No,n/a,0
Y,Kazakhstan,KAZ,Human Rights,Presence of programs and services targeted towards people of color,No,n/a,0
Y,Kazakhstan,KAZ,Human Rights,Presence of challenges and/or harms experienced by people of color,No,n/a,0
Y,Kazakhstan,KAZ,Human Rights,"Presence of programs and services targeted towards vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",Yes,"Number of organisations by type of treatment centre (Detoxification units in prison; Rehabilitation units for addicted inmates in prisons; Outpatient treatments in prisons) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.45} ~ Number of beds available by treatment center (Detoxification units in prison; Rehabilitation units for addicted inmates in prisons; Outpatient treatments in prisons) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.45} ~ Number of patients by type of treatment center (Detoxification Units; Outpatient Units (Detoxification units in prison; Rehabilitation units for addicted inmates in prisons; Outpatient treatments in prisons) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.45} ~",3
Y,Kazakhstan,KAZ,Human Rights,"Presence of challenges and/or harms experienced by vulnerable groups (incarcerated individuals, people of color, people who experience homelessness, LGBTQ+ community, sex workers)",No,n/a,0
Y,Kazakhstan,KAZ,Human Rights,Presence of other human rights metrics,No,n/a,0
Y,Kazakhstan,KAZ,Demand Reduction,Prevalence of drug use by age,Yes,"Number of minors who abuse drugs, psychotropic substances and precursors {Program of fight against drug addiction and drug business in the Republic of Kazakhstan, 2009-2011, np; Sectoral program on combating drug addiction and drug trafficking in the Republic of Kazakhstan, 2012-2016, np; Implementation of sectoral program of fight against drug abuse and drug trafficking in the Republic of Kazakhstan, 2012-2016, p.1, p.139} ~ number of people who consume drugs by age (up to 14 years inclusive; 15-17 years old; 18-30 years old) {Program of fight against drug addiction and drug business in the Republic of Kazakhstan, 2009-2011, np; Sectoral program on combating drug addiction and drug trafficking in the Republic of Kazakhstan, 2012-2016, np} ~ Number of people who have used drugs at least once (school children aged 14-15 years old) by type (marijuana) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.23, p.24} ~ Average age on the occasion of first usage of drugs among school children aged 14-15 years old {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.23} ~ The number of people consuming drugs systematically (40 times or more during their lives) among school children aged 14-15 years old {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.23} ~ Number of people who have consumed marijuana during the last 12 months among school children aged 14-15 years old {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.23} ~ The number of heroin injecting consumers among school aged children 14-15 years old {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.23} ~ Prevalence of pupils aged 14-15 years old who are current consumers of drugs {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.24} ~ Lifetime prevalence of heroin use among pupils aged 14-15 years old {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.24} ~ Ratio (%) of narcotic substances consumed among registered users under 18 years old (opiates, cannabinoids, sedatives, stimulants, hallucinogens, volatile organic compounds, polydrug use, injecting drug use) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.24} ~ Age (years) on the occasion of first consumption of primary drug (%) (Not known; <10; 11-15; 16-20; 21-25; 26-30; 31-35; 36-40; 41-45; 46>) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.53} ~ ",11
Y,Kazakhstan,KAZ,Demand Reduction,Prevalence of drug use by sex,Yes,"Number of women who abuse drugs, psychotropic substances and precursors {Program of fight against drug addiction and drug business in the Republic of Kazakhstan, 2009-2011, np; Sectoral program on combating drug addiction and drug trafficking in the Republic of Kazakhstan, 2012-2016, np; Implementation of sectoral program of fight against drug abuse and drug trafficking in the Republic of Kazakhstan, 2012-2016, p.1, p.139} ~ ",1
Y,Kazakhstan,KAZ,Demand Reduction,Prevalence of drug use by type,Yes,"The number of people who use drugs by type (heroin; opium; cannabinoids (marijuana and more)) {Program of fight against drug addiction and drug business in the Republic of Kazakhstan, 2009-2011, np; Sectoral program on combating drug addiction and drug trafficking in the Republic of Kazakhstan, 2012-2016, np} ~ Number of people who have used drugs at least once (school children aged 14-15 years old) by type (marijuana) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.23, p.24} ~ Number of people who have consumed marijuana during the last 12 months among school children aged 14-15 years old {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.23} ~ The number of heroin injecting consumers among school aged children 14-15 years old {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.23} ~ Lifetime prevalence of heroin use among pupils aged 14-15 years old {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.24} ~ Ratio (%) of narcotic substances consumed among registered users under 18 years old (opiates, cannabinoids, sedatives, stimulants, hallucinogens, volatile organic compounds, polydrug use, injecting drug use) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.24} ~ The number of khanka consumers as a percentage of injecting drug users {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.38} ~ Primary (All patients; patients treated for the first time) and Secondary (all patients; patients treated for the first time) substances among patients treated (Opiates (Heroin, Opium, Methadone/Buprenorphine, Other); Cocaine; Stimulants (Amphetamine, Methamphetamine, Other stimulants); Sedative and hypnotic substances (Barbiturates; Benzodiazepine; Other sedative substances); Hallucinogens (LSD; Ketaminel Other hallucinogens); Inhalants; Cannabis; Other substances; Total) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.53} ~",8
Y,Kazakhstan,KAZ,Demand Reduction,Number of people who use drugs,Yes,"Number of people (per 100 thousand population) who abuse drugs, psychotropic substances and precursors {Program of fight against drug addiction and drug business in the Republic of Kazakhstan, 2009-2011, np; Sectoral program on combating drug addiction and drug trafficking in the Republic of Kazakhstan, 2012-2016, np} ~ the number of people who consumed narcotic drugs, psychotropic substances and precursors in the past 12 months {Sectoral program on combating drug addiction and drug trafficking in the Republic of Kazakhstan, 2012-2016, np} ~ Frequency of consumption of the primary drug among patients treated (%) (Not known; Not regularly, on occasions, less than once per month; once per week or less; 2-6 days per week) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.54} ~",3
Y,Kazakhstan,KAZ,Demand Reduction,"Prevalence of drug use by mode of administration (oral, mucosa, inhalation, and injection)",Yes,"Number of outreach workers who were involved in work with injecting drugs and the proportion of them who are injecting drug users themselves {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.75} ~ Estimated number of injecting drug users (IDU) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.9, p.35} ~ Number of injecting drug users by region (Pavlodar Oblast; Western Kazakhstan Oblast; Western Kazakhstan Oblast; Northern Kazakhstan Oblast; Aktyubinsk Oblast) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.35} ~ Mode of administering drugs - usual pattern of consumption of primary drug among patients treated (Not known; inhalation, orally, smoking, injecting) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.54} ~ ",4
Y,Kazakhstan,KAZ,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT)",Yes,"% Coverage of narcotic addicts with primary drug treatment programs {Program of fight against drug addiction and drug business in the Republic of Kazakhstan, 2009-2011, np} ~ % of the transition from the original drug treatment to outpatient and inpatient care and rehabilitation {Program of fight against drug addiction and drug business in the Republic of Kazakhstan, 2009-2011, np} ~ prevalence of patients who have been exposed to opioids and underwent a complete course of treatment and rehabilitation, with a duration of one year or more {Program of fight against drug addiction and drug business in the Republic of Kazakhstan, 2009-2011, np} ~ The proportion of drug addicts who are in dispensary records of remission for 2 or more years with drug addicts in dispensary records (%) {Sectoral program on combating drug addiction and drug trafficking in the Republic of Kazakhstan, 2012-2016, np; Implementation of sectoral program of fight against drug abuse and drug trafficking in the Republic of Kazakhstan, 2012-2016, p.3} ~ Number of persons registered on dispensary narcological registration (and those registered for the first time) {Sectoral program on combating drug addiction and drug trafficking in the Republic of Kazakhstan, 2012-2016, np; National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.9, p.21; Implementation of sectoral program of fight against drug abuse and drug trafficking in the Republic of Kazakhstan, 2012-2016, p.1, p.139} ~Number of women registered with narcological services {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.21} ~ Number of persons registered and removed from narcological registration (registered; registered for the first time; removed from registration; removed because of long-term remission; removed because of death) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.22} ~ The coverage of IDUs in the Republic of Kazakhstan registered with the narcological organisations by testing (%) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.78} ~ Number of IDUs officially registered with the narcological service by region (Akmola Oblast; Aktyube Oblast; Almaty Oblast; Atyrau Oblast; Eastern Kazakhstan Oblast; Zhambyl Oblast; Western Kazakhstan Oblast; Karaganda Oblast; Kostanai Oblast; Kyzylorda Oblast; Magistau Oblast; Pavlodar Oblast; Northern Kazakhstan Oblast; Southern Kazakhstan Oblast; City of Almaty; City of Astana; Total Republic of Kazakhstan) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.36} ~ State expenditure for the provision of specialised narcological assistance (thousand KZT) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.17} ~ Approximate expenses by state for treatment of drug addicts (thousand KZT) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.17} ~ % of patients released from the medical and social rehabilitation programme that were in a state of remission one year later {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.41} ~ % of patients diagnosed with a substance use disorder that achieved remission after 1 year, and 2 or more years {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.41} ~ Number of organisations by type of treatment centre (Detoxification Units; Outpatient Units (dispensary units of narcological and psychiatric dispensaries; narcological rooms within primary healthcare organisations); Day patient clinics; Narcological units in psychiatric hospitals; Narcological units (beds) in the hospitals; Childrens' narcological units; medical and social rehabilitation; Post-treatment programs (outpatient; private narcological clinics; private narcological rooms) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.45} ~ Number of beds available by treatment center (Detoxification Units; Outpatient Units (dispensary units of narcological and psychiatric dispensaries; narcological rooms within primary healthcare organisations); Day patient clinics; specialised substitution treatment centres; Narcological units in psychiatric hospitals; Narcological units (beds) in the hospitals; Childrens' narcological units; medical and social rehabilitation; Post-treatment programs (outpatient); private narcological clinics; private narcological rooms) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.45} ~ Number of patients by type of treatment center (Detoxification Units; Outpatient Units (dispensary units of narcological and psychiatric dispensaries; narcological rooms within primary healthcare organisations); Day patient clinics; Narcological units in psychiatric hospitals; Narcological units (beds) in the hospitals; Childrens' narcological units; medical and social rehabilitation; Post-treatment programs (outpatient); private narcological rooms) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.45} ~ Number of outpatient treatment organisations providing narcological assistance and number of visits to such organisations for treatment (Number of dispensary units in narcological and psychiatric dispensaries; Number of narcologists in the narcological units; Number of narcological rooms in the primary healthcare organisations; Number of visits to narcologists in primary healthcare organisations; total number of visits to narcologists) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.46} ~ Characteristics of patients of the social rehabilitation clinic of NSPC MSPDA (Number of communities; Capacity; Number of patients released (Injecting drug users; heroin users; polydrug consumption; alcohol consumers); Average duration of treatment (days)) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.47} ~ Number of applications for treatment for drug addiction per 10,000 members of the population {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.47, p.55} ~ Demographic characteristics of all patients treated and patients treated for the first time (% of men, % of women) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.48, p.55} ~ Categorisation by ethnicity of all patients treated (Russians, Kazakhs, Tartars, Ukrainians, Uigurs, Koreans, Germans, Azeris, Uzbeks, Turks, Belorussians, Other, Not known, Total) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.49} ~ History of admissions among previously treated patients (x- # treatment cases, y-# clients) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.51} ~ % of IDUs covered by psychosocial consulting services {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.73} ~ % of IDUs who received consulting from medical specialists {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.73, p.78} ~ the number of IDUs treated in the treatment-preventive facilities {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.73, p.78}  ~ Coverage of IDUs by psychosocial consulting (RC AIDS) by region {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.77} ~ The main obstacle to application for professional assistance by drug addicts including those who are HIV-positive (%) (fear of the disclosure of the facts about their HIV-positive status to their relatives; fear of the disclosure of the facts about their drug consumption to their relatives; fear of registration with the narcological institutions) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.79} ~",27
Y,Kazakhstan,KAZ,Demand Reduction,"Coverage of treatment, without mention of medication-assisted treatment (MAT) by age",Yes,"% of coverage that children, adolescents, young people, psychoactive substances and psychotropic addicts receive through computer psychological testing programs {Program of fight against drug addiction and drug business in the Republic of Kazakhstan, 2009-2011, np} ~ Number of persons aged under 18 years old registered with the narcological service per 100,000 members of the corresponding population {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.24} ~ Number of youth health centres that are functioning in the country { National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.26} ~ Demographic characteristics of all patients treated and patients treated for the first time (Average age; aged < 25 years) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.48} ~",4
Y,Kazakhstan,KAZ,Demand Reduction,Level of access to opioid substitution treatment and medication assisted treatment (OST/MAT),Yes,"Number of patients participating in specialised substitution programs by treatment centre (Regional centre for drug addiction prevention and treatment (Pavlodar); Narcological dispensary of the city of Temirtau; Eastern Kazakhstan Regional Narcological Dispensary) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.43, p.45} ~ Number of organisations by type of treatment centre (specialised substitution treatment centres) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.45} ~ Number of beds available by treatment center (specialised substitution treatment centres) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.45} ~ ",3
Y,Kazakhstan,KAZ,Demand Reduction,Level of coverage of inpatient treatment,Yes,"% of the transition from the original drug treatment to outpatient and inpatient care and rehabilitation {Program of fight against drug addiction and drug business in the Republic of Kazakhstan, 2009-2011, np} ~ Number of persons who underwent inpatient treatment for drug addiction {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.9} ~  Number of people applying for inpatient treatment for the first time in their lives {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.39} ~ Duration of hospitalisation among patients who were treated (Detoxification <20 days; Rehabilitation 20-80 days; Social rehabilitation and integration 80> days) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.51} ~ ",4
Y,Kazakhstan,KAZ,Demand Reduction,Proportion of people who use drugs enrolled in voluntary treatment,Yes,"Source of direction for treatment (%) (independently) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.50} ~",1
Y,Kazakhstan,KAZ,Demand Reduction,Proportion of people who use drugs enrolled in coerced treatment,Yes,"Source of direction for treatment (%) (Not known, other, law-enforcement agency, family, narcolgical institution, narcologists) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.50} ~",1
Y,Kazakhstan,KAZ,Demand Reduction,Proportion of people who use drugs enrolled in compulsory treatment,Yes,"Number of organisations by type of treatment centre (Units for differentiated service of sentence (compulsory treatment in the public healthcare system by court decision)) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.45} ~ Number of beds available by treatment center (Units for differentiated service of sentence (compulsory treatment in the public healthcare system by court decision)) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.45} ~ Number of patients by type of treatment center (Units for differentiated service of sentence (compulsory treatment in the public healthcare system by court decision)) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.45} ~ Source of direction for treatment (%) (law-enforcement agency, narcolgical institution, narcologists) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.50} ~",4
Y,Kazakhstan,KAZ,Demand Reduction,Presence of prevention programming in law enforcement,No,n/a,0
Y,Kazakhstan,KAZ,Demand Reduction,Presence of prevention programming in the media,Yes,"Number of items published in anti-narcotic articles {Sectoral program on combating drug addiction and drug trafficking in the Republic of Kazakhstan, 2012-2016, np} ~ The number of video clips, radio commercials, feature films, documentary films, series of animated cartoon organised by the Ministry of Communications and Information {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.32} ~ Number of anti-drug publication that were published on the initiative of the Committee and Units for Countermeasures against the Drug Trade of the Department of Internal Affairs (number broadcasted on television; number published in the print media; number broadcasted on the radio; number published by information agencies) {Sectoral program on combating drug addiction and drug trafficking in the Republic of Kazakhstan, 2012-2016, np; National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.33} ~ Number of briefings and press conferences held for journalists to provide timely information to the general public on the measures taken for combating the drug business management of the Committee for Countermeasures Against the Drug Trade and the Department of Internal Affairs {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.32} ~ ",4
Y,Kazakhstan,KAZ,Demand Reduction,Presence of prevention programming in schools,Yes,"number of measures to ensure interdepartmental coordination: number of interaction with the health and education authorities, school inspectors, and universities {Sectoral program on combating drug addiction and drug trafficking in the Republic of Kazakhstan, 2012-2016, np} ~ Proportion of general education institutions implementing programs to prevent drug addiction and behavioral diseases from number of schools (%) {Sectoral program on combating drug addiction and drug trafficking in the Republic of Kazakhstan, 2012-2016, np; Implementation of sectoral program of fight against drug abuse and drug trafficking in the Republic of Kazakhstan, 2012-2016, p.3, p.139} ~ The number of psychologists, counsellors, and school police inspectors who worked in the comprehensive schools of the country {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.27} ~ The number of higher education institutions who have conducted round table discussions, educational training seminars, and public events, issued leaflets for distribution, and produced videos films on the harms and consequences of drug use {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.27} ~ Number of schools in seven regions of the country and the cities of Astana and Almaty that were equipped with the diagnostic system for the psychological testing of risks related to involvement in dependence on psychoactive substances among schoolchildren {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.27} ~ ",5
Y,Kazakhstan,KAZ,Demand Reduction,Presence of prevention programming in the workplace,No,n/a,0
Y,Kazakhstan,KAZ,Demand Reduction,Presence of prevention programming for youth and the community,Yes,"% risk of exposure of high risk groups (children, adolescents, teenagers) to psychoactive substances {Program of fight against drug addiction and drug business in the Republic of Kazakhstan, 2009-2011, np} ~number of preventive measures carried out {Sectoral program on combating drug addiction and drug trafficking in the Republic of Kazakhstan, 2012-2016, np} ~ number of seminars lectures and meetings, and round table discussions held for prevention {Sectoral program on combating drug addiction and drug trafficking in the Republic of Kazakhstan, 2012-2016, np} ~ number of sports competitions and tournaments {Sectoral program on combating drug addiction and drug trafficking in the Republic of Kazakhstan, 2012-2016, np} ~ Number of activities aimed at the primary prevention of drug addiction among young people and the total number of people covered {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.26; Sectoral program on combating drug addiction and drug trafficking in the Republic of Kazakhstan, 2012-2016, np} ~ The total number of sports clubs, gyms, sports centres, stadia and ice hockey rinks that are functioning in the country {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.26} ~ Prevalence of the population and students who visit these sports institutions every year {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.26} ~ Number of families covered by the FAST prevention programme {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.29} ~ The number of children covered by the Healthy Lifestyle Program through young tourist stations and tourist regional clubs to promote the physical development of children and formation of a healthy lifestyle {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.30} ~ The number of youth sports schools and the number of children covered {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.30} ~ The number of sports clubs that are functioning and the number of children and adolescents who do exercise {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.30} ~ The number of lectures and talks, seminars, round table discussions, and briefings aimed at the prevention of alcoholism, drug addiction, and smoking were conducted among adolescents {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.31} ~ The number of sports events and cultural events that were organized {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.31} ~ ",13
Y,Kazakhstan,KAZ,Demand Reduction,Presence of other demand reduction metrics,No,n/a,0
Y,Kazakhstan,KAZ,Supply Reduction,Size and value of the illegal drug market,Yes,"Number and proportion of crimes related to illicit trafficking in narcotic drugs and psychotropic substances {Program of fight against drug addiction and drug business in the Republic of Kazakhstan, 2009-2011, np; Sectoral program on combating drug addiction and drug trafficking in the Republic of Kazakhstan, 2012-2016, np} ~ Number of drug trafficking cases detected by agency (Ministry of Internal Affairs; KNB; Ministry of Finance) {Sectoral program on combating drug addiction and drug trafficking in the Republic of Kazakhstan, 2012-2016, np} ~ Number of administrative offenses related to illicit trafficking in narcotic drugs, psychotropic substances and precursors {Sectoral program on combating drug addiction and drug trafficking in the Republic of Kazakhstan, 2012-2016, np} ~ number of offenses related to illicit traffic in narcotic drugs, psychotropic substances and precursors, including those for non-realization purposes {Sectoral program on combating drug addiction and drug trafficking in the Republic of Kazakhstan, 2012-2016, np} ~ number of drug-smuggling cases {Program of fight against drug addiction and drug business in the Republic of Kazakhstan, 2009-2011, np; Sectoral program on combating drug addiction and drug trafficking in the Republic of Kazakhstan, 2012-2016, np} ~ The number of crimes related to drug smuggling by agency (Total, Ministry of Internal Affairs, KNB, Ministry of Finance) {Sectoral program on combating drug addiction and drug trafficking in the Republic of Kazakhstan, 2012-2016, np; National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.81; Implementation of sectoral program of fight against drug abuse and drug trafficking in the Republic of Kazakhstan, 2012-2016, p.2, p.141} ~ number of drug-related crimes {Program of fight against drug addiction and drug business in the Republic of Kazakhstan, 2009-2011, np; Sectoral program on combating drug addiction and drug trafficking in the Republic of Kazakhstan, 2012-2016, np; Implementation of sectoral program of fight against drug abuse and drug trafficking in the Republic of Kazakhstan, 2012-2016, p.2, p.141} ~the number of crimes committed in the past year {Sectoral program on combating drug addiction and drug trafficking in the Republic of Kazakhstan, 2012-2016, np} ~ the income of drug-related illicit trafficking in Kazakhstan {Sectoral program on combating drug addiction and drug trafficking in the Republic of Kazakhstan, 2012-2016, np} ~ number of crimes related to the sale of narcotic drugs, psychotropic substances and precursors. {Sectoral program on combating drug addiction and drug trafficking in the Republic of Kazakhstan, 2012-2016, np; Implementation of sectoral program of fight against drug abuse and drug trafficking in the Republic of Kazakhstan, 2012-2016, p.90} ~ number of cases that fall under the ""controlled delivery"" method {Sectoral program on combating drug addiction and drug trafficking in the Republic of Kazakhstan, 2012-2016, np} ~ The proportion of crimes under article 259 of the Criminal Code of the Republic of Kazakhstan {Sectoral program on combating drug addiction and drug trafficking in the Republic of Kazakhstan, 2012-2016, np} ~ total number of drug-related crimes registered in these periods were classified under Article 250 of the Criminal Code of the Republic of Kazakhstan, ""Smuggling substances withdrawn from circulation or confined objects"" , as well as Article 250 , ""Narcotic drugs or psychotropic substances the Item 260 of the Item 260 «Abuse or extortion», Article 261 «Attraction of narcotic drugs or psychotropic substances» , Article 262 «Illegal cultivation of the plants prohibited for the manufacture of narcotic substances» , Article 264 ""Organization and maintenance of brothels for the consumption of narcotic drugs, psychotropic substances or provision of premises for these purposes"" {Sectoral program on combating drug addiction and drug trafficking in the Republic of Kazakhstan, 2012-2016, np} ~ the number of crimes envisaged in Part 2 of the Criminal Code registered {Sectoral program on combating drug addiction and drug trafficking in the Republic of Kazakhstan, 2012-2016, np} ~ proportion of heroin transported by car, carriers, couriers and carriers. {Sectoral program on combating drug addiction and drug trafficking in the Republic of Kazakhstan, 2012-2016, np} ~ Weight (kg) of drugs imported by type (marijuana, opium, heroin, hashish/anasha): should be noted that there are cases involving non-medical consumption of a number of non-controlled medicines. {Sectoral program on combating drug addiction and drug trafficking in the Republic of Kazakhstan, 2012-2016, np} ~ The proportion of crimes committed by drug intoxicants from total number of crimes (%) {Sectoral program on combating drug addiction and drug trafficking in the Republic of Kazakhstan, 2012-2016, np} ~ The number of money laundering cases documented during the investigation of criminal cases on legalization of narcotic business income {Sectoral program on combating drug addiction and drug trafficking in the Republic of Kazakhstan, 2012-2016, np; Implementation of sectoral program of fight against drug abuse and drug trafficking in the Republic of Kazakhstan, 2012-2016, p.88, p.141} ~ Number of crimes due to the illicit purchase, transportation, or storing of narcotic substances by size (large or extra-large amount) without intent to sell {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.80} ~ Number of crimes due to the illicit purchase, transportation, or storing with intent to sell, production, processing, sending, or selling of narcotic substances in a large amount {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.80} ~ Number of crimes due to the illicit purchase, transportation, or storing with intent to sell, production, processing, sending, or selling of narcotic substances committed by an organised group {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.80} ~ Number of crimes due to the stealing or abstaining by blackmail of narcotic substances {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.81} ~ Number of crimes due to the consumption of narcotic substances {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.81} ~ Number of crimes due to the illicit turnover of toxic substances, as well as substances, tools, or equipment used for the production or processing of narcotic substances {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.81} ~ Number of crimes due to the organisation or maintenance of dens for the consumption of narcotic substances {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.81} ~ Number of crimes due to the violation of the rules for handling narcotic substances {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.81} ~ Number of crimes detected in the field of the legal circulation of drugs {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.82} ~ Number of criminal cases initiated within the framework of the ""Doping"" operation {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.82} ~ Main routes of drug trafficking and transportation routes in Kazakhstan {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.87} ~ % of drugs that are delivered using cars and railway transport {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.87} ~",30
Y,Kazakhstan,KAZ,Supply Reduction,Level of procedures related to crop eradication,Yes,"Number of crimes due to the illicit cultivation of plants containing narcotic substances {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.81} ~ Number of cases of the illicit planting of drugs by type (cannabis, opium poppy, olfeiferous poppy) that were registered (number of plants) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.89} ~ Number of wild cannabis cases (number of plants) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.89} ~ ",3
Y,Kazakhstan,KAZ,Supply Reduction,"Number of arrests, seizures, and offences",Yes,"Number in tons of marijuana and hashish seized from the Chu valley of Zhambyl region {Program of fight against drug addiction and drug business in the Republic of Kazakhstan, 2009-2011, np} ~ Weight of drugs seized by type in kilograms (Heroin; Opium; Opium poppy and poppy straw; Hashish; Cannabis resin; Marijuana (plant, roots, seeds, leaves, flower heads) {Program of fight against drug addiction and drug business in the Republic of Kazakhstan, 2009-2011, np; Sectoral program on combating drug addiction and drug trafficking in the Republic of Kazakhstan, 2012-2016, np ;National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.9, p.88; Implementation of sectoral program of fight against drug abuse and drug trafficking in the Republic of Kazakhstan, 2012-2016, p.88-89} ~ annual amount of drugs seized (including opiates) {Program of fight against drug addiction and drug business in the Republic of Kazakhstan, 2009-2011, np} ~ number of crimes and offenses detected in 12 months {Sectoral program on combating drug addiction and drug trafficking in the Republic of Kazakhstan, 2012-2016, np}~ the proportion of drug offenses {Sectoral program on combating drug addiction and drug trafficking in the Republic of Kazakhstan, 2012-2016, np} ~ total number of drug offenses recorded by agency (Ministry of Internal Affairs; KNB; Ministry of Finance) {Sectoral program on combating drug addiction and drug trafficking in the Republic of Kazakhstan, 2012-2016, np; Implementation of sectoral program of fight against drug abuse and drug trafficking in the Republic of Kazakhstan, 2012-2016, p.125} ~ the number of offenses related to administrative liability. {Sectoral program on combating drug addiction and drug trafficking in the Republic of Kazakhstan, 2012-2016, np} ~ Number of persons arrested for storing drugs (without intent to sell) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.9} ~ Number of persons arrested for drug dealing (including production) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.9} ~ Number of persons held liable for administrative offences related to the illicit handling of drugs (number of arrests, and number of fines imposed) {Sectoral program on combating drug addiction and drug trafficking in the Republic of Kazakhstan, 2012-2016, np; National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.81} ~",10
Y,Kazakhstan,KAZ,Supply Reduction,Level of law enforcement activity and interdiction in the market,Yes,"number of organized criminal groups blocked {Program of fight against drug addiction and drug business in the Republic of Kazakhstan, 2009-2011, np} ~ Number of administrative proceedings under Article 320 of the Administrative Violence Code of the Republic of Kazakhstan {Sectoral program on combating drug addiction and drug trafficking in the Republic of Kazakhstan, 2012-2016, np} ~ Number of sets of premises belonging to private enterprises that were checked (pharmacies, warehouses, treatment and preventive facilities, and industrial enterprises) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.82} ~ Number of special operations conducted by agency (Ministry of Internal Affairs; Committee of National Security; Customs Control Committee) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.89} ~ Number of policemen and district police inspectors were trained {Implementation of sectoral program of fight against drug abuse and drug trafficking in the Republic of Kazakhstan, 2012-2016, p.81} ~ ",5
Y,Kazakhstan,KAZ,Supply Reduction,"Price, purity and potency of drugs, and related process indicators",Yes,"Average street price of drugs by type (heroin/gram; opium/gram; marijuana/250 grams) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.9} ~ Retail prices (KZT) for drugs by type (Heroin (1g); Marijuana (250 grams); Hashish (20 grams); Opium (1 gram)) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.90} ~ Retail prices (in KZT) per gram of heroin by regions of the Republic of Kazakhstan {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.90} ~ Wholesale prices (per kilogram) for drugs by type (Heroin; Marijuana; Hashish; Opium) {p.91} ~ Potency of marijuana {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.91} ~ Purity of heroin, cocaine, amphetamine, MDMA, methamphetamine {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.91} ~",6
Y,Kazakhstan,KAZ,Supply Reduction,Number of people engaged with the criminal justice system,Yes,"number of people committing crimes due to the abuse of narcotic drugs and psychotropic substances {Program of fight against drug addiction and drug business in the Republic of Kazakhstan, 2009-2011, np} ~ the number of people detected by drug trafficking {Sectoral program on combating drug addiction and drug trafficking in the Republic of Kazakhstan, 2012-2016, np} ~ the number of women committing drug offenses {Sectoral program on combating drug addiction and drug trafficking in the Republic of Kazakhstan, 2012-2016, np; National Report on Drug Situation in the Republic of Kazakhstan, p.81; Implementation of sectoral program of fight against drug abuse and drug trafficking in the Republic of Kazakhstan, 2012-2016, p.3} ~ number of drug-related crimes committed by minors {Sectoral program on combating drug addiction and drug trafficking in the Republic of Kazakhstan, 2012-2016, np; National Report on Drug Situation in the Republic of Kazakhstan, p.81; Implementation of sectoral program of fight against drug abuse and drug trafficking in the Republic of Kazakhstan, 2012-2016, p.3} ~ Average age of men charged with committing drug offenses involving illicit drug trafficking. {Sectoral program on combating drug addiction and drug trafficking in the Republic of Kazakhstan, 2012-2016, np} ~ the number of people who refused to initiate criminal proceedings {Sectoral program on combating drug addiction and drug trafficking in the Republic of Kazakhstan, 2012-2016, np} ~ Number of people who violated Part 4 of Article 259 of the Criminal Code of the RoK by agency (Ministry of Internal Affairs; KNB; Ministry of Finance) {Sectoral program on combating drug addiction and drug trafficking in the Republic of Kazakhstan, 2012-2016, np} ~ Number of people who violated Article 37, Part 1, Art. 2 of the Criminal Procedure Code of the Republic of Kazakhstan. {Sectoral program on combating drug addiction and drug trafficking in the Republic of Kazakhstan, 2012-2016, np} ~ Number of persons held liable for failure to remove cannabis that was growing wild {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.82} ~ Number of people held liable for administrative offences related to the violation of the rules for handling narcotic substances, psychotropic substances, and precursors {Sectoral program on combating drug addiction and drug trafficking in the Republic of Kazakhstan, 2012-2016, np; Implementation of sectoral program of fight against drug abuse and drug trafficking in the Republic of Kazakhstan, 2012-2016, p.1, p.140National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.82} ~",10
Y,Kazakhstan,KAZ,Supply Reduction,Presence of other supply reduction metrics,Yes,"The number of registered applications, including the number of messages, including the fact that they were joined to the AEC earlier by one fact {Sectoral program on combating drug addiction and drug trafficking in the Republic of Kazakhstan, 2012-2016, np} ~ Number of penitentiary systems functioning (minimum security; high security; providing special treatment prison colonies; somatic hospitals; tuberculosis hospitals; juvenile corrective facilities; tightened regime; pre-trial detention centres) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.83} ~ ",2
Y,Kazakhstan,KAZ,International Cooperation,Level of engagement in international cooperation,Yes,"number of cases that were held in conjunction with the State Drug Control Service of the Kyrgyz Republic {Sectoral program on combating drug addiction and drug trafficking in the Republic of Kazakhstan, 2012-2016, np} ~ The agencies that implement harm reduction programmes in the Republic of Kazakhstan {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.95} ~ Number of non-governmental organisations and AIDS centres involved in the implementation of preventive activities conducted by the Global Fund to fight AIDS, TB, and Malaria in Kazakhstan {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.96} ~ Number of medical staff and outreach workers trained using funds from the GFATM grant {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.96} ~ Number of projects implemented by the UNODC in Kazakhstan (terrorism and crime prevention; fight against corruption and money laundering for the prevention of illicit drug trafficking; the prevention of drug use; the treatment of drug addiction; and the prevention and treatment of HIV infection among drug users in places of confinement) {National Report on Drug Situation in the Republic of Kazakhstan, 2012, p.97} ~",5